Audit Information |
12 Months Ended |
---|---|
Dec. 31, 2021 | |
Audit Information [Abstract] | |
Auditor Name | PricewaterhouseCoopers LLP |
Auditor Location | New York, New York |
Auditor Firm ID | 238 |
Consolidated Statements of Financial Position (Parenthetical) - USD ($) $ in Millions |
Dec. 31, 2021 |
Dec. 31, 2020 |
||
---|---|---|---|---|
Fixed Maturities, AFS, allowance for credit losses | $ 114 | $ 133 | ||
Fixed Maturities, Available-for-sale, Amortized Cost | 333,459 | 354,470 | ||
Fixed Maturities, HTM, allowance for credit losses | 5 | 9 | ||
Fixed Maturities, Held-to-maturity, Fair Value | 1,803 | 2,298 | ||
Fixed Maturities, Trading, amortized cost | 8,741 | 3,670 | ||
Equity securities, AFS, amortized cost | 5,815 | 5,968 | ||
Comm mtg and other loans, allowance for credit losses | 119 | 235 | ||
Commercial mortgage and other loans | [1] | 58,666 | 65,425 | |
Other invested assets, allowance for credit losses | [1] | 21,833 | 18,125 | |
Short term investments, allowance for credit losses | 6,635 | |||
Other liabilities, allowance for credit losses | [1] | 11,755 | 20,323 | |
Total Liabilities | $ 874,974 | $ 872,512 | ||
Preferred Stock, par value (in dollars per share) | $ 0.01 | $ 0.01 | ||
Preferred Stock, Shares Authorized | 10,000,000 | 10,000,000 | ||
Preferred Stock, Shares Issued | 0 | 0 | ||
Common Stock, par value (in dollars per share) | $ 0.01 | $ 0.01 | ||
Common Stock, Shares Authorized | 1,500,000,000 | 1,500,000,000 | ||
Common Stock, Shares, Issued | 666,305,189 | 666,305,189 | ||
Treasury Stock, Shares | 290,018,851 | 269,867,738 | ||
ASU 2016-13 | ||||
Short term investments, allowance for credit losses | $ 0 | $ 1 | ||
Other assets, allowance for credit losses | 19 | 11 | ||
Other liabilities, allowance for credit losses | 21 | 20 | ||
Leveraged lease loans | ||||
Other invested assets, allowance for credit losses | 2 | 2 | ||
Other invested assets, at fair value | 8,046 | 6,407 | ||
Fair value option | ||||
Commercial mortgage and other loans | $ 1,263 | $ 1,092 | ||
|
Consolidated Statements of Operations - USD ($) $ in Millions |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
REVENUES | |||
Premiums | $ 34,827 | $ 31,140 | $ 34,202 |
Policy charges and fee income | 5,944 | 6,029 | 5,978 |
Net investment income | 18,287 | 17,410 | 17,585 |
Asset management and service fees | 4,901 | 4,391 | 4,239 |
Other income (loss) | 2,951 | 1,950 | 3,262 |
Realized investment gains (losses), net | 4,024 | (3,887) | (459) |
Total revenues | 70,934 | 57,033 | 64,807 |
BENEFITS AND EXPENSES | |||
Policyholders’ benefits | 38,458 | 35,059 | 36,820 |
Interest credited to policyholders’ account balances | 3,482 | 4,538 | 4,880 |
Dividends to policyholders | 2,874 | 1,625 | 2,274 |
Amortization of deferred policy acquisition costs | 2,097 | 2,221 | 2,332 |
Goodwill impairment | 1,060 | 0 | 0 |
General and administrative expenses | 13,582 | 13,913 | 13,416 |
Total benefits and expenses | 61,553 | 57,356 | 59,722 |
Income (loss) before income taxes and equity in earnings of operating joint ventures | 9,381 | (323) | 5,085 |
Total income tax expense (benefit) | 1,674 | (81) | 947 |
INCOME (LOSS) BEFORE EQUITY IN EARNINGS OF OPERATING JOINT VENTURES | 7,707 | (242) | 4,138 |
Equity in earnings of operating joint ventures, net of taxes | 87 | 96 | 100 |
NET INCOME (LOSS) | 7,794 | (146) | 4,238 |
Less: Income (loss) attributable to noncontrolling interests | 70 | 228 | 52 |
NET INCOME (LOSS) ATTRIBUTABLE TO PRUDENTIAL FINANCIAL, INC. | $ 7,724 | $ (374) | $ 4,186 |
Basic earnings per share-Common Stock: | |||
Net income (loss) attributable to Prudential Financial, Inc. (in dollars per share) | $ 19.65 | $ (1.00) | $ 10.23 |
Diluted earnings per share-Common Stock: | |||
Net income (loss) attributable to Prudential Financial, Inc. (in dollars per share) | 19.51 | (1.00) | 10.11 |
Dividends declared per share of Common Stock (in dollars per share) | $ 4.60 | $ 4.40 | $ 4.00 |
Consolidated Statements of Comprehensive Income - USD ($) $ in Millions |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Statement of Comprehensive Income [Abstract] | |||
NET INCOME (LOSS) | $ 7,794 | $ (146) | $ 4,238 |
Other comprehensive income (loss), before tax: | |||
Foreign currency translation adjustments for the period | (1,138) | 523 | 67 |
Net unrealized investment gains (losses) | (11,712) | 7,229 | 17,195 |
Defined benefit pension and postretirement unrecognized periodic benefit (cost) | 1,107 | 210 | (322) |
Total | (11,743) | 7,962 | 16,940 |
Less: Income tax expense (benefit) related to other comprehensive income (loss) | (2,314) | 1,252 | 3,811 |
Other comprehensive income (loss), net of taxes | (9,429) | 6,710 | 13,129 |
Comprehensive income (loss) | (1,635) | 6,564 | 17,367 |
Less: Comprehensive income (loss) attributable to noncontrolling interests | 55 | 239 | 55 |
Comprehensive income (loss) attributable to Prudential Financial, Inc. | $ (1,690) | $ 6,325 | $ 17,312 |
Consolidated Statements of Equity - USD ($) $ in Millions |
Total |
Cumulative Effect, Period of Adoption, Adjustment |
[2] | ASU 2016-01 |
[1] | Common Stock |
Additional Paid-in Capital |
Retained Earnings |
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
|
[2] |
Retained Earnings
ASU 2016-01
|
[1] |
Common Stock Held in Treasury
Common Stock
|
Accumulated Other Comprehensive Income (Loss) |
Accumulated Other Comprehensive Income (Loss)
ASU 2016-01
|
[1] | Total Prudential Financial, Inc. Equity |
Total Prudential Financial, Inc. Equity
Cumulative Effect, Period of Adoption, Adjustment
|
[2] |
Total Prudential Financial, Inc. Equity
ASU 2016-01
|
[1] | Noncontrolling Interests |
||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Balance at Dec. 31, 2018 | $ 49,031 | $ (14) | $ 6 | $ 24,828 | $ 30,470 | $ (21) | $ (17,593) | $ 10,906 | $ 7 | $ 48,617 | $ (14) | $ 414 | ||||||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||||||||||||||||||
Common Stock acquired | (2,500) | (2,500) | (2,500) | |||||||||||||||||||||||
Exchangeable Surplus Notes conversion | 502 | 502 | 502 | |||||||||||||||||||||||
Assurance IQ acquisition | 454 | 79 | 375 | 454 | ||||||||||||||||||||||
Contributions from noncontrolling interests | 208 | 208 | ||||||||||||||||||||||||
Distributions to noncontrolling interests | (82) | (82) | ||||||||||||||||||||||||
Consolidations/(deconsolidations) of noncontrolling interests | 9 | 9 | ||||||||||||||||||||||||
Stock-based compensation programs | 388 | 123 | 265 | 388 | ||||||||||||||||||||||
Dividends declared on Common Stock | (1,644) | (1,644) | (1,644) | |||||||||||||||||||||||
Comprehensive income: | ||||||||||||||||||||||||||
Net income (loss) | 4,238 | 4,186 | 4,186 | 52 | ||||||||||||||||||||||
Other comprehensive income (loss), net of tax | 13,129 | 13,126 | 13,126 | 3 | ||||||||||||||||||||||
Total comprehensive income (loss) | 17,367 | 17,312 | 55 | |||||||||||||||||||||||
Balance at Dec. 31, 2019 | 63,719 | $ (99) | 6 | 25,532 | 32,991 | $ (99) | (19,453) | 24,039 | 63,115 | $ (99) | 604 | |||||||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||||||||||||||||||
Common Stock acquired | (500) | (500) | (500) | |||||||||||||||||||||||
Contributions from noncontrolling interests | 100 | 100 | ||||||||||||||||||||||||
Distributions to noncontrolling interests | (53) | (53) | ||||||||||||||||||||||||
Consolidations/(deconsolidations) of noncontrolling interests | (105) | (105) | ||||||||||||||||||||||||
Stock-based compensation programs | 353 | 52 | 301 | 353 | ||||||||||||||||||||||
Dividends declared on Common Stock | (1,769) | (1,769) | (1,769) | |||||||||||||||||||||||
Comprehensive income: | ||||||||||||||||||||||||||
Net income (loss) | (146) | (374) | (374) | 228 | ||||||||||||||||||||||
Other comprehensive income (loss), net of tax | 6,710 | 6,699 | 6,699 | 11 | ||||||||||||||||||||||
Total comprehensive income (loss) | 6,564 | 6,325 | 239 | |||||||||||||||||||||||
Balance at Dec. 31, 2020 | 68,210 | 6 | 25,584 | 30,749 | (19,652) | 30,738 | 67,425 | 785 | ||||||||||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||||||||||||||||||
Common Stock acquired | (2,500) | (2,500) | (2,500) | |||||||||||||||||||||||
Contributions from noncontrolling interests | 85 | 85 | ||||||||||||||||||||||||
Distributions to noncontrolling interests | (75) | (75) | ||||||||||||||||||||||||
Consolidations/(deconsolidations) of noncontrolling interests | (118) | (118) | ||||||||||||||||||||||||
Stock-based compensation programs | 462 | 148 | 314 | 462 | ||||||||||||||||||||||
Dividends declared on Common Stock | (1,821) | (1,821) | (1,821) | |||||||||||||||||||||||
Comprehensive income: | ||||||||||||||||||||||||||
Net income (loss) | 7,794 | 7,724 | 7,724 | 70 | ||||||||||||||||||||||
Other comprehensive income (loss), net of tax | (9,429) | (9,414) | (9,414) | (15) | ||||||||||||||||||||||
Total comprehensive income (loss) | (1,635) | (1,690) | 55 | |||||||||||||||||||||||
Balance at Dec. 31, 2021 | $ 62,608 | $ 6 | $ 25,732 | $ 36,652 | $ (21,838) | $ 21,324 | $ 61,876 | $ 732 | ||||||||||||||||||
|
Consolidated Statements of Cash Flows - USD ($) $ in Millions |
12 Months Ended | ||||||||
---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|||||||
CASH FLOWS FROM OPERATING ACTIVITIES | |||||||||
Net income (loss) | $ 7,794 | $ (146) | $ 4,238 | ||||||
Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||||||
Realized investment (gains) losses, net | (4,024) | 3,887 | 459 | ||||||
Policy charges and fee income | (2,302) | (2,652) | (2,616) | ||||||
Interest credited to policyholders’ account balances | 3,482 | 4,538 | 4,880 | ||||||
Goodwill impairment | 1,060 | 0 | 0 | ||||||
Depreciation and amortization | 204 | 457 | 460 | ||||||
(Gains) losses on assets supporting experience-rated contractholder liabilities, net | 299 | (743) | (971) | ||||||
Change in: | |||||||||
Deferred policy acquisition costs | (451) | (542) | (634) | ||||||
Future policy benefits and other insurance liabilities | 7,762 | 10,817 | 10,992 | ||||||
Income taxes | (62) | (424) | (339) | ||||||
Derivatives, net | (2,426) | (2,940) | 1,485 | ||||||
Other, net | (1,524) | (3,884) | 1,671 | ||||||
Cash flows from (used in) operating activities | 9,812 | 8,368 | 19,625 | ||||||
Proceeds from the sale/maturity/prepayment of: | |||||||||
Fixed maturities, available-for-sale | 64,759 | 44,106 | 52,306 | ||||||
Fixed maturities, held-to-maturity | 239 | 88 | 100 | ||||||
Fixed maturities, trading | 3,626 | 690 | 363 | ||||||
Assets supporting experience-rated contractholder liabilities | 18,863 | 29,162 | 15,281 | ||||||
Equity securities | 4,290 | 2,704 | 2,708 | ||||||
Commercial mortgage and other loans | 9,367 | 5,447 | 6,525 | ||||||
Policy loans | 2,019 | 2,528 | 2,279 | ||||||
Other invested assets | 2,972 | 1,815 | 1,783 | ||||||
Short-term investments | 32,696 | 47,339 | 38,095 | ||||||
Payments for the purchase/origination of: | |||||||||
Fixed maturities, available-for-sale | (65,174) | (56,523) | (64,570) | ||||||
Fixed maturities, trading | (5,675) | (1,413) | (876) | ||||||
Assets supporting experience-rated contractholder liabilities | (21,394) | (30,822) | (14,613) | ||||||
Equity securities | (4,430) | (3,168) | (2,813) | ||||||
Commercial mortgage and other loans | (9,434) | (6,107) | (10,677) | ||||||
Policy loans | (1,216) | (1,956) | (1,931) | ||||||
Other invested assets | (3,628) | (2,760) | (2,557) | ||||||
Short-term investments | (32,329) | (49,802) | (37,286) | ||||||
Acquisitions, net of cash acquired | 0 | 0 | (1,755) | ||||||
Dispositions, net of cash disposed | 132 | 1,454 | 0 | ||||||
Derivatives, net | (429) | 1,286 | 1,047 | ||||||
Other, net | (596) | (278) | (437) | ||||||
Cash flows from (used in) investing activities | (5,342) | (16,210) | (17,028) | ||||||
CASH FLOWS FROM FINANCING ACTIVITIES | |||||||||
Policyholders’ account deposits | 31,795 | 41,424 | 27,485 | ||||||
Policyholders’ account withdrawals | (29,227) | (34,701) | (26,662) | ||||||
Net change in securities sold under agreements to repurchase and cash collateral for loaned securities | 42 | 499 | 16 | ||||||
Cash dividends paid on Common Stock | (1,814) | (1,766) | (1,641) | ||||||
Net change in financing arrangements (maturities 90 days or less) | 297 | (21) | (181) | ||||||
Common Stock acquired | (2,500) | (500) | (2,500) | ||||||
Common Stock reissued for exercise of stock options | 200 | 153 | 133 | ||||||
Proceeds from the issuance of debt (maturities longer than 90 days) | 268 | 3,013 | 2,993 | ||||||
Repayments of debt (maturities longer than 90 days) | (1,708) | (2,743) | (1,429) | ||||||
Proceeds from notes issued by consolidated VIEs | 0 | 0 | 971 | ||||||
Repayments of notes issued by consolidated VIEs | 0 | (19) | (638) | ||||||
Other, net | (364) | (456) | (181) | ||||||
Cash flows from (used in) financing activities | (3,011) | 4,883 | (1,634) | ||||||
Effect of foreign exchange rate changes on cash balances | (309) | 340 | 16 | ||||||
NET INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS, RESTRICTED CASH AND RESTRICTED CASH EQUIVALENTS INCLUDING BALANCES CLASSIFIED AS HELD-FOR-SALE | 1,150 | (2,619) | 979 | ||||||
NET CHANGE IN CASH BALANCES CLASSIFIED AS HELD-FOR-SALE | 2,071 | 0 | 0 | ||||||
NET INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS, RESTRICTED CASH AND RESTRICTED CASH EQUIVALENTS | (921) | (2,619) | 979 | ||||||
CASH, CASH EQUIVALENTS, RESTRICTED CASH AND RESTRICTED CASH EQUIVALENTS, BEGINNING OF YEAR | 13,855 | 16,474 | 15,495 | ||||||
CASH, CASH EQUIVALENTS, RESTRICTED CASH AND RESTRICTED CASH EQUIVALENTS, END OF YEAR | 12,934 | 13,855 | 16,474 | ||||||
SUPPLEMENTAL CASH FLOW INFORMATION | |||||||||
Income taxes paid, net of refunds | 1,668 | 287 | 1,348 | ||||||
Interest paid | 1,452 | 1,531 | 1,521 | ||||||
HELD-FOR-SALE CLASSIFICATION | |||||||||
Assets classified as held-for-sale | 153,793 | [1] | 0 | 0 | |||||
Liabilities classified as held-for-sale | 151,359 | [1] | 0 | 0 | |||||
Net assets classified as held-for-sale | 2,434 | [1] | 0 | 0 | |||||
NON-CASH TRANSACTIONS DURING THE YEAR | |||||||||
Treasury Stock shares issued for stock-based compensation programs | 138 | 151 | 197 | ||||||
Conversion of surplus notes into Common Stock | 0 | 0 | 502 | ||||||
Treasury Stock shares issued | 454 | ||||||||
RECONCILIATION TO STATEMENTS OF FINANCIAL POSITION | |||||||||
Cash and cash equivalents | 12,888 | [2] | 13,701 | [2] | 16,327 | ||||
Restricted cash and restricted cash equivalents (included in “Other assets”) | 46 | 154 | 147 | ||||||
Total cash, cash equivalents, restricted cash and restricted cash equivalents | 12,934 | 13,855 | 16,474 | ||||||
Significant Pension Risk Transfer transactions: | |||||||||
NON-CASH TRANSACTIONS DURING THE YEAR | |||||||||
Assets received, excluding cash and cash equivalents | 5,377 | 703 | 3,166 | ||||||
Net cash received | 1,020 | 346 | 1,166 | ||||||
Liabilities assumed | 6,397 | 1,049 | 4,332 | ||||||
Acquisitions: | |||||||||
NON-CASH TRANSACTIONS DURING THE YEAR | |||||||||
Assets acquired, excluding cash and cash equivalents | 0 | 0 | 2,425 | ||||||
Liabilities assumed | 0 | 0 | 216 | ||||||
Treasury Stock shares issued | 0 | 0 | 454 | ||||||
Net cash paid on acquisition | $ 0 | $ 0 | $ 1,755 | ||||||
|
Business and Basis of Presentation |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2020 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Business and Basis of Presentation | BUSINESS AND BASIS OF PRESENTATION Prudential Financial, Inc. (“Prudential Financial”) and its subsidiaries (collectively, “Prudential” or the “Company”) provide a wide range of insurance, investment management, and other financial products and services to both individual and institutional customers throughout the United States and in many other countries. Principal products and services provided include life insurance, annuities, retirement solutions, mutual funds and investment management. The Company’s principal operations consist of PGIM (the Company’s global investment management business), the U.S. Businesses (consisting of the Retirement, Group Insurance, Individual Annuities, Individual Life and Assurance IQ businesses), the International Businesses, the Closed Block division, and the Company’s Corporate and Other operations. The Closed Block division is accounted for as a divested business that is reported separately from the Divested and Run-off Businesses that are included in Corporate and Other operations. Divested and Run-off Businesses consist of businesses that have been, or will be, sold or exited, including businesses that have been placed in wind-down status that do not qualify for “discontinued operations” accounting treatment under U.S. GAAP. The Company’s Corporate and Other operations include corporate items and initiatives that are not allocated to business segments as well as the Divested and Run-off Businesses described above. Basis of Presentation The Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”). The Consolidated Financial Statements include the accounts of Prudential Financial, entities over which the Company exercises control, including majority-owned subsidiaries and minority-owned entities such as limited partnerships in which the Company is the general partner and variable interest entities (“VIEs”) in which the Company is considered the primary beneficiary. See Note 4 for additional information on the Company’s consolidated variable interest entities. Intercompany balances and transactions have been eliminated. Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The most significant estimates include those used in determining deferred policy acquisition costs (“DAC”) and related amortization; policyholders’ account balances related to the fair value of embedded derivative instruments associated with the index-linked features of certain universal life and annuity products; value of business acquired (“VOBA”) and its amortization; amortization of deferred sales inducements (“DSI”); measurement of goodwill and any related impairment; valuation of investments including derivatives, measurement of allowance for credit losses, and the recognition of other-than-temporary impairments (“OTTI”); future policy benefits including guarantees; pension and other postretirement benefits; provision for income taxes and valuation of deferred tax assets; and accruals for contingent liabilities, including estimates for losses in connection with unresolved legal and regulatory matters. Reclassifications Certain amounts in prior periods have been reclassified to conform to the current period presentation. COVID-19 Since the first quarter of 2020, the novel coronavirus (“COVID-19”) has resulted in extreme stress and disruption in the global economy and financial markets. While markets have rebounded, the pandemic has adversely impacted, and may continue to adversely impact, the Company’s results of operations, financial condition and cash flows. Due to the highly uncertain nature of these conditions, it is not possible to estimate the ultimate impacts at this time. The risks may have manifested, and may continue to manifest, in the Company’s financial statements in the areas of, among others, i) insurance liabilities and related balances: potential changes to assumptions regarding investment returns, mortality, morbidity and policyholder behavior which are reflected in our insurance liabilities and certain related balances (e.g., DAC, VOBA, etc.) and; ii) investments: increased risk of loss on our investments due to default or deterioration in credit quality or value. The Company cannot predict what impact the COVID-19 pandemic will ultimately have on its businesses. Acquisitions Assurance IQ The Company completed its acquisition of Assurance IQ in October 2019. Assurance IQ is a wholly-owned subsidiary of the Company and the results of the Assurance IQ business are reported as a separate segment within the Company’s U.S. Businesses. The total purchase consideration included $2,212 million paid at closing, and $100 million of contingent consideration (see Note 23 for additional information regarding the contingent liability). In addition to the purchase consideration, the Company also granted approximately $160 million of cash and equity awards to Assurance IQ employees which are recognized as compensation expense over their requisite service periods. See Note 21 for further details on the equity awards issued as part of the transaction. The contingent consideration as well as additional compensation awards are payable in 2023, contingent upon Assurance IQ’s achievement of certain profitability targets. The Company recognized a goodwill asset of $2,140 million in connection with the acquisition. Based on the goodwill impairment test performed as of December 31, 2021, the Company recorded a goodwill impairment charge of $1,060 million, which reduced the Assurance IQ goodwill asset to $1,080 million as of December 31, 2021. See Note 2 and Note 10 for additional information regarding goodwill. Business Dispositions Prudential Annuities Life Assurance Corporation, Representing a Portion of Individual Annuities’ Traditional Variable Annuity Block of Business In September 2021, the Company entered into a definitive agreement to sell its equity interest in Prudential Annuities Life Assurance Corporation (“PALAC”), which represents a portion of its in-force traditional variable annuity block of business, to Fortitude Group Holdings, LLC. The transaction has a total value of approximately $2.2 billion, comprising the sales price for PALAC, a pre-closing net capital release to the Company and the expected tax impact from the sale. The PALAC block primarily consists of non-New York traditional variable annuities with guaranteed living benefits that were issued prior to 2011, which constitute approximately $30 billion or 18% of Prudential’s total in-force individual annuity account values as of December 31, 2021. The Company will retain, through a reinsurance agreement, its interest in all FlexGuard products and all fixed annuities and fixed indexed annuities remaining in PALAC. The Company expects to record a gain on the sale of the business upon the closing of the transaction, which is expected to occur in the first half of 2022, subject to the receipt of regulatory approvals and the satisfaction of customary closing conditions. Beginning in the third quarter of 2021, the Company reported the assets and liabilities of this block of business as “held-for-sale” with results continuing to be reported within the Individual Annuities segment. Full Service Retirement Business In July 2021, the Company entered into a definitive agreement with Great-West Life & Annuity Insurance Company (“Great-West”) pursuant to which the Company has agreed to sell to Great-West the Company’s Full Service Retirement business, primarily through a combination of (i) the sale of all of the outstanding equity interests of certain legal entities, including Prudential Retirement Insurance and Annuity Company (“PRIAC”); (ii) the ceding of certain insurance policies through reinsurance; and (iii) the sale, transfer and/or novation of certain in-scope contracts and brokerage accounts. The Company expects to record a gain on the sale of the business upon the closing of the transaction, which is expected to occur in the first half of 2022, subject to the receipt of regulatory approvals and the satisfaction of customary closing conditions. Total proceeds from the sale are expected to be approximately $2.8 billion, which includes cash consideration for the sale of PRIAC, ceding commission for the reinsured business and capital available to be released from PICA. Separately, the Company expects to incur approximately $400 million of taxes and transaction related costs. Beginning in the third quarter of 2021, the Company reported the assets and liabilities of the Full Service Retirement business as “held-for-sale” and has transferred the results of this business to Divested and Run-off Businesses within Corporate and Other operations. All prior period amounts have been restated, which impacts both segment reporting and adjusted operating income, but does not impact results reported under GAAP. The Full Service Retirement business generated pre-tax income of $190 million, $179 million and $237 million for the years ended December 31, 2021, 2020 and 2019, respectively. These amounts exclude the impacts of overhead costs, retained in the Company’s Corporate and Other operations, that will not be transferred to the buyer or eliminated with the sale. The table below reflects the carrying amounts of assets and liabilities held-for-sale related to the pending dispositions described above:
__________ (1)Under the terms of the sales agreements, certain of these assets and liabilities held-for-sale may be subject to capital transactions or substituted for other similar items prior to the closing of each transaction. (2)“Fixed maturities, available-for-sale, at fair value” with an allowance for credit losses of $1 million and “Commercial mortgage and other loans” net of allowance for credit losses of $15 million, as of December 31, 2021, respectively. (3)Includes $455 million of goodwill associated with Retirement Full Service as of December 31, 2021. The Prudential Life Insurance Company of Taiwan Inc. In June 2021, Prudential International Insurance Holdings, Ltd. (“PIIH”), a subsidiary of Prudential Financial, completed the sale of The Prudential Life Insurance Company of Taiwan Inc. (“POT”) to Taishin Financial Holding Co, Ltd. (the “Buyer”) for cash consideration of approximately NT5.5 billion, equal to approximately $200 million at then current exchange rates, and contingent consideration with a fair value of approximately $80 million as of December 31, 2021. The fair value of the contingent consideration is tied to the level of yields for the 10-year Taiwanese Government bond for two years after the signing of the transaction and can result in a maximum payout of $100 million if yields increase by 40 basis points. In connection with the transaction, the Company recognized a liability with a fair value of approximately $34 million as of December 31, 2021, representing its financial guarantee of certain insurance obligations of POT. The after-tax loss on the sale of POT was approximately $400 million, of which approximately $350 million was recorded during 2020, and approximately $50 million was recorded during 2021. Prior to the sale, in the third quarter of 2020, the Company transferred the results of POT and the anticipated impact of its sale from the International Businesses segment to Divested and Run-off Businesses within Corporate & Other operations. Prior period amounts were restated at that time, which impacted both segment reporting and adjusted operating income, but did not impact results reported under GAAP. Pramerica SGR (PGIM Italy Joint Venture) In March 2021, the Company sold its 35% ownership stake in Pramerica SGR, PGIM’s asset management joint venture in Italy, to its partner UBI Banca, which was acquired in 2020 by Intesa Sanpaolo Group. The after-tax gain on the sale of Pramerica SGR was approximately $330 million, which was recognized in adjusted operating income in the first quarter of 2021. The Prudential Life Insurance Company of Korea, Ltd. In August 2020, PIIH completed the sale of The Prudential Life Insurance Company of Korea, Ltd. (“POK”) to KB Financial Group Inc., for cash consideration of approximately ₩2.3 trillion, equal to approximately $1.9 billion. The Company recognized an approximate $800 million after-tax loss on the transaction in 2020. Prior to the sale, in the second quarter of 2020, the Company transferred the results of POK and the anticipated impact of its sale from the International Businesses segment to Divested and Run-off Businesses within Corporate & Other operations. Prior period amounts were restated at that time, which impacted both segment reporting and adjusted operating income, but did not impact results reported under GAAP.
|
Significant Accounting Policies and Pronouncements |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accounting Policies [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Significant Accounting Policies and Pronouncements | SIGNIFICANT ACCOUNTING POLICIES AND PRONOUNCEMENTS ASSETS Fixed maturities, available-for-sale, at fair value (“AFS debt securities”) includes bonds, notes and redeemable preferred stock that are carried at fair value. See Note 6 for additional information regarding the determination of fair value. The purchased cost of fixed maturities is adjusted for amortization of premiums and accretion of discounts to maturity or, if applicable, call date. AFS debt securities, where fair value is below amortized cost, are reviewed quarterly to determine whether the amortized cost basis of the security is recoverable. For mortgage-backed and asset-backed AFS debt securities, a credit impairment will be recognized in earnings as an allowance for credit losses and reported in “Realized investment gains (losses), net,” to the extent the amortized cost exceeds the net present value of projected future cash flows (the “net present value”) for the security. For all other AFS debt securities, qualitative factors are first considered including, but not limited to, the extent of the decline and the reasons for the decline in value (e.g., credit events, currency or interest-rate related, including general credit spread widening), and the financial condition of the issuer. If analysis of these qualitative factors results in the security needing to be impaired, a credit impairment will be recognized in earnings as an allowance for credit losses and reported in “Realized investment gains (losses), net,” to the extent the amortized cost exceeds the net present value of projected future cash flows (the “net present value”) for the security. A credit impairment recorded cannot exceed the difference between the amortized cost and fair value of the respective security. The net present value used to measure a credit impairment is calculated by discounting the Company’s best estimate of projected future cash flows at the effective interest rate implicit in the AFS debt security at the date of acquisition. Once the Company has deemed all or a portion of the amortized cost uncollectible, the allowance is removed from the balance sheet by writing down the amortized cost basis of the AFS debt security. Any amount of an AFS debt security’s change in fair value not recorded as an allowance for credit losses will be recorded in Other Comprehensive Income (loss) (“OCI”). When an AFS debt security’s fair value is below amortized cost and the Company has the intent to sell the AFS debt security, or it is more likely than not the Company will be required to sell the AFS debt security before its anticipated recovery, the amortized cost basis of the AFS debt security is written down to fair value and any previously recognized allowance is reversed. The write-down is reported in “Realized investment gains (losses), net.” Interest income, including amortization of premium and accretion of discount, are included in “Net investment income” under the effective yield method. Prepayment premiums are also included in “Net investment income.” For high credit quality mortgage-backed and asset-backed AFS debt securities (those rated AA or above), the amortized cost and effective yield of the securities are adjusted as necessary to reflect historical prepayment experience and changes in estimated future prepayments. The adjustments to amortized cost are recorded as a charge or credit to “Net investment income” in accordance with the retrospective method. For mortgage-backed and asset-backed AFS debt securities rated below AA, the effective yield is adjusted prospectively for any changes in the estimated timing and amount of cash flows unless the investment is purchased with credit deterioration or an allowance is currently recorded for the respective security. If an investment is impaired, any changes in the estimated timing and amount of cash flows will be recorded as the credit impairment, as opposed to a yield adjustment. If the asset is purchased with credit deterioration (or previously impaired), the effective yield will be adjusted if there are favorable changes in cash flows subsequent to the allowance being reduced to zero. For mortgage-backed and asset-backed AFS debt securities, cash flow estimates consider the payment terms of the underlying assets backing a particular security, including interest rate and prepayment assumptions based on data from widely accepted third-party data sources or internal estimates. In addition to interest rate and prepayment assumptions, cash flow estimates also include other assumptions regarding the underlying collateral including default rates and recoveries, which vary based on the asset type and geographic location, as well as the vintage year of the security. These assumptions can significantly impact income recognition, unrealized gains and loss recorded in OCI, and the amount of impairment recognized in earnings. The payment priority of the respective security is also considered. For all other AFS debt securities, cash flow estimates are driven by assumptions regarding probability of default and estimates regarding timing and amount of recoveries associated with a default. The Company has developed these estimates using information based on its historical experience as well as using market observable data, such as industry analyst reports and forecasts, sector credit ratings and other data relevant to the collectability of a security, such as the general payment terms of the security and the security’s position within the capital structure of the issuer. The associated unrealized gains and losses, net of tax, and the effect on DAC, VOBA, DSI, future policy benefits, policyholders’ account balances and policyholders’ dividends that would result from the realization of unrealized gains and losses, are included in “Accumulated other comprehensive income (loss)” (“AOCI”). Each of these balances is discussed in greater detail below. Fixed maturities, held-to-maturity, at amortized cost includes bonds that the Company has both the positive intent and ability to hold to maturity, and are carried at amortized cost, net of the current expected credit loss (“CECL”) allowance (“HTM debt securities”). Interest income for HTM debt securities is computed in the same manner as interest income for AFS debt securities. Credit impairment for HTM debt securities is recorded through a CECL allowance. The CECL allowance is generally determined based on probability of default and loss given default assumptions according to sector, credit quality and remaining time to maturity. Changes in the allowance are reported in “Realized investment gains (losses), net.” Once the Company has deemed all or a portion of the amortized cost uncollectible, the uncollectible portion of the allowance is removed from the balance sheet by writing down the amortized cost basis of the security. The CECL allowance represents the Company’s best estimate of expected credit losses over the remaining life of the assets. The determination of the allowance considers historical credit loss experience, current conditions, and reasonable and supportable forecasts. The allowance is calculated separately for each HTM debt security. Key inputs to the CECL model include unpaid principal balances, credit ratings, annual expected loss factors, average life adjusted for prepayment considerations, current and historical interest rate assumptions, and other factors influencing the Company’s view of the current stage of the economic cycle and future economic conditions. Subjective considerations include a review of whether historical loss experience is representative of current market conditions and the Company’s view of the credit cycle. Model assumptions and factors are reviewed and updated as appropriate. Fixed maturities, trading, at fair value consists of fixed maturities with embedded features that are considered derivatives and assets contained within consolidated variable interest entities. Realized and unrealized gains and losses on these investments are reported in “Other income (loss),” and interest and dividend income from these investments is reported in “Net investment income.” Assets supporting experience-rated contractholder liabilities, at fair value includes invested assets that consist of fixed maturities, equity securities, short-term investments and cash equivalents, that support certain products which are experience-rated, meaning that the investment results associated with these products are expected to ultimately accrue to contractholders. Realized and unrealized gains and losses for these investments are reported in “Other income (loss).” Interest and dividend income from these investments is reported in “Net investment income.” Equity securities, at fair value is comprised of common stock, mutual fund shares and non-redeemable preferred stock carried at fair value. Realized and unrealized gains and losses on these investments are reported in “Other income (loss),” and dividend income is reported in “Net investment income” on the ex-dividend date. Commercial mortgage and other loans consists of commercial mortgage loans, agricultural property loans, as well as certain other collateralized and uncollateralized loans. Uncollateralized loans primarily represent reverse dual currency loans and corporate loans held by the Company’s international insurance operations. Commercial mortgage and other loans originated and held for investment are generally carried at unpaid principal balance, net of unamortized deferred loan origination fees and expenses, and net of the CECL allowance. Certain off-balance sheet credit exposures (e.g., indemnification of serviced mortgage loans, and certain unfunded mortgage loan commitments where the Company cannot unconditionally cancel the commitment) are also subject to a CECL allowance. See Note 23 for additional information. The Company carries certain commercial mortgage loans originated within the Company’s commercial mortgage operations at fair value where the fair value option has been elected. Loans held for sale where the Company has not elected the fair value option are carried at the lower of cost or fair value. Commercial mortgage and other loans acquired, including those related to the acquisition of a business, are recorded at fair value when purchased, reflecting any premiums or discounts to unpaid principal balances. Interest income, and the amortization of the related premiums or discounts, are included in “Net investment income” under the effective yield method. Prepayment fees are also included in “Net investment income.” Effective January 1, 2020, the Company adopted ASU 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, and related ASUs, using a modified retrospective method for certain financial assets carried at amortized cost and certain off-balance sheet exposures. Adoption of these ASUs requires an entity to estimate lifetime credit losses for certain financial assets carried at amortized cost and certain off-balance sheet exposures based on relevant information about past events, current conditions, and reasonable and supportable forecasts that may affect the collectability of reported amounts. The most significant impact is that modifications made to the Company’s process for measuring credit losses for its commercial mortgage and other loans class classified as held for investment. The impact of the standard resulted in a decrease to “Total assets” of $122 million ($115 million of this decrease was recorded for commercial mortgage and other loans), a decrease to “Total liabilities” of $23 million, and a decreased to “Retained earnings” of $99 million upon adoption on January 1, 2020. The CECL allowance represents the Company’s best estimate of expected credit losses over the remaining life of the assets or off-balance sheet credit exposures. The determination of the allowance considers historical credit loss experience, current conditions, and reasonable and supportable forecasts. Prior to the adoption of ASU 2016-13, the allowance was based upon credit losses that were probable of occurring for recognized loans, not an estimate of credit losses that may occur over the remaining life of the asset. The allowance is calculated separately for commercial mortgage loans, agricultural mortgage loans, and other collateralized and uncollateralized loans. For commercial mortgage and agricultural mortgage loans, the allowance is calculated using an internally developed CECL model that pools together loans that share similar risk characteristics. Similar risk characteristics used to create the pools include, but are not limited to, vintage, maturity, credit rating, and collateral type. Key inputs to the CECL model include unpaid principal balances, internal credit ratings, annual expected loss factors, average lives of the loans adjusted for prepayment considerations, current and historical interest rate assumptions, and other factors influencing the Company’s view of the current stage of the economic cycle and future economic conditions. Subjective considerations include a review of whether historical loss experience is representative of current market conditions and the Company’s view of the credit cycle. Model assumptions and factors are reviewed and updated as appropriate. Information about certain key inputs is detailed below. Key factors in determining the internal credit ratings for commercial mortgage and agricultural mortgage loans include loan-to-value and debt-service-coverage ratios. Other factors include amortization, loan term, and estimated market value growth rate and volatility for the property type and region. The loan-to-value ratio compares the carrying amount of the loan to the fair value of the underlying property or properties collateralizing the loan, and is commonly expressed as a percentage. Loan-to-value ratios greater than 100% indicate that the carrying amount of the loan exceeds the collateral value. A loan-to-value ratio less than 100% indicates an excess of collateral value over the carrying amount of the loan. The debt service coverage ratio is a property’s net operating income as a percentage of its debt service payments. Debt service coverage ratios less than 1.0 indicates that property operations do not generate enough income to cover the loan’s current debt payments. A debt service coverage ratio greater than 1.0 indicates an excess of net operating income over the debt service payments. The values utilized in calculating these ratios are developed as part of the Company’s periodic review of the commercial mortgage loan and agricultural property loan portfolios, which includes an internal appraisal of the underlying collateral value. The Company’s periodic review also includes a quality re-rating process, whereby the internal quality rating originally assigned at underwriting is updated based on current loan, property and market information using a proprietary quality rating system. See Note 3 for additional information related to the loan-to-value ratios and debt service coverage ratios related to the Company’s commercial mortgage and agricultural loan portfolios. Annual expected loss rates are based on historical default and loss experience factors. Using average lives, the annual expected loss rates are converted into life-of-loan loss expectations. When individual loans no longer have the credit risk characteristics of the commercial or agricultural mortgage loan pools, they are removed from the pools and are evaluated individually for an allowance. The allowance is determined based on the outstanding loan balance less the present value of expected future cash flows discounted at the loan’s effective interest rate or the fair value of the collateral if the loan is collateral dependent. The CECL allowance on commercial mortgage and other loans can increase or decrease from period to period based on the factors noted above. The change in allowance is reported in “Realized investment gains (losses), net.” As it relates to unfunded commitments that are in scope of this guidance, the CECL allowance is reported in “Other liabilities,” and the change in the allowance is reported in “Realized investment gains (losses), net.” The CECL allowance for other collateralized and uncollateralized loans (e.g., corporate loans) carried at amortized cost is determined based on probability of default and loss given default assumptions by sector, credit quality and average lives of the loans. Additions to, or releases of, the allowance are reported in “Realized investment gains (losses), net.” Once the Company has deemed a portion of the amortized cost to be uncollectible, the uncollectible portion of allowance is removed from the balance sheet by writing down the amortized cost basis of the loan. The carrying amount of the loan is not adjusted for subsequent recoveries in value. Interest received on loans that are past due is either applied against the principal or reported as net investment income based on the Company’s assessment as to the collectability of the principal. The Company defines “past due” as principal or interest not collected at least 30 days past the scheduled contractual due date. See Note 3 for additional information about the Company’s past due loans. The Company discontinues accruing interest on loans after the loans become 90 days delinquent as to principal or interest payments, or earlier when the Company has doubts about collectability. When the Company discontinues accruing interest on a loan, any accrued but uncollectible interest on the loan and other loans backed by the same collateral, if any, is charged against interest income in the same period. Generally, a loan is restored to accrual status only after all delinquent interest and principal are brought current and, in the case of loans where the payment of interest has been interrupted for a substantial period, or the loan has been modified, a regular payment performance has been established. Commercial mortgage and other loans are occasionally restructured in a troubled debt restructuring (“TDR”). These restructurings generally include one or more of the following: full or partial payoffs outside of the original contract terms; changes to interest rates; extensions of maturity; or additions or modifications to covenants. Additionally, the Company may accept assets in full or partial satisfaction of the debt as part of a TDR. When restructurings occur, they are evaluated individually to determine whether the restructuring or modification constitutes a TDR as defined by authoritative accounting guidance. If the borrower is experiencing financial difficulty and the Company has granted a concession, the restructuring, including those that involve a partial payoff or the receipt of assets in full satisfaction of the debt is deemed to be a TDR. When there is a reasonable expectation that the Company will execute a TDR, all effects of the potential restructuring are considered for the estimation of the CECL allowance. When a loan is modified in a TDR, the CECL allowance of the loan is remeasured using the modified terms and the loan’s original effective yield, and the allowance is adjusted accordingly. The loan will be evaluated to determine whether the loan no longer has similar credit risk characteristics of the commercial or agricultural mortgage loan pools and need to be evaluated for an allowance on an individual basis. Subsequent to the modification, income is recognized prospectively based on the modified terms of the loan. In a TDR where the Company receives assets in full satisfaction of the debt, any CECL allowance is reversed and a direct write-down of the loan is recorded for the amount of the allowance, and any additional loss, net of recoveries, or any gain is recorded for the difference between the fair value of the assets received and the recorded investment in the loan. When assets are received in partial settlement, the same process is followed, and the remaining loan is evaluated prospectively for credit impairment based on the CECL allowance process noted above. The Company’s PGIM business provides commercial mortgage origination, underwriting and servicing for certain government sponsored entities (“GSEs”). The Company has agreed to indemnify the GSEs for a portion of the credit risk associated with certain of the mortgages it services. Management has established a CECL allowance that factors in historical loss information, current conditions and reasonable and supportable forecasts. The allowance also considers the remaining lives of the loans subject to the indemnification. The CECL allowance is included in “Other liabilities” and changes in the CECL allowance are reported in “Realized investment gains (losses), net.” See Note 23 for additional information. Prior to the adoption of ASU 2016-13, a credit loss allowance was not required. Policy loans represents funds loaned to policyholders up to the cash surrender value of the associated insurance policies and are carried at the unpaid principal balances due to the Company from the policyholders. Interest income on policy loans is recognized in “Net investment income” at the contract interest rate when earned. Policy loans are fully collateralized by the cash surrender value of the associated insurance policies. Other invested assets consists of the Company’s non-coupon investments in limited partnerships and limited liability companies (“LPs/LLCs”), other than operating joint ventures, as well as wholly-owned investment real estate, derivative assets and other investments. LPs/LLCs interests are accounted for using either the equity method of accounting, or at fair value with changes in fair value reported in “Other income (loss).” The Company’s income from investments in LPs/LLCs accounted for using the equity method, other than the Company’s investments in operating joint ventures, is included in “Net investment income.” The carrying value of these investments is written down, or impaired, to fair value when a decline in value is considered to be other-than-temporary. In applying the equity method (including assessment for OTTI), the Company uses financial information provided by the investee, generally on a one to three-month lag. The Company consolidates LPs/LLCs in certain other instances where it is deemed to exercise control, or is considered the primary beneficiary of a variable interest entity. See Note 4 for additional information about VIEs. The Company’s wholly-owned investment real estate consists of real estate which the Company has the intent to hold for the production of income as well as real estate held for sale. Real estate which the Company has the intent to hold for the production of income is carried at depreciated cost less any write-downs to fair value for impairment losses and is reviewed for impairment whenever events or circumstances indicate that the carrying value may not be recoverable. Real estate held for sale is carried at the lower of depreciated cost or fair value less estimated selling costs and is not further depreciated once classified as such. An impairment loss is recognized when the carrying value of the investment real estate exceeds the estimated undiscounted future cash flows (excluding interest charges) from the investment. At that time, the carrying value of the investment real estate is written down to fair value. Decreases in the carrying value of investment real estate held for the production of income due to OTTI are recorded in “Realized investment gains (losses), net.” Depreciation on real estate held for the production of income is computed using the straight-line method over the estimated useful lives of the properties and is included in “Net investment income.” Short-term investments primarily consists of highly liquid debt instruments with a maturity of twelve months or less and greater than three months when purchased, other than those debt instruments meeting this definition that are included in “Assets supporting experience-rated contractholder liabilities, at fair value.” These investments are generally carried at fair value or amortized cost that approximates fair value and include certain money market investments, funds managed similar to regulated money market funds, short-term debt securities issued by government-sponsored entities and other highly liquid debt instruments. Cash and cash equivalents includes cash on hand, amounts due from banks, certain money market investments, funds managed similar to regulated money market funds, other debt instruments with maturities of three months or less when purchased, other than cash equivalents that are included in “Assets supporting experience-rated contractholder liabilities, at fair value,” and receivables related to securities purchased under agreements to resell (see also “Securities sold under agreements to repurchase” below). These assets are generally carried at fair value or amortized cost which approximates fair value. Accrued investment income primarily includes accruals of interest and dividend income from investments that have been earned but not yet received. Deferred policy acquisition costs represent costs directly related to the successful acquisition of new and renewal insurance and annuity business that have been deferred to the extent such costs are deemed recoverable from future profits. Such DAC primarily includes commissions, costs of policy issuance and underwriting, and certain other expenses that are directly related to successfully acquired contracts. In each reporting period, capitalized DAC is amortized to “Amortization of DAC,” net of the accrual of imputed interest on DAC balances. DAC is subject to periodic recoverability testing. DAC, for applicable products, is adjusted for the impact of unrealized gains or losses on investments as if these gains or losses had been realized, with corresponding credits or charges included in AOCI. For traditional participating life insurance which are included in the Closed Block, DAC is amortized over the expected life of the contracts in proportion to gross margins based on historical and anticipated future experience. Any changes in estimated gross margins on unamortized DAC are reflected in the period such that estimated gross margins are revised on a retrospective basis. DAC related to non-participating traditional individual life insurance and longevity reinsurance contracts is amortized in proportion to gross premiums. DAC related to universal and variable life products and fixed and variable deferred annuity products are generally deferred and amortized over the expected life of the contracts in proportion to gross profits arising principally from investment margins, mortality and expense margins, and surrender charges, based on historical and anticipated future experience, which is updated periodically. The Company uses a reversion to the mean approach for equities to derive future equity return assumptions; however, if the projected equity return calculated using this approach is greater than the maximum equity return assumption, the maximum equity return is utilized, and if the projected equity return is negative, the return is floored at 0%. Gross profits also include impacts from the embedded derivatives associated with certain of the optional living benefit features of variable annuity contracts, and index-linked crediting features of certain universal life and annuity contracts and related hedging activities. Total gross profits include both actual gross profits and estimates of gross profits for future periods. The Company regularly evaluates and adjusts DAC balances with a corresponding charge or credit to current period earnings, representing a cumulative adjustment to all prior periods’ amortization, for the impact of actual gross profits and changes in the Company’s projections of estimated future gross profits. Adjustments to DAC balances result from: (i) the annual review of assumptions that reflect the comprehensive review of the assumptions used in estimating gross profits for future periods; (ii) quarterly adjustments for current period experience (also referred to as “experience true-up” adjustments) that reflect the impact of differences between actual gross profits for a given period and the previously estimated expected gross profits for that period; and (iii) quarterly adjustments for market performance (also referred to as “experience unlocking”) that reflect the impact of changes to the Company’s estimate of total gross profits to reflect actual fund performance and market conditions. For group annuity contracts (other than single premium group annuities), acquisition costs are generally deferred and amortized over the expected life of the contracts in proportion to gross profits. For group corporate-, bank- and trust-owned life insurance contracts, acquisition costs are generally deferred and amortized in proportion to lives insured. For single premium immediate annuities with life contingencies, single premium group annuities, including non-participating group annuity contracts, and single premium structured settlements with life contingencies, all acquisition costs are charged to expense immediately because generally all premiums are recognized as revenue at the inception of the contract. For funding agreement notes contracts, single premium structured settlement contracts without life contingencies, and single premium immediate annuities without life contingencies, acquisition expenses are deferred and amortized over the expected life of the contracts using the interest method. For other group life and disability insurance contracts and guaranteed investment contracts (“GICs”), acquisition costs are expensed as incurred. For some products, policyholders can elect to modify product benefits, features, rights or coverages by exchanging a contract for a new contract or by amendment, endorsement, or rider to a contract, or by the election of a feature or coverage within a contract. These transactions are known as internal replacements. If policyholders surrender traditional life insurance policies in exchange for life insurance policies that do not have fixed and guaranteed terms, the Company immediately charges to expense the remaining unamortized DAC on the surrendered policies. For other internal replacement transactions, except those that involve the addition of a nonintegrated contract feature that does not change the existing base contract, the unamortized DAC is immediately charged to expense if the terms of the new policies are not substantially similar to those of the former policies. If the new terms are substantially similar to those of the earlier policies, the DAC is retained with respect to the new policies and amortized over the expected life of the new policies. See Note 7 for additional information regarding DAC. Value of business acquired represents identifiable intangible assets to which a portion of the purchase price in a business acquisition is attributed under the application of purchase accounting. VOBA represents an adjustment to the stated value of in-force insurance contract liabilities to present them at fair value, determined as of the acquisition date. VOBA balances are subject to recoverability testing, in the manner in which they were acquired. The Company has established a VOBA asset primarily for its acquired life insurance products, accident and health products with fixed benefits, deferred annuity contracts, and defined contribution and defined benefit businesses. As of December 31, 2021, the majority of the VOBA balance relates to the 2011 acquisition of AIG Star Life Insurance Co., Ltd, AIG Edison Life Insurance Company, and AIG Financial Assurance Japan K.K. and AIG Edison Service Co., Ltd. (collectively, the “Star and Edison Businesses”.) The Company amortizes VOBA over the anticipated life of the acquired contracts using the same methodology and assumptions used to amortize DAC. The Company records amortization of VOBA in “General and administrative expenses.” VOBA, for applicable products, is adjusted for the impact of unrealized gains or losses on investments as if these gains or losses had been realized, with corresponding credits or charges included in AOCI. See Note 8 for additional information regarding VOBA. Assets held-for-sale consists of assets associated with pending business dispositions. The Company classifies a business as held-for-sale when management has approved or received approval from the Board to sell the business, the sale is probable to be completed within a year and certain other specified criteria are met. The business classified as held-for-sale is recorded at the lower of carrying value or estimated fair value, less costs to sell. If the carrying value of the business exceeds its estimated fair value, less costs to sell, a loss is recognized and reported in “Other income (loss)” when the criteria for the held-for-sale classification as described above are met. If the estimated fair value, less costs to sell, exceeds the carrying value of the business, the gain is recorded in “Other income (loss)” when the sale is completed. See Note 1 for additional information on the pending business dispositions classified as held-for-sale, including the composition of assets included as “Assets held-for-sale". Other assets consists primarily of prepaid pension benefit costs (see Note 18), certain restricted assets (e.g., cash and cash equivalents), trade receivables, goodwill and other intangible assets, “right-of-use” lease assets (see “Other liabilities” below), DSI, the Company’s investments in operating joint ventures, property and equipment, reinsurance recoverables (see “Reinsurance” below), and receivables resulting from sales of securities that had not yet settled at the balance sheet date. Trade receivables primarily relate to Assurance IQ and are reported net of the CECL allowance. The CECL allowance considers the credit quality of the counterparties and is generally determined based on probability of default and loss given default assumptions. Additions to or releases of the allowance are reported in “General and administrative expenses.” Property and equipment are carried at cost less accumulated depreciation. Depreciation is determined using the straight-line method over the estimated useful lives of the related assets, which generally range from 3 to 40 years. As a result of certain acquisitions, the Company recognizes an asset for goodwill representing the excess of cost over the net fair value of the assets acquired and liabilities assumed. Goodwill is assigned to reporting units at the date the goodwill is initially recorded. A reporting unit is an operating segment, or a unit one level below the operating segment if discrete financial information is prepared and regularly reviewed by management at that level. Once goodwill has been assigned to reporting units, it no longer retains its association with a particular acquisition, and all of the activities within a reporting unit, whether acquired or organically grown, are available to support the value of the goodwill. The Company tests goodwill for impairment annually as of December 31 and more frequently if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying amount. Accounting guidance provides for an optional qualitative assessment for testing goodwill impairment that may allow companies to skip the quantitative test. As part of the annual goodwill impairment test, the Company estimates the fair value of the reporting units by applying the quantitative test, which involves comparing each reporting unit’s fair value to its carrying value including goodwill. If the fair value of a reporting unit exceeds its carrying value, the applicable goodwill is considered not to be impaired. If the carrying value exceeds fair value, goodwill is reduced and an impairment charge to income is recognized for the excess. The measurement of a goodwill impairment loss includes the related income tax effect from any tax deductible goodwill. The impairment loss cannot exceed the amount of goodwill assigned to a reporting unit, and the loss establishes a new basis in the goodwill. Subsequent reversal of goodwill impairment losses is not permitted. Management is required to make significant estimates in determining the fair value of a reporting unit including, but not limited to: projected revenues and operating margins, applicable discount and growth rates, and comparative market multiples. See Note 10 for additional information on goodwill, including the recorded impairment charge in 2021. The Company offered various types of sales inducements to policyholders related to fixed and variable deferred annuity contracts. The Company defers sales inducements and amortizes them over the expected life of the policy using the same methodology and assumptions used to amortize DAC. Sales inducement balances are subject to periodic recoverability testing. The Company records amortization of DSI in “Interest credited to policyholders’ account balances.” DSI, for applicable products, is adjusted for the impact of unrealized gains or losses on investments as if these gains or losses had been realized, with corresponding credits or charges included in AOCI. See Note 13 for additional information regarding sales inducements. Identifiable intangible assets primarily include customer relationships and mortgage servicing rights and are recorded net of accumulated amortization. The Company tests identifiable intangible assets for impairment on an annual basis as of December 31 of each year or whenever events or circumstances suggest that the carrying value of an identifiable intangible asset may exceed the sum of the undiscounted cash flows expected to result from its use and eventual disposition. If this condition exists and the carrying value of an identifiable intangible asset exceeds its fair value, the excess is recognized as an impairment and is recorded as a charge against net income. Measuring intangible assets requires the use of estimates. Significant estimates include the projected net cash flow attributable to the intangible asset and the rate at which future net cash flows are discounted for purposes of estimating fair value, as applicable. See Note 10 for additional information regarding identifiable intangible assets. Investments in operating joint ventures are generally accounted for under the equity method. The carrying value of these investments is written down, or impaired, to fair value when a decline in value is considered to be other-than-temporary. See Note 9 for additional information on investments in operating joint ventures. Leases are recorded on the balance sheet as “right-of-use” assets and lease liabilities within “Other assets” and “Other liabilities” respectively. Leases are classified as either operating or finance leases and lease expense is recognized within “General and administrative expenses.” As a lessee, for operating leases, total lease expense is recognized using a straight-line method. Finance leases are treated as the purchase of an asset on a financing basis. Additionally, as a lessor, for sales-type and direct financing leases, the Company derecognizes the carrying value of the leased asset that is considered to have been transferred to a lessee and records a lease receivable and residual asset (“receivable and residual” approach). See Note 11 for additional information regarding leases. Separate account assets represents segregated funds that are invested for certain policyholders, pension funds and other customers. The assets consist primarily of equity securities, fixed maturities, real estate-related investments, real estate mortgage loans, short-term investments and derivative instruments and are reported at fair value. The assets of each account are legally segregated and are not subject to claims that arise out of any other business of the Company. Investment risks associated with market value changes are borne by the customers, except to the extent of minimum guarantees made by the Company with respect to certain accounts. The investment income and realized investment gains or losses from separate account assets generally accrue to the policyholders and are not included in the Company’s results of operations. Mortality, policy administration and surrender charges assessed against the accounts are included in “Policy charges and fee income.” Asset management fees charged to the accounts are included in “Asset management and service fees.” Seed money that the Company invests in separate accounts is reported in the appropriate general account asset line. Investment income and realized investment gains or losses from seed money invested in separate accounts accrue to the Company and are included in the Company’s results of operations. See Note 13 for additional information regarding separate account arrangements with contractual guarantees. See also “Separate account liabilities” below. LIABILITIES Future policy benefits represents liabilities that primarily consist of the present value of estimated future payments to or on behalf of policyholders, where the timing and amount of payment depends on policyholder mortality or morbidity, less the present value of future net premiums (the portion of the gross premium required to provide for all expected future benefits and expenses). For individual traditional participating life insurance products, the mortality and interest rate assumptions applied are those used to calculate the policies’ guaranteed cash surrender values. For life insurance, other than individual traditional participating life insurance, and annuity and disability products, expected mortality and morbidity are generally based on Company experience, industry data and/or other factors. Interest rate assumptions are based on factors such as market conditions and expected investment returns. Although mortality, morbidity and interest rate assumptions are “locked-in” upon the issuance of new insurance or annuity business with fixed and guaranteed terms, significant changes in experience or assumptions may require the Company to provide for expected future losses on a product by recognizing a premium deficiency. A premium deficiency exists when the liability for future policy benefits plus the present value of expected future gross premiums are determined to be insufficient to provide for expected future policy benefits and expenses. If a premium deficiency is recognized, the assumptions without a provision for the risk of adverse deviation as of the premium deficiency test date are locked-in and used in subsequent valuations. The net reserves continue to be subject to premium deficiency testing. In determining if a premium deficiency related to short-duration contracts exists, the Company considers, among other factors, anticipated investment income. Any adjustments to future policy benefit reserves related to net unrealized gains on securities classified as available-for-sale are included in AOCI. In certain instances, the policyholder liability for a particular line of business may not be deficient in the aggregate to trigger loss recognition, but the pattern of earnings may be such that profits are expected to be recognized in earlier years followed by losses in later years. In these situations, accounting standards require that an additional liability (Profits Followed by Losses or “PFL” liability) be recognized by an amount necessary to sufficiently offset the losses that would be recognized in later years. Historically, PFL liabilities have been predominantly associated with certain universal life contracts that measure GAAP reserves using a dynamic approach, and accordingly, are updated each quarter, using current in-force and market data, and as part of the annual assumption update, such that the liability as of each measurement date represents the Company’s current estimate of the present value of the amount necessary to offset anticipated future losses. See Note 12 for additional information regarding future policy benefits. The Company’s liability for future policy benefits also includes a liability for unpaid claims and claim adjustment expenses. The Company does not establish claim liabilities until a loss has been incurred. However, unpaid claims and claim adjustment expenses include estimates of claims that the Company believes have been incurred but have not yet been reported as of the balance sheet date. The Company’s liability for future policy benefits also includes net liabilities for guarantee benefits related to certain long-duration life and annuity contracts, which are discussed more fully in Note 13, and deferred profits. Policyholders’ account balances represents the contract value that has accrued to the benefit of the policyholder as of the balance sheet date. This liability is primarily associated with the accumulated account deposits, plus interest credited, less policyholder withdrawals and other charges assessed against the account balance, as applicable. These policyholders’ account balances also include provision for benefits under non-life contingent payout annuities and certain unearned revenues. See Note 12 for additional information regarding policyholders’ account balances. Policyholders’ account balances also include amounts representing the fair value of embedded derivative instruments associated with the index-linked features of certain universal life and annuity products. For additional information regarding the valuation of these embedded derivatives, see Note 6. Policyholders’ dividends includes dividends payable to policyholders and the policyholder dividend obligation associated with the participating policies included in the Closed Block. The dividends payable for participating policies included in the Closed Block are determined at the end of each year for the following year by the Board of Directors of The Prudential Insurance Company of America (“PICA”) based on its statutory results, capital position, ratings, and the emerging experience of the Closed Block. The policyholder dividend obligation represents amounts expected to be paid to Closed Block policyholders as an additional policyholder dividend unless otherwise offset by future Closed Block performance. Any adjustments to the policyholder dividend obligation related to net unrealized gains (losses) on securities classified as available-for-sale are included in AOCI. For additional information on the policyholder dividend obligation, see Note 15. The dividends payable for policies other than the participating policies included in the Closed Block include dividends payable in accordance with certain group and individual insurance policies. Securities sold under agreements to repurchase represents liabilities associated with securities repurchase agreements that are used primarily to earn spread income. As part of securities repurchase agreements, the Company transfers U.S. government and government agency securities to a third-party and receives cash as collateral. For securities repurchase agreements, the cash received is typically invested in cash equivalents, short-term investments or fixed maturities. Receivables associated with securities purchased under agreements to resell are generally reflected as cash equivalents. As part of securities resale agreements, the Company invests cash and receives as collateral U.S. government securities or other debt securities. Securities repurchase and resale agreements that satisfy certain criteria are treated as secured borrowing or secured lending arrangements. These agreements are carried at the amounts at which the securities will be subsequently resold or reacquired, as specified in the respective transactions. For securities purchased under agreements to resell, the Company’s policy is to take possession or control of the securities either directly or through a third-party custodian. These securities are valued daily and additional securities or cash collateral is received, or returned, when appropriate to protect against credit exposure. Securities to be resold are the same, or substantially the same, as the securities received. The majority of these transactions are with large brokerage firms and large banks. For securities sold under agreements to repurchase, the market value of the securities to be repurchased is monitored, and additional collateral is obtained where appropriate, to protect against credit exposure. The Company obtains collateral in an amount at least equal to 95% of the fair value of the securities sold. Securities to be repurchased are the same, or substantially the same, as those sold. The majority of these transactions are with highly rated money market funds. Income and expenses related to these transactions executed within the insurance companies used to earn spread income are reported as “Net investment income.” Cash collateral for loaned securities represents liabilities to return cash proceeds from security lending transactions. Securities lending transactions are used primarily to earn spread income. As part of securities lending transactions, the Company transfers U.S. and foreign debt and equity securities, as well as U.S. government and government agency securities, and receives cash as collateral. Cash proceeds from securities lending transactions are primarily used to earn spread income, and are typically invested in cash equivalents, short-term investments or fixed maturities. Securities lending transactions are treated as financing arrangements and are recorded at the amount of cash received. The Company obtains collateral in an amount equal to 102% and 105% of the fair value of the domestic and foreign securities, respectively. The Company monitors the market value of the securities loaned on a daily basis with additional collateral obtained as necessary. Substantially all of the Company’s securities lending transactions are with large brokerage firms and large banks. Income and expenses associated with securities lending transactions used to earn spread income are reported as “Net investment income.” The Company also enters into securities lending transactions where non-cash collateral, typically U.S. government, Japanese government, or other sovereign bonds are received. The collateral received is not reported on the Company’s Consolidated Statements of Financial Position. In these transactions, the Company receives a fee and obtains collateral in an amount equal to 102% to 105% of the fair value of the loaned securities. The Company monitors the market value of the securities loaned on a daily basis with additional collateral obtained as necessary. Substantially all of these transactions are with large brokerage firms and large banks. Income is reported as “Net investment income.” Income taxes primarily represents the net deferred tax liability and the Company’s estimated taxes payable for the current year and open audit years. The Company and its includible domestic subsidiaries file a consolidated federal income tax return that includes both life insurance companies and non-life insurance companies. Subsidiaries operating outside the U.S. are taxed, and income tax expense is recorded, based on applicable foreign statutes. See Note 16 for a discussion of certain non-U.S. jurisdictions for which the Company assumes repatriation of earnings. Items required by tax regulations to be included in the tax return may differ from the items reflected in the financial statements. As a result, the effective tax rate reflected in the financial statements may be different than the actual rate applied on the tax return. Some of these differences are permanent such as expenses that are not deductible in the Company’s tax return, and some differences are temporary, reversing over time, such as valuation of insurance reserves. Temporary differences create deferred tax assets and liabilities. Deferred tax assets generally represent items that can be used as a tax deduction or credit in future years for which the Company has already recorded the tax benefit in the Company’s Consolidated Statements of Operations. Deferred tax liabilities generally represent tax expense recognized in the Company’s financial statements for which payment has been deferred, or expenditures for which the Company has already taken a deduction in the Company’s tax return but have not yet been recognized in the Company’s financial statements. Deferred income taxes are recognized, based on enacted rates, when assets and liabilities have different values for financial statement and tax reporting purposes. The application of U.S. GAAP requires the Company to evaluate the recoverability of the Company’s deferred tax assets and establish a valuation allowance if necessary to reduce the Company’s deferred tax assets to an amount that is more likely than not expected to be realized. Considerable judgment is required in determining whether a valuation allowance is necessary, and if so, the amount of such valuation allowance. See Note 16 for a discussion of factors considered when evaluating the need for a valuation allowance. The U.S. Tax Cuts and Jobs Act of 2017 (“Tax Act of 2017”) included two new tax provisions that could impact the Company’s effective tax rate and cash tax payments. The Base Erosion and Anti-Abuse Tax (“BEAT”) taxes modified taxable income, starting at a rate of 10% in 2019 and increasing to 12.5% in 2026, and is due if the calculated BEAT amount that is determined without the benefit of foreign and certain tax credits is greater than the regular corporate tax in any given year. In general, modified taxable income is calculated by adding back to a taxpayer’s regular taxable income the amount of certain “base erosion tax benefits” with respect to payments to foreign affiliates, as well as the “base erosion percentage” of any net operating loss deductions. Final Regulations confirmed that benefit and claim payments made by our U.S. insurance business to our foreign affiliates on reinsurance assumed by the U.S. affiliates are not base erosion payments. The Global Intangible Low-Taxed Income (“GILTI”) provision applies a minimum U.S. tax to earnings of consolidated foreign subsidiaries in excess of a 10% deemed return on tangible assets of foreign subsidiaries by imposing the U.S. tax rate to 50% of earnings of such foreign affiliates and provides for a partial foreign tax credit for foreign income taxes. The amount of tax in any period on GILTI can depend on annual differences between U.S. taxable income recognition rules and taxable income recognition rules in the country of operations and the overall taxable income of U.S. operations, as well as U.S. expense allocation rules which limit the amount of foreign tax credits that can be applied to reduce the U.S. tax on the GILTI provision. Under certain circumstances, the taxable income of U.S. operations may cause more than 50% of earnings of foreign affiliates to be subject to the GILTI provision. In years that the PFI consolidated federal income tax return reports a net operating loss or has a loss attributable to U.S. sources of operations, the GILTI provision would cause a loss of U.S. tax benefits for some or all of those losses, effectively increasing the tax on foreign earnings. The Company accounts for the effects of the BEAT and GILTI provisions as a period cost if and when incurred. U.S. GAAP prescribes a comprehensive model for how a company should recognize, measure, present, and disclose in its financial statements uncertain tax positions that a company has taken or expects to take on tax returns. The application of this guidance is a two-step process. First, the Company determines whether it is more likely than not, based on the technical merits, that the tax position will be sustained upon examination. If a tax position does not meet the more likely than not recognition threshold, the benefit of that position is not recognized in the financial statements. The second step is measurement. The Company measures the tax position as the largest amount of benefit that is greater than 50 percent likely to be realized upon ultimate resolution with a taxing authority that has full knowledge of all relevant information. This measurement considers the amounts and probabilities of the outcomes that could be realized upon ultimate settlement using the facts, circumstances, and information available at the reporting date. The Company’s liability for income taxes includes a liability for unrecognized tax benefits, interest and penalties which relate to tax years still subject to review by the Internal Revenue Service (“IRS”) or other taxing jurisdictions. Audit periods remain open for review until the statute of limitations has passed. Generally, for tax years which produce net operating losses, capital losses or tax credit carryforwards (“tax attributes”), the statute of limitations does not close, to the extent of these tax attributes, until the expiration of the statute of limitations for the tax year in which they are fully utilized. The completion of review or the expiration of the statute of limitations for a given audit period could result in an adjustment to the liability for income taxes. The Company classifies all interest and penalties related to tax uncertainties as income tax expense. See Note 16 for additional information regarding income taxes. Short-term and long-term debt liabilities are primarily carried at an amount equal to unpaid principal balance, net of unamortized discount or premium and debt issue costs. Original-issue discount or premium and debt-issue costs are recognized as a component of interest expense over the period the debt is expected to be outstanding, using the interest method of amortization. Interest expense is generally presented within “General and administrative expenses” in the Company’s Consolidated Statements of Operations. Interest expense may also be reported within “Net investment income” for certain activity, as prescribed by specialized industry guidance. Short-term debt is debt coming due in the next twelve months, including that portion of debt otherwise classified as long-term. The short-term debt caption may exclude short-term debt items for which the Company has the intent and ability to refinance on a long-term basis in the near-term. See Note 17 for additional information regarding short-term and long-term debt. Liabilities held-for-sale consists of liabilities associated with pending business dispositions. See “Assets held-for-sale" above for further description of the held-for-sale classification. See Note 1 for additional information on the pending business dispositions, including the composition of liabilities included as “Liabilities held-for-sale”. Other liabilities consists primarily of trade payables, lease liabilities (see “Other assets” above), pension and other employee benefit liabilities (see Note 18), derivative liabilities (see “Derivative Financial Instruments” below), reinsurance payables (see “Reinsurance” below), and payables resulting from purchases of securities that had not yet settled at the balance sheet date. Notes issued by consolidated variable interest entities represents notes issued by certain asset-backed investment vehicles, primarily collateralized loan obligations (“CLOs”), which the Company is required to consolidate. The creditors of these VIEs do not have recourse to the Company in excess of the assets contained within the VIEs. The Company has elected the fair value option for the majority of these notes, and has based the fair value on the corresponding bank loan collateral. Changes in fair value are reported in “Other income (loss).” Separate account liabilities primarily represents the contractholders’ account balances in separate account assets and to a lesser extent borrowings of the separate account, and will be equal and offsetting to total separate account assets. See also “Separate account assets” above. Commitments and contingent liabilities are accrued if it is probable that a liability has been incurred and an amount is reasonably estimable. Management evaluates whether there are incremental legal or other costs directly associated with the ultimate resolution of the matter that are reasonably estimable and, if so, they are included in the accrual. These accruals are generally reported in “Other liabilities.” REVENUES AND BENEFITS AND EXPENSES Insurance Revenue and Expense Recognition Premiums from individual life products (other than universal and variable life contracts), as well as health insurance and long-term care products are recognized when due. When premiums are due over a significantly shorter period than the period over which benefits are provided, any gross premium in excess of the net premium is generally deferred and recognized into revenue in a constant relationship to insurance in force. Benefits are recorded as an expense when they are incurred. A liability for future policy benefits is recorded when premiums are recognized using the net level premium valuation methodology. Premiums from non-participating group annuities with life contingencies, single premium structured settlements with life contingencies and single premium immediate annuities with life contingencies are recognized when due. When premiums are due over a significantly shorter period than the period over which benefits are provided, any gross premium in excess of the net premium is generally deferred and recognized into revenue based on expected future benefit payments. Benefits are recorded as an expense when they are incurred. A liability for future policy benefits is recorded when premiums are recognized using the net level premium valuation methodology. Certain individual annuity contracts provide the contractholder a guarantee that the benefit received upon death or annuitization will be no less than a minimum prescribed amount. These benefits are accounted for as insurance contracts. The Company also provides contracts with certain living benefits which are considered embedded derivatives. See Note 13 for additional information regarding these contracts and Note 6 for information regarding the valuation of these embedded derivatives. Amounts received as payment for universal or variable group and individual life contracts, deferred fixed or variable annuities, structured settlements and other contracts without life contingencies, and participating group annuities are reported as deposits to “Policyholders’ account balances” and/or “Separate account liabilities.” Revenues from these contracts are reflected in “Policy charges and fee income” consisting primarily of fees assessed during the period against the policyholders’ account balances for mortality and other benefit charges, policy administration charges and surrender charges. In addition to fees, the Company earns investment income from the investment of deposits in the Company’s general account portfolio. Fees assessed that represent compensation to the Company for services to be provided in future periods and certain other fees are generally deferred and amortized into revenue over the life of the related contracts in proportion to estimated gross profits. Benefits and expenses for these products include claims in excess of related account balances, expenses of contract administration, interest credited to policyholders’ account balances and amortization of DAC, DSI and VOBA. Policyholders’ account balances also include amounts representing the fair value of embedded derivative instruments associated with the index-linked features of certain universal life and annuity products where changes in the value of the embedded derivatives are recorded though “Realized investment gains (losses), net”. For additional information regarding the valuation of these embedded derivatives, see Note 6. For group life (other than universal and variable group life contracts) and disability insurance, premiums are generally recognized over the period to which the premiums relate in proportion to the amount of insurance protection provided. Claim and claim adjustment expenses are recognized when incurred. Asset management and service fees principally includes asset-based asset management fees, which are recognized in the period in which the services are performed. In certain asset management fee arrangements, the Company is entitled to receive performance-based incentive fees when the return on assets under management exceeds certain benchmark returns or other performance targets. The Company may be required to return all, or part, of such performance-based incentive fees depending on future performance of these assets relative to performance benchmarks. The Company records performance-based incentive fee revenue when the contractual terms of the asset management fee arrangement have been satisfied and it is probable that a significant reversal in the amount of the fee will not occur. Under this principle the Company records a deferred performance- based incentive fee liability to the extent it receives cash related to the performance-based incentive fee prior to meeting the revenue recognition criteria delineated above. Other income (loss) includes realized and unrealized gains or losses from investments classified “Fixed maturities, trading, at fair value,” “Assets supporting experience-rated contractholder liabilities, at fair value,” “Equity securities, at fair value,” and “Other invested assets” that are measured at fair value and consolidated entities that follow specialized investment company fair value accounting. “Other income (loss)” also includes gains and losses primarily related to the remeasurement of foreign currency denominated assets and liabilities, as discussed in more detail under “Foreign Currency” below. Additionally, for digital insurance brokerage placement services provided by Assurance IQ, the Company earns both initial and renewal commissions as compensation for the placement of insurance policies with insurance carriers. At the effective date of the policy, the Company records within “Other income (loss)” the expected lifetime revenue for the initial and renewal commissions considering estimates of the timing of future policy cancellations. These estimates are reassessed each reporting period and any changes in estimates are reflected in the current period. Realized investment gains (losses), net includes realized gains or losses from sales and maturities of investments, changes to the allowance for credit losses, other impairments, fair value changes on mortgage loans where the fair value option has been elected, and derivative gains or losses. The derivative gains or losses include the impact of maturities, terminations and changes in fair value of the derivative instruments, including embedded derivatives, and other hedging instruments. Realized investment gains (losses) from the sales of securities are generally calculated using the specific identification method, with the exception of some of the Company’s International Businesses portfolios where the average cost method is used. OTHER ACCOUNTING POLICIES Share-Based Payments The Company applies the fair value-based measurement method in accounting for share-based payment transactions with employees except for equity instruments held by employee share ownership plans. Excess tax benefits (deficits) are recorded in earnings and represent the cumulative difference between the actual tax benefit realized and the amount of deferred tax assets recorded attributable to shared-based payment transactions. The Company accounts for non-employee stock options using the fair value method in accordance with authoritative guidance and related interpretations on accounting for equity instruments that are issued to other than employees for acquiring, or in conjunction with selling, goods or services. Earnings Per Share Earnings per share of Common Stock for 2021, 2020 and 2019 reflects the consolidated earnings of Prudential Financial. Basic earnings per share is computed by dividing available income attributable to common shareholders by the weighted average number of common shares outstanding for the period. Diluted earnings per share includes the effect of all dilutive potential common shares that were outstanding during the period. See Note 20 for additional information. Foreign Currency The currency in which the Company prepares its financial statements (the “reporting currency”) is the U.S. dollar. Assets, liabilities and results of foreign operations are recorded based on the functional currency of each foreign operation. The determination of the functional currency is based on economic facts and circumstances pertaining to each foreign operation. The local currencies of the Company’s foreign operations are typically their functional currencies with the most significant exception being the Company’s Japanese operations where multiple functional currencies exist. There are two distinct processes for expressing these foreign transactions and balances in the Company’s financial statements: foreign currency measurement and foreign currency translation. Foreign currency measurement is the process by which transactions in foreign currencies are expressed in the functional currency. Gains and losses resulting from foreign currency measurement are reported in current earnings in “Other income (loss).” Foreign currency translation is the process of expressing a foreign entity’s functional currency financial statements in the reporting currency. Assets and liabilities of foreign operations and subsidiaries reported in currencies other than U.S. dollars are translated at the exchange rate in effect at the end of the period. Revenues, benefits and other expenses are translated at the average rate prevailing during the period. The effects of translating the statements of operations and financial position of non-U.S. entities with functional currencies other than the U.S. dollar are included, net of related qualifying hedge gains and losses and income taxes, in “Foreign currency translation adjustment,” a component of AOCI. Derivative Financial Instruments Derivatives are financial instruments whose values are derived from interest rates, foreign exchange rates, financial indices, values of securities or commodities, credit spreads, market volatility, expected returns, and liquidity. Values can also be affected by changes in estimates and assumptions, including those related to counterparty behavior and non-performance risk (“NPR”) used in valuation models. Derivative financial instruments generally used by the Company include swaps, futures, forwards and options and may be exchange-traded or contracted in the over-the-counter (“OTC”) market. Certain of the Company’s OTC derivatives are cleared and settled through central clearing counterparties (OTC-cleared), while others are bilateral contracts between two counterparties (OTC-bilateral). Derivative positions are carried at fair value, generally by obtaining quoted market prices or through the use of valuation models. Derivatives are used to manage the interest rate and currency characteristics of assets or liabilities and to mitigate volatility of expected non-functional currency earnings and net investments in foreign operations resulting from changes in currency exchange rates. Additionally, derivatives may be used to reduce exposure to interest rate, credit, foreign currency and equity risks associated with assets held or expected to be purchased or sold, and liabilities incurred or expected to be incurred. As discussed in detail below, and in Note 5, all realized and unrealized changes in fair value of derivatives are recorded in current earnings, with the exception of cash flow hedges and hedges of net investments in foreign operations. The Company may also enter into intercompany derivatives, the results of which ultimately eliminate in consolidation over the term of the instrument; however, where applicable, derivative results are included in business gross profits which may impact the pattern by which DAC and other assets are amortized. Cash flows from derivatives are reported in the operating, investing, or financing activities sections in the Consolidated Statements of Cash Flows based on the nature and purpose of the derivative. Derivatives are recorded either as assets, within “Other invested assets,” or as liabilities, within “Other liabilities,” except for embedded derivatives which are recorded with the associated host contract. The Company nets the fair value of all derivative financial instruments with counterparties for which a master netting arrangement has been executed. The Company designates derivatives as either (1) a hedge of the fair value of a recognized asset or liability or unrecognized firm commitment (“fair value” hedge); (2) a hedge of a forecasted transaction or of the variability of cash flows to be received or paid related to a recognized asset or liability (“cash flow” hedge); (3) a foreign currency fair value or cash flow hedge (“foreign currency” hedge); (4) a hedge of a net investment in a foreign operation; or (5) a derivative that does not qualify for hedge accounting. To qualify for hedge accounting treatment, a derivative must be highly effective in mitigating the designated risk of the hedged item. Effectiveness of the hedge is formally assessed at inception and throughout the life of the hedging relationship. The Company formally documents at inception all relationships between hedging instruments and hedged items, as well as its risk-management objective and strategy for undertaking various hedge transactions. This process includes linking all derivatives designated as fair value, cash flow, or foreign currency hedges to specific assets and liabilities on the balance sheet or to specific firm commitments or forecasted transactions. Hedges of a net investment in a foreign operation are linked to the specific foreign operation. When a derivative is designated as a fair value hedge and is determined to be highly effective, changes in its fair value, along with changes in the fair value of the hedged asset or liability (including losses or gains on firm commitments), are reported on a net basis in the Consolidated Statements of Operations, generally in “Realized investment gains (losses), net.” When swaps are used in hedge accounting relationships, periodic settlements are recorded in the same Consolidated Statements of Operations line as the related settlements of the hedged items. When a derivative is designated as a cash flow hedge and is determined to be highly effective, changes in its fair value are recorded in AOCI until earnings are affected by the variability of cash flows being hedged (e.g., when periodic settlements on a variable-rate asset or liability are recorded in earnings). At that time, the related portion of deferred gains or losses on the derivative instrument is reclassified and reported in the Consolidated Statements of Operations line item associated with the hedged item. When a derivative is designated as a foreign currency hedge and is determined to be highly effective, changes in its fair value are recorded either in current period earnings if the hedge transaction is a fair value hedge (e.g., a hedge of a recognized foreign currency asset or liability) or in AOCI if the hedge transaction is a cash flow hedge (e.g., a foreign currency denominated forecasted transaction). When a derivative is used as a hedge of a net investment in a foreign operation, its change in fair value is accounted for in the same manner as a translation adjustment (i.e., reported in the cumulative translation adjustment account within AOCI). If it is determined that a derivative no longer qualifies as an effective fair value or cash flow hedge or management removes the hedge designation, the derivative will continue to be carried on the balance sheet at its fair value, with changes in fair value recognized currently in “Realized investment gains (losses), net.” In this scenario, the hedged asset or liability under a fair value hedge will no longer be adjusted for changes in fair value associated with the hedged risk and the existing basis adjustment is amortized to the Consolidated Statements of Operations line associated with the asset or liability. The component of AOCI related to discontinued cash flow hedges is reclassified to the Consolidated Statements of Operations line associated with the hedged cash flows consistent with the earnings impact of the original hedged cash flows. When hedge accounting is discontinued because the hedged item no longer meets the definition of a firm commitment, or because it is probable that the forecasted transaction will not occur by the end of the specified time period, the derivative will continue to be carried on the balance sheet at its fair value, with changes in fair value recognized currently in “Realized investment gains (losses), net.” Any asset or liability that was recorded pursuant to recognition of the firm commitment is removed from the balance sheet and recognized currently in “Realized investment gains (losses), net.” Gains and losses that were in AOCI pursuant to the cash flow hedge of a forecasted transaction are recognized immediately in “Realized investment gains (losses), net.” If a derivative does not qualify for hedge accounting, all changes in its fair value, including net receipts and payments, are included in “Realized investment gains (losses), net” without considering changes in the fair value of the economically associated assets or liabilities. The Company is a party to financial instruments that contain derivative instruments that are “embedded” in the financial instruments. At inception, the Company assesses whether the economic characteristics of the embedded instrument are clearly and closely related to the economic characteristics of the remaining component of the financial instrument (i.e., the host contract) and whether a separate instrument with the same terms as the embedded instrument would meet the definition of a derivative instrument. When it is determined that (1) the embedded instrument possesses economic characteristics that are not clearly and closely related to the economic characteristics of the host contract and (2) a separate instrument with the same terms would qualify as a derivative instrument, the embedded instrument qualifies as an embedded derivative that is separated from the host contract, carried at fair value, and changes in its fair value are included in “Realized investment gains (losses), net.” For certain financial instruments that contain an embedded derivative that otherwise would need to be bifurcated and reported at fair value, the Company may elect to carry the entire instrument at fair value and report it within “Other invested assets” or “Other liabilities.” Reinsurance For each of its reinsurance contracts, the Company determines if the contract provides indemnification against loss or liability relating to insurance risk in accordance with applicable accounting standards. The Company reviews all contractual features, particularly those that may limit the amount of insurance risk to which the reinsurer is subject or features that delay the timely reimbursement of claims. The Company participates in reinsurance arrangements in various capacities as either the ceding entity or as the reinsurer (i.e., assuming entity). See Note 14 for additional information about the Company’s reinsurance arrangements. Reinsurance assumed business is generally accounted for consistent with direct business. Amounts currently recoverable under reinsurance agreements are included in “Other assets” and amounts payable are included in “Other liabilities.” Revenues and benefits and expenses include amounts assumed under reinsurance agreements and are reflected net of reinsurance ceded. Reinsurance ceded arrangements do not discharge the Company as the primary insurer. Ceded balances would represent a liability of the Company in the event the reinsurers were unable to meet their obligations to the Company under the terms of the reinsurance agreements. Reinsurance recoverables are reported net of the CECL allowance. The CECL allowance considers the credit quality of the reinsurance counterparty and is generally determined based on the probability of default and loss given default assumptions, after considering any applicable collateral arrangements. Additions to or releases of the allowance are reported in “Policyholders’ benefits”. Reinsurance premiums, commissions, expense reimbursements, benefits and reserves related to reinsured long-duration contracts under coinsurance arrangements are accounted for over the life of the underlying reinsured contracts using assumptions consistent with those used to account for the underlying contracts. Coinsurance arrangements contrast with the Company’s yearly renewable term arrangements, where only mortality risk is transferred to the reinsurer and premiums are paid to the reinsurer to reinsure that risk. The mortality risk that is reinsured under yearly renewable term arrangements represents the difference between the stated death benefits in the underlying reinsured contracts and the corresponding reserves or account value carried by the Company on those same contracts. The premiums paid to the reinsurer are based upon negotiated amounts, not on the actual premiums paid by the underlying contract holders to the Company. As yearly renewable term arrangements are usually entered into by the Company with the expectation that the contracts will be in force for the lives of the underlying policies, they are considered to be long-duration reinsurance contracts. The cost of reinsurance for universal life products is generally recognized based on the gross assessments of the underlying direct policies. The cost of reinsurance for term insurance products is generally recognized in proportion to yearly renewable term premiums over the life of the underlying policies. The cost of reinsurance related to short-duration reinsurance contracts is accounted for over the reinsurance contract period. If the Company determines that a reinsurance agreement does not expose the reinsurer to a reasonable possibility of a significant loss from insurance risk, the Company records the agreement using the deposit method of accounting. Deposits received are included in “Other liabilities” and deposits made are included in “Other assets”. As amounts are paid or received, consistent with the underlying contracts, the deposit assets or liabilities are adjusted. Interest on such deposits is recorded as “Other income (loss)” or “General and administrative expenses,” as appropriate. RECENT ACCOUNTING PRONOUNCEMENTS Changes to U.S. GAAP are established by the Financial Accounting Standards Board (“FASB”) in the form of Accounting Standards Updates (“ASUs”) to the FASB Accounting Standards Codification (“ASC”). The Company considers the applicability and impact of all ASUs. ASUs listed below include those that have been adopted during the current fiscal year and/or those that have been issued but not yet adopted as of December 31, 2021, and as of the date of this filing. ASUs not listed below were assessed and determined to be either not applicable or not material. ASU issued but not yet adopted as of December 31, 2021— ASU 2018-12 ASU 2018-12, Financial Services—Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts, was issued by the FASB on August 15, 2018, and was amended by ASU 2019-09, Financial Services - Insurance (Topic 944): Effective Date, issued in October 2019, and ASU 2020-11, Financial Services—Insurance (Topic 944): Effective Date and Early Application, issued in November 2020. The Company will adopt ASU 2018-12 effective January 1, 2023 using the modified retrospective transition method where permitted, and apply the guidance as of January 1, 2021 (and record transition adjustments as of January 1, 2021) in the 2023 financial statements. The Company has an established governance framework to manage the implementation of the standard. The Company’s implementation efforts continue to progress including, but not limited to, implementing refinements to key accounting policy decisions, modifications to actuarial valuation models, updates to data sourcing capabilities, automation of key financial reporting and analytical processes and updates to internal controls over financial reporting. ASU 2018-12 will impact, at least to some extent, the accounting and disclosure requirements for all long-duration insurance and investment contracts issued by the Company. While the magnitude of impacts is still being assessed, the Company expects the standard to result in a significant decrease to “Total equity” upon adoption, primarily from remeasuring in-force contract liabilities using current upper-medium grade fixed income instrument yields through “Accumulated other comprehensive income (loss)”. The standard also requires significantly enhanced disclosures. In addition to the significant impacts to the balance sheet upon adoption, the Company also expects an impact to the pattern of earnings emergence following the transition date. Outlined below are four key areas of change, although there are other less significant policy changes not noted below.
Modifications related to COVID-19 We assess modifications to certain fixed income instruments on a case-by-case basis to evaluate whether a TDR has occurred. In response to the COVID-19 pandemic, the Coronavirus Aid, Relief and Economic Security Act ("CARES Act") provides a temporary suspension of TDR accounting for certain COVID-19 related modifications where the investment was not more than 30 days past due as of December 31, 2019 (“TDR Relief”). The TDR Relief was set to expire on December 31, 2020, but was extended through December 31, 2021 by the Consolidated Appropriations Act of 2021. The Company elected to apply the TDR Relief beginning in the first quarter of 2021. The TDR Relief does not apply to modifications completed 60 days after the national emergency related to COVID-19 ends, or December 31, 2021, whichever comes earlier. As of December 31, 2021, any such modifications did not have a material impact on the Company's results of operations.
|
Investments |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investments [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investments | INVESTMENTS Fixed Maturity Securities The following tables set forth the composition of fixed maturity securities (excluding investments classified as trading), as of the dates indicated:
__________ (1)Excludes “Assets held-for-sale” with amortized cost of $13,145 million, fair value of $13,569 million, unrealized gains of $572 million, unrealized losses of $147 million and allowance for credit losses of $1 million. See Note 1 for additional information on the pending dispositions. (2)Excludes notes with amortized cost of $5,941 million (fair value, $5,995 million), which have been offset with the associated debt under a netting agreement. (3)Includes credit-tranched securities collateralized loan obligations, education loans, auto loans, credit cards and other asset types. (4)Includes publicly-traded agency pass-through securities and collateralized mortgage obligations. (5)Excludes notes with amortized cost of $4,750 million (fair value, $5,394 million), which have been offset with the associated debt under a netting agreement.
__________ (1)Excludes notes with amortized cost of $5,966 million (fair value, $6,100 million), which have been offset with the associated debt under a netting agreement. (2)Includes credit-tranched securities collateralized by loan obligations, auto loans, education loans, home equity and other asset types. (3)Includes publicly-traded agency pass-through securities and collateralized mortgage obligations. (4)Excludes notes with amortized cost of $4,998 million (fair value, $5,821 million), which have been offset with the associated debt under a netting agreement. The following tables set forth the fair value and gross unrealized losses on available-for-sale fixed maturity securities without an allowance for credit losses aggregated by investment category and length of time that individual fixed maturity securities had been in a continuous unrealized loss position, as of the dates indicated:
__________ (1)Excludes “Assets held-for-sale” with fair value of $4,644 million and gross unrealized losses of $147 million. See Note 1 for additional information on the pending dispositions.
As of December 31, 2021 and 2020, the gross unrealized losses on fixed maturity available-for-sale securities without an allowance were composed of $1,242 million and $636 million, respectively, related to “1” highest quality or “2” high quality securities based on the National Association of Insurance Commissioners (“NAIC”) or equivalent rating and $463 million and $313 million, respectively, related to other than high or highest quality securities based on NAIC or equivalent rating. As of December 31, 2021, the $755 million of gross unrealized losses of twelve months or more were concentrated in the consumer non-cyclical, utility and finance sectors within corporate securities. As of December 31, 2020, the $463 million of gross unrealized losses of twelve months or more were concentrated in the energy, utility and finance sectors within corporate securities. In accordance with its policy described in Note 2, the Company concluded that an adjustment to earnings for credit losses related to these fixed maturity securities was not warranted at December 31, 2021. This conclusion was based on a detailed analysis of the underlying credit and cash flows on each security. Gross unrealized losses are primarily attributable to increases in interest rates, general credit spread widening, foreign currency exchange rate movements and the financial condition or near-term prospects of the issuer. As of December 31, 2021, the Company did not intend to sell these securities, and it was not more likely than not that the Company would be required to sell these securities before the anticipated recovery of the remaining amortized cost basis. The following table sets forth the amortized cost or amortized cost, net of allowance and fair value of fixed maturities by contractual maturities, as of the date indicated:
__________ (1)Excludes “Assets held-for-sale” with amortized cost of $13,145 million and fair value of $13,569 million. See Note 1 for additional information on the pending dispositions. (2)Excludes available-for-sale notes with amortized cost of $5,941 million (fair value, $5,995 million) and held-to-maturity notes with amortized cost of $4,750 million (fair value, $5,394 million), which have been offset with the associated debt under a netting agreement. Actual maturities may differ from contractual maturities because issuers may have the right to call or prepay obligations. Asset-backed, commercial mortgage-backed and residential mortgage-backed securities are shown separately in the table above, as they do not have a single maturity date. The following table sets forth the sources of fixed maturity proceeds and related investment gains (losses), as well as losses on write-downs and the allowance for credit losses of fixed maturities, for the periods indicated:
__________ (1)Excludes activity from non-cash related proceeds due to the timing of trade settlements of $450 million, $(470) million and $(13) million for the years ended December 31, 2021, 2020 and 2019, respectively. (2)For the year ended December 31, 2019, amounts exclude the portion of OTTI amounts remaining in OCI, representing any difference between the fair value of the impaired debt security and the net present value of its projected future cash flows at the time of impairment. (3)Amounts represent write-downs of credit adverse securities and securities actively marketed for sale. In addition, for the years ended December 31, 2020 and 2019, amounts also include write-downs on securities approaching maturities related to foreign exchange movements. (4)Effective January 1, 2020, credit losses on available-for-sale and held-to-maturity fixed maturity securities are recorded within the “allowance for credit losses”. (5)Excludes activity from non-cash related proceeds due to the timing of trade settlements of less than $(1) million, less than $(1) million and less than $1 million for the years ended December 31, 2021, 2020 and 2019, respectively. The following tables set forth the activity in the allowance for credit losses for fixed maturity securities, as of the dates indicated:
__________ (1) See Note 1 for additional information on the pending dispositions.
See Note 2 for additional information about the Company’s methodology for developing our allowance and expected losses. For the year ended December 31, 2021, the net decrease in the allowance for credit losses on available-for-sale securities was primarily related to the overall improving credit environment in the energy and consumer cyclical sectors within corporate securities, partially offset by net additions in the transportation, communications and utility sectors within corporate securities due to adverse projected cash flows. For the year ended December 31, 2020, the net increase in the allowance for credit losses on available-for-sale securities was primarily related to securities within the energy, communications and consumer cyclical sectors within corporate securities due to adverse projected cash flows, partially offset by a release on restructured securities in the energy sector within corporate securities and foreign government securities. The Company did not have any fixed maturity securities purchased with credit deterioration, as of both December 31, 2021 and 2020. Assets Supporting Experience-Rated Contractholder Liabilities The following table sets forth the composition of “Assets supporting experience-rated contractholder liabilities,” as of the dates indicated:
__________ (1)See Note 1 for additional information on the pending dispositions. (2)Includes publicly-traded agency pass-through securities and collateralized mortgage obligations. (3)Includes collateralized loan obligations, auto loans, education loans, home equity and other asset types. Collateralized loan obligations at fair value, including “Assets held-for-sale” were $1,607 million and $1,102 million as of December 31, 2021 and 2020, respectively, all of which were rated AA or above. (4)As a percentage of amortized cost, 97% and 94% of the portfolio including “Assets held-for-sale” was considered high or highest quality based on NAIC or equivalent ratings, as of December 31, 2021 and 2020, respectively. (5)As a percentage of amortized cost, 95% and 79% of the portfolio including “Assets held-for-sale” consisted of public securities as of December 31, 2021 and 2020, respectively. The net change in unrealized gains (losses) from assets supporting experience-rated contractholder liabilities including “Assets held-for-sale” still held at period end, recorded within “Other income (loss),” was $(708) million, $726 million and $996 million during the years ended December 31, 2021, 2020 and 2019, respectively. Equity Securities The net change in unrealized gains (losses) from equity securities still held at period end, including “Assets held-for-sale” recorded within “Other income (loss),” was $591 million, $205 million and $943 million during the years ended December 31, 2021, 2020 and 2019, respectively. Concentrations of Financial Instruments The Company monitors its concentrations of financial instruments and mitigates credit risk by maintaining a diversified investment portfolio which limits exposure to any single issuer. As of the dates indicated, the Company’s exposure to concentrations of credit risk of single issuers greater than 10% of the Company’s equity included securities of the U.S. government and certain U.S. government agencies and securities guaranteed by the U.S. government, as well as the securities disclosed below:
Commercial Mortgage and Other Loans The following table sets forth the composition of “Commercial mortgage and other loans,” as of the dates indicated:
__________ (1)Excludes “Assets held-for-sale” of $6,565 million net of allowance for credit losses of $15 million as of December 31, 2021. See Note 1 for additional information on the pending dispositions. (2)Includes loans which are carried at fair value under the fair value option and are collateralized primarily by apartment complexes. As of December 31, 2021 and 2020, the net carrying value of these loans was $1,263 million and $1,092 million, respectively. As of December 31, 2021, the commercial mortgage and agricultural property loans were secured by properties geographically dispersed throughout the United States (with the largest concentrations in California (29%), Texas (7%) and New York (7%)) and included loans secured by properties in Europe (6%), Asia (2%) and Australia (1%). The following table sets forth the activity in the allowance for credit losses for commercial mortgage and other loans, as of the dates indicated:
__________ (1) See Note 1 for additional information on the pending dispositions. See Note 2 for additional information about the Company’s methodology for developing our allowance and expected losses. For the year ended December 31, 2021, the net decrease in the allowance for credit losses on commercial mortgage and other loans was primarily related to the improving credit environment. For the year ended December 31, 2020, the increase in the allowance for credit losses on commercial mortgage and other loans was primarily related to the cumulative effect of adoption of ASU 2016-13. The following tables set forth key credit quality indicators based upon the recorded investment gross of allowance for credit losses, as of the date indicated:
__________ (1) Excludes “Assets held-for-sale” of $6,580 million. See Note 1 for additional information on the pending dispositions.
See Note 2 for additional information about the Company’s commercial mortgage and other loans credit quality monitoring process. The following tables set forth an aging of past due commercial mortgage and other loans based upon the recorded investment gross of allowance for credit losses, as well as the amount of commercial mortgage and other loans on non-accrual status, as of the dates indicated:
__________ (1)As of December 31, 2021, there were no loans in this category accruing interest. (2)For additional information regarding the Company’s policies for accruing interest on loans, see Note 2. (3)Excludes “Assets held-for-sale” of $6,580 million. See Note 1 for additional information on the pending dispositions.
__________ (1)As of December 31, 2020, there were no loans in this category accruing interest. (2)For additional information regarding the Company’s policies for accruing interest on loans, see Note 2. Loans on non-accrual status recognized interest income of $5 million and $2 million for the year ended December 31, 2021 and 2020, respectively. Loans on non-accrual status that did not have a related allowance for credit losses were $20 million and $15 million as of December 31, 2021 and 2020, respectively. The Company did not have any significant losses on commercial mortgage and other loans purchased with credit deterioration, as of both December 31, 2021 and 2020. Other Invested Assets The following table sets forth the composition of “Other invested assets,” as of the dates indicated:
__________ (1)Prior period amounts have been updated to conform to current period presentation. (2)As of December 31, 2021 and 2020, real estate held through direct ownership had mortgage debt of $274 million and $409 million, respectively. (3)Primarily includes strategic investments made by investment management operations, leveraged leases and member and activity stock held in the Federal Home Loan Banks of New York and Boston. For additional information regarding the Company’s holdings in the Federal Home Loan Banks of New York, see Note 17. (4)Excludes “Assets held-for-sale” of $104 million as of December 31, 2021. See Note 1 for additional information on the pending dispositions. In certain investment structures, the Company’s investment management business invests with other co-investors in an investment fund referred to as a feeder fund. In these structures, the invested capital of several feeder funds is pooled together and used to purchase ownership interests in another fund, referred to as a master fund. The master fund utilizes this invested capital and, in certain cases, other debt financing, to purchase various classes of assets on behalf of its investors. Specialized industry accounting for investment companies calls for the feeder fund to reflect its investment in the master fund as a single net asset equal to its proportionate share of the net assets of the master fund, regardless of its level of interest in the master fund. In cases where the Company consolidates the feeder fund, it retains the feeder fund’s net asset presentation and reports the consolidated feeder fund’s proportionate share of the net assets of the master fund in “Other invested assets,” with any unaffiliated investors’ non-controlling interest in the feeder fund reported in “Other liabilities” or “Noncontrolling interests.” The consolidated feeder funds’ investments in these master funds, reflected on this net asset basis, totaled $654 million and $459 million as of December 31, 2021 and 2020, respectively. There was $467 million and $201 million of unaffiliated interest in the consolidated feeder funds as of December 31, 2021 and 2020, respectively, and the master funds had gross assets of $76,600 million and $54,123 million, respectively, and gross liabilities of $73,882 million and $50,706 million, respectively, which are not included on the Company’s balance sheet. Equity Method Investments The following tables set forth summarized combined financial information for significant LP/LLC interests accounted for under the equity method, including the Company’s investments in operating joint ventures that are described in more detail in Note 9. Changes between periods in the tables below reflect changes in the activities within the operating joint ventures and LPs/LLCs, as well as changes in the Company’s level of investment in such entities:
__________ (1)Amount represents gross assets of each fund where the Company has a significant investment. These assets consist primarily of investments in real estate, investments in securities and other miscellaneous assets. (2)Amount represents gross liabilities of each fund where the Company has a significant investment. These liabilities consist primarily of third-party-borrowed funds, securities repurchase agreements and other miscellaneous liabilities. (3)Excludes “Assets held-for-sale” of $81 million. See Note 1 for additional information on the pending dispositions.
__________ (1)Amount represents gross revenue of each fund where the Company has a significant investment. This revenue consists of income from investments in real estate, investments in securities and other income. (2)Amount represents gross expenses of each fund where the Company has a significant investment. These expenses consist primarily of interest expense, investment management fees, salary expenses and other expenses. Accrued Investment Income The following table sets forth the composition of “Accrued investment income,” as of the dates indicated:
(1) Excludes “Assets held-for-sale” of $221 million as of December 31, 2021. See Note 1 for additional information on the pending dispositions. Write-downs on accrued investment income were less than $1 million for both the years ended December 31, 2021 and 2020. Net Investment Income The following table sets forth “Net investment income” by investment type, for the periods indicated:
__________ (1)Includes income on credit-linked notes which are reported on the same financial statement line items as related surplus notes, as conditions are met for right to offset. The carrying value of non-income producing assets included $437 million in available-for-sale fixed maturities, $72 million in trading fixed maturities and less than $1 million in other invested assets as of December 31, 2021. Non-income producing assets represent investments that had not produced income for the twelve months preceding December 31, 2021. Realized Investment Gains (Losses), Net The following table sets forth “Realized investment gains (losses), net” by investment type, for the periods indicated:
__________ (1)Includes fixed maturity securities classified as available-for-sale and held-to-maturity and excludes fixed maturity securities classified as trading. Net Unrealized Gains (Losses) on Investments within AOCI The following table sets forth net unrealized gains (losses) on investments, as of the dates indicated:
__________ (1)Effective January 1, 2020, per ASU 2016-13, fixed maturity securities, available-for-sale are no longer required to be disclosed “with OTTI” and “all other.” (2)Includes net unrealized gains of $425 million on “Assets held-for-sale” as of December 31, 2021. (3)For additional information on cash flow and fair value hedges, see Note 5. (4)As of December 31, 2021, there were no net unrealized losses on held-to-maturity securities that were previously transferred from available-for-sale. Includes net unrealized gains on certain joint ventures that are strategic in nature and are included in “Other assets.”Repurchase Agreements and Securities Lending In the normal course of business, the Company sells securities under agreements to repurchase and enters into securities lending transactions. The following table sets forth the composition of “Securities sold under agreements to repurchase,” as of the dates indicated:
The following table sets forth the composition of “Cash collateral for loaned securities” which represents the liability to return cash collateral received for the following types of securities loaned, as of the dates indicated:
__________ (1)The Company did not have any agreements with remaining contractual maturities greater than thirty days, as of the dates indicated. Securities Pledged The Company pledges as collateral investment securities it owns to unaffiliated parties through certain transactions, including securities lending, securities sold under agreements to repurchase, collateralized borrowings and postings of collateral with derivative counterparties. The following table sets forth the carrying value of investments pledged to third parties, as of the dates indicated:
__________ (1)Includes fixed maturity securities classified as available-for-sale and held-to-maturity and excludes fixed maturity securities classified as trading. The following table sets forth the carrying amount of the associated liabilities supported by the pledged collateral, as of the dates indicated:
In the normal course of its business activities, the Company accepts collateral that can be sold or repledged. The primary sources of this collateral are securities in customer accounts, securities purchased under agreements to resell and postings of collateral from OTC derivative counterparties. The fair value of this collateral was approximately $4,967 million as of December 31, 2021 (the largest components of which included $334 million of securities and $4,633 million of cash from OTC derivative counterparties) and $8,872 million as of December 31, 2020 (the largest components of which included $252 million of securities and $8,620 million of cash from OTC derivative counterparties). A portion of the aforementioned securities, for both periods, had either been sold or repledged. Assets on Deposit, Held in Trust, and Restricted as to Sale The following table provides assets on deposit, assets held in trust, and securities restricted as to sale, as of the dates indicated:
__________ (1)Represents assets held in voluntary trusts established primarily to fund guaranteed dividends to certain policyholders and to fund certain employee benefits. (2)Represents assets held in trust related to reinsurance agreements excluding reinsurance agreements between wholly-owned subsidiaries. Assets valued at $28.4 billion and $34.0 billion were held in trust related to reinsurance agreements between wholly-owned subsidiaries as of December 31, 2021 and 2020, respectively. (3)Includes member and activity stock associated with memberships in the Federal Home Loan Banks of New York and Boston. (4)Includes $553 million “Assets held-for-sale” related to the pending sales of PALAC and Full Service Retirement Business as of December 31, 2021.
|
Variable Interest Entities |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Variable Interest Entity, Measure of Activity [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Variable Interest Entities | VARIABLE INTEREST ENTITIES In the normal course of its activities, the Company enters into relationships with various special-purpose entities and other entities that are deemed to be VIEs. A VIE is an entity that either (1) has equity investors that lack certain essential characteristics of a controlling financial interest (including the ability to control activities of the entity, the obligation to absorb the entity’s expected losses and the right to receive the entity’s expected residual returns) or (2) lacks sufficient equity to finance its own activities without financial support provided by other entities, which in turn would be expected to absorb at least some of the expected losses of the VIE. The Company is the primary beneficiary if the Company has (1) the power to direct the activities of the VIE that most significantly impact the economic performance of the entity and (2) the obligation to absorb losses of the entity that could be potentially significant to the VIE or the right to receive benefits from the entity that could be potentially significant. If the Company determines that it is the VIE’s primary beneficiary, it consolidates the VIE. Consolidated Variable Interest Entities The Company is the investment manager of certain asset-backed investment vehicles, commonly referred to as CLOs, and certain other vehicles for which the Company earns fee income for investment management services. The Company may sell or syndicate investments through these vehicles, principally as part of the strategic investing activity of the Company’s investment management businesses. Additionally, the Company may invest in securities issued by these vehicles. The Company is also the investment manager of certain investment structures whose beneficial interests are wholly-owned by consolidated subsidiaries. The Company has analyzed these relationships and determined that for certain CLOs and other investment structures it is the primary beneficiary and consolidates these entities. This analysis includes a review of (1) the Company’s rights and responsibilities as investment manager and (2) variable interests (if any) held by the Company. The assets of these VIEs are restricted and must be used first to settle liabilities of the VIE. The Company is not required to provide, and has not provided, material financial or other support to any of these VIEs. Additionally, the Company is the primary beneficiary of certain VIEs in which the Company has invested, as part of its investment activities, but for which it is not the investment manager. These include structured investments issued by a VIE that manages yen-denominated investments coupled with cross-currency coupon swap agreements thereby creating synthetic dual currency investments. The Company’s involvement in the structuring of these investments combined with its economic interest indicates that the Company is the primary beneficiary. The Company has not provided material financial support or other support that was not contractually required to these VIEs. The table below reflects the carrying amount and balance sheet caption in which the assets and liabilities of consolidated VIEs are reported. The liabilities primarily comprise obligations under debt instruments issued by the VIEs. The creditors of these VIEs do not have recourse to the Company in excess of the assets contained within the VIEs.
__________ (1)Total assets of consolidated VIEs reflect $2,885 million and $2,538 million as of December 31, 2021 and 2020, respectively, related to VIEs whose beneficial interests are wholly-owned by consolidated subsidiaries. (2)Recourse is limited to the assets of the respective VIE and does not extend to the general credit of the Company. As of December 31, 2021, the maturity of this obligation was within 3 years. Unconsolidated Variable Interest Entities The Company has determined that it is not the primary beneficiary of certain VIEs for which it is the investment manager. These VIEs consist primarily of CLOs and investment funds for which the Company has determined that it is not the primary beneficiary as it does not have both (1) the power to direct the activities of the VIE that most significantly impact the economic performance of the entity and (2) the obligation to absorb losses of the entity that could be potentially significant to the VIE or the right to receive benefits from the entity that could be potentially significant. The Company’s maximum exposure to loss resulting from its relationship with unconsolidated VIEs for which it is the investment manager is limited to its investment in the VIEs, which was $997 million and $935 million at December 31, 2021 and 2020, respectively. These investments are reflected in “Fixed maturities, available-for-sale,” “Fixed maturities, trading,” “Equity securities” and “Other invested assets.” There are no liabilities associated with these unconsolidated VIEs on the Company’s Consolidated Statements of Financial Position. In the normal course of its activities, the Company will invest in LPs/LLCs which include hedge funds, private equity funds and real estate-related funds and may or may not be VIEs. The Company’s maximum exposure to loss on these investments, both VIEs and non-VIEs, is limited to the amount of its investment. The Company has determined that it is not required to consolidate these entities because either (1) it does not control them or (2) it does not have the obligation to absorb losses of these entities that could be potentially significant to the entities or the right to receive benefits from the entities that could be potentially significant. The Company classifies these investments as “Other invested assets” and its maximum exposure to loss associated with these entities, excluding “Assets held for sale,” was $15,966 million and $12,883 million as of December 31, 2021 and 2020, respectively. In addition, in the normal course of its activities, the Company will invest in structured investments including VIEs for which it is not the investment manager. These structured investments typically invest in fixed income investments and are managed by third parties and include asset-backed securities, commercial mortgage-backed securities and residential mortgage-backed securities. The Company’s maximum exposure to loss on these structured investments, both VIEs and non-VIEs, is limited to the amount of its investment. See Note 3 for details regarding the carrying amounts and classification of these assets. The Company has not provided material financial or other support that was not contractually required to these structures. The Company has determined that it is not the primary beneficiary of these structures due to the fact that it does not control these entities.
|
Derivative Instruments |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Instruments | DERIVATIVES AND HEDGING Types of Derivative and Hedging Instruments Interest Rate Contracts Interest rate swaps, options and futures are used by the Company to reduce risks from changes in interest rates, manage interest rate exposures arising from mismatches between assets and liabilities and to hedge against changes in their values it owns or anticipates acquiring or selling. Swaps may be attributed to specific assets or liabilities or to a portfolio of assets or liabilities. Under interest rate swaps, the Company agrees with counterparties to exchange, at specified intervals, the difference between fixed-rate and floating-rate interest amounts calculated by reference to an agreed upon notional principal amount. The Company also uses interest rate swaptions, caps, and floors to manage interest rate risk. A swaption is an option to enter into a swap with a forward starting effective date. The Company pays a premium for purchased swaptions and receives a premium for written swaptions. In an interest rate cap, the buyer receives payments at the end of each period in which the interest rate exceeds the agreed strike price. Similarly, in an interest rate floor, the buyer receives payments at the end of each period in which the interest rate is below the agreed strike price. Swaptions, caps and floors are included in interest rate options. In standardized exchange-traded interest rate futures transactions, the Company purchases or sells a specified number of contracts, the values of which are determined by the daily market values of underlying referenced investments. The Company enters into exchange-traded futures with regulated futures commission’s merchants who are members of a trading exchange. Equity Contracts Equity options, total return swaps, and futures are used by the Company to manage its exposure to the equity markets which impacts the value of assets and liabilities it owns or anticipates acquiring or selling. Equity index options are contracts which will settle in cash based on differentials in the underlying indices at the time of exercise and the strike price. The Company uses combinations of purchases and sales of equity index options to hedge the effects of adverse changes in equity indices within a predetermined range. Total return swaps are contracts whereby the Company agrees with counterparties to exchange, at specified intervals, the difference between the return on an asset (or market index) and London Inter-Bank Offered Rate (“LIBOR”) plus an associated funding spread based on a notional amount. The Company generally uses total return swaps to hedge the effect of adverse changes in equity indices. In standardized exchange-traded equity futures transactions, the Company purchases or sells a specified number of contracts, the values of which are determined by the daily market values of underlying referenced equity indices. The Company enters into exchange-traded futures with regulated futures commission’s merchants who are members of a trading exchange. Foreign Exchange Contracts Currency derivatives, including currency futures, options, forwards and swaps, and foreign currency denominated debts are used by the Company to reduce risks from changes in currency exchange rates with respect to investments denominated in foreign currencies that the Company either holds or intends to acquire or sell, and to hedge the currency risk associated with net investments in foreign operations and anticipated earnings of its foreign operations. Under currency forwards, the Company agrees with counterparties to deliver a specified amount of an identified currency at a specified future date. Typically, the price is agreed upon at the time of the contract and payment for such a contract is made at the specified future date. As noted above, the Company uses currency forwards to mitigate the impact of changes in currency exchange rates on U.S. dollar-equivalent earnings generated by certain of its non-U.S. businesses, primarily its international insurance and investment operations. The Company executes forward sales of the hedged currency in exchange for U.S. dollars at a specified exchange rate. The maturities of these currency forwards correspond with the future periods in which the non-U.S. dollar-denominated earnings are expected to be generated. Under currency swaps, the Company agrees with counterparties to exchange, at specified intervals, the difference between one currency and another at an exchange rate and calculated by reference to an agreed principal amount. Generally, the principal amount of each currency is exchanged at the beginning and termination of the currency swap by each party. Under foreign currency denominated debts, the Company uses a portion of its foreign currency denominated debt (same functional currency of its foreign subsidiaries) to hedge the risk of change in the net investment in a foreign subsidiary due to changes in exchange rates. These debt obligations reduce the Company’s foreign currency exposure from equity investment and act as hedge of the investment. Credit Contracts The Company writes credit default swaps to gain exposure similar to investment in public fixed maturity cash instruments. With these derivatives the Company sells credit protection on a single name reference, or certain index reference, and in return receives a quarterly premium. This premium or credit spread generally corresponds to the difference between the yield on the referenced name (or an index’s referenced names) public fixed maturity cash instruments and swap rates, at the time the agreement is executed. If there is an event of default by the referenced name or one of the referenced names in the index, as defined by the agreement, then the Company is obligated to pay the referenced amount of the contract to the counterparty and receive in return the referenced defaulted security or similar security (in the case of a credit default index) or pay the referenced amount less the auction recovery rate. See credit derivatives section for further discussion of guarantees. In addition to selling credit protection, the Company purchases credit protection using credit derivatives to hedge specific credit exposures in the Company’s investment portfolio. Other Contracts “To Be Announced” (“TBA”) Forward Contracts. The Company uses TBA forward contracts to gain exposure to the investment risk and return of mortgage-backed securities. TBA transactions can help the Company enhance the return on its investment portfolio, and can provide a more liquid and cost-effective method of achieving these goals than purchasing or selling individual mortgage-backed pools. Typically, the price is agreed upon at the time of the contract and payment for such a contract is made at a specified future date. Additionally, pursuant to the Company’s mortgage dollar roll program, TBAs or mortgage-backed securities are transferred to counterparties with a corresponding agreement to repurchase them at a future date. These transactions do not qualify as secured borrowings and are accounted for as derivatives. Loan Commitments. In its mortgage operations, the Company enters into commitments to fund commercial mortgage loans at specified interest rates and other applicable terms within specified periods of time. These commitments are legally binding agreements to extend credit to a counterparty. Loan commitments for loans that will be held for sale are recognized as derivatives and recorded at fair value. The determination of the fair value of loan commitments accounted for as derivatives considers various factors including, among others, terms of the related loan, the intended exit strategy for the loans based upon either securitization valuation models or investor purchase commitments, prevailing interest rates, origination income or expense, and the value of service rights. Loan commitments that relate to the origination of mortgage loans that will be held for investment are not accounted for as derivatives and accordingly are not recognized in the Company’s financial statements. See Note 23 for additional information. Embedded Derivatives. The Company offers certain products (for example, variable annuities) which may include guaranteed benefit features that are accounted for as embedded derivatives. These embedded derivatives are carried at fair value through “Realized investment gains (losses), net” based on the change in value of the underlying contractual guarantees, which are determined using valuation models. Synthetic Guarantees. The Company sells synthetic GICs, through both full service and investment-only sales channels, to investment vehicles primarily used by qualified defined contribution pension plans. The synthetic GICs are issued in respect of assets that are owned by the trustees of such plans, who invest the assets according to the contract terms agreed to with the Company. The contracts establish participant balances and credit interest thereon. The participant balances are supported by the underlying assets. In connection with certain participant-initiated withdrawals, the contract guarantees that after all underlying assets are liquidated, any remaining participant balances will be paid by the Company. These contracts are accounted for as derivatives and recorded at fair value. Primary Risks Managed by DerivativesThe table below provides a summary of the gross notional amount and fair value of derivatives contracts by the primary underlying risks, excluding embedded derivatives and associated reinsurance recoverables. Many derivative instruments contain multiple underlying risks. The fair value amounts below represent the value of derivative contracts prior to taking into account the netting effects of master netting agreements and cash collateral. This netting impact results in total derivative assets of $3,266 million and $1,906 million as of December 31, 2021 and 2020, respectively, and total derivative liabilities of $2,278 million and $792 million as of December 31, 2021 and 2020, respectively, reflected in the Consolidated Statements of Financial Position.
__________ (1)“Other” primarily includes derivative contracts used to improve the balance of the Company’s tail longevity and mortality risk. Under these contracts, the Company’s gains (losses) are capped at the notional amount. (2)Excludes embedded derivatives and associated reinsurance recoverables which contain multiple underlying risks. The fair value of these embedded derivatives was a net liability of $10,245 million and $20,119 million as of December 31, 2021, and 2020, respectively, primarily included in “Future policy benefits.” (3)Recorded in “Other invested assets” and “Other liabilities” on the Consolidated Statements of Financial Position. (4)Excludes “Assets held-for-sale” with fair value of $1,643 million and “Liabilities held-for-sale” with fair value of $1,503 million with outstanding gross notional amounts of $41,179 million as of December 31, 2021. See Note 1 for additional information on the pending dispositions. As of December 31, 2021, the following amounts were recorded on the Consolidated Statements of Financial Position related to the carrying amount of the hedged assets (liabilities) and cumulative basis adjustments included in the carrying amount for fair value hedges:
________ (1)There were no material fair value hedging adjustments for hedged assets and liabilities for which hedge accounting has been discontinued. Most of the Company’s derivatives do not qualify for hedge accounting for various reasons. For example: (i) derivatives that economically hedge embedded derivatives do not qualify for hedge accounting because changes in the fair value of the embedded derivatives are already recorded in net income; (ii) derivatives that are utilized as macro hedges of the Company’s exposure to various risks typically do not qualify for hedge accounting because they do not meet the criteria required under portfolio hedge accounting rules; and (iii) synthetic GICs, which are product standalone derivatives, do not qualify as hedging instruments under hedge accounting rules. Offsetting Assets and Liabilities The following table presents recognized derivative instruments (excluding embedded derivatives and associated reinsurance recoverables), and repurchase and reverse repurchase agreements that are offset in the Consolidated Statements of Financial Position, and/or are subject to an enforceable master netting arrangement or similar agreement, irrespective of whether they are offset in the Consolidated Statements of Financial Position:
__________ (1)Amounts exclude the excess of collateral received/pledged from/to the counterparty. (2)Excludes “Assets held-for-sale” with fair value of $1,643 million and “Liabilities held-for-sale” with fair value of $1,503 million. See Note 1 for additional information on the pending dispositions. For information regarding the rights of offset associated with the derivative assets and liabilities in the table above, see “—Counterparty Credit Risk” below. For securities purchased under agreements to resell and securities sold under agreements to repurchase, the Company monitors the value of the securities and maintains collateral, as appropriate, to protect against credit exposure. Where the Company has entered into repurchase and resale agreements with the same counterparty, in the event of default, the Company would generally be permitted to exercise rights of offset. For additional information on the Company’s accounting policy for securities repurchase and resale agreements, see Note 2. Cash Flow, Fair Value and Net Investment Hedges The primary derivative instruments used by the Company in its fair value, cash flow and net investment hedge accounting relationships are interest rate swaps, currency swaps, currency forwards, and foreign currency denominated debts. These instruments are only designated for hedge accounting in instances where the appropriate criteria are met. The Company does not use futures, options, credit, and equity derivatives in any of its fair value, cash flow or net investment hedge accounting relationships. The following table provides the financial statement classification and impact of derivatives used in qualifying and non-qualifying hedge relationships, including the offset of the hedged item in fair value hedge relationships.
__________ (1)Excluding changes related to net investment hedges using non-derivative instruments of $25 million for year ended December 31, 2021, $(21) million for year ended December 31, 2020, and $0 million for year ended December 31, 2019. Presented below is a rollforward of current period cash flow hedges in AOCI before taxes:
The changes in fair value of cash flow hedges are deferred in AOCI and are included in “Net unrealized investment gains (losses)” in the Consolidated Statements of Comprehensive Income; these amounts are then reclassified to earnings when the hedged item affects earnings. Using December 31, 2021 values, it is estimated that a pre-tax gain of approximately $289 million is expected to be reclassified from AOCI to earnings during the subsequent twelve months ending December 31, 2022. The exposures the Company is hedging with these qualifying cash flow hedges include the variability of future cash flows from forecasted transactions denominated in foreign currencies, the purchases of invested assets, and the receipt or payment of variable interest on existing financial instruments. The maximum length of time over which the Company is hedging its exposure to the variability in future cash flows for forecasted transactions is 30 years. There were no material amounts reclassified from AOCI into earnings relating to instances in which the Company discontinued cash flow hedge accounting because the forecasted transaction did not occur by the anticipated date or within the additional time period permitted by the authoritative guidance for the accounting for derivatives and hedging. In addition, there were no instances in which the Company discontinued fair value hedge accounting due to a hedged firm commitment no longer qualifying as a fair value hedge. For net investment hedges, in addition to derivatives, the Company uses foreign currency denominated debt to hedge the risk of change in the net investment in a foreign subsidiary due to changes in exchange rates. For effective net investment hedges, the amounts, before applicable taxes, recorded in the cumulative translation adjustment within AOCI were $16 million for the year ended December 31, 2021, $(149) million for the year ended December 31, 2020, and $4 million for the year ended December 31 2019. Credit Derivatives The following table provides a summary of the notional and fair value of written credit protection, presented as assets (liabilities). The Company’s maximum amount at risk under these credit derivatives, assuming the value of the underlying referenced securities become worthless, is equal to the notional amounts. These credit derivatives have maturities of less than 26 years for index references.
_________ (1)The NAIC rating designations are based on availability and the lowest ratings among Moody's Investors Service, Inc. ("Moody's"), Standard & Poor’s Rating Services (“S&P”) and Fitch Ratings Inc. (“Fitch”). If no rating is available from a rating agency, a NAIC 6 rating is used. (2)Single name credit default swaps may reference to the credit of corporate debt, sovereign debt, and structured finance. Index references NAIC designations are based on the lowest rated single name reference included in the index. (3)Excludes “Assets held-for-sale” with fair value of $54 million and “Liabilities held-for-sale” with fair value of $0 million. See Note 1 for additional information on the pending dispositions. In addition to writing credit protection, the Company has purchased credit protection using credit derivatives in order to hedge specific credit exposures in the Company’s investment portfolio. As of December 31, 2021 and 2020, the Company had $115 million and $307 million of outstanding notional amounts, reported at fair value as a liability of $1 million and $28 million, respectivelyCounterparty Credit Risk The Company is exposed to losses in the event of non-performance by counterparties to financial derivative transactions with a positive fair value. The Company manages credit risk by: (i) entering into derivative transactions with highly rated major international financial institutions and other creditworthy counterparties governed by master netting agreements, as applicable; (ii) trading through central clearing and OTC parties; (iii) obtaining collateral, such as cash and securities, when appropriate; and (iv) setting limits on single party credit exposures which are subject to periodic management review. Substantially all of the Company’s derivative agreements have zero thresholds which require daily full collateralization by the party in a liability position. In addition, certain of the Company’s derivative agreements contain credit-risk related contingent features; if the credit rating of one of the parties to the derivative agreement is to fall below a certain level, the party with positive fair value could request termination at the then fair value or demand immediate full collateralization from the party whose credit rating fell and is in a net liability position. As of December 31, 2021, there were no net liability derivative positions with counterparties with credit risk-related contingent features. All derivatives have been appropriately collateralized by the Company or the counterparty in accordance with the terms of the derivative agreements.
|
Fair Value of Assets and Liabilities |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value of Assets and Liabilities | FAIR VALUE OF ASSETS AND LIABILITIES Fair Value Measurement—Fair value represents the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The authoritative fair value guidance establishes a framework for measuring fair value that includes a hierarchy used to classify the inputs used in measuring fair value. The level in the fair value hierarchy within which the fair value measurement falls is determined based on the lowest level input that is significant to the fair value measurement. The levels of the fair value hierarchy are as follows: Level 1—Fair value is based on unadjusted quoted prices in active markets that are accessible to the Company for identical assets or liabilities. The Company’s Level 1 assets and liabilities primarily include certain cash equivalents and short-term investments, equity securities and derivative contracts that trade on an active exchange market. Level 2—Fair value is based on significant inputs, other than quoted prices included in Level 1, that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability through corroboration with observable market data. Level 2 inputs include quoted market prices in active markets for similar assets and liabilities, quoted market prices in markets that are not active for identical or similar assets or liabilities, and other market observable inputs. The Company’s Level 2 assets and liabilities include: fixed maturities (corporate public and private bonds, most government securities, certain asset-backed and mortgage-backed securities, etc.), certain equity securities (mutual funds, which do not trade in active markets because they are not publicly available), certain commercial mortgage loans, short-term investments and certain cash equivalents (primarily commercial paper), and certain OTC derivatives. Level 3—Fair value is based on at least one significant unobservable input for the asset or liability. The assets and liabilities in this category may require significant judgment or estimation in determining the fair value. The Company’s Level 3 assets and liabilities primarily include: certain private fixed maturities and equity securities, certain manually priced public equity securities and fixed maturities, certain highly structured OTC derivative contracts, certain consolidated real estate funds for which the Company is the general partner and embedded derivatives resulting from certain products with guaranteed benefits. Assets and Liabilities by Hierarchy Level—The tables below present the balances of assets and liabilities reported at fair value on a recurring basis, as of the dates indicated:
__________ (1)Excludes amounts for financial instruments reclassified to “Assets held-for-sale of $129,579 million and “Liabilities held-for-sale” of $6,214 million. Assets held-for-sale and liabilities held-for-sale are valued on a basis consistent with similar instruments described herein. See Note 1 for additional information on the pending dispositions. (2)“Netting” amounts represent cash collateral of $(3,164) million and $3,892 million as of December 31, 2021 and 2020, respectively. (3)Excludes notes with fair value of $5,995 million (carrying amount of $5,941 million) and $6,100 million (carrying amount of $5,966 million) as of December 31, 2021 and 2020, respectively, which have been offset with the associated payables under a netting agreement. (4)Includes credit-tranched securities collateralized by syndicated bank loans, sub-prime mortgages, auto loans, credit cards, education loans and other asset types. (5)All other represents cash equivalents and short-term investments. (6)Other invested assets excluded from the fair value hierarchy include certain hedge funds, private equity funds and other funds for which fair value is measured at net asset value (“NAV”) per share (or its equivalent) as a practical expedient. At December 31, 2021 and 2020, the fair values of such investments were $4,290 million and $4,136 million respectively. (7)Separate account assets included in the fair value hierarchy exclude investments in entities that calculate NAV per share (or its equivalent) as a practical expedient. Such investments excluded from the fair value hierarchy include investments in real estate, hedge funds and other invested assets. At December 31, 2021 and 2020, the fair value of such investments were $26,174 million and $23,007 million, respectively. (8)Separate account assets represent segregated funds that are invested for certain customers. Investment risks associated with market value changes are borne by the customers, except to the extent of minimum guarantees made by the Company with respect to certain accounts. Separate account liabilities are not included in the above table as they are reported at contract value and not fair value in the Company’s Consolidated Statements of Financial Position. (9)As of December 31, 2021, the net embedded derivative liability position of $9,069 million includes $611 million of embedded derivatives in an asset position and $9,680 million of embedded derivatives in a liability position. As of December 31, 2020, the net embedded derivative liability position of $18,879 million includes $520 million of embedded derivatives in an asset position and $19,399 million of embedded derivatives in a liability position. The methods and assumptions the Company uses to estimate the fair value of assets and liabilities measured at fair value on a recurring basis are summarized below. Fixed Maturity Securities—The fair values of the Company’s public fixed maturity securities are generally based on prices obtained from independent pricing services. Prices for each security are generally sourced from multiple pricing vendors, and a vendor hierarchy is maintained by asset type based on historical pricing experience and vendor expertise. The Company ultimately uses the price from the pricing service highest in the vendor hierarchy based on the respective asset type. The pricing hierarchy is updated for new financial products and recent pricing experience with various vendors. Consistent with the fair value hierarchy described above, securities with validated quotes from pricing services are generally reflected within Level 2, as they are primarily based on observable pricing for similar assets and/or other market observable inputs. Typical inputs used by these pricing services include but are not limited to, reported trades, benchmark yields, issuer spreads, bids, offers, and/or estimated cash flow, prepayment speeds and default rates. If the pricing information received from third-party pricing services is deemed not reflective of market activity or other inputs observable in the market, the Company may challenge the price through a formal process with the pricing service or classify the securities as Level 3. If the pricing service updates the price to be more consistent with the presented market observations, the security remains within Level 2. Internally-developed valuations or indicative broker quotes are also used to determine fair value in circumstances where vendor pricing is not available, or where the Company ultimately concludes that pricing information received from the independent pricing services is not reflective of market activity. If the Company concludes the values from both pricing services and brokers are not reflective of market activity, it may override the information with an internally-developed valuation. As of December 31, 2021 and 2020, overrides on a net basis were not material. Pricing service overrides, internally-developed valuations and indicative broker quotes are generally included in Level 3 in the fair value hierarchy. The Company conducts several specific price monitoring activities. Daily analyses identify price changes over predetermined thresholds defined at the financial instrument level. Various pricing integrity reports are reviewed on a daily and monthly basis to determine if pricing is reflective of market activity or if it would warrant any adjustments. Other procedures performed include, but are not limited to, reviews of third-party pricing services methodologies, reviews of pricing trends and back testing. The fair values of private fixed maturities, which are originated by internal private asset managers, are primarily determined using discounted cash flow models. These models primarily use observable inputs that include Treasury or similar base rates plus estimated credit spreads to value each security. The credit spreads are obtained through a survey of private market intermediaries who are active in both primary and secondary transactions, and consider, among other factors, the credit quality and the reduced liquidity associated with private placements. Internal adjustments are made to reflect variation in observed sector spreads. Since most private placements are valued using standard market observable inputs and inputs derived from, or corroborated by, market observable data including, but not limited to observed prices and spreads for similar publicly-traded issues, they have been reflected within Level 2. For certain private fixed maturities, the discounted cash flow model may incorporate significant unobservable inputs, which reflect the Company’s own assumptions about the inputs that market participants would use in pricing the asset. To the extent management determines that such unobservable inputs are significant to the price of a security, a Level 3 classification is made. Assets Supporting Experience-Rated Contractholder Liabilities—Assets supporting experience-rated contractholder liabilities consist primarily of fixed maturity securities, equity securities and derivatives whose fair values are determined consistent with similar instruments described above under “Fixed Maturity Securities” and below under “Equity Securities” and “Derivative Instruments.” Equity Securities—Equity securities consist principally of investments in common and preferred stock of publicly-traded companies, perpetual preferred stock, privately-traded securities, as well as mutual fund shares. The fair values of most publicly-traded equity securities are based on quoted market prices in active markets for identical assets and are classified within Level 1 in the fair value hierarchy. Estimated fair values for most privately traded equity securities are determined using discounted cash flow, earnings multiple and other valuation models that require a substantial level of judgment around inputs and therefore are classified within Level 3. The fair values of mutual fund shares that transact regularly (but do not trade in active markets because they are not publicly available) are based on transaction prices of identical fund shares and are classified within Level 2 in the fair value hierarchy. The fair values of perpetual preferred stock are based on inputs obtained from independent pricing services that are primarily based on indicative broker quotes. As a result, the fair values of perpetual preferred stock are classified as Level 3. Commercial Mortgage and Other Loans—The fair value of loans held and accounted for using the fair value option is determined utilizing pricing indicators from the whole loan market, where investors are committed to purchase these loans at a predetermined price, which is considered the principal exit market for these loans. The Company evaluates the valuation inputs used for these assets, including the existence of predetermined exit prices, the terms of the loans, prevailing interest rates and credit risk, and deems the primary pricing inputs are Level 2 inputs in the fair value hierarchy. Other Invested Assets—Other invested assets primarily include investments in LPs/LLCs, derivatives and certain limited partnerships which are consolidated because the Company is either deemed to exercise control or considered the primary beneficiary of a variable interest entity. These entities are primarily investment companies and follow specialized industry accounting whereby their assets are carried at fair value. The investments held by these entities include various feeder fund investments in underlying master funds (whose underlying holdings generally include public fixed maturities, equity securities and mutual funds), as well as wholly-owned real estate held within other investment funds. For the unconsolidated fund investments, the fair value is primarily determined by the fund managers and is measured at NAV as a practical expedient. Other Assets—Other assets reflected in Level 3 primarily include reinsurance recoverables which are carried at fair value and relate to the reinsurance of the Company’s living benefit guarantees on certain variable annuity contracts. The methods and assumptions used to estimate the fair value are consistent with those described below under “Future Policy Benefits.” Derivative Instruments—Derivatives are recorded at fair value either as assets, within “Other invested assets” or as liabilities, within “Other liabilities,” except for embedded derivatives which are recorded with the associated host contract. The fair values of derivative contracts can be affected by changes in interest rates, foreign exchange rates, commodity prices, credit spreads, market volatility, expected returns, NPR, liquidity and other factors. For derivative positions included within Level 3 of the fair value hierarchy, liquidity valuation adjustments are made to reflect the cost of exiting significant risk positions, and consider the bid-ask spread, maturity, complexity and other specific attributes of the underlying derivative position. The Company’s exchange-traded futures and options include Treasury futures, Eurodollar futures, commodity futures, Eurodollar options and commodity options. Exchange-traded futures and options are valued using quoted prices in active markets and are classified within Level 1 in the fair value hierarchy. The majority of the Company’s derivative positions are traded in the OTC derivative market and are classified within Level 2 in the fair value hierarchy. OTC derivatives classified within Level 2 are valued using models that utilize actively quoted or observable market input from external market data providers, third-party pricing vendors and/or recent trading activity. The Company’s policy is to use mid-market pricing in determining its best estimate of fair value. The fair values of most OTC derivatives, including interest rate and cross-currency swaps, currency forward contracts, commodity forward contracts, credit default swaps, loan commitments held for sale and TBA forward contracts on highly rated mortgage-backed securities issued by U.S. government sponsored entities are determined using discounted cash flow models. The fair values of European style option contracts are determined using Black-Scholes option pricing models. These models’ key inputs include the contractual terms of the respective contract, along with significant observable inputs, including interest rates, currency rates, credit spreads, equity prices, index dividend yields, NPR, volatility and other factors. The Company’s cleared interest rate swaps and credit derivatives linked to an index are valued using models that utilize actively quoted or observable market inputs, including the secured overnight financing rate (“SOFR”), obtained from external market data providers, third-party pricing vendors and/or recent trading activity. These derivatives are classified as Level 2 in the fair value hierarchy. The majority of the Company’s derivative agreements are with highly rated major international financial institutions. To reflect the market’s perception of its own and the counterparty’s NPR, the Company incorporates additional spreads over LIBOR into the discount rate used in determining the fair value of OTC derivative assets and liabilities after netting of collateral. Derivatives classified as Level 3 include look-back equity options and other structured products. These derivatives are valued based upon models, such as Monte Carlo simulation models and other techniques that utilize significant unobservable inputs. Level 3 methodologies are validated through periodic comparison of the Company’s fair values to external broker-dealer values. Cash Equivalents and Short-Term Investments—Cash equivalents and short-term investments include money market instruments, commercial paper and other highly liquid debt instruments. Certain money market instruments are valued using unadjusted quoted prices in active markets that are accessible for identical assets and are primarily classified as Level 1. The remaining instruments in this category are generally fair valued based on market observable inputs and these investments have primarily been classified within Level 2. Separate Account Assets—Separate account assets include mutual funds, fixed maturity securities, treasuries, equity securities, real estate and commercial mortgage loans for which values are determined consistent with similar instruments described above under “Fixed Maturity Securities,” “Equity Securities” and “Commercial Mortgage and Other Loans.” Future Policy Benefits—The liability for future policy benefits is related to guarantees primarily associated with the living benefit features of certain variable annuity contracts offered by the Company’s Individual Annuities segment, including guaranteed minimum accumulation benefits (“GMAB”), guaranteed withdrawal benefits (“GMWB”) and guaranteed minimum income and withdrawal benefits (“GMIWB”), accounted for as embedded derivatives. The fair values of these liabilities are calculated as the present value of future expected benefit payments to customers less the present value of future expected rider fees attributable to the embedded derivative feature. This methodology could result in either a liability or asset balance, given changing capital market conditions and various actuarial assumptions. Since there is no observable active market for the transfer of these obligations, the valuations are calculated using internally-developed models with option pricing techniques. The models are based on a risk neutral valuation framework and incorporate premiums for risks inherent in valuation techniques, inputs, and the general uncertainty around the timing and amount of future cash flows. The determination of these risk premiums requires the use of management’s judgment. The significant inputs to the valuation models for these embedded derivatives include capital market assumptions, such as interest rate levels and volatility assumptions, the Company’s market-perceived NPR, as well as actuarially determined assumptions, including contractholder behavior, such as lapse rates, benefit utilization rates, withdrawal rates, and mortality rates. Since many of these assumptions are unobservable and are considered to be significant inputs to the liability valuation, the liability included in future policy benefits has been reflected within Level 3 in the fair value hierarchy. Capital market inputs and actual policyholders’ account values are updated each quarter based on capital market conditions as of the end of the quarter, including interest rates, equity markets and volatility. In the risk neutral valuation, the initial swap curve drives the total return used to grow the policyholders’ account values. The Company’s discount rate assumption is based on the LIBOR swap curve adjusted for an additional spread relative to LIBOR to reflect NPR. Actuarial assumptions, including contractholder behavior and mortality, are reviewed at least annually, and updated based upon emerging experience, future expectations and other data, including any observable market data. These assumptions are generally updated annually unless a material change that the Company feels is indicative of a long-term trend is observed in an interim period. Policyholders’ Account Balances—The liability for policyholders’ account balances is related to certain embedded derivative instruments associated with certain universal life and annuity products that provide the policyholders with the index-linked interest credited over contract specified term periods. The fair values of these liabilities are determined using discounted cash flow models which include capital market assumptions such as interest rates and equity index volatility assumptions, the Company’s market-perceived NPR and actuarially determined assumptions for mortality, lapses and projected hedge costs. As there is no observable active market for these liabilities, the fair value is determined as the present value of account balances paid to policyholders in excess of contractually guaranteed minimums using option pricing techniques for index term periods that contain deposits as of the valuation date, and the expected option cost for future index term periods, where the terms of index crediting rates have not yet been declared by the Company. Premiums for risks inherent in valuation techniques, inputs, and the general uncertainty around the timing and amount of future cash flows are also incorporated in the fair value of these liabilities. Since the valuation of these liabilities require the use of management’s judgement to determine these risk premiums and the use of unobservable inputs, these liabilities are reflected within Level 3 in the fair value hierarchy. Capital market inputs, including interest rates and equity markets volatility, and actual policyholders’ account values are updated each quarter. Actuarial assumptions are reviewed at least annually and updated based upon emerging experience, future expectations and other data, including any observable market data. Aside from these annual updates, assumptions are generally updated only if a material change is observed in an interim period that the Company believes is indicative of a long-term trend. Other Liabilities—Other liabilities include certain derivative instruments and the contingent consideration liability associated with the acquisition of Assurance IQ. The fair values of derivative instruments are primarily determined consistent with those described above under “Derivative Instruments.” For the contingent consideration liability, see Note 1 for additional information. Notes issued by Consolidated VIEs—These notes are based on the fair values of corresponding bank loan collateral. Since the notes are valued based on reference collateral, they are classified as Level 3. See Note 4 and “Fair Value Option” below for additional information. Quantitative Information Regarding Internally-Priced Level 3 Assets and Liabilities—The tables below present quantitative information on significant internally-priced Level 3 assets and liabilities:
__________ (1)Conversely, the impact of a decrease in input would have the opposite impact on fair value as that presented in the table. (2)Includes assets classified as fixed maturities available-for-sale, assets supporting experience-rated contractholder liabilities and fixed maturities, trading. (3)Excludes notes which have been offset with the associated payables under a netting agreement. (4)Represents multiples of earnings before interest, taxes, depreciation and amortization (“EBITDA”), and are amounts used when the Company has determined that market participants would use such multiples when valuing the investments. (5)Includes certain investments where enterprise value is less than the amount needed to support senior and subordinated claims. These investments typically use a range of discount rates (10% to 20%), therefore presenting a range, rather than a weighted average, is a more meaningful representation of the unobservable inputs used in the valuation. (6)Changes in the fair value of separate account assets are borne by customers and thus are offset by changes in separate account liabilities on the Company’s Consolidated Statements of Financial Position. As a result, changes in value associated with these investments are not reflected in the Company’s Consolidated Statements of Operations. (7)Future policy benefits primarily represent general account liabilities for the living benefit features of the Company’s variable annuity contracts which are accounted for as embedded derivatives. Since the valuation methodology for these liabilities uses a range of inputs that vary at the contract level over the cash flow projection period, presenting a range, rather than a weighted average, is a more meaningful representation of the unobservable inputs used in the valuation. (8)Policyholders’ account balances primarily represent general account liabilities for the index-linked interest credited on certain of the Company’s life and annuity products that are accounted for as embedded derivatives. Since the valuation methodology for these liabilities uses a range of inputs that vary at the contract level over the cash flow projection period, presenting a range, rather than a weighted average, is a more meaningful representation of the unobservable inputs used in the valuation. (9)Lapse rates for contracts with living benefit guarantees are adjusted at the contract level based on the in-the-moneyness of the living benefit and reflect other factors, such as the applicability of any surrender charges. Lapse rates are reduced when contracts are more in-the-money. Lapse rates for contracts with index-linked crediting guarantees may be adjusted at the contract level based on the applicability of any surrender charges, product type, and market related factors such as interest rates. Lapse rates are also generally assumed to be lower for the period where surrender charges apply. For any given contract, lapse rates vary throughout the period over which cash flows are projected for the purposes of valuing these embedded derivatives. (10)The spread over the LIBOR swap curve represents the premium added to the proxy for the risk-free rate (LIBOR) to reflect the Company’s estimates of rates that a market participant would use to value the living benefits in both the accumulation and payout phases and index-linked interest crediting guarantees. This spread includes an estimate of NPR, which is the risk that the obligation will not be fulfilled by the Company. NPR is primarily estimated by utilizing the credit spreads associated with issuing funding agreements, adjusted for any illiquidity risk premium. In order to reflect the financial strength ratings of the Company, credit spreads associated with funding agreements, as opposed to credit spread associated with debt, are utilized in developing this estimate because funding agreements, living benefit guarantees, and index-linked interest crediting guarantees are insurance liabilities and are therefore senior to debt. (11)The utilization rate assumption estimates the percentage of contracts that will utilize the benefit during the contract duration, and begin lifetime withdrawals at various time intervals from contract inception. The remaining contractholders are assumed to either begin lifetime withdrawals immediately or never utilize the benefit. Utilization assumptions may vary by product type, tax status, and age. The impact of changes in these assumptions is highly dependent on the product type, the age of the contractholder at the time of the sale, and the timing of the first lifetime income withdrawal. Range reflects the utilization rate for the vast majority of business with living benefits. (12)The withdrawal rate assumption estimates the magnitude of annual contractholder withdrawals relative to the maximum allowable amount under the contract. These assumptions vary based on the age of the contractholder, the tax status of the contract and the duration since the contractholder began lifetime withdrawals. As of both December 31, 2021 and 2020, the minimum withdrawal rate assumption is 76% and maximum withdrawal rate assumption may be greater than 100%.The fair value of the liability will generally increase the closer the withdrawal rate is to 100% and decrease as the withdrawal rate moves further away from 100%. (13)The range reflects the mortality rates for the vast majority of business with living benefits and other contracts, with policyholders ranging from 45 to 90 years old. While the majority of living benefits have a minimum age requirement, certain other contracts do not have an age restriction. This results in contractholders with mortality rates approaching 0% for certain benefits. Mortality rates may vary by product, age, and duration. A mortality improvement assumption is also incorporated into the overall mortality table. Interrelationships Between Unobservable Inputs—In addition to the sensitivities of fair value measurements to changes in each unobservable input in isolation, as reflected in the table above, interrelationships between these inputs may also exist, such that a change in one unobservable input may give rise to a change in another or multiple inputs. Examples of such interrelationships for significant internally-priced Level 3 assets and liabilities are as follows: Corporate Securities—The rate used to discount future cash flows reflects current risk-free rates plus credit and liquidity spread requirements that market participants would use to value an asset. The discount rate may be influenced by many factors, including market cycles, expectations of default, collateral, term, and asset complexity. Each of these factors can influence discount rates, either in isolation, or in response to other factors. Future Policy Benefits—The Company expects efficient benefit utilization and withdrawal rates to generally be correlated with lapse rates. However, behavior is generally highly dependent on the facts and circumstances surrounding the individual contractholder, such as their liquidity needs or tax situation, which could drive lapse behavior independent of other contractholder behavior assumptions. To the extent more efficient contractholder behavior results in greater in-the-moneyness at the contract level, lapse rates may decline for those contracts. Similarly, to the extent that increases in equity volatility are correlated with overall declines in the capital markets, lapse rates may decline as contracts become more in-the-money. Changes in Level 3 Assets and Liabilities––The following tables describe changes in fair values of Level 3 assets and liabilities as of the dates indicated, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets and liabilities still held at the end of their respective periods. When a determination is made to classify assets and liabilities within Level 3, the determination is based on significance of the unobservable inputs in the overall fair value measurement. All transfers are based on changes in the observability of the valuation inputs, including the availability of pricing service information that the Company can validate. Transfers into Level 3 are generally the result of unobservable inputs utilized within valuation methodologies and the use of indicative broker quotes for assets that were previously valued using observable inputs. Transfers out of Level 3 are generally due to the use of observable inputs in valuation methodologies as well as the availability of pricing service information for certain assets that the Company can validate.
The following tables summarize the portion of changes in fair values of Level 3 assets and liabilities included in earnings and OCI for the year ended December 31, 2019, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets and liabilities still held as of December 31, 2019:
__________ (1)“Other,” for the periods ended December 31, 2021 and 2020, primarily represent deconsolidation of VIE, reclassifications of certain assets between reporting categories and foreign currency translation. (2)Transfers out of level 3 for the period ended December 31, 2021, included $218 million of corporate securities and $79 million of structured securities reclassified from Fixed maturities, available for sale to “Assets held-for-sale”, and $4,162 million of Future Policy Benefits and $2,040 million of Policyholders’ account balances reclassified to "Liabilities held-for-sale". See Note 1 for additional information on the pending dispositions. (3)Unrealized gains or losses related to assets still held at the end of the period do not include amortization or accretion of premiums and discounts. (4)Includes U.S. corporate public, U.S. corporate private, foreign corporate public and foreign corporate private securities. (5)Includes asset-backed, commercial mortgage-backed and residential mortgage-backed securities. (6)Separate account assets represent segregated funds that are invested for certain customers. Investment risks associated with market value changes are borne by the customers, except to the extent of minimum guarantees made by the Company with respect to certain accounts. Separate account liabilities are not included in the above table as they are reported at contract value and not fair value in the Company’s Consolidated Statements of Financial Position. (7)Issuances and settlements for Policyholders’ account balances are presented net in the rollforward. Prior period amounts have been updated to conform to current period presentation. (8)Effective January 1, 2020, the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period were added prospectively due to adoption of ASU 2018-13. Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement. Derivative Fair Value Information The following tables present the balances of certain derivative assets and liabilities measured at fair value on a recurring basis, as of the date indicated, by primary underlying risks. These tables exclude embedded derivatives and associated reinsurance recoverables. The derivative assets and liabilities shown below are included in “Other invested assets” or “Other liabilities” in the tables contained within the sections “—Assets and Liabilities by Hierarchy Level” and “—Changes in Level 3 Assets and Liabilities,” above.
__________ (1)“Netting” amounts represent cash collateral and the impact of offsetting asset and liability positions held with the same counterparty, subject to master netting agreement. (2)Excludes “Assets held-for-sale” with fair value of $1,643 million and “Liabilities held-for-sale” with fair value of $1,503 million. See Note 1 for additional information on the pending dispositions. Changes in Level 3 derivative assets and liabilities—The following tables provide a summary of the changes in fair value of Level 3 derivative assets and liabilities as of the dates indicated, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets and liabilities still held at the end of their respective periods:
__________ (1)Represents conversion of warrants to equity shares. (2)Transfers into or out of Level 3 are generally reported at the value as of the beginning of the quarter in which the transfers occur for any such positions still held at the end of the quarter. (3)Related to warrants received in restructuring a certain asset that resulted in reclassification of reporting category. (4)Total realized and unrealized gains (losses) as well as unrealized gains (losses) for assets still held at the end of the period are recorded in “Realized investment gains (losses), net.” Nonrecurring Fair Value Measurements—The following tables represent information for assets measured at fair value on a nonrecurring basis. The fair value measurement is nonrecurring as these assets are measured at fair value only when there is a triggering event (e.g., an evidence of impairment). Assets included in the table are those that were impaired during the respective reporting periods and that are still held as of the reporting date. The estimated fair values for these amounts were determined using significant unobservable inputs (Level 3).
__________ (1)Commercial mortgage loans are valued based on discounted cash flows utilizing market rates or the fair value of the underlying real estate collateral. (2)Mortgage servicing rights are valued using a discounted cash flow model. The model incorporates assumptions for servicing revenues, which are adjusted for expected prepayments, delinquency rates, escrow deposit income and estimated loan servicing expenses. The discount rates incorporated into the model are determined based on the estimated returns a market participant would require for this business plus a liquidity and risk premium. This estimate includes available relevant data from any active market sales of mortgage servicing rights. (3)Based on the goodwill impairment test performed as of December 31, 2021, the Company recognized a goodwill impairment charge for Assurance IQ. The fair value was determined using weighting of both market approach valuation techniques, based on both sales and EBITDA forward multiples, and discounted cash flow approach valuation techniques. The valuation included unobservable inputs such as forward market multiples of comparable peer companies and an implied control premium under the market approaches, as well as forecasted cash flows, discount rate applied, expected synergies and growth rate assumptions under the discounted cash flow approaches. The inputs and assumptions applied are consistent with how a market participant would value Assurance IQ and the related goodwill. See Note 10 for more information on the valuation of Assurance IQ and the resulting impairment charge. Fair Value Option The fair value option allows the Company to elect fair value as an alternative measurement for selected financial assets and financial liabilities not otherwise reported at fair value. Such elections have been made by the Company to help mitigate volatility in earnings that result from different measurement attributes. Electing the fair value option also allows the Company to achieve consistent accounting for certain assets and liabilities. Changes in fair value are reflected in “Realized investment gains (losses), net” for commercial mortgage and other loans and “Other income (loss)” for other assets and notes issued by consolidated VIEs. Changes in fair value due to instrument-specific credit risk are estimated using changes in credit spreads and quality ratings for the period reported. Interest income on commercial mortgage and other loans is included in “Net investment income.” Interest income on these loans is recorded based on the effective interest rate as determined at the closing of the loan. The following tables present information regarding assets and liabilities where the fair value option has been elected:
__________ (1)As of December 31, 2021, for loans for which the fair value option has been elected, there were no loans in non-accrual status and none of the loans were more than 90 days past due and still accruing. Fair Value of Financial Instruments The table below presents the carrying amount and fair value by fair value hierarchy level of certain financial instruments that are not reported at fair value. The financial instruments presented below are reported at carrying value on the Company’s Consolidated Statements of Financial Position. In some cases, as described below, the carrying amount equals or approximates fair value.
__________ (1)Excludes amounts for financial instruments reclassified to “Assets held-for-sale” of $6,936 million or “Liabilities held-for-sale” of $101,992 million. See Note 1 for additional information on the pending dispositions. (2)Carrying values presented herein differ from those in the Company’s Consolidated Statements of Financial Position because certain items within the respective financial statement captions are not considered financial instruments or out of scope under authoritative guidance relating to disclosures of the fair value of financial instruments. (3)Excludes notes with fair value of $5,394 million (carrying amount of $4,750 million) and $5,821 million (carrying amount of $4,998 million) as of December 31, 2021 and 2020, respectively, which have been offset with the associated payables under a netting agreement. (4)Includes notes with fair value of $11,389 million (carrying amount of $10,691 million) and $11,921 million (carrying amount of $10,964 million) as of December 31, 2021 and 2020, respectively, which have been offset with the associated receivables under a netting agreement. The fair values presented above have been determined by using available market information and by applying market valuation methodologies, as described in more detail below. Fixed Maturities, Held-to-Maturity The fair values of public fixed maturity securities are generally based on prices from third-party pricing services, which are reviewed for reasonableness; however, for certain public fixed maturity securities and investments in private placement fixed maturity securities, this information is either not available or not reliable. For these public fixed maturity securities, the fair value is based on indicative broker quotes, if available, or determined using a discounted cash flow model or other internally-developed models. For private fixed maturities, fair value is determined using a discounted cash flow model. In determining the fair value of certain fixed maturity securities, the discounted cash flow model may also use unobservable inputs, which reflect the Company’s own assumptions about the inputs market participants would use in pricing the security. Commercial Mortgage and Other Loans The fair value of most commercial mortgage loans is based upon the present value of the expected future cash flows discounted at the appropriate U.S. Treasury rate or foreign government bond rate (for non-U.S. dollar-denominated loans) plus an appropriate credit spread for loans of similar quality, average life and currency. The quality ratings for these loans, a primary determinant of the credit spreads and a significant component of the pricing process, are based on an internally-developed methodology. Certain commercial mortgage loans are valued incorporating other factors, including the terms of the loans, the relative strength of the underlying collateral, the principal exit strategies for the loans, prevailing interest rates and credit risk. Policy Loans The Company’s valuation technique for policy loans is to discount cash flows at the current policy loan coupon rate. Policy loans are fully collateralized by the cash surrender value of underlying insurance policies. As a result, the carrying value of the policy loans approximates the fair value. Short-Term Investments, Cash and Cash Equivalents, Accrued Investment Income and Other Assets The Company believes that due to the short-term nature of certain assets, the carrying value approximates fair value. These assets include: certain short-term investments, which are not securities, recorded at amortized cost and include quality loans; cash and cash equivalent instruments; accrued investment income; and other assets that meet the definition of financial instruments, including receivables, such as reinsurance recoverables, unsettled trades, accounts receivable and restricted cash. Policyholders’ Account Balances—Investment Contracts Only the portion of policyholders’ account balances related to products that are investment contracts (those without significant mortality or morbidity risk) are reflected in the table above. For fixed deferred annuities, single premium endowments, payout annuities and other similar contracts without life contingencies, fair values are generally derived using discounted projected cash flows based on interest rates that are representative of the Company’s financial strength ratings, and hence reflect the Company’s NPR. For GICs, funding agreements, structured settlements without life contingencies and other similar products, fair values are generally derived using discounted projected cash flows based on interest rates being offered for similar contracts with maturities consistent with those of the contracts being valued. For those balances that can be withdrawn by the customer at any time without prior notice or penalty, the fair value is the amount estimated to be payable to the customer as of the reporting date, which is generally the carrying value. For defined contribution and defined benefit contracts and certain other products, the fair value is the market value of the assets supporting the liabilities. Securities Sold Under Agreements to Repurchase The Company receives collateral for selling securities under agreements to repurchase, or pledges collateral under agreements to resell. Repurchase and resale agreements are also generally short-term in nature and, therefore, the carrying amounts of these instruments approximate fair value. Cash Collateral for Loaned Securities Cash collateral for loaned securities represents the collateral received or paid in connection with loaning or borrowing securities, similar to the securities sold under agreement to repurchase above. Due to the short-term nature of these transactions, the carrying value approximates fair value. Debt The fair value of short-term and long-term debt, as well as notes issued by consolidated VIEs, is generally determined by either prices obtained from independent pricing services, which are validated by the Company, or discounted cash flow models. With the exception of the notes issued by consolidated VIEs for which recourse is limited to the assets of the respective VIE and does not extend to the general credit of the Company, the fair values of these instruments consider the Company’s NPR. Discounted cash flow models predominately use market observable inputs such as the borrowing rates currently available to the Company for debt and financial instruments with similar terms and remaining maturities. For commercial paper issuances and other debt with a maturity of less than 90 days, the carrying value approximates fair value. Other Liabilities Other liabilities are primarily payables, such as reinsurance payables, unsettled trades, drafts and accrued expense payables. Due to the short-term until settlement of most of these liabilities, the Company believes that carrying value approximates fair value. Separate Account Liabilities—Investment Contracts Only the portion of separate account liabilities related to products that are investment contracts are reflected in the table above. Separate account liabilities are recorded at the amount credited to the contractholder, which reflects the change in fair value of the corresponding separate account assets including contractholder deposits less withdrawals and fees; therefore, carrying value approximates fair value.
|
Deferred Policy Acquisition Costs |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Deferred Policy Acquisition Costs Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Deferred Policy Acquisition Costs | DEFERRED POLICY ACQUISITION COSTS The balances of and changes in DAC as of and for the years ended December 31, are as follows:
__________ (1)See Note 1 for additional information on the pending dispositions. (2)“Other” for 2021 represents the sale of The Prudential Life Insurance Company of Taiwan Inc. “Other” for 2020 primarily represents the impact related to the sale of The Prudential Life Insurance Company of Korea, Ltd. of $(1,193) million. “Other” for 2019 primarily represents the impact related to the sale of the Company’s Pramerica of Italy subsidiary of $(46) million and DAC ceded to a third-party reinsurer of $(14) million.
|
Value of Business Acquired |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Present Value of Future Insurance Profits [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Value of Business Acquired | VALUE OF BUSINESS ACQUIRED The balances of and changes in VOBA as of and for the years ended December 31, are as follows:
__________ (1)See Note 1 for additional information on the pending dispositions. The following table provides VOBA balances for the year ended December 31, 2021:
__________ (1)Excludes “Assets held-for-sale” of $215 million as of December 31, 2021. See Note 1 for additional information on the pending dispositions. The following table provides estimated future amortization, net of interest, for the periods indicated:
__________ (1)VOBA classified as “Assets held-for-sale” of $215 million as of December 31, 2021 is excluded from the estimated future amortization amounts. See Note 1 for additional information on the pending dispositions.
|
Investments In Operating Joint Ventures |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity Method Investments and Joint Ventures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investments In Operating Joint Ventures | INVESTMENTS IN OPERATING JOINT VENTURES The Company has made investments in certain joint ventures that are strategic in nature and made other than for the sole purpose of generating investment income. These investments are primarily accounted for under the equity method of accounting and are included in “Other assets” in the Company’s Consolidated Statements of Financial Position. The earnings from these investments are primarily included on an after-tax basis in “Equity in earnings of operating joint ventures, net of taxes” in the Company’s Consolidated Statements of Operations. The summarized financial information for the Company’s operating joint ventures has been included in the summarized combined financial information for all significant equity method investments shown in Note 3. The following table sets forth information related to the Company’s investments in operating joint ventures as of and for the years ended December 31:
__________ (1)In March of 2021, the Company sold its 35% ownership stake in Pramerica SGR, an asset management joint venture within PGIM. See Note 1 for additional information on the disposition. For the years ended December 31, 2021, 2020 and 2019, the Company recognized $11 million, $30 million and $29 million, respectively, of asset management fee income for services the Company provided to these operating joint ventures.
|
Goodwill and Other Intangibles |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goodwill and Intangible Assets Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goodwill and Other Intangibles | GOODWILL AND OTHER INTANGIBLES The changes in the carrying value of goodwill by reportable segment are as follows:
__________ (1)Prior period amounts have been reclassified to conform to current period presentation. (2)The goodwill associated with Assurance IQ includes a measurement period adjustment made during 2020. The goodwill reclassification between International Businesses and Corporate and Other relates to an operation that became classified as a divested business and transferred to Corporate and Other during 2020. (3)During 2021, PGIM completed the acquisitions of Montana Capital Partners, a European-based private equity secondaries asset manager, and Green Harvest Asset Management LLC, a separately managed account platform providing customized solutions for the high net worth market. (4)The Full Service Retirement business has been classified as divested business and transferred to Corporate and Other, and its assets, including goodwill, are reclassified to “Assets held-for-sale” as of December 31, 2021. See Note 1 for more information on this pending disposition. The Company tests goodwill for impairment annually, as of December 31, and more frequently if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying amount, as discussed in further detail in Note 2. The Company performed the annual goodwill impairment test using the quantitative approach for all reporting units at December 31, 2021. While the estimated fair value of PGIM and Gibraltar and Other, within the International Businesses segment, significantly exceeded their carrying value as of December 31, 2021, the test resulted in a $1,060 million pre-tax ($837 million after-tax) non-cash impairment charge, related to the goodwill assigned to Assurance IQ. The annual quantitative goodwill impairment test for Assurance IQ estimated the fair value of the businesses by weighting the results from discounted cash flow valuation techniques and market valuation techniques based on both sales and EBITDA forward multiples. The decline in the estimated fair value of Assurance IQ below its carrying value as of December 31, 2021 was driven by a combination of factors as discussed below. The estimated fair value of Assurance IQ as of December 31, 2021 was significantly impacted by the decline in the value of comparable publicly traded companies, particularly during the last three months of the year, as the market multiples are utilized in both the market approaches and in estimating the terminal value under the discounted cash flow approaches. The deterioration in the peer valuations was mainly driven by sector-wide concerns attributed to margin compression and increased customer attrition, among other factors. In addition, revisions to the business long-term forecasts following the annual Medicare enrollment period in the fourth quarter of 2021, reflected lower growth rates in Medicare sales driven by slower agent growth, and increased operating expenses, along with other changes in business plans, including shifts in the product mix. The long-term forecasts also incorporated changes in the expected synergies to be realized and were reflective of the current and expected industry and market conditions and trends. These revisions led to declines in the cash flow projections, used as part of the discounted cash flow approaches, consistent with how a market participant would assess the outlook of the business. The combination of the decline in peer valuations with the revisions to the business forecast, caused the estimated fair value of Assurance IQ to decline below its carrying value as of December 31, 2021 and resulted in a non-cash goodwill impairment charge of $1,060 million pre-tax, or $837 million after-tax. Estimating the fair value of reporting units is a subjective process that involves the use of significant estimates by management. For all reporting units tested, unanticipated changes in business performance or regulatory environment, market declines or other events impacting the fair value of these businesses, including changes in market multiples, discount rates, interest rates and growth rates assumptions or increases in the level of equity required to support these businesses, could cause additional goodwill impairment charges in future periods. Other Intangibles Other intangible balances at December 31, are as follows:
__________ (1)Includes “Assets held-for-sale” of $39 million as of December 31, 2021. See Note 1 for more information on the pending dispositions. The fair values of net mortgage servicing rights were $324 million and $309 million at December 31, 2021 and 2020, respectively. Amortization expense for other intangibles was $110 million, $102 million and $65 million for the years ending December 31, 2021, 2020 and 2019, respectively. The amortization expense amounts for 2021, 2020 and 2019 do not include impairments recorded for mortgage servicing rights or other intangibles. See the nonrecurring fair value measurements section of Note 6 for more information regarding these impairments. The following table provides estimated future amortization for the periods indicated:
|
Leases |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Leases [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Operating Leases, Lessee | LEASES The Company occupies leased office space and other facilities in many locations under various long-term leases and has entered into numerous leases covering the long-term use of computers and other equipment. The leases, depending on their specific terms, are classified as either operating or finance with the vast majority of leases falling under the operating classification. The leases in the Company’s portfolio have remaining lease terms from less than one year to 27 years, some of which include options to extend the leases for up to 20 years, and some of which include options to terminate the leases within 4 years. An analysis of all economic and non-economic factors associated with leases containing certain options, including factors such as the existence of cancellation penalties, leasehold improvements made to the underlying assets and location of the underlying assets, is conducted to determine whether those leases are reasonably certain to renew, and hence, should be included in the lease term that is used to establish the right-of-use assets and lease liabilities for those arrangements. The Company does not have residual guarantees associated with its lessee arrangements, nor are there any restrictions or covenants associated with its lease arrangements. Lessee Supplemental balance sheet information related to leases where the Company is the lessee is included below. Right-of-use assets and lease liabilities are included within “Other assets” and “Other liabilities” respectively.
Maturities of operating lease liabilities are as follows:
As of December 31, 2021, the Company has an additional $192 million of payments on operating leases that have not yet commenced, primarily for properties to be used by various domestic operations. These operating leases will commence between 2022 and 2023 with lease terms from 5 years to 15 years. Lease expense is included in “General and administrative expenses,” which consisted of operating lease and short-term costs. Operating lease costs were $153 million, $156 million, and $138 million for the years ended December 31, 2021, 2020, and 2019, respectively. Short-term lease costs were $96 million, $104 million, and $101 million for the years ended December 31, 2021, 2020, and 2019, respectively. Short-term lease costs relate to those leases with terms of twelve months or less that do not include an option to purchase the underlying asset that is reasonably certain of exercise. Lessor The Company directly owns real estate properties within its investment portfolio. Such real estate is leased to third-parties, with the Company serving as the lessor. The terms of the leases vary depending on property type (e.g., commercial or residential). In most cases, the lessee has an option to renew the lease contract based on market rates but does not have an option to purchase the property. The terms of the leases may also include provisions for the use of common areas. Such non-lease components are not separately accounted for by the Company, as a result of applying the practical expedient discussed in Note 2. Lease income included in “Net investment income” were $115 million, $161 million, and $182 million for the years ended December 31, 2021, 2020, and 2019, respectively.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Operating Leases, Lessor | LEASES The Company occupies leased office space and other facilities in many locations under various long-term leases and has entered into numerous leases covering the long-term use of computers and other equipment. The leases, depending on their specific terms, are classified as either operating or finance with the vast majority of leases falling under the operating classification. The leases in the Company’s portfolio have remaining lease terms from less than one year to 27 years, some of which include options to extend the leases for up to 20 years, and some of which include options to terminate the leases within 4 years. An analysis of all economic and non-economic factors associated with leases containing certain options, including factors such as the existence of cancellation penalties, leasehold improvements made to the underlying assets and location of the underlying assets, is conducted to determine whether those leases are reasonably certain to renew, and hence, should be included in the lease term that is used to establish the right-of-use assets and lease liabilities for those arrangements. The Company does not have residual guarantees associated with its lessee arrangements, nor are there any restrictions or covenants associated with its lease arrangements. Lessee Supplemental balance sheet information related to leases where the Company is the lessee is included below. Right-of-use assets and lease liabilities are included within “Other assets” and “Other liabilities” respectively.
Maturities of operating lease liabilities are as follows:
As of December 31, 2021, the Company has an additional $192 million of payments on operating leases that have not yet commenced, primarily for properties to be used by various domestic operations. These operating leases will commence between 2022 and 2023 with lease terms from 5 years to 15 years. Lease expense is included in “General and administrative expenses,” which consisted of operating lease and short-term costs. Operating lease costs were $153 million, $156 million, and $138 million for the years ended December 31, 2021, 2020, and 2019, respectively. Short-term lease costs were $96 million, $104 million, and $101 million for the years ended December 31, 2021, 2020, and 2019, respectively. Short-term lease costs relate to those leases with terms of twelve months or less that do not include an option to purchase the underlying asset that is reasonably certain of exercise. Lessor The Company directly owns real estate properties within its investment portfolio. Such real estate is leased to third-parties, with the Company serving as the lessor. The terms of the leases vary depending on property type (e.g., commercial or residential). In most cases, the lessee has an option to renew the lease contract based on market rates but does not have an option to purchase the property. The terms of the leases may also include provisions for the use of common areas. Such non-lease components are not separately accounted for by the Company, as a result of applying the practical expedient discussed in Note 2. Lease income included in “Net investment income” were $115 million, $161 million, and $182 million for the years ended December 31, 2021, 2020, and 2019, respectively.
|
Policyholders' Liabilities |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Liability for Future Policy Benefits and Unpaid Claims and Claims Adjustment Expense [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Policyholders' Liabilities | POLICYHOLDERS’ LIABILITIES Future Policy Benefits Future policy benefits at December 31 for the years indicated are as follows:
__________ (1)See Note 1 for additional information on the pending dispositions Life insurance liabilities include reserves for death, endowment, and other policy benefits. Individual and group annuities and supplementary contracts liabilities include reserves for life contingent individual immediate annuities and life contingent group annuities. Other contract liabilities include liabilities for variable annuity living benefit guarantees and certain other reserves for long-term care, group, annuities and individual life and health products. Future policy benefits for individual participating traditional life insurance are based on the net level premium method, calculated using the guaranteed mortality and nonforfeiture interest rates which range from 2.5% to 7.5%. Participating insurance represented 2% and 3% of direct individual life insurance in force as of December 31, 2021 and 2020, respectively, and 10%, 10%, and 11% of direct individual life insurance premiums for 2021, 2020, and 2019, respectively. Future policy benefits for individual non-participating traditional life insurance policies, group life polices, group and individual long-term care policies and individual health insurance policies are generally equal to the present value of future benefit payments and related expenses, less the present value of future net premiums. Assumptions as to mortality, morbidity and persistency are based on the Company’s experience, industry data, and/or other factors, when the basis of the reserve is established. Interest rates used in the determination of the present values range from (0.1)% to 7.8%. Future policy benefits for individual and group annuities and supplementary contracts with life contingencies are generally equal to the present value of expected future payments. Assumptions as to mortality are based on the Company’s experience, industry data, and/or other factors, when the basis of the reserve is established. The interest rates used in the determination of the present values range from (0.2)% to 12.1%; less than 1% of the reserves are based on an interest rate in excess of 8%. Future policy benefits for other contract liabilities are generally equal to the present value of expected future payments based on the Company’s experience, except for example, certain group insurance coverages for which future policy benefits are equal to gross unearned premium reserves. The interest rates used in the determination of the present values range from 0.6% to 6.5%. The Company’s liability for future policy benefits is also inclusive of liabilities for guaranteed benefits related to certain long-duration life and annuity contracts. Liabilities for guaranteed benefits with embedded derivative features are primarily in “other contract liabilities” in the table above. The remaining liabilities for guaranteed benefits are primarily reflected with the underlying contract in the table above. See Note 13 for additional information regarding liabilities for guaranteed benefits related to certain long-duration life and annuity contracts. Reserves for recognizing a premium deficiency included in “Future policy benefits” are established, if necessary, when the liability for future policy benefits plus the present value of expected future gross premiums are determined to be insufficient to provide for expected future policy benefits and expenses. Additionally, in certain instances the policyholder liability for a particular line of business may not be deficient in the aggregate to trigger loss recognition, but the pattern of earnings may be such that profits are expected to be recognized in earlier years followed by losses in later years. In these situations, accounting standards require that an additional PFL liability be recognized by an amount necessary to sufficiently offset the losses that would be recognized in later years. Premium deficiencies have been recognized in the past for the group single premium annuity business, which consists of limited-payment, long-duration traditional, non-participating annuities; structured settlements; single premium immediate annuities with life contingencies; long-term care; certain individual health policies; and certain interest-sensitive life products. The Company’s liability for future policy benefits is also inclusive of liabilities for claims reserves and unpaid claims and claim settlement expenses. Unpaid claims and claim settlement expenses primarily reflect the Company’s present value of future disability claim payments and expenses as well as estimates of claims incurred but not yet reported as of the balance sheet date related to group disability products. Unpaid claim liabilities that are discounted use interest rates ranging from 1.8% to 6.4%. Claims reserves for claims reported but not yet paid and claims incurred but not yet reported are primarily reflected with the underlying contract in the table above. Policyholders’ Account Balances Policyholders’ account balances at December 31 for the years indicated are as follows:
__________ (1)See Note 1 for additional information on the pending dispositions. Policyholders’ account balances primarily represent an accumulation of account deposits plus credited interest less withdrawals, expense charges and mortality charges, if applicable. These policyholders’ account balances also include provisions for benefits under non-life contingent payout annuities and certain unearned revenues. Policyholders’ account balances also include amounts representing the fair value of embedded derivative instruments associated with the index-linked features of certain universal life and annuity products. See Note 6 for additional information on the fair value of these embedded derivative instruments. Included in “Funding agreements” at December 31, 2021 and 2020 are $4,959 million and $4,402 million, respectively, related to the Company’s Funding Agreement Notes Issuance Program (“FANIP”). Under this program, which has a maximum authorized amount of $15 billion of medium-term notes and $3 billion of commercial paper, Delaware statutory trusts issue short-term commercial paper and/or medium-term notes to investors that are secured by funding agreements issued to the trusts by PICA. The outstanding commercial paper and notes have fixed or floating interest rates that range from 0.0% to 3.5% and original maturities ranging from one month to five years. Included in the amounts at December 31, 2021 and 2020 are funding agreements which secure the medium-term note liability, which are carried at amortized cost, of $3,117 million and $2,414 million, respectively, and short-term note liability of $1,847 million and $1,991 million, respectively. Also included in “Funding agreements” are collateralized funding agreements issued to the Federal Home Loan Bank of New York (“FHLBNY”) at December 31, 2021 and 2020 totaling $1,050 million and $2,522 million, respectively. These obligations, which are carried at amortized cost, have fixed interest rates that range from 0.620% to 1.925% and original maturities ranging from nine months to seven years. For additional details on the FHLBNY program, see Note 17. Interest crediting rates range from 0% to 6.3% for interest-sensitive life contracts and from 0% to 13.3% for contracts other than interest-sensitive life. Less than 1% of policyholders’ account balances have interest crediting rates in excess of 8%.
|
Certain Long-Duration Contracts with Guarantees |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Long-Duration Contracts, Assumptions Supporting Guarantee Obligations [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Certain Long-Duration Contracts With Guarantees | CERTAIN LONG-DURATION CONTRACTS WITH GUARANTEES The Company issues variable annuity contracts through its separate accounts for which investment income and investment gains and losses accrue directly to, and investment risk is borne by, the contractholder. The Company also issued variable annuity contracts with general and separate account options where the Company contractually guarantees to the contractholder a return of no less than total deposits made to the contract adjusted for any partial withdrawals (“return of net deposits”). In certain of these variable annuity contracts, the Company also contractually guarantees to the contractholder a return of no less than (1) total deposits made to the contract adjusted for any partial withdrawals plus a minimum return (“minimum return”), and/or (2) the highest contract value on a specified date adjusted for any withdrawals (“contract value”). These guarantees include benefits that are payable in the event of death, annuitization or at specified dates during the accumulation period and withdrawal and income benefits payable during specified periods. The Company also issues annuity contracts and single premium life contracts with market value adjusted investment options (“MVAs”). Annuity contracts and single premium life contracts with MVAs provide for a return of principal plus a fixed rate of return if held-to-maturity, or, alternatively, a “market adjusted value” if surrendered prior to maturity or if funds are reallocated to other investment options. The market value adjustment may result in a gain or loss to the Company, depending on crediting rates or an indexed rate at surrender, as applicable. The Company also issues fixed deferred, fixed index, and immediate annuity contracts that have a guaranteed credited rate, annuity benefit, and withdrawal benefit. The Company also issues indexed variable annuity contracts for which the return is tied to the return of specific indices where the Company contractually guarantees to the contractholder a return of no less than total deposits made to the contract adjusted for any partial withdrawals upon death. In certain of these indexed variable annuity contracts, the Company also contractually guarantees to the contractholder withdrawal benefits payable during specific periods. In addition, the Company issues certain variable life, variable universal life and universal life contracts where the Company contractually guarantees to the contractholder a death benefit even when there is insufficient value to cover monthly mortality and expense charges, whereas otherwise the contract would typically lapse (“no-lapse guarantee”). Variable life and variable universal life contracts are offered with general and separate account options. The assets supporting the variable portion of all variable annuities are carried at fair value and reported as “Separate account assets” with an equivalent amount reported as “Separate account liabilities.” Amounts assessed against the contractholders for mortality, administration, and other services are included within revenue in “Policy charges and fee income” and changes in liabilities for minimum guarantees are generally included in “Policyholders’ benefits” or “Realized investment gains (losses), net.” For those guarantees of benefits that are payable in the event of death, the net amount at risk is generally defined as the current guaranteed minimum death benefit in excess of the current account balance at the balance sheet date. The Company’s primary risk exposures for these contracts relates to actual deviations from, or changes to, the assumptions used in the original pricing of these products, including fixed income and equity market returns, contract lapses and contractholder mortality. For guarantees of benefits that are payable at annuitization, the net amount at risk is generally defined as the present value of the minimum guaranteed annuity payments available to the contractholder determined in accordance with the terms of the contract in excess of the current account balance. The Company’s primary risk exposures for these contracts relates to actual deviations from, or changes to, the assumptions used in the original pricing of these products, including fixed income and equity market returns, timing of annuitization, contract lapses and contractholder mortality. For guarantees of benefits that are payable at withdrawal, the net amount at risk is generally defined as the present value of the minimum guaranteed withdrawal payments available to the contractholder determined in accordance with the terms of the contract in excess of the current account balance. For guarantees of accumulation balances, the net amount at risk is generally defined as the guaranteed minimum accumulation balance minus the current account balance. The Company’s primary risk exposures for these contracts relates to actual deviations from, or changes to, the assumptions used in the original pricing of these products, including equity market returns, interest rates, market volatility and contractholder behavior. The Company’s contracts with guarantees may offer more than one type of guarantee in each contract; therefore, the amounts listed may not be mutually exclusive. The liabilities related to the net amount at risk are reflected within “Future policy benefits.” As of December 31, 2021 and 2020, the Company had the following guarantees associated with these contracts, by product and guarantee type:
__________ (1)Includes income and withdrawal benefits.
Account balances of variable annuity contracts with guarantees were invested in separate account investment options as follows:
In addition to the amounts invested in separate account investment options above, $7,159 million at December 31, 2021, and $7,729 million at December 31, 2020, of account balances of variable annuity contracts with guarantees, inclusive of contracts with MVA features, were invested in general account investment options. For the years ended December 31, 2021, 2020 and 2019, there were no transfers of assets, other than cash, from the general account to any separate account, and accordingly no gains or losses recorded. Liabilities for Guarantee Benefits The table below summarizes the changes in general account liabilities for guarantees. The liabilities for GMDB and GMIB are included in “Future policy benefits” and the related changes in the liabilities are included in “Policyholders’ benefits.” GMAB, GMWB and GMIWB are accounted for as embedded derivatives and are recorded at fair value within “Future policy benefits.” Changes in the fair value of these derivatives, including changes in the Company’s own risk of non-performance, along with any fees attributed or payments made relating to the derivative, are recorded in “Realized investment gains (losses), net.” See Note 6 for additional information regarding the methodology used in determining the fair value of these embedded derivatives. The Company maintains a portfolio of derivative investments that serve as a partial hedge of the risks associated with these products, for which the changes in fair value are also recorded in “Realized investment gains (losses), net.” This portfolio of derivative investments does not qualify for hedge accounting treatment under U.S. GAAP. Additionally, the Company externally reinsures the guaranteed benefit features associated with certain contracts. See Note 14 for further information regarding the external reinsurance arrangement.
__________ (1)Incurred guarantee benefits include the portion of assessments established as additions to reserves as well as changes in estimates affecting the reserves. Also includes changes in the fair value of features considered to be derivatives. (2)Other primarily represents foreign currency translation. (3)Includes the impact from the sale of POK. (4)See Note 1 for additional information on the pending dispositions. (5)Includes the impact from the sale of POT. The GMDB, which includes the liability for no-lapse guarantees, and GMIB liability are established when associated assessments (which include all policy charges including charges for administration, mortality, expense, surrender, and other, regardless of how characterized) are recognized. This liability is established using current best estimate assumptions and is based on the ratio of the present value of total expected excess payments (e.g., payments in excess of account value) over the life of the contract divided by the present value of total expected assessments (i.e., benefit ratio). The liability equals the current benefit ratio multiplied by cumulative assessments recognized to date, plus interest, less cumulative excess payments to date. Similar to as described above for DAC, the reserves are subject to adjustments based on annual reviews of assumptions and quarterly adjustments for experience, including market performance. These adjustments reflect the impact on the benefit ratio of using actual historical experience from the issuance date to the balance sheet date plus updated estimates of future experience. The updated benefit ratio is then applied to all prior periods’ assessments to derive an adjustment to the reserve recognized through a benefit or charge to current period earnings. The GMAB features provide the contractholder with a guaranteed return of initial account value or an enhanced value if applicable. The most significant of the Company’s GMAB features are the guaranteed return option features, which includes an automatic rebalancing element that reduces the Company’s exposure to these guarantees. The GMAB liability is calculated as the present value of future expected payments in excess of the account balance less the present value of future expected rider fees attributable to the embedded derivative feature. The GMWB features provide the contractholder with access to a guaranteed remaining balance if the account value is reduced to zero through a combination of market declines and withdrawals. The guaranteed remaining balance is generally equal to the protected value under the contract, which is initially established as the greater of the account value or cumulative deposits when withdrawals commence, less cumulative withdrawals. The contractholder also has the option, after a specified time period, to reset the guaranteed remaining balance to the then current account value, if greater. The contractholder accesses the guaranteed remaining balance through payments over time, subject to maximum annual limits. The GMWB liability is calculated as the present value of future expected payments to customers less the present value of future expected rider fees attributable to the embedded derivative feature. The GMIWB features, taken collectively, provide a contractholder two optional methods to receive guaranteed minimum payments over time, a “withdrawal” option or an “income” option. The withdrawal option (which was available under only one of the GMIWBs and is no longer offered) guarantees that a contractholder can withdraw an amount each year until the cumulative withdrawals reach a total guaranteed balance. The income option (which varies among the Company’s GMIWBs) in general guarantees the contractholder the ability to withdraw an amount each year for life (or for joint lives, in the case of any spousal version of the benefit) where such amount is equal to a percentage of a protected value under the benefit. The contractholder also has the potential to increase this annual amount, based on certain subsequent increases in account value that may occur. The GMIWB can be elected by the contractholder upon issuance of an appropriate deferred variable annuity contract or at any time following contract issue prior to annuitization. Certain GMIWB features include an automatic rebalancing element that reduces the Company’s exposure to these guarantees. The GMIWB liability is calculated as the present value of future expected payments to customers less the present value of future expected rider fees attributable to the embedded derivative feature. Sales Inducements The Company defers sales inducements and amortizes them over the anticipated life of the policy using the same methodology and assumptions used to amortize DAC. DSI is included in “Other assets.” The Company has offered various types of sales inducements including: (1) a bonus whereby the policyholder’s initial account balance is increased by an amount equal to a specified percentage of the customer’s initial deposit; (2) additional credits after a certain number of years a contract is held; and (3) enhanced interest crediting rates that are higher than the normal general account interest rate credited in certain product lines. Changes in DSI, reported as “Interest credited to policyholders’ account balances,” are as follows:
__________ (1)See Note 1 for additional information on the pending dispositions. (2)Represents the impact from the sale of POT.
|
Reinsurance |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reinsurance Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reinsurance | REINSURANCE The Company participates in reinsurance with third parties primarily to provide additional capacity for future growth, limit the maximum net loss potential arising from large risks and acquire or dispose of businesses. Effective April 1, 2015, the Company entered into an agreement with Union Hamilton Reinsurance, Ltd. (“Union Hamilton”) an external counterparty, to reinsure approximately 50% of the Prudential Premier® Retirement Variable Annuity with Highest Daily Lifetime Income (“HDI”) v.3.0 business, a guaranteed benefit feature. This reinsurance agreement covered most new HDI v.3.0 variable annuity business issued between April 1, 2015 and December 31, 2016 on a quota share basis, with Union Hamilton’s cumulative quota share amounting to $2.9 billion of new rider premiums as of December 31, 2016. Reinsurance on business subject to this agreement remains in force for the duration of the underlying annuity contracts. New sales subsequent to December 31, 2016 are not covered by this external reinsurance agreement. This reinsurance agreement is accounted for as an embedded derivative. In January 2013, the Company acquired the Hartford Life Business through reinsurance transactions with three subsidiaries of Hartford Financial Services Group, Inc. (“Hartford Financial”). Under the related agreements, the Company provided reinsurance for approximately 700,000 life insurance policies with net retained face amount in force of approximately $141 billion. The Company acquired the general account business through a coinsurance arrangement and, for certain types of general account policies, a modified coinsurance arrangement. The Company acquired the separate account business through a modified coinsurance arrangement. In May 2018, Hartford Financial sold a group of operating subsidiaries, which included two of the Company’s counterparties to these reinsurance arrangements, to Talcott Resolution Life Insurance Company (“Talcott Resolution”). Talcott Resolution was acquired by Sixth Street in July 2021. There was no impact to the terms, rights or obligations of the Company, or operation of these reinsurance arrangements, as a result of these changes in control of such counterparties. Since 2011, the Company has entered into a number of reinsurance agreements to assume pension liabilities in the United Kingdom. Under these arrangements, the Company assumes the longevity risk, and in some arrangements, also the investment risk associated with the pension benefits of certain specified beneficiaries. In 2006, the Company acquired the variable annuity business of The Allstate Corporation (“Allstate”) through a reinsurance transaction. The reinsurance arrangements with Allstate include a coinsurance arrangement associated with the general account liabilities assumed and a modified coinsurance arrangement associated with the separate account liabilities assumed. The reinsurance payable, which represents the Company’s obligation under the modified coinsurance arrangement, is netted with the reinsurance receivable in the Consolidated Statements of Financial Position. During the fourth quarter of 2021, Allstate sold the two counterparties to the aforementioned variable annuity reinsurance transaction to third parties. The Company anticipates there will be no impact to the terms, rights or obligations of the Company, or operation of these reinsurance arrangements, as a result of this change in control of such counterparties. In 2004, the Company acquired the retirement business of CIGNA and subsequently entered into various reinsurance arrangements. The Company still has indemnity coinsurance and modified coinsurance without assumption arrangements in effect related to this acquisition. For the domestic business, life and disability reinsurance is accomplished through various plans of reinsurance, primarily yearly renewable term, per person excess, excess of loss, and coinsurance. On policies sold since 2000, the Company has reinsured a significant portion of the individual life mortality risk. Placement of reinsurance is accomplished primarily on an automatic basis with some specific risks reinsured on a facultative basis. The Company is authorized and has historically retained up to $30 million per life, but reduced its operating retention limit to $20 million per life in 2013. Retention in excess of the operating limit is on an exception basis. The international business primarily uses reinsurance to obtain experience with respect to certain new product offerings and to a lesser extent, to mitigate mortality risk for certain protection products and for capital management purposes. Reinsurance amounts included in the Consolidated Statements of Operations for premiums, policy charges and fee income, and policyholders’ benefits for the years ended December 31, are as follows:
Reinsurance recoverables at December 31, are as follows:
__________ (1)Primarily represents reinsurance recoverables established under the reinsurance agreement with Union Hamilton related to the ceding of certain embedded derivative liabilities associated with the Company’s guaranteed benefits of $110 million and $204 million as of December 31, 2021 and 2020, respectively. (2)Includes reinsurance recoverables established under the reinsurance arrangements associated with the acquisition of the Hartford Life Business of $2,178 million and $2,245 million as of December 31, 2021 and 2020, respectively. The Company has also recorded reinsurance payables related to the Hartford Life Business acquisition of $1,341 million and $1,362 million as of December 31, 2021 and 2020, respectively. (3)Net of $(10) million and $(5) million of loss allowance as of December 31, 2021 and 2020, respectively. (4)Excludes reinsurance recoverables of $30 million related to “Asset held-for-sale” operations as of December 31, 2021. See Note 1 for additional information on the pending dispositions. Excluding the reinsurance recoverables associated with the acquisition of the Hartford Life Business, four major reinsurance companies account for approximately 61% of the reinsurance recoverables as of December 31, 2021. The Company periodically reviews the financial condition of its reinsurers, amounts recoverable therefrom, and unearned reinsurance premium, in order to reduce its exposure to loss from reinsurer insolvencies. Any expected credit losses are reflected in the CECL allowance, after considering any collateral the Company obtained in the form of a trust, letter of credit, or funds withheld arrangement. See Note 2 for additional details regarding CECL. Under the Company’s international longevity reinsurance transactions, the Company obtains collateral from its counterparties to mitigate counterparty default risk.
|
Closed Block |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Closed Block Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Closed Block | CLOSED BLOCK On December 18, 2001, the date of demutualization, PICA established a closed block for certain in-force participating insurance policies and annuity products, along with corresponding assets used for the payment of benefits and policyholders’ dividends on these products, (collectively the “Closed Block”), and ceased offering these participating products. The recorded assets and liabilities were allocated to the Closed Block at their historical carrying amounts. The Closed Block forms the principal component of the Closed Block division. See Note 22 for financial information on the Closed Block. The insurance policies and annuity contracts comprising the Closed Block are managed in accordance with the Plan of Reorganization approved by the New Jersey Department of Banking and Insurance (“NJDOBI”) on December 18, 2001, and PICA is directly obligated for the insurance policies and annuity contracts in the Closed Block. The policies included in the Closed Block are specified individual life insurance policies and individual annuity contracts that were in force on the date of demutualization and for which PICA is currently paying or expects to pay experience-based policy dividends. Assets have been allocated to the Closed Block in an amount that has been determined to produce cash flows which, together with revenues from policies included in the Closed Block, are expected to be sufficient to support obligations and liabilities relating to these policies, including provision for payment of benefits, certain expenses and taxes and to provide for continuation of the policyholder dividend scales in effect in 2000, assuming experience underlying such scales continues. To the extent that, over time, cash flows from the assets allocated to the Closed Block and claims and other experience related to the Closed Block are, in the aggregate, more or less favorable than what was assumed when the Closed Block was established, total dividends paid to Closed Block policyholders may be greater than or less than the total dividends that would have been paid to these policyholders if the policyholder dividend scales in effect in 2000 had been continued. Any cash flows in excess of amounts assumed will be available for distribution over time to Closed Block policyholders and will not be available to shareholders. If the Closed Block has insufficient funds to make guaranteed policy benefit payments, such payments will be made from PICA’s assets outside of the Closed Block. The Closed Block will continue in effect as long as any policy in the Closed Block remains in force unless, with the consent of the New Jersey insurance regulator, it is terminated earlier. The excess of Closed Block liabilities over Closed Block assets at the date of the demutualization (adjusted to eliminate the impact of related amounts in AOCI) represented the estimated maximum future earnings at that date from the Closed Block expected to result from operations attributed to the Closed Block after income taxes. In establishing the Closed Block, the Company developed an actuarial calculation of the timing of such maximum future earnings. If actual cumulative earnings of the Closed Block from inception through the end of any given period are greater than the expected cumulative earnings, only the expected earnings will be recognized in income. Any excess of actual cumulative earnings over expected cumulative earnings will represent undistributed accumulated earnings attributable to policyholders, which are recorded as a policyholder dividend obligation. The policyholder dividend obligation represents amounts to be paid to Closed Block policyholders as an additional policyholder dividend unless otherwise offset by future Closed Block performance that is less favorable than originally expected. If the actual cumulative earnings of the Closed Block from its inception through the end of any given period are less than the expected cumulative earnings of the Closed Block, the Company will recognize only the actual earnings in income. As of December 31, 2021 and 2020, the Company recognized a policyholder dividend obligation of $4,387 million and $2,920 million, respectively, to Closed Block policyholders for the excess of actual cumulative earnings over the expected cumulative earnings. Additionally, accumulated net unrealized investment gains that have arisen subsequent to the establishment of the Closed Block have been reflected as a policyholder dividend obligation of $3,640 million and $5,867 million at December 31, 2021 and 2020, respectively, to be paid to Closed Block policyholders unless offset by future experience, with a corresponding amount reported in AOCI. In December 2019, PICA’s Board of Directors acted to decrease the dividend scale on Closed Block policies. In December 2020, PICA’s Board of Directors acted to decrease the dividend scale on Closed Block policies. In December 2021, PICA’s Board of Directors approved a continuation of the dividend scale on Closed Block policies. The actions taken by PICA’s Board of Directors resulted in decreases of approximately $79 million, $147 million and $68 million for the years ended December 31, 2019, 2020 and 2021, respectively, in the liability for policyholders’ dividends recognized. Closed Block liabilities and assets designated to the Closed Block at December 31, as well as maximum future earnings to be recognized from these liabilities and assets, are as follows:
Information regarding the policyholder dividend obligation is as follows:
__________ (1)See Note 2 for more information. Closed Block revenues and benefits and expenses for the years ended December 31, are as follows:
|
Income Taxes |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Income Tax Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Income Taxes | INCOME TAXES The following schedule discloses significant components of income tax expense (benefit) for each year presented:
Reconciliation of Expected Tax at Statutory Rates to Reported Income Tax Expense (Benefit) The differences between income taxes expected at the U.S. federal statutory income tax rate of 21% applicable for 2021, 2020 and 2019, and the reported income tax expense (benefit) are summarized as follows:
__________ (1)Prior period amounts have been updated to conform to current period presentation. The effective tax rate is the ratio of “Total income tax expense (benefit)” divided by “Income before income taxes and equity in earnings of operating joint ventures.” The Company’s effective tax rate for fiscal years 2021, 2020 and 2019 was 17.8%, 25.1% and 18.6%, respectively. The following is a description of items that had a significant impact on the difference between the Company’s statutory U.S. federal income tax rate of 21% applicable for 2021, 2020 and 2019, and the Company’s effective tax rate during the periods presented: Non-Taxable Investment Income. The U.S. Dividends Received Deduction (“DRD”) reduces the amount of dividend income subject to U.S. tax and is included in the non-taxable investment income shown in the table above. More specifically, the U.S. DRD constitutes $115 million of the total $292 million of 2021 non-taxable investment income, $109 million of the total $228 million of 2020 non-taxable investment income, and $122 million of the total $270 million of 2019 non-taxable investment income. The DRD for the current period was estimated using information from 2020, current year investment results, and current year’s equity market performance. The actual current year DRD can vary based on factors such as, but not limited to, changes in the amount of dividends received that are eligible for the DRD, changes in the amount of distributions received from fund investments, changes in the account balances of variable life and annuity contracts, and the Company’s taxable income before the DRD. Foreign Taxes at Other Than U.S. Rates. The statutory income tax rate in the Company’s largest non-U.S. tax jurisdiction is approximately 28% in Japan as compared to the U.S. federal income tax rate of 21% applicable for 2021, 2020 and 2019. The 952 Election. The Company made a tax election, effective for the 2017 and later tax years, to subject earnings from its insurance operations in Brazil to tax in the U.S. in the tax year earned, net of related foreign tax credits. This election has the effect of reducing the rate at which the Company will incur taxes on these earnings from the approximately 40% tax rate in Brazil to the 21% tax rate in the U.S. In conjunction with this election, the Company remeasured its related deferred tax assets from the previous 45% rate in Brazil to the new rate of 21% in the U.S., which resulted in additional income tax expense at the time of election. The net effect of the lower tax rate was a net increase (decrease) in income tax expense of $(3) million in 2019, $19 million in 2020, and $(18) million in 2021. In October 2019, the IRS issued a legal memorandum, applicable to all taxpayers, in which the IRS argues that the election became inoperable in 1998. The Company disagrees with the IRS’s position and intends to defend its position. This matter has been assigned to the IRS Independent Office of Appeals, an independent dispute resolution function within the IRS. The Appeals process is intended to reach resolution without litigation, while the Company preserves all available legal remedies, including litigation, if it does not agree with the outcome at Appeals. If the Company is ultimately not successful, it will not be able to claim a U.S. tax credit for the Brazil taxes in excess of the U.S. tax rate, and thus will have a higher tax expense over time. Low-Income Housing and Other Tax Credits. These amounts include incentives within the U.S. tax code for the development of affordable housing aiming at low-income Americans. The Company routinely makes such investments that generate a tax credit which reduces the Company’s effective tax rate. Changes in Tax Law. The following is a notable change in tax law that impacted the Company’s effective tax rate for the periods presented: The CARES Act. On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) was enacted into law. One provision of the CARES Act amends the Tax Act of 2017 and allows companies with net operating losses (“NOLs”) originating in 2020, 2019 or 2018 to carry back those losses for up to five years. For 2020, the Company recorded an income tax benefit of $149 million and $51 million from carrying the estimated 2020 NOL and 2018 NOL back to tax years that have a 35% tax rate. Sale of Subsidiary. This line item is primarily related to the difference between tax basis and GAAP basis for subsidiaries sold. See Note 1 for additional information on the sale of subsidiary-related items. Other. This line item represents insignificant reconciling items that are individually less than 5% of the computed expected federal income tax expense (benefit) and have therefore been aggregated for purposes of this reconciliation in accordance with relevant disclosure guidance. GILTI High Tax Exclusion. On July 20, 2020, the U.S. Treasury and the Internal Revenue Service issued Final Regulations which will allow an annual election to exclude from the U.S. tax return certain GILTI amounts when the taxes paid by a foreign affiliate exceed 18.9% (90% of U.S. statutory rate of 21%) of the GILTI amount for that foreign affiliate (the “high-tax exception”). These regulations are effective for the 2021 taxable year with an election to apply to any taxable year beginning after 2017. In many of the countries in which we operate, including Japan, there are differences between local tax rules used to determine the tax base and the U.S. tax principles used to determine GILTI. Also, our Japan affiliates have a different tax year than the U.S. calendar tax year used to determine GILTI. Therefore, while many of the countries, including Japan, have a statutory tax rate above the 18.9% threshold, separate affiliates may not meet the 18.9% threshold each year and, as such, may not qualify for this exclusion. The Company made the high-tax exception election for the 2020 tax year and anticipates to make the high-tax exception election for the 2021 tax year and recorded a lower GILTI cost included in “Total income tax expense” for 2020 and 2021. The Treasury Department and the IRS also issued Proposed Regulations on July 20, 2020 which would require that, if a high-tax exception election is made with respect to GILTI in any year, an election having the same effect must also be made with regard to income taxed under Subpart F of the Tax Code. Such an election under Subpart F of the Tax Code would apply to the Full Inclusion election made by the Company for its insurance operations in Brazil, thereby increasing the tax rate applied to our Brazil insurance operations. The Proposed Regulations will be effective for taxable years beginning after they are issued in final form. Schedule of Deferred Tax Assets and Deferred Tax Liabilities
__________ (1)Prior period amounts have been updated to conform to current period presentation. The application of U.S. GAAP requires the Company to evaluate the recoverability of deferred tax assets and establish a valuation allowance if necessary to reduce the deferred tax asset to an amount that is more likely than not expected to be realized. Considerable judgment is required in determining whether a valuation allowance is necessary, and if so, the amount of such valuation allowance. In evaluating the need for a valuation allowance, the Company considers many factors, including: (1) the nature of the deferred tax assets and liabilities; (2) whether they are ordinary or capital; (3) in which tax jurisdictions they were generated and the timing of their reversal; (4) taxable income in prior carryback years as well as projected taxable earnings exclusive of reversing temporary differences and carryforwards; (5) the length of time that carryovers can be utilized in the various taxing jurisdictions; (6) any unique tax rules that would impact the utilization of the deferred tax assets; and (7) any tax planning strategies that the Company would employ to avoid a tax benefit from expiring unused. Although realization is not assured, management believes it is more likely than not that the deferred tax assets, net of valuation allowances, will be realized. A valuation allowance has been recorded against deferred tax assets related to federal, state and local taxes and foreign operations. Adjustments to the valuation allowance are made to reflect changes in management’s assessment of the amount of the deferred tax asset that is realizable and the amount of deferred tax asset actually realized during the year. The valuation allowance includes amounts recorded in connection with deferred tax assets as follows:
The following table sets forth the amount and expiration dates of federal, state and foreign operating, capital loss and tax credit carryforwards for tax purposes, as of the periods indicated:
__________ (1)Unlimited carryforward. (2)Certain state net operating loss carryforwards expire between 2022 and 2041, whereas others have an unlimited carryforward. (3)$52 million expires between 2022 and 2036 and $195 million has an unlimited carryforward. (4)Expires between 2028 and 2031. These relate to foreign non-general basket tax credits. Consistent with the Tax Act of 2017, the Company provides applicable U.S. income tax for all unremitted earnings of the Company’s foreign affiliates. For certain foreign affiliates organized in withholding tax jurisdictions, the Company considers the unremitted foreign earnings of those affiliates to be indefinitely reinvested, and therefore does not provide for the withholding tax when calculating its current and deferred tax obligations. For certain other foreign affiliates organized in withholding tax jurisdictions, the Company does not consider unremitted earnings indefinitely reinvested, and therefore provides for foreign withholding tax when calculating its current and deferred tax obligations. The following table summarizes the Company’s indefinite reinvestment assertions for jurisdictions in which the Company operates that impose a withholding tax on dividends that is not eliminated by a tax treaty or may be subject to other foreign country tax upon a remittance:
The Company made no changes with respect to its repatriation assumptions in 2019. During the second and third quarters of 2020, respectively, the Company determined that the earnings of its Korean and Taiwan insurance operations would be repatriated to the United States; accordingly, these earnings were not considered indefinitely reinvested, and the Company recognized an income tax expense of $132 million in “Income (loss) before equity in earnings of operating joint ventures” during 2020. During the second quarter of 2020, the Company changed the permanent investment assertion for Europrisa Management Company S.A (Luxembourg) due to a plan to liquidate the company, which gave rise to an immaterial amount of income tax expense during 2020. The Company made no changes with respect to its repatriation assumptions in 2021. The following table sets forth the undistributed earnings of foreign subsidiaries, where the Company assumes indefinite reinvestment of such earnings and for which, in 2021, 2020, and 2019, U.S. deferred taxes have not been provided, and for which foreign deferred withholding taxes have not been provided. The net tax liability that may arise if the 2021 earnings were remitted which includes any foreign exchange impacts, is immaterial.
__________ (1)Consistent with the Tax Act of 2017, the Company provides U.S. income tax for all unremitted earnings of the Company’s foreign affiliates as of December 31, 2017. The Company’s “Income (loss) before income taxes and equity in earnings of operating joint ventures” includes income (loss) from domestic operations of $7,575 million, $(3,226) million and $1,985 million, and income (loss) from foreign operations of $1,806 million, $2,903 million and $3,101 million for the years ended December 31, 2021, 2020 and 2019, respectively. Tax Audit and Unrecognized Tax Benefits The Company’s liability for income taxes includes the liability for unrecognized tax benefits and interest that relate to tax years still subject to review by the IRS or other taxing authorities. The completion of review or the expiration of the Federal statute of limitations for a given audit period could result in an adjustment to the liability for income taxes. The following table reconciles the total amount of unrecognized tax benefits at the beginning and end of the periods indicated:
The Company does not anticipate any significant changes within the next twelve months to its total unrecognized tax benefits related to tax years for which the statute of limitations has not expired. The Company classifies all interest and penalties related to tax uncertainties as income tax expense (benefit). The amounts recognized in the consolidated financial statements for tax-related interest and penalties for the years ended December 31 are as follows:
Listed below are the tax years that remain subject to examination, by major tax jurisdiction, as of December 31, 2021:
The Company participates in the IRS’s Compliance Assurance Program. Under this program, the IRS assigns an examination team to review completed transactions as they occur in order to reach agreement with the Company on how they should be reported in the relevant tax returns. If disagreements arise, accelerated resolutions programs are available to resolve the disagreements in a timely manner. Some of the Company’s affiliates in Japan file a consolidated tax return, while others file separate tax returns. The Company’s affiliates in Japan are subject to audits by the local taxing authority. The general statute of limitations is five years from when the return is filed. The Japanese National Tax Service conducted tax audits of some non-insurance companies during the reporting period, which had no material impact on the Company’s 2021, 2020 or 2019 results. In August 2020, the Company sold an affiliate in South Korea that filed a separate tax return and was subject to audits by the local taxing authority. The general statute of limitations is five years from when the return is filed. During 2020, the Korean tax authority completed a routine tax audit of Prudential of Korea for 2017, 2016, and 2015 tax years. While these activities had no material impact on the Company’s 2021, 2020 or 2019 results, the tax authority raised questions about the treatment of foreign tax credits. The Company is responsible via an indemnity for taxes and other costs that may arise from the dispute.
|
Short-Term and Long-Term Debt |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Short-Term and Long-Term Debt | SHORT-TERM AND LONG-TERM DEBT Short-term Debt The table below presents the Company’s short-term debt at December 31, for the years indicated as follows:
__________ (1)The surplus notes have corresponding assets where rights to set-off exist, thereby reducing the amount of surplus notes. (2)Includes a $98 million bridge loan and $7 million drawn on a revolving line of credit held by a subsidiary at December 31, 2021. (3)Includes Prudential Financial debt of $25 million and $424 million at December 31, 2021 and 2020, respectively. At December 31, 2021 and 2020, the Company was in compliance with all covenants related to the above debt. Commercial Paper Prudential Financial has a commercial paper program with an authorized capacity of $3.0 billion. Prudential Financial’s commercial paper borrowings have generally been used to fund the working capital needs of its subsidiaries and provide short-term liquidity at Prudential Financial. Prudential Funding, LLC (“Prudential Funding”), a wholly-owned subsidiary of PICA, has a commercial paper program, with an authorized capacity of $7.0 billion. Prudential Funding commercial paper borrowings generally have served as an additional source of financing to meet the working capital needs of PICA and its subsidiaries. Prudential Funding also lends to other subsidiaries of Prudential Financial up to limits agreed with the NJDOBI. Prudential Funding maintains a support agreement with PICA whereby PICA has agreed to maintain Prudential Funding’s tangible net worth at a positive level. Additionally, Prudential Financial has issued a subordinated guarantee covering Prudential Funding’s $7.0 billion commercial paper program. Federal Home Loan Bank of New York PICA is a member of the FHLBNY. Membership allows PICA access to the FHLBNY’s financial services, including the ability to obtain collateralized loans and to issue collateralized funding agreements. Under applicable law, the funding agreements issued to the FHLBNY have priority claim status above debt holders of PICA. FHLBNY borrowings and funding agreements are collateralized by qualifying mortgage-related assets or U.S. Treasury securities, the fair value of which must be maintained at certain specified levels relative to outstanding borrowings. FHLBNY membership requires PICA to own member stock and borrowings require the purchase of activity-based stock in an amount equal to 4.5% of outstanding borrowings. Under FHLBNY guidelines, if any of PICA’s financial strength ratings decline below A-/A3/A- Negative by S&P/Moody’s/Fitch, respectively, and the FHLBNY does not receive written assurances from the NJDOBI regarding PICA’s solvency, new borrowings from the FHLBNY would be limited to a term of 90 days or less. Currently there are no restrictions on the term of borrowings from the FHLBNY. All FHLBNY stock purchased by PICA is classified as restricted general account investments within “Other invested assets,” and the carrying value of these investments was $80.5 million and $147.4 million as of December 31, 2021 and 2020, respectively. NJDOBI permits PICA to pledge collateral to the FHLBNY in an amount of up to 5% of its prior year-end statutory net admitted assets, excluding separate account assets. Based on PICA’s statutory net admitted assets as of December 31, 2020, the 5% limitation equates to a maximum amount of eligible assets of $7.7 billion and an estimated maximum borrowing capacity (after taking into account required collateralization levels) of approximately $6.9 billion. Nevertheless, FHLBNY borrowings are subject to the FHLBNY’s discretion and to the availability of qualifying assets at PICA. In the first quarter of 2020, PICA issued $3.6 billion in funding agreements under the FHLBNY facility. As of December 31, 2021, $1.0 billion of funding agreements remain outstanding under this facility maturing in February 2027 with a rate of 1.925%. These funding agreements are reflected as “Policyholders’ account balances” on the Consolidated Statements of Financial Position and as such are not included in the foregoing table. Federal Home Loan Bank of Boston PRIAC is a member of the Federal Home Loan Bank of Boston (“FHLBB”). Membership allows PRIAC access to collateralized advances which will be classified in “Short-term debt” or “Long-term debt,” depending on the maturity date of the obligation. PRIAC’s membership in FHLBB requires the ownership of member stock and borrowings from FHLBB require the purchase of activity-based stock in an amount between 3.0% and 4.5% of outstanding borrowings, depending on the maturity date of the obligation. All FHLBB stock purchased by PRIAC is classified as restricted general account investments within “Other invested assets,” and the carrying value of these investments was $6 million as of both December 31, 2021 and 2020. As of December 31, 2021, PRIAC had no advances outstanding under the FHLBB facility. Under Connecticut state insurance law, without the prior consent of the Connecticut Insurance Department, the amount of assets insurers may pledge to secure debt obligations is limited to the lesser of 5% of prior-year statutory admitted assets or 25% of prior-year statutory surplus, resulting in a maximum borrowing capacity for PRIAC under the FHLBB facility of approximately $264 million as of December 31, 2021. As a result of the Company’s agreement to sell its Full Service Retirement business to Great-West, which includes the sale of all of its outstanding equity interests in PRIAC, we expect that the Company will no longer be a member of the FHLBB as of the closing of the sale.Credit Facilities As of December 31, 2021, the Company maintained syndicated, unsecured committed credit facilities as described below.
In July 2021, the Company amended and restated its $4.0 billion -year credit facility that has both Prudential Financial and Prudential Funding as borrowers and a syndicate of financial institutions as lenders, extending the term of the facility to July 2026. The credit facility contains customary representations and warranties, covenants and events of default and borrowings are not contingent on the borrowers’ credit ratings nor subject to material adverse change clauses. Borrowings under this facility are conditioned on the continued satisfaction of customary conditions, including Prudential Financial’s maintenance of consolidated net worth of at least $23.5 billion, which is calculated as U.S. GAAP equity, excluding AOCI, equity of noncontrolling interests and equity attributable to the Closed Block. The Company expects that it may borrow under the facility from time to time to fund its working capital needs. In addition, amounts under this credit facility may be drawn in the form of standby letters of credit that can be used to meet the Company’s operating needs. The amended and restated facility also includes certain sustainability-linked pricing adjustments, by which the applicable interest rate margins and commitment fee may be decreased or increased if the Company achieves, or fails to achieve, certain specified targets relating to its reduction of domestic greenhouse gas emissions and its increase in diversity among its senior leaders. The ¥100 billion -year facility was entered into by Prudential Holdings of Japan, Inc. (“PHJ”) in September 2019. This facility also contains customary representations and warranties, covenants, and events of default and borrowings are not contingent on the borrower’s credit ratings nor subject to material adverse change clauses. Borrowings under each of these credit facilities may be used for general corporate purposes. As of December 31, 2021, the Company was in compliance with the covenants under each of these credit facilities. In addition to the above credit facilities, the Company had access to $205 million of certain other lines of credit at December 31, 2021, of which $175 million was for the sole use of certain real estate separate accounts. The separate account facilities include loan-to-value ratio requirements and other financial covenants, and recourse on obligations under these facilities is limited to the assets of the applicable separate account. At December 31, 2021, $55 million of these credit facilities were used. The Company also has access to uncommitted lines of credit from financial institutions. Agreements for Senior Notes Issuance In November 2013, Prudential Financial entered into a -year put option agreement with a Delaware trust upon the completion of the sale of $1.5 billion of trust securities by that Delaware trust in a Rule 144A private placement. The trust invested the proceeds from the sale of the trust securities in a portfolio of principal and interest strips of U.S. Treasury securities. The put option agreement provides Prudential Financial the right to sell to the trust at any time up to $1.5 billion of 4.419% senior notes due November 2023 and receive in exchange a corresponding amount of U.S. Treasury securities held by the trust. In return, the Company agreed to pay a semi-annual put premium to the trust at a rate of 1.777% per annum applied to the unexercised portion of the put option. The put option agreement with the trust provides Prudential Financial with a source of liquid assets. The put option described above will be exercised automatically in full upon the Company’s failure to make certain payments to the trust, such as paying the put option premium or reimbursing the trust for its expenses, if the Company’s failure to pay is not cured within 30 days, and upon an event involving its bankruptcy. The Company is also required to exercise the put option if its consolidated stockholders’ equity, calculated in accordance with U.S. GAAP but excluding AOCI, falls below $7.0 billion, subject to adjustment in certain cases. The Company has a one-time right to unwind a prior voluntary exercise of the put option by repurchasing all of the senior notes then held by the trust in exchange for a corresponding amount of U.S. Treasury securities. Finally, Prudential Financial may redeem all but not less than all outstanding senior notes prior to their maturity at a redemption price equal to the greater of par or a make-whole price, following a voluntary exercise in full of the put option. In May 2020, Prudential Financial entered into a ten-year facility agreement with a Delaware trust upon the completion of the sale of $1.5 billion of trust securities by that Delaware trust in a Rule 144A private placement. The trust invested the proceeds from the sale of the trust securities in a portfolio of principal and/or interest strips of U.S. Treasury securities. The facility agreement provides Prudential Financial the right to issue and sell to the trust from time to time up to $1.5 billion of 2.850% senior notes due May 15, 2030 and receive in exchange a corresponding amount of the U.S. Treasury securities held by the trust. In return, the Company agreed to pay a semi-annual facility fee to the trust at a rate of 2.175% per annum applied to the maximum amount of senior notes that the Company could issue and sell to the trust. Similar to the Company’s put option agreement, the facility agreement with the trust provides Prudential Financial with a source of liquid assets. The right to issue senior notes described above will be exercised automatically in full upon the Company’s failure to make certain payments to the trust, such as paying the facility fee or reimbursing the trust for its expenses, if the Company’s failure to pay is not cured within 30 days, and upon an event involving its bankruptcy. The Company is also required to exercise this issuance right if its consolidated stockholders’ equity, calculated in accordance with U.S. GAAP but excluding AOCI, falls below $9.0 billion, subject to adjustment in certain cases. Prior to any involuntary exercise of the issuance right, the Company has the right to repurchase any of its senior notes then held by the trust in exchange for a corresponding amount of U.S. Treasury securities. Finally, Prudential Financial may redeem any outstanding senior notes, in whole or in part, prior to February 15, 2030, at a redemption price equal to the greater of par or a make-whole price, or thereafter, at par. Long-term Debt The table below presents the Company’s long-term debt at December 31, for the years indicated as follows:
__________ (1)Ranges of interest rates are for the year ended December 31, 2021. (2)Includes $29 million of debt denominated in foreign currency at both December 31, 2021 and 2020. (3)Includes Prudential Financial debt of $7,564 million and subsidiary debt of $54 million denominated in foreign currency at December 31, 2021. (4)Assets under set-off arrangements represent a reduction in the amount of surplus notes included in long-term debt, resulting from an arrangement where valid rights of set-off exist and it is the intent of both parties to settle on a net basis under legally enforceable arrangements. These assets include available-for-sale securities that are reported at fair value. (5)Includes Prudential Financial debt of $17,673 million and $18,561 million at December 31, 2021 and 2020, respectively. At December 31, 2021 and 2020, the Company was in compliance with all debt covenants related to the borrowings in the table above. The following table presents the contractual maturities of the Company’s long-term debt as of December 31, 2021:
Senior Notes Under its shelf registration statement, the Company has issued Medium-Term Notes and InterNotes® Retail Notes. In addition, the Company completed a debt exchange offer in 2017, pursuant to which it issued two series of Senior Notes. The table below presents the Company’s balances related to these issuances, as well as its mortgage debt balance, as of December 31 for the years indicated as follows:
__________ (1)Includes $197 million of notes from current portion of long-term debt as of December 31, 2021. Medium-Term Notes Program. The outstanding balance of this program decreased by $1.3 billion from December 31, 2020, primarily driven by $910 million in debt redemptions and $400 million in debt maturities. On August 30, 2021, the Company redeemed, at a make-whole redemption price, $700 million principal amount of its 3.500% medium-term notes due in 2024 and $210 million of the previously outstanding $600 million principal amount of its 3.878% medium-term notes due in 2028. In addition to the total principal redemption of $910 million, the Company made a make-whole payment of $91 million, which is reflected in “General and administrative expenses”. The weighted average interest rate on outstanding Senior Notes, Medium-Term Notes, and InterNotes® Retail Notes, including the effect of interest rate hedging activity, was 4.39% and 4.45% for the years ended December 31, 2021 and 2020, respectively, excluding the effect of debt issued to consolidated subsidiaries. Mortgage Debt. Mortgage debt decreased by $135 million from December 31, 2020, due to maturities and prepayments. This mortgage debt is issued by the Company’s subsidiaries and has recourse only to real estate property held for investment by those subsidiaries. Funding Agreement Notes Issuance Program (“FANIP”). The Company maintains a FANIP in which statutory trusts issue medium-term notes and commercial paper secured by funding agreements issued to the trusts by PICA. These obligations are included in “Policyholders’ account balances” and not included in the foregoing table. See Note 12 for further discussion of these obligations. Surplus Notes As of December 31, 2021, PICA had $344 million of fixed-rate surplus notes outstanding. These notes are subordinated to other PICA borrowings and policyholder obligations, and the payment of interest and principal may only be made with the prior approval of the NJDOBI. The NJDOBI could prohibit the payment of the interest and principal on the surplus notes if certain statutory capital requirements are not met. At December 31, 2021 and 2020, the Company met these statutory capital requirements. Surplus Notes with Set-Off Arrangements
__________ (1)Prudential has agreed to reimburse one of the external counterparties for any payment under the credit linked notes funded by it in an amount of up to $0.5 billion. (2)Includes $0.5 billion of notes from current portion of long-term debt. (3)The current financing capacity available under the facility is $3.5 billion but can be increased to a maximum potential size of $4.5 billion. Surplus Notes Supporting Regulation XXX and Guideline AXXX Reserves As shown in the table above, the Company’s captive reinsurance subsidiaries maintain facilities with external counterparties providing for the issuance of surplus notes by the captive to finance reserves required under Regulation XXX and Guideline AXXX. Under these facilities, the captives receive in exchange for the surplus notes one or more credit-linked notes issued by special-purpose affiliates in aggregate principal amounts equal to the surplus notes issued. The captives hold the credit-linked notes as assets supporting the non-economic portion of the statutory reserves required to be held by the Company’s domestic insurance subsidiaries under Regulation XXX and Guideline AXXX in connection with the reinsurance of term life or universal life insurance policies through the captive. The non-economic portion of the statutory reserve equals the difference between the statutory reserve required under Regulation XXX and Guideline AXXX and the amount the Company considers necessary to maintain solvency for moderately adverse experience. The credit-linked notes are redeemable for cash upon the occurrence of a liquidity stress event affecting the captives and external counterparties have agreed to fund these payments in return for a fee. Under certain of these different transactions, Prudential Financial has agreed to reimburse the captive for investment losses in excess of specified amounts. For each of the above transactions, because valid rights of set-off exist, interest and principal payments on the surplus notes and on the related credit-linked notes are settled on a net basis, and the surplus notes are reflected in the Company’s total consolidated borrowings on a net basis. The surplus notes for the captive reinsurance subsidiaries described above are subordinated to policyholder obligations, and the repayment of principal may only be made with prior approval of the Arizona Department of Insurance and Financial Institutions, the domiciliary insurance regulator of the captives. The payment of interest on the surplus notes has been approved by the Arizona Department of Insurance and Financial Institutions, subject to its ability to withdraw that approval. Other Surplus Notes The surplus note facility listed under “Other Notes” in the table above reflects a financing facility that Prudential Legacy Insurance Company of New Jersey (“PLIC”) has entered into with certain external counterparties and a special-purpose affiliate, pursuant to which PLIC may, at its option, issue and sell to the affiliate up to $4.0 billion in aggregate principal amount of surplus notes, in return for an equal principal amount of credit-linked notes. The credit-linked notes are redeemable for cash upon the occurrence of a liquidity stress event affecting PLIC, and external counterparties have agreed to fund these payments in return for a fee. Upon issuance, PLIC would hold any credit-linked notes as assets to support future statutory surplus needs within PLIC. Junior Subordinated Notes Prudential Financial’s junior subordinated notes outstanding are considered hybrid securities that receive enhanced equity treatment from the rating agencies. These notes outstanding, along with their key terms, are as follows:
The Company has the right to defer interest payments on these notes for specified periods, typically 5 to 10 years without resulting in a default, during which time interest will be compounded. On or after the optional redemption dates, Prudential Financial may redeem the notes at par plus accrued and unpaid interest. Prior to those optional redemption dates, redemptions generally are subject to a make-whole price; however, the Company may redeem the notes prior to these dates at par upon the occurrence of certain events, such as a future change in the regulatory capital treatment of the notes with respect to the Company. Limited Recourse Notes In 2014, the Company entered into financing transactions pursuant to which it issued $500 million of limited recourse notes and, in return, obtained $500 million of asset-backed notes issued by a designated series of a Delaware master trust and ultimately contributed the asset-backed notes to its subsidiary, PRIAC. The asset-backed notes mature from 2022 through 2027, with a portion of these notes having the option to extend through 2028, subject to conditions. The master trust’s payment obligations under each of the asset-backed notes are secured by corresponding payment obligations of a third-party financial institution and a portfolio of specified assets that have an aggregate value at least equal to the principal amount of the applicable asset-backed note. The principal amount of each asset-backed note is payable to PRIAC in cash at any time upon demand by PRIAC or, if not repaid earlier, at maturity. Each of the limited recourse notes obligates Prudential Financial to reimburse the applicable third-party financial institution for any principal payments received on the corresponding asset-backed note, but there is no obligation to reimburse any portion of a principal payment that is needed by PRIAC to pay then current claims to its policyholders. Each limited recourse note bears interest at a rate equal to the rate on the corresponding asset-backed note, plus an amount representing fees payable to the applicable third-party financial institution. As of December 31, 2021, no principal payments have been received or are currently due on the asset-backed notes and, as a result, there was no payment obligation under the limited recourse notes. Accordingly, the notes are not reflected in the Consolidated Financial Statements as of December 31, 2021. As a result of the Company’s agreement to sell its Full Service Retirement business to Great-West, which includes the sale of all of its outstanding equity interests in PRIAC, we expect the $500 million of limited-recourse notes will be canceled as of the closing of the sale. Interest Expense In order to modify exposure to interest rate and currency exchange rate movements, the Company utilizes derivative instruments, primarily interest rate swaps, in conjunction with some of its debt issues. The impact of these derivative instruments is not reflected in the rates presented in the tables above. For those derivative instruments that qualify for hedge accounting, interest expense was $2 million, $2 million, and less than $1 million for the years ended December 31, 2021, 2020 and 2019, respectively. See Note 5 for additional information on the Company’s use of derivative instruments. |
Employee Benefit Plans |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Retirement Benefits [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Employee Benefit Plans | EMPLOYEE BENEFIT PLANS Pension and Other Postretirement Plans The Company has funded and non-funded non-contributory defined benefit pension plans (“Pension Benefits”), which cover substantially all of its employees. For some employees, benefits are based on final average earnings and length of service (the “traditional formula”), while benefits for other employees are based on an account balance that takes into consideration age, length of service and earnings during their career (the “cash balance formula”). At December 31, 2021, approximately 78% of the Company’s Pension Benefits relate to its domestic qualified pension plan, which initially determined benefits based on the traditional formula. Effective January 1, 2001, active domestic employees covered under this plan were given the option to convert from the traditional formula to the cash balance formula, and all new domestic employees began accruing benefits under the cash balance formula. As of December 31, 2021, approximately 67% and 33% of the benefit obligation under this plan relates to participants under the traditional formula and cash balance formula, respectively. At December 31, 2021, the vast majority of active employees under this plan are accruing benefits under the cash balance formula. The Company provides certain health care and life insurance benefits for its retired employees, their beneficiaries and covered dependents (“Other Postretirement Benefits”). The health care plan is contributory; the life insurance plan is non-contributory. Substantially all of the Company’s U.S. employees are eligible to receive Other Postretirement Benefits if they retire after age 55 with at least 10 years of service or under certain circumstances after age 50 with at least 20 years of continuous service. On November 30, 2021, the Company announced that it will modify the Retiree Medical Savings Account (“RMSA”) plan, one of the components of Other Postretirement Benefits. The RMSA plan will no longer be offered to new employees effective January 1, 2022, while active employees will no longer receive service credits and retirees will no longer receive interest credits at some point after June 30, 2022. In addition, the Company added a 20-year time limit for retirees to utilize the RMSA plan (previously there was no time limit). Prepaid benefits costs and accrued benefit liabilities are included in “Other assets” and “Other liabilities,” respectively, in the Company’s Consolidated Statements of Financial Position. The status of these plans as of December 31, 2021 and 2020 is summarized below:
__________ (1)For 2021, actuarial gains for pension and other postretirement benefits were primarily driven by an increase in the discount rate. (2)For 2020, actuarial losses for pension and other postretirement benefits were primarily driven by a decrease in the discount rate. In addition to the plan assets above, the Company in 2007 established an irrevocable trust, commonly referred to as a “rabbi trust,” for the purpose of holding assets of the Company to be used to satisfy its obligations with respect to certain non-qualified retirement plans ($1,327 million and $1,360 million benefit obligation at December 31, 2021 and 2020, respectively). Assets held in the rabbi trust are available to the general creditors of the Company in the event of insolvency or bankruptcy. The Company may from time to time in its discretion make contributions to the trust to fund accrued benefits payable to participants in one or more of the plans, and, in the case of a change in control of the Company, as defined in the trust agreement, the Company will be required to make contributions to the trust to fund the accrued benefits, vested and unvested, payable on a pre-tax basis to participants in the plans. The Company did not make any discretionary payments to the trust in 2021 and 2020. As of December 31, 2021 and 2020, the assets in the trust had a carrying value of $1,109 million and $1,044 million, respectively. The Company also maintains a separate rabbi trust for the purpose of holding assets of the Company to be used to satisfy its obligations with respect to certain other non-qualified retirement plans ($73 million and $77 million benefit obligation at December 31, 2021 and 2020, respectively), as well as certain cash-based deferred compensation arrangements. As of December 31, 2021 and 2020, the assets in the trust had a carrying value of $102 million and $111 million, respectively. Pension benefits for foreign plans comprised 12% and 13% of the ending benefit obligation for both 2021 and 2020, respectively. Foreign pension plans comprised 4% of the ending fair value of plan assets for both 2021 and 2020, respectively. There are no material foreign postretirement plans. Information for pension plans with a projected benefit obligation in excess of plan assets
Information for pension plans with an accumulated benefit obligation in excess of plan assets
Components of Net Periodic Benefit Cost The Company uses market related value to determine components of net periodic (benefit) cost. Market related value recognizes certain changes in fair value of plan assets over a period of five years. Changes in the fair value of U.S. equities, international equities, real estate and other assets are recognized over a five year period. However, changes in the fair value for fixed maturity assets (including short-term investments) are recognized immediately for the purposes of market related value. Net periodic (benefit) cost included in “General and administrative expenses” in the Company’s Consolidated Statements of Operations for the years ended December 31, includes the following components:
__________ (1)For 2021, 2020 and 2019, certain employees were provided special termination benefits under non-qualified plans in the form of unreduced early retirement benefits as a result of their involuntary termination. (2)For 2021 and 2020, certain employees were provided special termination benefits under non-qualified plans in the form of unreduced early retirement benefits as a result of their participation in the Voluntary Separation Program that was offered to eligible U.S.-based employees in 2019. (3)For 2019, certain employees were provided special termination benefits in the qualified and non-qualified plans in the form of retirement eligibility bridging as a result of their participation in the Voluntary Separation Program that was offered to eligible U.S.-based employees. Changes in Accumulated Other Comprehensive Income (Loss) The benefit obligation is based upon actuarial assumptions such as discount, termination, retirement, mortality and salary growth rates. Changes at year-end in these actuarial assumptions, along with experience changes based on updated participant census data are deferred in AOCI. Plan assets generate actuarial gains and losses when actual returns on plan assets differ from expected returns on plan assets, and these differences are also deferred in AOCI. The cumulative deferred gain (loss) within AOCI is amortized into earnings if it exceeds 10% of the greater of the benefit obligation or plan assets at the beginning of the year, and the amortization period is based upon the actuarially calculated expected future years of service for a given plan. The amounts recorded in AOCI as of the end of the period, which have not yet been recognized as a component of net periodic (benefit) cost, and the related changes in these items during the period that are recognized in “Other comprehensive income (loss)” are as follows:
__________ (1)For 2019, deferred losses for pension were driven by a decrease in discount rate partially offset by favorable asset performance. Deferred gains for other postretirement benefits were driven by favorable asset performance partially offset by a decrease in discount rate. (2)For 2020, deferred losses for pension and other postretirement benefits were driven by a decrease in discount rate partially offset by favorable asset performance. (3)For 2021, deferred gains for pension and other postretirement benefits were driven by an increase in discount rate and favorable asset performance. The Company’s assumptions related to the calculation of the domestic benefit obligation (end of period) and the determination of net periodic (benefit) cost (beginning of period) are presented in the table below:
The domestic discount rate used to value the pension and postretirement obligations at December 31, 2021 and December 31, 2020 is based upon the value of a portfolio of Aa-rated investments whose cash flows would be available to pay the benefit obligation’s cash flows when due. The December 31, 2021 portfolio is selected from a compilation of approximately 420 Aa-rated bonds across the full range of maturities. Since yields can vary widely at each maturity point, the Company generally avoids using the highest and lowest yielding bonds at the maturity points, so as to avoid relying on bonds that might be mispriced or misrated. This refinement process generally results in having a distribution from the 10th to 90th percentile. The Aa-rated portfolio is then selected and, accordingly, its value is a measure of the benefit obligation. A single equivalent discount rate is calculated to equate the value of the Aa-rated portfolio to the cash flows for the benefit obligation. The result is rounded to the nearest 5 basis points and the benefit obligation is recalculated using the rounded discount rate. The pension and postretirement expected long-term rates of return on plan assets for 2021 were determined based upon an approach that considered the allocation of plan assets as of December 31, 2020. Expected returns are estimated by asset class as noted in the discussion of investment policies and strategies below. Expected returns on asset classes are developed using a building-block approach that is forward looking and are not strictly based upon historical returns. The building blocks for equity returns include inflation, real return, a term premium, an equity risk premium, capital appreciation, expenses, the effect of active management and the effect of rebalancing. The building blocks for fixed maturity returns include inflation, real return, a term premium, credit spread, capital appreciation, effect of active management, expenses and the effect of rebalancing. The Company applied the same approach to the determination of the expected rate of return on plan assets in 2022. The expected rate of return for 2022 is 6.00% and 7.00% for pension and postretirement, respectively. The assumptions for foreign pension plans are based on local markets. There are no material foreign postretirement plans. Plan Assets The investment goal of the domestic pension plan assets is to generate an above benchmark return on a diversified portfolio of stocks, bonds and other investments. The cash requirements of the pension obligation, which include a traditional formula principally representing payments to annuitants and a cash balance formula that allows lump sum payments and annuity payments, are designed to be met by the bonds and short-term investments in the portfolio. The investment goal of the domestic postretirement plan assets is to generate an above benchmark return on a diversified portfolio of stocks, bonds, and other investments, while meeting the cash requirements for the postretirement obligation that includes a medical benefit including prescription drugs, a dental benefit and a life benefit. The pension and postretirement plans risk management practices include guidelines for asset concentration, credit rating, liquidity and tax efficiency. The pension and postretirement plans do not invest in leveraged derivatives. Derivatives such as futures contracts are used to reduce transaction costs and change asset concentration, while interest rate swaps and futures are used to adjust duration. The plan fiduciaries for the Company’s pension and postretirement plans have developed guidelines for asset allocations reflecting a percentage of total assets by asset class, which are reviewed on an annual basis. Asset allocation targets as of December 31, 2021 are as follows:
To implement the investment strategy, plan assets are invested in funds that primarily invest in securities that correspond to one of the asset categories under the investment guidelines. However, at any point in time, some of the assets in a fund may be of a different nature than the specified asset category. Assets held with PICA are in either pooled separate accounts or single client separate accounts. Assets held with a bank are either in common/collective trusts or single client trusts. Pooled separate accounts and common/collective trusts hold assets for multiple investors. Each investor owns a “unit of account.” The asset allocation targets above include the underlying asset mix in the Pooled Separate Accounts and Common/Collective Trusts. Single client separate accounts or trusts hold assets for only one investor, the domestic qualified pension plan, and each security in the fund is treated as individually owned. There were no investments in Prudential Financial Common Stock as of December 31, 2021 and December 31, 2020 for either the pension or postretirement plans. The authoritative guidance around fair value established a framework for measuring fair value. Fair value is disclosed using a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value, as described in Note 6. The following describes the valuation methodologies used for pension and postretirement plans assets measured at fair value. Insurance Company Pooled Separate Accounts, Common/Collective Trusts, and United Kingdom Insurance Pooled Funds—Insurance company pooled separate accounts are invested via group annuity contracts issued by PICA. Assets are represented by a “unit of account.” The redemption value of those units is based on a per unit value whose value is the result of the accumulated values of underlying investments. The unit of account value is used as a practical expedient to estimate fair value. Equities—See Note 6 for a discussion of the valuation methodologies for equity securities. U.S. Government Securities (both Federal and State & Other), Non–U.S. Government Securities, and Corporate Debt—See Note 6 for a discussion of the valuation methodologies for fixed maturity securities. Interest Rate Swaps—See Note 6 for a discussion of the valuation methodologies for derivative instruments. Registered Investment Companies (Mutual Funds)—Securities are priced at the NAV, which is the closing price published by the registered investment company on the reporting date. Short-term Investments—Securities are valued initially at cost and thereafter adjusted for amortization of any discount or premium (i.e., amortized cost). Amortized cost approximates fair value. Partnerships—The value of interests owned in partnerships is based on valuations of the underlying investments that include private placements, structured debt, real estate, equities, fixed maturities, commodities and other investments. Hedge Funds—The value of interests in hedge funds is based on the underlying investments that include equities, debt and other investments. Variable Life Insurance Policies—These assets are held in group and individual variable life insurance policies issued by PICA. Group policies are invested in Insurance Company Pooled Separate Accounts. Individual policies are invested in Registered Investment Companies (Mutual Funds). The value of interest in these policies is the cash surrender value (contract value) of the policies based on the underlying investments. The variable life insurance policies are valued at contract value which approximates fair value. Pension plan asset allocations in accordance with the investment guidelines are as follows:
_______________ (1)Interest rate swaps notional amount is $433 million and $13 million for the years ended December 31, 2021 and 2020, respectively. (2)This category primarily consists of cash and cash equivalents, short-term investments, payables and receivables, and open future contract positions (including fixed income collateral). (3)The pension plan excludes from the fair value hierarchy investments that are measured at NAV per share (or its equivalent) as a practical expedient to estimate fair value. Changes in Fair Value of Level 3 Pension Assets
Postretirement plan asset allocations in accordance with the investment guidelines are as follows:
__________ (1)Prior period amounts have been updated to conform to current period presentation. (2)The postretirement plan excludes from the fair value hierarchy investments that are measured at NAV per share (or its equivalent) as a practical expedient to estimate fair value. (3)There were no changes in the fair value of Level 3 postretirement assets from December 31, 2020 through December 31, 2021. The expected benefit payments for the Company’s pension and postretirement plans, as well as the expected Medicare Part D subsidy receipts related to the Company’s postretirement plan, for the years indicated are as follows:
The Company anticipates that it will make cash contributions in 2022 of approximately $190 million to the pension plans and approximately $10 million to the postretirement plans. Postemployment Benefits The Company accrues postemployment benefits for income continuance and health and life benefits provided to former or inactive employees who are not retirees. The net accumulated liability for these benefits at December 31, 2021 and 2020 was $34 million and $15 million, respectively, and is included in “Other liabilities.” Other Employee Benefits The Company sponsors voluntary savings plans for employees (401(k) plans). The plans provide for salary reduction contributions by employees and matching contributions by the Company of up to 4% of annual salary. The matching contributions by the Company included in “General and administrative expenses” were $80 million, $82 million and $84 million for the years ended December 31, 2021, 2020 and 2019, respectively.
|
Equity |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity Note [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity | EQUITY Preferred Stock As of December 31, 2021, 2020 and 2019, the Company had 10,000,000 shares of preferred stock authorized but none issued or outstanding. Common Stock On the date of demutualization in December 2001, Prudential Financial completed an initial public offering of its Common Stock. The shares of Common Stock issued were in addition to shares of Common Stock the Company distributed to policyholders as part of the demutualization. The Common Stock is traded on the New York Stock Exchange under the symbol “PRU”. In the event of a liquidation, dissolution or winding-up of the Company, holders of Common Stock would be entitled to receive a proportionate share of the net assets of the Company that remain after paying all liabilities and the liquidation preferences of any preferred stock. The changes in the number of shares of Common Stock issued, held in treasury and outstanding, are as follows for the periods indicated:
__________ (1)Represents net shares issued from treasury pursuant to the Company’s stock-based compensation programs. (2)In August 2019, as a result of the note holders’ exercise of the exchange option on $500 million of surplus notes, the Company issued approximately 6.2 million shares of Common Stock at an exchange rate equal to 12.3877 shares of Common Stock per each $1,000 principal amount of surplus notes. The Company’s obligations under the surplus notes are now satisfied. For additional information, see Note 20. (3)In October 2019, the Company issued approximately 5.5 million shares of Common Stock as part of consideration paid for the Assurance IQ acquisition. For additional information about the acquisition, see Note 1. Additional paid-in capital “Additional paid-in capital” is primarily comprised of the cumulative excess between: (a) the total cash received by the Company in conjunction with past issuances of Common Stock shares or Common Stock shares reissued from treasury in conjunction with the Company’s stock-based compensation program and (b) the total par value associated with those shares ($.01 per share). Common stock held in treasury Common Stock held in treasury represents the Company’s previously issued shares of stock which have been repurchased by the Company but not retired. These shares are accounted for at the cost at which they were acquired. Common Stock held in treasury is typically impacted by repurchases of shares under the Board of Directors approved share repurchase program and by reissuances of shares associated with our stock-based compensation programs, or for other purposes, which are accounted for at average cost upon reissuance. Gains resulting from the reissuance of Common Stock held in treasury are credited to “Additional paid-in capital”. Losses resulting from the reissuance of Common Stock held in treasury are charged first to “Additional paid-in capital” to the extent the Company has previously recorded gains on treasury share transactions, then to “Retained earnings”. The Board of Directors may from time to time, at its discretion, authorize management to repurchase shares of Common Stock of the Company. The timing and amount of share repurchases are determined by management based upon market conditions and other considerations, and repurchases may be executed in the open market, through derivative, accelerated repurchase and other negotiated transactions and through prearranged trading plans complying with Rule 10b5-1(c) under the Securities Exchange Act of 1934 (the “Exchange Act”). Numerous factors could affect the timing and amount of any future repurchases under the share repurchase authorization, including increased capital needs of the Company due to changes in regulatory capital requirements, opportunities for growth and acquisitions, and the effect of adverse market conditions on the segments. The following table summarizes share repurchases for each of the past three years as well as the share repurchase authorization for 2022, which was approved by the Board of Directors in November 2021:
__________ * Share repurchase authorization for a future period. (1)In April 2020, the Company suspended Common Stock repurchases under the 2020 share repurchase authorization and did not resume share repurchases for the remainder of the authorization period. Accumulated Other Comprehensive Income (Loss) AOCI represents the cumulative OCI items that are reported separate from net income and detailed on the Consolidated Statements of Comprehensive Income. Each of the components that comprise OCI are described in further detail in Note 2 (Foreign Currency Translation Adjustment and Net Unrealized Investment Gains (Losses)) and Note 18 (Pension and Postretirement Unrecognized Net Periodic Benefit (Cost)). The balance of and changes in each component of AOCI as of and for the years ended December 31, are as follows:
__________ (1)Includes cash flow hedges of $1,019 million, $(168) million and $832 million as of December 31, 2021, 2020, and 2019, respectively, and fair value hedges of $(35) million, $10 million, and $0 million as of December 31, 2021, 2020, and 2019, respectively. Reclassifications out of Accumulated Other Comprehensive Income (Loss)
__________ (1)All amounts are shown before tax. (2)Positive amounts indicate gains/benefits reclassified out of AOCI. Negative amounts indicate losses/costs reclassified out of AOCI. (3)See Note 5 for additional information on cash flow and fair value hedges. (4)See table below for additional information on unrealized investment gains (losses), including the impact on deferred policy acquisition and other costs, future policy benefits and policyholders’ dividends. (5)See Note 18 for information on employee benefit plans. Net Unrealized Investment Gains (Losses) Net unrealized investment gains (losses) on available-for-sale fixed maturity securities and certain other invested assets and other assets are included in the Company’s Consolidated Statements of Financial Position as a component of AOCI. Changes in these amounts include reclassification adjustments to exclude from “Other comprehensive income (loss)” those items that are included as part of “Net income (loss)” for a period that had been part of “Other comprehensive income (loss)” in earlier periods. The amounts for the periods indicated below, split between amounts related to available-for-sale fixed maturity securities on which an OTTI loss had been previously recognized, an allowance for credit losses has been recorded, and all other net unrealized investment gains (losses), are as follows:
__________ (1)Includes cash flow and fair value hedges. See Note 5 for additional information. (2)Represents net unrealized gains (losses) for which an OTTI loss had been previously recognized. Retained earnings Retained earnings primarily represents the cumulative net income earned by the Company that has been retained by the Company as of the reporting date. Other unique items, included but not limited to the adoption of new accounting standards updates, may also impact retained earnings. In any given period, retained earnings may increase due to net income and may decrease due to net losses or the declaration of dividends. The declaration and payment of dividends on the Common Stock is limited by New Jersey corporate law, pursuant to which Prudential Financial is prohibited from paying a Common Stock dividend if, after giving effect to that dividend, either (a) the Company would be unable to pay its debts as they become due in the usual course of its business or (b) the Company’s total assets would be less than its liabilities. In addition, the terms of the Company’s outstanding junior subordinated debt include a “dividend stopper” provision that restricts the payment of dividends on the Common Stock if interest payments are not made on the junior subordinated debt. Other than the above limitations, the Company’s Retained earnings balance is free of restrictions for the payment of Common Stock dividends; however, Common Stock dividends will be dependent upon financial conditions, results of operations, cash needs, future prospects and other factors, including cash available to Prudential Financial, the parent holding company. The principal sources of funds available to Prudential Financial are dividends and returns of capital from its subsidiaries, loans from its subsidiaries, repayments of operating loans from its subsidiaries, and cash and other highly liquid assets. The primary uses of funds at Prudential Financial include servicing its debt, operating expenses, capital contributions and loans to subsidiaries, the payment of declared shareholder dividends and repurchases of outstanding shares of Common Stock if executed under Board authority. As of December 31, 2021, Prudential Financial had highly liquid assets (excluding amounts held in an intercompany liquidity account) of $3,553 million predominantly including cash, short-term investments, U.S. Treasury securities, obligations of other U.S. government authorities and agencies, and/or foreign government bonds. Future cash available at Prudential Financial to support the payment of future Common Stock dividends is dependent on the receipt of dividends or other funds from its subsidiaries, the majority of which are subject to comprehensive regulation, including limitations on their payment of dividends and other transfers of funds, which are discussed in this Note further below. Non-controlling interests For certain subsidiaries, the Company owns a controlling interest that is less than 100% ownership of the subsidiary but must consolidate 100% of the subsidiary’s financial statements in accordance with U.S. GAAP. Non-controlling interests represent the portion of equity ownership in a consolidated subsidiary that is not attributable to the Company. Insurance Subsidiaries - Statutory Financial Information and Restrictions on Payments of Dividends U.S. Insurance Subsidiaries—Statutory Financial Information The Company’s domestic insurance subsidiaries are required to prepare statutory financial statements in accordance with statutory accounting practices prescribed or permitted by the insurance department of the state of domicile. Statutory accounting practices primarily differ from U.S. GAAP by charging policy acquisition costs to expense as incurred, establishing future policy benefit liabilities using different actuarial assumptions as well as valuing investments and certain assets and accounting for deferred taxes on a different basis. The risk-based capital (“RBC”) ratio is a primary measure by which the Company and its insurance regulators evaluate the capital adequacy of PICA and the Company’s other domestic insurance subsidiaries. RBC is determined by NAIC-prescribed formulas that consider, among other things, risks related to the type and quality of the invested assets, insurance-related risks associated with an insurer’s products and liabilities, interest rate risks and general business risks. Insurers that have less statutory capital than required are considered to have inadequate capital and are subject to varying degrees of regulatory action depending upon the level of capital inadequacy. The Company expects to report RBC ratios as of December 31, 2021 above the regulatory required minimums that would require corrective action and above our “AA” financial strength target levels for both PICA and PALAC. The following table summarizes certain statutory financial information for the Company’s two largest U.S. insurance subsidiaries for the periods indicated:
__________ (1)Prior year amounts have been updated to conform to finalized statutory filing where applicable. U.S. Insurance Subsidiaries—Restrictions on Payment of Dividends to Prudential Financial, the Parent Holding Company With respect to PICA, a New Jersey domiciled insurance subsidiary which is also the Company’s primary domestic insurance subsidiary, New Jersey insurance law provides that, except in the case of extraordinary dividends (as described below), all dividends or other distributions paid by PICA may be paid only from unassigned surplus, as determined pursuant to statutory accounting principles, less cumulative unrealized investment gains and losses and revaluation of assets as of the prior calendar year-end. As of December 31, 2021, PICA’s unassigned surplus less applicable adjustments for cumulative unrealized investment gains was $8,934 million. PICA must give prior notification to the NJDOBI of its intent to pay any such dividend or distribution. Also, if any dividend, together with other dividends or distributions made within the preceding twelve months, exceeds the greater of (i) 10% of statutory capital and surplus as of the preceding December 31 or (ii) its statutory net gain from operations excluding realized investment gains and losses for the twelve-month period ending on the preceding December 31, the dividend is considered to be an “extraordinary dividend” and requires the prior approval of the NJDOBI. Under New Jersey insurance law, PICA is permitted to pay an ordinary dividend of up to $1,912 million in 2022, without prior approval of the NJDOBI. Of the $1,912 million, $812 million is permitted to be paid prior to December 13, 2022, and the remaining $1,100 million is permitted to be paid after December 13, 2022. The laws regulating dividends of the states where the Company’s other domestic insurance subsidiaries are domiciled are similar, but not identical, to New Jersey. With respect to PALAC, an Arizona domiciled insurance subsidiary of the Company, Arizona insurance law provides that if any dividend, together with other dividends or distributions made within the preceding twelve months, exceeds the lesser of (i) 10% of statutory capital and surplus as of the preceding December 31 or (ii) its statutory net gain from operations excluding realized investment gains and losses for the twelve month period ending on the preceding December 31, the dividend is considered to be an “extraordinary dividend” and requires prior approval of the Arizona Department of Insurance. Under Arizona law, PALAC has no ordinary dividend capacity during 2022. All dividends will be considered extraordinary and will require prior approval from the Arizona Department of Insurance. International Insurance Subsidiaries—Statutory Financial Information The Company’s international insurance subsidiaries prepare financial statements in accordance with local regulatory requirements. These statutory accounting practices differ from U.S. GAAP primarily by charging policy acquisition costs to expense as incurred and establishing future policy benefit liabilities using different actuarial assumptions, as well as valuing investments and certain assets and accounting for deferred taxes on a different basis. The Japan Financial Services Agency (“FSA”) utilizes a solvency margin ratio to evaluate the capital adequacy of Japanese insurance companies. The solvency margin ratio considers the level of solvency margin capital to a solvency margin risk amount, which is calculated in a similar manner to RBC. As of December 31, 2021, the Company expects The Prudential Life Insurance Company Ltd. (“Prudential of Japan”) and Gibraltar Life both had solvency margin capital in excess of 3.5 times the regulatory required minimums that would require corrective action. All of the Company’s domestic and international insurance subsidiaries have capital and surplus levels that exceed their respective regulatory minimum requirements, and none utilized prescribed or permitted practices that vary materially from the practices prescribed by the NAIC or equivalent regulatory bodies for results reported as of December 31, 2021 and 2020, respectively, or for the years ended December 31, 2021, 2020 and 2019, respectively. International Insurance Subsidiaries—Restrictions on Payment of Dividends to Prudential Financial, the Parent Holding Company The Company’s international insurance operations are subject to dividend restrictions from the regulatory authorities in the jurisdictions in which they operate. With respect to Prudential of Japan and Gibraltar Life, the Company’s most significant international insurance subsidiaries, both of which are domiciled in Japan, Japan insurance law provides that common stock dividends may be paid in an amount of up to 83% of prior fiscal year statutory after-tax earnings, after certain reserving thresholds are met, including providing for policyholder dividends. If statutory retained earnings exceed 100% of statutory paid-in capital, 100% of prior year statutory after-tax earnings may be paid, after reserving thresholds are met. Dividends in excess of these amounts and other forms of capital distribution require the prior approval of the FSA. Additionally, Prudential of Japan and Gibraltar Life must give prior notification to the FSA of their intent to pay any dividend or distribution. For the year ended December 31, 2021, Prudential Financial received $1,184 million from its international insurance subsidiaries, which includes $994 million of in-kind dividends in the form of extinguishment of debt held by international insurance subsidiaries. In addition to paying Common Stock dividends, the Company’s international insurance operations may return capital to Prudential Financial through, or facilitated by, other means, such as the repayment of Preferred Stock obligations held by Prudential Financial or other affiliates, affiliated lending, affiliated derivatives and reinsurance with U.S.- and Bermuda-based affiliates. The Company’s Japan insurance operations have entered into reinsurance agreements with Gibraltar Re, the Company’s Bermuda-based reinsurance affiliate, to reinsure the mortality and morbidity risk associated with a portion of the in-force contracts as well as newly-issued contracts for certain products. The Company expects these transactions will allow it to more efficiently manage its capital and risk profile. The current regulatory fiscal year end for both Prudential of Japan and Gibraltar Life is March 31, 2022, after which time the common stock dividend amount permitted to be paid without prior approval from the FSA can be determined. In addition, although prior regulatory approval may not be required by law for the payment of dividends up to the limitations described above, in practice, the Company would typically discuss any dividend payments with the applicable regulatory authority prior to payment. Additionally, the payment of dividends by the Company’s subsidiaries is subject to declaration by their Board of Directors and may be affected by market conditions and other factors.
|
Earnings Per Share |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share | EARNINGS PER SHARE A reconciliation of the numerators and denominators of the basic and diluted per share computations of Common Stock based on the consolidated earnings of Prudential Financial for the years ended December 31, is as follows:
Unvested share-based payment awards that contain nonforfeitable rights to dividends are participating securities and included in the computation of earnings per share pursuant to the two-class method. Under this method, earnings attributable to Prudential Financial are allocated between Common Stock and the participating awards, as if the awards were a second class of stock. During periods of net income available to holders of Common Stock, the calculation of earnings per share excludes the income attributable to participating securities in the numerator and the dilutive impact of these securities from the denominator. In the event of a net loss available to holders of Common Stock, undistributed earnings are not allocated to participating securities and the denominator excludes the dilutive impact of these securities as they do not share in the losses of the Company. Undistributed earnings allocated to participating unvested share-based payment awards for the years ended December 31, 2021, 2020 and 2019, as applicable, were based on 5.8 million, 4.9 million and 4.6 million of such awards, respectively, weighted for the period they were outstanding. Stock options and shares related to deferred and long-term compensation programs that are considered antidilutive are excluded from the computation of diluted earnings per share. Stock options are considered antidilutive based on application of the treasury stock method or in the event of a net loss available to holders of Common Stock. Shares related to deferred and long-term compensation programs are considered antidilutive in the event of a net loss available to holders of Common Stock. For the years ended December 31, the number of stock options and shares related to deferred and long-term compensation programs that were considered antidilutive and were excluded from the computation of diluted earnings per share, weighted for the portion of the period they were outstanding, are as follows:
In September 2009, the Company issued $500 million of surplus notes with an interest rate of 5.36% per annum which were exchangeable at the option of the note holders for shares of Common Stock. In August 2019, as a result of the note holders’ exercise of the exchange option, the Company issued approximately 6.2 million shares of Common Stock at an exchange rate equal to 12.3877 shares of Common Stock per each $1,000 principal amount of surplus notes. The Company’s obligations under the surplus notes are now satisfied. In calculating diluted earnings per share under the if-converted method, for the year ended December 31, 2019, the potential shares that would be issued assuming a hypothetical exchange, weighted for the period the notes were outstanding, are added to the denominator, and the related interest expense, net of tax, is excluded from the numerator, if the overall effect is dilutive.
|
Share-Based Payments |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-based Payment Arrangement [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-based Payment Arrangement | SHARE-BASED PAYMENTS Omnibus Incentive Plan Prudential Financial, Inc.’s Omnibus Incentive Plan provides stock-based awards including stock options, stock appreciation rights, restricted stock shares, restricted stock units, stock settled performance shares, and cash settled performance units. Dividend equivalents are generally provided on restricted stock shares and restricted stock units outstanding as of the record date. Dividend equivalents are generally accrued on target performance shares and units outstanding as of the record date. These dividend equivalents are paid only on the performance shares and units released up to a maximum of the target number of shares and units awarded. Generally, the requisite service period is the vesting period. There were 12,362,031 authorized shares available for grant under the Omnibus Incentive Plan as of December 31, 2021. Assurance IQ Acquisition The Company acquired Assurance IQ on October 10, 2019. The terms of the acquisition included compensation awards that involved share-based payment arrangements that are linked to retention and therefore fall under the reporting requirements of ASC 718, Stock Compensation. These compensation awards include stock options, restricted stock units and performance shares. Compensation Costs Compensation cost for restricted stock units, performance shares and performance units granted to employees is measured by the share price of the underlying Common Stock at the date of grant. Compensation cost for employee stock options is based on the fair values estimated on the grant date. Under the Omnibus Incentive Plan, the fair value of each stock option award is estimated using a binomial option pricing model on the date of grant for stock options issued to employees. For the awards related to the Assurance IQ acquisition, the fair value of each stock option award is based on its intrinsic value on the date of grant. The weighted average grant date assumptions used in the binomial option valuation model are as follows:
There were no stock options granted in 2021. Expected volatility is based on historical volatility of Prudential Financial’s Common Stock and implied volatility from traded options on Prudential Financial’s Common Stock. The Company uses historical data and expectations of future exercise patterns to estimate option exercises and employee terminations within the valuation model. The expected term of options granted represents the period of time that options granted are expected to be outstanding. The risk-free rate for periods associated with the expected term of the option is based on the U.S. Treasury yield curve in effect at the time of grant. The following table summarizes the compensation cost recognized and the related income tax benefit for stock options, restricted stock units, performance shares and performance units for the years ended December 31:
__________ (1) Compensation costs related to retirement eligible participants are recorded on the grant date (typically in the first quarter of every year).
Compensation costs related to stock-based compensation plans capitalized in deferred acquisition costs for the years ended December 31, 2021, 2020 and 2019 were de minimis. Stock Options Each stock option granted under the Omnibus Incentive Plan has an exercise price at the fair market value of Prudential Financial’s Common Stock on the date of grant and has a maximum term of 10 years. Generally, one third of the option grant vests in each of the first three years. Options granted related to the Assurance IQ acquisition have an exercise price based on the original strike price of the Assurance IQ options that they replaced and have a maximum term of 10 years from the date the Assurance IQ options were originally granted. Options granted related to the Assurance IQ acquisition generally vest quarterly over three years. A summary of the status of the Company’s stock option grants is as follows:
The weighted average grant date fair value of employee stock options granted under the Omnibus Incentive Plan during the years ended December 31, 2020 and 2019 was $18.00 and $20.02, respectively. For the Assurance IQ acquisition related awards, the weighted average grant date fair value of employee stock options granted during the year ended December 31, 2019 was $86.31. No Assurance IQ acquisition related options were granted in 2020 or 2021. The total intrinsic value (i.e., market price of the stock less the option exercise price) of employee stock options exercised during the years ended December 31, 2021, 2020 and 2019 was $48 million, $13 million, and $21 million, respectively. For the Assurance IQ acquisition related awards, the total intrinsic value of employee stock options exercised during the years ended December 31, 2021, 2020 and 2019 was $15 million, $10 million and $3 million, respectively. The weighted average remaining contractual term and the aggregate intrinsic value of stock options outstanding and exercisable as of December 31, 2021 is as follows:
Restricted Stock Units, Performance Share Awards and Performance Unit Awards A restricted stock unit is an unfunded, unsecured right to receive a share of Prudential Financial’s Common Stock at the end of a specified period of time, which is subject to forfeiture and transfer restrictions. Generally, the restrictions will lapse on the third anniversary of the date of grant. Performance shares and performance units are awards denominated in Prudential Financial’s Common Stock. The number of units is determined over the performance period and may be adjusted based on the satisfaction of certain performance goals for the Company. Performance share awards are payable in Prudential Financial’s Common Stock. Performance unit awards are payable in cash. Effective October 2019, the Company modified certain provisions of its long term compensation plan to settle the performance units component in Prudential Financial Common Stock. As a result, outstanding performance units were converted to performance shares except for certain employee directed deferrals in the deferred compensation plan which remain as performance units for the full life of the grant. Beginning in 2020, the Company no longer grants performance unit awards. A summary of the Company’s restricted stock units, performance shares and performance unit awards under the Omnibus Incentive Plan is as follows:
__________ (1)Performance share and performance unit awards reflect the target units awarded, reduced for forfeitures and releases to date. The actual number of units to be awarded at the end of each performance period will range between 0% and 150% of the target number of units granted, based upon a measure of the reported performance for the Company relative to stated goals. Performance awards granted to senior management in 2021 include a stated goal related to diversity & inclusion that can modify the performance result by +/- 10%. (2)Effective October 1, 2019, the Company modified existing performance share and performance unit awards to remove features of the grants that prevent having a mutual understanding of the key terms and conditions of the award between the employee and employer until the grants vested. Consequently, the weighted average grant date fair value as of December 31, 2021 is the closing stock price of Prudential Financial’s common stock as of September 30, 2019 for performance shares that were outstanding on September 30, 2019. The weighted average grant date fair value for performance shares granted after September 30, 2019 is the closing stock price of Prudential Financial’s common stock on the date the awards were granted. (3)Represents the difference between the target units granted and the actual units awarded based upon the attainment of performance goals for the Company. A summary of the Company’s restricted stock units and performance share awards related to the Assurance IQ acquisition is as follows:
__________ (1)Performance share awards related to the Assurance IQ acquisition reflect the maximum number of units that have been awarded under the terms of the acquisition. The actual number of units that will be awarded at the end of the performance period will range between 0% and 100% of the number of units granted, based upon a predetermined formula for achieving certain targets for gross revenues, net of associated selling expenses, between $900 million and $1,300 million. (2)Represents the difference between the target units granted and the actual units awarded based upon the attainment of performance goals for the Company. The fair market value of restricted stock units, performance shares and performance units released under the Omnibus Incentive Plan for the years ended December 31, 2021, 2020 and 2019 was $155 million, $191 million and $255 million, respectively. The fair market value of restricted stock units for the Assurance IQ acquisition related awards under the Omnibus Incentive Plan for the year ended December 31, 2021 and 2020 was $3 million and $2 million. The weighted average grant date fair value for restricted stock units granted under the Omnibus Incentive Plan during the years ended December 31, 2021, 2020 and 2019 was $81.82, $93.88 and $93.35, respectively. The weighted average grant date fair value for performance shares and performance units granted under the Omnibus Incentive Plan during the years ended December 31, 2021, 2020 and 2019 was $81.43, $95.42 and $90.68, respectively. The weighted average grant date fair value for restricted stock units granted for the Assurance IQ acquisition during the year ended December 31, 2019 was $87.67. No restricted units were granted in 2020 or 2021. The weighted average grant date fair value for performance shares granted for the Assurance IQ acquisition during the years ended December 31, 2020 and 2019 was $63.30 and $89.91 respectively . Unrecognized Compensation Cost Unrecognized compensation cost for stock options under the Omnibus Incentive Plan as of December 31, 2021 was $1 million with a weighted average recognition period of 1.06 years. Unrecognized compensation cost for restricted stock units, performance shares and performance units under the Omnibus Incentive Plan as of December 31, 2021 was $170 million with a weighted average recognition period of 1.76 years. Unrecognized compensation cost for stock options related to the Assurance IQ acquisition as of December 31, 2021 was $13 million with a weighted average recognition period of 1.24 years. Unrecognized compensation cost for restricted stock units and performance shares related to the Assurance IQ acquisition as of December 31, 2021 was $3.98 million with a weighted average recognition period of 2.17 years. Tax Benefits Realized The Company’s tax benefit realized for exercises of stock options under the Omnibus Incentive Plan during the years ended December 31, 2021, 2020 and 2019 was $12 million, $3 million and $5 million, respectively. The tax benefit realized for exercises of stock options related to the Assurance IQ acquisition during the years ended December 31, 2021, 2020 and 2019 were $4 million, $3 million and $2 million, respectively. The Company’s tax benefit realized upon vesting of restricted stock units, performance shares and performance units under the Omnibus Incentive Plan for the years ended December 31, 2021, 2020 and 2019 was $30 million, $44 million and $52 million, respectively. The tax benefit realized upon vesting of restricted stock units and performance shares related to the Assurance IQ acquisition during the year ended December 31, 2021 and 2020 were $1 million and $1 million, respectively. There were no vested restricted stock units or performance shares related to the Assurance IQ acquisition for the year ended December 31, 2019. Settlement of Awards |
Segment Information |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Information | SEGMENT INFORMATION Segments The Company operates through eight segments: PGIM (our global investment management business); Retirement, Group Insurance, Individual Annuities, Individual Life, and Assurance IQ (collectively referred to as the U.S. Businesses); International Businesses; and Closed Block. In addition, the Company reports certain of its results of operations in its Corporate and Other operations. The PGIM segment provides investment management services and solutions related to public fixed income, public equity, real estate debt and equity, private credit and other alternatives, and multi-asset class strategies, to institutional and retail clients globally, as well as the Company’s general account. The U.S. Businesses offer a broad range of products and solutions that cover protection, retirement, savings, income and investment needs. The U.S. Businesses are organized into five segments: •The Retirement segment provides a broad range of retirement investment and income products and services to retirement plan sponsors in the public, private and not-for-profit sectors. •The Group Insurance segment provides a full range of group life, long-term and short-term group disability, and group corporate-, bank- and trust-owned life insurance in the U.S. primarily to institutional clients for use in connection with employee and membership benefits plans. •The Individual Annuities segment develops and distributes individual variable and fixed annuity products, primarily to the U.S. mass affluent and affluent markets. •The Individual Life segment develops and distributes individual variable life, term life and universal life insurance products primarily to the U.S. mass middle, mass affluent and affluent markets. •The Assurance IQ segment leverages data science and technology to primarily distribute third-party products (such as Medicare, life, health, and property and casualty products) and a proprietary term life product directly to retail shoppers, primarily through its digital and agent channels. Additionally, Assurance IQ may help customers fulfill financial wellness needs by matching them with other product providers or intermediaries. The International Businesses develops and distributes life insurance, retirement products and certain accident and health products with fixed benefits to mass affluent and affluent customers through our Life Planner operations in Japan, Brazil, Argentina and Mexico. Our Gibraltar Life and Other operations also provide similar products to broad middle income and mass affluent customers across Japan, and through our joint ventures in Chile, China, India and Indonesia, and our strategic investments in Ghana and Kenya through multiple distribution channels (including banks, independent agencies and Life Consultants). The Closed Block division includes certain in-force participating insurance and annuity products and corresponding assets that are used for the payment of benefits, expenses and policyholders’ dividends related to these products, as well as certain related assets and liabilities. In connection with demutualization, the Company ceased offering these participating products. The Closed Block division is accounted for as a divested business that is reported separately from the Divested and Run-off Businesses that are included in the Company’s Corporate and Other operations. See Note 15 for additional information on the Closed Block. Corporate and Other Operations consists primarily of: (1) capital that is not deployed in any business segment; (2) investments not allocated to business segments, including debt-financed investment portfolios, and tax credit and other tax-enhanced investments financed by business segments; (3) capital debt, including any related interest expense and financing costs, that is used or will be used to meet the capital requirements of the Company; (4) our qualified and non-qualified pension and other employee benefit plans, after allocations to business segments; (5) corporate-level activities, after allocations to business segments, including strategic expenditures, acquisition and disposition costs, corporate governance, corporate advertising, philanthropic activities, deferred compensation, and costs related to certain contingencies and legal matters; (6) expenses associated with the multi-year plan of programs that span across our businesses and the functional areas that support those businesses; (7) certain retained obligations relating to pre-demutualization policyholders; (8) impacts of risk management activities pursuant to our Risk Appetite Framework; (9) the foreign currency income hedging program used to hedge certain non-U.S. dollar denominated earnings in our International Businesses segment; (10) intercompany arrangements with our International Businesses and PGIM segments to translate non-U.S. dollar-denominated earnings at fixed currency exchange rates; and (11) transactions with and between other segments, including the elimination of intercompany transactions for consolidation purposes. Segment Accounting Policies. The accounting policies of the segments are the same as those described in Note 2. Results for each segment include earnings on attributed equity established at a level which management considers necessary to support each segment’s risks. Operating expenses specifically identifiable to a particular segment are allocated to that segment as incurred. Operating expenses not identifiable to a specific segment that are incurred in connection with the generation of segment revenues are generally allocated based upon the segment’s historical percentage of general and administrative expenses. For information related to significant acquisitions and dispositions, see Note 1. For information related to the adoption of new accounting pronouncements, see Note 2. The segments’ results in prior years have been revised for these items, as applicable, to conform to the current year presentation. Adjusted Operating Income The Company analyzes the operating performance of each segment using “adjusted operating income.” Adjusted operating income does not equate to “Income (loss) before income taxes and equity in earnings of operating joint ventures” or “Net income (loss)” as determined in accordance with U.S. GAAP but is the measure of segment profit or loss used by the Company’s chief operating decision maker to evaluate segment performance and allocate resources and, consistent with authoritative guidance, is the measure of segment performance presented below. Adjusted operating income is calculated by adjusting each segment’s “Income (loss) before income taxes and equity in earnings of operating joint ventures” for the following items, which are described in greater detail below: •Realized investment gains (losses), net, and related adjustments; •Charges related to realized investment gains (losses), net; •Market experience updates; •Divested and Run-off Businesses; •Equity in earnings of operating joint ventures and earnings attributable to noncontrolling interests; and •Other adjustments. These items are important to an understanding of overall results of operations. Adjusted operating income is not a substitute for income determined in accordance with U.S. GAAP, and the Company’s definition of adjusted operating income may differ from that used by other companies. The Company, however, believes that the presentation of adjusted operating income as measured for management purposes enhances the understanding of results of operations by highlighting the results from ongoing operations and the underlying profitability factors of its businesses. Realized investment gains (losses), net, and related adjustments Realized investment gains (losses), net Adjusted operating income excludes “Realized investment gains (losses), net,” except for certain items described below. Significant activity excluded from adjusted operating income includes impairments and credit-related gains (losses) from sales of securities, the timing of which depends largely on market credit cycles and can vary considerably across periods, and interest rate-related gains (losses) from sales of securities, which are largely subject to the Company’s discretion and influenced by market opportunities, as well as the Company’s tax and capital profile. Additionally, adjusted operating income excludes realized investment gains (losses) from products that contain embedded derivatives, and from associated derivative portfolios that are part of an asset/liability management program related to the risk of those products. The following table sets forth the significant components of “Realized investment gains (losses), net” that are included in adjusted operating income and, as a result, are reflected as adjustments to “Realized investment gains (losses), net” for purposes of calculating adjusted operating income:
__________ (1)Prior period amounts have been updated to conform to current period presentation. (2)In addition to the items in the table above, “Realized investment gains (losses), net, and related charges and adjustments” also includes an adjustment to reflect “Realized investment gains (losses), net” related to Divested and Run-off Businesses. See “Divested and Run-off Businesses” discussed below. Terminated Hedges of Foreign Currency Earnings. The amounts shown in the table above primarily reflect the impact of an intercompany arrangement between Corporate and Other operations and the International Businesses segment, pursuant to which the non-U.S. dollar-denominated earnings in all countries for a particular year, including its interim reporting periods, are translated at fixed currency exchange rates. The fixed rates are determined in connection with a currency hedging program designed to mitigate the risk that unfavorable rate changes will reduce the segment’s U.S. dollar-equivalent earnings. Pursuant to this program, the Company’s Corporate and Other operations may execute forward currency contracts with third-parties to sell the net exposure of projected earnings from the hedged currency in exchange for U.S. dollars at a specified exchange rate. The maturities of these contracts correspond with the future periods in which the identified non-U.S. dollar-denominated earnings are expected to be generated. These contracts do not qualify for hedge accounting under U.S. GAAP, so the resulting profits or losses are recorded in “Realized investment gains (losses), net.” When the contracts are terminated in the same period that the expected earnings emerge, the resulting positive or negative cash flow effect is included in adjusted operating income. Current Period Yield Adjustments. The Company uses interest rate and currency swaps and other derivatives to manage interest and currency exchange rate exposures arising from mismatches between assets and liabilities, including duration mismatches. For derivative contracts that do not qualify for hedge accounting treatment, the periodic swap settlements, as well as certain other derivative related yield adjustments are recorded in “Realized investment gains (losses), net,” and are included in adjusted operating income to reflect the after-hedge yield of the underlying instruments. In certain instances, when these derivative contracts are terminated or offset before their final maturity, the resulting realized gains or losses are recognized in adjusted operating income over periods that generally approximate the expected terms of the derivatives or underlying instruments in order for adjusted operating income to reflect the after-hedge yield of the underlying instruments. Included in the amounts shown in the table above are gains (losses) on certain derivative contracts that were terminated or offset before their final maturity of $66 million, $45 million and $44 million for the years ended 2021, 2020 and 2019, respectively. As of December 31, 2021, there was a $1,099 million deferred net gain related to certain derivative contracts that were terminated or offset before their final maturity, primarily within the Individual Annuities segment and International Businesses. Also included in the amounts shown in the table above are fees related to synthetic GICs of $111 million, $113 million and $125 million for the years ended 2021, 2020 and 2019, respectively. Synthetic GICs are accounted for as derivatives under U.S. GAAP and, therefore, these fees are recorded in “Realized investment gains (losses), net.” See Note 5 for additional information on synthetic GICs. Principal Source of Earnings. The Company conducts certain activities for which realized investment gains (losses) are a principal source of earnings for its businesses and are therefore included in adjusted operating income, particularly within the Company’s PGIM segment. For example, PGIM’s strategic investing business makes investments for sale or syndication to other investors or for placement or co-investment in the Company’s managed funds and structured products. The realized investment gains (losses) associated with the sale of these strategic investments, as well as the majority of derivative results, are a principal activity for this business and included in adjusted operating income. In addition, the realized investment gains (losses) associated with loans originated by the Company’s commercial mortgage operations, as well as related derivative results and retained mortgage servicing rights, are a principal activity for this business and are therefore included in adjusted operating income. Adjustments related to Realized investment gains (losses), net The following table sets forth certain other items excluded from adjusted operating income and reflected as an adjustment to “Realized investment gains (losses), net” for purposes of calculating adjusted operating income:
__________ (1)Prior period amounts have been updated to conform to current period presentation. (2)Adjusted operating income excludes net investment gains (losses) on assets supporting experience-rated contractholder liabilities, related derivatives, and commercial mortgage and other loans. The activity for derivatives and commercial mortgage and other loans that support these experience-rated products are reported in “Realized investment gains (losses), net” and excluded from adjusted operating income. Investments carried at fair value through net income. The Company has certain investments in its general account portfolios that are carried at fair value with changes in fair value reported in “Other income (loss).” Examples include the Company’s investments in equity securities and fixed maturities designated as trading. Consistent with the exclusion of realized investment gains (losses) with respect to other investments managed on a consistent basis, the net gains or losses on these investments are excluded from adjusted operating income. Foreign Currency Exchange Movements. The Company has certain assets and liabilities for which, under U.S. GAAP, the changes in value, including those associated with changes in foreign currency exchange rates during the period, are recorded in “Other income (loss).” To the extent the foreign currency exposure on these assets and liabilities is economically hedged or considered part of the Company’s capital funding strategies for its international subsidiaries, the change in value included in “Other income (loss)” is excluded from adjusted operating income. The insurance liabilities are supported by investments denominated in corresponding currencies, including a significant portion designated as available-for-sale. While these non-yen denominated assets and liabilities are economically hedged, unrealized gains (losses) on available-for-sale investments, including those arising from foreign currency exchange rate movements, are recorded in AOCI under U.S. GAAP, while the non-yen denominated liabilities are remeasured for foreign currency exchange rate movements, with the related change in value recorded in earnings within “Other income (loss).” Due to this non-economic volatility that has been reflected in U.S. GAAP earnings, the change in value recorded within “Other income (loss)” is excluded from adjusted operating income. Other Activities. The Company excludes certain other items from adjusted operating income that are consistent with similar adjustments described above. Charges related to realized investment gains (losses), net Charges that relate to realized investment gains (losses) are also excluded from adjusted operating income, and include the following: •The portion of the amortization of DAC, VOBA, unearned revenue reserves and DSI for certain products that is related to net realized investment gains (losses). •Policyholder dividends and interest credited to policyholders’ account balances that relate to certain life policies that pass back certain realized investment gains (losses) to the policyholder, and reserves for future policy benefits for certain policies that are affected by net realized investment gains (losses). •Market value adjustments paid or received upon a contractholder’s surrender of certain of the Company’s annuity products as these amounts mitigate the net realized investment gains or losses incurred upon the disposition of the underlying invested assets. Market experience updates The Company had historically recognized the immediate impacts from changes in current market conditions on estimates of profitability in current period adjusted operating income. Beginning with the second quarter of 2019 these impacts are excluded from adjusted operating income, which the Company believes enhances the understanding of underlying performance trends. These amounts represent the impact of those changes on DAC and other costs and reserves, primarily related to variable annuity and variable and universal life products. Divested and Run-off Businesses The contribution to income (loss) of Divested and Run-off Businesses that have been or will be sold or exited, including businesses that have been placed in wind down, but that did not qualify for “discontinued operations” accounting treatment under U.S. GAAP, are excluded from adjusted operating income as the results of Divested and Run-off Businesses are not considered relevant to understanding the Company’s ongoing operating results. The Closed Block division is accounted for as a divested business because it consists primarily of certain participating insurance and annuity products that the Company ceased selling at demutualization in 2001. See Note 15 for further information on the Closed Block. Equity in earnings of operating joint ventures and earnings attributable to noncontrolling interests Equity in earnings of operating joint ventures, on a pre-tax basis, are included in adjusted operating income as these results are a principal source of earnings. These earnings are reflected on a U.S. GAAP basis on an after-tax basis as a separate line on the Company’s Consolidated Statements of Operations. Earnings attributable to noncontrolling interests are excluded from adjusted operating income. Earnings attributable to noncontrolling interests represents the portion of earnings from consolidated entities that relates to the equity interests of minority investors, and are reflected on a U.S. GAAP basis as a separate line on the Company’s Consolidated Statements of Operations. Other adjustments Other adjustments represent all other adjustments that are excluded from adjusted operating income. These primarily include losses related to the impairment of goodwill, as well as certain components of the consideration for business acquisitions, which are recognized as compensation expense over the requisite service periods, and changes in the fair value of contingent consideration. See Note 1 and Note 2 for additional information. Reconciliation of adjusted operating income and net income (loss) The table below reconciles adjusted operating income before income taxes to income before income taxes and equity in earnings of operating joint ventures:
__________ (1)Effective third quarter of 2021, the results of the Full Service Retirement business are excluded from the Retirement segment and are included in Divested and Run-off Businesses. Prior period amounts have been updated to conform to current period presentation. See Note 1 to the Consolidated Financial Statements for additional information. (2)Individual Annuities segment results reflect DAC as if the Individual Annuities business is a stand-alone operation. The elimination of intersegment costs capitalized in accordance with this policy is included in consolidating adjustments within Corporate and Other operations. (3)Assurance IQ was acquired by the Company in October 2019. See Note 1 for additional information. (4)In the fourth quarter of 2021, the Company recognized a goodwill impairment of $1,060 million related to Assurance IQ. See Note 2 and Note 10 for additional information. Reconciliation of select financial information The tables below present certain financial information for the Company’s segments and its Corporate and Other operations, including assets by segment and revenues, and benefits and expenses by segment on an adjusted operating income basis, and the reconciliation of the segment totals to amounts reported in the Consolidated Financial Statements.
__________ (1)Effective third quarter of 2021, the results of the Full Service Retirement business are excluded from the Retirement segment and are included in the Divested and Run-off Businesses in Corporate and Other. Prior period amounts have been updated to conform to current period presentation. See Note 1 for additional information about these dispositions. (2)Certain assets are classified as “held-for-sale” as of December 31, 2021. See Note 1 for additional information about the pending dispositions.
__________ (1)Effective third quarter of 2021, the results of the Full Service Retirement business are excluded from the Retirement segment and are included in the Divested and Run-off Businesses in Corporate and Other. Prior period amounts have been updated to conform to current period presentation. See Note 1 for additional information about these dispositions. (2)Assurance IQ was acquired by the Company in October 2019. See Note 1 for additional information. Revenues, calculated in accordance with U.S. GAAP, for the years ended December 31, include the following by geographic location that are 10 percent or more of the Company’s total consolidated revenue:
__________ (1)Prior period amounts have been updated to conform to current period presentation. Intersegment revenues Management has determined the intersegment revenues with reference to market rates. Intersegment revenues are eliminated in consolidation in Corporate and Other operations. The PGIM segment revenues include intersegment revenues, primarily consisting of asset-based management and administration fees, for the years ended December 31, as follows:
Segments may also enter into internal derivative contracts with other segments. For adjusted operating income, each segment accounts for the internal derivative results consistent with the manner in which that segment accounts for other similar external derivatives. Asset management and service fees The table below presents asset management and service fees, predominantly related to investment management activities, for the periods indicated:
|
Commitments and Contingent Liabilities |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingencies Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingent Liabilities | COMMITMENTS AND CONTINGENT LIABILITIES Commitments and Guarantees Commercial Mortgage Loan Commitments
__________ (1)Includes commitments of $21 million related to held-for-sale operations as of December 31, 2021. See Note 1 for additional information on the pending dispositions. In connection with the Company’s commercial mortgage operations, it originates commercial mortgage loans. Commitments for loans that will be held for sale are recognized as derivatives and recorded at fair value. In certain of these transactions, the Company pre-arranges that it will sell the loan to an investor, including to government sponsored entities as discussed below, after the Company funds the loan. The above amount includes unfunded commitments that are not unconditionally cancellable. For related credit exposure, there was an allowance for credit losses of $1 million and $0 million as of December 31, 2021 and 2020, respectively. The change in allowance is $0 million and a reduction of $2 million for the years ended December 31, 2021 and 2020, respectively. Commitments to Purchase Investments (excluding Commercial Mortgage Loans)
__________ (1)Includes commitments of $118 million related to held-for-sale operations as of December 31, 2021. See Note 1 for additional information on the pending dispositions. The Company has other commitments to purchase or fund investments, some of which are contingent upon events or circumstances not under the Company’s control, including those at the discretion of the Company’s counterparties. The Company anticipates a portion of these commitments will ultimately be funded from its separate accounts. The above amount includes unfunded commitments that are not unconditionally cancellable. There were no related charges for credit losses for either the years ended December 31, 2021 or 2020. Indemnification of Securities Lending and Securities Repurchase Transactions
__________ (1)Includes $30 million and $34 million related to securities repurchase transactions as of December 31, 2021 and 2020, respectively. (2)Includes $29 million and $34 million related to securities repurchase transactions as of December 31, 2021 and 2020, respectively. In the normal course of business, the Company may facilitate securities lending or securities repurchase transactions on behalf of certain client accounts (collectively, “the accounts”). In certain of these arrangements, the Company has provided an indemnification to the accounts to hold them harmless against losses caused by counterparty (i.e., borrower) defaults associated with such transactions facilitated by the Company. In securities lending transactions, collateral is provided by the counterparty to the accounts at the inception of the transaction in an amount at least equal to 102% of the fair value of the loaned securities and the collateral is maintained daily to equal at least 102% of the fair value of the loaned securities. In securities repurchase transactions, collateral is provided by the counterparty to the accounts at the inception of the transaction in an amount at least equal to 95% of the fair value of the securities subject to repurchase and the collateral is maintained daily to equal at least 95% of the fair value of the securities subject to repurchase. The Company is only at risk if the counterparty to the transaction defaults and the value of the collateral held is less than the value of the securities loaned to, or subject to repurchase from, such counterparty. The Company believes the possibility of any payments under these indemnities is remote. Credit Derivatives Written As discussed further in Note 5, the Company writes credit derivatives under which the Company is obligated to pay the counterparty the referenced amount of the contract and receive in return the defaulted security or similar security. Guarantees of Asset Values
Certain contracts underwritten by the Retirement segment include guarantees related to financial assets owned by the guaranteed party. These contracts are accounted for as derivatives and carried at fair value. The collateral supporting these guarantees is not reflected on the Consolidated Statements of Financial Position. Indemnification of Serviced Mortgage Loans
__________ (1)As of both December 31, 2021 and 2020, the accrued liability associated with guarantees includes an allowance for credit losses of $20 million. The change in allowance is $0 million and $1 million as of December 31, 2021 and 2020, respectively. As part of the commercial mortgage activities of the Company’s PGIM segment, the Company provides commercial mortgage origination, underwriting and servicing for certain government sponsored entities, such as Fannie Mae and Freddie Mac. The Company has agreed to indemnify the government sponsored entities for a portion of the credit risk associated with certain of the mortgages it services through a delegated authority arrangement. Under these arrangements, the Company originates multi-family mortgages for sale to the government sponsored entities based on underwriting standards they specify, and makes payments to them for a specified percentage share of losses they incur on certain loans serviced by the Company. The Company’s percentage share of losses incurred generally varies from 4% to 20% of the loan balance, and is typically based on a first-loss exposure for a stated percentage of the loan balance, plus a shared exposure with the government sponsored entity for any losses in excess of the stated first-loss percentage, subject to a contractually specified maximum percentage. The Company determines the liability related to this exposure using historical loss experience, and the size and remaining life of the asset. The Company serviced $22,963 million and $21,465 million of mortgages subject to these loss-sharing arrangements as of December 31, 2021 and 2020, respectively, all of which are collateralized by first priority liens on the underlying multi-family residential properties. As of December 31, 2021, these mortgages had a weighted-average debt service coverage ratio of 1.93 times and a weighted-average loan-to-value ratio of 63%. As of December 31, 2020, these mortgages had a weighted-average debt service coverage ratio of 1.99 times and a weighted-average loan-to-value ratio of 63%. The Company had $2 million of losses related to indemnifications that were settled for the year ended December 31, 2021, and no losses for the years ended December 31, 2020 and 2019. Other Guarantees
The Company is also subject to other financial guarantees and indemnity arrangements. The Company has provided indemnities and guarantees related to acquisitions, dispositions, investments and other transactions that are triggered by, among other things, breaches of representations, warranties or covenants provided by the Company. These obligations are typically subject to various time limitations, defined by the contract or by operation of law, such as statutes of limitation. In some cases, the maximum potential obligation is subject to contractual limitations, while in other cases such limitations are not specified or applicable. As of December 31, 2021 and 2020, there are $0 million and $9 million, respectively, of yield maintenance guarantees related to certain investments the Company sold. The Company does not expect to make any payments on these guarantees and is not carrying any liabilities associated with these guarantees. Since certain of these obligations are not subject to limitations, it is not possible to determine the maximum potential amount due under these guarantees. The accrued liability identified above relates to the sale of POT and represents a financial guarantee of certain insurance obligations of POT. See Note 1 for additional information regarding the sale. Insolvency Assessments Most of the jurisdictions in which the Company is admitted to transact business require insurers doing business within the jurisdiction to participate in guarantee associations, which are organized to pay contractual benefits owed pursuant to insurance policies issued by impaired, insolvent or failed insurers. These associations levy assessments, up to prescribed limits, on all member insurers in a particular state on the basis of the proportionate share of the premiums written by member insurers in the lines of business in which the impaired, insolvent or failed insurer engaged. Some states permit member insurers to recover assessments paid through full or partial premium tax offsets. In addition, Japan has established the Japan Policyholders Protection Corporation as a contingency to protect policyholders against the insolvency of life insurance companies in Japan through assessments to companies licensed to provide life insurance. Assets and liabilities held for insolvency assessments were as follows:
Assurance IQ Contingent Consideration Liability In October 2019, the Company completed its acquisition of Assurance IQ. See Note 1 for additional information regarding the transaction, including the establishment of $100 million of contingent consideration. The contingent consideration liability is reported at fair value, which is determined based on the present value of expected payments under the arrangement, using an internally-developed option pricing model based on a number of assumptions, including certain unobservable assumptions discounted at an estimated market interest rate. The fair value of the liability is updated each reporting period, with changes in fair value reported within “Other income.” The fair value of the contingent consideration liability was zero as of December 31, 2021 and December 31, 2020. Contingent Liabilities On an ongoing basis, the Company and its regulators review its operations including, but not limited to, sales and other customer interface procedures and practices, and procedures for meeting obligations to its customers and other parties. These reviews may result in the modification or enhancement of processes or the imposition of other action plans, including concerning management oversight, sales and other customer interface procedures and practices, and the timing or computation of payments to customers and other parties. In certain cases, if appropriate, the Company may offer customers or other parties remediation and may incur charges, including the cost of such remediation, administrative costs and regulatory fines. The Company is subject to the laws and regulations of states and other jurisdictions concerning the identification, reporting and escheatment of unclaimed or abandoned funds, and is subject to audit and examination for compliance with these requirements. It is possible that the results of operations or the cash flow of the Company in a particular quarterly or annual period could be materially affected as a result of payments in connection with the matters discussed above or other matters depending, in part, upon the results of operations or cash flow for such period. Management believes, however, that ultimate payments in connection with these matters, after consideration of applicable reserves and rights to indemnification, should not have a material adverse effect on the Company’s financial position. Litigation and Regulatory Matters The Company is subject to legal and regulatory actions in the ordinary course of its businesses. Pending legal and regulatory actions include proceedings relating to aspects of the Company’s businesses and operations that are specific to it and proceedings that are typical of the businesses in which it operates, including in both cases businesses that have been either divested or placed in wind-down status. Some of these proceedings have been brought on behalf of various alleged classes of complainants. In certain of these matters, the plaintiffs are seeking large and/or indeterminate amounts, including punitive or exemplary damages. The outcome of litigation or a regulatory matter, and the amount or range of potential loss at any particular time, is often inherently uncertain. The Company establishes accruals for litigation and regulatory matters when it is probable that a loss has been incurred and the amount of that loss can be reasonably estimated. For litigation and regulatory matters where a loss may be reasonably possible, but not probable, or is probable but not reasonably estimable, no accrual is established but the matter, if potentially material, is disclosed, including matters discussed below. The Company estimates that as of December 31, 2021, the aggregate range of reasonably possible losses in excess of accruals established for those litigation and regulatory matters for which such an estimate currently can be made is less than $250 million. Any estimate is not an indication of expected loss, if any, or the Company’s maximum possible loss exposure on such matters. The Company reviews relevant information with respect to its litigation and regulatory matters on a quarterly and annual basis and updates its accruals, disclosures and estimates of reasonably possible loss based on such reviews. Labor and Employment Matters Prudential of Brazil Labor and Employment Matters Prudential of Brazil (“POB”) sells insurance products to consumers through life planner franchisees (“Life Planners”), who are engaged as independent life insurance brokers and not as employees. When a Life Planner’s contractual relationship with POB is terminated, in many cases the Life Planner commences a labor suit against POB alleging entitlement to employment related benefits. POB is a defendant in numerous such lawsuits in Brazil brought by former Life Planners and has been subject to regulatory actions challenging the validity of POB’s franchise model. POB has continued to receive additional labor suits and regulatory actions involving the operation of its franchise model notwithstanding steps that POB has taken to attempt to mitigate the labor risk by modifying its franchise model. POB continues to modify its franchise model to further mitigate this risk. Individual Annuities, Individual Life and Group Insurance Behfarin v. Pruco Life In July 2017, a putative class action complaint entitled Richard Behfarin v. Pruco Life Insurance Company was filed in the United States District Court for the Central District of California, alleging that the Company imposes charges on owners of universal life policies to cure defaults and/or reinstate lapses, that are inconsistent with the applicable universal life policy. The complaint includes claims for breach of contract, breach of implied covenant of good faith and fair dealing, and violation of California law, and seeks unspecified damages along with declaratory and injunctive relief. In September 2017, the Company filed its answer to the complaint. In September 2018, plaintiff filed a motion for class certification. In October 2019, plaintiff filed: (1) the First Amended Complaint adding Prudential Insurance Company of America and Pruco Life Insurance Company of New Jersey as defendants; and (2) a motion seeking preliminary certification of a settlement class, appointment of a class representative and class counsel, and preliminary approval of the proposed class action settlement. In November 2019, the court issued an order granting the motion for preliminary approval of the settlement. In June 2020, the court issued an order: (i) granting plaintiffs’ motion for certification of the settlement class; (ii) approving the proposed nationwide class settlement agreement; (iii) approving the class notice; (iv) awarding attorneys’ fees and costs to plaintiffs and a reduced incentive award to Behfarin; and (v) dismissing the action with prejudice, but maintaining jurisdiction over the settlement. This matter is now closed. Moreland, Socorro v. PICA, et al. In June 2020, a putative class action complaint entitled Socorro Moreland v. The Prudential Insurance Company of America; Pruco Life Insurance Company, was filed in the United States District Court for the Northern District of California, alleging that the Company failed to comply with California laws requiring that life insurance policies issued and delivered in California: (i) provide for a 60-day grace period pre-lapse during which a policy must stay in force; (ii) provide a 30-day written notice of pending lapse; and (iii) notify policyowners of their right to designate additional recipients for lapse notices. The complaint asserts claims for violation of California law, breach of contract, unfair competition, and bad faith violation of the implied covenant of good faith and fair dealing, and seeks unspecified damages, declaratory and injunctive relief. In August 2020, defendants filed an answer to the complaint and a motion to stay the action pending the California Supreme Court’s decision, in McHugh v. Protective Life Insurance, on the question of whether the California lapse statutes apply to policies that were in force when the statutes went into effect on January 1, 2013, or solely to policies issued after that date. The Moreland court granted defendants’ motion to stay in October 2020. Subsequently, in August 2021, the California Supreme Court in McHugh determined that the California lapse statutes apply to policies that were in force as of January 1, 2013. In October 2021, the Moreland court lifted the stay order. Escheatment Litigation Total Asset Recovery Services, LLC v. MetLife, Inc., et al., Prudential Financial, Inc., The Prudential Insurance Company of America, and Prudential Insurance Agency, LLC In December 2017, Total Asset Recovery Services, LLC, on behalf of the State of New York, filed a Second Amended Complaint in the Supreme Court of the State of New York, County of New York, against, among other 19 defendants, Prudential Financial, Inc., The Prudential Insurance Company of America and Prudential Insurance Agency, LLC, alleging that the Company failed to escheat life insurance proceeds in violation of the New York False Claims Act. The second amended complaint seeks injunctive relief, compensatory damages, civil penalties, treble damages, prejudgment interest, attorneys’ fees and costs. In May 2018, defendants filed a motion to dismiss the Second Amended Complaint. In April 2019, defendants’ motion to dismiss the Second Amended Complaint was granted and plaintiff subsequently filed a Notice of Appeal with the New York State Supreme Court, First Department. In December 2020, the New York Supreme Court, First Department, reversed and vacated the judgment of the trial court and granted leave to plaintiff to file a third amended complaint. In March 2021, the plaintiff filed a third amended complaint asserting claims against all defendants for violation of the New York False Claims Act, and seeking injunctive relief, compensatory and treble damages, attorneys’ fees and costs. Securities Litigation City of Warren v. PFI, et al. In November 2019, a putative class action complaint entitled City of Warren Police and Fire Retirement System v. Prudential Financial, Inc., Charles F. Lowrey and Kenneth Y. Tanji, was filed in the United States District Court for the District of New Jersey. The complaint asserts claims for federal securities law violations against PFI, and Charles Lowrey, PFI’s chief executive officer, and Kenneth Tanji, PFI’s chief financial officer, individually, and alleges that: (i) the Company's reserve assumptions failed to account for adversely developing mortality experience in the Individual Life business segment; (ii) the Company's reserves were insufficient to satisfy its future policy benefit liabilities; and (iii) the Company materially understated its liabilities and overstated net income due to flawed assumptions in calculating mortality experience. The putative class includes all purchasers of PFI common stock between February 15, 2019 and August 2, 2019. In March 2020, the court issued an order consolidating this action with Donald P. Crawford v. PFI, et al. under the caption In re Prudential Financial, Inc. Securities Litigation. In June 2020, plaintiffs filed an amended complaint and added Robert M. Falzon, PFI’s vice chairman, as an individual defendant. In August 2020, the Company filed a motion to dismiss the amended complaint. In December 2020, the court issued an order granting defendants’ motion to dismiss the amended complaint with prejudice and plaintiff subsequently filed, in January 2021, a Notice of Appeal to the United States Court of Appeals for the Third Circuit. Donel Davidson v. Charles F. Lowrey, et al. In September 2020, a shareholder derivative complaint entitled Pekin Police Pension Fund, Derivatively on Behalf of Prudential Financial, Inc. v. Charles F. Lowrey, et al., was filed in the United States District Court for the District of New Jersey (the “Derivative Complaint”) against PFI as a “nominal” defendant, PFI’s chairman and chief executive officer, vice chairman, chief financial officer, certain former officers of PFI, and all of the current outside directors of PFI’s Board. The Derivative Complaint asserts claims for federal securities law violations, breach of fiduciary duty, waste of corporate assets, and unjust enrichment, and alleges that: (i) the Company's reserve assumptions failed to account for adversely developing mortality experience in the Individual Life business segment; (ii) the Company's reserves were insufficient to satisfy its future policy benefit liabilities; (iii) the Company materially understated its liabilities and overstated net income due to flawed assumptions in calculating mortality experience; and (iv) the individual defendants breached their duty of care and loyalty to the Company by allowing the alleged improper activity. In December 2020, the Court issued an order substituting Donel Davidson for Pekin Police Pension Fund as the named plaintiff. In March 2021, the court issued an order consolidating this action with Robert Lalor, Derivatively on behalf of Prudential Financial, Inc. v. Charles F. Lowrey, et al. under the caption In re Prudential Financial, Inc. Derivative Litigation. In May 2021, the Company filed a motion to dismiss the complaint. Daniel Plaut v. Prudential Financial, Inc. In October 2020, a shareholder derivative complaint entitled Daniel Plaut, Derivatively on Behalf of Prudential Financial, Inc. v. Charles F. Lowrey, et al., was filed in the Superior Court of New Jersey, Law Division, Essex County (the “Derivative Complaint”) against PFI as a “nominal” defendant, PFI’s chairman and chief executive officer, vice chairman, and all of the current outside directors of PFI’s Board. The Derivative Complaint asserts claims for breach of fiduciary duty, unjust enrichment, and abuse of control and alleges that: (i) the Company's reserve assumptions failed to account for adversely developing mortality experience in the Individual Life business segment; (ii) the Company's reserves were insufficient to satisfy its future policy benefit liabilities; (iii) the Company materially understated its liabilities and overstated net income due to flawed assumptions in calculating mortality experience; and (iv) the individual defendants engaged in corporate misconduct, mismanagement and waste through their participation in the alleged wrongdoing. Robert Lalor v. Charles F. Lowrey, et al. In November 2020, a verified shareholder derivative complaint entitled Robert Lalor, derivatively on behalf of Prudential Financial, Inc. v. Charles F. Lowrey, et al., was filed in the United States District Court for the District of New Jersey (the “Derivative Complaint”) against PFI as a “nominal” defendant, PFI’s chairman and chief executive officer, vice chairman, chief financial officer, certain former officers of PFI, and all of the current outside directors of PFI’s Board. The Derivative Complaint asserts claims for federal securities law violations, breach of fiduciary duty, waste of corporate assets, and unjust enrichment, and alleges that: (i) the Company's reserve assumptions failed to account for adversely developing mortality experience in the Individual Life business segment; (ii) the Company's reserves were insufficient to satisfy its future policy benefit liabilities; (iii) the Company materially understated its liabilities and overstated net income due to flawed assumptions in calculating mortality experience; and (iv) the individual defendants had irreconcilable conflicts of interest and breached their duties of candor, loyalty, oversight and supervision. In March 2021, the court issued an order consolidating this action with Donel Davidson, Derivatively on Behalf of Prudential Financial, Inc. v. Charles F. Lowrey, et al. under the caption In re Prudential Financial, Inc. Derivative Litigation. Case updates will be consolidated with the Donel Davidson action. Shareholder Demands In January 2020, the Board of Directors received a shareholder demand letter containing allegations: (i) of wrongdoing similar to those alleged in the City of Warren and Crawford complaints; and (ii) that certain of the Company’s current and former directors and executive officers breached their fiduciary duties of loyalty, due care and candor. The demand letter requests that the Board of Directors investigate and commence legal proceedings against the named individuals to recover for the Company’s benefit the damages purportedly sustained by the Company as a result of the alleged breaches. In February 2020, the Board of Directors authorized the creation of a special committee to investigate the allegations set forth in the shareholder demand letter. In April 2020, the Company received additional shareholder demands raising allegations similar to those contained in the January 2020 demand, and may be subject prospectively to additional activity relating to these matters. In January 2021, the special committee completed its investigation, and in February 2021, the Board provided notice rejecting the shareholder demands and dissolved the special committee. Assurance IQ, LLC The Company has received a civil investigative demand and other inquiries related to the appropriateness of Assurance IQ’s supplemental health product sales and marketing activity. The Company is cooperating with regulators and may become subject to additional regulatory inquiries and other investigations and actions related to this matter. William James Griffin, et al. v. Benefytt Technologies, Inc., et al. and Assurance IQ, LLC In February 2021, an amended putative class action complaint entitled William James Griffin, et al. v. Benefytt Technologies, Inc. (f/k/a Health Insurance Innovations, Inc.), Health Plan Intermediaries Holdings, Inc. and Assurance IQ, LLC, was filed in the United States District Court for the Southern District of Florida, alleging that the defendants violated the Racketeering Influenced and Corrupt Organizations Act, and engaged in a conspiracy to defraud customers through the sale of limited indemnity and short term health insurance products to individuals seeking comprehensive medical insurance. The complaint seeks unspecified treble damages, declaratory and injunctive relief. In June 2021, the Company filed a motion to dismiss the amended complaint. Other Matters Cho v. PICA, et al. In November 2019, a putative class action complaint entitled Cho v. The Prudential Insurance Company of America, et. al., was filed in the United States District Court for the District of New Jersey. The Complaint purports to be brought on behalf of participants in the Prudential Employee Savings Plan (the “Plan”) and (i) alleges that defendants failed to fulfill their fiduciary obligations under the Employee Retirement Income Security Act of 1974, in the administration, management and operation of the Plan, including engaging in prohibited transactions; and (ii) seeks declaratory, injunctive and equitable relief, and unspecified damages including interest, attorneys’ fees and costs. In January 2020, defendants filed a motion to dismiss the complaint. In September 2020, plaintiff filed an amended complaint and added as individual defendants certain PFI officers and current and former members of the Company’s Administrative Committee and Investment Oversight Committee. In December 2020, defendants filed a motion to dismiss the amended complaint. In September 2021, the court granted defendants’ motion to dismiss the amended complaint without prejudice. In October 2021, plaintiff filed a second amended complaint asserting claims against defendants under the Employee Retirement Income Security Act of 1974 for breach of fiduciary duty, prohibited transactions and failure to monitor fiduciaries. The second amended complaint seeks declaratory, injunctive and equitable relief, unspecified damages, attorneys’ fees and costs. In December 2021, defendants filed a motion to dismiss the second amended complaint. Doyle C. Stone v. PFI, et al. In February 2021, a putative class action complaint entitled Doyle C. Stone v. Prudential Financial, Inc., Pruco Life Insurance Company, was filed in the United States District Court for the District of New Jersey. The complaint asserts claims against Prudential Financial, Inc. and Pruco Life Insurance Company for violation of the New Jersey Consumer Fraud Act, breach of contract, breach of fiduciary duty, breach of implied duty of good faith and fair dealing, misrepresentation and unjust enrichment, based on: (i) the Company’s alleged deficient identification, notification and payment practices for retirement plan participants in transferred group retirement, annuity and insurance plans (“Plan Participants”); and (ii) improper transfer of Plan Participant funds to its own accounts. The putative class includes all Plan Participants from January 2015 to the present. In April 2021, defendants filed a motion to dismiss the complaint. In June 2021, plaintiff filed a notice of voluntary dismissal of the complaint, without prejudice. In August 2021, plaintiff filed a new putative class action complaint in the United States District Court for the District of New Jersey (the “Second Complaint”), asserting claims against Prudential Financial, Inc. and Pruco Life Insurance Company for violation of the New Jersey Consumer Fraud Act, breach of fiduciary duty, unjust enrichment and common law fraud. The putative class includes all Plan Participants from January 2015 until the present. In September 2021, defendants filed a motion to dismiss the Second Complaint. In November 2021, the court issued an order granting defendants’ motion and dismissed plaintiff’s: (i) fraud claims without prejudice; and (ii) breach of fiduciary duty and unjust enrichment claims with prejudice. In January 2022, plaintiff filed a Notice of Voluntary Dismissal With Prejudice that was approved by the Court. This matter is now closed. LIBOR Litigation Prudential Investment Portfolios 2, f/k/a Dryden Core Investment Fund, o/b/o Prudential Core Short-Term Bond Fund and Prudential Core Taxable Money Market Fund v. Bank of America Corporation, et al. In May 2014, Prudential Investment Portfolios 2, on behalf of the Prudential Core Short-Term Bond Fund and the Prudential Core Taxable Money Market Fund (the “Funds”), filed an action against ten banks in the United States District Court for the District of New Jersey asserting that the banks participated in the setting of LIBOR, a major benchmark interest rate. The complaint alleges that the defendant banks manipulated LIBOR, and asserts, among other things, claims for common law fraud, negligent misrepresentation, breach of contract, intentional interference with contract and with prospective economic relations, unjust enrichment, breaches of the New Jersey Civil RICO (“Racketeer Influenced and Corrupt Organizations Act”) statute, and violations of the Sherman Act. In June 2014, the United States Judicial Panel on Multidistrict Litigation transferred the action to the United States District Court for the Southern District of New York, where it has been consolidated for pre-trial purposes with other pending LIBOR-related actions. In October 2014, the Funds filed an amended complaint. In November 2014, the defendants filed a motion to dismiss the amended complaint. In August 2015, the court issued a decision granting in part, and denying in part, defendants' motions to dismiss. The court dismissed certain of the Funds' claims, including those alleging fraud based on offering material statements; New Jersey RICO; and express breach of contract. The court upheld certain of the Funds' claims, including those alleging fraud based on false LIBOR submissions to the British Bankers’ Association; negligent misrepresentation; unjust enrichment; and breach of the implied covenant of good faith and fair dealing. Following the August 2015 decision, granting in part defendants' motions to dismiss, in September 2015, Prudential filed the following LIBOR complaints: (i) in the Southern District of New York, captioned Prudential Investment Portfolios 2 et al. v. Barclays Bank PLC, et al. (the “New York Complaint”), naming as defendants Barclays Bank PLC, Barclays Capital Inc., Barclays PLC, Citibank, N.A., Citigroup Funding Inc., Credit Suisse AG, Credit Suisse Group AG, Credit Suisse (USA) Inc., Deutsche Bank AG, HSBC Bank plc, HSBC Holdings PLC, JPMorgan Chase & Co., JPMorgan Chase Bank, N.A., Royal Bank of Canada, and The Royal Bank of Scotland PLC. These defendants were dismissed from the original LIBOR action on jurisdictional grounds. The New York complaint reasserts the causes of action brought in the original LIBOR action; and (ii) in the Western district of North Carolina, captioned Prudential Investment Portfolios 2 et al. v. Bank of America Corporation et al. (the “North Carolina Complaint”), naming as defendants Bank of America Corporation and Bank of America, N.A. These defendants were dismissed from the original LIBOR action on jurisdictional grounds. The North Carolina Complaint reasserts the causes of action brought in the original LIBOR action. Both the New York Complaint and the North Carolina Complaint have been transferred for pre-trial purposes to the LIBOR multi-district litigation presided over by Judge Buchwald in the U.S. District Court for the Southern District of New York. In May 2016, the Second Circuit Court of Appeals vacated the district court’s dismissal of the LIBOR plaintiffs’ antitrust claims and remanded to the district court the question of whether plaintiffs possess standing as “efficient enforcers” of applicable antitrust laws. In July 2016, defendants filed a joint motion to dismiss all antitrust claims based on lack of standing and lack of personal jurisdiction. In December 2016, the motion was granted in part and denied in part. In January 2017, the United States Supreme Court denied defendants’ petition for certiorari. In February 2017, the court clarified its December 2016 order, holding that antitrust claims only exist against panel banks, not their affiliates. This clarification resulted in the Funds’ New Jersey antitrust claims being dismissed for lack of personal jurisdiction. The Funds antitrust claims in the New York and North Carolina actions remain pending. In July 2017, the Funds obtained an entry of judgment on the New Jersey antitrust claims dismissed on personal jurisdiction grounds. In July 2017, the Funds filed with the Second Circuit Court an appeal from the dismissal of their New Jersey anti-trust claims. In June 2019, the court issued two orders approving stipulations dismissing with prejudice Prudential’s claims against Citigroup Inc., Citibank, N.A., Citigroup Funding Inc., and Citigroup Global Markets Inc. In December 2019, the court issued two orders approving stipulations dismissing with prejudice Prudential’s claims against HSBC Holdings PLC, HSBC Bank PLC, HSBC Finance Corp., HSBC Securities (USA) Inc., and HSBC USA Inc. In May 2020, the court issued two orders approving stipulations dismissing with prejudice Prudential’s claims against Barclays Bank PLC, Barclays Capital Inc., and Barclays PLC. In August 2020, the court issued two orders approving stipulations dismissing with prejudice, Prudential’s claims against Deutsche Bank AG. In October 2020, the court issued orders approving stipulations dismissing with prejudice, Prudential’s claims against JPMorgan Chase & Co., JPMorgan Chase Bank, N.A., and J.P. Morgan Securities LLC, f/k/a/ J.P. Morgan Securities Inc., Bank of America Corporation, Bank of America, N.A., and Merrill Lynch, Pierce, Fenner & Smith Inc., f/k/a Banc of America Securities LLC. In December 2021, the Second Circuit Court of Appeals affirmed the district court’s order dismissing federal and state antitrust claims based on lack of privity with a defendant bank and reversed the district court’s personal jurisdiction based dismissal of the non-U.S. incorporated defendants. In February 2022, the court issued orders approving stipulations dismissing with prejudice Prudential’s claims against Credit Suisse Group AG, Credit Suisse AG, Credit Suisse (USA) Inc., and Credit Suisse Securities (USA) LLC. Regulatory Variable Products The Company has received regulatory inquiries and requests for information from state and federal regulators, including subpoenas from the U.S. Securities and Exchange Commission, concerning the appropriateness of variable product sales and replacement activity. The Company is cooperating with regulators and may become subject to additional regulatory inquiries and other actions related to this matter. Summary The Company’s litigation and regulatory matters are subject to many uncertainties, and given their complexity and scope, their outcome cannot be predicted. It is possible that the Company’s results of operations or cash flow in a particular quarterly or annual period could be materially affected by an ultimate unfavorable resolution of pending litigation and regulatory matters depending, in part, upon the results of operations or cash flow for such period. In light of the unpredictability of the Company’s litigation and regulatory matters, it is also possible that in certain cases an ultimate unfavorable resolution of one or more pending litigation or regulatory matters could have a material adverse effect on the Company’s financial statements. Management believes, however, that, based on information currently known to it, the ultimate outcome of all pending litigation and regulatory matters, after consideration of applicable reserves and rights to indemnification, is not likely to have a material adverse effect on the Company’s financial statements.
|
Subsequent Events |
12 Months Ended |
---|---|
Dec. 31, 2021 | |
Subsequent Events [Abstract] | |
Subsequent Events | Common Stock Dividend Declaration On February 3, 2022, Prudential Financial’s Board of Directors declared a cash dividend of $1.20 per share of Common Stock, payable on March 11, 2022 to shareholders of record as of February 15, 2022.
|
Schedule I - Summary of Investments Other Than investments in Related Parties Schedule I - Summary of Investments Other Than Investments In Related Parties |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule I - Summary of Investments Other Than Investments In Related Parties | PRUDENTIAL FINANCIAL, INC. Schedule I Summary of Investments Other Than Investments in Related Parties As of December 31, 2021 (in millions)
__________ (1)See Note 3 to the Consolidated Financial Statements for the composition of the Company’s “Assets supporting experience-rated contractholder liabilities, at fair value.” (2)Includes collateralized commercial mortgage and other loans of $58,109 million and uncollateralized loans of $557 million. (3)Excludes “Assets held-for-sale” of $40,669 million as of December 31, 2021.
|
Schedule II - Condensed Financial Information of Registrant |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Condensed Financial Information Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule II - Condensed Financial Information of Registrant | PRUDENTIAL FINANCIAL, INC. Schedule II Condensed Financial Information of Registrant Condensed Statements of Financial Positions as of December 31, 2021 and 2020 (in millions)
See Notes to Condensed Financial Information of Registrant PRUDENTIAL FINANCIAL, INC. Schedule II Condensed Financial Information of Registrant Condensed Statements of Operations for the Years Ended December 31, 2021, 2020 and 2019 (in millions)
See Notes to Condensed Financial Information of Registrant PRUDENTIAL FINANCIAL, INC. Schedule II Condensed Financial Information of Registrant Condensed Statements of Cash Flows for the Years Ended December 31, 2021, 2020 and 2019 (in millions)
See Notes to Condensed Financial Information of Registrant PRUDENTIAL FINANCIAL, INC. Schedule II Condensed Financial Information of Registrant Notes to Condensed Financial Information of Registrant 2. OTHER INVESTMENTS Prudential Financial’s other investments as of December 31, 2021 and 2020 consisted primarily of highly liquid debt investments and intercompany enterprise liquidity account funds. 3. DEBT A summary of Prudential Financial’s short- and long-term debt is as follows:
__________ (1)Ranges of interest rates are for the year ended December 31, 2021. (2)The weighted average interest rate on outstanding commercial paper was 0.12% at both December 31, 2021 and 2020. Long-term Debt In order to manage exposure to interest rate movements, Prudential Financial utilizes derivative instruments, primarily interest rate swaps, in conjunction with some of its debt issues. The impact of these derivative instruments is not reflected in the rates presented in the table above. For those derivatives that qualify for hedge accounting treatment, interest expense was $0.0 million, $0.4 million, and $0.3 million for each of the years ended December 31, 2021, 2020 and 2019, respectively. Schedule of Long-term Debt Maturities The following table presents Prudential Financial’s contractual maturities for long-term debt as of December 31, 2021:
5. COMMITMENTS AND GUARANTEES Prudential Financial has issued a subordinated guarantee covering a subsidiary’s domestic commercial paper program. As of December 31, 2021, there was $395 million outstanding under this commercial paper program. Prudential Financial has provided guarantees of the payment of principal and interest on intercompany loans between affiliates. As of December 31, 2021, Prudential Financial had issued guarantees of outstanding loans totaling $4.0 billion between international insurance subsidiaries and other affiliates. In 2013, Prudential Financial entered into a $500 million indemnity and guarantee agreement with Wells Fargo Bank Northwest, N.A. Under this agreement, Prudential Financial guaranteed obligations with respect to an affiliated loan from PICA to an affiliate. The loan proceeds were utilized to construct the Prudential Tower home office in Newark, New Jersey. Prudential Financial is also subject to other financial guarantees, net worth maintenance agreements and indemnity arrangements, including those made in the normal course of business guaranteeing the performance of, or representations made by, Prudential Financial subsidiaries. Prudential Financial has provided indemnities and guarantees related to acquisitions and dispositions, investments, debt issuances and other transactions, including those provided as part of its ongoing operations that are triggered by, among other things, breaches of representations, warranties or covenants provided by Prudential Financial or its subsidiaries. These obligations are typically subject to various time limitations, defined by the contract or by operation of law, such as statutes of limitation. In some cases, the maximum potential obligation is subject to contractual limitations, while in other cases such limitations are not specified or applicable. Since certain of these obligations are not subject to limitations, it is not possible to determine the maximum potential amount due under these guarantees. At December 31, 2021, Prudential Financial has no accrued liabilities associated with other financial guarantees or indemnity arrangements.
|
Schedule III - Supplementary Insurance Information |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule III - Supplementary Insurance Information | PRUDENTIAL FINANCIAL, INC. Schedule III Supplementary Insurance Information As of and for the Year Ended December 31, 2021 (in millions)
PRUDENTIAL FINANCIAL, INC. Schedule III Supplementary Insurance Information As of and for the Year Ended December 31, 2020 (in millions)
PRUDENTIAL FINANCIAL, INC. Schedule III Supplementary Insurance Information As of and for the Year Ended December 31, 2019 (in millions)
__________ (1)Includes reclassification of “Assets held-for sale” for Deferred Policy Acquisition Costs of $(1,097) million and “Liabilities held-for-sale” for Future Policy Benefits, Losses, Claims, Expenses of $(4,505) million, and Other Policy Claims and Benefits Payable of $(11,750) million. See Note 1 for details of the assets and liabilities classified as “held-for-sale” as of December 31, 2021. (2)Includes reclassification of “Assets held-for sale” for Deferred Policy Acquisition Costs of $(100) million and “Liabilities held-for-sale” for Future Policy Benefits, Losses, Claims, Expenses of $(157) million, and Other Policy Claims and Benefits Payable of $(28,164) million. See Note 1 for details of the assets and liabilities classified as “held-for-sale” as of December 31, 2021. (3)Effective third quarter of 2021, the company is reporting the assets and liabilities of the Full Service Retirement business as "held-for-sale" and has transferred the results of this business to divested and Run-off Businesses within Corporate and Other operations. Prior period amounts have been updated to conform to current period presentation. See Note 1 for additional information. (4)Effective second quarter of 2020, the carrying amount of assets of POK are excluded from the International Businesses and are included in the Divested and Run-off Businesses in Corporate and Other. Effective third quarter of 2020, the carrying amount of assets of POT are excluded from the International Businesses and are included in the Divested and Run-off Businesses in Corporate and Other. Prior period amounts have been updated to conform to current period presentation. See Note 1 for additional information.
|
Schedule IV - Reinsurance |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule IV - Reinsurance | PRUDENTIAL FINANCIAL, INC. Schedule IV Reinsurance As of and For the Years Ended December 31, 2021, 2020 and 2019 ($ in millions)
|
Significant Accounting Policies and Pronouncements (Policies) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accounting Policies [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Basis of Presentation | Basis of Presentation The Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”). The Consolidated Financial Statements include the accounts of Prudential Financial, entities over which the Company exercises control, including majority-owned subsidiaries and minority-owned entities such as limited partnerships in which the Company is the general partner and variable interest entities (“VIEs”) in which the Company is considered the primary beneficiary. See Note 4 for additional information on the Company’s consolidated variable interest entities. Intercompany balances and transactions have been eliminated.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Use of Estimates | Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The most significant estimates include those used in determining deferred policy acquisition costs (“DAC”) and related amortization; policyholders’ account balances related to the fair value of embedded derivative instruments associated with the index-linked features of certain universal life and annuity products; value of business acquired (“VOBA”) and its amortization; amortization of deferred sales inducements (“DSI”); measurement of goodwill and any related impairment; valuation of investments including derivatives, measurement of allowance for credit losses, and the recognition of other-than-temporary impairments (“OTTI”); future policy benefits including guarantees; pension and other postretirement benefits; provision for income taxes and valuation of deferred tax assets; and accruals for contingent liabilities, including estimates for losses in connection with unresolved legal and regulatory matters.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reclassifications | Reclassifications Certain amounts in prior periods have been reclassified to conform to the current period presentation.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investments and Investment-Related Liabilities | Fixed maturities, available-for-sale, at fair value (“AFS debt securities”) includes bonds, notes and redeemable preferred stock that are carried at fair value. See Note 6 for additional information regarding the determination of fair value. The purchased cost of fixed maturities is adjusted for amortization of premiums and accretion of discounts to maturity or, if applicable, call date. AFS debt securities, where fair value is below amortized cost, are reviewed quarterly to determine whether the amortized cost basis of the security is recoverable. For mortgage-backed and asset-backed AFS debt securities, a credit impairment will be recognized in earnings as an allowance for credit losses and reported in “Realized investment gains (losses), net,” to the extent the amortized cost exceeds the net present value of projected future cash flows (the “net present value”) for the security. For all other AFS debt securities, qualitative factors are first considered including, but not limited to, the extent of the decline and the reasons for the decline in value (e.g., credit events, currency or interest-rate related, including general credit spread widening), and the financial condition of the issuer. If analysis of these qualitative factors results in the security needing to be impaired, a credit impairment will be recognized in earnings as an allowance for credit losses and reported in “Realized investment gains (losses), net,” to the extent the amortized cost exceeds the net present value of projected future cash flows (the “net present value”) for the security. A credit impairment recorded cannot exceed the difference between the amortized cost and fair value of the respective security. The net present value used to measure a credit impairment is calculated by discounting the Company’s best estimate of projected future cash flows at the effective interest rate implicit in the AFS debt security at the date of acquisition. Once the Company has deemed all or a portion of the amortized cost uncollectible, the allowance is removed from the balance sheet by writing down the amortized cost basis of the AFS debt security. Any amount of an AFS debt security’s change in fair value not recorded as an allowance for credit losses will be recorded in Other Comprehensive Income (loss) (“OCI”). When an AFS debt security’s fair value is below amortized cost and the Company has the intent to sell the AFS debt security, or it is more likely than not the Company will be required to sell the AFS debt security before its anticipated recovery, the amortized cost basis of the AFS debt security is written down to fair value and any previously recognized allowance is reversed. The write-down is reported in “Realized investment gains (losses), net.” Interest income, including amortization of premium and accretion of discount, are included in “Net investment income” under the effective yield method. Prepayment premiums are also included in “Net investment income.” For high credit quality mortgage-backed and asset-backed AFS debt securities (those rated AA or above), the amortized cost and effective yield of the securities are adjusted as necessary to reflect historical prepayment experience and changes in estimated future prepayments. The adjustments to amortized cost are recorded as a charge or credit to “Net investment income” in accordance with the retrospective method. For mortgage-backed and asset-backed AFS debt securities rated below AA, the effective yield is adjusted prospectively for any changes in the estimated timing and amount of cash flows unless the investment is purchased with credit deterioration or an allowance is currently recorded for the respective security. If an investment is impaired, any changes in the estimated timing and amount of cash flows will be recorded as the credit impairment, as opposed to a yield adjustment. If the asset is purchased with credit deterioration (or previously impaired), the effective yield will be adjusted if there are favorable changes in cash flows subsequent to the allowance being reduced to zero. For mortgage-backed and asset-backed AFS debt securities, cash flow estimates consider the payment terms of the underlying assets backing a particular security, including interest rate and prepayment assumptions based on data from widely accepted third-party data sources or internal estimates. In addition to interest rate and prepayment assumptions, cash flow estimates also include other assumptions regarding the underlying collateral including default rates and recoveries, which vary based on the asset type and geographic location, as well as the vintage year of the security. These assumptions can significantly impact income recognition, unrealized gains and loss recorded in OCI, and the amount of impairment recognized in earnings. The payment priority of the respective security is also considered. For all other AFS debt securities, cash flow estimates are driven by assumptions regarding probability of default and estimates regarding timing and amount of recoveries associated with a default. The Company has developed these estimates using information based on its historical experience as well as using market observable data, such as industry analyst reports and forecasts, sector credit ratings and other data relevant to the collectability of a security, such as the general payment terms of the security and the security’s position within the capital structure of the issuer. The associated unrealized gains and losses, net of tax, and the effect on DAC, VOBA, DSI, future policy benefits, policyholders’ account balances and policyholders’ dividends that would result from the realization of unrealized gains and losses, are included in “Accumulated other comprehensive income (loss)” (“AOCI”). Each of these balances is discussed in greater detail below. Fixed maturities, held-to-maturity, at amortized cost includes bonds that the Company has both the positive intent and ability to hold to maturity, and are carried at amortized cost, net of the current expected credit loss (“CECL”) allowance (“HTM debt securities”). Interest income for HTM debt securities is computed in the same manner as interest income for AFS debt securities. Credit impairment for HTM debt securities is recorded through a CECL allowance. The CECL allowance is generally determined based on probability of default and loss given default assumptions according to sector, credit quality and remaining time to maturity. Changes in the allowance are reported in “Realized investment gains (losses), net.” Once the Company has deemed all or a portion of the amortized cost uncollectible, the uncollectible portion of the allowance is removed from the balance sheet by writing down the amortized cost basis of the security. The CECL allowance represents the Company’s best estimate of expected credit losses over the remaining life of the assets. The determination of the allowance considers historical credit loss experience, current conditions, and reasonable and supportable forecasts. The allowance is calculated separately for each HTM debt security. Key inputs to the CECL model include unpaid principal balances, credit ratings, annual expected loss factors, average life adjusted for prepayment considerations, current and historical interest rate assumptions, and other factors influencing the Company’s view of the current stage of the economic cycle and future economic conditions. Subjective considerations include a review of whether historical loss experience is representative of current market conditions and the Company’s view of the credit cycle. Model assumptions and factors are reviewed and updated as appropriate. Fixed maturities, trading, at fair value consists of fixed maturities with embedded features that are considered derivatives and assets contained within consolidated variable interest entities. Realized and unrealized gains and losses on these investments are reported in “Other income (loss),” and interest and dividend income from these investments is reported in “Net investment income.” Assets supporting experience-rated contractholder liabilities, at fair value includes invested assets that consist of fixed maturities, equity securities, short-term investments and cash equivalents, that support certain products which are experience-rated, meaning that the investment results associated with these products are expected to ultimately accrue to contractholders. Realized and unrealized gains and losses for these investments are reported in “Other income (loss).” Interest and dividend income from these investments is reported in “Net investment income.” Equity securities, at fair value is comprised of common stock, mutual fund shares and non-redeemable preferred stock carried at fair value. Realized and unrealized gains and losses on these investments are reported in “Other income (loss),” and dividend income is reported in “Net investment income” on the ex-dividend date. Commercial mortgage and other loans consists of commercial mortgage loans, agricultural property loans, as well as certain other collateralized and uncollateralized loans. Uncollateralized loans primarily represent reverse dual currency loans and corporate loans held by the Company’s international insurance operations. Commercial mortgage and other loans originated and held for investment are generally carried at unpaid principal balance, net of unamortized deferred loan origination fees and expenses, and net of the CECL allowance. Certain off-balance sheet credit exposures (e.g., indemnification of serviced mortgage loans, and certain unfunded mortgage loan commitments where the Company cannot unconditionally cancel the commitment) are also subject to a CECL allowance. See Note 23 for additional information. The Company carries certain commercial mortgage loans originated within the Company’s commercial mortgage operations at fair value where the fair value option has been elected. Loans held for sale where the Company has not elected the fair value option are carried at the lower of cost or fair value. Commercial mortgage and other loans acquired, including those related to the acquisition of a business, are recorded at fair value when purchased, reflecting any premiums or discounts to unpaid principal balances. Interest income, and the amortization of the related premiums or discounts, are included in “Net investment income” under the effective yield method. Prepayment fees are also included in “Net investment income.” Effective January 1, 2020, the Company adopted ASU 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, and related ASUs, using a modified retrospective method for certain financial assets carried at amortized cost and certain off-balance sheet exposures. Adoption of these ASUs requires an entity to estimate lifetime credit losses for certain financial assets carried at amortized cost and certain off-balance sheet exposures based on relevant information about past events, current conditions, and reasonable and supportable forecasts that may affect the collectability of reported amounts. The most significant impact is that modifications made to the Company’s process for measuring credit losses for its commercial mortgage and other loans class classified as held for investment. The impact of the standard resulted in a decrease to “Total assets” of $122 million ($115 million of this decrease was recorded for commercial mortgage and other loans), a decrease to “Total liabilities” of $23 million, and a decreased to “Retained earnings” of $99 million upon adoption on January 1, 2020. The CECL allowance represents the Company’s best estimate of expected credit losses over the remaining life of the assets or off-balance sheet credit exposures. The determination of the allowance considers historical credit loss experience, current conditions, and reasonable and supportable forecasts. Prior to the adoption of ASU 2016-13, the allowance was based upon credit losses that were probable of occurring for recognized loans, not an estimate of credit losses that may occur over the remaining life of the asset. The allowance is calculated separately for commercial mortgage loans, agricultural mortgage loans, and other collateralized and uncollateralized loans. For commercial mortgage and agricultural mortgage loans, the allowance is calculated using an internally developed CECL model that pools together loans that share similar risk characteristics. Similar risk characteristics used to create the pools include, but are not limited to, vintage, maturity, credit rating, and collateral type. Key inputs to the CECL model include unpaid principal balances, internal credit ratings, annual expected loss factors, average lives of the loans adjusted for prepayment considerations, current and historical interest rate assumptions, and other factors influencing the Company’s view of the current stage of the economic cycle and future economic conditions. Subjective considerations include a review of whether historical loss experience is representative of current market conditions and the Company’s view of the credit cycle. Model assumptions and factors are reviewed and updated as appropriate. Information about certain key inputs is detailed below. Key factors in determining the internal credit ratings for commercial mortgage and agricultural mortgage loans include loan-to-value and debt-service-coverage ratios. Other factors include amortization, loan term, and estimated market value growth rate and volatility for the property type and region. The loan-to-value ratio compares the carrying amount of the loan to the fair value of the underlying property or properties collateralizing the loan, and is commonly expressed as a percentage. Loan-to-value ratios greater than 100% indicate that the carrying amount of the loan exceeds the collateral value. A loan-to-value ratio less than 100% indicates an excess of collateral value over the carrying amount of the loan. The debt service coverage ratio is a property’s net operating income as a percentage of its debt service payments. Debt service coverage ratios less than 1.0 indicates that property operations do not generate enough income to cover the loan’s current debt payments. A debt service coverage ratio greater than 1.0 indicates an excess of net operating income over the debt service payments. The values utilized in calculating these ratios are developed as part of the Company’s periodic review of the commercial mortgage loan and agricultural property loan portfolios, which includes an internal appraisal of the underlying collateral value. The Company’s periodic review also includes a quality re-rating process, whereby the internal quality rating originally assigned at underwriting is updated based on current loan, property and market information using a proprietary quality rating system. See Note 3 for additional information related to the loan-to-value ratios and debt service coverage ratios related to the Company’s commercial mortgage and agricultural loan portfolios. Annual expected loss rates are based on historical default and loss experience factors. Using average lives, the annual expected loss rates are converted into life-of-loan loss expectations. When individual loans no longer have the credit risk characteristics of the commercial or agricultural mortgage loan pools, they are removed from the pools and are evaluated individually for an allowance. The allowance is determined based on the outstanding loan balance less the present value of expected future cash flows discounted at the loan’s effective interest rate or the fair value of the collateral if the loan is collateral dependent. The CECL allowance on commercial mortgage and other loans can increase or decrease from period to period based on the factors noted above. The change in allowance is reported in “Realized investment gains (losses), net.” As it relates to unfunded commitments that are in scope of this guidance, the CECL allowance is reported in “Other liabilities,” and the change in the allowance is reported in “Realized investment gains (losses), net.” The CECL allowance for other collateralized and uncollateralized loans (e.g., corporate loans) carried at amortized cost is determined based on probability of default and loss given default assumptions by sector, credit quality and average lives of the loans. Additions to, or releases of, the allowance are reported in “Realized investment gains (losses), net.” Once the Company has deemed a portion of the amortized cost to be uncollectible, the uncollectible portion of allowance is removed from the balance sheet by writing down the amortized cost basis of the loan. The carrying amount of the loan is not adjusted for subsequent recoveries in value. Interest received on loans that are past due is either applied against the principal or reported as net investment income based on the Company’s assessment as to the collectability of the principal. The Company defines “past due” as principal or interest not collected at least 30 days past the scheduled contractual due date. See Note 3 for additional information about the Company’s past due loans. The Company discontinues accruing interest on loans after the loans become 90 days delinquent as to principal or interest payments, or earlier when the Company has doubts about collectability. When the Company discontinues accruing interest on a loan, any accrued but uncollectible interest on the loan and other loans backed by the same collateral, if any, is charged against interest income in the same period. Generally, a loan is restored to accrual status only after all delinquent interest and principal are brought current and, in the case of loans where the payment of interest has been interrupted for a substantial period, or the loan has been modified, a regular payment performance has been established. Commercial mortgage and other loans are occasionally restructured in a troubled debt restructuring (“TDR”). These restructurings generally include one or more of the following: full or partial payoffs outside of the original contract terms; changes to interest rates; extensions of maturity; or additions or modifications to covenants. Additionally, the Company may accept assets in full or partial satisfaction of the debt as part of a TDR. When restructurings occur, they are evaluated individually to determine whether the restructuring or modification constitutes a TDR as defined by authoritative accounting guidance. If the borrower is experiencing financial difficulty and the Company has granted a concession, the restructuring, including those that involve a partial payoff or the receipt of assets in full satisfaction of the debt is deemed to be a TDR. When there is a reasonable expectation that the Company will execute a TDR, all effects of the potential restructuring are considered for the estimation of the CECL allowance. When a loan is modified in a TDR, the CECL allowance of the loan is remeasured using the modified terms and the loan’s original effective yield, and the allowance is adjusted accordingly. The loan will be evaluated to determine whether the loan no longer has similar credit risk characteristics of the commercial or agricultural mortgage loan pools and need to be evaluated for an allowance on an individual basis. Subsequent to the modification, income is recognized prospectively based on the modified terms of the loan. In a TDR where the Company receives assets in full satisfaction of the debt, any CECL allowance is reversed and a direct write-down of the loan is recorded for the amount of the allowance, and any additional loss, net of recoveries, or any gain is recorded for the difference between the fair value of the assets received and the recorded investment in the loan. When assets are received in partial settlement, the same process is followed, and the remaining loan is evaluated prospectively for credit impairment based on the CECL allowance process noted above. The Company’s PGIM business provides commercial mortgage origination, underwriting and servicing for certain government sponsored entities (“GSEs”). The Company has agreed to indemnify the GSEs for a portion of the credit risk associated with certain of the mortgages it services. Management has established a CECL allowance that factors in historical loss information, current conditions and reasonable and supportable forecasts. The allowance also considers the remaining lives of the loans subject to the indemnification. The CECL allowance is included in “Other liabilities” and changes in the CECL allowance are reported in “Realized investment gains (losses), net.” See Note 23 for additional information. Prior to the adoption of ASU 2016-13, a credit loss allowance was not required. Policy loans represents funds loaned to policyholders up to the cash surrender value of the associated insurance policies and are carried at the unpaid principal balances due to the Company from the policyholders. Interest income on policy loans is recognized in “Net investment income” at the contract interest rate when earned. Policy loans are fully collateralized by the cash surrender value of the associated insurance policies. Other invested assets consists of the Company’s non-coupon investments in limited partnerships and limited liability companies (“LPs/LLCs”), other than operating joint ventures, as well as wholly-owned investment real estate, derivative assets and other investments. LPs/LLCs interests are accounted for using either the equity method of accounting, or at fair value with changes in fair value reported in “Other income (loss).” The Company’s income from investments in LPs/LLCs accounted for using the equity method, other than the Company’s investments in operating joint ventures, is included in “Net investment income.” The carrying value of these investments is written down, or impaired, to fair value when a decline in value is considered to be other-than-temporary. In applying the equity method (including assessment for OTTI), the Company uses financial information provided by the investee, generally on a one to three-month lag. The Company consolidates LPs/LLCs in certain other instances where it is deemed to exercise control, or is considered the primary beneficiary of a variable interest entity. See Note 4 for additional information about VIEs. The Company’s wholly-owned investment real estate consists of real estate which the Company has the intent to hold for the production of income as well as real estate held for sale. Real estate which the Company has the intent to hold for the production of income is carried at depreciated cost less any write-downs to fair value for impairment losses and is reviewed for impairment whenever events or circumstances indicate that the carrying value may not be recoverable. Real estate held for sale is carried at the lower of depreciated cost or fair value less estimated selling costs and is not further depreciated once classified as such. An impairment loss is recognized when the carrying value of the investment real estate exceeds the estimated undiscounted future cash flows (excluding interest charges) from the investment. At that time, the carrying value of the investment real estate is written down to fair value. Decreases in the carrying value of investment real estate held for the production of income due to OTTI are recorded in “Realized investment gains (losses), net.” Depreciation on real estate held for the production of income is computed using the straight-line method over the estimated useful lives of the properties and is included in “Net investment income.” Short-term investments primarily consists of highly liquid debt instruments with a maturity of twelve months or less and greater than three months when purchased, other than those debt instruments meeting this definition that are included in “Assets supporting experience-rated contractholder liabilities, at fair value.” These investments are generally carried at fair value or amortized cost that approximates fair value and include certain money market investments, funds managed similar to regulated money market funds, short-term debt securities issued by government-sponsored entities and other highly liquid debt instruments.Accrued investment income primarily includes accruals of interest and dividend income from investments that have been earned but not yet received.Notes issued by consolidated variable interest entities represents notes issued by certain asset-backed investment vehicles, primarily collateralized loan obligations (“CLOs”), which the Company is required to consolidate. The creditors of these VIEs do not have recourse to the Company in excess of the assets contained within the VIEs. The Company has elected the fair value option for the majority of these notes, and has based the fair value on the corresponding bank loan collateral. Changes in fair value are reported in “Other income (loss).”
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cash and Cash Equivalents | Cash and cash equivalents includes cash on hand, amounts due from banks, certain money market investments, funds managed similar to regulated money market funds, other debt instruments with maturities of three months or less when purchased, other than cash equivalents that are included in “Assets supporting experience-rated contractholder liabilities, at fair value,” and receivables related to securities purchased under agreements to resell (see also “Securities sold under agreements to repurchase” below). These assets are generally carried at fair value or amortized cost which approximates fair value. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
DAC | Deferred policy acquisition costs represent costs directly related to the successful acquisition of new and renewal insurance and annuity business that have been deferred to the extent such costs are deemed recoverable from future profits. Such DAC primarily includes commissions, costs of policy issuance and underwriting, and certain other expenses that are directly related to successfully acquired contracts. In each reporting period, capitalized DAC is amortized to “Amortization of DAC,” net of the accrual of imputed interest on DAC balances. DAC is subject to periodic recoverability testing. DAC, for applicable products, is adjusted for the impact of unrealized gains or losses on investments as if these gains or losses had been realized, with corresponding credits or charges included in AOCI. For traditional participating life insurance which are included in the Closed Block, DAC is amortized over the expected life of the contracts in proportion to gross margins based on historical and anticipated future experience. Any changes in estimated gross margins on unamortized DAC are reflected in the period such that estimated gross margins are revised on a retrospective basis. DAC related to non-participating traditional individual life insurance and longevity reinsurance contracts is amortized in proportion to gross premiums. DAC related to universal and variable life products and fixed and variable deferred annuity products are generally deferred and amortized over the expected life of the contracts in proportion to gross profits arising principally from investment margins, mortality and expense margins, and surrender charges, based on historical and anticipated future experience, which is updated periodically. The Company uses a reversion to the mean approach for equities to derive future equity return assumptions; however, if the projected equity return calculated using this approach is greater than the maximum equity return assumption, the maximum equity return is utilized, and if the projected equity return is negative, the return is floored at 0%. Gross profits also include impacts from the embedded derivatives associated with certain of the optional living benefit features of variable annuity contracts, and index-linked crediting features of certain universal life and annuity contracts and related hedging activities. Total gross profits include both actual gross profits and estimates of gross profits for future periods. The Company regularly evaluates and adjusts DAC balances with a corresponding charge or credit to current period earnings, representing a cumulative adjustment to all prior periods’ amortization, for the impact of actual gross profits and changes in the Company’s projections of estimated future gross profits. Adjustments to DAC balances result from: (i) the annual review of assumptions that reflect the comprehensive review of the assumptions used in estimating gross profits for future periods; (ii) quarterly adjustments for current period experience (also referred to as “experience true-up” adjustments) that reflect the impact of differences between actual gross profits for a given period and the previously estimated expected gross profits for that period; and (iii) quarterly adjustments for market performance (also referred to as “experience unlocking”) that reflect the impact of changes to the Company’s estimate of total gross profits to reflect actual fund performance and market conditions. For group annuity contracts (other than single premium group annuities), acquisition costs are generally deferred and amortized over the expected life of the contracts in proportion to gross profits. For group corporate-, bank- and trust-owned life insurance contracts, acquisition costs are generally deferred and amortized in proportion to lives insured. For single premium immediate annuities with life contingencies, single premium group annuities, including non-participating group annuity contracts, and single premium structured settlements with life contingencies, all acquisition costs are charged to expense immediately because generally all premiums are recognized as revenue at the inception of the contract. For funding agreement notes contracts, single premium structured settlement contracts without life contingencies, and single premium immediate annuities without life contingencies, acquisition expenses are deferred and amortized over the expected life of the contracts using the interest method. For other group life and disability insurance contracts and guaranteed investment contracts (“GICs”), acquisition costs are expensed as incurred. For some products, policyholders can elect to modify product benefits, features, rights or coverages by exchanging a contract for a new contract or by amendment, endorsement, or rider to a contract, or by the election of a feature or coverage within a contract. These transactions are known as internal replacements. If policyholders surrender traditional life insurance policies in exchange for life insurance policies that do not have fixed and guaranteed terms, the Company immediately charges to expense the remaining unamortized DAC on the surrendered policies. For other internal replacement transactions, except those that involve the addition of a nonintegrated contract feature that does not change the existing base contract, the unamortized DAC is immediately charged to expense if the terms of the new policies are not substantially similar to those of the former policies. If the new terms are substantially similar to those of the earlier policies, the DAC is retained with respect to the new policies and amortized over the expected life of the new policies. See Note 7 for additional information regarding DAC.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
VOBA | Value of business acquired represents identifiable intangible assets to which a portion of the purchase price in a business acquisition is attributed under the application of purchase accounting. VOBA represents an adjustment to the stated value of in-force insurance contract liabilities to present them at fair value, determined as of the acquisition date. VOBA balances are subject to recoverability testing, in the manner in which they were acquired. The Company has established a VOBA asset primarily for its acquired life insurance products, accident and health products with fixed benefits, deferred annuity contracts, and defined contribution and defined benefit businesses. As of December 31, 2021, the majority of the VOBA balance relates to the 2011 acquisition of AIG Star Life Insurance Co., Ltd, AIG Edison Life Insurance Company, and AIG Financial Assurance Japan K.K. and AIG Edison Service Co., Ltd. (collectively, the “Star and Edison Businesses”.) The Company amortizes VOBA over the anticipated life of the acquired contracts using the same methodology and assumptions used to amortize DAC. The Company records amortization of VOBA in “General and administrative expenses.” VOBA, for applicable products, is adjusted for the impact of unrealized gains or losses on investments as if these gains or losses had been realized, with corresponding credits or charges included in AOCI. See Note 8 for additional information regarding VOBA. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Assets and Liabilities held-for-sale | Assets held-for-sale consists of assets associated with pending business dispositions. The Company classifies a business as held-for-sale when management has approved or received approval from the Board to sell the business, the sale is probable to be completed within a year and certain other specified criteria are met. The business classified as held-for-sale is recorded at the lower of carrying value or estimated fair value, less costs to sell. If the carrying value of the business exceeds its estimated fair value, less costs to sell, a loss is recognized and reported in “Other income (loss)” when the criteria for the held-for-sale classification as described above are met. If the estimated fair value, less costs to sell, exceeds the carrying value of the business, the gain is recorded in “Other income (loss)” when the sale is completed. See Note 1 for additional information on the pending business dispositions classified as held-for-sale, including the composition of assets included as “Assets held-for-sale".Liabilities held-for-sale consists of liabilities associated with pending business dispositions. See “Assets held-for-sale" above for further description of the held-for-sale classification. See Note 1 for additional information on the pending business dispositions, including the composition of liabilities included as “Liabilities held-for-sale”. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Assets and Other Liabilities | Other assets consists primarily of prepaid pension benefit costs (see Note 18), certain restricted assets (e.g., cash and cash equivalents), trade receivables, goodwill and other intangible assets, “right-of-use” lease assets (see “Other liabilities” below), DSI, the Company’s investments in operating joint ventures, property and equipment, reinsurance recoverables (see “Reinsurance” below), and receivables resulting from sales of securities that had not yet settled at the balance sheet date. Trade receivables primarily relate to Assurance IQ and are reported net of the CECL allowance. The CECL allowance considers the credit quality of the counterparties and is generally determined based on probability of default and loss given default assumptions. Additions to or releases of the allowance are reported in “General and administrative expenses.” Property and equipment are carried at cost less accumulated depreciation. Depreciation is determined using the straight-line method over the estimated useful lives of the related assets, which generally range from 3 to 40 years. As a result of certain acquisitions, the Company recognizes an asset for goodwill representing the excess of cost over the net fair value of the assets acquired and liabilities assumed. Goodwill is assigned to reporting units at the date the goodwill is initially recorded. A reporting unit is an operating segment, or a unit one level below the operating segment if discrete financial information is prepared and regularly reviewed by management at that level. Once goodwill has been assigned to reporting units, it no longer retains its association with a particular acquisition, and all of the activities within a reporting unit, whether acquired or organically grown, are available to support the value of the goodwill. The Company tests goodwill for impairment annually as of December 31 and more frequently if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying amount. Accounting guidance provides for an optional qualitative assessment for testing goodwill impairment that may allow companies to skip the quantitative test. As part of the annual goodwill impairment test, the Company estimates the fair value of the reporting units by applying the quantitative test, which involves comparing each reporting unit’s fair value to its carrying value including goodwill. If the fair value of a reporting unit exceeds its carrying value, the applicable goodwill is considered not to be impaired. If the carrying value exceeds fair value, goodwill is reduced and an impairment charge to income is recognized for the excess. The measurement of a goodwill impairment loss includes the related income tax effect from any tax deductible goodwill. The impairment loss cannot exceed the amount of goodwill assigned to a reporting unit, and the loss establishes a new basis in the goodwill. Subsequent reversal of goodwill impairment losses is not permitted. Management is required to make significant estimates in determining the fair value of a reporting unit including, but not limited to: projected revenues and operating margins, applicable discount and growth rates, and comparative market multiples. See Note 10 for additional information on goodwill, including the recorded impairment charge in 2021. The Company offered various types of sales inducements to policyholders related to fixed and variable deferred annuity contracts. The Company defers sales inducements and amortizes them over the expected life of the policy using the same methodology and assumptions used to amortize DAC. Sales inducement balances are subject to periodic recoverability testing. The Company records amortization of DSI in “Interest credited to policyholders’ account balances.” DSI, for applicable products, is adjusted for the impact of unrealized gains or losses on investments as if these gains or losses had been realized, with corresponding credits or charges included in AOCI. See Note 13 for additional information regarding sales inducements. Identifiable intangible assets primarily include customer relationships and mortgage servicing rights and are recorded net of accumulated amortization. The Company tests identifiable intangible assets for impairment on an annual basis as of December 31 of each year or whenever events or circumstances suggest that the carrying value of an identifiable intangible asset may exceed the sum of the undiscounted cash flows expected to result from its use and eventual disposition. If this condition exists and the carrying value of an identifiable intangible asset exceeds its fair value, the excess is recognized as an impairment and is recorded as a charge against net income. Measuring intangible assets requires the use of estimates. Significant estimates include the projected net cash flow attributable to the intangible asset and the rate at which future net cash flows are discounted for purposes of estimating fair value, as applicable. See Note 10 for additional information regarding identifiable intangible assets. Investments in operating joint ventures are generally accounted for under the equity method. The carrying value of these investments is written down, or impaired, to fair value when a decline in value is considered to be other-than-temporary. See Note 9 for additional information on investments in operating joint ventures. Other liabilities consists primarily of trade payables, lease liabilities (see “Other assets” above), pension and other employee benefit liabilities (see Note 18), derivative liabilities (see “Derivative Financial Instruments” below), reinsurance payables (see “Reinsurance” below), and payables resulting from purchases of securities that had not yet settled at the balance sheet date.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Lessor, Leases | Leases are recorded on the balance sheet as “right-of-use” assets and lease liabilities within “Other assets” and “Other liabilities” respectively. Leases are classified as either operating or finance leases and lease expense is recognized within “General and administrative expenses.” As a lessee, for operating leases, total lease expense is recognized using a straight-line method. Finance leases are treated as the purchase of an asset on a financing basis. Additionally, as a lessor, for sales-type and direct financing leases, the Company derecognizes the carrying value of the leased asset that is considered to have been transferred to a lessee and records a lease receivable and residual asset (“receivable and residual” approach). See Note 11 for additional information regarding leases. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Lessee, Leases | Leases are recorded on the balance sheet as “right-of-use” assets and lease liabilities within “Other assets” and “Other liabilities” respectively. Leases are classified as either operating or finance leases and lease expense is recognized within “General and administrative expenses.” As a lessee, for operating leases, total lease expense is recognized using a straight-line method. Finance leases are treated as the purchase of an asset on a financing basis. Additionally, as a lessor, for sales-type and direct financing leases, the Company derecognizes the carrying value of the leased asset that is considered to have been transferred to a lessee and records a lease receivable and residual asset (“receivable and residual” approach). See Note 11 for additional information regarding leases. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Separate Account Assets and Liabilities | Separate account assets represents segregated funds that are invested for certain policyholders, pension funds and other customers. The assets consist primarily of equity securities, fixed maturities, real estate-related investments, real estate mortgage loans, short-term investments and derivative instruments and are reported at fair value. The assets of each account are legally segregated and are not subject to claims that arise out of any other business of the Company. Investment risks associated with market value changes are borne by the customers, except to the extent of minimum guarantees made by the Company with respect to certain accounts. The investment income and realized investment gains or losses from separate account assets generally accrue to the policyholders and are not included in the Company’s results of operations. Mortality, policy administration and surrender charges assessed against the accounts are included in “Policy charges and fee income.” Asset management fees charged to the accounts are included in “Asset management and service fees.” Seed money that the Company invests in separate accounts is reported in the appropriate general account asset line. Investment income and realized investment gains or losses from seed money invested in separate accounts accrue to the Company and are included in the Company’s results of operations. See Note 13 for additional information regarding separate account arrangements with contractual guarantees. See also “Separate account liabilities” below. Separate account liabilities primarily represents the contractholders’ account balances in separate account assets and to a lesser extent borrowings of the separate account, and will be equal and offsetting to total separate account assets. See also “Separate account assets” above. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Future Policy Benefits | Future policy benefits represents liabilities that primarily consist of the present value of estimated future payments to or on behalf of policyholders, where the timing and amount of payment depends on policyholder mortality or morbidity, less the present value of future net premiums (the portion of the gross premium required to provide for all expected future benefits and expenses). For individual traditional participating life insurance products, the mortality and interest rate assumptions applied are those used to calculate the policies’ guaranteed cash surrender values. For life insurance, other than individual traditional participating life insurance, and annuity and disability products, expected mortality and morbidity are generally based on Company experience, industry data and/or other factors. Interest rate assumptions are based on factors such as market conditions and expected investment returns. Although mortality, morbidity and interest rate assumptions are “locked-in” upon the issuance of new insurance or annuity business with fixed and guaranteed terms, significant changes in experience or assumptions may require the Company to provide for expected future losses on a product by recognizing a premium deficiency. A premium deficiency exists when the liability for future policy benefits plus the present value of expected future gross premiums are determined to be insufficient to provide for expected future policy benefits and expenses. If a premium deficiency is recognized, the assumptions without a provision for the risk of adverse deviation as of the premium deficiency test date are locked-in and used in subsequent valuations. The net reserves continue to be subject to premium deficiency testing. In determining if a premium deficiency related to short-duration contracts exists, the Company considers, among other factors, anticipated investment income. Any adjustments to future policy benefit reserves related to net unrealized gains on securities classified as available-for-sale are included in AOCI. In certain instances, the policyholder liability for a particular line of business may not be deficient in the aggregate to trigger loss recognition, but the pattern of earnings may be such that profits are expected to be recognized in earlier years followed by losses in later years. In these situations, accounting standards require that an additional liability (Profits Followed by Losses or “PFL” liability) be recognized by an amount necessary to sufficiently offset the losses that would be recognized in later years. Historically, PFL liabilities have been predominantly associated with certain universal life contracts that measure GAAP reserves using a dynamic approach, and accordingly, are updated each quarter, using current in-force and market data, and as part of the annual assumption update, such that the liability as of each measurement date represents the Company’s current estimate of the present value of the amount necessary to offset anticipated future losses. See Note 12 for additional information regarding future policy benefits. The Company’s liability for future policy benefits also includes a liability for unpaid claims and claim adjustment expenses. The Company does not establish claim liabilities until a loss has been incurred. However, unpaid claims and claim adjustment expenses include estimates of claims that the Company believes have been incurred but have not yet been reported as of the balance sheet date. The Company’s liability for future policy benefits also includes net liabilities for guarantee benefits related to certain long-duration life and annuity contracts, which are discussed more fully in Note 13, and deferred profits.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Policyholders' Account Balances | Policyholders’ account balances represents the contract value that has accrued to the benefit of the policyholder as of the balance sheet date. This liability is primarily associated with the accumulated account deposits, plus interest credited, less policyholder withdrawals and other charges assessed against the account balance, as applicable. These policyholders’ account balances also include provision for benefits under non-life contingent payout annuities and certain unearned revenues. See Note 12 for additional information regarding policyholders’ account balances. Policyholders’ account balances also include amounts representing the fair value of embedded derivative instruments associated with the index-linked features of certain universal life and annuity products. For additional information regarding the valuation of these embedded derivatives, see Note 6. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Policyholders' Dividends | Policyholders’ dividends includes dividends payable to policyholders and the policyholder dividend obligation associated with the participating policies included in the Closed Block. The dividends payable for participating policies included in the Closed Block are determined at the end of each year for the following year by the Board of Directors of The Prudential Insurance Company of America (“PICA”) based on its statutory results, capital position, ratings, and the emerging experience of the Closed Block. The policyholder dividend obligation represents amounts expected to be paid to Closed Block policyholders as an additional policyholder dividend unless otherwise offset by future Closed Block performance. Any adjustments to the policyholder dividend obligation related to net unrealized gains (losses) on securities classified as available-for-sale are included in AOCI. For additional information on the policyholder dividend obligation, see Note 15. The dividends payable for policies other than the participating policies included in the Closed Block include dividends payable in accordance with certain group and individual insurance policies. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Securities repurchase and resale agreements and securities loaned transactions | Securities sold under agreements to repurchase represents liabilities associated with securities repurchase agreements that are used primarily to earn spread income. As part of securities repurchase agreements, the Company transfers U.S. government and government agency securities to a third-party and receives cash as collateral. For securities repurchase agreements, the cash received is typically invested in cash equivalents, short-term investments or fixed maturities. Receivables associated with securities purchased under agreements to resell are generally reflected as cash equivalents. As part of securities resale agreements, the Company invests cash and receives as collateral U.S. government securities or other debt securities. Securities repurchase and resale agreements that satisfy certain criteria are treated as secured borrowing or secured lending arrangements. These agreements are carried at the amounts at which the securities will be subsequently resold or reacquired, as specified in the respective transactions. For securities purchased under agreements to resell, the Company’s policy is to take possession or control of the securities either directly or through a third-party custodian. These securities are valued daily and additional securities or cash collateral is received, or returned, when appropriate to protect against credit exposure. Securities to be resold are the same, or substantially the same, as the securities received. The majority of these transactions are with large brokerage firms and large banks. For securities sold under agreements to repurchase, the market value of the securities to be repurchased is monitored, and additional collateral is obtained where appropriate, to protect against credit exposure. The Company obtains collateral in an amount at least equal to 95% of the fair value of the securities sold. Securities to be repurchased are the same, or substantially the same, as those sold. The majority of these transactions are with highly rated money market funds. Income and expenses related to these transactions executed within the insurance companies used to earn spread income are reported as “Net investment income.” Cash collateral for loaned securities represents liabilities to return cash proceeds from security lending transactions. Securities lending transactions are used primarily to earn spread income. As part of securities lending transactions, the Company transfers U.S. and foreign debt and equity securities, as well as U.S. government and government agency securities, and receives cash as collateral. Cash proceeds from securities lending transactions are primarily used to earn spread income, and are typically invested in cash equivalents, short-term investments or fixed maturities. Securities lending transactions are treated as financing arrangements and are recorded at the amount of cash received. The Company obtains collateral in an amount equal to 102% and 105% of the fair value of the domestic and foreign securities, respectively. The Company monitors the market value of the securities loaned on a daily basis with additional collateral obtained as necessary. Substantially all of the Company’s securities lending transactions are with large brokerage firms and large banks. Income and expenses associated with securities lending transactions used to earn spread income are reported as “Net investment income.” The Company also enters into securities lending transactions where non-cash collateral, typically U.S. government, Japanese government, or other sovereign bonds are received. The collateral received is not reported on the Company’s Consolidated Statements of Financial Position. In these transactions, the Company receives a fee and obtains collateral in an amount equal to 102% to 105% of the fair value of the loaned securities. The Company monitors the market value of the securities loaned on a daily basis with additional collateral obtained as necessary. Substantially all of these transactions are with large brokerage firms and large banks. Income is reported as “Net investment income.”
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Income Taxes | Income taxes primarily represents the net deferred tax liability and the Company’s estimated taxes payable for the current year and open audit years. The Company and its includible domestic subsidiaries file a consolidated federal income tax return that includes both life insurance companies and non-life insurance companies. Subsidiaries operating outside the U.S. are taxed, and income tax expense is recorded, based on applicable foreign statutes. See Note 16 for a discussion of certain non-U.S. jurisdictions for which the Company assumes repatriation of earnings. Items required by tax regulations to be included in the tax return may differ from the items reflected in the financial statements. As a result, the effective tax rate reflected in the financial statements may be different than the actual rate applied on the tax return. Some of these differences are permanent such as expenses that are not deductible in the Company’s tax return, and some differences are temporary, reversing over time, such as valuation of insurance reserves. Temporary differences create deferred tax assets and liabilities. Deferred tax assets generally represent items that can be used as a tax deduction or credit in future years for which the Company has already recorded the tax benefit in the Company’s Consolidated Statements of Operations. Deferred tax liabilities generally represent tax expense recognized in the Company’s financial statements for which payment has been deferred, or expenditures for which the Company has already taken a deduction in the Company’s tax return but have not yet been recognized in the Company’s financial statements. Deferred income taxes are recognized, based on enacted rates, when assets and liabilities have different values for financial statement and tax reporting purposes. The application of U.S. GAAP requires the Company to evaluate the recoverability of the Company’s deferred tax assets and establish a valuation allowance if necessary to reduce the Company’s deferred tax assets to an amount that is more likely than not expected to be realized. Considerable judgment is required in determining whether a valuation allowance is necessary, and if so, the amount of such valuation allowance. See Note 16 for a discussion of factors considered when evaluating the need for a valuation allowance. The U.S. Tax Cuts and Jobs Act of 2017 (“Tax Act of 2017”) included two new tax provisions that could impact the Company’s effective tax rate and cash tax payments. The Base Erosion and Anti-Abuse Tax (“BEAT”) taxes modified taxable income, starting at a rate of 10% in 2019 and increasing to 12.5% in 2026, and is due if the calculated BEAT amount that is determined without the benefit of foreign and certain tax credits is greater than the regular corporate tax in any given year. In general, modified taxable income is calculated by adding back to a taxpayer’s regular taxable income the amount of certain “base erosion tax benefits” with respect to payments to foreign affiliates, as well as the “base erosion percentage” of any net operating loss deductions. Final Regulations confirmed that benefit and claim payments made by our U.S. insurance business to our foreign affiliates on reinsurance assumed by the U.S. affiliates are not base erosion payments. The Global Intangible Low-Taxed Income (“GILTI”) provision applies a minimum U.S. tax to earnings of consolidated foreign subsidiaries in excess of a 10% deemed return on tangible assets of foreign subsidiaries by imposing the U.S. tax rate to 50% of earnings of such foreign affiliates and provides for a partial foreign tax credit for foreign income taxes. The amount of tax in any period on GILTI can depend on annual differences between U.S. taxable income recognition rules and taxable income recognition rules in the country of operations and the overall taxable income of U.S. operations, as well as U.S. expense allocation rules which limit the amount of foreign tax credits that can be applied to reduce the U.S. tax on the GILTI provision. Under certain circumstances, the taxable income of U.S. operations may cause more than 50% of earnings of foreign affiliates to be subject to the GILTI provision. In years that the PFI consolidated federal income tax return reports a net operating loss or has a loss attributable to U.S. sources of operations, the GILTI provision would cause a loss of U.S. tax benefits for some or all of those losses, effectively increasing the tax on foreign earnings. The Company accounts for the effects of the BEAT and GILTI provisions as a period cost if and when incurred. U.S. GAAP prescribes a comprehensive model for how a company should recognize, measure, present, and disclose in its financial statements uncertain tax positions that a company has taken or expects to take on tax returns. The application of this guidance is a two-step process. First, the Company determines whether it is more likely than not, based on the technical merits, that the tax position will be sustained upon examination. If a tax position does not meet the more likely than not recognition threshold, the benefit of that position is not recognized in the financial statements. The second step is measurement. The Company measures the tax position as the largest amount of benefit that is greater than 50 percent likely to be realized upon ultimate resolution with a taxing authority that has full knowledge of all relevant information. This measurement considers the amounts and probabilities of the outcomes that could be realized upon ultimate settlement using the facts, circumstances, and information available at the reporting date. The Company’s liability for income taxes includes a liability for unrecognized tax benefits, interest and penalties which relate to tax years still subject to review by the Internal Revenue Service (“IRS”) or other taxing jurisdictions. Audit periods remain open for review until the statute of limitations has passed. Generally, for tax years which produce net operating losses, capital losses or tax credit carryforwards (“tax attributes”), the statute of limitations does not close, to the extent of these tax attributes, until the expiration of the statute of limitations for the tax year in which they are fully utilized. The completion of review or the expiration of the statute of limitations for a given audit period could result in an adjustment to the liability for income taxes. The Company classifies all interest and penalties related to tax uncertainties as income tax expense. See Note 16 for additional information regarding income taxes.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Short-Term and Long-Term Debt | Short-term and long-term debt liabilities are primarily carried at an amount equal to unpaid principal balance, net of unamortized discount or premium and debt issue costs. Original-issue discount or premium and debt-issue costs are recognized as a component of interest expense over the period the debt is expected to be outstanding, using the interest method of amortization. Interest expense is generally presented within “General and administrative expenses” in the Company’s Consolidated Statements of Operations. Interest expense may also be reported within “Net investment income” for certain activity, as prescribed by specialized industry guidance. Short-term debt is debt coming due in the next twelve months, including that portion of debt otherwise classified as long-term. The short-term debt caption may exclude short-term debt items for which the Company has the intent and ability to refinance on a long-term basis in the near-term. See Note 17 for additional information regarding short-term and long-term debt. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Contingent Liabilities | Commitments and contingent liabilities are accrued if it is probable that a liability has been incurred and an amount is reasonably estimable. Management evaluates whether there are incremental legal or other costs directly associated with the ultimate resolution of the matter that are reasonably estimable and, if so, they are included in the accrual. These accruals are generally reported in “Other liabilities.” | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Insurance Revenue and Expense Recognition | Insurance Revenue and Expense Recognition Premiums from individual life products (other than universal and variable life contracts), as well as health insurance and long-term care products are recognized when due. When premiums are due over a significantly shorter period than the period over which benefits are provided, any gross premium in excess of the net premium is generally deferred and recognized into revenue in a constant relationship to insurance in force. Benefits are recorded as an expense when they are incurred. A liability for future policy benefits is recorded when premiums are recognized using the net level premium valuation methodology. Premiums from non-participating group annuities with life contingencies, single premium structured settlements with life contingencies and single premium immediate annuities with life contingencies are recognized when due. When premiums are due over a significantly shorter period than the period over which benefits are provided, any gross premium in excess of the net premium is generally deferred and recognized into revenue based on expected future benefit payments. Benefits are recorded as an expense when they are incurred. A liability for future policy benefits is recorded when premiums are recognized using the net level premium valuation methodology. Certain individual annuity contracts provide the contractholder a guarantee that the benefit received upon death or annuitization will be no less than a minimum prescribed amount. These benefits are accounted for as insurance contracts. The Company also provides contracts with certain living benefits which are considered embedded derivatives. See Note 13 for additional information regarding these contracts and Note 6 for information regarding the valuation of these embedded derivatives. Amounts received as payment for universal or variable group and individual life contracts, deferred fixed or variable annuities, structured settlements and other contracts without life contingencies, and participating group annuities are reported as deposits to “Policyholders’ account balances” and/or “Separate account liabilities.” Revenues from these contracts are reflected in “Policy charges and fee income” consisting primarily of fees assessed during the period against the policyholders’ account balances for mortality and other benefit charges, policy administration charges and surrender charges. In addition to fees, the Company earns investment income from the investment of deposits in the Company’s general account portfolio. Fees assessed that represent compensation to the Company for services to be provided in future periods and certain other fees are generally deferred and amortized into revenue over the life of the related contracts in proportion to estimated gross profits. Benefits and expenses for these products include claims in excess of related account balances, expenses of contract administration, interest credited to policyholders’ account balances and amortization of DAC, DSI and VOBA. Policyholders’ account balances also include amounts representing the fair value of embedded derivative instruments associated with the index-linked features of certain universal life and annuity products where changes in the value of the embedded derivatives are recorded though “Realized investment gains (losses), net”. For additional information regarding the valuation of these embedded derivatives, see Note 6. For group life (other than universal and variable group life contracts) and disability insurance, premiums are generally recognized over the period to which the premiums relate in proportion to the amount of insurance protection provided. Claim and claim adjustment expenses are recognized when incurred.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Asset Management and Service Fees | Asset management and service fees principally includes asset-based asset management fees, which are recognized in the period in which the services are performed. In certain asset management fee arrangements, the Company is entitled to receive performance-based incentive fees when the return on assets under management exceeds certain benchmark returns or other performance targets. The Company may be required to return all, or part, of such performance-based incentive fees depending on future performance of these assets relative to performance benchmarks. The Company records performance-based incentive fee revenue when the contractual terms of the asset management fee arrangement have been satisfied and it is probable that a significant reversal in the amount of the fee will not occur. Under this principle the Company records a deferred performance-based incentive fee liability to the extent it receives cash related to the performance-based incentive fee prior to meeting the revenue recognition criteria delineated above. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Income | Other income (loss) includes realized and unrealized gains or losses from investments classified “Fixed maturities, trading, at fair value,” “Assets supporting experience-rated contractholder liabilities, at fair value,” “Equity securities, at fair value,” and “Other invested assets” that are measured at fair value and consolidated entities that follow specialized investment company fair value accounting. “Other income (loss)” also includes gains and losses primarily related to the remeasurement of foreign currency denominated assets and liabilities, as discussed in more detail under “Foreign Currency” below. Additionally, for digital insurance brokerage placement services provided by Assurance IQ, the Company earns both initial and renewal commissions as compensation for the placement of insurance policies with insurance carriers. At the effective date of the policy, the Company records within “Other income (loss)” the expected lifetime revenue for the initial and renewal commissions considering estimates of the timing of future policy cancellations. These estimates are reassessed each reporting period and any changes in estimates are reflected in the current period. Realized investment gains (losses), net includes realized gains or losses from sales and maturities of investments, changes to the allowance for credit losses, other impairments, fair value changes on mortgage loans where the fair value option has been elected, and derivative gains or losses. The derivative gains or losses include the impact of maturities, terminations and changes in fair value of the derivative instruments, including embedded derivatives, and other hedging instruments. Realized investment gains (losses) from the sales of securities are generally calculated using the specific identification method, with the exception of some of the Company’s International Businesses portfolios where the average cost method is used.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-Based Payments | Share-Based Payments The Company applies the fair value-based measurement method in accounting for share-based payment transactions with employees except for equity instruments held by employee share ownership plans. Excess tax benefits (deficits) are recorded in earnings and represent the cumulative difference between the actual tax benefit realized and the amount of deferred tax assets recorded attributable to shared-based payment transactions. The Company accounts for non-employee stock options using the fair value method in accordance with authoritative guidance and related interpretations on accounting for equity instruments that are issued to other than employees for acquiring, or in conjunction with selling, goods or services.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share | Earnings Per Share Earnings per share of Common Stock for 2021, 2020 and 2019 reflects the consolidated earnings of Prudential Financial. Basic earnings per share is computed by dividing available income attributable to common shareholders by the weighted average number of common shares outstanding for the period. Diluted earnings per share includes the effect of all dilutive potential common shares that were outstanding during the period. See Note 20 for additional information.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Foreign Currency | Foreign Currency The currency in which the Company prepares its financial statements (the “reporting currency”) is the U.S. dollar. Assets, liabilities and results of foreign operations are recorded based on the functional currency of each foreign operation. The determination of the functional currency is based on economic facts and circumstances pertaining to each foreign operation. The local currencies of the Company’s foreign operations are typically their functional currencies with the most significant exception being the Company’s Japanese operations where multiple functional currencies exist. There are two distinct processes for expressing these foreign transactions and balances in the Company’s financial statements: foreign currency measurement and foreign currency translation. Foreign currency measurement is the process by which transactions in foreign currencies are expressed in the functional currency. Gains and losses resulting from foreign currency measurement are reported in current earnings in “Other income (loss).” Foreign currency translation is the process of expressing a foreign entity’s functional currency financial statements in the reporting currency. Assets and liabilities of foreign operations and subsidiaries reported in currencies other than U.S. dollars are translated at the exchange rate in effect at the end of the period. Revenues, benefits and other expenses are translated at the average rate prevailing during the period. The effects of translating the statements of operations and financial position of non-U.S. entities with functional currencies other than the U.S. dollar are included, net of related qualifying hedge gains and losses and income taxes, in “Foreign currency translation adjustment,” a component of AOCI.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Financial Instruments | Derivative Financial Instruments Derivatives are financial instruments whose values are derived from interest rates, foreign exchange rates, financial indices, values of securities or commodities, credit spreads, market volatility, expected returns, and liquidity. Values can also be affected by changes in estimates and assumptions, including those related to counterparty behavior and non-performance risk (“NPR”) used in valuation models. Derivative financial instruments generally used by the Company include swaps, futures, forwards and options and may be exchange-traded or contracted in the over-the-counter (“OTC”) market. Certain of the Company’s OTC derivatives are cleared and settled through central clearing counterparties (OTC-cleared), while others are bilateral contracts between two counterparties (OTC-bilateral). Derivative positions are carried at fair value, generally by obtaining quoted market prices or through the use of valuation models. Derivatives are used to manage the interest rate and currency characteristics of assets or liabilities and to mitigate volatility of expected non-functional currency earnings and net investments in foreign operations resulting from changes in currency exchange rates. Additionally, derivatives may be used to reduce exposure to interest rate, credit, foreign currency and equity risks associated with assets held or expected to be purchased or sold, and liabilities incurred or expected to be incurred. As discussed in detail below, and in Note 5, all realized and unrealized changes in fair value of derivatives are recorded in current earnings, with the exception of cash flow hedges and hedges of net investments in foreign operations. The Company may also enter into intercompany derivatives, the results of which ultimately eliminate in consolidation over the term of the instrument; however, where applicable, derivative results are included in business gross profits which may impact the pattern by which DAC and other assets are amortized. Cash flows from derivatives are reported in the operating, investing, or financing activities sections in the Consolidated Statements of Cash Flows based on the nature and purpose of the derivative. Derivatives are recorded either as assets, within “Other invested assets,” or as liabilities, within “Other liabilities,” except for embedded derivatives which are recorded with the associated host contract. The Company nets the fair value of all derivative financial instruments with counterparties for which a master netting arrangement has been executed. The Company designates derivatives as either (1) a hedge of the fair value of a recognized asset or liability or unrecognized firm commitment (“fair value” hedge); (2) a hedge of a forecasted transaction or of the variability of cash flows to be received or paid related to a recognized asset or liability (“cash flow” hedge); (3) a foreign currency fair value or cash flow hedge (“foreign currency” hedge); (4) a hedge of a net investment in a foreign operation; or (5) a derivative that does not qualify for hedge accounting. To qualify for hedge accounting treatment, a derivative must be highly effective in mitigating the designated risk of the hedged item. Effectiveness of the hedge is formally assessed at inception and throughout the life of the hedging relationship. The Company formally documents at inception all relationships between hedging instruments and hedged items, as well as its risk-management objective and strategy for undertaking various hedge transactions. This process includes linking all derivatives designated as fair value, cash flow, or foreign currency hedges to specific assets and liabilities on the balance sheet or to specific firm commitments or forecasted transactions. Hedges of a net investment in a foreign operation are linked to the specific foreign operation. When a derivative is designated as a fair value hedge and is determined to be highly effective, changes in its fair value, along with changes in the fair value of the hedged asset or liability (including losses or gains on firm commitments), are reported on a net basis in the Consolidated Statements of Operations, generally in “Realized investment gains (losses), net.” When swaps are used in hedge accounting relationships, periodic settlements are recorded in the same Consolidated Statements of Operations line as the related settlements of the hedged items. When a derivative is designated as a cash flow hedge and is determined to be highly effective, changes in its fair value are recorded in AOCI until earnings are affected by the variability of cash flows being hedged (e.g., when periodic settlements on a variable-rate asset or liability are recorded in earnings). At that time, the related portion of deferred gains or losses on the derivative instrument is reclassified and reported in the Consolidated Statements of Operations line item associated with the hedged item. When a derivative is designated as a foreign currency hedge and is determined to be highly effective, changes in its fair value are recorded either in current period earnings if the hedge transaction is a fair value hedge (e.g., a hedge of a recognized foreign currency asset or liability) or in AOCI if the hedge transaction is a cash flow hedge (e.g., a foreign currency denominated forecasted transaction). When a derivative is used as a hedge of a net investment in a foreign operation, its change in fair value is accounted for in the same manner as a translation adjustment (i.e., reported in the cumulative translation adjustment account within AOCI). If it is determined that a derivative no longer qualifies as an effective fair value or cash flow hedge or management removes the hedge designation, the derivative will continue to be carried on the balance sheet at its fair value, with changes in fair value recognized currently in “Realized investment gains (losses), net.” In this scenario, the hedged asset or liability under a fair value hedge will no longer be adjusted for changes in fair value associated with the hedged risk and the existing basis adjustment is amortized to the Consolidated Statements of Operations line associated with the asset or liability. The component of AOCI related to discontinued cash flow hedges is reclassified to the Consolidated Statements of Operations line associated with the hedged cash flows consistent with the earnings impact of the original hedged cash flows. When hedge accounting is discontinued because the hedged item no longer meets the definition of a firm commitment, or because it is probable that the forecasted transaction will not occur by the end of the specified time period, the derivative will continue to be carried on the balance sheet at its fair value, with changes in fair value recognized currently in “Realized investment gains (losses), net.” Any asset or liability that was recorded pursuant to recognition of the firm commitment is removed from the balance sheet and recognized currently in “Realized investment gains (losses), net.” Gains and losses that were in AOCI pursuant to the cash flow hedge of a forecasted transaction are recognized immediately in “Realized investment gains (losses), net.” If a derivative does not qualify for hedge accounting, all changes in its fair value, including net receipts and payments, are included in “Realized investment gains (losses), net” without considering changes in the fair value of the economically associated assets or liabilities. The Company is a party to financial instruments that contain derivative instruments that are “embedded” in the financial instruments. At inception, the Company assesses whether the economic characteristics of the embedded instrument are clearly and closely related to the economic characteristics of the remaining component of the financial instrument (i.e., the host contract) and whether a separate instrument with the same terms as the embedded instrument would meet the definition of a derivative instrument. When it is determined that (1) the embedded instrument possesses economic characteristics that are not clearly and closely related to the economic characteristics of the host contract and (2) a separate instrument with the same terms would qualify as a derivative instrument, the embedded instrument qualifies as an embedded derivative that is separated from the host contract, carried at fair value, and changes in its fair value are included in “Realized investment gains (losses), net.” For certain financial instruments that contain an embedded derivative that otherwise would need to be bifurcated and reported at fair value, the Company may elect to carry the entire instrument at fair value and report it within “Other invested assets” or “Other liabilities.”
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reinsurance | Reinsurance For each of its reinsurance contracts, the Company determines if the contract provides indemnification against loss or liability relating to insurance risk in accordance with applicable accounting standards. The Company reviews all contractual features, particularly those that may limit the amount of insurance risk to which the reinsurer is subject or features that delay the timely reimbursement of claims. The Company participates in reinsurance arrangements in various capacities as either the ceding entity or as the reinsurer (i.e., assuming entity). See Note 14 for additional information about the Company’s reinsurance arrangements. Reinsurance assumed business is generally accounted for consistent with direct business. Amounts currently recoverable under reinsurance agreements are included in “Other assets” and amounts payable are included in “Other liabilities.” Revenues and benefits and expenses include amounts assumed under reinsurance agreements and are reflected net of reinsurance ceded. Reinsurance ceded arrangements do not discharge the Company as the primary insurer. Ceded balances would represent a liability of the Company in the event the reinsurers were unable to meet their obligations to the Company under the terms of the reinsurance agreements. Reinsurance recoverables are reported net of the CECL allowance. The CECL allowance considers the credit quality of the reinsurance counterparty and is generally determined based on the probability of default and loss given default assumptions, after considering any applicable collateral arrangements. Additions to or releases of the allowance are reported in “Policyholders’ benefits”. Reinsurance premiums, commissions, expense reimbursements, benefits and reserves related to reinsured long-duration contracts under coinsurance arrangements are accounted for over the life of the underlying reinsured contracts using assumptions consistent with those used to account for the underlying contracts. Coinsurance arrangements contrast with the Company’s yearly renewable term arrangements, where only mortality risk is transferred to the reinsurer and premiums are paid to the reinsurer to reinsure that risk. The mortality risk that is reinsured under yearly renewable term arrangements represents the difference between the stated death benefits in the underlying reinsured contracts and the corresponding reserves or account value carried by the Company on those same contracts. The premiums paid to the reinsurer are based upon negotiated amounts, not on the actual premiums paid by the underlying contract holders to the Company. As yearly renewable term arrangements are usually entered into by the Company with the expectation that the contracts will be in force for the lives of the underlying policies, they are considered to be long-duration reinsurance contracts. The cost of reinsurance for universal life products is generally recognized based on the gross assessments of the underlying direct policies. The cost of reinsurance for term insurance products is generally recognized in proportion to yearly renewable term premiums over the life of the underlying policies. The cost of reinsurance related to short-duration reinsurance contracts is accounted for over the reinsurance contract period.If the Company determines that a reinsurance agreement does not expose the reinsurer to a reasonable possibility of a significant loss from insurance risk, the Company records the agreement using the deposit method of accounting. Deposits received are included in “Other liabilities” and deposits made are included in “Other assets”. As amounts are paid or received, consistent with the underlying contracts, the deposit assets or liabilities are adjusted. Interest on such deposits is recorded as “Other income (loss)” or “General and administrative expenses,” as appropriate.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Future Adoption Of New Accounting Pronouncements | ASU issued but not yet adopted as of December 31, 2021— ASU 2018-12 ASU 2018-12, Financial Services—Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts, was issued by the FASB on August 15, 2018, and was amended by ASU 2019-09, Financial Services - Insurance (Topic 944): Effective Date, issued in October 2019, and ASU 2020-11, Financial Services—Insurance (Topic 944): Effective Date and Early Application, issued in November 2020. The Company will adopt ASU 2018-12 effective January 1, 2023 using the modified retrospective transition method where permitted, and apply the guidance as of January 1, 2021 (and record transition adjustments as of January 1, 2021) in the 2023 financial statements. The Company has an established governance framework to manage the implementation of the standard. The Company’s implementation efforts continue to progress including, but not limited to, implementing refinements to key accounting policy decisions, modifications to actuarial valuation models, updates to data sourcing capabilities, automation of key financial reporting and analytical processes and updates to internal controls over financial reporting. ASU 2018-12 will impact, at least to some extent, the accounting and disclosure requirements for all long-duration insurance and investment contracts issued by the Company. While the magnitude of impacts is still being assessed, the Company expects the standard to result in a significant decrease to “Total equity” upon adoption, primarily from remeasuring in-force contract liabilities using current upper-medium grade fixed income instrument yields through “Accumulated other comprehensive income (loss)”. The standard also requires significantly enhanced disclosures. In addition to the significant impacts to the balance sheet upon adoption, the Company also expects an impact to the pattern of earnings emergence following the transition date. Outlined below are four key areas of change, although there are other less significant policy changes not noted below.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Modifications related to COVID-19 | Modifications related to COVID-19 We assess modifications to certain fixed income instruments on a case-by-case basis to evaluate whether a TDR has occurred. In response to the COVID-19 pandemic, the Coronavirus Aid, Relief and Economic Security Act ("CARES Act") provides a temporary suspension of TDR accounting for certain COVID-19 related modifications where the investment was not more than 30 days past due as of December 31, 2019 (“TDR Relief”). The TDR Relief was set to expire on December 31, 2020, but was extended through December 31, 2021 by the Consolidated Appropriations Act of 2021. The Company elected to apply the TDR Relief beginning in the first quarter of 2021. The TDR Relief does not apply to modifications completed 60 days after the national emergency related to COVID-19 ends, or December 31, 2021, whichever comes earlier. As of December 31, 2021, any such modifications did not have a material impact on the Company's results of operations.
|
Organization, Consolidation and Presentation of Financial Statements (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disclosure of Long Lived Assets and Liabilities Held-for-sale | The table below reflects the carrying amounts of assets and liabilities held-for-sale related to the pending dispositions described above:
__________ (1)Under the terms of the sales agreements, certain of these assets and liabilities held-for-sale may be subject to capital transactions or substituted for other similar items prior to the closing of each transaction. (2)“Fixed maturities, available-for-sale, at fair value” with an allowance for credit losses of $1 million and “Commercial mortgage and other loans” net of allowance for credit losses of $15 million, as of December 31, 2021, respectively. (3)Includes $455 million of goodwill associated with Retirement Full Service as of December 31, 2021.
|
Investments (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investments [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fixed Maturities, Available-for-sale, Debt Securities | The following tables set forth the composition of fixed maturity securities (excluding investments classified as trading), as of the dates indicated:
__________ (1)Excludes “Assets held-for-sale” with amortized cost of $13,145 million, fair value of $13,569 million, unrealized gains of $572 million, unrealized losses of $147 million and allowance for credit losses of $1 million. See Note 1 for additional information on the pending dispositions. (2)Excludes notes with amortized cost of $5,941 million (fair value, $5,995 million), which have been offset with the associated debt under a netting agreement. (3)Includes credit-tranched securities collateralized loan obligations, education loans, auto loans, credit cards and other asset types. (4)Includes publicly-traded agency pass-through securities and collateralized mortgage obligations. (5)Excludes notes with amortized cost of $4,750 million (fair value, $5,394 million), which have been offset with the associated debt under a netting agreement.
__________ (1)Excludes notes with amortized cost of $5,966 million (fair value, $6,100 million), which have been offset with the associated debt under a netting agreement. (2)Includes credit-tranched securities collateralized by loan obligations, auto loans, education loans, home equity and other asset types. (3)Includes publicly-traded agency pass-through securities and collateralized mortgage obligations. (4)Excludes notes with amortized cost of $4,998 million (fair value, $5,821 million), which have been offset with the associated debt under a netting agreement.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fixed Maturities, Held-to-maturity Securities |
__________ (1)Excludes “Assets held-for-sale” with amortized cost of $13,145 million, fair value of $13,569 million, unrealized gains of $572 million, unrealized losses of $147 million and allowance for credit losses of $1 million. See Note 1 for additional information on the pending dispositions. (2)Excludes notes with amortized cost of $5,941 million (fair value, $5,995 million), which have been offset with the associated debt under a netting agreement. (3)Includes credit-tranched securities collateralized loan obligations, education loans, auto loans, credit cards and other asset types. (4)Includes publicly-traded agency pass-through securities and collateralized mortgage obligations. (5)Excludes notes with amortized cost of $4,750 million (fair value, $5,394 million), which have been offset with the associated debt under a netting agreement.
__________ (1)Excludes notes with amortized cost of $5,966 million (fair value, $6,100 million), which have been offset with the associated debt under a netting agreement. (2)Includes credit-tranched securities collateralized by loan obligations, auto loans, education loans, home equity and other asset types. (3)Includes publicly-traded agency pass-through securities and collateralized mortgage obligations. (4)Excludes notes with amortized cost of $4,998 million (fair value, $5,821 million), which have been offset with the associated debt under a netting agreement.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value | The following tables set forth the fair value and gross unrealized losses on available-for-sale fixed maturity securities without an allowance for credit losses aggregated by investment category and length of time that individual fixed maturity securities had been in a continuous unrealized loss position, as of the dates indicated:
__________ (1)Excludes “Assets held-for-sale” with fair value of $4,644 million and gross unrealized losses of $147 million. See Note 1 for additional information on the pending dispositions.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fixed Maturities Classified by Contractual Maturity Date | The following table sets forth the amortized cost or amortized cost, net of allowance and fair value of fixed maturities by contractual maturities, as of the date indicated:
__________ (1)Excludes “Assets held-for-sale” with amortized cost of $13,145 million and fair value of $13,569 million. See Note 1 for additional information on the pending dispositions. (2)Excludes available-for-sale notes with amortized cost of $5,941 million (fair value, $5,995 million) and held-to-maturity notes with amortized cost of $4,750 million (fair value, $5,394 million), which have been offset with the associated debt under a netting agreement.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sources of Fixed Maturity Proceeds and Related Investment Gains (Losses) as well as Losses on Impairments | The following table sets forth the sources of fixed maturity proceeds and related investment gains (losses), as well as losses on write-downs and the allowance for credit losses of fixed maturities, for the periods indicated:
__________ (1)Excludes activity from non-cash related proceeds due to the timing of trade settlements of $450 million, $(470) million and $(13) million for the years ended December 31, 2021, 2020 and 2019, respectively. (2)For the year ended December 31, 2019, amounts exclude the portion of OTTI amounts remaining in OCI, representing any difference between the fair value of the impaired debt security and the net present value of its projected future cash flows at the time of impairment. (3)Amounts represent write-downs of credit adverse securities and securities actively marketed for sale. In addition, for the years ended December 31, 2020 and 2019, amounts also include write-downs on securities approaching maturities related to foreign exchange movements. (4)Effective January 1, 2020, credit losses on available-for-sale and held-to-maturity fixed maturity securities are recorded within the “allowance for credit losses”. (5)Excludes activity from non-cash related proceeds due to the timing of trade settlements of less than $(1) million, less than $(1) million and less than $1 million for the years ended December 31, 2021, 2020 and 2019, respectively.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Credit Losses Recognized in Earnings on Fixed Maturity Securities Held by the Company for which a Portion of the OTTI Loss was Recognized in OCI | The following tables set forth the activity in the allowance for credit losses for fixed maturity securities, as of the dates indicated:
__________ (1) See Note 1 for additional information on the pending dispositions.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Assets Supporting Experience-Rated Contractholder Liabilities | The following table sets forth the composition of “Assets supporting experience-rated contractholder liabilities,” as of the dates indicated:
__________ (1)See Note 1 for additional information on the pending dispositions. (2)Includes publicly-traded agency pass-through securities and collateralized mortgage obligations. (3)Includes collateralized loan obligations, auto loans, education loans, home equity and other asset types. Collateralized loan obligations at fair value, including “Assets held-for-sale” were $1,607 million and $1,102 million as of December 31, 2021 and 2020, respectively, all of which were rated AA or above. (4)As a percentage of amortized cost, 97% and 94% of the portfolio including “Assets held-for-sale” was considered high or highest quality based on NAIC or equivalent ratings, as of December 31, 2021 and 2020, respectively. (5)As a percentage of amortized cost, 95% and 79% of the portfolio including “Assets held-for-sale” consisted of public securities as of December 31, 2021 and 2020, respectively.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Securities Concentrations of Credit Risk | As of the dates indicated, the Company’s exposure to concentrations of credit risk of single issuers greater than 10% of the Company’s equity included securities of the U.S. government and certain U.S. government agencies and securities guaranteed by the U.S. government, as well as the securities disclosed below:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commercial Mortgage and Other Loans | The following table sets forth the composition of “Commercial mortgage and other loans,” as of the dates indicated:
__________ (1)Excludes “Assets held-for-sale” of $6,565 million net of allowance for credit losses of $15 million as of December 31, 2021. See Note 1 for additional information on the pending dispositions. (2)Includes loans which are carried at fair value under the fair value option and are collateralized primarily by apartment complexes. As of December 31, 2021 and 2020, the net carrying value of these loans was $1,263 million and $1,092 million, respectively.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allowance for Credit Losses | The following table sets forth the activity in the allowance for credit losses for commercial mortgage and other loans, as of the dates indicated:
__________ (1) See Note 1 for additional information on the pending dispositions.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financing Receivable Credit Quality Indicators | The following tables set forth key credit quality indicators based upon the recorded investment gross of allowance for credit losses, as of the date indicated:
__________ (1) Excludes “Assets held-for-sale” of $6,580 million. See Note 1 for additional information on the pending dispositions.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Aging of Past Due Commercial Mortgage and Other Loans and Nonaccrual Status | The following tables set forth an aging of past due commercial mortgage and other loans based upon the recorded investment gross of allowance for credit losses, as well as the amount of commercial mortgage and other loans on non-accrual status, as of the dates indicated:
__________ (1)As of December 31, 2021, there were no loans in this category accruing interest. (2)For additional information regarding the Company’s policies for accruing interest on loans, see Note 2. (3)Excludes “Assets held-for-sale” of $6,580 million. See Note 1 for additional information on the pending dispositions.
__________ (1)As of December 31, 2020, there were no loans in this category accruing interest. (2)For additional information regarding the Company’s policies for accruing interest on loans, see Note 2.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Invested Assets | The following table sets forth the composition of “Other invested assets,” as of the dates indicated:
__________ (1)Prior period amounts have been updated to conform to current period presentation. (2)As of December 31, 2021 and 2020, real estate held through direct ownership had mortgage debt of $274 million and $409 million, respectively. (3)Primarily includes strategic investments made by investment management operations, leveraged leases and member and activity stock held in the Federal Home Loan Banks of New York and Boston. For additional information regarding the Company’s holdings in the Federal Home Loan Banks of New York, see Note 17. (4)Excludes “Assets held-for-sale” of $104 million as of December 31, 2021. See Note 1 for additional information on the pending dispositions.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity Method Investments | The following tables set forth summarized combined financial information for significant LP/LLC interests accounted for under the equity method, including the Company’s investments in operating joint ventures that are described in more detail in Note 9. Changes between periods in the tables below reflect changes in the activities within the operating joint ventures and LPs/LLCs, as well as changes in the Company’s level of investment in such entities:
__________ (1)Amount represents gross assets of each fund where the Company has a significant investment. These assets consist primarily of investments in real estate, investments in securities and other miscellaneous assets. (2)Amount represents gross liabilities of each fund where the Company has a significant investment. These liabilities consist primarily of third-party-borrowed funds, securities repurchase agreements and other miscellaneous liabilities. (3)Excludes “Assets held-for-sale” of $81 million. See Note 1 for additional information on the pending dispositions.
__________ (1)Amount represents gross revenue of each fund where the Company has a significant investment. This revenue consists of income from investments in real estate, investments in securities and other income. (2)Amount represents gross expenses of each fund where the Company has a significant investment. These expenses consist primarily of interest expense, investment management fees, salary expenses and other expenses. The following table sets forth information related to the Company’s investments in operating joint ventures as of and for the years ended December 31:
__________ (1)In March of 2021, the Company sold its 35% ownership stake in Pramerica SGR, an asset management joint venture within PGIM. See Note 1 for additional information on the disposition.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accrued Investment Income | The following table sets forth the composition of “Accrued investment income,” as of the dates indicated:
(1) Excludes “Assets held-for-sale” of $221 million as of December 31, 2021. See Note 1 for additional information on the pending dispositions.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Net Investment Income | The following table sets forth “Net investment income” by investment type, for the periods indicated:
__________ (1)Includes income on credit-linked notes which are reported on the same financial statement line items as related surplus notes, as conditions are met for right to offset.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Realized Investment Gains (Losses), Net | The following table sets forth “Realized investment gains (losses), net” by investment type, for the periods indicated:
__________ (1)Includes fixed maturity securities classified as available-for-sale and held-to-maturity and excludes fixed maturity securities classified as trading.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Net Unrealized Gains (Losses) on Investment | The following table sets forth net unrealized gains (losses) on investments, as of the dates indicated:
__________ (1)Effective January 1, 2020, per ASU 2016-13, fixed maturity securities, available-for-sale are no longer required to be disclosed “with OTTI” and “all other.” (2)Includes net unrealized gains of $425 million on “Assets held-for-sale” as of December 31, 2021. (3)For additional information on cash flow and fair value hedges, see Note 5. (4)As of December 31, 2021, there were no net unrealized losses on held-to-maturity securities that were previously transferred from available-for-sale. Includes net unrealized gains on certain joint ventures that are strategic in nature and are included in “Other assets.”
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Repurchase Agreements and Securities Lending | The following table sets forth the composition of “Securities sold under agreements to repurchase,” as of the dates indicated:
The following table sets forth the composition of “Cash collateral for loaned securities” which represents the liability to return cash collateral received for the following types of securities loaned, as of the dates indicated:
__________ (1)The Company did not have any agreements with remaining contractual maturities greater than thirty days, as of the dates indicated.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Securities Pledged | The following table sets forth the carrying value of investments pledged to third parties, as of the dates indicated:
__________ (1)Includes fixed maturity securities classified as available-for-sale and held-to-maturity and excludes fixed maturity securities classified as trading. The following table sets forth the carrying amount of the associated liabilities supported by the pledged collateral, as of the dates indicated:
The following table provides assets on deposit, assets held in trust, and securities restricted as to sale, as of the dates indicated:
__________ (1)Represents assets held in voluntary trusts established primarily to fund guaranteed dividends to certain policyholders and to fund certain employee benefits. (2)Represents assets held in trust related to reinsurance agreements excluding reinsurance agreements between wholly-owned subsidiaries. Assets valued at $28.4 billion and $34.0 billion were held in trust related to reinsurance agreements between wholly-owned subsidiaries as of December 31, 2021 and 2020, respectively. (3)Includes member and activity stock associated with memberships in the Federal Home Loan Banks of New York and Boston. (4)Includes $553 million “Assets held-for-sale” related to the pending sales of PALAC and Full Service Retirement Business as of December 31, 2021.
|
Variable Interest Entities (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Variable Interest Entity, Measure of Activity [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Consolidated Variable Interest Entities | The table below reflects the carrying amount and balance sheet caption in which the assets and liabilities of consolidated VIEs are reported. The liabilities primarily comprise obligations under debt instruments issued by the VIEs. The creditors of these VIEs do not have recourse to the Company in excess of the assets contained within the VIEs.
__________ (1)Total assets of consolidated VIEs reflect $2,885 million and $2,538 million as of December 31, 2021 and 2020, respectively, related to VIEs whose beneficial interests are wholly-owned by consolidated subsidiaries. (2)Recourse is limited to the assets of the respective VIE and does not extend to the general credit of the Company. As of December 31, 2021, the maturity of this obligation was within 3 years.
|
Derivative Instruments (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value | The table below provides a summary of the gross notional amount and fair value of derivatives contracts by the primary underlying risks, excluding embedded derivatives and associated reinsurance recoverables. Many derivative instruments contain multiple underlying risks. The fair value amounts below represent the value of derivative contracts prior to taking into account the netting effects of master netting agreements and cash collateral. This netting impact results in total derivative assets of $3,266 million and $1,906 million as of December 31, 2021 and 2020, respectively, and total derivative liabilities of $2,278 million and $792 million as of December 31, 2021 and 2020, respectively, reflected in the Consolidated Statements of Financial Position.
__________ (1)“Other” primarily includes derivative contracts used to improve the balance of the Company’s tail longevity and mortality risk. Under these contracts, the Company’s gains (losses) are capped at the notional amount. (2)Excludes embedded derivatives and associated reinsurance recoverables which contain multiple underlying risks. The fair value of these embedded derivatives was a net liability of $10,245 million and $20,119 million as of December 31, 2021, and 2020, respectively, primarily included in “Future policy benefits.” (3)Recorded in “Other invested assets” and “Other liabilities” on the Consolidated Statements of Financial Position. (4)Excludes “Assets held-for-sale” with fair value of $1,643 million and “Liabilities held-for-sale” with fair value of $1,503 million with outstanding gross notional amounts of $41,179 million as of December 31, 2021. See Note 1 for additional information on the pending dispositions.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of financial instruments in a fair value hedge accounting relationship | As of December 31, 2021, the following amounts were recorded on the Consolidated Statements of Financial Position related to the carrying amount of the hedged assets (liabilities) and cumulative basis adjustments included in the carrying amount for fair value hedges:
________ (1)There were no material fair value hedging adjustments for hedged assets and liabilities for which hedge accounting has been discontinued.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Offsetting Assets | The following table presents recognized derivative instruments (excluding embedded derivatives and associated reinsurance recoverables), and repurchase and reverse repurchase agreements that are offset in the Consolidated Statements of Financial Position, and/or are subject to an enforceable master netting arrangement or similar agreement, irrespective of whether they are offset in the Consolidated Statements of Financial Position:
__________ (1)Amounts exclude the excess of collateral received/pledged from/to the counterparty. (2)Excludes “Assets held-for-sale” with fair value of $1,643 million and “Liabilities held-for-sale” with fair value of $1,503 million. See Note 1 for additional information on the pending dispositions.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Offsetting Liabilities | The following table presents recognized derivative instruments (excluding embedded derivatives and associated reinsurance recoverables), and repurchase and reverse repurchase agreements that are offset in the Consolidated Statements of Financial Position, and/or are subject to an enforceable master netting arrangement or similar agreement, irrespective of whether they are offset in the Consolidated Statements of Financial Position:
__________ (1)Amounts exclude the excess of collateral received/pledged from/to the counterparty. (2)Excludes “Assets held-for-sale” with fair value of $1,643 million and “Liabilities held-for-sale” with fair value of $1,503 million. See Note 1 for additional information on the pending dispositions.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance | The following table provides the financial statement classification and impact of derivatives used in qualifying and non-qualifying hedge relationships, including the offset of the hedged item in fair value hedge relationships.
__________ (1)Excluding changes related to net investment hedges using non-derivative instruments of $25 million for year ended December 31, 2021, $(21) million for year ended December 31, 2020, and $0 million for year ended December 31, 2019.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Derivative Instruments Recognized in Accumulated Other Comprehensive Income(Loss) Before Taxes | Presented below is a rollforward of current period cash flow hedges in AOCI before taxes:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disclosure of Credit Derivatives | The following table provides a summary of the notional and fair value of written credit protection, presented as assets (liabilities). The Company’s maximum amount at risk under these credit derivatives, assuming the value of the underlying referenced securities become worthless, is equal to the notional amounts. These credit derivatives have maturities of less than 26 years for index references.
_________ (1)The NAIC rating designations are based on availability and the lowest ratings among Moody's Investors Service, Inc. ("Moody's"), Standard & Poor’s Rating Services (“S&P”) and Fitch Ratings Inc. (“Fitch”). If no rating is available from a rating agency, a NAIC 6 rating is used. (2)Single name credit default swaps may reference to the credit of corporate debt, sovereign debt, and structured finance. Index references NAIC designations are based on the lowest rated single name reference included in the index. (3)Excludes “Assets held-for-sale” with fair value of $54 million and “Liabilities held-for-sale” with fair value of $0 million. See Note 1 for additional information on the pending dispositions.
|
Fair Value of Assets and Liabilities (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value, Assets and Liabilities Measured on Recurring Basis | The tables below present the balances of assets and liabilities reported at fair value on a recurring basis, as of the dates indicated:
__________ (1)Excludes amounts for financial instruments reclassified to “Assets held-for-sale of $129,579 million and “Liabilities held-for-sale” of $6,214 million. Assets held-for-sale and liabilities held-for-sale are valued on a basis consistent with similar instruments described herein. See Note 1 for additional information on the pending dispositions. (2)“Netting” amounts represent cash collateral of $(3,164) million and $3,892 million as of December 31, 2021 and 2020, respectively. (3)Excludes notes with fair value of $5,995 million (carrying amount of $5,941 million) and $6,100 million (carrying amount of $5,966 million) as of December 31, 2021 and 2020, respectively, which have been offset with the associated payables under a netting agreement. (4)Includes credit-tranched securities collateralized by syndicated bank loans, sub-prime mortgages, auto loans, credit cards, education loans and other asset types. (5)All other represents cash equivalents and short-term investments. (6)Other invested assets excluded from the fair value hierarchy include certain hedge funds, private equity funds and other funds for which fair value is measured at net asset value (“NAV”) per share (or its equivalent) as a practical expedient. At December 31, 2021 and 2020, the fair values of such investments were $4,290 million and $4,136 million respectively. (7)Separate account assets included in the fair value hierarchy exclude investments in entities that calculate NAV per share (or its equivalent) as a practical expedient. Such investments excluded from the fair value hierarchy include investments in real estate, hedge funds and other invested assets. At December 31, 2021 and 2020, the fair value of such investments were $26,174 million and $23,007 million, respectively. (8)Separate account assets represent segregated funds that are invested for certain customers. Investment risks associated with market value changes are borne by the customers, except to the extent of minimum guarantees made by the Company with respect to certain accounts. Separate account liabilities are not included in the above table as they are reported at contract value and not fair value in the Company’s Consolidated Statements of Financial Position. (9)As of December 31, 2021, the net embedded derivative liability position of $9,069 million includes $611 million of embedded derivatives in an asset position and $9,680 million of embedded derivatives in a liability position. As of December 31, 2020, the net embedded derivative liability position of $18,879 million includes $520 million of embedded derivatives in an asset position and $19,399 million of embedded derivatives in a liability position.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Inputs, Assets and Liabilities, Quantitative Information | The tables below present quantitative information on significant internally-priced Level 3 assets and liabilities:
__________ (1)Conversely, the impact of a decrease in input would have the opposite impact on fair value as that presented in the table. (2)Includes assets classified as fixed maturities available-for-sale, assets supporting experience-rated contractholder liabilities and fixed maturities, trading. (3)Excludes notes which have been offset with the associated payables under a netting agreement. (4)Represents multiples of earnings before interest, taxes, depreciation and amortization (“EBITDA”), and are amounts used when the Company has determined that market participants would use such multiples when valuing the investments. (5)Includes certain investments where enterprise value is less than the amount needed to support senior and subordinated claims. These investments typically use a range of discount rates (10% to 20%), therefore presenting a range, rather than a weighted average, is a more meaningful representation of the unobservable inputs used in the valuation. (6)Changes in the fair value of separate account assets are borne by customers and thus are offset by changes in separate account liabilities on the Company’s Consolidated Statements of Financial Position. As a result, changes in value associated with these investments are not reflected in the Company’s Consolidated Statements of Operations. (7)Future policy benefits primarily represent general account liabilities for the living benefit features of the Company’s variable annuity contracts which are accounted for as embedded derivatives. Since the valuation methodology for these liabilities uses a range of inputs that vary at the contract level over the cash flow projection period, presenting a range, rather than a weighted average, is a more meaningful representation of the unobservable inputs used in the valuation. (8)Policyholders’ account balances primarily represent general account liabilities for the index-linked interest credited on certain of the Company’s life and annuity products that are accounted for as embedded derivatives. Since the valuation methodology for these liabilities uses a range of inputs that vary at the contract level over the cash flow projection period, presenting a range, rather than a weighted average, is a more meaningful representation of the unobservable inputs used in the valuation. (9)Lapse rates for contracts with living benefit guarantees are adjusted at the contract level based on the in-the-moneyness of the living benefit and reflect other factors, such as the applicability of any surrender charges. Lapse rates are reduced when contracts are more in-the-money. Lapse rates for contracts with index-linked crediting guarantees may be adjusted at the contract level based on the applicability of any surrender charges, product type, and market related factors such as interest rates. Lapse rates are also generally assumed to be lower for the period where surrender charges apply. For any given contract, lapse rates vary throughout the period over which cash flows are projected for the purposes of valuing these embedded derivatives. (10)The spread over the LIBOR swap curve represents the premium added to the proxy for the risk-free rate (LIBOR) to reflect the Company’s estimates of rates that a market participant would use to value the living benefits in both the accumulation and payout phases and index-linked interest crediting guarantees. This spread includes an estimate of NPR, which is the risk that the obligation will not be fulfilled by the Company. NPR is primarily estimated by utilizing the credit spreads associated with issuing funding agreements, adjusted for any illiquidity risk premium. In order to reflect the financial strength ratings of the Company, credit spreads associated with funding agreements, as opposed to credit spread associated with debt, are utilized in developing this estimate because funding agreements, living benefit guarantees, and index-linked interest crediting guarantees are insurance liabilities and are therefore senior to debt. (11)The utilization rate assumption estimates the percentage of contracts that will utilize the benefit during the contract duration, and begin lifetime withdrawals at various time intervals from contract inception. The remaining contractholders are assumed to either begin lifetime withdrawals immediately or never utilize the benefit. Utilization assumptions may vary by product type, tax status, and age. The impact of changes in these assumptions is highly dependent on the product type, the age of the contractholder at the time of the sale, and the timing of the first lifetime income withdrawal. Range reflects the utilization rate for the vast majority of business with living benefits. (12)The withdrawal rate assumption estimates the magnitude of annual contractholder withdrawals relative to the maximum allowable amount under the contract. These assumptions vary based on the age of the contractholder, the tax status of the contract and the duration since the contractholder began lifetime withdrawals. As of both December 31, 2021 and 2020, the minimum withdrawal rate assumption is 76% and maximum withdrawal rate assumption may be greater than 100%.The fair value of the liability will generally increase the closer the withdrawal rate is to 100% and decrease as the withdrawal rate moves further away from 100%. (13)The range reflects the mortality rates for the vast majority of business with living benefits and other contracts, with policyholders ranging from 45 to 90 years old. While the majority of living benefits have a minimum age requirement, certain other contracts do not have an age restriction. This results in contractholders with mortality rates approaching 0% for certain benefits. Mortality rates may vary by product, age, and duration. A mortality improvement assumption is also incorporated into the overall mortality table.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation | The following tables describe changes in fair values of Level 3 assets and liabilities as of the dates indicated, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets and liabilities still held at the end of their respective periods. When a determination is made to classify assets and liabilities within Level 3, the determination is based on significance of the unobservable inputs in the overall fair value measurement. All transfers are based on changes in the observability of the valuation inputs, including the availability of pricing service information that the Company can validate. Transfers into Level 3 are generally the result of unobservable inputs utilized within valuation methodologies and the use of indicative broker quotes for assets that were previously valued using observable inputs. Transfers out of Level 3 are generally due to the use of observable inputs in valuation methodologies as well as the availability of pricing service information for certain assets that the Company can validate.
The following tables summarize the portion of changes in fair values of Level 3 assets and liabilities included in earnings and OCI for the year ended December 31, 2019, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets and liabilities still held as of December 31, 2019:
__________ (1)“Other,” for the periods ended December 31, 2021 and 2020, primarily represent deconsolidation of VIE, reclassifications of certain assets between reporting categories and foreign currency translation. (2)Transfers out of level 3 for the period ended December 31, 2021, included $218 million of corporate securities and $79 million of structured securities reclassified from Fixed maturities, available for sale to “Assets held-for-sale”, and $4,162 million of Future Policy Benefits and $2,040 million of Policyholders’ account balances reclassified to "Liabilities held-for-sale". See Note 1 for additional information on the pending dispositions. (3)Unrealized gains or losses related to assets still held at the end of the period do not include amortization or accretion of premiums and discounts. (4)Includes U.S. corporate public, U.S. corporate private, foreign corporate public and foreign corporate private securities. (5)Includes asset-backed, commercial mortgage-backed and residential mortgage-backed securities. (6)Separate account assets represent segregated funds that are invested for certain customers. Investment risks associated with market value changes are borne by the customers, except to the extent of minimum guarantees made by the Company with respect to certain accounts. Separate account liabilities are not included in the above table as they are reported at contract value and not fair value in the Company’s Consolidated Statements of Financial Position. (7)Issuances and settlements for Policyholders’ account balances are presented net in the rollforward. Prior period amounts have been updated to conform to current period presentation. (8)Effective January 1, 2020, the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period were added prospectively due to adoption of ASU 2018-13. Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation | The following tables describe changes in fair values of Level 3 assets and liabilities as of the dates indicated, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets and liabilities still held at the end of their respective periods. When a determination is made to classify assets and liabilities within Level 3, the determination is based on significance of the unobservable inputs in the overall fair value measurement. All transfers are based on changes in the observability of the valuation inputs, including the availability of pricing service information that the Company can validate. Transfers into Level 3 are generally the result of unobservable inputs utilized within valuation methodologies and the use of indicative broker quotes for assets that were previously valued using observable inputs. Transfers out of Level 3 are generally due to the use of observable inputs in valuation methodologies as well as the availability of pricing service information for certain assets that the Company can validate.
The following tables summarize the portion of changes in fair values of Level 3 assets and liabilities included in earnings and OCI for the year ended December 31, 2019, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets and liabilities still held as of December 31, 2019:
__________ (1)“Other,” for the periods ended December 31, 2021 and 2020, primarily represent deconsolidation of VIE, reclassifications of certain assets between reporting categories and foreign currency translation. (2)Transfers out of level 3 for the period ended December 31, 2021, included $218 million of corporate securities and $79 million of structured securities reclassified from Fixed maturities, available for sale to “Assets held-for-sale”, and $4,162 million of Future Policy Benefits and $2,040 million of Policyholders’ account balances reclassified to "Liabilities held-for-sale". See Note 1 for additional information on the pending dispositions. (3)Unrealized gains or losses related to assets still held at the end of the period do not include amortization or accretion of premiums and discounts. (4)Includes U.S. corporate public, U.S. corporate private, foreign corporate public and foreign corporate private securities. (5)Includes asset-backed, commercial mortgage-backed and residential mortgage-backed securities. (6)Separate account assets represent segregated funds that are invested for certain customers. Investment risks associated with market value changes are borne by the customers, except to the extent of minimum guarantees made by the Company with respect to certain accounts. Separate account liabilities are not included in the above table as they are reported at contract value and not fair value in the Company’s Consolidated Statements of Financial Position. (7)Issuances and settlements for Policyholders’ account balances are presented net in the rollforward. Prior period amounts have been updated to conform to current period presentation. (8)Effective January 1, 2020, the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period were added prospectively due to adoption of ASU 2018-13. Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Assets and Liabilities Measured on Recurring Basis, Derivatives | The following tables present the balances of certain derivative assets and liabilities measured at fair value on a recurring basis, as of the date indicated, by primary underlying risks. These tables exclude embedded derivatives and associated reinsurance recoverables. The derivative assets and liabilities shown below are included in “Other invested assets” or “Other liabilities” in the tables contained within the sections “—Assets and Liabilities by Hierarchy Level” and “—Changes in Level 3 Assets and Liabilities,” above.
__________ (1)“Netting” amounts represent cash collateral and the impact of offsetting asset and liability positions held with the same counterparty, subject to master netting agreement. (2)Excludes “Assets held-for-sale” with fair value of $1,643 million and “Liabilities held-for-sale” with fair value of $1,503 million. See Note 1 for additional information on the pending dispositions.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Assets and Liabilities Measured on Recurring Basis Unobservable Input Reconciliation, Derivatives | The following tables provide a summary of the changes in fair value of Level 3 derivative assets and liabilities as of the dates indicated, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets and liabilities still held at the end of their respective periods:
__________ (1)Represents conversion of warrants to equity shares. (2)Transfers into or out of Level 3 are generally reported at the value as of the beginning of the quarter in which the transfers occur for any such positions still held at the end of the quarter. (3)Related to warrants received in restructuring a certain asset that resulted in reclassification of reporting category. (4)Total realized and unrealized gains (losses) as well as unrealized gains (losses) for assets still held at the end of the period are recorded in “Realized investment gains (losses), net.”
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Measurements, Nonrecurring | The following tables represent information for assets measured at fair value on a nonrecurring basis. The fair value measurement is nonrecurring as these assets are measured at fair value only when there is a triggering event (e.g., an evidence of impairment). Assets included in the table are those that were impaired during the respective reporting periods and that are still held as of the reporting date. The estimated fair values for these amounts were determined using significant unobservable inputs (Level 3).
__________ (1)Commercial mortgage loans are valued based on discounted cash flows utilizing market rates or the fair value of the underlying real estate collateral. (2)Mortgage servicing rights are valued using a discounted cash flow model. The model incorporates assumptions for servicing revenues, which are adjusted for expected prepayments, delinquency rates, escrow deposit income and estimated loan servicing expenses. The discount rates incorporated into the model are determined based on the estimated returns a market participant would require for this business plus a liquidity and risk premium. This estimate includes available relevant data from any active market sales of mortgage servicing rights. (3)Based on the goodwill impairment test performed as of December 31, 2021, the Company recognized a goodwill impairment charge for Assurance IQ. The fair value was determined using weighting of both market approach valuation techniques, based on both sales and EBITDA forward multiples, and discounted cash flow approach valuation techniques. The valuation included unobservable inputs such as forward market multiples of comparable peer companies and an implied control premium under the market approaches, as well as forecasted cash flows, discount rate applied, expected synergies and growth rate assumptions under the discounted cash flow approaches. The inputs and assumptions applied are consistent with how a market participant would value Assurance IQ and the related goodwill. See Note 10 for more information on the valuation of Assurance IQ and the resulting impairment charge.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value, Option | The following tables present information regarding assets and liabilities where the fair value option has been elected:
__________ (1)As of December 31, 2021, for loans for which the fair value option has been elected, there were no loans in non-accrual status and none of the loans were more than 90 days past due and still accruing.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosure Financial Instruments Not Carried at Fair Value | The table below presents the carrying amount and fair value by fair value hierarchy level of certain financial instruments that are not reported at fair value. The financial instruments presented below are reported at carrying value on the Company’s Consolidated Statements of Financial Position. In some cases, as described below, the carrying amount equals or approximates fair value.
__________ (1)Excludes amounts for financial instruments reclassified to “Assets held-for-sale” of $6,936 million or “Liabilities held-for-sale” of $101,992 million. See Note 1 for additional information on the pending dispositions. (2)Carrying values presented herein differ from those in the Company’s Consolidated Statements of Financial Position because certain items within the respective financial statement captions are not considered financial instruments or out of scope under authoritative guidance relating to disclosures of the fair value of financial instruments. (3)Excludes notes with fair value of $5,394 million (carrying amount of $4,750 million) and $5,821 million (carrying amount of $4,998 million) as of December 31, 2021 and 2020, respectively, which have been offset with the associated payables under a netting agreement. (4)Includes notes with fair value of $11,389 million (carrying amount of $10,691 million) and $11,921 million (carrying amount of $10,964 million) as of December 31, 2021 and 2020, respectively, which have been offset with the associated receivables under a netting agreement.
|
Deferred Policy Acquisition Costs (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Deferred Policy Acquisition Costs Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule Of Deferred Policy Acquisition Costs | The balances of and changes in DAC as of and for the years ended December 31, are as follows:
__________ (1)See Note 1 for additional information on the pending dispositions. (2)“Other” for 2021 represents the sale of The Prudential Life Insurance Company of Taiwan Inc. “Other” for 2020 primarily represents the impact related to the sale of The Prudential Life Insurance Company of Korea, Ltd. of $(1,193) million. “Other” for 2019 primarily represents the impact related to the sale of the Company’s Pramerica of Italy subsidiary of $(46) million and DAC ceded to a third-party reinsurer of $(14) million.
|
Value of Business Acquired (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Present Value of Future Insurance Profits [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Value of Business Acquired | The balances of and changes in VOBA as of and for the years ended December 31, are as follows:
__________ (1)See Note 1 for additional information on the pending dispositions. The following table provides VOBA balances for the year ended December 31, 2021:
__________ (1)Excludes “Assets held-for-sale” of $215 million as of December 31, 2021. See Note 1 for additional information on the pending dispositions.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Estimated Future VOBA Amortization, Net of Interest | The following table provides estimated future amortization, net of interest, for the periods indicated:
__________ (1)VOBA classified as “Assets held-for-sale” of $215 million as of December 31, 2021 is excluded from the estimated future amortization amounts. See Note 1 for additional information on the pending dispositions. The following table provides estimated future amortization for the periods indicated:
|
Investments in Operating Joint Ventures (Tables) |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity Method Investments and Joint Ventures [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity Method Investments | The following tables set forth summarized combined financial information for significant LP/LLC interests accounted for under the equity method, including the Company’s investments in operating joint ventures that are described in more detail in Note 9. Changes between periods in the tables below reflect changes in the activities within the operating joint ventures and LPs/LLCs, as well as changes in the Company’s level of investment in such entities:
__________ (1)Amount represents gross assets of each fund where the Company has a significant investment. These assets consist primarily of investments in real estate, investments in securities and other miscellaneous assets. (2)Amount represents gross liabilities of each fund where the Company has a significant investment. These liabilities consist primarily of third-party-borrowed funds, securities repurchase agreements and other miscellaneous liabilities. (3)Excludes “Assets held-for-sale” of $81 million. See Note 1 for additional information on the pending dispositions.
__________ (1)Amount represents gross revenue of each fund where the Company has a significant investment. This revenue consists of income from investments in real estate, investments in securities and other income. (2)Amount represents gross expenses of each fund where the Company has a significant investment. These expenses consist primarily of interest expense, investment management fees, salary expenses and other expenses. The following table sets forth information related to the Company’s investments in operating joint ventures as of and for the years ended December 31:
__________ (1)In March of 2021, the Company sold its 35% ownership stake in Pramerica SGR, an asset management joint venture within PGIM. See Note 1 for additional information on the disposition.
|
Goodwill and Other Intangibles (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goodwill and Intangible Assets Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Goodwill | The changes in the carrying value of goodwill by reportable segment are as follows:
__________ (1)Prior period amounts have been reclassified to conform to current period presentation. (2)The goodwill associated with Assurance IQ includes a measurement period adjustment made during 2020. The goodwill reclassification between International Businesses and Corporate and Other relates to an operation that became classified as a divested business and transferred to Corporate and Other during 2020. (3)During 2021, PGIM completed the acquisitions of Montana Capital Partners, a European-based private equity secondaries asset manager, and Green Harvest Asset Management LLC, a separately managed account platform providing customized solutions for the high net worth market. (4)The Full Service Retirement business has been classified as divested business and transferred to Corporate and Other, and its assets, including goodwill, are reclassified to “Assets held-for-sale” as of December 31, 2021. See Note 1 for more information on this pending disposition.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Finite-Lived Intangible Assets | Other intangible balances at December 31, are as follows:
__________ (1)Includes “Assets held-for-sale” of $39 million as of December 31, 2021. See Note 1 for more information on the pending dispositions.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Indefinite-Lived Intangible Assets | Other intangible balances at December 31, are as follows:
__________ (1)Includes “Assets held-for-sale” of $39 million as of December 31, 2021. See Note 1 for more information on the pending dispositions.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Estimated Future Amortization Expense of Other Intangibles | The following table provides estimated future amortization, net of interest, for the periods indicated:
__________ (1)VOBA classified as “Assets held-for-sale” of $215 million as of December 31, 2021 is excluded from the estimated future amortization amounts. See Note 1 for additional information on the pending dispositions. The following table provides estimated future amortization for the periods indicated:
|
Leases (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Leases [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Lessee Supplemental Balance Sheet Information Related to Operating Leases | Supplemental balance sheet information related to leases where the Company is the lessee is included below. Right-of-use assets and lease liabilities are included within “Other assets” and “Other liabilities” respectively.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Lessee Maturities of Operating Lease Liabilities | Maturities of operating lease liabilities are as follows:
|
Policyholders' Liabilities (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Liability for Future Policy Benefits and Unpaid Claims and Claims Adjustment Expense [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Liability for Future Policy Benefits, by Product Segment | Future policy benefits at December 31 for the years indicated are as follows:
__________ (1)See Note 1 for additional information on the pending dispositions Policyholders’ account balances at December 31 for the years indicated are as follows:
__________ (1)See Note 1 for additional information on the pending dispositions.
|
Certain Long-Duration Contracts with Guarantees (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Long-Duration Contracts, Assumptions Supporting Guarantee Obligations [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Net Amount of Risk by Product and Guarantee | As of December 31, 2021 and 2020, the Company had the following guarantees associated with these contracts, by product and guarantee type:
__________ (1)Includes income and withdrawal benefits.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Fair Value of Separate Accounts by Major Category of Investment | Account balances of variable annuity contracts with guarantees were invested in separate account investment options as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Minimum Guaranteed Benefit Liabilities | The table below summarizes the changes in general account liabilities for guarantees. The liabilities for GMDB and GMIB are included in “Future policy benefits” and the related changes in the liabilities are included in “Policyholders’ benefits.” GMAB, GMWB and GMIWB are accounted for as embedded derivatives and are recorded at fair value within “Future policy benefits.” Changes in the fair value of these derivatives, including changes in the Company’s own risk of non-performance, along with any fees attributed or payments made relating to the derivative, are recorded in “Realized investment gains (losses), net.” See Note 6 for additional information regarding the methodology used in determining the fair value of these embedded derivatives. The Company maintains a portfolio of derivative investments that serve as a partial hedge of the risks associated with these products, for which the changes in fair value are also recorded in “Realized investment gains (losses), net.” This portfolio of derivative investments does not qualify for hedge accounting treatment under U.S. GAAP. Additionally, the Company externally reinsures the guaranteed benefit features associated with certain contracts. See Note 14 for further information regarding the external reinsurance arrangement.
__________ (1)Incurred guarantee benefits include the portion of assessments established as additions to reserves as well as changes in estimates affecting the reserves. Also includes changes in the fair value of features considered to be derivatives. (2)Other primarily represents foreign currency translation. (3)Includes the impact from the sale of POK. (4)See Note 1 for additional information on the pending dispositions. (5)Includes the impact from the sale of POT.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Deferred Sales Inducements | Changes in DSI, reported as “Interest credited to policyholders’ account balances,” are as follows:
__________ (1)See Note 1 for additional information on the pending dispositions. (2)Represents the impact from the sale of POT.
|
Reinsurance (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reinsurance Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Effects of Reinsurance | Reinsurance amounts included in the Consolidated Statements of Operations for premiums, policy charges and fee income, and policyholders’ benefits for the years ended December 31, are as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reinsurance Recoverables | Reinsurance recoverables at December 31, are as follows:
__________ (1)Primarily represents reinsurance recoverables established under the reinsurance agreement with Union Hamilton related to the ceding of certain embedded derivative liabilities associated with the Company’s guaranteed benefits of $110 million and $204 million as of December 31, 2021 and 2020, respectively. (2)Includes reinsurance recoverables established under the reinsurance arrangements associated with the acquisition of the Hartford Life Business of $2,178 million and $2,245 million as of December 31, 2021 and 2020, respectively. The Company has also recorded reinsurance payables related to the Hartford Life Business acquisition of $1,341 million and $1,362 million as of December 31, 2021 and 2020, respectively. (3)Net of $(10) million and $(5) million of loss allowance as of December 31, 2021 and 2020, respectively. (4)Excludes reinsurance recoverables of $30 million related to “Asset held-for-sale” operations as of December 31, 2021. See Note 1 for additional information on the pending dispositions.
|
Closed Block (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Closed Block Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Closed Block Liabilities and Assets | Closed Block liabilities and assets designated to the Closed Block at December 31, as well as maximum future earnings to be recognized from these liabilities and assets, are as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Closed Block Dividend Obligation | Information regarding the policyholder dividend obligation is as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Closed Block Revenues Benefits Expenses | Closed Block revenues and benefits and expenses for the years ended December 31, are as follows:
|
Income Taxes (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Income Tax Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Components of Income Tax Expense (Benefit) | The following schedule discloses significant components of income tax expense (benefit) for each year presented:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Effective Income Tax Rate Reconciliation | The differences between income taxes expected at the U.S. federal statutory income tax rate of 21% applicable for 2021, 2020 and 2019, and the reported income tax expense (benefit) are summarized as follows:
__________ (1)Prior period amounts have been updated to conform to current period presentation.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Deferred Tax Assets and Liabilities |
__________ (1)Prior period amounts have been updated to conform to current period presentation.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Operating And Capital Loss Carryforwards | The valuation allowance includes amounts recorded in connection with deferred tax assets as follows:
The following table sets forth the amount and expiration dates of federal, state and foreign operating, capital loss and tax credit carryforwards for tax purposes, as of the periods indicated:
__________ (1)Unlimited carryforward. (2)Certain state net operating loss carryforwards expire between 2022 and 2041, whereas others have an unlimited carryforward. (3)$52 million expires between 2022 and 2036 and $195 million has an unlimited carryforward. (4)Expires between 2028 and 2031. These relate to foreign non-general basket tax credits.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Undistributed Earnings Of Foreign Subsidiaries Assuming Permanent Reinvestment | The following table sets forth the undistributed earnings of foreign subsidiaries, where the Company assumes indefinite reinvestment of such earnings and for which, in 2021, 2020, and 2019, U.S. deferred taxes have not been provided, and for which foreign deferred withholding taxes have not been provided. The net tax liability that may arise if the 2021 earnings were remitted which includes any foreign exchange impacts, is immaterial.
__________ (1)Consistent with the Tax Act of 2017, the Company provides U.S. income tax for all unremitted earnings of the Company’s foreign affiliates as of December 31, 2017.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Unrecognized Tax Benefits Reconciliation | The following table reconciles the total amount of unrecognized tax benefits at the beginning and end of the periods indicated:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Amounts Recognized In Consolidated Financial Statements For Tax Related Interest And Penalties | The amounts recognized in the consolidated financial statements for tax-related interest and penalties for the years ended December 31 are as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Open Tax Years By Major Tax Jurisdictions | Listed below are the tax years that remain subject to examination, by major tax jurisdiction, as of December 31, 2021:
|
Short-Term and Long-Term Debt (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Short-term Debt | The table below presents the Company’s short-term debt at December 31, for the years indicated as follows:
__________ (1)The surplus notes have corresponding assets where rights to set-off exist, thereby reducing the amount of surplus notes. (2)Includes a $98 million bridge loan and $7 million drawn on a revolving line of credit held by a subsidiary at December 31, 2021. (3)Includes Prudential Financial debt of $25 million and $424 million at December 31, 2021 and 2020, respectively.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Line of Credit Facilities | As of December 31, 2021, the Company maintained syndicated, unsecured committed credit facilities as described below.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Long-term Debt Instruments |
__________ (1)Ranges of interest rates are for the year ended December 31, 2021. (2)Includes $29 million of debt denominated in foreign currency at both December 31, 2021 and 2020. (3)Includes Prudential Financial debt of $7,564 million and subsidiary debt of $54 million denominated in foreign currency at December 31, 2021. (4)Assets under set-off arrangements represent a reduction in the amount of surplus notes included in long-term debt, resulting from an arrangement where valid rights of set-off exist and it is the intent of both parties to settle on a net basis under legally enforceable arrangements. These assets include available-for-sale securities that are reported at fair value. (5)Includes Prudential Financial debt of $17,673 million and $18,561 million at December 31, 2021 and 2020, respectively.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Maturities of Long-term Debt | The following table presents the contractual maturities of the Company’s long-term debt as of December 31, 2021:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Senior Notes | The table below presents the Company’s balances related to these issuances, as well as its mortgage debt balance, as of December 31 for the years indicated as follows:
__________ (1)Includes $197 million of notes from current portion of long-term debt as of December 31, 2021.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Surplus Notes with Set-Off Arrangements |
__________ (1)Prudential has agreed to reimburse one of the external counterparties for any payment under the credit linked notes funded by it in an amount of up to $0.5 billion. (2)Includes $0.5 billion of notes from current portion of long-term debt. (3)The current financing capacity available under the facility is $3.5 billion but can be increased to a maximum potential size of $4.5 billion.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Junior Subordinated Notes | Prudential Financial’s junior subordinated notes outstanding are considered hybrid securities that receive enhanced equity treatment from the rating agencies. These notes outstanding, along with their key terms, are as follows:
|
Employee Benefit Plans (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Retirement Benefits [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Status of Employee Benefit Plans | The status of these plans as of December 31, 2021 and 2020 is summarized below:
__________ (1)For 2021, actuarial gains for pension and other postretirement benefits were primarily driven by an increase in the discount rate. (2)For 2020, actuarial losses for pension and other postretirement benefits were primarily driven by a decrease in the discount rate.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Benefit Obligations in Excess of Fair Value of Plan Assets |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Net Benefit Costs | Net periodic (benefit) cost included in “General and administrative expenses” in the Company’s Consolidated Statements of Operations for the years ended December 31, includes the following components:
__________ (1)For 2021, 2020 and 2019, certain employees were provided special termination benefits under non-qualified plans in the form of unreduced early retirement benefits as a result of their involuntary termination. (2)For 2021 and 2020, certain employees were provided special termination benefits under non-qualified plans in the form of unreduced early retirement benefits as a result of their participation in the Voluntary Separation Program that was offered to eligible U.S.-based employees in 2019. (3)For 2019, certain employees were provided special termination benefits in the qualified and non-qualified plans in the form of retirement eligibility bridging as a result of their participation in the Voluntary Separation Program that was offered to eligible U.S.-based employees.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Accumulated Benefit Obligations in Excess of Fair Value of Plan Assets |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Changes in Accumulated Other Comprehensive Income | The amounts recorded in AOCI as of the end of the period, which have not yet been recognized as a component of net periodic (benefit) cost, and the related changes in these items during the period that are recognized in “Other comprehensive income (loss)” are as follows:
__________ (1)For 2019, deferred losses for pension were driven by a decrease in discount rate partially offset by favorable asset performance. Deferred gains for other postretirement benefits were driven by favorable asset performance partially offset by a decrease in discount rate. (2)For 2020, deferred losses for pension and other postretirement benefits were driven by a decrease in discount rate partially offset by favorable asset performance. (3)For 2021, deferred gains for pension and other postretirement benefits were driven by an increase in discount rate and favorable asset performance.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Assumptions Used | The Company’s assumptions related to the calculation of the domestic benefit obligation (end of period) and the determination of net periodic (benefit) cost (beginning of period) are presented in the table below:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Plans Assets-Fair Value and Allocation % (Target/Actual) | Asset allocation targets as of December 31, 2021 are as follows:
Pension plan asset allocations in accordance with the investment guidelines are as follows:
_______________ (1)Interest rate swaps notional amount is $433 million and $13 million for the years ended December 31, 2021 and 2020, respectively. (2)This category primarily consists of cash and cash equivalents, short-term investments, payables and receivables, and open future contract positions (including fixed income collateral). (3)The pension plan excludes from the fair value hierarchy investments that are measured at NAV per share (or its equivalent) as a practical expedient to estimate fair value. Postretirement plan asset allocations in accordance with the investment guidelines are as follows:
__________ (1)Prior period amounts have been updated to conform to current period presentation. (2)The postretirement plan excludes from the fair value hierarchy investments that are measured at NAV per share (or its equivalent) as a practical expedient to estimate fair value. (3)There were no changes in the fair value of Level 3 postretirement assets from December 31, 2020 through December 31, 2021.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Effect of Significant Unobservable Inputs, Changes in Plan Assets |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Expected Benefit Payments | The expected benefit payments for the Company’s pension and postretirement plans, as well as the expected Medicare Part D subsidy receipts related to the Company’s postretirement plan, for the years indicated are as follows:
|
Equity (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity Note [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common Stock Disclosure | The changes in the number of shares of Common Stock issued, held in treasury and outstanding, are as follows for the periods indicated:
__________ (1)Represents net shares issued from treasury pursuant to the Company’s stock-based compensation programs. (2)In August 2019, as a result of the note holders’ exercise of the exchange option on $500 million of surplus notes, the Company issued approximately 6.2 million shares of Common Stock at an exchange rate equal to 12.3877 shares of Common Stock per each $1,000 principal amount of surplus notes. The Company’s obligations under the surplus notes are now satisfied. For additional information, see Note 20. (3)In October 2019, the Company issued approximately 5.5 million shares of Common Stock as part of consideration paid for the Assurance IQ acquisition. For additional information about the acquisition, see Note 1.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share Repurchases Authorizations | The following table summarizes share repurchases for each of the past three years as well as the share repurchase authorization for 2022, which was approved by the Board of Directors in November 2021:
__________ * Share repurchase authorization for a future period. (1)In April 2020, the Company suspended Common Stock repurchases under the 2020 share repurchase authorization and did not resume share repurchases for the remainder of the authorization period.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Components of Accumulated Other Comprehensive Income (Loss) | The balance of and changes in each component of AOCI as of and for the years ended December 31, are as follows:
__________ (1)Includes cash flow hedges of $1,019 million, $(168) million and $832 million as of December 31, 2021, 2020, and 2019, respectively, and fair value hedges of $(35) million, $10 million, and $0 million as of December 31, 2021, 2020, and 2019, respectively.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reclassification Out Of Accumulated Other Comprehensive Income (Loss) | Reclassifications out of Accumulated Other Comprehensive Income (Loss)
__________ (1)All amounts are shown before tax. (2)Positive amounts indicate gains/benefits reclassified out of AOCI. Negative amounts indicate losses/costs reclassified out of AOCI. (3)See Note 5 for additional information on cash flow and fair value hedges. (4)See table below for additional information on unrealized investment gains (losses), including the impact on deferred policy acquisition and other costs, future policy benefits and policyholders’ dividends. (5)See Note 18 for information on employee benefit plans.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
OTTI, Allowance and All Other Net Unrealized Investment Gain Loss AOCI Rollforward | The amounts for the periods indicated below, split between amounts related to available-for-sale fixed maturity securities on which an OTTI loss had been previously recognized, an allowance for credit losses has been recorded, and all other net unrealized investment gains (losses), are as follows:
__________ (1)Includes cash flow and fair value hedges. See Note 5 for additional information. (2)Represents net unrealized gains (losses) for which an OTTI loss had been previously recognized.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Statutory Financial Information | The following table summarizes certain statutory financial information for the Company’s two largest U.S. insurance subsidiaries for the periods indicated:
__________ (1)Prior year amounts have been updated to conform to finalized statutory filing where applicable.
|
Earnings Per Share (Tables) |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reconciliation of Earnings Per Share | A reconciliation of the numerators and denominators of the basic and diluted per share computations of Common Stock based on the consolidated earnings of Prudential Financial for the years ended December 31, is as follows:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share Computation | For the years ended December 31, the number of stock options and shares related to deferred and long-term compensation programs that were considered antidilutive and were excluded from the computation of diluted earnings per share, weighted for the portion of the period they were outstanding, are as follows:
|
Share-Based Payments (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-based Payment Arrangement [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Share Based Payment Award Stock Options Valuation Assumptions | The weighted average grant date assumptions used in the binomial option valuation model are as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan | The following table summarizes the compensation cost recognized and the related income tax benefit for stock options, restricted stock units, performance shares and performance units for the years ended December 31:
__________ (1) Compensation costs related to retirement eligible participants are recorded on the grant date (typically in the first quarter of every year).
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Share Based Compensation Stock Options Activity | A summary of the status of the Company’s stock option grants is as follows:
The weighted average remaining contractual term and the aggregate intrinsic value of stock options outstanding and exercisable as of December 31, 2021 is as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Nonvested Share Activity | A summary of the Company’s restricted stock units, performance shares and performance unit awards under the Omnibus Incentive Plan is as follows:
__________ (1)Performance share and performance unit awards reflect the target units awarded, reduced for forfeitures and releases to date. The actual number of units to be awarded at the end of each performance period will range between 0% and 150% of the target number of units granted, based upon a measure of the reported performance for the Company relative to stated goals. Performance awards granted to senior management in 2021 include a stated goal related to diversity & inclusion that can modify the performance result by +/- 10%. (2)Effective October 1, 2019, the Company modified existing performance share and performance unit awards to remove features of the grants that prevent having a mutual understanding of the key terms and conditions of the award between the employee and employer until the grants vested. Consequently, the weighted average grant date fair value as of December 31, 2021 is the closing stock price of Prudential Financial’s common stock as of September 30, 2019 for performance shares that were outstanding on September 30, 2019. The weighted average grant date fair value for performance shares granted after September 30, 2019 is the closing stock price of Prudential Financial’s common stock on the date the awards were granted. (3)Represents the difference between the target units granted and the actual units awarded based upon the attainment of performance goals for the Company.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-Based Payments | A summary of the Company’s restricted stock units and performance share awards related to the Assurance IQ acquisition is as follows:
__________ (1)Performance share awards related to the Assurance IQ acquisition reflect the maximum number of units that have been awarded under the terms of the acquisition. The actual number of units that will be awarded at the end of the performance period will range between 0% and 100% of the number of units granted, based upon a predetermined formula for achieving certain targets for gross revenues, net of associated selling expenses, between $900 million and $1,300 million. (2)Represents the difference between the target units granted and the actual units awarded based upon the attainment of performance goals for the Company.
|
Segment Information (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reconciliation of Operating Profit (Loss) from Segments to Consolidated | The following table sets forth the significant components of “Realized investment gains (losses), net” that are included in adjusted operating income and, as a result, are reflected as adjustments to “Realized investment gains (losses), net” for purposes of calculating adjusted operating income:
__________ (1)Prior period amounts have been updated to conform to current period presentation. (2)In addition to the items in the table above, “Realized investment gains (losses), net, and related charges and adjustments” also includes an adjustment to reflect “Realized investment gains (losses), net” related to Divested and Run-off Businesses. See “Divested and Run-off Businesses” discussed below. The following table sets forth certain other items excluded from adjusted operating income and reflected as an adjustment to “Realized investment gains (losses), net” for purposes of calculating adjusted operating income:
__________ (1)Prior period amounts have been updated to conform to current period presentation. (2)Adjusted operating income excludes net investment gains (losses) on assets supporting experience-rated contractholder liabilities, related derivatives, and commercial mortgage and other loans. The activity for derivatives and commercial mortgage and other loans that support these experience-rated products are reported in “Realized investment gains (losses), net” and excluded from adjusted operating income. The table below reconciles adjusted operating income before income taxes to income before income taxes and equity in earnings of operating joint ventures:
__________ (1)Effective third quarter of 2021, the results of the Full Service Retirement business are excluded from the Retirement segment and are included in Divested and Run-off Businesses. Prior period amounts have been updated to conform to current period presentation. See Note 1 to the Consolidated Financial Statements for additional information. (2)Individual Annuities segment results reflect DAC as if the Individual Annuities business is a stand-alone operation. The elimination of intersegment costs capitalized in accordance with this policy is included in consolidating adjustments within Corporate and Other operations. (3)Assurance IQ was acquired by the Company in October 2019. See Note 1 for additional information. (4)In the fourth quarter of 2021, the Company recognized a goodwill impairment of $1,060 million related to Assurance IQ. See Note 2 and Note 10 for additional information.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Segment Reporting Information, by Segment | The tables below present certain financial information for the Company’s segments and its Corporate and Other operations, including assets by segment and revenues, and benefits and expenses by segment on an adjusted operating income basis, and the reconciliation of the segment totals to amounts reported in the Consolidated Financial Statements.
__________ (1)Effective third quarter of 2021, the results of the Full Service Retirement business are excluded from the Retirement segment and are included in the Divested and Run-off Businesses in Corporate and Other. Prior period amounts have been updated to conform to current period presentation. See Note 1 for additional information about these dispositions. (2)Certain assets are classified as “held-for-sale” as of December 31, 2021. See Note 1 for additional information about the pending dispositions.
__________ (1)Effective third quarter of 2021, the results of the Full Service Retirement business are excluded from the Retirement segment and are included in the Divested and Run-off Businesses in Corporate and Other. Prior period amounts have been updated to conform to current period presentation. See Note 1 for additional information about these dispositions. (2)Assurance IQ was acquired by the Company in October 2019. See Note 1 for additional information.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule Of Revenues From Domestic And Foreign Operations | Revenues, calculated in accordance with U.S. GAAP, for the years ended December 31, include the following by geographic location that are 10 percent or more of the Company’s total consolidated revenue:
__________ (1)Prior period amounts have been updated to conform to current period presentation.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule Of Intersegment Revenues | The PGIM segment revenues include intersegment revenues, primarily consisting of asset-based management and administration fees, for the years ended December 31, as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Asset Mgmt and Service Fees | The table below presents asset management and service fees, predominantly related to investment management activities, for the periods indicated:
|
Commitments and Contingent Liabilities (Tables) |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingent Liabilities [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mortgage Loans | The following table sets forth the composition of “Commercial mortgage and other loans,” as of the dates indicated:
__________ (1)Excludes “Assets held-for-sale” of $6,565 million net of allowance for credit losses of $15 million as of December 31, 2021. See Note 1 for additional information on the pending dispositions. (2)Includes loans which are carried at fair value under the fair value option and are collateralized primarily by apartment complexes. As of December 31, 2021 and 2020, the net carrying value of these loans was $1,263 million and $1,092 million, respectively.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Insolvency Assessment | Assets and liabilities held for insolvency assessments were as follows:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments | Commercial Mortgage Loans | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingent Liabilities [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mortgage Loans | Commercial Mortgage Loan Commitments
__________ (1)Includes commitments of $21 million related to held-for-sale operations as of December 31, 2021. See Note 1 for additional information on the pending dispositions.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments | Investments | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingent Liabilities [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments to Purchase Investments (excluding Commercial Mortgage Loans) | Commitments to Purchase Investments (excluding Commercial Mortgage Loans)
__________ (1)Includes commitments of $118 million related to held-for-sale operations as of December 31, 2021. See Note 1 for additional information on the pending dispositions.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Indemnification | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingent Liabilities [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Indemnification of Securities Lending and Securities Repurchase Transactions | Indemnification of Securities Lending and Securities Repurchase Transactions
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Indemnification | Serviced Mortgage Loans | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingent Liabilities [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mortgage Loans | Indemnification of Serviced Mortgage Loans
__________ (1)As of both December 31, 2021 and 2020, the accrued liability associated with guarantees includes an allowance for credit losses of $20 million. The change in allowance is $0 million and $1 million as of December 31, 2021 and 2020, respectively.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Guarantee of Asset Values | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingent Liabilities [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Guarantees | Guarantees of Asset Values
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Guarantees | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingent Liabilities [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Guarantees | Other Guarantees
|
Business and Basis of Presentation (Acquisitions Narratives) (Details) - USD ($) $ in Millions |
1 Months Ended | 12 Months Ended | ||||
---|---|---|---|---|---|---|
Oct. 31, 2019 |
Dec. 31, 2021 |
Dec. 31, 2020 |
Apr. 30, 2020 |
Dec. 31, 2019 |
Dec. 31, 2018 |
|
Business Acquisition [Line Items] | ||||||
Goodwill | $ 1,804 | $ 3,035 | $ 3,013 | $ 863 | ||
Impairments | (1,060) | |||||
Assurance IQ | ||||||
Business Acquisition [Line Items] | ||||||
Goodwill | 1,080 | 2,140 | $ 2,140 | $ 2,128 | $ 0 | |
Impairments | (1,060) | |||||
Acquisition of Assurance IQ, Inc. | ||||||
Business Acquisition [Line Items] | ||||||
Consideration transferred | $ 2,212 | |||||
Contingent consideration, liability | 100 | $ 0 | $ 0 | |||
Equity interest issued, value | $ 160 |
Business and Basis of Presentation (Dispositions Narratives) (Details) $ in Millions, ₩ in Trillions |
3 Months Ended | 12 Months Ended | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2021
USD ($)
|
Mar. 31, 2020
USD ($)
|
Dec. 31, 2021
USD ($)
|
Jun. 30, 2021
USD ($)
|
Dec. 31, 2020
USD ($)
|
Dec. 31, 2019
USD ($)
|
Sep. 30, 2021
USD ($)
|
Sep. 30, 2021
TWD ($)
|
Sep. 15, 2021
USD ($)
|
Jul. 21, 2021
USD ($)
|
Mar. 01, 2021 |
Aug. 31, 2020
USD ($)
|
Aug. 31, 2020
KRW (₩)
|
Aug. 11, 2020
USD ($)
|
|
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||||||||||||||
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest | $ 9,381,000,000 | $ (323,000,000) | $ 5,085,000,000 | |||||||||||
Other Income | 2,951,000,000 | 1,950,000,000 | 3,262,000,000 | |||||||||||
Other Guarantees | ||||||||||||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||||||||||||||
Accrued Liability associated with guarantee | 34,000,000 | 0 | ||||||||||||
Held-for-sale | Individual Annuities PALAC | ||||||||||||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||||||||||||||
Cash considerations for sale of a business | $ 2,200,000,000 | |||||||||||||
Held-for-sale | Individual Annuities PALAC | Variable Annuity | ||||||||||||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||||||||||||||
Net Amount at Risk by Product and Guarantee, Net Amount at Risk | $ 30,000,000,000 | |||||||||||||
Net Amount at Risk by Product and Guarantee, Net Amount at Risk, Percentage Held-For-Sale | 18.00% | |||||||||||||
Held-for-sale | Retirement Full Service | ||||||||||||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||||||||||||||
Cash considerations for sale of a business | $ 2,800,000,000 | |||||||||||||
Business Acquisition, Transaction Costs | $ 400,000,000 | |||||||||||||
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest | $ 190,000,000 | 179,000,000 | $ 237,000,000 | |||||||||||
Held-for-sale | The Prudential Life Insurance Company of Taiwan Inc. | ||||||||||||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||||||||||||||
Cash considerations for sale of a business | $ 200,000,000 | $ 5,500 | ||||||||||||
Other Income | $ (50,000,000) | $ (400,000,000) | $ (350,000,000) | |||||||||||
Business Combination, Contingent Consideration, Asset | 80,000,000 | |||||||||||||
Held-for-sale | The Prudential Life Insurance Company of Taiwan Inc. | Other Guarantees | ||||||||||||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||||||||||||||
Accrued Liability associated with guarantee | $ 34,000,000 | |||||||||||||
Held-for-sale | The Prudential Life Insurance Company of Taiwan Inc. | Maximum | ||||||||||||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||||||||||||||
Business Combination, Contingent Consideration, Asset | $ 100,000,000 | |||||||||||||
Held-for-sale | The Prudential Life Insurance Company of Korea, Ltd. | ||||||||||||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||||||||||||||
Cash considerations for sale of a business | $ 1,900,000,000 | ₩ 2.3 | ||||||||||||
Other Income | $ (800,000,000) | |||||||||||||
Disposal Group, Disposed of by Sale, Not Discontinued Operations | Pramerica SGR | ||||||||||||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||||||||||||||
Other Income | $ 330,000,000 | |||||||||||||
Equity Method Investment, Ownership Percentage | 35.00% |
Business and Basis of Presentation (Held-For-Sale Table) (Details) - USD ($) $ in Millions |
Dec. 31, 2021 |
Dec. 31, 2020 |
Apr. 30, 2020 |
Dec. 31, 2019 |
Dec. 31, 2018 |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||||||||||
Fixed maturities, available-for-sale, at fair value | $ 333,459 | $ 354,470 | |||||||||
Fixed Maturities, Trading, amortized cost | 8,741 | 3,670 | |||||||||
Assets supporting experience-rated contractholder liabilities, at fair value | 3,358 | 24,115 | |||||||||
Equity securities, at fair value (cost: 2021- $25; 2020- $25) | [1] | 8,574 | 8,135 | ||||||||
Commercial mortgage and other loans (net of $119 and $235 allowance for credit losses; includes $1,263 and $1,092 of loans measured at fair value under the fair value option at December 31, 2021 and 2020, respectively | [1] | 58,666 | 65,425 | ||||||||
Policy loans | 10,386 | 11,271 | |||||||||
Other invested assets | [1] | 21,833 | 18,125 | ||||||||
Cash and cash equivalents | 12,888 | [1] | 13,701 | [1] | $ 16,327 | ||||||
Accrued investment income | [1] | 2,855 | 3,193 | ||||||||
Deferred Policy Acquisition Cost | 18,192 | 19,027 | 19,912 | $ 20,058 | |||||||
Value of business acquired | 771 | 1,103 | 1,110 | 1,850 | |||||||
Other assets | [1] | 10,739 | 22,801 | ||||||||
Separate account assets | 246,145 | 327,277 | |||||||||
Assets held-for-sale | 153,793 | [2] | 0 | 0 | |||||||
Future policy benefits | 290,784 | 306,343 | |||||||||
Total policyholders’ account balances | 122,633 | 161,682 | |||||||||
Cash collateral for loaned securities | 4,251 | 3,499 | |||||||||
Other liabilities | [1] | 11,755 | 20,323 | ||||||||
Separate account liabilities | 246,145 | 327,277 | |||||||||
Liabilities held-for-sale | 151,359 | [2] | 0 | 0 | |||||||
Goodwill | 1,804 | 3,035 | 3,013 | 863 | |||||||
Fixed Maturities, AFS, allowance for credit losses | 114 | 133 | |||||||||
Fixed Maturities | |||||||||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||||||||||
Fixed maturities, available-for-sale, at fair value | 333,459 | 354,470 | |||||||||
Assets supporting experience-rated contractholder liabilities, at fair value | 1,057 | 21,414 | |||||||||
Accrued investment income | 2,398 | 2,676 | |||||||||
Fixed Maturities, AFS, allowance for credit losses | 114 | 133 | |||||||||
Assurance IQ | |||||||||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||||||||||
Goodwill | 1,080 | $ 2,140 | $ 2,140 | $ 2,128 | $ 0 | ||||||
Retirement Full Service | |||||||||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||||||||||
Goodwill | 455 | ||||||||||
Held-for-sale | |||||||||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||||||||||
Fixed maturities, available-for-sale, at fair value | 13,569 | ||||||||||
Fixed Maturities, Trading, amortized cost | 401 | ||||||||||
Assets supporting experience-rated contractholder liabilities, at fair value | 18,818 | ||||||||||
Equity securities, at fair value (cost: 2021- $25; 2020- $25) | 322 | ||||||||||
Commercial mortgage and other loans (net of $119 and $235 allowance for credit losses; includes $1,263 and $1,092 of loans measured at fair value under the fair value option at December 31, 2021 and 2020, respectively | 6,565 | ||||||||||
Policy loans | 12 | ||||||||||
Other invested assets | 104 | ||||||||||
Short-term investments (net of allowance for credit losses: 2021-$0; 2020-$1) | 878 | ||||||||||
Cash and cash equivalents | 2,071 | ||||||||||
Accrued investment income | 221 | ||||||||||
Deferred Policy Acquisition Cost | 1,197 | ||||||||||
Value of business acquired | 215 | ||||||||||
Other assets | 11,318 | ||||||||||
Separate account assets | 98,102 | ||||||||||
Assets held-for-sale | 153,793 | ||||||||||
Future policy benefits | 4,662 | ||||||||||
Total policyholders’ account balances | 39,914 | ||||||||||
Other liabilities | 8,681 | ||||||||||
Separate account liabilities | 98,102 | ||||||||||
Liabilities held-for-sale | 151,359 | ||||||||||
Held-for-sale | Retirement Full Service | |||||||||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||||||||||
Fixed maturities, available-for-sale, at fair value | 4,798 | ||||||||||
Fixed Maturities, Trading, amortized cost | 374 | ||||||||||
Assets supporting experience-rated contractholder liabilities, at fair value | 18,818 | ||||||||||
Equity securities, at fair value (cost: 2021- $25; 2020- $25) | 0 | ||||||||||
Commercial mortgage and other loans (net of $119 and $235 allowance for credit losses; includes $1,263 and $1,092 of loans measured at fair value under the fair value option at December 31, 2021 and 2020, respectively | 5,068 | ||||||||||
Policy loans | 0 | ||||||||||
Other invested assets | 10 | ||||||||||
Short-term investments (net of allowance for credit losses: 2021-$0; 2020-$1) | 3 | ||||||||||
Cash and cash equivalents | 56 | ||||||||||
Accrued investment income | 160 | ||||||||||
Deferred Policy Acquisition Cost | 100 | ||||||||||
Value of business acquired | 185 | ||||||||||
Other assets | 674 | ||||||||||
Separate account assets | 65,835 | ||||||||||
Assets held-for-sale | 96,081 | ||||||||||
Future policy benefits | 157 | ||||||||||
Total policyholders’ account balances | 28,164 | ||||||||||
Other liabilities | 374 | ||||||||||
Separate account liabilities | 65,835 | ||||||||||
Liabilities held-for-sale | 94,530 | ||||||||||
Held-for-sale | Individual Annuities PALAC | |||||||||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||||||||||
Fixed maturities, available-for-sale, at fair value | 8,771 | ||||||||||
Fixed Maturities, Trading, amortized cost | 27 | ||||||||||
Assets supporting experience-rated contractholder liabilities, at fair value | 0 | ||||||||||
Equity securities, at fair value (cost: 2021- $25; 2020- $25) | 322 | ||||||||||
Commercial mortgage and other loans (net of $119 and $235 allowance for credit losses; includes $1,263 and $1,092 of loans measured at fair value under the fair value option at December 31, 2021 and 2020, respectively | 1,497 | ||||||||||
Policy loans | 12 | ||||||||||
Other invested assets | 94 | ||||||||||
Short-term investments (net of allowance for credit losses: 2021-$0; 2020-$1) | 875 | ||||||||||
Cash and cash equivalents | 2,015 | ||||||||||
Accrued investment income | 61 | ||||||||||
Deferred Policy Acquisition Cost | 1,097 | ||||||||||
Value of business acquired | 30 | ||||||||||
Other assets | 10,644 | ||||||||||
Separate account assets | 32,267 | ||||||||||
Assets held-for-sale | 57,712 | ||||||||||
Future policy benefits | 4,505 | ||||||||||
Total policyholders’ account balances | 11,750 | ||||||||||
Other liabilities | 8,307 | ||||||||||
Separate account liabilities | 32,267 | ||||||||||
Liabilities held-for-sale | 56,829 | ||||||||||
Held-for-sale | |||||||||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||||||||||
Fixed maturities, available-for-sale, at fair value | 13,145 | ||||||||||
Assets supporting experience-rated contractholder liabilities, at fair value | 18,818 | ||||||||||
Other invested assets | 104 | ||||||||||
Accrued investment income | 221 | ||||||||||
Loans and Leases Receivable, Allowance | 15 | ||||||||||
Held-for-sale | Fixed Maturities | |||||||||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||||||||||
Fixed maturities, available-for-sale, at fair value | 13,145 | ||||||||||
Assets supporting experience-rated contractholder liabilities, at fair value | 17,706 | ||||||||||
Fixed Maturities, AFS, allowance for credit losses | $ 1 | ||||||||||
|
Significant Accounting Policies and Pronouncements (Summary of Transition Impact) (Details) - USD ($) $ in Millions |
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
Dec. 31, 2018 |
||
---|---|---|---|---|---|---|
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||
Fixed maturities, held-to-maturity | [1] | $ 1,514 | $ 1,930 | |||
Commercial mortgage and other loans | [1] | 58,666 | 65,425 | |||
Other invested assets | [1] | 21,833 | 18,125 | |||
Deferred policy acquisition cost | 18,192 | 19,027 | $ 19,912 | $ 20,058 | ||
Other assets | [1] | 10,739 | 22,801 | |||
Total assets | 937,582 | 940,722 | ||||
Policyholder's dividends | 8,731 | 9,524 | ||||
Other liabilities | [1] | 11,755 | 20,323 | |||
Income taxes | 9,513 | 12,022 | ||||
Total liabilities | 874,974 | 872,512 | ||||
Retained earnings | 36,652 | 30,749 | ||||
Total equity | 62,608 | 68,210 | $ 63,719 | $ 49,031 | ||
TOTAL LIABILITIES AND EQUITY | 937,582 | 940,722 | ||||
ASU 2016-13 | ||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||
Other liabilities | $ 21 | $ 20 | ||||
|
Significant Accounting Policies and Pronouncements (Narratives) (Details) - USD ($) $ in Millions |
12 Months Ended | |||
---|---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
Dec. 31, 2018 |
|
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||
Retained earnings | $ 36,652 | $ 30,749 | ||
Accumulated other comprehensive income (loss) | 21,324 | 30,738 | ||
Total equity | $ 62,608 | 68,210 | $ 63,719 | $ 49,031 |
Loan-to-value ratios (greater than) | 100.00% | |||
Loan-to-value ratio (less than) | 100.00% | |||
Debt service coverage ratios (less than) | 1.0 | |||
Repurchase and Resale Agreements, Collateral, Percentage | 95.00% | |||
Uncertain Tax Positions Measurement Percentage (greater than) | 50.00% | |||
Operating Lease, Right-of-Use Asset | $ 395 | 466 | ||
Operating Lease, Liability | 432 | 511 | ||
Accumulated Other Comprehensive Income (Loss) | ||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||
Accumulated other comprehensive income (loss) | 21,324 | 30,738 | 24,039 | 10,906 |
Total equity | 21,324 | 30,738 | 24,039 | 10,906 |
Retained Earnings | ||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||
Total equity | $ 36,652 | $ 30,749 | $ 32,991 | $ 30,470 |
United States | Securities Lending and Securities Repurchase Transactions | ||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||
Guarantor Obligations, Liquidation Proceeds, Percentage | 102.00% | |||
Other Countries | Securities Lending and Securities Repurchase Transactions | ||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||
Guarantor Obligations, Liquidation Proceeds, Percentage | 105.00% | |||
Minimum | ||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||
Estimated useful life | 3 years | |||
Maximum | ||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||
Estimated useful life | 40 years |
Investments (Fixed Maturities Securities Excluding Investments Classified as Trading) (Details) - USD ($) $ in Millions |
Dec. 31, 2021 |
Dec. 31, 2020 |
||
---|---|---|---|---|
Summary Of Investments Other Than Investments In Related Parties Reportable Data [Line Items] | ||||
Debt Securities, Available-for-sale, Amortized Cost | $ 333,459 | $ 354,470 | ||
Fixed Maturities, AFS, allowance for credit losses | 114 | 133 | ||
Fixed Maturities, Available for Sale, Fair Value | [1] | 372,410 | 412,905 | |
Amortized Cost | [1] | 1,514 | 1,930 | |
Fixed Maturities, Held-to-maturity, Fair Value | 1,803 | 2,298 | ||
Fixed Maturities, HTM, allowance for credit losses | 5 | 9 | ||
Held-for-sale | ||||
Summary Of Investments Other Than Investments In Related Parties Reportable Data [Line Items] | ||||
Debt Securities, Available-for-sale, Amortized Cost | 13,145 | |||
Fixed Maturities, Available for Sale, Fair Value | 13,569 | |||
Fixed maturities | ||||
Summary Of Investments Other Than Investments In Related Parties Reportable Data [Line Items] | ||||
Debt Securities, Available-for-sale, Amortized Cost | 333,459 | 354,470 | ||
Gross Unrealized Gains | 40,795 | 59,548 | ||
Gross Unrealized Losses | 1,730 | 980 | ||
Fixed Maturities, AFS, allowance for credit losses | 114 | 133 | ||
Fixed Maturities, Available for Sale, Fair Value | 372,410 | 412,905 | ||
Amortized Cost | 1,519 | 1,939 | ||
Gross Unrealized Gains | 284 | 359 | ||
Gross Unrealized Losses | 0 | 0 | ||
Fixed Maturities, Held-to-maturity, Fair Value | 1,803 | 2,298 | ||
Fixed Maturities, HTM, allowance for credit losses | 5 | 9 | ||
Amortized Cost, Net of Allowance | 1,514 | 1,930 | ||
Fixed maturities | Held-for-sale | ||||
Summary Of Investments Other Than Investments In Related Parties Reportable Data [Line Items] | ||||
Debt Securities, Available-for-sale, Amortized Cost | 13,145 | |||
Gross Unrealized Gains | 572 | |||
Gross Unrealized Losses | 147 | |||
Fixed Maturities, AFS, allowance for credit losses | 1 | |||
Fixed Maturities, Available for Sale, Fair Value | 13,569 | |||
Fixed maturities | U.S. Treasury securities and obligations of U.S. government authorities and agencies | ||||
Summary Of Investments Other Than Investments In Related Parties Reportable Data [Line Items] | ||||
Debt Securities, Available-for-sale, Amortized Cost | 26,231 | 30,766 | ||
Gross Unrealized Gains | 5,958 | 9,699 | ||
Gross Unrealized Losses | 31 | 17 | ||
Fixed Maturities, AFS, allowance for credit losses | 0 | 0 | ||
Fixed Maturities, Available for Sale, Fair Value | 32,158 | 40,448 | ||
Fixed maturities | Obligations of U.S. states and their political subdivisions | ||||
Summary Of Investments Other Than Investments In Related Parties Reportable Data [Line Items] | ||||
Debt Securities, Available-for-sale, Amortized Cost | 10,445 | 10,668 | ||
Gross Unrealized Gains | 1,781 | 2,144 | ||
Gross Unrealized Losses | 8 | 1 | ||
Fixed Maturities, AFS, allowance for credit losses | 0 | 0 | ||
Fixed Maturities, Available for Sale, Fair Value | 12,218 | 12,811 | ||
Fixed maturities | Foreign government bonds | ||||
Summary Of Investments Other Than Investments In Related Parties Reportable Data [Line Items] | ||||
Debt Securities, Available-for-sale, Amortized Cost | 83,363 | 94,110 | ||
Gross Unrealized Gains | 11,842 | 16,373 | ||
Gross Unrealized Losses | 529 | 239 | ||
Fixed Maturities, AFS, allowance for credit losses | 7 | 0 | ||
Fixed Maturities, Available for Sale, Fair Value | 94,669 | 110,244 | ||
Amortized Cost | 833 | 935 | ||
Gross Unrealized Gains | 221 | 270 | ||
Gross Unrealized Losses | 0 | 0 | ||
Fixed Maturities, Held-to-maturity, Fair Value | 1,054 | 1,205 | ||
Fixed Maturities, HTM, allowance for credit losses | 0 | 0 | ||
Amortized Cost, Net of Allowance | 833 | 935 | ||
Fixed maturities | U.S. public corporate securities | ||||
Summary Of Investments Other Than Investments In Related Parties Reportable Data [Line Items] | ||||
Debt Securities, Available-for-sale, Amortized Cost | 98,836 | 95,299 | ||
Gross Unrealized Gains | 13,721 | 18,516 | ||
Gross Unrealized Losses | 390 | 213 | ||
Fixed Maturities, AFS, allowance for credit losses | 12 | 47 | ||
Fixed Maturities, Available for Sale, Fair Value | 112,155 | 113,555 | ||
Fixed maturities | U.S. private corporate securities | ||||
Summary Of Investments Other Than Investments In Related Parties Reportable Data [Line Items] | ||||
Debt Securities, Available-for-sale, Amortized Cost | 35,019 | 36,894 | ||
Gross Unrealized Gains | 2,583 | 4,196 | ||
Gross Unrealized Losses | 162 | 134 | ||
Fixed Maturities, AFS, allowance for credit losses | 58 | 19 | ||
Fixed Maturities, Available for Sale, Fair Value | 37,382 | 40,937 | ||
Fixed maturities | Foreign public corporate securities | ||||
Summary Of Investments Other Than Investments In Related Parties Reportable Data [Line Items] | ||||
Debt Securities, Available-for-sale, Amortized Cost | 24,877 | 25,857 | ||
Gross Unrealized Gains | 2,571 | 3,768 | ||
Gross Unrealized Losses | 118 | 64 | ||
Fixed Maturities, AFS, allowance for credit losses | 21 | 24 | ||
Fixed Maturities, Available for Sale, Fair Value | 27,309 | 29,537 | ||
Amortized Cost | 486 | 651 | ||
Gross Unrealized Gains | 49 | 68 | ||
Gross Unrealized Losses | 0 | 0 | ||
Fixed Maturities, Held-to-maturity, Fair Value | 535 | 719 | ||
Fixed Maturities, HTM, allowance for credit losses | 5 | 9 | ||
Amortized Cost, Net of Allowance | 481 | 642 | ||
Fixed maturities | Foreign private corporate securities | ||||
Summary Of Investments Other Than Investments In Related Parties Reportable Data [Line Items] | ||||
Debt Securities, Available-for-sale, Amortized Cost | 28,047 | 28,668 | ||
Gross Unrealized Gains | 1,448 | 3,183 | ||
Gross Unrealized Losses | 442 | 226 | ||
Fixed Maturities, AFS, allowance for credit losses | 16 | 33 | ||
Fixed Maturities, Available for Sale, Fair Value | 29,037 | 31,592 | ||
Amortized Cost | 9 | 87 | ||
Gross Unrealized Gains | 0 | 1 | ||
Gross Unrealized Losses | 0 | 0 | ||
Fixed Maturities, Held-to-maturity, Fair Value | 9 | 88 | ||
Fixed Maturities, HTM, allowance for credit losses | 0 | 0 | ||
Amortized Cost, Net of Allowance | 9 | 87 | ||
Fixed maturities | Asset-backed securities | ||||
Summary Of Investments Other Than Investments In Related Parties Reportable Data [Line Items] | ||||
Debt Securities, Available-for-sale, Amortized Cost | 11,402 | 14,489 | ||
Gross Unrealized Gains | 137 | 176 | ||
Gross Unrealized Losses | 14 | 74 | ||
Fixed Maturities, AFS, allowance for credit losses | 0 | 0 | ||
Fixed Maturities, Available for Sale, Fair Value | 11,525 | 14,591 | ||
Fixed maturities | Commercial mortgage-backed securities | ||||
Summary Of Investments Other Than Investments In Related Parties Reportable Data [Line Items] | ||||
Debt Securities, Available-for-sale, Amortized Cost | 12,490 | 15,036 | ||
Gross Unrealized Gains | 631 | 1,288 | ||
Gross Unrealized Losses | 22 | 11 | ||
Fixed Maturities, AFS, allowance for credit losses | 0 | 10 | ||
Fixed Maturities, Available for Sale, Fair Value | 13,099 | 16,303 | ||
Fixed maturities | Residential mortgage-backed securities | ||||
Summary Of Investments Other Than Investments In Related Parties Reportable Data [Line Items] | ||||
Debt Securities, Available-for-sale, Amortized Cost | 2,749 | 2,683 | ||
Gross Unrealized Gains | 123 | 205 | ||
Gross Unrealized Losses | 14 | 1 | ||
Fixed Maturities, AFS, allowance for credit losses | 0 | 0 | ||
Fixed Maturities, Available for Sale, Fair Value | 2,858 | 2,887 | ||
Amortized Cost | 191 | 266 | ||
Gross Unrealized Gains | 14 | 20 | ||
Gross Unrealized Losses | 0 | 0 | ||
Fixed Maturities, Held-to-maturity, Fair Value | 205 | 286 | ||
Fixed Maturities, HTM, allowance for credit losses | 0 | 0 | ||
Amortized Cost, Net of Allowance | 191 | 266 | ||
Prudential Netting Agreement | Fixed maturities | ||||
Summary Of Investments Other Than Investments In Related Parties Reportable Data [Line Items] | ||||
Amortized Cost | 4,750 | 4,998 | ||
Fixed Maturities, Held-to-maturity, Fair Value | 5,394 | 5,821 | ||
Prudential Netting Agreement | Fixed maturities | U.S. private corporate securities | ||||
Summary Of Investments Other Than Investments In Related Parties Reportable Data [Line Items] | ||||
Debt Securities, Available-for-sale, Amortized Cost | 5,941 | 5,966 | ||
Fixed Maturities, Available for Sale, Fair Value | $ 5,995 | $ 6,100 | ||
|
Investments (Fair Value and Losses by Investment Category and Length of Time in a Loss Position) (Details) - Fixed maturities - USD ($) $ in Millions |
Dec. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Debt Securities[Line Items] | ||
Less than Twelve Months, Fair Value | $ 41,351 | $ 19,718 |
Less than Twelve Months, Unrealized Losses | 950 | 486 |
Twelve Months or More, Fair Value | 13,937 | 9,605 |
Twelve Months or More, Unrealized Losses | 755 | 463 |
Total, Fair Value | 55,288 | 29,323 |
Total, Unrealized Losses | 1,705 | 949 |
Held-for-sale | ||
Debt Securities[Line Items] | ||
Total, Fair Value | 4,644 | |
Total, Unrealized Losses | 147 | |
U.S. Treasury securities and obligations of U.S. government authorities and agencies | ||
Debt Securities[Line Items] | ||
Less than Twelve Months, Fair Value | 1,521 | 750 |
Less than Twelve Months, Unrealized Losses | 15 | 17 |
Twelve Months or More, Fair Value | 269 | 0 |
Twelve Months or More, Unrealized Losses | 16 | 0 |
Total, Fair Value | 1,790 | 750 |
Total, Unrealized Losses | 31 | 17 |
Obligations of U.S. states and their political subdivisions | ||
Debt Securities[Line Items] | ||
Less than Twelve Months, Fair Value | 289 | 73 |
Less than Twelve Months, Unrealized Losses | 5 | 1 |
Twelve Months or More, Fair Value | 71 | 0 |
Twelve Months or More, Unrealized Losses | 3 | 0 |
Total, Fair Value | 360 | 73 |
Total, Unrealized Losses | 8 | 1 |
Foreign government bonds | ||
Debt Securities[Line Items] | ||
Less than Twelve Months, Fair Value | 4,534 | 6,536 |
Less than Twelve Months, Unrealized Losses | 244 | 231 |
Twelve Months or More, Fair Value | 6,945 | 39 |
Twelve Months or More, Unrealized Losses | 282 | 8 |
Total, Fair Value | 11,479 | 6,575 |
Total, Unrealized Losses | 526 | 239 |
U.S. public corporate securities | ||
Debt Securities[Line Items] | ||
Less than Twelve Months, Fair Value | 12,403 | 3,905 |
Less than Twelve Months, Unrealized Losses | 219 | 87 |
Twelve Months or More, Fair Value | 2,947 | 1,197 |
Twelve Months or More, Unrealized Losses | 152 | 106 |
Total, Fair Value | 15,350 | 5,102 |
Total, Unrealized Losses | 371 | 193 |
U.S. private corporate securities | ||
Debt Securities[Line Items] | ||
Less than Twelve Months, Fair Value | 4,362 | 1,712 |
Less than Twelve Months, Unrealized Losses | 84 | 52 |
Twelve Months or More, Fair Value | 848 | 843 |
Twelve Months or More, Unrealized Losses | 78 | 82 |
Total, Fair Value | 5,210 | 2,555 |
Total, Unrealized Losses | 162 | 134 |
Foreign public corporate securities | ||
Debt Securities[Line Items] | ||
Less than Twelve Months, Fair Value | 3,652 | 1,412 |
Less than Twelve Months, Unrealized Losses | 76 | 30 |
Twelve Months or More, Fair Value | 802 | 376 |
Twelve Months or More, Unrealized Losses | 42 | 23 |
Total, Fair Value | 4,454 | 1,788 |
Total, Unrealized Losses | 118 | 53 |
Foreign private corporate securities | ||
Debt Securities[Line Items] | ||
Less than Twelve Months, Fair Value | 6,350 | 798 |
Less than Twelve Months, Unrealized Losses | 270 | 34 |
Twelve Months or More, Fair Value | 1,604 | 2,371 |
Twelve Months or More, Unrealized Losses | 169 | 192 |
Total, Fair Value | 7,954 | 3,169 |
Total, Unrealized Losses | 439 | 226 |
Asset-backed securities | ||
Debt Securities[Line Items] | ||
Less than Twelve Months, Fair Value | 6,568 | 4,132 |
Less than Twelve Months, Unrealized Losses | 13 | 25 |
Twelve Months or More, Fair Value | 170 | 4,685 |
Twelve Months or More, Unrealized Losses | 1 | 49 |
Total, Fair Value | 6,738 | 8,817 |
Total, Unrealized Losses | 14 | 74 |
Commercial mortgage-backed securities | ||
Debt Securities[Line Items] | ||
Less than Twelve Months, Fair Value | 921 | 284 |
Less than Twelve Months, Unrealized Losses | 11 | 8 |
Twelve Months or More, Fair Value | 263 | 93 |
Twelve Months or More, Unrealized Losses | 11 | 3 |
Total, Fair Value | 1,184 | 377 |
Total, Unrealized Losses | 22 | 11 |
Residential mortgage-backed securities | ||
Debt Securities[Line Items] | ||
Less than Twelve Months, Fair Value | 751 | 116 |
Less than Twelve Months, Unrealized Losses | 13 | 1 |
Twelve Months or More, Fair Value | 18 | 1 |
Twelve Months or More, Unrealized Losses | 1 | 0 |
Total, Fair Value | 769 | 117 |
Total, Unrealized Losses | $ 14 | $ 1 |
Investments (Amortized Cost and Fair Value of Fixed Maturities by Contractual Maturities) (Details) - USD ($) $ in Millions |
Dec. 31, 2021 |
Dec. 31, 2020 |
||
---|---|---|---|---|
Available for Sale, Amortized Cost | ||||
Due in one year or less | $ 8,049 | |||
Due after one year through five years | 47,965 | |||
Due after five years through ten years | 69,291 | |||
Due after ten years | 181,513 | |||
Debt Securities, Available-for-sale, Amortized Cost | 333,459 | $ 354,470 | ||
Available-for-Sale, Fair Value | ||||
Due in one year or less | 8,454 | |||
Due after one year through five years | 50,818 | |||
Due after five years through ten years | 75,508 | |||
Due after ten years | 210,148 | |||
Fixed Maturities, Available for Sale, Fair Value | [1] | 372,410 | 412,905 | |
Held-to-Maturity, Amortized Cost | ||||
Due in one year or less | 0 | |||
Due after one year through five years | 482 | |||
Due after five years through ten years | 30 | |||
Due after ten years | 811 | |||
Amortized Cost | [1] | 1,514 | 1,930 | |
Held-to-Maturity, Fair Value | ||||
Due in one year or less | 0 | |||
Due after one year through five years | 535 | |||
Due after five years through ten years | 32 | |||
Due after ten years | 1,031 | |||
Fixed Maturities, Held-to-maturity, Fair Value | 1,803 | 2,298 | ||
Held-for-sale | ||||
Available for Sale, Amortized Cost | ||||
Debt Securities, Available-for-sale, Amortized Cost | 13,145 | |||
Available-for-Sale, Fair Value | ||||
Fixed Maturities, Available for Sale, Fair Value | 13,569 | |||
Asset-backed securities | ||||
Available for Sale, Amortized Cost | ||||
Debt Maturities, without single maturity date | 11,402 | |||
Available-for-Sale, Fair Value | ||||
Debt Maturities, without Single Maturity Date | 11,525 | |||
Held-to-Maturity, Amortized Cost | ||||
Debt Maturities, without Single Maturity Date | 0 | |||
Held-to-Maturity, Fair Value | ||||
Debt Maturities, without Single Maturity Date | 0 | |||
Commercial mortgage-backed securities | ||||
Available for Sale, Amortized Cost | ||||
Debt Maturities, without single maturity date | 12,490 | |||
Available-for-Sale, Fair Value | ||||
Debt Maturities, without Single Maturity Date | 13,099 | |||
Held-to-Maturity, Amortized Cost | ||||
Debt Maturities, without Single Maturity Date | 0 | |||
Held-to-Maturity, Fair Value | ||||
Debt Maturities, without Single Maturity Date | 0 | |||
Residential mortgage-backed securities | ||||
Available for Sale, Amortized Cost | ||||
Debt Maturities, without single maturity date | 2,749 | |||
Available-for-Sale, Fair Value | ||||
Debt Maturities, without Single Maturity Date | 2,858 | |||
Held-to-Maturity, Amortized Cost | ||||
Debt Maturities, without Single Maturity Date | 191 | |||
Held-to-Maturity, Fair Value | ||||
Debt Maturities, without Single Maturity Date | 205 | |||
Fixed Maturities | ||||
Available for Sale, Amortized Cost | ||||
Debt Securities, Available-for-sale, Amortized Cost | 333,459 | 354,470 | ||
Available-for-Sale, Fair Value | ||||
Fixed Maturities, Available for Sale, Fair Value | 372,410 | 412,905 | ||
Held-to-Maturity, Amortized Cost | ||||
Amortized Cost | 1,519 | 1,939 | ||
Held-to-Maturity, Fair Value | ||||
Fixed Maturities, Held-to-maturity, Fair Value | 1,803 | 2,298 | ||
Fixed Maturities | Held-for-sale | ||||
Available for Sale, Amortized Cost | ||||
Debt Securities, Available-for-sale, Amortized Cost | 13,145 | |||
Available-for-Sale, Fair Value | ||||
Fixed Maturities, Available for Sale, Fair Value | 13,569 | |||
Fixed Maturities | U.S. private corporate securities | ||||
Available for Sale, Amortized Cost | ||||
Debt Securities, Available-for-sale, Amortized Cost | 35,019 | 36,894 | ||
Available-for-Sale, Fair Value | ||||
Fixed Maturities, Available for Sale, Fair Value | 37,382 | 40,937 | ||
Fixed Maturities | Asset-backed securities | ||||
Available for Sale, Amortized Cost | ||||
Debt Securities, Available-for-sale, Amortized Cost | 11,402 | 14,489 | ||
Available-for-Sale, Fair Value | ||||
Fixed Maturities, Available for Sale, Fair Value | 11,525 | 14,591 | ||
Fixed Maturities | Commercial mortgage-backed securities | ||||
Available for Sale, Amortized Cost | ||||
Debt Securities, Available-for-sale, Amortized Cost | 12,490 | 15,036 | ||
Available-for-Sale, Fair Value | ||||
Fixed Maturities, Available for Sale, Fair Value | 13,099 | 16,303 | ||
Fixed Maturities | Residential mortgage-backed securities | ||||
Available for Sale, Amortized Cost | ||||
Debt Securities, Available-for-sale, Amortized Cost | 2,749 | 2,683 | ||
Available-for-Sale, Fair Value | ||||
Fixed Maturities, Available for Sale, Fair Value | 2,858 | 2,887 | ||
Held-to-Maturity, Amortized Cost | ||||
Amortized Cost | 191 | 266 | ||
Held-to-Maturity, Fair Value | ||||
Fixed Maturities, Held-to-maturity, Fair Value | 205 | 286 | ||
Fixed Maturities | Prudential Netting Agreement | ||||
Held-to-Maturity, Amortized Cost | ||||
Amortized Cost | 4,750 | 4,998 | ||
Held-to-Maturity, Fair Value | ||||
Fixed Maturities, Held-to-maturity, Fair Value | 5,394 | 5,821 | ||
Fixed Maturities | Prudential Netting Agreement | U.S. private corporate securities | ||||
Available for Sale, Amortized Cost | ||||
Debt Securities, Available-for-sale, Amortized Cost | 5,941 | 5,966 | ||
Available-for-Sale, Fair Value | ||||
Fixed Maturities, Available for Sale, Fair Value | $ 5,995 | $ 6,100 | ||
|
Investments (Fixed Maturity Proceeds) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Debt Securities[Line Items] | |||
Proceeds from maturities/prepayments - AFS | $ 64,759 | $ 44,106 | $ 52,306 |
Proceeds from maturities/prepayments - HTM | 239 | 88 | 100 |
Fixed maturities | Available-for-sale | |||
Debt Securities[Line Items] | |||
Proceeds from sales | 36,333 | 21,013 | 32,283 |
Proceeds from maturities/prepayments - AFS | 27,976 | 23,563 | 20,036 |
Gross investment gains from sales and maturities | 2,565 | 1,690 | 1,715 |
Gross investment losses from sales and maturities | (648) | (524) | (434) |
OTTI recognized in earnings | (315) | ||
Write-downs recognized in earnings | (1) | (304) | |
(Addition to) release of allowance for credit losses - AFS | 19 | (133) | |
Fixed maturities | Held-to-maturity | |||
Debt Securities[Line Items] | |||
Proceeds from maturities/prepayments - HTM | 239 | 88 | 99 |
(Addition to) release of allowance for credit Losses - HTM | 4 | 0 | |
Fixed maturities | Available-for-sale | |||
Debt Securities[Line Items] | |||
Noncash or Part Noncash Divestiture, Amount of Consideration Received (Paid) | 450 | 470 | 13 |
Fixed maturities | Held-to-maturity | |||
Debt Securities[Line Items] | |||
Noncash or Part Noncash Divestiture, Amount of Consideration Received (Paid) | $ 1 | $ 1 | $ 1 |
Investments (Credit Losses Recognized In Earnings on Fixed Maturity Securities Held by the Company) (Details) - Fixed Maturities - USD ($) $ in Millions |
12 Months Ended | |
---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
|
Available-for-sale | ||
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] | ||
Balance, beginning of period | $ 133 | $ 0 |
Additions to allowance for credit losses not previously recorded | 96 | 295 |
Reductions for securities sold during the period | (57) | (165) |
Additions (reductions) on securities with previous allowance | (57) | 14 |
Reclassified to “Assets held-for sale” | (1) | |
Write-downs charged against the allowance | (11) | |
Balance, ending of period | 114 | 133 |
Available-for-sale | U.S. Treasury securities and obligations of U.S. government authorities and agencies | ||
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] | ||
Balance, beginning of period | 0 | 0 |
Additions to allowance for credit losses not previously recorded | 0 | 0 |
Reductions for securities sold during the period | 0 | 0 |
Additions (reductions) on securities with previous allowance | 0 | 0 |
Reclassified to “Assets held-for sale” | 0 | |
Write-downs charged against the allowance | 0 | |
Balance, ending of period | 0 | 0 |
Available-for-sale | Foreign government bonds | ||
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] | ||
Balance, beginning of period | 0 | 0 |
Additions to allowance for credit losses not previously recorded | 7 | 39 |
Reductions for securities sold during the period | 0 | (39) |
Additions (reductions) on securities with previous allowance | 0 | 0 |
Reclassified to “Assets held-for sale” | 0 | |
Write-downs charged against the allowance | 0 | |
Balance, ending of period | 7 | 0 |
Available-for-sale | Corporate securities | ||
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] | ||
Balance, beginning of period | 123 | 0 |
Additions to allowance for credit losses not previously recorded | 89 | 255 |
Reductions for securities sold during the period | (48) | (126) |
Additions (reductions) on securities with previous allowance | (56) | 5 |
Reclassified to “Assets held-for sale” | (1) | |
Write-downs charged against the allowance | (11) | |
Balance, ending of period | 107 | 123 |
Available-for-sale | Asset-backed securities | ||
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] | ||
Balance, beginning of period | 0 | 0 |
Additions to allowance for credit losses not previously recorded | 0 | 0 |
Reductions for securities sold during the period | 0 | 0 |
Additions (reductions) on securities with previous allowance | 0 | 0 |
Reclassified to “Assets held-for sale” | 0 | |
Write-downs charged against the allowance | 0 | |
Balance, ending of period | 0 | 0 |
Available-for-sale | Commercial mortgage-backed securities | ||
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] | ||
Balance, beginning of period | 10 | 0 |
Additions to allowance for credit losses not previously recorded | 0 | 1 |
Reductions for securities sold during the period | (9) | 0 |
Additions (reductions) on securities with previous allowance | (1) | 9 |
Reclassified to “Assets held-for sale” | 0 | |
Write-downs charged against the allowance | 0 | |
Balance, ending of period | 0 | 10 |
Available-for-sale | Residential mortgage-backed securities | ||
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] | ||
Balance, beginning of period | 0 | 0 |
Additions to allowance for credit losses not previously recorded | 0 | 0 |
Reductions for securities sold during the period | 0 | 0 |
Additions (reductions) on securities with previous allowance | 0 | 0 |
Reclassified to “Assets held-for sale” | 0 | |
Write-downs charged against the allowance | 0 | |
Balance, ending of period | 0 | 0 |
Held-to-maturity | ||
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] | ||
Balance, beginning of period | 9 | 0 |
Cumulative effect of adoption of ASU 2016-13 | 9 | |
Current period provision for expected losses | (3) | |
Change in foreign exchange | (1) | |
Balance, ending of period | 5 | 9 |
Held-to-maturity | U.S. Treasury securities and obligations of U.S. government authorities and agencies | ||
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] | ||
Balance, beginning of period | 0 | 0 |
Cumulative effect of adoption of ASU 2016-13 | 0 | |
Current period provision for expected losses | 0 | |
Change in foreign exchange | 0 | |
Balance, ending of period | 0 | 0 |
Held-to-maturity | Foreign government bonds | ||
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] | ||
Balance, beginning of period | 0 | 0 |
Cumulative effect of adoption of ASU 2016-13 | 0 | |
Current period provision for expected losses | 0 | |
Change in foreign exchange | 0 | |
Balance, ending of period | 0 | 0 |
Held-to-maturity | Corporate securities | ||
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] | ||
Balance, beginning of period | 9 | 0 |
Cumulative effect of adoption of ASU 2016-13 | 9 | |
Current period provision for expected losses | (3) | |
Change in foreign exchange | (1) | |
Balance, ending of period | 5 | 9 |
Held-to-maturity | Asset-backed securities | ||
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] | ||
Balance, beginning of period | 0 | 0 |
Cumulative effect of adoption of ASU 2016-13 | 0 | |
Current period provision for expected losses | 0 | |
Change in foreign exchange | 0 | |
Balance, ending of period | 0 | 0 |
Held-to-maturity | Commercial mortgage-backed securities | ||
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] | ||
Balance, beginning of period | 0 | 0 |
Cumulative effect of adoption of ASU 2016-13 | 0 | |
Current period provision for expected losses | 0 | |
Change in foreign exchange | 0 | |
Balance, ending of period | 0 | 0 |
Held-to-maturity | Residential mortgage-backed securities | ||
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] | ||
Balance, beginning of period | 0 | 0 |
Cumulative effect of adoption of ASU 2016-13 | 0 | |
Current period provision for expected losses | 0 | |
Change in foreign exchange | 0 | |
Balance, ending of period | $ 0 | $ 0 |
Investments (Assets Supporting Experience-Rated Contractholder Liabilities) (Details) - USD ($) $ in Millions |
Dec. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Assets Supporting Experience-Rated Contractholder Liabilities [Line Items] | ||
Assets supporting experience-rated contractholder liabilities, at amortized cost | $ 2,861 | $ 22,438 |
Assets supporting experience-rated contractholder liabilities, at fair value | 3,358 | 24,115 |
Held-for-sale | ||
Assets Supporting Experience-Rated Contractholder Liabilities [Line Items] | ||
Assets supporting experience-rated contractholder liabilities, at amortized cost | 18,346 | |
Assets supporting experience-rated contractholder liabilities, at fair value | 18,818 | |
Fixed maturities | ||
Assets Supporting Experience-Rated Contractholder Liabilities [Line Items] | ||
Assets supporting experience-rated contractholder liabilities, at amortized cost | 1,044 | 20,119 |
Assets supporting experience-rated contractholder liabilities, at fair value | 1,057 | 21,414 |
Fixed maturities | Held-for-sale | ||
Assets Supporting Experience-Rated Contractholder Liabilities [Line Items] | ||
Assets supporting experience-rated contractholder liabilities, at amortized cost | 17,232 | |
Assets supporting experience-rated contractholder liabilities, at fair value | 17,706 | |
Equity securities | ||
Assets Supporting Experience-Rated Contractholder Liabilities [Line Items] | ||
Assets supporting experience-rated contractholder liabilities, at amortized cost | 1,787 | 1,661 |
Assets supporting experience-rated contractholder liabilities, at fair value | 2,271 | 2,043 |
Equity securities | Held-for-sale | ||
Assets Supporting Experience-Rated Contractholder Liabilities [Line Items] | ||
Assets supporting experience-rated contractholder liabilities, at amortized cost | 328 | |
Assets supporting experience-rated contractholder liabilities, at fair value | 326 | |
Short-term investments and cash equivalents | ||
Assets Supporting Experience-Rated Contractholder Liabilities [Line Items] | ||
Assets supporting experience-rated contractholder liabilities, at amortized cost | 30 | 658 |
Assets supporting experience-rated contractholder liabilities, at fair value | 30 | 658 |
Short-term investments and cash equivalents | Held-for-sale | ||
Assets Supporting Experience-Rated Contractholder Liabilities [Line Items] | ||
Assets supporting experience-rated contractholder liabilities, at amortized cost | 786 | |
Assets supporting experience-rated contractholder liabilities, at fair value | 786 | |
Corporate securities | Fixed maturities | ||
Assets Supporting Experience-Rated Contractholder Liabilities [Line Items] | ||
Assets supporting experience-rated contractholder liabilities, at amortized cost | 101 | 14,442 |
Assets supporting experience-rated contractholder liabilities, at fair value | 103 | 15,472 |
Corporate securities | Fixed maturities | Held-for-sale | ||
Assets Supporting Experience-Rated Contractholder Liabilities [Line Items] | ||
Assets supporting experience-rated contractholder liabilities, at amortized cost | 12,112 | |
Assets supporting experience-rated contractholder liabilities, at fair value | 12,463 | |
Commercial mortgage-backed securities | Fixed maturities | ||
Assets Supporting Experience-Rated Contractholder Liabilities [Line Items] | ||
Assets supporting experience-rated contractholder liabilities, at amortized cost | 0 | 1,743 |
Assets supporting experience-rated contractholder liabilities, at fair value | 0 | 1,839 |
Commercial mortgage-backed securities | Fixed maturities | Held-for-sale | ||
Assets Supporting Experience-Rated Contractholder Liabilities [Line Items] | ||
Assets supporting experience-rated contractholder liabilities, at amortized cost | 1,799 | |
Assets supporting experience-rated contractholder liabilities, at fair value | 1,830 | |
Residential mortgage-backed securities | Fixed maturities | ||
Assets Supporting Experience-Rated Contractholder Liabilities [Line Items] | ||
Assets supporting experience-rated contractholder liabilities, at amortized cost | 0 | 964 |
Assets supporting experience-rated contractholder liabilities, at fair value | 0 | 1,018 |
Residential mortgage-backed securities | Fixed maturities | Held-for-sale | ||
Assets Supporting Experience-Rated Contractholder Liabilities [Line Items] | ||
Assets supporting experience-rated contractholder liabilities, at amortized cost | 658 | |
Assets supporting experience-rated contractholder liabilities, at fair value | 683 | |
Asset-backed securities | Fixed maturities | ||
Assets Supporting Experience-Rated Contractholder Liabilities [Line Items] | ||
Assets supporting experience-rated contractholder liabilities, at amortized cost | 0 | 1,665 |
Assets supporting experience-rated contractholder liabilities, at fair value | 0 | 1,697 |
Asset-backed securities | Fixed maturities | Held-for-sale | ||
Assets Supporting Experience-Rated Contractholder Liabilities [Line Items] | ||
Assets supporting experience-rated contractholder liabilities, at amortized cost | 2,079 | |
Assets supporting experience-rated contractholder liabilities, at fair value | 2,093 | |
Foreign government bonds | Fixed maturities | ||
Assets Supporting Experience-Rated Contractholder Liabilities [Line Items] | ||
Assets supporting experience-rated contractholder liabilities, at amortized cost | 761 | 934 |
Assets supporting experience-rated contractholder liabilities, at fair value | 761 | 945 |
Foreign government bonds | Fixed maturities | Held-for-sale | ||
Assets Supporting Experience-Rated Contractholder Liabilities [Line Items] | ||
Assets supporting experience-rated contractholder liabilities, at amortized cost | 240 | |
Assets supporting experience-rated contractholder liabilities, at fair value | 237 | |
U.S. government authorities and agencies and obligations of U.S. states | Fixed maturities | ||
Assets Supporting Experience-Rated Contractholder Liabilities [Line Items] | ||
Assets supporting experience-rated contractholder liabilities, at amortized cost | 182 | 371 |
Assets supporting experience-rated contractholder liabilities, at fair value | 193 | $ 443 |
U.S. government authorities and agencies and obligations of U.S. states | Fixed maturities | Held-for-sale | ||
Assets Supporting Experience-Rated Contractholder Liabilities [Line Items] | ||
Assets supporting experience-rated contractholder liabilities, at amortized cost | 344 | |
Assets supporting experience-rated contractholder liabilities, at fair value | $ 400 | |
Public Securities | ||
Assets Supporting Experience-Rated Contractholder Liabilities [Line Items] | ||
Assets supporting experience-rated contractholder liabilities, at amortized cost percentage | 95.00% | 79.00% |
Collateralized loan obligations | ||
Assets Supporting Experience-Rated Contractholder Liabilities [Line Items] | ||
Assets supporting experience-rated contractholder liabilities, at fair value | $ 1,607 | $ 1,102 |
NAIC High or Highest Quality Rating | Fixed maturities | ||
Assets Supporting Experience-Rated Contractholder Liabilities [Line Items] | ||
Assets supporting experience-rated contractholder liabilities, at amortized cost percentage | 97.00% | 94.00% |
Investments (Narrative) (Details) - USD ($) $ in Millions |
12 Months Ended | ||||
---|---|---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|||
Schedule of Investments [Line Items] | |||||
Master funds gross assets | $ 76,600 | $ 54,123 | |||
Master funds gross liabilities | 73,882 | 50,706 | |||
Unaffiliated interest | 467 | 201 | |||
Consolidated feeder funds’ investments | 654 | 459 | |||
Fixed Maturities, Available for Sale, Fair Value | [1] | 372,410 | 412,905 | ||
Fixed maturities, trading, at fair value | [1] | 8,823 | 3,914 | ||
Other invested assets | [1] | 21,833 | 18,125 | ||
Write-down on accrued investment income receivable | 1 | 1 | |||
Fixed maturity securities purchased with credit deterioration | 0 | 0 | |||
Loans on non-accrual status recognized in interest income | 5 | 2 | |||
Loans on non-accrual status do not have allowance for credit losses | 20 | 15 | |||
Commercial mortgage and other loans purchased with credit deterioration | 0 | 0 | |||
Fair value of collateral | 4,967 | 8,872 | |||
Held-for-sale | |||||
Schedule of Investments [Line Items] | |||||
Fixed Maturities, Available for Sale, Fair Value | 13,569 | ||||
Other invested assets | 104 | ||||
Fixed maturities | |||||
Schedule of Investments [Line Items] | |||||
Total Unrealised Losses | 1,705 | 949 | |||
Gross unrealized losses of twelve months or more concentrated in various sectors | 755 | 463 | |||
Fixed Maturities, Available for Sale, Fair Value | 372,410 | 412,905 | |||
Fixed maturities | Held-for-sale | |||||
Schedule of Investments [Line Items] | |||||
Total Unrealised Losses | 147 | ||||
Fixed Maturities, Available for Sale, Fair Value | 13,569 | ||||
Corporate securities | |||||
Schedule of Investments [Line Items] | |||||
Gross unrealized losses of twelve months or more concentrated in various sectors | 755 | 463 | |||
Other Income | Equity securities | |||||
Schedule of Investments [Line Items] | |||||
Unrealized Gain (Loss) on Investments | 591 | 205 | $ 943 | ||
Other Income | Assets supporting experience-rated contractholder liabilities | Held-for-sale | |||||
Schedule of Investments [Line Items] | |||||
Unrealized Gain (Loss) on Investments | (708) | 726 | $ 996 | ||
Investments | |||||
Schedule of Investments [Line Items] | |||||
Fair value of collateral | 334 | 252 | |||
Cash | |||||
Schedule of Investments [Line Items] | |||||
Fair value of collateral | 4,633 | 8,620 | |||
Carrying value of non-income producing assets | |||||
Schedule of Investments [Line Items] | |||||
Fixed Maturities, Available for Sale, Fair Value | 437 | ||||
Fixed maturities, trading, at fair value | 72 | ||||
Other invested assets | $ 1 | ||||
California | |||||
Schedule of Investments [Line Items] | |||||
Commercial mortgage loan, concentration percentage | 29.00% | ||||
Texas | |||||
Schedule of Investments [Line Items] | |||||
Commercial mortgage loan, concentration percentage | 7.00% | ||||
New York | |||||
Schedule of Investments [Line Items] | |||||
Commercial mortgage loan, concentration percentage | 7.00% | ||||
Europe | |||||
Schedule of Investments [Line Items] | |||||
Commercial mortgage loan, concentration percentage | 6.00% | ||||
Asia | |||||
Schedule of Investments [Line Items] | |||||
Commercial mortgage loan, concentration percentage | 2.00% | ||||
Australia | |||||
Schedule of Investments [Line Items] | |||||
Commercial mortgage loan, concentration percentage | 1.00% | ||||
NAIC High or Highest Quality Rating | Fixed maturities | |||||
Schedule of Investments [Line Items] | |||||
Total Unrealised Losses | $ 1,242 | 636 | |||
NAIC Other Than High or Highest Quality Rating | Fixed maturities | |||||
Schedule of Investments [Line Items] | |||||
Total Unrealised Losses | $ 463 | $ 313 | |||
|
Investments (Concentrations of Credit Risk) (Details) - Investments in Japanese government and government agency securities: - USD ($) $ in Millions |
Dec. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items] | ||
Concentration of credit risk at amortized cost | $ 75,499 | $ 82,059 |
Concentration of credit risk at fair value | 85,408 | 94,817 |
Assets supporting experience-rated contractholder liabilities | ||
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items] | ||
Concentration of credit risk at amortized cost | 983 | 849 |
Concentration of credit risk at fair value | 977 | 855 |
Available-for-sale | Fixed Maturities | ||
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items] | ||
Concentration of credit risk at amortized cost | 73,681 | 80,273 |
Concentration of credit risk at fair value | 83,382 | 92,764 |
Held-to-maturity | Fixed Maturities | ||
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items] | ||
Concentration of credit risk at amortized cost | 812 | 912 |
Concentration of credit risk at fair value | 1,026 | 1,173 |
Trading | Fixed Maturities | ||
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items] | ||
Concentration of credit risk at amortized cost | 23 | 25 |
Concentration of credit risk at fair value | $ 23 | $ 25 |
Investments (Commercial Mortgage and Other Loans) (Details) - USD ($) $ in Millions |
12 Months Ended | |
---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
|
Commercial Mortgage and Other Loans [Line Items] | ||
Commercial mortgage and agricultural property loans by property type | $ 58,087 | $ 64,784 |
Other loans | 698 | 876 |
Total commercial mortgage and other loans | $ 58,666 | $ 65,425 |
% of Total | 100.00% | 100.00% |
Net carrying value of commercial loans held for sale | $ 1,263 | $ 1,092 |
Held-for-sale | ||
Commercial Mortgage and Other Loans [Line Items] | ||
Allowance for credit losses, other loans | 15 | |
Total commercial mortgage and other loans | 6,565 | |
Commercial Mortgage Loans | ||
Commercial Mortgage and Other Loans [Line Items] | ||
Commercial mortgage and agricultural property loans by property type | $ 52,567 | $ 60,736 |
% of Total | 90.50% | 93.80% |
Commercial mortgage and agricultural property loans | ||
Commercial Mortgage and Other Loans [Line Items] | ||
Allowance for credit losses | $ (115) | $ (227) |
Total net loans | 57,972 | 64,557 |
Uncollateralized loans | ||
Commercial Mortgage and Other Loans [Line Items] | ||
Other loans | 561 | 655 |
Residential property loans | ||
Commercial Mortgage and Other Loans [Line Items] | ||
Other loans | 67 | 101 |
Other Collateralized Loans | ||
Commercial Mortgage and Other Loans [Line Items] | ||
Other loans | 70 | 120 |
Other loans | ||
Commercial Mortgage and Other Loans [Line Items] | ||
Total net loans | 694 | 868 |
Allowance for credit losses, other loans | (4) | (8) |
Office | ||
Commercial Mortgage and Other Loans [Line Items] | ||
Commercial mortgage and agricultural property loans by property type | $ 10,225 | $ 12,750 |
% of Total | 17.60% | 19.70% |
Retail | ||
Commercial Mortgage and Other Loans [Line Items] | ||
Commercial mortgage and agricultural property loans by property type | $ 6,779 | $ 7,326 |
% of Total | 11.70% | 11.30% |
Apartment/Multi-Family | ||
Commercial Mortgage and Other Loans [Line Items] | ||
Commercial mortgage and agricultural property loans by property type | $ 16,742 | $ 18,330 |
% of Total | 28.80% | 28.30% |
Industrial | ||
Commercial Mortgage and Other Loans [Line Items] | ||
Commercial mortgage and agricultural property loans by property type | $ 13,009 | $ 14,954 |
% of Total | 22.40% | 23.10% |
Hospitality | ||
Commercial Mortgage and Other Loans [Line Items] | ||
Commercial mortgage and agricultural property loans by property type | $ 1,876 | $ 2,395 |
% of Total | 3.20% | 3.70% |
Other | ||
Commercial Mortgage and Other Loans [Line Items] | ||
Commercial mortgage and agricultural property loans by property type | $ 3,936 | $ 4,981 |
% of Total | 6.80% | 7.70% |
Agricultural property loans | ||
Commercial Mortgage and Other Loans [Line Items] | ||
Commercial mortgage and agricultural property loans by property type | $ 5,520 | $ 4,048 |
% of Total | 9.50% | 6.20% |
Investments (Allowance for Credit Losses) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Allowance for Loan and Lease Losses [Roll Forward] | |||
Balance, beginning of year | $ 235 | $ 121 | $ 128 |
Cumulative effect of adoption of ASU 2016-13 | 115 | ||
Addition to (release of) allowance for expected losses | (98) | 3 | (6) |
Reclassified to “Asset held-for-sale” | (15) | ||
Charge-offs, net of recoveries | (1) | ||
Write-downs charged against the allowance | (7) | ||
Other | (3) | 3 | |
Total ending balance | 119 | 235 | 121 |
Commercial Mortgage Loans | |||
Allowance for Loan and Lease Losses [Roll Forward] | |||
Balance, beginning of year | 218 | 114 | 120 |
Cumulative effect of adoption of ASU 2016-13 | 110 | ||
Addition to (release of) allowance for expected losses | (92) | 1 | (5) |
Reclassified to “Asset held-for-sale” | (15) | ||
Charge-offs, net of recoveries | (1) | ||
Write-downs charged against the allowance | (7) | ||
Other | 0 | 0 | |
Total ending balance | 111 | 218 | 114 |
Agricultural Property Loans | |||
Allowance for Loan and Lease Losses [Roll Forward] | |||
Balance, beginning of year | 9 | 3 | 3 |
Cumulative effect of adoption of ASU 2016-13 | 5 | ||
Addition to (release of) allowance for expected losses | (5) | 1 | 0 |
Reclassified to “Asset held-for-sale” | 0 | ||
Charge-offs, net of recoveries | 0 | ||
Write-downs charged against the allowance | 0 | ||
Other | 0 | 0 | |
Total ending balance | 4 | 9 | 3 |
Residential property loans | |||
Allowance for Loan and Lease Losses [Roll Forward] | |||
Balance, beginning of year | 0 | 0 | 0 |
Cumulative effect of adoption of ASU 2016-13 | 0 | ||
Addition to (release of) allowance for expected losses | 0 | 0 | 0 |
Reclassified to “Asset held-for-sale” | 0 | ||
Charge-offs, net of recoveries | 0 | ||
Write-downs charged against the allowance | 0 | ||
Other | 0 | 0 | |
Total ending balance | 0 | 0 | 0 |
Other Collateralized Loans | |||
Allowance for Loan and Lease Losses [Roll Forward] | |||
Balance, beginning of year | 3 | 0 | 0 |
Cumulative effect of adoption of ASU 2016-13 | 0 | ||
Addition to (release of) allowance for expected losses | 0 | 0 | 0 |
Reclassified to “Asset held-for-sale” | 0 | ||
Charge-offs, net of recoveries | 0 | ||
Write-downs charged against the allowance | 0 | ||
Other | (3) | 3 | |
Total ending balance | 0 | 3 | 0 |
Uncollateralized loans | |||
Allowance for Loan and Lease Losses [Roll Forward] | |||
Balance, beginning of year | 5 | 4 | 5 |
Cumulative effect of adoption of ASU 2016-13 | 0 | ||
Addition to (release of) allowance for expected losses | (1) | 1 | (1) |
Reclassified to “Asset held-for-sale” | 0 | ||
Charge-offs, net of recoveries | 0 | ||
Write-downs charged against the allowance | 0 | ||
Other | 0 | 0 | |
Total ending balance | $ 4 | $ 5 | $ 4 |
Investments (Credit Quality Indicators) (Details) - USD ($) $ in Millions |
Dec. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Recording investment gross of allowance for credit losses | $ 58,785 | $ 65,660 |
Held-for-sale | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Recording investment gross of allowance for credit losses | 6,580 | |
Commercial Mortgage Loans | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Current Year | 7,069 | 6,021 |
One Years Prior | 3,654 | 10,264 |
Two Years Prior | 7,917 | 9,069 |
Three Years Prior | 7,963 | 7,219 |
Four Years Prior | 5,109 | 6,831 |
Prior | 20,855 | 21,332 |
Revolving loans | 0 | |
Recording investment gross of allowance for credit losses | 52,567 | 60,736 |
Commercial Mortgage Loans | ≥ 1.2X | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Current Year | 6,803 | 5,901 |
One Years Prior | 3,356 | 9,429 |
Two Years Prior | 6,828 | 8,587 |
Three Years Prior | 7,384 | 6,954 |
Four Years Prior | 4,445 | 6,382 |
Prior | 16,864 | 18,904 |
Revolving loans | 0 | |
Recording investment gross of allowance for credit losses | 45,680 | 56,157 |
Commercial Mortgage Loans | 1.0X to 1.2X | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Current Year | 266 | 118 |
One Years Prior | 154 | 711 |
Two Years Prior | 662 | 383 |
Three Years Prior | 478 | 263 |
Four Years Prior | 234 | 384 |
Prior | 2,069 | 1,719 |
Revolving loans | 0 | |
Recording investment gross of allowance for credit losses | 3,863 | 3,578 |
Commercial Mortgage Loans | Less than 1.0X | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Current Year | 0 | 2 |
One Years Prior | 144 | 124 |
Two Years Prior | 427 | 99 |
Three Years Prior | 101 | 2 |
Four Years Prior | 430 | 65 |
Prior | 1,922 | 709 |
Revolving loans | 0 | |
Recording investment gross of allowance for credit losses | 3,024 | 1,001 |
Agricultural property loans | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Current Year | 2,050 | 964 |
One Years Prior | 895 | 545 |
Two Years Prior | 528 | 388 |
Three Years Prior | 371 | 530 |
Four Years Prior | 370 | 367 |
Prior | 1,226 | 1,254 |
Revolving loans | 80 | |
Recording investment gross of allowance for credit losses | 5,520 | 4,048 |
Agricultural property loans | ≥ 1.2X | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Current Year | 2,007 | 941 |
One Years Prior | 870 | 544 |
Two Years Prior | 517 | 381 |
Three Years Prior | 364 | 468 |
Four Years Prior | 312 | 308 |
Prior | 1,121 | 1,202 |
Revolving loans | 80 | |
Recording investment gross of allowance for credit losses | 5,271 | 3,844 |
Agricultural property loans | 1.0X to 1.2X | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Current Year | 43 | 23 |
One Years Prior | 25 | 0 |
Two Years Prior | 10 | 1 |
Three Years Prior | 1 | 59 |
Four Years Prior | 58 | 1 |
Prior | 41 | 40 |
Revolving loans | 0 | |
Recording investment gross of allowance for credit losses | 178 | 124 |
Agricultural property loans | Less than 1.0X | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Current Year | 0 | 0 |
One Years Prior | 0 | 1 |
Two Years Prior | 1 | 6 |
Three Years Prior | 6 | 3 |
Four Years Prior | 0 | 58 |
Prior | 64 | 12 |
Revolving loans | 0 | |
Recording investment gross of allowance for credit losses | 71 | 80 |
0%-59.99% | Commercial Mortgage Loans | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Current Year | 1,287 | 828 |
One Years Prior | 467 | 2,693 |
Two Years Prior | 2,459 | 3,217 |
Three Years Prior | 3,211 | 3,854 |
Four Years Prior | 3,072 | 3,223 |
Prior | 14,011 | 15,360 |
Revolving loans | 0 | |
Recording investment gross of allowance for credit losses | 24,507 | 29,175 |
0%-59.99% | Agricultural property loans | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Current Year | 1,958 | 956 |
One Years Prior | 887 | 494 |
Two Years Prior | 494 | 349 |
Three Years Prior | 334 | 527 |
Four Years Prior | 370 | 367 |
Prior | 1,226 | 1,254 |
Revolving loans | 80 | |
Recording investment gross of allowance for credit losses | 5,349 | 3,947 |
60%-69.99% | Commercial Mortgage Loans | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Current Year | 3,101 | 2,678 |
One Years Prior | 1,941 | 4,981 |
Two Years Prior | 4,124 | 4,291 |
Three Years Prior | 3,631 | 2,239 |
Four Years Prior | 1,356 | 2,667 |
Prior | 4,161 | 4,058 |
Revolving loans | 0 | |
Recording investment gross of allowance for credit losses | 18,314 | 20,914 |
60%-69.99% | Agricultural property loans | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Current Year | 92 | 8 |
One Years Prior | 5 | 51 |
Two Years Prior | 29 | 39 |
Three Years Prior | 37 | 3 |
Four Years Prior | 0 | 0 |
Prior | 0 | 0 |
Revolving loans | 0 | |
Recording investment gross of allowance for credit losses | 163 | 101 |
70%-79.99% | Commercial Mortgage Loans | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Current Year | 2,497 | 2,492 |
One Years Prior | 1,207 | 2,587 |
Two Years Prior | 1,327 | 1,500 |
Three Years Prior | 1,059 | 1,057 |
Four Years Prior | 631 | 918 |
Prior | 2,108 | 1,409 |
Revolving loans | 0 | |
Recording investment gross of allowance for credit losses | 8,829 | 9,963 |
70%-79.99% | Agricultural property loans | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Current Year | 0 | 0 |
One Years Prior | 0 | 0 |
Two Years Prior | 0 | 0 |
Three Years Prior | 0 | 0 |
Four Years Prior | 0 | 0 |
Prior | 0 | 0 |
Revolving loans | 0 | |
Recording investment gross of allowance for credit losses | 0 | 0 |
80% or greater | Commercial Mortgage Loans | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Current Year | 184 | 23 |
One Years Prior | 39 | 3 |
Two Years Prior | 7 | 61 |
Three Years Prior | 62 | 69 |
Four Years Prior | 50 | 23 |
Prior | 575 | 505 |
Revolving loans | 0 | |
Recording investment gross of allowance for credit losses | 917 | 684 |
80% or greater | Agricultural property loans | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Current Year | 0 | 0 |
One Years Prior | 3 | 0 |
Two Years Prior | 5 | 0 |
Three Years Prior | 0 | 0 |
Four Years Prior | 0 | 0 |
Prior | 0 | 0 |
Revolving loans | 0 | |
Recording investment gross of allowance for credit losses | $ 8 | $ 0 |
Investments (Analysis of Past Due Commercial Mortgage and Other Loans) (Details) - USD ($) $ in Millions |
Dec. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Financing Receivable, Past Due [Line Items] | ||
Total Loans | $ 58,785 | $ 65,660 |
Non-Accrual Status | 22 | 21 |
Held-for-sale | ||
Financing Receivable, Past Due [Line Items] | ||
Total Loans | 6,580 | |
Current | ||
Financing Receivable, Past Due [Line Items] | ||
Total Loans | 58,782 | 65,484 |
30-59 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Total Loans | 0 | 41 |
60-89 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Total Loans | 0 | 119 |
90 days or more past due | ||
Financing Receivable, Past Due [Line Items] | ||
Total Loans | 3 | 16 |
Total Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Total Loans | 3 | 176 |
Commercial Mortgage Loans | ||
Financing Receivable, Past Due [Line Items] | ||
Total Loans | 52,567 | 60,736 |
Non-Accrual Status | 2 | 5 |
Commercial Mortgage Loans | Current | ||
Financing Receivable, Past Due [Line Items] | ||
Total Loans | 52,565 | 60,614 |
Commercial Mortgage Loans | 30-59 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Total Loans | 0 | 3 |
Commercial Mortgage Loans | 60-89 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Total Loans | 0 | 119 |
Commercial Mortgage Loans | 90 days or more past due | ||
Financing Receivable, Past Due [Line Items] | ||
Total Loans | 2 | 0 |
Commercial Mortgage Loans | Total Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Total Loans | 2 | 122 |
Agricultural property loans | ||
Financing Receivable, Past Due [Line Items] | ||
Total Loans | 5,520 | 4,048 |
Non-Accrual Status | 19 | 15 |
Agricultural property loans | Current | ||
Financing Receivable, Past Due [Line Items] | ||
Total Loans | 5,520 | 3,996 |
Agricultural property loans | 30-59 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Total Loans | 0 | 37 |
Agricultural property loans | 60-89 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Total Loans | 0 | 0 |
Agricultural property loans | 90 days or more past due | ||
Financing Receivable, Past Due [Line Items] | ||
Total Loans | 0 | 15 |
Agricultural property loans | Total Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Total Loans | 0 | 52 |
Residential property loans | ||
Financing Receivable, Past Due [Line Items] | ||
Total Loans | 67 | 101 |
Non-Accrual Status | 1 | 1 |
Residential property loans | Current | ||
Financing Receivable, Past Due [Line Items] | ||
Total Loans | 66 | 99 |
Residential property loans | 30-59 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Total Loans | 0 | 1 |
Residential property loans | 60-89 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Total Loans | 0 | 0 |
Residential property loans | 90 days or more past due | ||
Financing Receivable, Past Due [Line Items] | ||
Total Loans | 1 | 1 |
Residential property loans | Total Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Total Loans | 1 | 2 |
Other Collateralized Loans | ||
Financing Receivable, Past Due [Line Items] | ||
Total Loans | 70 | 120 |
Non-Accrual Status | 0 | 0 |
Other Collateralized Loans | Current | ||
Financing Receivable, Past Due [Line Items] | ||
Total Loans | 70 | 120 |
Other Collateralized Loans | 30-59 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Total Loans | 0 | 0 |
Other Collateralized Loans | 60-89 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Total Loans | 0 | 0 |
Other Collateralized Loans | 90 days or more past due | ||
Financing Receivable, Past Due [Line Items] | ||
Total Loans | 0 | 0 |
Other Collateralized Loans | Total Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Total Loans | 0 | 0 |
Uncollateralized loans | ||
Financing Receivable, Past Due [Line Items] | ||
Total Loans | 561 | 655 |
Non-Accrual Status | 0 | 0 |
Uncollateralized loans | Current | ||
Financing Receivable, Past Due [Line Items] | ||
Total Loans | 561 | 655 |
Uncollateralized loans | 30-59 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Total Loans | 0 | 0 |
Uncollateralized loans | 60-89 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Total Loans | 0 | 0 |
Uncollateralized loans | 90 days or more past due | ||
Financing Receivable, Past Due [Line Items] | ||
Total Loans | 0 | 0 |
Uncollateralized loans | Total Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Total Loans | 0 | 0 |
Loans | 90 days or more past due | ||
Financing Receivable, Past Due [Line Items] | ||
Accruing Interest | $ 0 | $ 0 |
Investments (Other Invested Assets) (Details) - USD ($) $ in Millions |
Dec. 31, 2021 |
Dec. 31, 2020 |
||
---|---|---|---|---|
Other Invested Assets [Line Items] | ||||
Other invested assets | [1] | $ 21,833 | $ 18,125 | |
Held-for-sale | ||||
Other Invested Assets [Line Items] | ||||
Other invested assets | 104 | |||
LPs/LLCs | ||||
Other Invested Assets [Line Items] | ||||
Other invested assets | 15,966 | 12,883 | ||
Real estate held through direct ownership | ||||
Other Invested Assets [Line Items] | ||||
Other invested assets | 1,789 | 2,027 | ||
Derivative Instruments | ||||
Other Invested Assets [Line Items] | ||||
Other invested assets | 3,280 | 1,915 | ||
Other | ||||
Other Invested Assets [Line Items] | ||||
Other invested assets | 798 | 1,300 | ||
Mortgage Debt | Real estate-related | ||||
Other Invested Assets [Line Items] | ||||
Other invested assets | 274 | 409 | ||
Equity method | LPs/LLCs | ||||
Other Invested Assets [Line Items] | ||||
Other invested assets | 11,676 | 8,747 | ||
Equity method | Private equity | LPs/LLCs | ||||
Other Invested Assets [Line Items] | ||||
Other invested assets | 6,509 | 4,311 | ||
Equity method | Hedge funds | LPs/LLCs | ||||
Other Invested Assets [Line Items] | ||||
Other invested assets | 2,797 | 2,451 | ||
Equity method | Real estate-related | LPs/LLCs | ||||
Other Invested Assets [Line Items] | ||||
Other invested assets | 2,370 | 1,985 | ||
Fair Value | ||||
Other Invested Assets [Line Items] | ||||
Other invested assets | 81 | 153 | ||
Fair Value | LPs/LLCs | ||||
Other Invested Assets [Line Items] | ||||
Other invested assets | 4,290 | 4,136 | ||
Fair Value | Private equity | LPs/LLCs | ||||
Other Invested Assets [Line Items] | ||||
Other invested assets | 1,852 | 1,786 | ||
Fair Value | Hedge funds | LPs/LLCs | ||||
Other Invested Assets [Line Items] | ||||
Other invested assets | 2,119 | 2,036 | ||
Fair Value | Real estate-related | LPs/LLCs | ||||
Other Invested Assets [Line Items] | ||||
Other invested assets | $ 319 | $ 314 | ||
|
Investments (Equity Method Investments, Statement of Financial Position) (Details) - USD ($) $ in Millions |
Dec. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Schedule of Equity Method Investments [Line Items] | ||
Total assets | $ 937,582 | $ 940,722 |
Total liabilities | 874,974 | 872,512 |
Partner's Capital | 61,876 | 67,425 |
Total liabilities and partner's capital | 937,582 | 940,722 |
Held-for-sale | ||
Schedule of Equity Method Investments [Line Items] | ||
Carrying value | 81 | |
Equity Method Investment | ||
Schedule of Equity Method Investments [Line Items] | ||
Total assets | 689,767 | 424,712 |
Total liabilities | 111,189 | 35,705 |
Partner's Capital | 578,578 | 389,007 |
Total liabilities and partner's capital | 689,767 | 424,712 |
Total liabilities and partners’ capital included above | 12,141 | 9,475 |
Equity in LP/LLC interests not included above | 852 | 666 |
Carrying value | $ 12,993 | $ 10,141 |
Investments (Equity Method Investments, Statement of Operations) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Investments [Abstract] | |||
Total revenues | $ 128,429 | $ 42,964 | $ 11,430 |
Total Expenses | (21,235) | (8,887) | (5,800) |
Net earnings (losses) | 107,194 | 34,077 | 5,630 |
Equity in net earnings (losses) included above | 2,085 | 744 | 525 |
Equity in net earnings (losses) of LP/LLC interests not included above | 161 | 28 | 11 |
Total equity in net earnings (loss) | $ 2,246 | $ 772 | $ 536 |
Investments (Accrued Investment Income) (Details) - USD ($) $ in Millions |
Dec. 31, 2021 |
Dec. 31, 2020 |
||
---|---|---|---|---|
Net Investment Income [Line Items] | ||||
Accrued investment income | [1] | $ 2,855 | $ 3,193 | |
Held-for-sale | ||||
Net Investment Income [Line Items] | ||||
Accrued investment income | 221 | |||
Fixed Maturities | ||||
Net Investment Income [Line Items] | ||||
Accrued investment income | 2,398 | 2,676 | ||
Equity securities | ||||
Net Investment Income [Line Items] | ||||
Accrued investment income | 5 | 7 | ||
Commercial mortgage and other loans | ||||
Net Investment Income [Line Items] | ||||
Accrued investment income | 175 | 205 | ||
Policy loans | ||||
Net Investment Income [Line Items] | ||||
Accrued investment income | 253 | 274 | ||
Other invested assets | ||||
Net Investment Income [Line Items] | ||||
Accrued investment income | 22 | 27 | ||
Short-term investments and cash equivalents | ||||
Net Investment Income [Line Items] | ||||
Accrued investment income | $ 2 | $ 4 | ||
|
Investments (Net Investment Income) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Schedule of Investment Income, Reported Amounts, by Category [Line Items] | |||
Gross investment income | $ 18,946 | $ 18,146 | $ 18,577 |
Less: investment expenses | (659) | (736) | (992) |
Net investment income | 18,287 | 17,410 | 17,585 |
Assets supporting experience-rated contractholder liabilities | |||
Schedule of Investment Income, Reported Amounts, by Category [Line Items] | |||
Gross investment income | 601 | 700 | 731 |
Equity securities | |||
Schedule of Investment Income, Reported Amounts, by Category [Line Items] | |||
Gross investment income | 162 | 162 | 160 |
Commercial mortgage and other loans | |||
Schedule of Investment Income, Reported Amounts, by Category [Line Items] | |||
Gross investment income | 2,552 | 2,485 | 2,584 |
Policy loans | |||
Schedule of Investment Income, Reported Amounts, by Category [Line Items] | |||
Gross investment income | 533 | 584 | 619 |
Other invested assets | |||
Schedule of Investment Income, Reported Amounts, by Category [Line Items] | |||
Gross investment income | 2,617 | 1,318 | 1,005 |
Short-term investments and cash equivalents | |||
Schedule of Investment Income, Reported Amounts, by Category [Line Items] | |||
Gross investment income | 63 | 197 | 453 |
Available-for-sale | Fixed Maturities | |||
Schedule of Investment Income, Reported Amounts, by Category [Line Items] | |||
Gross investment income | 11,999 | 12,339 | 12,644 |
Held-to-maturity | Fixed Maturities | |||
Schedule of Investment Income, Reported Amounts, by Category [Line Items] | |||
Gross investment income | 226 | 235 | 232 |
Trading | Fixed Maturities | |||
Schedule of Investment Income, Reported Amounts, by Category [Line Items] | |||
Gross investment income | $ 193 | $ 126 | $ 149 |
Investments (Realized Investment Gains Losses Net) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Gain (Loss) on Securities [Line Items] | |||
Realized investment gains (losses), net | $ 4,024 | $ (3,887) | $ (459) |
Fixed Maturities | |||
Gain (Loss) on Securities [Line Items] | |||
Realized investment gains (losses), net | 1,939 | 729 | 966 |
Commercial mortgage and other loans | |||
Gain (Loss) on Securities [Line Items] | |||
Realized investment gains (losses), net | 173 | 103 | 44 |
Investment Real Estate | |||
Gain (Loss) on Securities [Line Items] | |||
Realized investment gains (losses), net | 108 | (16) | 78 |
LPs/LLCs | |||
Gain (Loss) on Securities [Line Items] | |||
Realized investment gains (losses), net | (14) | 2 | (38) |
Derivatives | |||
Gain (Loss) on Securities [Line Items] | |||
Realized investment gains (losses), net | 1,796 | (4,715) | (1,513) |
Other | |||
Gain (Loss) on Securities [Line Items] | |||
Realized investment gains (losses), net | $ 22 | $ 10 | $ 4 |
Investments (Net Unrealized Gains Losses on Investments by Asset Class) (Details) - USD ($) $ in Millions |
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
---|---|---|---|
Gain (Loss) on Securities [Line Items] | |||
Net unrealized gains (losses) on investments | $ 40,467 | $ 58,417 | $ 45,339 |
Held-for-sale | |||
Gain (Loss) on Securities [Line Items] | |||
Net unrealized gains (losses) on investments | 425 | ||
Fixed Maturities | Available-for-sale | OTTI | |||
Gain (Loss) on Securities [Line Items] | |||
Net unrealized gains (losses) on investments | 243 | ||
Fixed Maturities | Available-for-sale | All other | |||
Gain (Loss) on Securities [Line Items] | |||
Net unrealized gains (losses) on investments | 44,279 | ||
Fixed Maturities | Available-for-sale | With an allowance | |||
Gain (Loss) on Securities [Line Items] | |||
Net unrealized gains (losses) on investments | 23 | (25) | |
Fixed Maturities | Available-for-sale | Without an allowance | |||
Gain (Loss) on Securities [Line Items] | |||
Net unrealized gains (losses) on investments | 39,467 | 58,593 | |
Derivatives designated as cash flow hedges | |||
Gain (Loss) on Securities [Line Items] | |||
Net unrealized gains (losses) on investments | 1,019 | (168) | 832 |
Derivatives designated as fair value hedges | |||
Gain (Loss) on Securities [Line Items] | |||
Net unrealized gains (losses) on investments | (35) | 10 | 0 |
Other Investments | |||
Gain (Loss) on Securities [Line Items] | |||
Net unrealized gains (losses) on investments | (7) | $ 7 | $ (15) |
Other Investments | Held-to-maturity | |||
Gain (Loss) on Securities [Line Items] | |||
Net unrealized gains (losses) on investments | $ 0 |
Investments (Repurchase Agreements and Securities Lending Transactions) (Details) - USD ($) $ in Millions |
Dec. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
Total securities sold under agreements to repurchase | $ 10,185 | $ 10,894 |
Total cash collateral for loaned securities | 4,251 | 3,499 |
Overnight & Continuous | ||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
Total securities sold under agreements to repurchase | 9,747 | 10,348 |
Total cash collateral for loaned securities | 4,251 | 3,499 |
Up to 30 Days | ||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
Total securities sold under agreements to repurchase | 0 | 546 |
Total cash collateral for loaned securities | 0 | 0 |
30 to 90 Days | ||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
Total securities sold under agreements to repurchase | 438 | 0 |
Total cash collateral for loaned securities | 0 | 0 |
U.S. Treasury securities and obligations of U.S. government authorities and agencies | ||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
Total securities sold under agreements to repurchase | 9,482 | 10,094 |
Total cash collateral for loaned securities | 1 | 0 |
U.S. Treasury securities and obligations of U.S. government authorities and agencies | Overnight & Continuous | ||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
Total securities sold under agreements to repurchase | 9,044 | 9,548 |
Total cash collateral for loaned securities | 1 | 0 |
U.S. Treasury securities and obligations of U.S. government authorities and agencies | Up to 30 Days | ||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
Total securities sold under agreements to repurchase | 0 | 546 |
Total cash collateral for loaned securities | 0 | 0 |
U.S. Treasury securities and obligations of U.S. government authorities and agencies | 30 to 90 Days | ||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
Total securities sold under agreements to repurchase | 438 | 0 |
Obligations of U.S. states and their political subdivisions | ||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
Total cash collateral for loaned securities | 84 | 108 |
Obligations of U.S. states and their political subdivisions | Overnight & Continuous | ||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
Total cash collateral for loaned securities | 84 | 108 |
Obligations of U.S. states and their political subdivisions | Up to 30 Days | ||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
Total cash collateral for loaned securities | 0 | 0 |
Foreign government bonds | ||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
Total cash collateral for loaned securities | 205 | 426 |
Foreign government bonds | Overnight & Continuous | ||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
Total cash collateral for loaned securities | 205 | 426 |
Foreign government bonds | Up to 30 Days | ||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
Total cash collateral for loaned securities | 0 | 0 |
U.S. public corporate securities | ||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
Total cash collateral for loaned securities | 2,834 | 2,360 |
U.S. public corporate securities | Overnight & Continuous | ||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
Total cash collateral for loaned securities | 2,834 | 2,360 |
U.S. public corporate securities | Up to 30 Days | ||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
Total cash collateral for loaned securities | 0 | 0 |
Foreign public corporate securities | ||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
Total cash collateral for loaned securities | 643 | 567 |
Foreign public corporate securities | Overnight & Continuous | ||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
Total cash collateral for loaned securities | 643 | 567 |
Foreign public corporate securities | Up to 30 Days | ||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
Total cash collateral for loaned securities | 0 | 0 |
Commercial mortgage-backed securities | ||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
Total securities sold under agreements to repurchase | 486 | 463 |
Commercial mortgage-backed securities | Overnight & Continuous | ||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
Total securities sold under agreements to repurchase | 486 | 463 |
Commercial mortgage-backed securities | Up to 30 Days | ||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
Total securities sold under agreements to repurchase | 0 | 0 |
Commercial mortgage-backed securities | 30 to 90 Days | ||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
Total securities sold under agreements to repurchase | 0 | 0 |
Residential mortgage-backed securities | ||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
Total securities sold under agreements to repurchase | 217 | 337 |
Residential mortgage-backed securities | Overnight & Continuous | ||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
Total securities sold under agreements to repurchase | 217 | 337 |
Residential mortgage-backed securities | Up to 30 Days | ||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
Total securities sold under agreements to repurchase | 0 | 0 |
Residential mortgage-backed securities | 30 to 90 Days | ||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
Total securities sold under agreements to repurchase | 0 | 0 |
Equity securities | ||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
Total cash collateral for loaned securities | 484 | 38 |
Equity securities | Overnight & Continuous | ||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
Total cash collateral for loaned securities | 484 | 38 |
Equity securities | Up to 30 Days | ||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
Total cash collateral for loaned securities | $ 0 | $ 0 |
Investments (Securities Pledged) (Details) - USD ($) $ in Millions |
Dec. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Financial Instruments Owned and Pledged as Collateral [Line Items] | ||
Total securities pledged | $ 20,305 | $ 23,761 |
Total liabilities supported by the pledged collateral | 17,173 | 17,642 |
Fixed maturities | ||
Financial Instruments Owned and Pledged as Collateral [Line Items] | ||
Total securities pledged | 16,411 | 19,608 |
Assets supporting experience-rated contractholder liabilities | ||
Financial Instruments Owned and Pledged as Collateral [Line Items] | ||
Total securities pledged | 34 | 29 |
Separate account assets | ||
Financial Instruments Owned and Pledged as Collateral [Line Items] | ||
Total securities pledged | 2,673 | 3,191 |
Equity securities | ||
Financial Instruments Owned and Pledged as Collateral [Line Items] | ||
Total securities pledged | 868 | 416 |
Securities sold under agreements to repurchase | ||
Financial Instruments Owned and Pledged as Collateral [Line Items] | ||
Total liabilities supported by the pledged collateral | 10,185 | 10,894 |
Cash collateral for loaned securities | ||
Financial Instruments Owned and Pledged as Collateral [Line Items] | ||
Total liabilities supported by the pledged collateral | 4,251 | 3,499 |
Separate account liabilities | ||
Financial Instruments Owned and Pledged as Collateral [Line Items] | ||
Total liabilities supported by the pledged collateral | 2,737 | 3,249 |
Other | ||
Financial Instruments Owned and Pledged as Collateral [Line Items] | ||
Total securities pledged | 319 | 450 |
Trading | Fixed maturities | ||
Financial Instruments Owned and Pledged as Collateral [Line Items] | ||
Total securities pledged | $ 0 | $ 67 |
Investments (Assets on Deposit, Held in Trust and Restricted as to Sale) (Details) - USD ($) $ in Millions |
Dec. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Assets on Deposit, Held in Trust and Restricted as to Sale [Line Items] | ||
Assets on deposit with governmental authorities or trustees | $ 33 | $ 31 |
Assets held in voluntary trusts | 484 | 539 |
Assets held in trust related to reinsurance and other agreements | 16,235 | 16,614 |
Securities restricted as to sale | 86 | 153 |
Total assets on deposit, assets held in trust and securities restricted as to sale | 16,838 | 17,337 |
Held-for-sale | ||
Assets on Deposit, Held in Trust and Restricted as to Sale [Line Items] | ||
Total assets on deposit, assets held in trust and securities restricted as to sale | 553 | |
Wholly-owned subsidiaries | ||
Assets on Deposit, Held in Trust and Restricted as to Sale [Line Items] | ||
Assets held in trust related to reinsurance and other agreements | $ 28,400 | $ 34,000 |
Variable Interest Entities (Assets and Liabilities of Consolidated VIEs) (Details) - USD ($) $ in Millions |
12 Months Ended | |
---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
|
Variable Interest Entity [Line Items] | ||
Assets | $ 937,582 | $ 940,722 |
Total liabilities | 874,974 | 872,512 |
Consolidated VIEs for Which the Company is the Investment Manager | ||
Variable Interest Entity [Line Items] | ||
Assets | 4,855 | 4,292 |
Total liabilities | 779 | 561 |
Consolidated VIEs for Which the Company is the Investment Manager | Wholly-owned Beneficial Interests | ||
Variable Interest Entity [Line Items] | ||
Assets | 2,885 | 2,538 |
Consolidated VIEs for Which the Company is the Investment Manager | Assets supporting experience-rated contractholder liabilities | ||
Variable Interest Entity [Line Items] | ||
Assets | 0 | 0 |
Consolidated VIEs for Which the Company is the Investment Manager | Equity securities | ||
Variable Interest Entity [Line Items] | ||
Assets | 79 | 42 |
Consolidated VIEs for Which the Company is the Investment Manager | Commercial mortgage and other loans | ||
Variable Interest Entity [Line Items] | ||
Assets | 915 | 975 |
Consolidated VIEs for Which the Company is the Investment Manager | Other | ||
Variable Interest Entity [Line Items] | ||
Assets | 2,846 | 2,221 |
Consolidated VIEs for Which the Company is the Investment Manager | Cash and cash equivalents | ||
Variable Interest Entity [Line Items] | ||
Assets | 128 | 101 |
Consolidated VIEs for Which the Company is the Investment Manager | Accrued investment income | ||
Variable Interest Entity [Line Items] | ||
Assets | 1 | 2 |
Consolidated VIEs for Which the Company is the Investment Manager | Other assets | ||
Variable Interest Entity [Line Items] | ||
Assets | 499 | 594 |
Consolidated VIEs for Which the Company is the Investment Manager | Other liabilities | ||
Variable Interest Entity [Line Items] | ||
Total liabilities | 505 | 256 |
Consolidated VIEs for Which the Company is the Investment Manager | Notes Issued By Consolidated V I E | ||
Variable Interest Entity [Line Items] | ||
Total liabilities | 274 | 305 |
Other Consolidated VIEs | ||
Variable Interest Entity [Line Items] | ||
Assets | 1,978 | 2,077 |
Total liabilities | 2 | 2 |
Other Consolidated VIEs | Assets supporting experience-rated contractholder liabilities | ||
Variable Interest Entity [Line Items] | ||
Assets | 0 | 0 |
Other Consolidated VIEs | Equity securities | ||
Variable Interest Entity [Line Items] | ||
Assets | 0 | 0 |
Other Consolidated VIEs | Commercial mortgage and other loans | ||
Variable Interest Entity [Line Items] | ||
Assets | 0 | 0 |
Other Consolidated VIEs | Other | ||
Variable Interest Entity [Line Items] | ||
Assets | 138 | 127 |
Other Consolidated VIEs | Cash and cash equivalents | ||
Variable Interest Entity [Line Items] | ||
Assets | 0 | 0 |
Other Consolidated VIEs | Accrued investment income | ||
Variable Interest Entity [Line Items] | ||
Assets | 3 | 4 |
Other Consolidated VIEs | Other assets | ||
Variable Interest Entity [Line Items] | ||
Assets | 785 | 768 |
Other Consolidated VIEs | Other liabilities | ||
Variable Interest Entity [Line Items] | ||
Total liabilities | 2 | 2 |
Other Consolidated VIEs | Notes Issued By Consolidated V I E | ||
Variable Interest Entity [Line Items] | ||
Total liabilities | 0 | 0 |
Available-for-sale | Consolidated VIEs for Which the Company is the Investment Manager | Fixed maturities | ||
Variable Interest Entity [Line Items] | ||
Assets | 200 | 110 |
Available-for-sale | Other Consolidated VIEs | Fixed maturities | ||
Variable Interest Entity [Line Items] | ||
Assets | 262 | 296 |
Held-to-maturity | Consolidated VIEs for Which the Company is the Investment Manager | Fixed maturities | ||
Variable Interest Entity [Line Items] | ||
Assets | 9 | 87 |
Held-to-maturity | Other Consolidated VIEs | Fixed maturities | ||
Variable Interest Entity [Line Items] | ||
Assets | 790 | 882 |
Trading | Consolidated VIEs for Which the Company is the Investment Manager | Fixed maturities | ||
Variable Interest Entity [Line Items] | ||
Assets | 178 | 160 |
Trading | Other Consolidated VIEs | Fixed maturities | ||
Variable Interest Entity [Line Items] | ||
Assets | $ 0 | $ 0 |
Maximum | Consolidated VIEs for Which the Company is the Investment Manager | Notes Issued By Consolidated V I E | ||
Variable Interest Entity [Line Items] | ||
Debt Instrument, Term | 3 years |
Variable Interest Entities (Narrative) (Details) - USD ($) |
Dec. 31, 2021 |
Dec. 31, 2020 |
||
---|---|---|---|---|
Variable Interest Entity [Line Items] | ||||
Total Liabilities | $ 874,974,000,000 | $ 872,512,000,000 | ||
Other invested assets | [1] | 21,833,000,000 | 18,125,000,000 | |
Total liabilities | 874,974,000,000 | 872,512,000,000 | ||
Unconsolidated VIEs | ||||
Variable Interest Entity [Line Items] | ||||
Total Liabilities | 0 | |||
Total liabilities | 0 | |||
Joint ventures and limited partnerships | ||||
Variable Interest Entity [Line Items] | ||||
Other invested assets | 15,966,000,000 | 12,883,000,000 | ||
Fixed maturities, available-for-sale, Fixed maturities, trading, Equity securities and Other invested assets | ||||
Variable Interest Entity [Line Items] | ||||
Maximum exposure to loss resulting from investment in unconsolidated VIEs | 997,000,000 | 935,000,000 | ||
Other | Joint ventures and limited partnerships | ||||
Variable Interest Entity [Line Items] | ||||
Maximum exposure to loss resulting from investment in unconsolidated VIEs | $ 15,966,000,000 | $ 12,883,000,000 | ||
|
Derivative Instruments (Narrative) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |||
Total derivative assets | $ 3,266 | $ 1,906 | |
Total derivative liabilities | 2,278 | 792 | |
Anticipated pre-tax loss reclassified from accumulated other comprehensive income (loss) to earnings | $ 289 | ||
Maximum Length of Time Hedged in Cash Flow Hedge (future cash flows) | 30 years | ||
Net investment hedges income (loss) before taxes | $ 16 | (149) | $ 4 |
Non-derivative AOCI Net Investment Hedge Before Tax | 25 | (21) | $ 0 |
Derivative [Line Items] | |||
Credit Risk Derivatives, at Fair Value, Asset Net (Liability) | 128 | 63 | |
Credit Derivative Protection Purchased Notional Amount | 115 | 307 | |
Held-for-sale | |||
Derivative [Line Items] | |||
Credit Risk Derivative Assets, at Fair Value | 54 | ||
Credit Risk Derivative Liabilities, at Fair Value | 0 | ||
Credit Default Swap, Buying Protection | |||
Derivative [Line Items] | |||
Credit Risk Derivatives, at Fair Value, Asset Net (Liability) | $ 1 | $ 28 | |
Credit Index Product | |||
Derivative [Line Items] | |||
Credit Derivatives Written Max Length Of Maturities | 26 years |
Derivative Instruments (Gross Notional Amount and Fair Value of Derivatives Contracts) (Details) - USD ($) $ in Millions |
Dec. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Derivative [Line Items] | ||
Notional | $ 471,246 | $ 445,049 |
Assets | 17,416 | 23,273 |
Liabilities | (19,592) | (18,267) |
Embedded Derivative, Fair Value of Embedded Derivative, Net | (10,245) | (20,119) |
Held-for-sale | ||
Derivative [Line Items] | ||
Notional | 41,179 | |
Assets | 1,643 | |
Liabilities | (1,503) | |
Derivatives Designated as Hedge Accounting Instruments: | ||
Derivative [Line Items] | ||
Notional | 29,900 | 28,533 |
Assets | 2,033 | 1,924 |
Liabilities | (371) | (1,251) |
Derivatives Designated as Hedge Accounting Instruments: | Interest Rate Swaps | ||
Derivative [Line Items] | ||
Notional | 3,591 | 3,065 |
Assets | 805 | 978 |
Liabilities | (69) | (90) |
Derivatives Designated as Hedge Accounting Instruments: | Interest Rate Forwards | ||
Derivative [Line Items] | ||
Notional | 248 | 249 |
Assets | 15 | 0 |
Liabilities | (2) | (8) |
Derivatives Designated as Hedge Accounting Instruments: | Foreign Currency Forwards | ||
Derivative [Line Items] | ||
Notional | 4,789 | 2,577 |
Assets | 62 | 68 |
Liabilities | (107) | (116) |
Derivatives Designated as Hedge Accounting Instruments: | Foreign Currency Swaps | ||
Derivative [Line Items] | ||
Notional | 21,272 | 22,642 |
Assets | 1,151 | 878 |
Liabilities | (193) | (1,037) |
Derivatives Not Qualifying as Hedge Accounting Instruments: | ||
Derivative [Line Items] | ||
Notional | 441,346 | 416,516 |
Assets | 15,383 | 21,349 |
Liabilities | (19,221) | (17,016) |
Derivatives Not Qualifying as Hedge Accounting Instruments: | Interest Rate Swaps | ||
Derivative [Line Items] | ||
Notional | 196,124 | 178,803 |
Assets | 10,515 | 17,174 |
Liabilities | (14,430) | (13,172) |
Derivatives Not Qualifying as Hedge Accounting Instruments: | Interest Rate Forwards | ||
Derivative [Line Items] | ||
Notional | 4,709 | 2,910 |
Assets | 41 | 25 |
Liabilities | (11) | 0 |
Derivatives Not Qualifying as Hedge Accounting Instruments: | Foreign Currency Forwards | ||
Derivative [Line Items] | ||
Notional | 28,235 | 35,478 |
Assets | 1,046 | 764 |
Liabilities | (1,209) | (647) |
Derivatives Not Qualifying as Hedge Accounting Instruments: | Foreign Currency Options | ||
Derivative [Line Items] | ||
Notional | 0 | 0 |
Assets | 0 | 0 |
Liabilities | 0 | 0 |
Derivatives Not Qualifying as Hedge Accounting Instruments: | Foreign Currency Swaps | ||
Derivative [Line Items] | ||
Notional | 12,683 | 13,661 |
Assets | 751 | 537 |
Liabilities | (216) | (601) |
Derivatives Not Qualifying as Hedge Accounting Instruments: | Interest Rate Futures | ||
Derivative [Line Items] | ||
Notional | 17,429 | 15,778 |
Assets | 76 | 99 |
Liabilities | (9) | (5) |
Derivatives Not Qualifying as Hedge Accounting Instruments: | Interest Rate Options | ||
Derivative [Line Items] | ||
Notional | 15,353 | 14,593 |
Assets | 710 | 914 |
Liabilities | (265) | (233) |
Derivatives Not Qualifying as Hedge Accounting Instruments: | Credit Default Swaps | ||
Derivative [Line Items] | ||
Notional | 3,489 | 3,360 |
Assets | 128 | 63 |
Liabilities | (1) | (28) |
Derivatives Not Qualifying as Hedge Accounting Instruments: | Equity Futures | ||
Derivative [Line Items] | ||
Notional | 6,178 | 5,668 |
Assets | 1 | 10 |
Liabilities | (10) | (25) |
Derivatives Not Qualifying as Hedge Accounting Instruments: | Equity Options | ||
Derivative [Line Items] | ||
Notional | 60,057 | 36,250 |
Assets | 2,065 | 1,731 |
Liabilities | (2,640) | (1,028) |
Derivatives Not Qualifying as Hedge Accounting Instruments: | Total Return Swaps | ||
Derivative [Line Items] | ||
Notional | 13,850 | 22,489 |
Assets | 49 | 32 |
Liabilities | (430) | (1,277) |
Derivatives Not Qualifying as Hedge Accounting Instruments: | Other | ||
Derivative [Line Items] | ||
Notional | 1,255 | 1,262 |
Assets | 0 | 0 |
Liabilities | 0 | 0 |
Derivatives Not Qualifying as Hedge Accounting Instruments: | Synthetic GICs | ||
Derivative [Line Items] | ||
Notional | 81,984 | 86,264 |
Assets | 1 | 0 |
Liabilities | $ 0 | $ 0 |
Derivative Instruments Derivative Instruments (Hedged Item Offset By Derivatives Achieving Fair Value Hedge Accounting) (Details) (Details) - USD ($) $ in Millions |
Dec. 31, 2021 |
Dec. 31, 2020 |
||
---|---|---|---|---|
Derivative [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | [1] | $ 372,410 | $ 412,905 | |
Commercial mortgage and other loans | [1] | 58,666 | 65,425 | |
Policyholders’ account balances | (122,633) | (161,682) | ||
Future policy benefits | (290,784) | (306,343) | ||
Carrying Amount of the Hedged Assets (Liabilities) | ||||
Derivative [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 641 | 402 | ||
Commercial mortgage and other loans | 17 | 20 | ||
Policyholders’ account balances | (1,552) | (1,627) | ||
Future policy benefits | (3,001) | (1,585) | ||
Cumulative Adjustment Included in Carrying Amount | ||||
Derivative [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 63 | 79 | ||
Commercial mortgage and other loans | 1 | 2 | ||
Policyholders’ account balances | (170) | (303) | ||
Future policy benefits | $ (279) | $ (372) | ||
|
Derivative Instruments (Offsetting Assets and Liabilities) (Details) - USD ($) $ in Millions |
Dec. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Derivative Assets | ||
Gross Amounts of Recognized Financial Instruments | $ 17,272 | $ 23,144 |
Gross Amounts Offset in the Statements of Financial Position | (14,150) | (21,367) |
Net Amounts Presented in the Statements of Financial Position | 3,122 | 1,777 |
Financial Instruments/Collateral | (802) | (806) |
Net Amount | 2,320 | 971 |
Securities purchased under agreement to resell | ||
Gross Amounts of Recognized Financial Instruments | 704 | 252 |
Gross Amounts Offset in the Statements of Financial Position | 0 | 0 |
Net Amounts Presented in the Statements of Financial Position | 704 | 252 |
Financial Instruments/Collateral | (704) | (252) |
Net Amount | 0 | 0 |
Total Assets | ||
Gross Amounts of Recognized Financial Instruments | 17,976 | 23,396 |
Gross Amounts Offset in the Statements of Financial Position | (14,150) | (21,367) |
Net Amounts Presented in the Statements of Financial Position | 3,826 | 2,029 |
Financial Instruments/Collateral | (1,506) | (1,058) |
Net Amount | 2,320 | 971 |
Derivative Liabilities | ||
Gross Amounts of Recognized Financial Instruments | 19,587 | 18,265 |
Gross Amounts Offset in the Statement of Financial Position | (17,314) | (17,475) |
Net Amounts Presented in the Statement of Financial Position | 2,273 | 790 |
Financial Instruments/Collateral | (797) | (790) |
Net Amount | 1,476 | 0 |
Securities sold under agreement to repurchase | ||
Gross Amounts of Recognized Financial Instruments | 10,185 | 10,894 |
Gross Amounts Offset in the Statement of Financial Position | 0 | 0 |
Net Amounts Presented in the Statement of Financial Position | 10,185 | 10,894 |
Financial Instruments/Collateral | (9,699) | (10,432) |
Net Amount | 486 | 462 |
Total Liabilities | ||
Gross Amounts of Recognized Financial Instruments | 29,772 | 29,159 |
Gross Amounts Offset in the Statement of Financial Position | (17,314) | (17,475) |
Net Amounts Presented in the Statement of Financial Position | 12,458 | 11,684 |
Financial Instruments/Collateral | (10,496) | (11,222) |
Net Amount | $ 1,962 | $ 462 |
Derivative Instruments (Financial Statement Classification and Impact of Derivatives Used in Qualifying and Non-qualifying Hedge Relationships) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Derivative Instruments Gain Loss [Line Items] | |||
Non-derivative AOCI Net Investment Hedge Before Tax | $ 25 | $ (21) | $ 0 |
Gain (Loss) on Investments | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 1,793 | (4,711) | (1,506) |
Gain (Loss) on Investments | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 1,699 | (4,847) | (1,698) |
Investment Income | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 282 | 326 | 298 |
Investment Income | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Other Income (Loss) | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 183 | (182) | (92) |
Other Income (Loss) | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 2 | (5) | 5 |
Interest Expense | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | (1) | 0 |
Interest Expense | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Interest Credited To Policyholders’ Account Balances | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 35 | 40 | 8 |
Interest Credited To Policyholders’ Account Balances | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Policyholder Benefts | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 17 | 30 | 15 |
Policyholder Benefts | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
AOCI | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 1,132 | (1,118) | 16 |
AOCI | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Fair value hedges | Gain (Loss) on Investments | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 12 | (17) | (14) |
Fair value hedges | Investment Income | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | (9) | (8) | (7) |
Fair value hedges | Other Income (Loss) | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Fair value hedges | Interest Expense | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Fair value hedges | Interest Credited To Policyholders’ Account Balances | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | (98) | 236 | 194 |
Fair value hedges | Policyholder Benefts | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | (67) | 232 | 155 |
Fair value hedges | AOCI | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Fair Value Hedged Item | Gain (Loss) on Investments | |||
Derivative Instruments Gain Loss [Line Items] | |||
Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge | (17) | 16 | 12 |
Change In Unrealized Gain (Loss) On Hedged Item In Fair Value Net Of Hedging Instrument | (5) | (1) | (2) |
Fair Value Hedged Item | Investment Income | |||
Derivative Instruments Gain Loss [Line Items] | |||
Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge | 18 | 19 | 23 |
Change In Unrealized Gain (Loss) On Hedged Item In Fair Value Net Of Hedging Instrument | 9 | 11 | 16 |
Fair Value Hedged Item | Other Income (Loss) | |||
Derivative Instruments Gain Loss [Line Items] | |||
Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge | 0 | 0 | 0 |
Change In Unrealized Gain (Loss) On Hedged Item In Fair Value Net Of Hedging Instrument | 0 | 0 | 0 |
Fair Value Hedged Item | Interest Expense | |||
Derivative Instruments Gain Loss [Line Items] | |||
Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge | 0 | 0 | 0 |
Change In Unrealized Gain (Loss) On Hedged Item In Fair Value Net Of Hedging Instrument | 0 | 0 | 0 |
Fair Value Hedged Item | Interest Credited To Policyholders’ Account Balances | |||
Derivative Instruments Gain Loss [Line Items] | |||
Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge | 133 | (196) | (186) |
Change In Unrealized Gain (Loss) On Hedged Item In Fair Value Net Of Hedging Instrument | 35 | 40 | 8 |
Fair Value Hedged Item | Policyholder Benefts | |||
Derivative Instruments Gain Loss [Line Items] | |||
Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge | 90 | (201) | (140) |
Change In Unrealized Gain (Loss) On Hedged Item In Fair Value Net Of Hedging Instrument | 17 | 30 | 15 |
Fair Value Hedged Item | AOCI | |||
Derivative Instruments Gain Loss [Line Items] | |||
Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge | 0 | 0 | 0 |
Change In Unrealized Gain (Loss) On Hedged Item In Fair Value Net Of Hedging Instrument | (46) | 10 | 0 |
Cash flow hedges | Gain (Loss) on Investments | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 99 | 144 | 194 |
Cash flow hedges | Investment Income | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 273 | 315 | 282 |
Cash flow hedges | Other Income (Loss) | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 181 | (303) | (97) |
Cash flow hedges | Interest Expense | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | (1) | 0 |
Cash flow hedges | Interest Credited To Policyholders’ Account Balances | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Cash flow hedges | Policyholder Benefts | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Cash flow hedges | AOCI | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 1,187 | (1,000) | 12 |
Net investment hedges | Gain (Loss) on Investments | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | (7) | 0 |
Net investment hedges | Investment Income | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Net investment hedges | Other Income (Loss) | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 126 | 0 |
Net investment hedges | Interest Expense | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Net investment hedges | Interest Credited To Policyholders’ Account Balances | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Net investment hedges | Policyholder Benefts | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Net investment hedges | AOCI | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | (9) | (128) | 4 |
Interest Rate | Gain (Loss) on Investments | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | (1,875) | 5,800 | 4,533 |
Interest Rate | Investment Income | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Interest Rate | Other Income (Loss) | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Interest Rate | Interest Expense | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Interest Rate | Interest Credited To Policyholders’ Account Balances | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Interest Rate | Policyholder Benefts | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Interest Rate | AOCI | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Interest Rate | Fair value hedges | Gain (Loss) on Investments | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 20 | (17) | (14) |
Interest Rate | Fair value hedges | Investment Income | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | (9) | (8) | (7) |
Interest Rate | Fair value hedges | Other Income (Loss) | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Interest Rate | Fair value hedges | Interest Expense | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Interest Rate | Fair value hedges | Interest Credited To Policyholders’ Account Balances | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | (98) | 236 | 194 |
Interest Rate | Fair value hedges | Policyholder Benefts | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | (73) | 186 | 155 |
Interest Rate | Fair value hedges | AOCI | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Interest Rate | Fair Value Hedged Item | Gain (Loss) on Investments | |||
Derivative Instruments Gain Loss [Line Items] | |||
Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge | (24) | 16 | 11 |
Interest Rate | Fair Value Hedged Item | Investment Income | |||
Derivative Instruments Gain Loss [Line Items] | |||
Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge | 16 | 18 | 20 |
Interest Rate | Fair Value Hedged Item | Other Income (Loss) | |||
Derivative Instruments Gain Loss [Line Items] | |||
Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge | 0 | 0 | 0 |
Interest Rate | Fair Value Hedged Item | Interest Expense | |||
Derivative Instruments Gain Loss [Line Items] | |||
Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge | 0 | 0 | 0 |
Interest Rate | Fair Value Hedged Item | Interest Credited To Policyholders’ Account Balances | |||
Derivative Instruments Gain Loss [Line Items] | |||
Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge | 133 | (196) | (186) |
Interest Rate | Fair Value Hedged Item | Policyholder Benefts | |||
Derivative Instruments Gain Loss [Line Items] | |||
Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge | 96 | (155) | (140) |
Interest Rate | Fair Value Hedged Item | AOCI | |||
Derivative Instruments Gain Loss [Line Items] | |||
Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge | 0 | 0 | 0 |
Interest Rate | Cash flow hedges | Gain (Loss) on Investments | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | (2) | 40 | 58 |
Interest Rate | Cash flow hedges | Investment Income | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 2 | 1 | 0 |
Interest Rate | Cash flow hedges | Other Income (Loss) | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Interest Rate | Cash flow hedges | Interest Expense | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | (1) | 0 |
Interest Rate | Cash flow hedges | Interest Credited To Policyholders’ Account Balances | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Interest Rate | Cash flow hedges | Policyholder Benefts | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Interest Rate | Cash flow hedges | AOCI | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | (13) | 7 | (25) |
Currency | Gain (Loss) on Investments | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | (364) | 100 | 14 |
Currency | Investment Income | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Currency | Other Income (Loss) | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | (3) | (1) | 5 |
Currency | Interest Expense | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Currency | Interest Credited To Policyholders’ Account Balances | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Currency | Policyholder Benefts | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Currency | AOCI | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Currency | Fair value hedges | Gain (Loss) on Investments | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | (8) | 0 | 0 |
Currency | Fair value hedges | Investment Income | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Currency | Fair value hedges | Other Income (Loss) | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Currency | Fair value hedges | Interest Expense | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Currency | Fair value hedges | Interest Credited To Policyholders’ Account Balances | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Currency | Fair value hedges | Policyholder Benefts | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 6 | 46 | 0 |
Currency | Fair value hedges | AOCI | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Currency | Fair Value Hedged Item | Gain (Loss) on Investments | |||
Derivative Instruments Gain Loss [Line Items] | |||
Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge | 7 | 0 | 1 |
Currency | Fair Value Hedged Item | Investment Income | |||
Derivative Instruments Gain Loss [Line Items] | |||
Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge | 2 | 1 | 3 |
Currency | Fair Value Hedged Item | Other Income (Loss) | |||
Derivative Instruments Gain Loss [Line Items] | |||
Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge | 0 | 0 | 0 |
Currency | Fair Value Hedged Item | Interest Expense | |||
Derivative Instruments Gain Loss [Line Items] | |||
Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge | 0 | 0 | 0 |
Currency | Fair Value Hedged Item | Interest Credited To Policyholders’ Account Balances | |||
Derivative Instruments Gain Loss [Line Items] | |||
Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge | 0 | 0 | 0 |
Currency | Fair Value Hedged Item | Policyholder Benefts | |||
Derivative Instruments Gain Loss [Line Items] | |||
Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge | (6) | (46) | 0 |
Currency | Fair Value Hedged Item | AOCI | |||
Derivative Instruments Gain Loss [Line Items] | |||
Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge | 0 | 0 | 0 |
Currency | Amortization of Gain(loss) excluded from assessment of effectiveness | Gain (Loss) on Investments | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | |
Currency | Amortization of Gain(loss) excluded from assessment of effectiveness | Investment Income | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | |
Currency | Amortization of Gain(loss) excluded from assessment of effectiveness | Other Income (Loss) | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | |
Currency | Amortization of Gain(loss) excluded from assessment of effectiveness | Interest Expense | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | |
Currency | Amortization of Gain(loss) excluded from assessment of effectiveness | Interest Credited To Policyholders’ Account Balances | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | |
Currency | Amortization of Gain(loss) excluded from assessment of effectiveness | Policyholder Benefts | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | (6) | (1) | |
Currency | Amortization of Gain(loss) excluded from assessment of effectiveness | AOCI | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | (46) | 10 | |
Currency | Cash flow hedges | Gain (Loss) on Investments | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | (4) | 5 | 6 |
Currency | Cash flow hedges | Investment Income | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Currency | Cash flow hedges | Other Income (Loss) | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Currency | Cash flow hedges | Interest Expense | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Currency | Cash flow hedges | Interest Credited To Policyholders’ Account Balances | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Currency | Cash flow hedges | Policyholder Benefts | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Currency | Cash flow hedges | AOCI | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 48 | (69) | (62) |
Currency | Net investment hedges | Gain (Loss) on Investments | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | (7) | 0 |
Currency | Net investment hedges | Investment Income | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Currency | Net investment hedges | Other Income (Loss) | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 126 | 0 |
Currency | Net investment hedges | Interest Expense | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Currency | Net investment hedges | Interest Credited To Policyholders’ Account Balances | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Currency | Net investment hedges | Policyholder Benefts | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Currency | Net investment hedges | AOCI | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | (9) | (128) | 4 |
Currency/Interest Rate | Gain (Loss) on Investments | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 802 | (188) | 394 |
Currency/Interest Rate | Investment Income | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Currency/Interest Rate | Other Income (Loss) | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 5 | (4) | 0 |
Currency/Interest Rate | Interest Expense | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Currency/Interest Rate | Interest Credited To Policyholders’ Account Balances | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Currency/Interest Rate | Policyholder Benefts | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Currency/Interest Rate | AOCI | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Currency/Interest Rate | Cash flow hedges | Gain (Loss) on Investments | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 105 | 99 | 130 |
Currency/Interest Rate | Cash flow hedges | Investment Income | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 271 | 314 | 282 |
Currency/Interest Rate | Cash flow hedges | Other Income (Loss) | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 181 | (303) | (97) |
Currency/Interest Rate | Cash flow hedges | Interest Expense | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Currency/Interest Rate | Cash flow hedges | Interest Credited To Policyholders’ Account Balances | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Currency/Interest Rate | Cash flow hedges | Policyholder Benefts | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Currency/Interest Rate | Cash flow hedges | AOCI | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 1,152 | (938) | 99 |
Currency/Interest Rate | Net investment hedges | Gain (Loss) on Investments | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Currency/Interest Rate | Net investment hedges | Investment Income | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Currency/Interest Rate | Net investment hedges | Other Income (Loss) | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Currency/Interest Rate | Net investment hedges | Interest Expense | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Currency/Interest Rate | Net investment hedges | Interest Credited To Policyholders’ Account Balances | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Currency/Interest Rate | Net investment hedges | Policyholder Benefts | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Currency/Interest Rate | Net investment hedges | AOCI | Derivatives Designated as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Credit | Gain (Loss) on Investments | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 61 | (56) | 123 |
Credit | Investment Income | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Credit | Other Income (Loss) | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Credit | Interest Expense | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Credit | Interest Credited To Policyholders’ Account Balances | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Credit | Policyholder Benefts | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Credit | AOCI | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Equity | Gain (Loss) on Investments | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | (2,600) | (5,623) | (4,057) |
Equity | Investment Income | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Equity | Other Income (Loss) | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Equity | Interest Expense | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Equity | Interest Credited To Policyholders’ Account Balances | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Equity | Policyholder Benefts | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Equity | AOCI | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Other Contract | Gain (Loss) on Investments | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 1 | 2 | 0 |
Other Contract | Investment Income | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Other Contract | Other Income (Loss) | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Other Contract | Interest Expense | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Other Contract | Interest Credited To Policyholders’ Account Balances | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Other Contract | Policyholder Benefts | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Other Contract | AOCI | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Embedded Derivative Financial Instruments | Gain (Loss) on Investments | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 5,674 | (4,882) | (2,705) |
Embedded Derivative Financial Instruments | Investment Income | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Embedded Derivative Financial Instruments | Other Income (Loss) | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Embedded Derivative Financial Instruments | Interest Expense | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Embedded Derivative Financial Instruments | Interest Credited To Policyholders’ Account Balances | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Embedded Derivative Financial Instruments | Policyholder Benefts | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
Embedded Derivative Financial Instruments | AOCI | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
Derivative Instruments Gain Loss [Line Items] | |||
Derivative Instruments Gain (Loss) Recognized In Income Net | $ 0 | $ 0 | $ 0 |
Derivative Instruments (Current Period Cash Flow Hedges in AOCI (loss) before Taxes) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items] | |||
Cumulative Effect of New Accounting Principle in Period of Adoption | $ 9 | ||
Cash flow hedges in AOCI | |||
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items] | |||
Balance, beginning | $ (168) | $ 832 | 811 |
Amount recorded in AOCI | 1,740 | (845) | 391 |
Amount reclassified from AOCI to income | (553) | (155) | (379) |
Ending Balance | 1,019 | (168) | 832 |
Interest Rate | Cash flow hedges in AOCI | |||
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items] | |||
Amount recorded in AOCI | (13) | 47 | 33 |
Amount reclassified from AOCI to income | 0 | (40) | (58) |
Currency | Cash flow hedges in AOCI | |||
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items] | |||
Amount recorded in AOCI | 44 | (64) | (56) |
Amount reclassified from AOCI to income | 4 | (5) | (6) |
Currency/Interest Rate | Cash flow hedges in AOCI | |||
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items] | |||
Amount recorded in AOCI | 1,709 | (828) | 414 |
Amount reclassified from AOCI to income | $ (557) | $ (110) | $ (315) |
Derivative Instruments (Credit Derivatives) (Details) - USD ($) $ in Millions |
Dec. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Derivative [Line Items] | ||
Credit Derivative, Maximum Exposure, Undiscounted | $ 3,374 | $ 3,053 |
Credit Risk Derivatives, at Fair Value, Asset Net (Liability) | 128 | 63 |
Held-for-sale | ||
Derivative [Line Items] | ||
Credit Risk Derivative Assets, at Fair Value | 54 | |
Credit Risk Derivative Liabilities, at Fair Value | 0 | |
Single Name | ||
Derivative [Line Items] | ||
Credit Derivative, Maximum Exposure, Undiscounted | 0 | 0 |
Credit Risk Derivatives, at Fair Value, Asset Net (Liability) | 0 | 0 |
Credit Default Index | ||
Derivative [Line Items] | ||
Credit Derivative, Maximum Exposure, Undiscounted | 3,374 | 3,053 |
Credit Risk Derivatives, at Fair Value, Asset Net (Liability) | 128 | 63 |
NAIC 1 | ||
Derivative [Line Items] | ||
Credit Derivative, Maximum Exposure, Undiscounted | 49 | 50 |
Credit Risk Derivatives, at Fair Value, Asset Net (Liability) | 0 | 0 |
NAIC 1 | Single Name | ||
Derivative [Line Items] | ||
Credit Derivative, Maximum Exposure, Undiscounted | 0 | 0 |
Credit Risk Derivatives, at Fair Value, Asset Net (Liability) | 0 | 0 |
NAIC 1 | Credit Default Index | ||
Derivative [Line Items] | ||
Credit Derivative, Maximum Exposure, Undiscounted | 49 | 50 |
Credit Risk Derivatives, at Fair Value, Asset Net (Liability) | 0 | 0 |
NAIC 2 | ||
Derivative [Line Items] | ||
Credit Derivative, Maximum Exposure, Undiscounted | 0 | 0 |
Credit Risk Derivatives, at Fair Value, Asset Net (Liability) | 0 | 0 |
NAIC 2 | Single Name | ||
Derivative [Line Items] | ||
Credit Derivative, Maximum Exposure, Undiscounted | 0 | 0 |
Credit Risk Derivatives, at Fair Value, Asset Net (Liability) | 0 | 0 |
NAIC 2 | Credit Default Index | ||
Derivative [Line Items] | ||
Credit Derivative, Maximum Exposure, Undiscounted | 0 | 0 |
Credit Risk Derivatives, at Fair Value, Asset Net (Liability) | 0 | 0 |
NAIC 3 | ||
Derivative [Line Items] | ||
Credit Derivative, Maximum Exposure, Undiscounted | 2,397 | 3,003 |
Credit Risk Derivatives, at Fair Value, Asset Net (Liability) | 41 | 63 |
NAIC 3 | Single Name | ||
Derivative [Line Items] | ||
Credit Derivative, Maximum Exposure, Undiscounted | 0 | 0 |
Credit Risk Derivatives, at Fair Value, Asset Net (Liability) | 0 | 0 |
NAIC 3 | Credit Default Index | ||
Derivative [Line Items] | ||
Credit Derivative, Maximum Exposure, Undiscounted | 2,397 | 3,003 |
Credit Risk Derivatives, at Fair Value, Asset Net (Liability) | 41 | 63 |
NAIC 4 | ||
Derivative [Line Items] | ||
Credit Derivative, Maximum Exposure, Undiscounted | 0 | 0 |
Credit Risk Derivatives, at Fair Value, Asset Net (Liability) | 0 | 0 |
NAIC 4 | Single Name | ||
Derivative [Line Items] | ||
Credit Derivative, Maximum Exposure, Undiscounted | 0 | 0 |
Credit Risk Derivatives, at Fair Value, Asset Net (Liability) | 0 | 0 |
NAIC 4 | Credit Default Index | ||
Derivative [Line Items] | ||
Credit Derivative, Maximum Exposure, Undiscounted | 0 | 0 |
Credit Risk Derivatives, at Fair Value, Asset Net (Liability) | 0 | 0 |
NAIC 5 | ||
Derivative [Line Items] | ||
Credit Derivative, Maximum Exposure, Undiscounted | 0 | 0 |
Credit Risk Derivatives, at Fair Value, Asset Net (Liability) | 0 | 0 |
NAIC 5 | Single Name | ||
Derivative [Line Items] | ||
Credit Derivative, Maximum Exposure, Undiscounted | 0 | 0 |
Credit Risk Derivatives, at Fair Value, Asset Net (Liability) | 0 | 0 |
NAIC 5 | Credit Default Index | ||
Derivative [Line Items] | ||
Credit Derivative, Maximum Exposure, Undiscounted | 0 | 0 |
Credit Risk Derivatives, at Fair Value, Asset Net (Liability) | 0 | 0 |
NAIC 6 | ||
Derivative [Line Items] | ||
Credit Derivative, Maximum Exposure, Undiscounted | 928 | 0 |
Credit Risk Derivatives, at Fair Value, Asset Net (Liability) | 87 | 0 |
NAIC 6 | Single Name | ||
Derivative [Line Items] | ||
Credit Derivative, Maximum Exposure, Undiscounted | 0 | 0 |
Credit Risk Derivatives, at Fair Value, Asset Net (Liability) | 0 | 0 |
NAIC 6 | Credit Default Index | ||
Derivative [Line Items] | ||
Credit Derivative, Maximum Exposure, Undiscounted | 928 | 0 |
Credit Risk Derivatives, at Fair Value, Asset Net (Liability) | $ 87 | $ 0 |
Fair Value of Assets and Liabilities (Balances of Assets and Liabilities Measured at Fair Value on a Recurring Basis) (Details) - USD ($) $ in Millions |
Dec. 31, 2021 |
Dec. 31, 2020 |
||
---|---|---|---|---|
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | [1] | $ 372,410 | $ 412,905 | |
Assets supporting experience-rated contractholder liabilities | 3,358 | 24,115 | ||
Fixed maturities, trading | [1] | 8,823 | 3,914 | |
Equity securities, Fair Value | [1] | 8,574 | 8,135 | |
Commercial mortgage and other loans | [1] | 58,666 | 65,425 | |
Other invested assets | [1] | 21,833 | 18,125 | |
Short-term investments | 6,635 | |||
Other assets | [1] | 10,739 | 22,801 | |
Separate account assets | 246,145 | 327,277 | ||
TOTAL ASSETS | 937,582 | 940,722 | ||
Future policy benefits | 290,784 | 306,343 | ||
Other liabilities | [1] | 11,755 | 20,323 | |
Total liabilities | 874,974 | 872,512 | ||
Netting increase (decrease) | 14,150 | 21,367 | ||
Embedded Derivative, Fair Value of Embedded Derivative, Net Liability | 10,245 | 20,119 | ||
Debt Securities, Available-for-sale, Amortized Cost | 333,459 | 354,470 | ||
Held-for-sale | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 13,569 | |||
Assets supporting experience-rated contractholder liabilities | 18,818 | |||
Other invested assets | 104 | |||
Debt Securities, Available-for-sale, Amortized Cost | 13,145 | |||
Fixed maturities | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 372,410 | 412,905 | ||
Assets supporting experience-rated contractholder liabilities | 1,057 | 21,414 | ||
Debt Securities, Available-for-sale, Amortized Cost | 333,459 | 354,470 | ||
Fixed maturities | Held-for-sale | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 13,569 | |||
Assets supporting experience-rated contractholder liabilities | 17,706 | |||
Debt Securities, Available-for-sale, Amortized Cost | 13,145 | |||
Future policy benefits | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Embedded Derivative, Fair Value of Embedded Derivative, Net Liability | 9,069 | 18,879 | ||
Embedded Derivative, Fair Value of Embedded Derivative Gross Asset | 611 | 520 | ||
Embedded Derivative, Fair Value of Embedded Derivative Gross Liability | 9,680 | 19,399 | ||
U.S. Treasury securities and obligations of U.S. government authorities and agencies | Fixed maturities | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 32,158 | 40,448 | ||
Debt Securities, Available-for-sale, Amortized Cost | 26,231 | 30,766 | ||
Obligations of U.S. states and their political subdivisions | Fixed maturities | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 12,218 | 12,811 | ||
Debt Securities, Available-for-sale, Amortized Cost | 10,445 | 10,668 | ||
Foreign government bonds | Fixed maturities | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 94,669 | 110,244 | ||
Assets supporting experience-rated contractholder liabilities | 761 | 945 | ||
Debt Securities, Available-for-sale, Amortized Cost | 83,363 | 94,110 | ||
Foreign government bonds | Fixed maturities | Held-for-sale | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Assets supporting experience-rated contractholder liabilities | 237 | |||
U.S. public corporate securities | Fixed maturities | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 112,155 | 113,555 | ||
Debt Securities, Available-for-sale, Amortized Cost | 98,836 | 95,299 | ||
U.S. private corporate securities | Fixed maturities | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 37,382 | 40,937 | ||
Debt Securities, Available-for-sale, Amortized Cost | 35,019 | 36,894 | ||
Foreign public corporate securities | Fixed maturities | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 27,309 | 29,537 | ||
Debt Securities, Available-for-sale, Amortized Cost | 24,877 | 25,857 | ||
Foreign private corporate securities | Fixed maturities | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 29,037 | 31,592 | ||
Debt Securities, Available-for-sale, Amortized Cost | 28,047 | 28,668 | ||
Corporate securities | Fixed maturities | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Assets supporting experience-rated contractholder liabilities | 103 | 15,472 | ||
Corporate securities | Fixed maturities | Held-for-sale | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Assets supporting experience-rated contractholder liabilities | 12,463 | |||
Asset-backed securities | Fixed maturities | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 11,525 | 14,591 | ||
Assets supporting experience-rated contractholder liabilities | 0 | 1,697 | ||
Debt Securities, Available-for-sale, Amortized Cost | 11,402 | 14,489 | ||
Asset-backed securities | Fixed maturities | Held-for-sale | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Assets supporting experience-rated contractholder liabilities | 2,093 | |||
Commercial mortgage-backed securities | Fixed maturities | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 13,099 | 16,303 | ||
Assets supporting experience-rated contractholder liabilities | 0 | 1,839 | ||
Debt Securities, Available-for-sale, Amortized Cost | 12,490 | 15,036 | ||
Commercial mortgage-backed securities | Fixed maturities | Held-for-sale | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Assets supporting experience-rated contractholder liabilities | 1,830 | |||
Residential mortgage-backed securities | Fixed maturities | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 2,858 | 2,887 | ||
Assets supporting experience-rated contractholder liabilities | 0 | 1,018 | ||
Debt Securities, Available-for-sale, Amortized Cost | 2,749 | 2,683 | ||
Residential mortgage-backed securities | Fixed maturities | Held-for-sale | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Assets supporting experience-rated contractholder liabilities | 683 | |||
Fair Value, Measurements, Recurring | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 372,410 | 412,905 | ||
Assets supporting experience-rated contractholder liabilities | 3,348 | 24,076 | ||
Fixed maturities, trading | 8,823 | 3,914 | ||
Equity securities, Fair Value | 8,377 | 7,998 | ||
Commercial mortgage and other loans | 1,263 | 1,092 | ||
Other invested assets | 3,756 | 2,271 | ||
Short-term investments | 5,643 | 6,310 | ||
Cash equivalents | 5,259 | 5,482 | ||
Other assets | 164 | 268 | ||
Separate account assets | 219,971 | 304,270 | ||
TOTAL ASSETS | 629,014 | 768,586 | ||
Future policy benefits | 9,068 | 18,879 | ||
Policyholders' account balances | 1,436 | 1,914 | ||
Other liabilities | 1,860 | 385 | ||
Notes issued by consolidated VIEs | 0 | 0 | ||
Total liabilities | 12,364 | 21,178 | ||
Assets Netting | (14,150) | (21,367) | ||
Liabilities Netting | (17,314) | (17,475) | ||
Netting increase (decrease) | 3,164 | 3,892 | ||
Fair Value, Measurements, Recurring | Held-for-sale | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
TOTAL ASSETS | 129,579 | |||
Total liabilities | 6,214 | |||
Fair Value, Measurements, Recurring | Other invested assets | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Assets Netting | (14,150) | (21,367) | ||
Fair Value, Measurements, Recurring | Other liabilities | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Liabilities Netting | (17,314) | (17,475) | ||
Fair Value, Measurements, Recurring | U.S. Treasury securities and obligations of U.S. government authorities and agencies | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 32,158 | 40,448 | ||
Assets supporting experience-rated contractholder liabilities | 193 | 212 | ||
Fair Value, Measurements, Recurring | Obligations of U.S. states and their political subdivisions | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 12,218 | 12,811 | ||
Assets supporting experience-rated contractholder liabilities | 0 | 231 | ||
Fair Value, Measurements, Recurring | Foreign government bonds | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 94,669 | 110,244 | ||
Assets supporting experience-rated contractholder liabilities | 761 | 945 | ||
Fair Value, Measurements, Recurring | U.S. public corporate securities | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 112,155 | 113,555 | ||
Fair Value, Measurements, Recurring | U.S. private corporate securities | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 37,382 | 40,937 | ||
Fair Value, Measurements, Recurring | Foreign public corporate securities | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 27,309 | 29,537 | ||
Fair Value, Measurements, Recurring | Foreign private corporate securities | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 29,037 | 31,592 | ||
Fair Value, Measurements, Recurring | Corporate securities | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Assets supporting experience-rated contractholder liabilities | 103 | 15,472 | ||
Fair Value, Measurements, Recurring | Asset-backed securities | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 11,525 | 14,591 | ||
Assets supporting experience-rated contractholder liabilities | 0 | 1,697 | ||
Fair Value, Measurements, Recurring | Commercial mortgage-backed securities | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 13,099 | 16,303 | ||
Assets supporting experience-rated contractholder liabilities | 0 | 1,839 | ||
Fair Value, Measurements, Recurring | Residential mortgage-backed securities | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 2,858 | 2,887 | ||
Assets supporting experience-rated contractholder liabilities | 0 | 1,018 | ||
Fair Value, Measurements, Recurring | Equity securities | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Assets supporting experience-rated contractholder liabilities | 2,271 | 2,043 | ||
Fair Value, Measurements, Recurring | All other | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Assets supporting experience-rated contractholder liabilities | 20 | 619 | ||
Fair Value, Measurements, Recurring | Level 1 | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 0 | 0 | ||
Assets supporting experience-rated contractholder liabilities | 864 | 1,834 | ||
Fixed maturities, trading | 0 | 0 | ||
Equity securities, Fair Value | 7,386 | 6,207 | ||
Commercial mortgage and other loans | 0 | 0 | ||
Other invested assets | 409 | 227 | ||
Short-term investments | 1,199 | 405 | ||
Cash equivalents | 753 | 1,476 | ||
Other assets | 0 | 0 | ||
Separate account assets | 12,305 | 51,826 | ||
TOTAL ASSETS | 22,916 | 61,975 | ||
Future policy benefits | 0 | 0 | ||
Policyholders' account balances | 0 | 0 | ||
Other liabilities | 33 | 32 | ||
Notes issued by consolidated VIEs | 0 | 0 | ||
Total liabilities | 33 | 32 | ||
Fair Value, Measurements, Recurring | Level 1 | U.S. Treasury securities and obligations of U.S. government authorities and agencies | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 0 | 0 | ||
Assets supporting experience-rated contractholder liabilities | 0 | 0 | ||
Fair Value, Measurements, Recurring | Level 1 | Obligations of U.S. states and their political subdivisions | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 0 | 0 | ||
Assets supporting experience-rated contractholder liabilities | 0 | 0 | ||
Fair Value, Measurements, Recurring | Level 1 | Foreign government bonds | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 0 | 0 | ||
Assets supporting experience-rated contractholder liabilities | 0 | 0 | ||
Fair Value, Measurements, Recurring | Level 1 | U.S. public corporate securities | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 0 | 0 | ||
Fair Value, Measurements, Recurring | Level 1 | U.S. private corporate securities | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 0 | 0 | ||
Fair Value, Measurements, Recurring | Level 1 | Foreign public corporate securities | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 0 | 0 | ||
Fair Value, Measurements, Recurring | Level 1 | Foreign private corporate securities | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 0 | 0 | ||
Fair Value, Measurements, Recurring | Level 1 | Corporate securities | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Assets supporting experience-rated contractholder liabilities | 0 | 0 | ||
Fair Value, Measurements, Recurring | Level 1 | Asset-backed securities | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 0 | 0 | ||
Assets supporting experience-rated contractholder liabilities | 0 | 0 | ||
Fair Value, Measurements, Recurring | Level 1 | Commercial mortgage-backed securities | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 0 | 0 | ||
Assets supporting experience-rated contractholder liabilities | 0 | 0 | ||
Fair Value, Measurements, Recurring | Level 1 | Residential mortgage-backed securities | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 0 | 0 | ||
Assets supporting experience-rated contractholder liabilities | 0 | 0 | ||
Fair Value, Measurements, Recurring | Level 1 | Equity securities | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Assets supporting experience-rated contractholder liabilities | 862 | 1,784 | ||
Fair Value, Measurements, Recurring | Level 1 | All other | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Assets supporting experience-rated contractholder liabilities | 2 | 50 | ||
Fair Value, Measurements, Recurring | Level 2 | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 365,090 | 406,862 | ||
Assets supporting experience-rated contractholder liabilities | 2,484 | 21,607 | ||
Fixed maturities, trading | 8,402 | 3,671 | ||
Equity securities, Fair Value | 192 | 1,131 | ||
Commercial mortgage and other loans | 1,263 | 1,092 | ||
Other invested assets | 17,004 | 23,045 | ||
Short-term investments | 4,114 | 5,728 | ||
Cash equivalents | 4,436 | 4,005 | ||
Other assets | 0 | 0 | ||
Separate account assets | 206,383 | 250,623 | ||
TOTAL ASSETS | 609,368 | 717,764 | ||
Future policy benefits | 0 | 0 | ||
Policyholders' account balances | 0 | 0 | ||
Other liabilities | 19,141 | 17,828 | ||
Notes issued by consolidated VIEs | 0 | 0 | ||
Total liabilities | 19,141 | 17,828 | ||
Fair Value, Measurements, Recurring | Level 2 | U.S. Treasury securities and obligations of U.S. government authorities and agencies | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 32,158 | 40,298 | ||
Assets supporting experience-rated contractholder liabilities | 193 | 212 | ||
Fair Value, Measurements, Recurring | Level 2 | Obligations of U.S. states and their political subdivisions | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 12,210 | 12,807 | ||
Assets supporting experience-rated contractholder liabilities | 0 | 231 | ||
Fair Value, Measurements, Recurring | Level 2 | Foreign government bonds | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 94,659 | 110,233 | ||
Assets supporting experience-rated contractholder liabilities | 761 | 926 | ||
Fair Value, Measurements, Recurring | Level 2 | U.S. public corporate securities | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 112,073 | 113,486 | ||
Fair Value, Measurements, Recurring | Level 2 | U.S. private corporate securities | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 35,344 | 38,689 | ||
Fair Value, Measurements, Recurring | Level 2 | Foreign public corporate securities | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 27,184 | 29,384 | ||
Fair Value, Measurements, Recurring | Level 2 | Foreign private corporate securities | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 25,966 | 28,727 | ||
Fair Value, Measurements, Recurring | Level 2 | Corporate securities | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Assets supporting experience-rated contractholder liabilities | 103 | 14,990 | ||
Fair Value, Measurements, Recurring | Level 2 | Asset-backed securities | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 11,200 | 14,068 | ||
Assets supporting experience-rated contractholder liabilities | 0 | 1,583 | ||
Fair Value, Measurements, Recurring | Level 2 | Commercial mortgage-backed securities | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 11,763 | 16,294 | ||
Assets supporting experience-rated contractholder liabilities | 0 | 1,839 | ||
Fair Value, Measurements, Recurring | Level 2 | Residential mortgage-backed securities | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 2,533 | 2,876 | ||
Assets supporting experience-rated contractholder liabilities | 0 | 1,018 | ||
Fair Value, Measurements, Recurring | Level 2 | Equity securities | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Assets supporting experience-rated contractholder liabilities | 1,409 | 259 | ||
Fair Value, Measurements, Recurring | Level 2 | All other | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Assets supporting experience-rated contractholder liabilities | 18 | 549 | ||
Fair Value, Measurements, Recurring | Level 3 | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 7,320 | 6,043 | ||
Assets supporting experience-rated contractholder liabilities | 0 | 635 | ||
Fixed maturities, trading | 421 | 243 | ||
Equity securities, Fair Value | 799 | 660 | ||
Commercial mortgage and other loans | 0 | 0 | ||
Other invested assets | 493 | 366 | ||
Short-term investments | 330 | 177 | ||
Cash equivalents | 70 | 1 | ||
Other assets | 164 | 268 | ||
Separate account assets | 1,283 | 1,821 | ||
TOTAL ASSETS | 10,880 | 10,214 | ||
Future policy benefits | 9,068 | 18,879 | ||
Policyholders' account balances | 1,436 | 1,914 | ||
Other liabilities | 0 | 0 | ||
Notes issued by consolidated VIEs | 0 | 0 | ||
Total liabilities | 10,504 | 20,793 | ||
Fair Value, Measurements, Recurring | Level 3 | U.S. Treasury securities and obligations of U.S. government authorities and agencies | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 0 | 150 | ||
Assets supporting experience-rated contractholder liabilities | 0 | 0 | ||
Fair Value, Measurements, Recurring | Level 3 | Obligations of U.S. states and their political subdivisions | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 8 | 4 | ||
Assets supporting experience-rated contractholder liabilities | 0 | 0 | ||
Fair Value, Measurements, Recurring | Level 3 | Foreign government bonds | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 10 | 11 | ||
Assets supporting experience-rated contractholder liabilities | 0 | 19 | ||
Fair Value, Measurements, Recurring | Level 3 | U.S. public corporate securities | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 82 | 69 | ||
Fair Value, Measurements, Recurring | Level 3 | U.S. private corporate securities | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 2,038 | 2,248 | ||
Fair Value, Measurements, Recurring | Level 3 | Foreign public corporate securities | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 125 | 153 | ||
Fair Value, Measurements, Recurring | Level 3 | Foreign private corporate securities | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 3,071 | 2,865 | ||
Fair Value, Measurements, Recurring | Level 3 | Corporate securities | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Assets supporting experience-rated contractholder liabilities | 0 | 482 | ||
Fair Value, Measurements, Recurring | Level 3 | Asset-backed securities | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 325 | 523 | ||
Assets supporting experience-rated contractholder liabilities | 0 | 114 | ||
Fair Value, Measurements, Recurring | Level 3 | Commercial mortgage-backed securities | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 1,336 | 9 | ||
Assets supporting experience-rated contractholder liabilities | 0 | 0 | ||
Fair Value, Measurements, Recurring | Level 3 | Residential mortgage-backed securities | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 325 | 11 | ||
Assets supporting experience-rated contractholder liabilities | 0 | 0 | ||
Fair Value, Measurements, Recurring | Level 3 | Equity securities | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Assets supporting experience-rated contractholder liabilities | 0 | 0 | ||
Fair Value, Measurements, Recurring | Level 3 | All other | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Assets supporting experience-rated contractholder liabilities | 0 | 20 | ||
Prudential Netting Agreement | U.S. private corporate securities | Fixed maturities | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fixed Maturities, Available for Sale, Fair Value | 5,995 | 6,100 | ||
Debt Securities, Available-for-sale, Amortized Cost | 5,941 | 5,966 | ||
Other invested assets | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fair value investment measured at NAV per share | 4,290 | 4,136 | ||
Separate account assets | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fair value investment measured at NAV per share | $ 26,174 | $ 23,007 | ||
|
Fair Value of Assets and Liabilities (Quantitative Info for Level 3 Inputs) (Details) - USD ($) $ in Millions |
12 Months Ended | |
---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
|
Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||
Future policy benefits | $ 290,784 | $ 306,343 |
Fair Value, Measurements, Recurring | ||
Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||
Future policy benefits | 9,068 | 18,879 |
Policyholders' account balances | $ 1,436 | 1,914 |
Level 3 | Minimum | ||
Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||
Fair Value Inputs, Policyholder Age | 45 years | |
Level 3 | Minimum | Future policy benefits | ||
Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||
Mortality rate | 0.00% | |
Level 3 | Maximum | ||
Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||
Fair Value Inputs, Policyholder Age | 90 years | |
Level 3 | Fair Value, Measurements, Recurring | ||
Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||
Future policy benefits | $ 9,068 | 18,879 |
Policyholders' account balances | $ 1,436 | $ 1,914 |
Level 3 | Internal | Minimum | Discounted cash flow | Future policy benefits | ||
Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||
Lapse rate | 1.00% | 1.00% |
Spread over LIBOR | 0.03% | 0.06% |
Utilization rate | 39.00% | 39.00% |
Withdrawal rate (greater than maximum range) | 76.00% | 76.00% |
Mortality rate | 0.00% | 0.00% |
Equity volatility curve | 16.00% | 18.00% |
Level 3 | Internal | Minimum | Discounted cash flow | Policyholders’ account balances | ||
Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||
Lapse rate | 1.00% | 1.00% |
Spread over LIBOR | 0.03% | 0.06% |
Mortality rate | 0.00% | 0.00% |
Equity volatility curve | 12.00% | 6.00% |
Level 3 | Internal | Minimum | Discounted cash flow | Corporate securities | ||
Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||
Discount rate | 0.31% | 0.40% |
Level 3 | Internal | Minimum | Discounted cash flow | Equity securities | ||
Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||
Discount rate | 0.50% | 0.50% |
Level 3 | Internal | Minimum | Discounted cash flow | Separate accounts commercial mortgage loan | ||
Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||
Spread | 1.05% | 1.60% |
Level 3 | Internal | Minimum | Market comparables | Corporate securities | ||
Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||
EBITDA multiples | 4.1 | 7.0 |
Level 3 | Internal | Minimum | Market comparables | Equity securities | ||
Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||
EBITDA multiples | 1 | 1 |
Level 3 | Internal | Minimum | Liquidation | Corporate securities | ||
Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||
Liquidation value | 11.31% | 12.13% |
Level 3 | Internal | Minimum | Net asset value | Equity securities | ||
Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||
Share price | 1 | 1 |
Level 3 | Internal | Maximum | Discounted cash flow | Future policy benefits | ||
Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||
Lapse rate | 20.00% | 20.00% |
Spread over LIBOR | 1.14% | 1.17% |
Utilization rate | 96.00% | 96.00% |
Withdrawal rate (greater than maximum range) | 100.00% | 100.00% |
Mortality rate | 15.00% | 15.00% |
Equity volatility curve | 25.00% | 26.00% |
Level 3 | Internal | Maximum | Discounted cash flow | Policyholders’ account balances | ||
Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||
Lapse rate | 6.00% | 42.00% |
Spread over LIBOR | 1.14% | 1.17% |
Mortality rate | 23.00% | 24.00% |
Equity volatility curve | 27.00% | 42.00% |
Level 3 | Internal | Maximum | Discounted cash flow | Corporate securities | ||
Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||
Discount rate | 20.00% | 25.00% |
Level 3 | Internal | Maximum | Discounted cash flow | Equity securities | ||
Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||
Discount rate | 20.00% | 20.00% |
Level 3 | Internal | Maximum | Discounted cash flow | Separate accounts commercial mortgage loan | ||
Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||
Spread | 1.98% | 2.98% |
Level 3 | Internal | Maximum | Market comparables | Corporate securities | ||
Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||
EBITDA multiples | 19.2 | 15.0 |
Level 3 | Internal | Maximum | Market comparables | Equity securities | ||
Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||
EBITDA multiples | 7.5 | 8.8 |
Level 3 | Internal | Maximum | Liquidation | Corporate securities | ||
Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||
Liquidation value | 62.58% | 15.00% |
Level 3 | Internal | Maximum | Net asset value | Equity securities | ||
Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||
Share price | 1,498 | 1,414 |
Level 3 | Internal | Weighted Average | Discounted cash flow | Corporate securities | ||
Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||
Discount rate | 5.00% | 4.28% |
Level 3 | Internal | Weighted Average | Discounted cash flow | Separate accounts commercial mortgage loan | ||
Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||
Spread | 1.18% | 1.80% |
Level 3 | Internal | Weighted Average | Market comparables | Corporate securities | ||
Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||
EBITDA multiples | 8.9 | 9.0 |
Level 3 | Internal | Weighted Average | Market comparables | Equity securities | ||
Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||
EBITDA multiples | 4.0 | 3.3 |
Level 3 | Internal | Weighted Average | Liquidation | Corporate securities | ||
Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||
Liquidation value | 55.57% | 13.02% |
Level 3 | Internal | Weighted Average | Net asset value | Equity securities | ||
Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||
Share price | 594 | 495 |
Level 3 | Internal | Fair Value, Measurements, Recurring | Future policy benefits | ||
Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||
Future policy benefits | $ 9,068 | $ 18,879 |
Level 3 | Internal | Fair Value, Measurements, Recurring | Policyholders’ account balances | ||
Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||
Policyholders' account balances | 1,436 | 1,914 |
Level 3 | Internal | Fair Value, Measurements, Recurring | Corporate securities | ||
Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||
Corporate securities | 4,800 | 3,697 |
Level 3 | Internal | Fair Value, Measurements, Recurring | Equity securities | ||
Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||
Equity securities | 277 | 195 |
Level 3 | Internal | Fair Value, Measurements, Recurring | Separate accounts commercial mortgage loan | ||
Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||
Commercial mortgage loans | $ 150 | $ 775 |
Fair Value of Assets and Liabilities (Changes in Level 3 Assets and Liabilities) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Corporate securities | Held-for-sale | |||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
Transfers out of Level 3 | $ 218 | ||
Structured securities | Held-for-sale | |||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
Transfers out of Level 3 | 79 | ||
Equity securities | |||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
Fair Value, beginning of period | 660 | $ 633 | |
Purchases | 171 | 59 | |
Sales | (98) | (50) | |
Issuances | 0 | 0 | |
Settlements | (24) | (6) | |
Other | (31) | 11 | |
Transfers into Level 3 | 76 | 0 | |
Transfers out of Level 3 | (72) | (1) | |
Fair Value, end of period | 799 | 660 | $ 633 |
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 117 | 14 | |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 145 | 11 | |
Equity securities | Realized investment gains (losses), net | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 0 | 0 | 0 |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 0 | 0 | 0 |
Equity securities | Other Income | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 117 | 14 | 42 |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 145 | 11 | 34 |
Equity securities | Interest credited to policyholders' account balances | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 0 | 0 | 0 |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 0 | 0 | 0 |
Equity securities | Included in other comprehensive income (loss) | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 0 | 0 | 0 |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 0 | 0 | |
Equity securities | Net investment income | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 0 | 0 | 0 |
Assets supporting experience-rated contractholder liabilities | Realized investment gains (losses), net | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 0 | 0 | 0 |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 0 | 0 | 0 |
Assets supporting experience-rated contractholder liabilities | Other Income | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | (6) | (22) | (4) |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 0 | (22) | (5) |
Assets supporting experience-rated contractholder liabilities | Interest credited to policyholders' account balances | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 0 | 0 | 0 |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 0 | 0 | 0 |
Assets supporting experience-rated contractholder liabilities | Included in other comprehensive income (loss) | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 0 | 0 | 0 |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 0 | 0 | |
Assets supporting experience-rated contractholder liabilities | Net investment income | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 7 | 4 | 9 |
Assets supporting experience-rated contractholder liabilities | Foreign government bonds | |||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
Fair Value, beginning of period | 19 | 24 | |
Purchases | 0 | 0 | |
Sales | (14) | 0 | |
Issuances | 0 | 0 | |
Settlements | (5) | (5) | |
Other | 0 | 0 | |
Transfers into Level 3 | 0 | 0 | |
Transfers out of Level 3 | 0 | 0 | |
Fair Value, end of period | 0 | 19 | 24 |
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 0 | 0 | |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 0 | 0 | |
Assets supporting experience-rated contractholder liabilities | Corporate securities | |||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
Fair Value, beginning of period | 482 | 637 | |
Purchases | 17 | 6 | |
Sales | 0 | (9) | |
Issuances | 0 | 0 | |
Settlements | (113) | (182) | |
Other | (157) | (19) | |
Transfers into Level 3 | 71 | 99 | |
Transfers out of Level 3 | (306) | (33) | |
Fair Value, end of period | 0 | 482 | 637 |
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 6 | (17) | |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 0 | (25) | |
Assets supporting experience-rated contractholder liabilities | Structured securities | |||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
Fair Value, beginning of period | 114 | 69 | |
Purchases | 221 | 191 | |
Sales | (8) | 0 | |
Issuances | 0 | 0 | |
Settlements | (38) | (33) | |
Other | 0 | 0 | |
Transfers into Level 3 | 2 | 1 | |
Transfers out of Level 3 | (286) | (113) | |
Fair Value, end of period | 0 | 114 | 69 |
Total gains (losses) (realized/unrealized): | |||
Included in earnings | (5) | (1) | |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 0 | 3 | |
Assets supporting experience-rated contractholder liabilities | Equity securities | |||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
Fair Value, beginning of period | 0 | 0 | |
Purchases | 0 | 0 | |
Sales | 0 | 0 | |
Issuances | 0 | 0 | |
Settlements | 0 | 0 | |
Other | 0 | 0 | |
Transfers into Level 3 | 0 | 0 | |
Transfers out of Level 3 | 0 | 0 | |
Fair Value, end of period | 0 | 0 | 0 |
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 0 | 0 | |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 0 | 0 | |
Assets supporting experience-rated contractholder liabilities | All other activity | |||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
Fair Value, beginning of period | 20 | 0 | |
Purchases | 1 | 134 | |
Sales | (1) | 0 | |
Issuances | 0 | 0 | |
Settlements | (20) | (5) | |
Other | 0 | (2) | |
Transfers into Level 3 | 0 | 0 | |
Transfers out of Level 3 | 0 | (107) | |
Fair Value, end of period | 0 | 20 | 0 |
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 0 | 0 | |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 0 | 0 | |
Other invested assets | |||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
Fair Value, beginning of period | 366 | 567 | |
Purchases | 193 | 209 | |
Sales | (55) | 0 | |
Issuances | 0 | 4 | |
Settlements | (50) | (5) | |
Other | 0 | (415) | |
Transfers into Level 3 | 0 | 8 | |
Transfers out of Level 3 | 0 | (9) | |
Fair Value, end of period | 493 | 366 | 567 |
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 39 | 7 | |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 40 | 7 | |
Other invested assets | Realized investment gains (losses), net | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 7 | 0 | (1) |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 6 | 0 | (1) |
Other invested assets | Other Income | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 32 | 7 | 12 |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 34 | 7 | 0 |
Other invested assets | Interest credited to policyholders' account balances | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 0 | 0 | 0 |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 0 | 0 | 0 |
Other invested assets | Included in other comprehensive income (loss) | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 0 | 0 | 0 |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 0 | 0 | |
Other invested assets | Net investment income | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 0 | 0 | 0 |
Short-term investments | |||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
Fair Value, beginning of period | 177 | 155 | |
Purchases | 783 | 327 | |
Sales | 0 | 0 | |
Issuances | 0 | 0 | |
Settlements | (597) | (115) | |
Other | (26) | (48) | |
Transfers into Level 3 | 5 | 0 | |
Transfers out of Level 3 | (13) | (143) | |
Fair Value, end of period | 330 | 177 | 155 |
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 1 | 1 | |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | (1) | (1) | |
Short-term investments | Realized investment gains (losses), net | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 0 | 1 | 0 |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | (1) | (1) | 0 |
Short-term investments | Other Income | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 0 | 0 | 0 |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 0 | 0 | 0 |
Short-term investments | Interest credited to policyholders' account balances | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 0 | 0 | 0 |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 0 | 0 | 0 |
Short-term investments | Included in other comprehensive income (loss) | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 0 | 0 | 0 |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 0 | 0 | |
Short-term investments | Net investment income | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 1 | 0 | 0 |
Cash equivalents | |||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
Fair Value, beginning of period | 1 | 131 | |
Purchases | 82 | 0 | |
Sales | 0 | 0 | |
Issuances | 0 | 0 | |
Settlements | 0 | 0 | |
Other | (4) | (130) | |
Transfers into Level 3 | 0 | 0 | |
Transfers out of Level 3 | (8) | 0 | |
Fair Value, end of period | 70 | 1 | 131 |
Total gains (losses) (realized/unrealized): | |||
Included in earnings | (1) | 0 | |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | (1) | 0 | |
Cash equivalents | Realized investment gains (losses), net | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | (1) | 0 | 0 |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | (1) | 0 | 0 |
Cash equivalents | Other Income | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 0 | 0 | 0 |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 0 | 0 | 0 |
Cash equivalents | Interest credited to policyholders' account balances | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 0 | 0 | 0 |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 0 | 0 | 0 |
Cash equivalents | Included in other comprehensive income (loss) | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 0 | 0 | 0 |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 0 | 0 | |
Cash equivalents | Net investment income | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 0 | 0 | 0 |
Other assets | |||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
Fair Value, beginning of period | 268 | 113 | |
Purchases | 55 | 69 | |
Sales | 0 | 0 | |
Issuances | 0 | 0 | |
Settlements | (9) | (1) | |
Other | 0 | 0 | |
Transfers into Level 3 | 0 | 0 | |
Transfers out of Level 3 | (76) | 0 | |
Fair Value, end of period | 164 | 268 | 113 |
Total gains (losses) (realized/unrealized): | |||
Included in earnings | (74) | 87 | |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | (44) | 88 | |
Other assets | Realized investment gains (losses), net | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | (113) | 87 | 44 |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | (44) | 88 | 44 |
Other assets | Other Income | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 0 | 0 | 0 |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 0 | 0 | 0 |
Other assets | Interest credited to policyholders' account balances | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 0 | 0 | 0 |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 0 | 0 | 0 |
Other assets | Included in other comprehensive income (loss) | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 39 | 0 | 0 |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 0 | 0 | |
Other assets | Net investment income | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 0 | 0 | 0 |
Separate accounts assets | |||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
Fair Value, beginning of period | 1,821 | 1,717 | |
Purchases | 298 | 242 | |
Sales | (81) | (71) | |
Issuances | 0 | 0 | |
Settlements | (30) | (84) | |
Other | (615) | 0 | |
Transfers into Level 3 | 67 | 43 | |
Transfers out of Level 3 | (503) | (169) | |
Fair Value, end of period | 1,283 | 1,821 | 1,717 |
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 326 | 143 | |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 199 | 157 | |
Separate accounts assets | Realized investment gains (losses), net | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 0 | 0 | 0 |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 0 | 0 | 0 |
Separate accounts assets | Other Income | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 0 | 0 | 0 |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 0 | 0 | 0 |
Separate accounts assets | Interest credited to policyholders' account balances | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 326 | 143 | 180 |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 199 | 157 | 170 |
Separate accounts assets | Included in other comprehensive income (loss) | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 0 | 0 | 0 |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 0 | 0 | |
Separate accounts assets | Net investment income | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 0 | 0 | 4 |
Future policy benefits | |||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
Fair Value, beginning of period | (18,879) | (12,831) | |
Purchases | 0 | 0 | |
Sales | 0 | 0 | |
Issuances | (1,322) | (1,304) | |
Settlements | 0 | 0 | |
Other | 12 | 93 | |
Transfers into Level 3 | 0 | 0 | |
Transfers out of Level 3 | 4,162 | 0 | |
Fair Value, end of period | (9,068) | (18,879) | (12,831) |
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 6,959 | (4,837) | |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 4,654 | (5,263) | |
Future policy benefits | Held-for-sale | |||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
Transfers out of Level 3 | 4,162 | ||
Future policy benefits | Realized investment gains (losses), net | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 6,959 | (4,837) | (2,685) |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 4,654 | (5,263) | (2,999) |
Future policy benefits | Other Income | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 0 | 0 | 0 |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 0 | 0 | 0 |
Future policy benefits | Interest credited to policyholders' account balances | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 0 | 0 | 0 |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 0 | 0 | 0 |
Future policy benefits | Included in other comprehensive income (loss) | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 0 | 0 | 0 |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 0 | 0 | |
Future policy benefits | Net investment income | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 0 | 0 | 0 |
Policyholders’ account balances | |||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
Fair Value, beginning of period | (1,914) | (1,316) | |
Purchases | 0 | 0 | |
Sales | 0 | 0 | |
Issuances | (389) | (370) | |
Settlements | 0 | 0 | |
Other | 0 | 0 | |
Transfers into Level 3 | 1 | 0 | |
Transfers out of Level 3 | 2,040 | 0 | |
Fair Value, end of period | (1,436) | (1,914) | (1,316) |
Total gains (losses) (realized/unrealized): | |||
Included in earnings | (1,174) | (228) | |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | (10) | (155) | |
Policyholders’ account balances | Held-for-sale | |||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
Transfers out of Level 3 | 2,040 | ||
Policyholders’ account balances | Realized investment gains (losses), net | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | (1,174) | (228) | (933) |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | (10) | (155) | (917) |
Policyholders’ account balances | Other Income | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 0 | 0 | 0 |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 0 | 0 | 0 |
Policyholders’ account balances | Interest credited to policyholders' account balances | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 0 | 0 | 0 |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 0 | 0 | 0 |
Policyholders’ account balances | Included in other comprehensive income (loss) | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 0 | 0 | 0 |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 0 | 0 | |
Policyholders’ account balances | Net investment income | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 0 | 0 | 0 |
Other liabilities | |||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
Fair Value, beginning of period | 0 | (105) | |
Purchases | 0 | 0 | |
Sales | 0 | 0 | |
Issuances | 0 | 0 | |
Settlements | 0 | 0 | |
Other | 0 | 0 | |
Transfers into Level 3 | 0 | 0 | |
Transfers out of Level 3 | 0 | 0 | |
Fair Value, end of period | 0 | 0 | (105) |
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 0 | 105 | |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 0 | 105 | |
Other liabilities | Realized investment gains (losses), net | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 0 | 0 | 0 |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 0 | 0 | 0 |
Other liabilities | Other Income | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 0 | 105 | (5) |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 0 | 105 | (5) |
Other liabilities | Interest credited to policyholders' account balances | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 0 | 0 | 0 |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 0 | 0 | 0 |
Other liabilities | Included in other comprehensive income (loss) | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 0 | 0 | 0 |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 0 | 0 | |
Other liabilities | Net investment income | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 0 | 0 | 0 |
Notes issued by consolidated VIEs | |||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
Fair Value, beginning of period | 0 | (800) | |
Purchases | 0 | 0 | |
Sales | 0 | 0 | |
Issuances | 0 | 0 | |
Settlements | 0 | 0 | |
Other | 0 | 775 | |
Transfers into Level 3 | 0 | 0 | |
Transfers out of Level 3 | 0 | 0 | |
Fair Value, end of period | 0 | 0 | (800) |
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 0 | 25 | |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 0 | 25 | |
Notes issued by consolidated VIEs | Realized investment gains (losses), net | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 0 | 0 | 15 |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 0 | 0 | 15 |
Notes issued by consolidated VIEs | Other Income | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 0 | 25 | 0 |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 0 | 25 | 0 |
Notes issued by consolidated VIEs | Interest credited to policyholders' account balances | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 0 | 0 | 0 |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 0 | 0 | 0 |
Notes issued by consolidated VIEs | Included in other comprehensive income (loss) | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 0 | 0 | 0 |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 0 | 0 | |
Notes issued by consolidated VIEs | Net investment income | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 0 | 0 | 0 |
Available-for-sale | Fixed Maturities | Realized investment gains (losses), net | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 45 | (111) | (67) |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | (43) | (139) | (98) |
Available-for-sale | Fixed Maturities | Other Income | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 0 | 0 | 0 |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 0 | 0 | 0 |
Available-for-sale | Fixed Maturities | Interest credited to policyholders' account balances | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 0 | 0 | 0 |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 0 | 0 | 0 |
Available-for-sale | Fixed Maturities | Included in other comprehensive income (loss) | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | (163) | 368 | 86 |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | (153) | 331 | |
Available-for-sale | Fixed Maturities | Net investment income | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 4 | 9 | 18 |
Available-for-sale | Fixed Maturities | U.S. government | |||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
Fair Value, beginning of period | 150 | 105 | |
Purchases | 0 | 45 | |
Sales | (150) | 0 | |
Issuances | 0 | 0 | |
Settlements | 0 | 0 | |
Other | 0 | 0 | |
Transfers into Level 3 | 0 | 0 | |
Transfers out of Level 3 | 0 | 0 | |
Fair Value, end of period | 0 | 150 | 105 |
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 0 | 0 | |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 0 | 0 | |
Available-for-sale | Fixed Maturities | U.S. states | |||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
Fair Value, beginning of period | 4 | 4 | |
Purchases | 0 | 0 | |
Sales | 0 | 0 | |
Issuances | 0 | 0 | |
Settlements | 0 | 0 | |
Other | 4 | 0 | |
Transfers into Level 3 | 0 | 0 | |
Transfers out of Level 3 | 0 | 0 | |
Fair Value, end of period | 8 | 4 | 4 |
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 0 | 0 | |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 0 | 0 | |
Available-for-sale | Fixed Maturities | Foreign government bonds | |||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
Fair Value, beginning of period | 11 | 22 | |
Purchases | 0 | 0 | |
Sales | 0 | 0 | |
Issuances | 0 | 0 | |
Settlements | (1) | 0 | |
Other | 0 | 0 | |
Transfers into Level 3 | 0 | 1 | |
Transfers out of Level 3 | 0 | (12) | |
Fair Value, end of period | 10 | 11 | 22 |
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 0 | 0 | |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 0 | 0 | |
Available-for-sale | Fixed Maturities | Corporate securities | |||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
Fair Value, beginning of period | 5,335 | 3,236 | |
Purchases | 1,560 | 1,144 | |
Sales | (47) | (127) | |
Issuances | 114 | 0 | |
Settlements | (1,278) | (1,021) | |
Other | (8) | (16) | |
Transfers into Level 3 | 386 | 2,178 | |
Transfers out of Level 3 | (542) | (333) | |
Fair Value, end of period | 5,316 | 5,335 | 3,236 |
Total gains (losses) (realized/unrealized): | |||
Included in earnings | (204) | 274 | |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | (258) | 203 | |
Available-for-sale | Fixed Maturities | Structured securities | |||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
Fair Value, beginning of period | 543 | 948 | |
Purchases | 1,546 | 685 | |
Sales | (3) | (18) | |
Issuances | 0 | 0 | |
Settlements | (248) | (547) | |
Other | 10 | 156 | |
Transfers into Level 3 | 1,779 | 178 | |
Transfers out of Level 3 | (1,731) | (851) | |
Fair Value, end of period | 1,986 | 543 | 948 |
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 90 | (8) | |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 62 | (11) | |
Trading | Fixed Maturities | |||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
Fair Value, beginning of period | 243 | 287 | |
Purchases | 50 | 33 | |
Sales | (55) | (33) | |
Issuances | 0 | 0 | |
Settlements | (21) | 0 | |
Other | 161 | 9 | |
Transfers into Level 3 | 52 | 19 | |
Transfers out of Level 3 | (45) | (48) | |
Fair Value, end of period | 421 | 243 | 287 |
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 36 | (24) | |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 34 | (24) | |
Trading | Fixed Maturities | Realized investment gains (losses), net | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 0 | 0 | 0 |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 0 | 0 | 0 |
Trading | Fixed Maturities | Other Income | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 36 | (25) | (27) |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 34 | (24) | (27) |
Trading | Fixed Maturities | Interest credited to policyholders' account balances | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 0 | 0 | 0 |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 0 | 0 | 0 |
Trading | Fixed Maturities | Included in other comprehensive income (loss) | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 0 | 0 | 0 |
Unrealized gains (losses) for assets/liabilities still held: | |||
Included in earnings | 0 | 0 | |
Trading | Fixed Maturities | Net investment income | |||
Total gains (losses) (realized/unrealized): | |||
Included in earnings | $ 0 | $ 1 | $ 1 |
Fair Value of Assets and Liabilities (Derivative Assets and Liabilities Measured at Fair Value on a Recurring Basis) (Details) - USD ($) $ in Millions |
Dec. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total derivative assets | $ 3,266 | $ 1,906 |
Netting | (14,150) | (21,367) |
Total derivative liabilities | 2,278 | 792 |
Netting | (17,314) | (17,475) |
Interest Rate | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total derivative assets | 12,163 | 19,190 |
Total derivative liabilities | 14,786 | 13,508 |
Currency | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total derivative assets | 1,108 | 832 |
Total derivative liabilities | 1,316 | 763 |
Credit | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total derivative assets | 128 | 63 |
Total derivative liabilities | 1 | 28 |
Currency/Interest Rate | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total derivative assets | 1,902 | 1,415 |
Total derivative liabilities | 409 | 1,638 |
Equity | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total derivative assets | 2,115 | 1,773 |
Total derivative liabilities | 3,080 | 2,330 |
Commodity | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total derivative assets | 0 | 0 |
Total derivative liabilities | 0 | 0 |
Level 1 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total derivative assets | 318 | 227 |
Total derivative liabilities | 20 | 30 |
Level 1 | Interest Rate | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total derivative assets | 76 | 99 |
Total derivative liabilities | 9 | 5 |
Level 1 | Currency | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total derivative assets | 0 | 0 |
Total derivative liabilities | 0 | 0 |
Level 1 | Credit | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total derivative assets | 0 | 0 |
Total derivative liabilities | 0 | 0 |
Level 1 | Currency/Interest Rate | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total derivative assets | 0 | 0 |
Total derivative liabilities | 0 | 0 |
Level 1 | Equity | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total derivative assets | 242 | 128 |
Total derivative liabilities | 11 | 25 |
Level 1 | Commodity | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total derivative assets | 0 | 0 |
Total derivative liabilities | 0 | 0 |
Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total derivative assets | 17,096 | 23,046 |
Total derivative liabilities | 19,572 | 18,237 |
Level 2 | Interest Rate | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total derivative assets | 12,086 | 19,091 |
Total derivative liabilities | 14,777 | 13,503 |
Level 2 | Currency | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total derivative assets | 1,108 | 832 |
Total derivative liabilities | 1,316 | 763 |
Level 2 | Credit | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total derivative assets | 128 | 63 |
Total derivative liabilities | 1 | 28 |
Level 2 | Currency/Interest Rate | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total derivative assets | 1,902 | 1,415 |
Total derivative liabilities | 409 | 1,638 |
Level 2 | Equity | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total derivative assets | 1,872 | 1,645 |
Total derivative liabilities | 3,069 | 2,305 |
Level 2 | Commodity | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total derivative assets | 0 | 0 |
Total derivative liabilities | 0 | 0 |
Level 3 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total derivative assets | 2 | 0 |
Total derivative liabilities | 0 | 0 |
Level 3 | Interest Rate | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total derivative assets | 1 | 0 |
Total derivative liabilities | 0 | 0 |
Level 3 | Currency | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total derivative assets | 0 | 0 |
Total derivative liabilities | 0 | 0 |
Level 3 | Credit | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total derivative assets | 0 | 0 |
Total derivative liabilities | 0 | 0 |
Level 3 | Currency/Interest Rate | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total derivative assets | 0 | 0 |
Total derivative liabilities | 0 | 0 |
Level 3 | Equity | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total derivative assets | 1 | 0 |
Total derivative liabilities | 0 | 0 |
Level 3 | Commodity | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total derivative assets | 0 | 0 |
Total derivative liabilities | 0 | 0 |
Fair Value, Measurements, Recurring | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Netting | $ (3,164) | $ (3,892) |
Fair Value of Assets and Liabilities (Changes in Level 3 Derivative Assets and Liabilities) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Equity | |||
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward] | |||
Fair Value, beginning of period | $ 0 | $ 0 | $ 0 |
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 1 | 0 | 0 |
Purchases | 1 | 0 | 0 |
Sales | 0 | 0 | 0 |
Issuances | 0 | 0 | 0 |
Settlements | (1) | 0 | 0 |
Other | 0 | 0 | 0 |
Transfers into Level 3 | 0 | 0 | 0 |
Transfers out of Level 3 | 0 | 0 | 0 |
Fair Value, end of period | 1 | 0 | 0 |
Unrealized gains (losses) for assets still held: | |||
Included in earnings | 1 | 0 | 0 |
Interest Rate | |||
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward] | |||
Fair Value, beginning of period | 0 | 1 | 2 |
Total gains (losses) (realized/unrealized): | |||
Included in earnings | 1 | (1) | (1) |
Purchases | 0 | 0 | 0 |
Sales | 0 | 0 | 0 |
Issuances | 0 | 0 | 0 |
Settlements | 0 | 0 | 0 |
Other | 0 | 0 | 0 |
Transfers into Level 3 | 0 | 0 | 0 |
Transfers out of Level 3 | 0 | 0 | 0 |
Fair Value, end of period | 1 | 0 | 1 |
Unrealized gains (losses) for assets still held: | |||
Included in earnings | $ 1 | $ 0 | $ (2) |
Fair Value of Assets and Liabilities (Nonrecurring Fair Value Measurements) (Details) - Fair Value, Measurements, Nonrecurring - Level 3 - USD ($) $ in Millions |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Commercial mortgage loans | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Realized gains (losses) net | $ 0 | $ 0 | $ 2 |
Carrying value after measurement as of period end | 0 | 0 | |
Mortgage servicing rights | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Realized gains (losses) net | 6 | (25) | 11 |
Carrying value after measurement as of period end | 75 | 307 | |
Investment real estate | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Realized gains (losses) net | (15) | (24) | 0 |
Carrying value after measurement as of period end | 326 | 31 | |
Goodwill | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Realized gains (losses) net | (1,060) | 0 | $ 0 |
Carrying value after measurement as of period end | $ 1,080 | $ 0 |
Fair Value of Assets and Liabilities (Changes in Fair Values Recorded in Earnings for FVO Assets-Liabilities) (Details) - USD ($) $ in Millions |
12 Months Ended | ||||
---|---|---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|||
Fair Value, Option, Quantitative Disclosures [Line Items] | |||||
Interest expense | $ 1,478 | $ 1,560 | $ 1,551 | ||
Commercial mortgage and other loans | [1] | 58,666 | 65,425 | ||
Other assets | [1] | 10,739 | 22,801 | ||
Commercial mortgage and other loans | |||||
Fair Value, Option, Quantitative Disclosures [Line Items] | |||||
Interest income | 15 | 17 | 20 | ||
Fair value option loans in non-accrual status | 0 | ||||
Fair value option loans in more than 90 days past due and still accruing | 0 | ||||
Notes issued by consolidated VIEs | |||||
Fair Value, Option, Quantitative Disclosures [Line Items] | |||||
Changes in fair value | 0 | (25) | (15) | ||
Interest expense | 0 | 32 | $ 45 | ||
Fair value option | |||||
Fair Value, Option, Quantitative Disclosures [Line Items] | |||||
Commercial mortgage and other loans | 1,263 | 1,092 | |||
Other assets | 59 | 10 | |||
Notes issued by consolidated VIEs | 0 | 0 | |||
Fair value option, aggregate contractual principal | |||||
Fair Value, Option, Quantitative Disclosures [Line Items] | |||||
Commercial mortgage and other loans | 1,253 | 1,073 | |||
Notes issued by consolidated VIEs | $ 0 | $ 0 | |||
|
Fair Value of Assets and Liabilities (Financial Instruments where Carrying Amounts and Fair Values May Differ) (Details) - USD ($) $ in Millions |
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
||||
---|---|---|---|---|---|---|---|
Assets: | |||||||
Fixed maturities, held-to-maturity | [1] | $ 1,514 | $ 1,930 | ||||
Assets supporting experience-rated contractholder liabilities | 3,358 | 24,115 | |||||
Commercial mortgage and other loans | [1] | 58,666 | 65,425 | ||||
Policy loans | 10,386 | 11,271 | |||||
Other invested assets | [1] | 21,833 | 18,125 | ||||
Cash and cash equivalents | 12,888 | [1] | 13,701 | [1] | $ 16,327 | ||
Accrued investment income | [1] | 2,855 | 3,193 | ||||
Liabilities: | |||||||
Securities sold under agreements to repurchase | 10,185 | 10,894 | |||||
Cash collateral for loaned securities | 4,251 | 3,499 | |||||
Short-term debt | 722 | 925 | |||||
Long-term debt | 18,622 | 19,718 | |||||
Held-for-sale | |||||||
Assets: | |||||||
Assets supporting experience-rated contractholder liabilities | 18,818 | ||||||
Other invested assets | 104 | ||||||
Accrued investment income | 221 | ||||||
Fair Value | |||||||
Assets: | |||||||
Fixed maturities, held-to-maturity | 1,803 | 2,298 | |||||
Assets supporting experience-rated contractholder liabilities | 10 | 39 | |||||
Commercial mortgage and other loans | 60,001 | 67,584 | |||||
Policy loans | 10,386 | 11,271 | |||||
Other invested assets | 81 | 153 | |||||
Short-term Investments | 992 | 1,490 | |||||
Cash and cash equivalents | 7,629 | 8,219 | |||||
Accrued investment income | 2,855 | 3,193 | |||||
Other assets | 2,763 | 3,520 | |||||
Total assets | 86,520 | 97,767 | |||||
Liabilities: | |||||||
Policyholders’ account balances—investment contracts | 72,381 | 110,473 | |||||
Securities sold under agreements to repurchase | 10,185 | 10,894 | |||||
Cash collateral for loaned securities | 4,251 | 3,499 | |||||
Short-term debt | 722 | 940 | |||||
Long-term debt | 21,926 | 23,468 | |||||
Notes issued by consolidated VIEs | 274 | 305 | |||||
Other liabilities | 7,106 | 7,674 | |||||
Separate account liabilities-investment contracts | 53,414 | 109,677 | |||||
Total liabilities | 170,259 | 266,930 | |||||
Fair Value | Held-for-sale | |||||||
Assets: | |||||||
Total assets | 6,936 | ||||||
Liabilities: | |||||||
Total liabilities | 101,992 | ||||||
Carrying Amount | |||||||
Assets: | |||||||
Fixed maturities, held-to-maturity | 1,514 | 1,930 | |||||
Assets supporting experience-rated contractholder liabilities | 10 | 39 | |||||
Commercial mortgage and other loans | 57,403 | 64,333 | |||||
Policy loans | 10,386 | 11,271 | |||||
Other invested assets | 81 | 153 | |||||
Short-term Investments | 992 | 1,490 | |||||
Cash and cash equivalents | 7,629 | 8,219 | |||||
Accrued investment income | 2,855 | 3,193 | |||||
Other assets | 2,762 | 3,517 | |||||
Total assets | 83,632 | 94,145 | |||||
Liabilities: | |||||||
Policyholders’ account balances—investment contracts | 71,290 | 107,526 | |||||
Securities sold under agreements to repurchase | 10,185 | 10,894 | |||||
Cash collateral for loaned securities | 4,251 | 3,499 | |||||
Short-term debt | 722 | 925 | |||||
Long-term debt | 18,622 | 19,718 | |||||
Notes issued by consolidated VIEs | 274 | 305 | |||||
Other liabilities | 7,106 | 7,674 | |||||
Separate account liabilities-investment contracts | 53,414 | 109,677 | |||||
Total liabilities | 165,864 | 260,218 | |||||
Level 1 | Fair Value | |||||||
Assets: | |||||||
Fixed maturities, held-to-maturity | 0 | 0 | |||||
Assets supporting experience-rated contractholder liabilities | 3 | 39 | |||||
Commercial mortgage and other loans | 0 | 0 | |||||
Policy loans | 0 | 0 | |||||
Other invested assets | 0 | 0 | |||||
Short-term Investments | 972 | 1,464 | |||||
Cash and cash equivalents | 7,108 | 7,951 | |||||
Accrued investment income | 0 | 0 | |||||
Other assets | 47 | 154 | |||||
Total assets | 8,130 | 9,608 | |||||
Liabilities: | |||||||
Policyholders’ account balances—investment contracts | 0 | 0 | |||||
Securities sold under agreements to repurchase | 0 | 0 | |||||
Cash collateral for loaned securities | 0 | 0 | |||||
Short-term debt | 0 | 0 | |||||
Long-term debt | 613 | 644 | |||||
Notes issued by consolidated VIEs | 0 | 0 | |||||
Other liabilities | 0 | 0 | |||||
Separate account liabilities-investment contracts | 0 | 0 | |||||
Total liabilities | 613 | 644 | |||||
Level 2 | Fair Value | |||||||
Assets: | |||||||
Fixed maturities, held-to-maturity | 1,794 | 2,209 | |||||
Assets supporting experience-rated contractholder liabilities | 7 | 0 | |||||
Commercial mortgage and other loans | 64 | 107 | |||||
Policy loans | 0 | 0 | |||||
Other invested assets | 81 | 153 | |||||
Short-term Investments | 20 | 26 | |||||
Cash and cash equivalents | 521 | 268 | |||||
Accrued investment income | 2,855 | 3,193 | |||||
Other assets | 2,677 | 2,917 | |||||
Total assets | 8,019 | 8,873 | |||||
Liabilities: | |||||||
Policyholders’ account balances—investment contracts | 33,550 | 36,820 | |||||
Securities sold under agreements to repurchase | 10,185 | 10,894 | |||||
Cash collateral for loaned securities | 4,251 | 3,499 | |||||
Short-term debt | 518 | 794 | |||||
Long-term debt | 20,414 | 21,685 | |||||
Notes issued by consolidated VIEs | 0 | 0 | |||||
Other liabilities | 7,053 | 7,626 | |||||
Separate account liabilities-investment contracts | 28,567 | 86,046 | |||||
Total liabilities | 104,538 | 167,364 | |||||
Level 3 | Fair Value | |||||||
Assets: | |||||||
Fixed maturities, held-to-maturity | 9 | 89 | |||||
Assets supporting experience-rated contractholder liabilities | 0 | 0 | |||||
Commercial mortgage and other loans | 59,937 | 67,477 | |||||
Policy loans | 10,386 | 11,271 | |||||
Other invested assets | 0 | 0 | |||||
Short-term Investments | 0 | 0 | |||||
Cash and cash equivalents | 0 | 0 | |||||
Accrued investment income | 0 | 0 | |||||
Other assets | 39 | 449 | |||||
Total assets | 70,371 | 79,286 | |||||
Liabilities: | |||||||
Policyholders’ account balances—investment contracts | 38,831 | 73,653 | |||||
Securities sold under agreements to repurchase | 0 | 0 | |||||
Cash collateral for loaned securities | 0 | 0 | |||||
Short-term debt | 204 | 146 | |||||
Long-term debt | 899 | 1,139 | |||||
Notes issued by consolidated VIEs | 274 | 305 | |||||
Other liabilities | 53 | 48 | |||||
Separate account liabilities-investment contracts | 24,847 | 23,631 | |||||
Total liabilities | 65,108 | 98,922 | |||||
Prudential Netting Agreement | Fair Value | |||||||
Assets: | |||||||
Fixed maturities, held-to-maturity | 5,394 | 5,821 | |||||
Liabilities: | |||||||
Long-term debt | 11,389 | 11,921 | |||||
Prudential Netting Agreement | Carrying Amount | |||||||
Assets: | |||||||
Fixed maturities, held-to-maturity | 4,750 | 4,998 | |||||
Liabilities: | |||||||
Long-term debt | $ 10,691 | $ 10,964 | |||||
|
Deferred Policy Acquisition Costs (Balance of and Changes in DAC) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward] | |||
Balance, beginning of period | $ 19,027 | $ 19,912 | $ 20,058 |
Capitalization of commissions, sales and issue expenses | 2,548 | 2,763 | 2,966 |
Amortization—Impact of assumption and experience unlocking and true-ups | 35 | (36) | (164) |
Amortization—All other | (2,132) | (2,185) | (2,168) |
Change due to unrealized investment gains and losses | 717 | (379) | (713) |
Foreign currency translation | (457) | 142 | (8) |
Reclassified to assets held-for-sale | (1,197) | 0 | 0 |
Other | (349) | (1,190) | (59) |
Balance, end of period | $ 18,192 | 19,027 | 19,912 |
Reclassification of ceded DAC to third party reinsurer | (14) | ||
The Prudential Life Insurance Company of Korea, Ltd. | |||
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward] | |||
Impact on sale of business | $ (1,193) | ||
Pramerica of Italy | |||
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward] | |||
Impact on sale of business | $ (46) |
Value of Business Acquired (Balance of and Changes in VOBA) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Movement Analysis of Value of Business Acquired [Roll Forward] | |||
Balance, beginning of period | $ 1,103 | $ 1,110 | $ 1,850 |
Amortization—Impact of assumption and experience unlocking and true-ups | 5 | (317) | (139) |
Amortization—All other | (124) | (212) | (235) |
Change due to unrealized investment gains and losses | 67 | 418 | (478) |
Interest | 25 | 56 | 64 |
Foreign currency translation | (90) | 48 | 10 |
Reclassified of assets held-for-sale | (215) | 0 | 0 |
Other | 0 | 0 | 38 |
Balance, end of period | 771 | $ 1,103 | $ 1,110 |
CIGNA | |||
Movement Analysis of Value of Business Acquired [Roll Forward] | |||
Balance, end of period | 29 | ||
Gibraltar Life | |||
Movement Analysis of Value of Business Acquired [Roll Forward] | |||
Balance, end of period | 740 | ||
Gibraltar BSN Life Berhad | |||
Movement Analysis of Value of Business Acquired [Roll Forward] | |||
Balance, end of period | $ 2 |
Value of Business Acquired (Estimated Future VOBA Amortization, Net of Interest) (Details) - USD ($) $ in Millions |
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
Dec. 31, 2018 |
---|---|---|---|---|
Present Value of Future Insurance Profits [Abstract] | ||||
Estimated future VOBA amortization - 2022 | $ 73 | |||
Estimated future VOBA amortization - 2023 | 66 | |||
Estimated future VOBA amortization - 2024 | 61 | |||
Estimated future VOBA amortization - 2025 | 56 | |||
Estimated future VOBA amortization - 2026 | 52 | |||
Estimated future VOBA amortization - Thereafter | 463 | |||
Total estimated future VOBA amortization | 771 | $ 1,103 | $ 1,110 | $ 1,850 |
Reclassified of assets held-for-sale | $ 215 | $ 0 | $ 0 |
Investments in Operating Joint Ventures (Investments in Operating Joint Ventures) (Details) - USD ($) $ in Millions |
12 Months Ended | |||
---|---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
Mar. 01, 2021 |
|
Equity Method Investments and Joint Ventures [Abstract] | ||||
Investment in operating joint ventures | $ 1,317 | $ 1,394 | $ 1,309 | |
Dividends received from operating joint ventures | 116 | 60 | 70 | |
After-tax equity in earnings of operating joint ventures | $ 87 | $ 96 | $ 100 | |
Disposal Group, Disposed of by Sale, Not Discontinued Operations | Pramerica SGR | ||||
Schedule of Equity Method Investments [Line Items] | ||||
Equity Method Investment, Ownership Percentage | 35.00% |
Investments in Operating Joint Ventures (Narrative) (Details) - USD ($) $ in Millions |
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
---|---|---|---|
Schedule of Equity Method Investments [Line Items] | |||
Investment in operating joint ventures | $ 1,317 | $ 1,394 | $ 1,309 |
Asset management fee income | |||
Schedule of Equity Method Investments [Line Items] | |||
Investment in operating joint ventures | $ 11 | $ 30 | $ 29 |
Goodwill and Other Intangibles (Changes in the Book Value of Goodwill by Segment) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Goodwill [Roll Forward] | |||
Goodwill balance, Beginning of the year | $ 3,035 | $ 3,013 | $ 863 |
Acquisitions | 304 | 2,150 | |
Impairments | (1,060) | ||
Effect of foreign currency translation | (20) | 0 | |
Effect of foreign currency translation and other | 22 | ||
Reclassified to "Assets held-for-sale" | (455) | ||
Goodwill balance, End of the year | 1,804 | 3,035 | 3,013 |
PGIM | |||
Goodwill [Roll Forward] | |||
Goodwill balance, Beginning of the year | 258 | 254 | 233 |
Acquisitions | 304 | 22 | |
Impairments | 0 | ||
Effect of foreign currency translation | (4) | (1) | |
Effect of foreign currency translation and other | 4 | ||
Reclassified to "Assets held-for-sale" | 0 | ||
Goodwill balance, End of the year | 558 | 258 | 254 |
Assurance IQ | |||
Goodwill [Roll Forward] | |||
Goodwill balance, Beginning of the year | 2,140 | 2,128 | 0 |
Acquisitions | 0 | 2,128 | |
Impairments | (1,060) | ||
Effect of foreign currency translation | 0 | 0 | |
Effect of foreign currency translation and other | 12 | ||
Reclassified to "Assets held-for-sale" | 0 | ||
Goodwill balance, End of the year | 1,080 | 2,140 | 2,128 |
International Businesses | |||
Goodwill [Roll Forward] | |||
Goodwill balance, Beginning of the year | 144 | 165 | 164 |
Acquisitions | 0 | 0 | |
Impairments | 0 | ||
Effect of foreign currency translation | (14) | 1 | |
Effect of foreign currency translation and other | (21) | ||
Reclassified to "Assets held-for-sale" | 0 | ||
Goodwill balance, End of the year | 130 | 144 | 165 |
Corporate and Other | |||
Goodwill [Roll Forward] | |||
Goodwill balance, Beginning of the year | 483 | 456 | 456 |
Acquisitions | 0 | 0 | |
Impairments | 0 | ||
Effect of foreign currency translation | (2) | 0 | |
Effect of foreign currency translation and other | 27 | ||
Reclassified to "Assets held-for-sale" | (455) | ||
Goodwill balance, End of the year | 26 | 483 | 456 |
Other | |||
Goodwill [Roll Forward] | |||
Goodwill balance, Beginning of the year | 10 | 10 | 10 |
Acquisitions | 0 | 0 | |
Impairments | 0 | ||
Effect of foreign currency translation | 0 | 0 | |
Effect of foreign currency translation and other | 0 | ||
Reclassified to "Assets held-for-sale" | 0 | ||
Goodwill balance, End of the year | $ 10 | $ 10 | $ 10 |
Goodwill and Other Intangibles (Other Intangibles) (Details) - USD ($) $ in Millions |
Dec. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Finite and Indefinite-Lived Intangible Assets [Line Items] | ||
Not subject to amortization | $ 68 | $ 69 |
Total | 619 | 580 |
Reclassified of assets held-for-sale | 39 | |
Mortgage servicing rights | ||
Finite and Indefinite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Amount | 864 | 819 |
Accumulated Amortization | (543) | (512) |
Net Carrying Amount | 321 | 307 |
Customer relationships | ||
Finite and Indefinite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Amount | 308 | 247 |
Accumulated Amortization | (194) | (175) |
Net Carrying Amount | 114 | 72 |
Software and other | ||
Finite and Indefinite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Amount | 200 | 192 |
Accumulated Amortization | (84) | (60) |
Net Carrying Amount | $ 116 | $ 132 |
Goodwill and Other Intangibles (Goodwill Narrative) (Details) $ in Millions |
12 Months Ended |
---|---|
Dec. 31, 2021
USD ($)
| |
Goodwill [Line Items] | |
Goodwill impairment pre-tax | $ 1,060 |
Assurance IQ | |
Goodwill [Line Items] | |
Goodwill impairment pre-tax | 1,060 |
Goodwill impairment after tax | $ (837) |
Goodwill and Other Intangibles (Other Intangibles Narrative) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Finite and Indefinite-Lived Intangible Assets [Line Items] | |||
Amortization expense for other intangibles | $ 110 | $ 102 | $ 65 |
Mortgage servicing rights | |||
Finite and Indefinite-Lived Intangible Assets [Line Items] | |||
Net Carrying Amount | 321 | 307 | |
Mortgage servicing rights | Fair Value | |||
Finite and Indefinite-Lived Intangible Assets [Line Items] | |||
Net Carrying Amount | $ 324 | $ 309 |
Goodwill and Other Intangibles (Future Amortization Expense) (Details) $ in Millions |
Dec. 31, 2021
USD ($)
|
---|---|
Goodwill and Intangible Assets Disclosure [Abstract] | |
Estimated future amortization expense - 2022 | $ 104 |
Estimated future amortization expense - 2023 | 88 |
Estimated future amortization expense - 2024 | 81 |
Estimated future amortization expense - 2025 | 70 |
Estimated future amortization expense - 2026 | $ 46 |
Leases (Narrative) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Lessee, Lease, Description [Line Items] | |||
Leases with options to extend | 20 years | ||
Leases with options to terminate | 4 years | ||
Operating leases that have not yet commenced | $ 192 | ||
Operating lease costs | 153 | $ 156 | $ 138 |
Short-term lease costs | 96 | 104 | 101 |
Net investment income | |||
Income and Expenses, Lessor [Abstract] | |||
Lease Income | $ 115 | $ 161 | $ 182 |
Minimum | |||
Lessee, Lease, Description [Line Items] | |||
Remaining lease terms | 1 year | ||
Operating lease term not yet commenced | 5 years | ||
Maximum | |||
Lessee, Lease, Description [Line Items] | |||
Remaining lease terms | 27 years | ||
Operating lease term not yet commenced | 15 years |
Leases (Lessee Right-of-Use Assets and Lease Liabilities) (Details) - USD ($) $ in Millions |
Dec. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Leases [Abstract] | ||
Right-of-use assets | $ 395 | $ 466 |
Lease liabilities | $ 432 | $ 511 |
Weighted average remaining lease term | 6 years | 6 years |
Weighted average discount rate | 2.25% | 2.22% |
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List] | Other assets | Other assets |
Operating Lease, Liability, Statement of Financial Position [Extensible List] | Other liabilities | Other liabilities |
Leases (Maturities of Operating Lease Liabilities) (Details) - USD ($) $ in Millions |
Dec. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Leases [Abstract] | ||
2022 | $ 129 | |
2023 | 100 | |
2024 | 84 | |
2025 | 59 | |
2026 | 28 | |
Thereafter | 69 | |
Total lease payments | 469 | |
Less imputed interest | (37) | |
Total | $ 432 | $ 511 |
Policyholders' Liabilities (Future Policy Benefits) (Details) - USD ($) $ in Millions |
Dec. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Liability for Future Policy Benefits and Unpaid Claims and Claims Adjustment Expense [Abstract] | ||
Life insurance | $ 188,777 | $ 195,245 |
Individual and group annuities and supplementary contracts | 77,779 | 77,254 |
Other contract liabilities | 25,695 | 30,873 |
Reclassified to Liabilities held-for-sale | (4,662) | 0 |
Subtotal future policy benefits excluding unpaid claims and claim settlement expenses | 287,589 | 303,372 |
Unpaid claims and claim settlement expenses | 3,195 | 2,971 |
Total future policy benefits | $ 290,784 | $ 306,343 |
Policyholders' Liabilities (Narrative) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Liability for Future Policy Benefit, by Product Segment [Line Items] | |||
Policyholders’ account balances | $ 122,633 | $ 161,682 | |
FANIP maximum authorized amount | $ 2,000 | ||
Minimum | |||
Liability for Future Policy Benefit, by Product Segment [Line Items] | |||
Unpaid claims and claim settlement expenses interest rate | 1.80% | ||
Maximum | |||
Liability for Future Policy Benefit, by Product Segment [Line Items] | |||
Unpaid claims and claim settlement expenses interest rate | 6.40% | ||
Individual participating life insurance | |||
Liability for Future Policy Benefit, by Product Segment [Line Items] | |||
Participating policies direct in force | 2.00% | 3.00% | |
Participating policies direct premiums | 10.00% | 10.00% | 11.00% |
Individual participating life insurance | Minimum | |||
Liability for Future Policy Benefit, by Product Segment [Line Items] | |||
Liabilities for future policy benefits, interest rate | 2.50% | ||
Individual participating life insurance | Maximum | |||
Liability for Future Policy Benefit, by Product Segment [Line Items] | |||
Liabilities for future policy benefits, interest rate | 7.50% | ||
Individual nonparticipating life insurance | Minimum | |||
Liability for Future Policy Benefit, by Product Segment [Line Items] | |||
Liabilities for future policy benefits, interest rate | (0.10%) | ||
Individual nonparticipating life insurance | Maximum | |||
Liability for Future Policy Benefit, by Product Segment [Line Items] | |||
Liabilities for future policy benefits, interest rate | 7.80% | ||
Individual and group annuities and supplementary contracts | |||
Liability for Future Policy Benefit, by Product Segment [Line Items] | |||
Percentage of reserves based on interest rates in excess of 8 Percent (less than) | 1.00% | ||
Individual and group annuities and supplementary contracts | Minimum | |||
Liability for Future Policy Benefit, by Product Segment [Line Items] | |||
Liabilities for future policy benefits, interest rate | (0.20%) | ||
Individual and group annuities and supplementary contracts | Maximum | |||
Liability for Future Policy Benefit, by Product Segment [Line Items] | |||
Liabilities for future policy benefits, interest rate | 12.10% | ||
Other contract liabilities | Minimum | |||
Liability for Future Policy Benefit, by Product Segment [Line Items] | |||
Liabilities for future policy benefits, interest rate | 0.60% | ||
Other contract liabilities | Maximum | |||
Liability for Future Policy Benefit, by Product Segment [Line Items] | |||
Liabilities for future policy benefits, interest rate | 6.50% | ||
Funding agreements | |||
Liability for Future Policy Benefit, by Product Segment [Line Items] | |||
Policyholders’ account balances | $ 6,023 | $ 6,938 | |
Interest-sensitive life contracts | |||
Liability for Future Policy Benefit, by Product Segment [Line Items] | |||
Policyholders’ account balances | $ 41,283 | 41,711 | |
Interest-sensitive life contracts | Minimum | |||
Liability for Future Policy Benefit, by Product Segment [Line Items] | |||
Liability for policyholder contract deposits, interest rate | 0.00% | ||
Interest-sensitive life contracts | Maximum | |||
Liability for Future Policy Benefit, by Product Segment [Line Items] | |||
Liability for policyholder contract deposits, interest rate | 6.30% | ||
Other than interest-sensitive life contracts | |||
Liability for Future Policy Benefit, by Product Segment [Line Items] | |||
Less than 1% of policyholders' account balances have interest crediting rates in excess of 8% | 1.00% | ||
Other than interest-sensitive life contracts | Minimum | |||
Liability for Future Policy Benefit, by Product Segment [Line Items] | |||
Liability for policyholder contract deposits, interest rate | 0.00% | ||
Other than interest-sensitive life contracts | Maximum | |||
Liability for Future Policy Benefit, by Product Segment [Line Items] | |||
Liability for policyholder contract deposits, interest rate | 13.30% | ||
Delaware Statutory Trust | Funding agreements | Prudential Insurance | |||
Liability for Future Policy Benefit, by Product Segment [Line Items] | |||
Policyholders’ account balances | $ 4,959 | 4,402 | |
Medium-term Notes, at amortized cost | 3,117 | 2,414 | |
Commercial Paper | $ 1,847 | 1,991 | |
Delaware Statutory Trust | Funding agreements | Minimum | Prudential Insurance | |||
Liability for Future Policy Benefit, by Product Segment [Line Items] | |||
Liability for policyholder contract deposits, interest rate | 0.00% | ||
Weighted average maturity of outstanding commercial paper, in days | 1 month | ||
Delaware Statutory Trust | Funding agreements | Maximum | Prudential Insurance | |||
Liability for Future Policy Benefit, by Product Segment [Line Items] | |||
Liability for policyholder contract deposits, interest rate | 3.50% | ||
Weighted average maturity of outstanding commercial paper, in days | 5 years | ||
Medium-term notes | Delaware Statutory Trust | Funding agreements | Prudential Insurance | |||
Liability for Future Policy Benefit, by Product Segment [Line Items] | |||
FANIP maximum authorized amount | $ 15,000 | ||
Commercial Paper | Delaware Statutory Trust | Funding agreements | Prudential Insurance | |||
Liability for Future Policy Benefit, by Product Segment [Line Items] | |||
FANIP maximum authorized amount | $ 3,000 | ||
Federal Home Loan Bank of New York | Funding agreements | Minimum | |||
Liability for Future Policy Benefit, by Product Segment [Line Items] | |||
Liability for policyholder contract deposits, interest rate | 0.62% | ||
Federal Home Loan Bank of New York | Funding agreements | Maximum | |||
Liability for Future Policy Benefit, by Product Segment [Line Items] | |||
Liability for policyholder contract deposits, interest rate | 1.925% | ||
Federal Home Loan Bank of New York | Medium-term notes | Funding agreements | |||
Liability for Future Policy Benefit, by Product Segment [Line Items] | |||
Funding agreement issued to FHLBNY | $ 1,050 | $ 2,522 |
Policyholders' Liabilities (Policyholders' Account Balances) (Details) - USD ($) $ in Millions |
Dec. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Liability for Policyholders' Account Balance, by Product Segment [Line Items] | ||
Total policyholders’ account balances | $ (122,633) | $ (161,682) |
Held-for-sale | ||
Liability for Policyholders' Account Balance, by Product Segment [Line Items] | ||
Total policyholders’ account balances | (39,914) | 0 |
Individual annuities | ||
Liability for Policyholders' Account Balance, by Product Segment [Line Items] | ||
Total policyholders’ account balances | (52,230) | (47,663) |
Group annuities | ||
Liability for Policyholders' Account Balance, by Product Segment [Line Items] | ||
Total policyholders’ account balances | (30,400) | (30,700) |
Guaranteed investment contracts and guaranteed interest accounts | ||
Liability for Policyholders' Account Balance, by Product Segment [Line Items] | ||
Total policyholders’ account balances | (13,717) | (14,071) |
Funding agreements | ||
Liability for Policyholders' Account Balance, by Product Segment [Line Items] | ||
Total policyholders’ account balances | (6,023) | (6,938) |
Interest-sensitive life contracts | ||
Liability for Policyholders' Account Balance, by Product Segment [Line Items] | ||
Total policyholders’ account balances | (41,283) | (41,711) |
Dividend accumulation and other deposit type funds | ||
Liability for Policyholders' Account Balance, by Product Segment [Line Items] | ||
Total policyholders’ account balances | $ (18,894) | $ (20,599) |
Certain Long-Duration Contracts with Guarantees (Variable Annuity, Variable Life, Variable Universal Life and Universal Life Contracts) (Details) - USD ($) $ in Millions |
12 Months Ended | |
---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
|
Annuity Contracts | Return of net deposits | In the Event of Death | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Account value | $ 132,811 | $ 133,726 |
Net amount at risk | $ 200 | $ 214 |
Average attained age of contractholders | 69 years | 68 years |
Annuity Contracts | Return of net deposits | At Annuitization / Accumulation | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Account value | $ 16 | $ 17 |
Net amount at risk | $ 0 | $ 0 |
Average attained age of contractholders | 76 years | 75 years |
Annuity Contracts | Minimum return or contract value | In the Event of Death | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Account value | $ 30,527 | $ 31,157 |
Net amount at risk | $ 2,055 | $ 2,327 |
Average attained age of contractholders | 71 years | 70 years |
Annuity Contracts | Minimum return or contract value | At Annuitization / Accumulation | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Account value | $ 147,924 | $ 148,841 |
Net amount at risk | $ 3,509 | $ 4,203 |
Average attained age of contractholders | 69 years | 68 years |
Average period remaining until earliest expected annuitization | 2 months 12 days | 2 months 12 days |
Variable Life, Variable Universal Life and Universal Life Contracts | In the Event of Death | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Separate account value | $ 9,844 | $ 8,939 |
General account value | 19,789 | 19,279 |
Net amount at risk | $ 223,587 | $ 222,703 |
Average attained age of contractholders | 57 years | 55 years |
Certain Long-Duration Contracts With Guarantees (Separate Account Investment Options) (Details) - Annuity Contracts - USD ($) $ in Millions |
Dec. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Fair Value, Separate Account Investment [Line Items] | ||
Separate Account Investment Options | $ 159,647 | $ 159,975 |
Equity funds | ||
Fair Value, Separate Account Investment [Line Items] | ||
Separate Account Investment Options | 95,594 | 94,270 |
Bond funds | ||
Fair Value, Separate Account Investment [Line Items] | ||
Separate Account Investment Options | 59,241 | 62,549 |
Money market funds | ||
Fair Value, Separate Account Investment [Line Items] | ||
Separate Account Investment Options | $ 4,812 | $ 3,156 |
Certain Long-Duration Contracts with Guarantees (Narrative) (Details) - USD ($) $ in Millions |
Dec. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Annuity Contracts | Market Value Adjusted | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
General Account Investment Option | $ 7,159 | $ 7,729 |
Certain Long-Duration Contracts with Guarantees (Liabilities for Guarantee Benefits) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
GMDB | Variable Life, Variable Universal Life and Universal Life Contracts | |||
Movement in Liabilities for Guarantees on Long-Duration Contracts, Guaranteed Benefit Liability, Gross [Roll Forward] | |||
Beginning balance | $ 9,509 | $ 7,602 | $ 5,418 |
Incurred guarantee benefits | 1,076 | 1,389 | 1,492 |
Paid guarantee benefits | (189) | (126) | (111) |
Change in unrealized investment gains and losses | (326) | 721 | 805 |
Reclassified to "Liabilities held-for-sale" | 0 | ||
Other | (9) | (77) | (2) |
Ending balance | 10,061 | 9,509 | 7,602 |
GMDB | Annuity Contracts | |||
Movement in Liabilities for Guarantees on Long-Duration Contracts, Guaranteed Benefit Liability, Gross [Roll Forward] | |||
Beginning balance | 863 | 753 | 713 |
Incurred guarantee benefits | 10 | 162 | 82 |
Paid guarantee benefits | (70) | (89) | (69) |
Change in unrealized investment gains and losses | (55) | 38 | 27 |
Reclassified to "Liabilities held-for-sale" | (216) | ||
Other | 0 | (1) | 0 |
Ending balance | 532 | 863 | 753 |
GMIB | Annuity Contracts | |||
Movement in Liabilities for Guarantees on Long-Duration Contracts, Guaranteed Benefit Liability, Gross [Roll Forward] | |||
Beginning balance | 368 | 355 | 378 |
Incurred guarantee benefits | (24) | 12 | (8) |
Paid guarantee benefits | 0 | (4) | (4) |
Change in unrealized investment gains and losses | (17) | (8) | (15) |
Reclassified to "Liabilities held-for-sale" | (5) | ||
Other | (89) | 13 | 4 |
Ending balance | 233 | 368 | 355 |
GMAB/GMWB/GMIWB | Annuity Contracts | |||
Movement in Liabilities for Guarantees on Long-Duration Contracts, Guaranteed Benefit Liability, Gross [Roll Forward] | |||
Beginning balance | 18,881 | 12,831 | 8,927 |
Incurred guarantee benefits | (5,638) | 6,103 | 3,905 |
Paid guarantee benefits | 0 | 0 | 0 |
Change in unrealized investment gains and losses | 0 | 0 | 0 |
Reclassified to "Liabilities held-for-sale" | (4,163) | ||
Other | (12) | (53) | (1) |
Ending balance | $ 9,068 | $ 18,881 | $ 12,831 |
Certain Long-Duration Contracts with Guarantees (Sales Inducements) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Movement in Deferred Sales Inducements [Roll Forward] | |||
Beginning balance | $ 820 | $ 935 | $ 1,024 |
Capitalization | 1 | 1 | 1 |
Amortization—Impact of assumption and experience unlocking and true-ups | 40 | 104 | 108 |
Amortization—All other | (166) | (166) | (163) |
Change in unrealized investment gains and losses | 76 | (54) | (35) |
Reclassified to "Liabilities held-for-sale" | (295) | ||
Other | (2) | ||
Ending balance | $ 474 | $ 820 | $ 935 |
Reinsurance (Narrative) (Details) $ in Millions |
12 Months Ended | |||||
---|---|---|---|---|---|---|
Apr. 01, 2015 |
Jan. 02, 2013
USD ($)
policy
|
Dec. 31, 2016
USD ($)
|
Dec. 31, 2013
USD ($)
|
Dec. 31, 2012
USD ($)
|
Dec. 31, 2021
company
|
|
Effects of Reinsurance [Line Items] | ||||||
Number of major reinsurance companies | company | 4 | |||||
Reinsurance recoverable percentage of the major reinsurance companies | 61.00% | |||||
Domestic Business, per Life | ||||||
Effects of Reinsurance [Line Items] | ||||||
Reinsurance retention policy, amount retained | $ 20 | $ 30 | ||||
Hartford Life Business | ||||||
Effects of Reinsurance [Line Items] | ||||||
Reinsurance retention policy, amount retained | $ 141,000 | |||||
Business acquisition number of life insurance policies acquired reinsurance | policy | 700,000 | |||||
Quote Share Reinsurance | Union Hamilton | ||||||
Effects of Reinsurance [Line Items] | ||||||
Reinsurance retention policy, reinsured risk percentage | 50.00% | |||||
Reinsurance retention policy, amount retained | $ 2,900 |
Reinsurance (Reinsurance Amounts Included in the Consolidated Statements of Operations) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Reinsurance Disclosures [Abstract] | |||
Direct premiums | $ 31,623 | $ 29,091 | $ 33,260 |
Reinsurance assumed | 5,581 | 4,336 | 3,022 |
Reinsurance ceded | (2,377) | (2,287) | (2,080) |
Premiums | 34,827 | 31,140 | 34,202 |
Direct policy charges and fee income | 5,261 | 5,341 | 5,252 |
Reinsurance assumed | 1,204 | 1,192 | 1,181 |
Reinsurance ceded | (521) | (504) | (455) |
Policy charges and fee income | 5,944 | 6,029 | 5,978 |
Direct policyholders’ benefits | 34,861 | 32,514 | 35,601 |
Reinsurance assumed | 7,024 | 5,659 | 4,304 |
Reinsurance ceded | (3,427) | (3,114) | (3,085) |
Policyholders’ benefits | $ 38,458 | $ 35,059 | $ 36,820 |
Reinsurance (Reinsurance Recoverables) (Details) - USD ($) $ in Millions |
Dec. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Effects of Reinsurance [Line Items] | ||
Total reinsurance recoverables | $ 7,351 | $ 7,354 |
Reinsurance recoverables net of loss allowance | (10) | (5) |
Held-for-sale | ||
Effects of Reinsurance [Line Items] | ||
Total reinsurance recoverables | 30 | |
Individual and group annuities | ||
Effects of Reinsurance [Line Items] | ||
Total reinsurance recoverables | 185 | 273 |
Life insurance | ||
Effects of Reinsurance [Line Items] | ||
Total reinsurance recoverables | 6,770 | 6,649 |
Other reinsurance | ||
Effects of Reinsurance [Line Items] | ||
Total reinsurance recoverables | 396 | 432 |
Hartford Life Business | Life insurance | ||
Effects of Reinsurance [Line Items] | ||
Total reinsurance recoverables | 2,178 | 2,245 |
Reinsurance payables | 1,341 | 1,362 |
Union Hamilton | Individual and group annuities | ||
Effects of Reinsurance [Line Items] | ||
Total reinsurance recoverables | $ 110 | $ 204 |
Closed Block (Narrative) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Policyholders’ dividend obligation | $ 8,027 | $ 8,787 | $ 6,149 |
Dividend Declared | |||
Increase (decrease) in liability | 68 | 147 | $ 79 |
Excess Of Actual Cumulative Earnings Over Expected Cumulative Earnings | |||
Policyholders’ dividend obligation | 4,387 | 2,920 | |
Net unrealized gains (losses) on all other investments | |||
Policyholders’ dividend obligation | $ 3,640 | $ 5,867 |
Closed Block (Closed Block Liabilities and Assets Designated to Closed Block; Maximum Future Earnings to be Recognized) (Details) - USD ($) $ in Millions |
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
---|---|---|---|
Closed Block liabilities | |||
Future policy benefits | $ 45,596 | $ 46,762 | |
Policyholders’ dividends payable | 616 | 635 | |
Policyholders’ dividend obligation | 8,027 | 8,787 | $ 6,149 |
Policyholders’ account balances | 4,737 | 4,874 | |
Other Closed Block liabilities | 3,107 | 3,141 | |
Total Closed Block liabilities | 62,083 | 64,199 | |
Closed Block assets | |||
Fixed maturities, available-for-sale, at fair value | 38,160 | 41,959 | |
Fixed maturities, trading, at fair value | 1,137 | 277 | |
Equity securities, at fair value | 2,288 | 2,345 | |
Commercial mortgage and other loans | 8,241 | 8,421 | |
Policy loans | 3,815 | 4,064 | |
Other invested assets | 4,358 | 3,610 | |
Short-term investments | 557 | 124 | |
Total investments | 58,556 | 60,800 | |
Cash and cash equivalents | 451 | 269 | |
Accrued investment income | 392 | 431 | |
Other Closed Block assets | 137 | 92 | |
Total Closed Block assets | 59,536 | 61,592 | |
Excess of reported Closed Block liabilities over Closed Block assets | 2,547 | 2,607 | |
Portion of above representing accumulated other comprehensive income (loss): | |||
Net unrealized investment gains (losses) | 3,535 | 5,810 | |
Allocated to policyholder dividend obligation | (3,640) | (5,867) | |
Future earnings to be recognized from Closed Block assets and Closed Block liabilities | $ 2,442 | $ 2,550 |
Closed Block (Information Regarding Policyholder Dividend Obligation) (Details) - USD ($) $ in Millions |
12 Months Ended | |
---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
|
Movement in Closed Block Dividend Obligation [Roll Forward] | ||
Balance, January 1 | $ 8,787 | $ 6,149 |
Impact from earnings allocable to policyholder dividend obligation | 1,468 | 117 |
Change in net unrealized investment gains (losses) allocated to policyholder dividend obligation | (2,228) | 2,534 |
Balance, December 31 | 8,027 | 8,787 |
ASU 2016-01 | ||
Movement in Closed Block Dividend Obligation [Roll Forward] | ||
Cumulative-effect adjustment from the adoption of ASU 2016-01 | $ 0 | $ (13) |
Closed Block (Closed Block Revenues and Benefits and Expenses) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Revenues | |||
Premiums | $ 1,789 | $ 1,981 | $ 2,207 |
Net investment income | 2,514 | 2,255 | 2,332 |
Realized investment gains (losses), net | 807 | 182 | 521 |
Other income (loss) | 880 | 362 | 589 |
Total Closed Block revenues | 5,990 | 4,780 | 5,649 |
Benefits and Expenses | |||
Policyholders’ benefits | 2,557 | 2,758 | 2,906 |
Interest credited to policyholders’ account balances | 124 | 127 | 130 |
Dividends to policyholders | 2,794 | 1,549 | 2,187 |
General and administrative expenses | 312 | 327 | 351 |
Total Closed Block benefits and expenses | 5,787 | 4,761 | 5,574 |
Closed Block revenues, net of Closed Block benefits and expenses, before income taxes | 203 | 19 | 75 |
Income tax expense (benefit) | 123 | (43) | 10 |
Closed Block revenues, net of Closed Block benefits and expenses and income taxes | $ 80 | $ 62 | $ 65 |
Income Taxes (Components of Income Tax Expense (Benefit)) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Current tax expense (benefit): | |||
U.S. | $ 1,094 | $ (571) | $ 86 |
State and local | 24 | 11 | 2 |
Foreign | 770 | 848 | 879 |
Total current tax expense (benefit) | 1,888 | 288 | 967 |
Deferred tax expense (benefit): | |||
U.S. | 16 | (362) | 57 |
State and local | (1) | 1 | (1) |
Foreign | (229) | (8) | (76) |
Total deferred tax expense (benefit) | (214) | (369) | (20) |
Total income tax expense (benefit) on income (loss) before equity in earnings of operating joint ventures | 1,674 | (81) | 947 |
Income tax expense (benefit) on equity in earnings of operating joint ventures | 33 | 47 | 43 |
Income tax expense (benefit) on discontinued operations | 0 | 0 | 0 |
Income tax expense (benefit) reported in equity related to: | |||
Other comprehensive income (loss) | (2,314) | 1,252 | 3,811 |
Total income taxes | $ (607) | $ 1,218 | $ 4,801 |
Income Taxes (Narrative) (Details) - USD ($) $ in Millions |
12 Months Ended | ||||
---|---|---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
Dec. 31, 2018 |
Dec. 31, 2017 |
|
Change in Accounting Estimate [Line Items] | |||||
Total income tax expense (benefit) | $ 1,674 | $ (81) | $ 947 | ||
Effective tax rate | 17.80% | 25.10% | 18.60% | ||
U.S. federal income tax rate | 21.00% | 35.00% | |||
Net Operating Loss Carryback | $ 149 | $ 51 | |||
U.S. federal income tax rate | 21.00% | 35.00% | |||
DRD constituting non-taxable investment income | $ 115 | 109 | $ 122 | ||
Non-taxable investment income | $ 292 | 228 | 270 | ||
Percent of income tax expense (benefit) | 5.00% | ||||
Income (loss) from domestic operations | $ 7,575 | (3,226) | 1,985 | ||
Income (loss) from foreign operations | 1,806 | 2,903 | 3,101 | ||
Korea and Taiwan insurance operations | |||||
Change in Accounting Estimate [Line Items] | |||||
Total income tax expense (benefit) | 132 | ||||
Brazil Full Inclusion | |||||
Change in Accounting Estimate [Line Items] | |||||
Tax adjustment impact | $ (18) | $ 19 | $ (3) | ||
Japan Statutory Tax Rate | |||||
Change in Accounting Estimate [Line Items] | |||||
Effective tax rate | 28.00% | ||||
Brazil Statutory Tax Rate | |||||
Change in Accounting Estimate [Line Items] | |||||
Effective tax rate | 40.00% | 45.00% |
Income Taxes (Reconciliation To Effective Rate) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Income Tax Disclosure [Abstract] | |||
Expected federal income tax expense (benefit) | $ 1,970 | $ (68) | $ 1,068 |
Non-taxable investment income | (292) | (228) | (270) |
Foreign taxes at other than U.S. rate | 149 | 250 | 234 |
Low-income housing and other tax credits | (126) | (112) | (118) |
Changes in tax law | 10 | (192) | (2) |
Sale of subsidiary | (26) | 277 | 4 |
Non-controlling interest | (14) | (48) | (11) |
Non-deductible expenses | 11 | 14 | 23 |
Change in valuation allowance | 13 | 17 | (1) |
State taxes | 18 | 10 | 1 |
Other | (39) | (1) | 19 |
Total income tax expense (benefit) on income (loss) before equity in earnings of operating joint ventures | $ 1,674 | $ (81) | $ 947 |
Effective tax rate | 17.80% | 25.10% | 18.60% |
Income Taxes (Deferred Tax Assets and Liabilities) (Details) - USD ($) $ in Millions |
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
Dec. 31, 2018 |
---|---|---|---|---|
Deferred tax assets: | ||||
Insurance reserves | $ 296 | $ 1,693 | ||
Policyholders’ dividends | 1,741 | 1,901 | ||
Net operating and capital loss carryforwards | 260 | 205 | ||
Employee benefits | 617 | 929 | ||
Investments | 398 | 0 | ||
Goodwill and other intangibles | 149 | 0 | ||
Other | 0 | 404 | ||
Deferred tax assets before valuation allowance | 3,461 | 5,132 | ||
Valuation allowance | (147) | (143) | $ (136) | $ (117) |
Deferred tax assets after valuation allowance | 3,314 | 4,989 | ||
Deferred tax liabilities: | ||||
Net unrealized investment gains | 9,456 | 13,841 | ||
Deferred policy acquisition costs | 3,307 | 3,430 | ||
Investments | 0 | 43 | ||
Value of business acquired | 261 | 270 | ||
Goodwill and other intangibles | 0 | 29 | ||
Other | 116 | 0 | ||
Deferred tax liabilities | 13,140 | 17,613 | ||
Net deferred tax liability | $ (9,826) | $ (12,624) |
Income Taxes (Valuation Allowance on Deferred Tax Assets) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Valuation Allowance, Deferred Tax Asset [Roll Forward] | |||
Balance, beginning of year | $ 143 | $ 136 | $ 117 |
Charged to costs and expenses | 6 | 22 | 32 |
Other adjustments | (2) | (15) | (13) |
Balance, ending of year | 147 | 143 | 136 |
Federal | |||
Valuation Allowance, Deferred Tax Asset [Roll Forward] | |||
Balance, beginning of year | 15 | 3 | 0 |
Charged to costs and expenses | 5 | 12 | 3 |
Other adjustments | 0 | 0 | 0 |
Balance, ending of year | 20 | 15 | 3 |
State | |||
Valuation Allowance, Deferred Tax Asset [Roll Forward] | |||
Balance, beginning of year | 116 | 127 | 106 |
Charged to costs and expenses | (8) | 5 | 34 |
Other adjustments | (1) | (16) | (13) |
Balance, ending of year | 107 | 116 | 127 |
Foreign Operations | |||
Valuation Allowance, Deferred Tax Asset [Roll Forward] | |||
Balance, beginning of year | 12 | 6 | 11 |
Charged to costs and expenses | 9 | 5 | (5) |
Other adjustments | (1) | 1 | 0 |
Balance, ending of year | $ 20 | $ 12 | $ 6 |
Income Taxes (Operating and Capital Loss Carryforwards) (Details) - USD ($) $ in Millions |
Dec. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Federal | ||
Operating Loss Carryforwards [Line Items] | ||
Operating loss carryforwards | $ 327 | $ 231 |
State and local | ||
Operating Loss Carryforwards [Line Items] | ||
Operating loss carryforwards | 1,895 | 1,880 |
Foreign operations | ||
Operating Loss Carryforwards [Line Items] | ||
Operating loss carryforwards | 268 | 136 |
Foreign operations | Operating loss expiring between 2022 and 2036 | ||
Operating Loss Carryforwards [Line Items] | ||
Operating loss carryforwards | 52 | |
Foreign operations | Operating loss unlimited carryforward | ||
Operating Loss Carryforwards [Line Items] | ||
Operating loss carryforwards | 195 | |
Federal foreign | ||
Operating Loss Carryforwards [Line Items] | ||
Tax credit carryforwards | 12 | 9 |
General business credits | ||
Operating Loss Carryforwards [Line Items] | ||
Tax credit carryforwards | $ 0 | $ 82 |
Income Taxes (Undistributed Earnings) (Details) - USD ($) $ in Millions |
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
---|---|---|---|
Income Tax Disclosure [Abstract] | |||
Undistributed earnings of foreign subsidiaries | $ 209 | $ 176 | $ 2,764 |
Income Taxes (Unrecognized Tax Benefits) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] | |||
Amount | $ 17 | $ 18 | $ 20 |
Increases in unrecognized tax benefits—prior years | 4 | 0 | 0 |
(Decreases) in unrecognized tax benefits—prior years | (9) | (1) | (2) |
Increases in unrecognized tax benefits—current year | 0 | 0 | 0 |
(Decreases) in unrecognized tax benefits—current year | 0 | 0 | 0 |
Settlements with taxing authorities | 0 | 0 | 0 |
Amount | 12 | 17 | 18 |
Unrecognized tax benefits that, if recognized, would favorably impact the effective rate | $ 12 | $ 0 | $ 0 |
Income Taxes (Amounts Recognized for Tax Related Interest and Penalties) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Income Tax Disclosure [Abstract] | |||
Interest and penalties recognized in the Consolidated Statements of Operations | $ 4 | $ 1 | $ 1 |
Interest and penalties recognized in liabilities in the Consolidated Statements of Financial Position | $ 7 | $ 3 |
Short-Term and Long-Term Debt (Short-Term Debt) (Details) - USD ($) $ in Millions |
12 Months Ended | |
---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
|
Short Term Debt [Line Items] | ||
Short-term debt | $ 722 | $ 925 |
Weighted average interest rate on outstanding short-term debt | 0.08% | 0.11% |
Long-term debt | $ 18,622 | $ 19,718 |
Surplus notes subject to set-off arrangements | ||
Short Term Debt [Line Items] | ||
Long-term Debt, Current Maturities | 500 | 500 |
Surplus notes subject to set-off arrangements | Floating-rate notes: | ||
Short Term Debt [Line Items] | ||
Long-term debt | 2,330 | 2,330 |
Less: assets under set-off arrangements | ||
Short Term Debt [Line Items] | ||
Short-term debt | 500 | 500 |
Long-term debt | 10,191 | 10,464 |
Mortgages | Floating-rate notes: | ||
Short Term Debt [Line Items] | ||
Long-term debt | 54 | 257 |
Commercial paper | ||
Short Term Debt [Line Items] | ||
Short-term debt | $ 420 | $ 380 |
Weighted average maturity of outstanding commercial paper, in days | 16 days | 18 days |
Foreign public corporate securities | Mortgages | Floating-rate notes: | ||
Short Term Debt [Line Items] | ||
Long-term debt | $ 29 | $ 29 |
Senior notes | ||
Short Term Debt [Line Items] | ||
Short-term debt | 0 | 399 |
Current portion of long-term debt | ||
Short Term Debt [Line Items] | ||
Short-term debt | 697 | 1,027 |
Short-term Debt | ||
Short Term Debt [Line Items] | ||
Long-term Debt, Current Maturities | 1,222 | 1,425 |
Borrowings due overnight | Commercial paper | ||
Short Term Debt [Line Items] | ||
Short-term debt | 150 | 75 |
Daily average outstanding | Commercial paper | ||
Short Term Debt [Line Items] | ||
Short-term debt | 1,414 | 1,602 |
Prudential Financial | ||
Short Term Debt [Line Items] | ||
Short-term debt | 25 | 424 |
Long-term debt | 17,673 | 18,561 |
Prudential Financial | Commercial paper | ||
Short Term Debt [Line Items] | ||
Short-term debt | $ 25 | $ 25 |
Weighted average interest rate on outstanding short-term debt | 0.12% | 0.12% |
Prudential Financial | Current portion of long-term debt | ||
Short Term Debt [Line Items] | ||
Short-term debt | $ 0 | $ 399 |
Prudential Funding, LLC | Commercial paper | ||
Short Term Debt [Line Items] | ||
Short-term debt | 395 | 355 |
Mortgages | ||
Short Term Debt [Line Items] | ||
Short-term debt | 197 | 128 |
Line of Credit | ||
Short Term Debt [Line Items] | ||
Short-term debt | 7 | |
Other Short-term Borrowings | 105 | $ 18 |
Bridge Loan | ||
Short Term Debt [Line Items] | ||
Short-term debt | 98 | |
Senior notes | Medium-term Notes | ||
Short Term Debt [Line Items] | ||
Debt Instrument, Face Amount | $ 910 |
Short-Term and Long-Term Debt (Narrative) (Details) $ in Thousands, ¥ in Millions |
1 Months Ended | 12 Months Ended | ||||||
---|---|---|---|---|---|---|---|---|
Nov. 30, 2013
USD ($)
|
Dec. 31, 2021
USD ($)
|
Dec. 31, 2021
JPY (¥)
|
Dec. 31, 2020
USD ($)
|
Dec. 31, 2019
USD ($)
|
Dec. 31, 2021
JPY (¥)
|
May 15, 2020
USD ($)
Rate
|
Feb. 18, 2015
USD ($)
|
|
Debt Instrument [Line Items] | ||||||||
Long-term debt | $ 18,622,000 | $ 19,718,000 | ||||||
Interest expense | 1,478,000 | 1,560,000 | $ 1,551,000 | |||||
Capacity | 2,000,000 | |||||||
Prudential Financial | ||||||||
Debt Instrument [Line Items] | ||||||||
Long-term debt | 17,673,000 | 18,561,000 | ||||||
Interest expense | 1,088,000 | 1,157,000 | 1,161,000 | |||||
Minimum statutory consolidated net worth | $ 23,500,000 | |||||||
Prudential Insurance | Federal Home Loan Bank of New York | ||||||||
Debt Instrument [Line Items] | ||||||||
Purchase requirement activity-based stock of the outstanding borrowings | 4.50% | 4.50% | ||||||
Debt Instrument, Term Upon Certain Events | 90 days | 90 days | ||||||
Other long-term investments | $ 80,500 | 147,400 | ||||||
Pledge collateral of prior year-end statutory net admitted assets | 5.00% | 5.00% | ||||||
Maximum amount of pledged asset | $ 7,700,000 | |||||||
Debt Issuance Costs, Net | 3,600,000 | |||||||
Debt Instrument, Unused Borrowing Capacity, Amount | 6,900,000 | |||||||
PRIAC | Federal Home Loan Bank of Boston | ||||||||
Debt Instrument [Line Items] | ||||||||
Other long-term investments | 6,000 | $ 6,000 | ||||||
Outstanding amount of notes | 0 | |||||||
Debt Instrument, Unused Borrowing Capacity, Amount | 264,000 | |||||||
Prudential Financial and Prudential Funding | ||||||||
Debt Instrument [Line Items] | ||||||||
Capacity | $ 4,000,000 | |||||||
Line of Credit Facility, Expiration Period | 5 years | 5 years | ||||||
Proceeds from Lines of Credit | $ 0 | |||||||
Prudential Holdings of Japan | ||||||||
Debt Instrument [Line Items] | ||||||||
Capacity | ¥ | ¥ 100,000 | |||||||
Line of Credit Facility, Expiration Period | 5 years | 5 years | ||||||
Proceeds from Lines of Credit | ¥ | ¥ 0 | |||||||
Other Subsidiaries | ||||||||
Debt Instrument [Line Items] | ||||||||
Capacity | $ 205,000 | |||||||
PLIC | ||||||||
Debt Instrument [Line Items] | ||||||||
Future Debt Instrument Authorized | $ 4,000,000 | |||||||
Minimum | PRIAC | Federal Home Loan Bank of Boston | ||||||||
Debt Instrument [Line Items] | ||||||||
Purchase requirement activity-based stock of the outstanding borrowings | 3.00% | 3.00% | ||||||
Maximum | Prudential Insurance | Federal Home Loan Bank of New York | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt Instrument, Interest Rate, Stated Percentage | 1.925% | 1.925% | ||||||
Maximum | PRIAC | Federal Home Loan Bank of Boston | ||||||||
Debt Instrument [Line Items] | ||||||||
Purchase requirement activity-based stock of the outstanding borrowings | 4.50% | 4.50% | ||||||
Commercial paper | Prudential Financial | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt Instrument Authorized | $ 3,000,000 | |||||||
Commercial paper | Prudential Funding, LLC | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt Instrument Authorized | 7,000,000 | |||||||
Real estate separate accounts | Other Subsidiaries | ||||||||
Debt Instrument [Line Items] | ||||||||
Capacity | 175,000 | |||||||
Proceeds from Lines of Credit | $ 55,000 | |||||||
Put Option | Prudential Financial | ||||||||
Debt Instrument [Line Items] | ||||||||
Term of contract | 10 years | |||||||
Debt Instrument, Interest Rate | 1.777% | 1.777% | ||||||
Derivative, Time To Cure | 30 days | |||||||
Minimum Equity Less AOCI For Automatic Exercise | $ 7,000,000 | |||||||
Minimum Equity Less AOCI for Automatic Exercise | $ 9,000,000 | |||||||
Private Placement | Prudential Financial | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt Instrument, Face Amount | $ 1,500,000 | $ 1,500,000 | ||||||
Debt Instrument, Interest Rate, Stated Percentage | 4.419% | 2.85% | ||||||
Debt Instrument, Interest Rate | Rate | 2.175% | |||||||
Senior notes | ||||||||
Debt Instrument [Line Items] | ||||||||
Long-term Debt, Weighted Average Interest Rate, at Point in Time | 4.39% | 4.45% | 4.39% | |||||
Medium-term Notes | ||||||||
Debt Instrument [Line Items] | ||||||||
Increase (decrease) in debt | $ (1,300,000) | |||||||
Asset-backed securities | ||||||||
Debt Instrument [Line Items] | ||||||||
Assets Under Set Off Arrangements | 500,000 | |||||||
Derivative Financial Instruments, Liabilities | ||||||||
Debt Instrument [Line Items] | ||||||||
Interest expense | 2,000 | $ 2,000 | 1,000 | |||||
Current And Long Term Debt | ||||||||
Debt Instrument [Line Items] | ||||||||
Interest Expense, Debt | 1,474,000 | 1,575,000 | 1,563,000 | |||||
Junior subordinated debt | Prudential Financial | ||||||||
Debt Instrument [Line Items] | ||||||||
Long-term debt | $ 7,564,000 | 7,554,000 | ||||||
Junior subordinated debt | Minimum | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt Instrument, Deferral Period | 5 years | 5 years | ||||||
Junior subordinated debt | Minimum | Prudential Financial | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt Instrument, Interest Rate, Stated Percentage | 3.70% | 3.70% | ||||||
Junior subordinated debt | Maximum | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt Instrument, Deferral Period | 10 years | 10 years | ||||||
Junior subordinated debt | Maximum | Prudential Financial | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt Instrument, Interest Rate, Stated Percentage | 5.88% | 5.88% | ||||||
Limited Recourse Note | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt Instrument, Face Amount | $ 500,000 | |||||||
Long-term Debt | Prudential Insurance | Federal Home Loan Bank of New York | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt Issuance Costs, Net | 1,000,000 | |||||||
Retail Medium Term Note | ||||||||
Debt Instrument [Line Items] | ||||||||
Outstanding amount of notes | 269,000 | 270,000 | ||||||
Derivatives | Prudential Financial | ||||||||
Debt Instrument [Line Items] | ||||||||
Interest expense | 0 | 400 | $ 300 | |||||
Fixed rate | Senior notes | Prudential Financial | ||||||||
Debt Instrument [Line Items] | ||||||||
Long-term debt | $ 10,109,000 | 11,007,000 | ||||||
Fixed rate | Senior notes | Minimum | Prudential Financial | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt Instrument, Interest Rate, Stated Percentage | 1.50% | 1.50% | ||||||
Fixed rate | Senior notes | Maximum | Prudential Financial | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt Instrument, Interest Rate, Stated Percentage | 6.63% | 6.63% | ||||||
Floating rate debt | Subordinated Debt | Prudential Financial | ||||||||
Debt Instrument [Line Items] | ||||||||
Long-term debt | $ 344,000 | |||||||
Senior notes | Medium-term Notes | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt Instrument, Face Amount | 910,000 | |||||||
Payment for Debt Extinguishment or Debt Prepayment Cost | 91,000 | |||||||
Senior notes | Maturing in 2024 | Medium-term Notes | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt Instrument, Face Amount | $ 700,000 | |||||||
Debt Instrument, Interest Rate, Stated Percentage | 3.50% | 3.50% | ||||||
Senior notes | Maturing in 2028 | Medium-term Notes | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt Instrument, Face Amount | $ 210,000 | |||||||
Debt Instrument, Interest Rate, Stated Percentage | 3.878% | 3.878% | ||||||
Subordinated Debt | Fixed rate | ||||||||
Debt Instrument [Line Items] | ||||||||
Long-term debt | $ 344,000 | 343,000 | ||||||
Subordinated Debt | Fixed rate | Minimum | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt Instrument, Interest Rate, Stated Percentage | 8.30% | 8.30% | ||||||
Senior notes | Private Placement | Prudential Financial | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt Instrument, Face Amount | $ 1,500,000 | |||||||
Senior notes | Investment Real Estate | Mortgages | ||||||||
Debt Instrument [Line Items] | ||||||||
Long-term Debt | $ 274,000 | 409,000 | ||||||
Increase (decrease) in debt | (135,000) | |||||||
Senior notes | Fixed rate | ||||||||
Debt Instrument [Line Items] | ||||||||
Long-term debt | $ 10,282,000 | $ 11,179,000 | ||||||
Senior notes | Fixed rate | Minimum | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt Instrument, Interest Rate, Stated Percentage | 1.50% | 1.50% | ||||||
Senior notes | Fixed rate | Maximum | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt Instrument, Interest Rate, Stated Percentage | 6.75% | 6.75% | ||||||
Senior notes | Maturing in 2028 | Medium-term Notes | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt Instrument, Face Amount | $ 600,000 | |||||||
Senior notes | Long-term Debt | Medium-term Notes | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt Instrument, Face Amount | $ 400,000 |
Short-Term and Long-Term Debt (Credit Facilities) (Details) - 12 months ended Dec. 31, 2021 ¥ in Millions, $ in Millions |
USD ($) |
JPY (¥) |
JPY (¥) |
---|---|---|---|
CreditFacility [Line Items] | |||
Capacity | $ 2,000 | ||
Prudential Financial and Prudential Funding | |||
CreditFacility [Line Items] | |||
Original Term | 5 years | 5 years | |
Capacity | $ 4,000 | ||
Amount Outstanding | $ 0 | ||
Prudential Holdings of Japan | |||
CreditFacility [Line Items] | |||
Original Term | 5 years | 5 years | |
Capacity | ¥ | ¥ 100,000 | ||
Amount Outstanding | ¥ | ¥ 0 |
Short-Term and Long-Term Debt (Long-Term Debt) (Details) - USD ($) $ in Millions |
Dec. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Debt Instrument [Line Items] | ||
Long-term debt | $ 18,622 | $ 19,718 |
Surplus notes | Fixed-rate notes: | ||
Debt Instrument [Line Items] | ||
Long-term debt | 344 | 343 |
Surplus notes subject to set-off arrangements | Fixed-rate notes: | ||
Debt Instrument [Line Items] | ||
Long-term debt | 7,861 | 8,134 |
Surplus notes subject to set-off arrangements | Floating-rate notes: | ||
Debt Instrument [Line Items] | ||
Long-term debt | 2,330 | 2,330 |
Senior notes | Fixed-rate notes: | ||
Debt Instrument [Line Items] | ||
Long-term debt | 10,282 | 11,179 |
Mortgages | Fixed-rate notes: | ||
Debt Instrument [Line Items] | ||
Long-term debt | 24 | 24 |
Mortgages | Floating-rate notes: | ||
Debt Instrument [Line Items] | ||
Long-term debt | 54 | 257 |
Mortgages | Debt denominated in foreign currency | Floating-rate notes: | ||
Debt Instrument [Line Items] | ||
Long-term debt | 29 | 29 |
Junior subordinated debt | ||
Debt Instrument [Line Items] | ||
Long-term debt | 7,618 | 7,615 |
Subtotal | ||
Debt Instrument [Line Items] | ||
Long-term debt | 28,813 | 30,182 |
Less: assets under set-off arrangements | ||
Debt Instrument [Line Items] | ||
Long-term debt | 10,191 | 10,464 |
Line of Credit | Floating-rate notes: | ||
Debt Instrument [Line Items] | ||
Long-term debt | 300 | 300 |
Prudential Financial | ||
Debt Instrument [Line Items] | ||
Long-term debt | 17,673 | 18,561 |
Prudential Financial | Surplus notes | Floating-rate notes: | ||
Debt Instrument [Line Items] | ||
Long-term debt | 344 | |
Prudential Financial | Senior notes | Fixed-rate notes: | ||
Debt Instrument [Line Items] | ||
Long-term debt | 10,109 | $ 11,007 |
Prudential Financial | Junior subordinated debt | ||
Debt Instrument [Line Items] | ||
Long-term debt | 7,564 | |
Subsidiaries | Junior subordinated debt | ||
Debt Instrument [Line Items] | ||
Long-term debt | $ 54 | |
Minimum | Surplus notes | Fixed-rate notes: | ||
Debt Instrument [Line Items] | ||
Interest Rate | 8.30% | |
Minimum | Surplus notes subject to set-off arrangements | Fixed-rate notes: | ||
Debt Instrument [Line Items] | ||
Interest Rate | 2.23% | |
Minimum | Surplus notes subject to set-off arrangements | Floating-rate notes: | ||
Debt Instrument [Line Items] | ||
Interest Rate | 1.49% | |
Minimum | Senior notes | Fixed-rate notes: | ||
Debt Instrument [Line Items] | ||
Interest Rate | 1.50% | |
Minimum | Mortgages | Fixed-rate notes: | ||
Debt Instrument [Line Items] | ||
Interest Rate | 3.85% | |
Minimum | Mortgages | Floating-rate notes: | ||
Debt Instrument [Line Items] | ||
Interest Rate | 1.57% | |
Minimum | Junior subordinated debt | ||
Debt Instrument [Line Items] | ||
Interest Rate | 1.55% | |
Minimum | Line of Credit | Fixed-rate notes: | ||
Debt Instrument [Line Items] | ||
Interest Rate | 1.33% | |
Minimum | Prudential Financial | Senior notes | Fixed-rate notes: | ||
Debt Instrument [Line Items] | ||
Interest Rate | 1.50% | |
Maximum | Surplus notes subject to set-off arrangements | Fixed-rate notes: | ||
Debt Instrument [Line Items] | ||
Interest Rate | 5.26% | |
Maximum | Surplus notes subject to set-off arrangements | Floating-rate notes: | ||
Debt Instrument [Line Items] | ||
Interest Rate | 1.64% | |
Maximum | Senior notes | Fixed-rate notes: | ||
Debt Instrument [Line Items] | ||
Interest Rate | 6.75% | |
Maximum | Mortgages | Floating-rate notes: | ||
Debt Instrument [Line Items] | ||
Interest Rate | 1.86% | |
Maximum | Junior subordinated debt | ||
Debt Instrument [Line Items] | ||
Interest Rate | 5.88% | |
Maximum | Line of Credit | Fixed-rate notes: | ||
Debt Instrument [Line Items] | ||
Interest Rate | 1.41% | |
Maximum | Prudential Financial | Senior notes | Fixed-rate notes: | ||
Debt Instrument [Line Items] | ||
Interest Rate | 6.63% |
Short-Term and Long-Term Debt (Contractual Maturities for Long-Term Debt) (Details) - USD ($) $ in Millions |
Dec. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Debt Disclosure [Abstract] | ||
2023 | $ 203 | |
2024 | 324 | |
2025 | 345 | |
2026 | 500 | |
2027 and thereafter | 17,250 | |
Long-term debt | $ 18,622 | $ 19,718 |
Short-Term and Long-Term Debt (Senior Notes and Mortgage Debt) (Details) - USD ($) $ in Millions |
Dec. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Medium-term Notes | ||
Debt Instrument [Line Items] | ||
Debt, Long-term and Short-term, Combined Amount | $ 8,544 | $ 9,847 |
Medium-term Notes | Senior notes | ||
Debt Instrument [Line Items] | ||
Debt, Long-term and Short-term, Combined Amount | 10,556 | 11,988 |
Senior notes | ||
Debt Instrument [Line Items] | ||
Debt, Long-term and Short-term, Combined Amount | 1,469 | 1,462 |
Retail Medium Term Note | ||
Debt Instrument [Line Items] | ||
Outstanding amount of notes | 269 | 270 |
Mortgages | Investment Real Estate | Senior notes | ||
Debt Instrument [Line Items] | ||
Long-term Debt | 274 | $ 409 |
Short-term Debt | $ 197 |
Short-Term and Long-Term Debt (Surplus Notes with Set-Off Arrangements) (Details) - USD ($) $ in Millions |
Dec. 31, 2021 |
Dec. 31, 2020 |
Jun. 11, 2020 |
Mar. 31, 2020 |
Feb. 18, 2015 |
---|---|---|---|---|---|
Debt Instrument [Line Items] | |||||
Capacity | $ 2,000 | ||||
Prudential Arizona Reinsurance Universal Company | |||||
Debt Instrument [Line Items] | |||||
Future Debt Instrument Authorized | $ 1,200 | ||||
PLIC | |||||
Debt Instrument [Line Items] | |||||
Future Debt Instrument Authorized | $ 4,000 | ||||
Surplus notes subject to set-off arrangements | |||||
Debt Instrument [Line Items] | |||||
Outstanding amount of notes | 10,691 | $ 10,964 | |||
Future Debt Instrument Authorized | 16,450 | ||||
Floating Rate Debt Surplus Notes Subject To Set Off Arrangement | Captive Reinsurance Subsidiary | |||||
Debt Instrument [Line Items] | |||||
Estimated maximum borrowing capacity, after taking into account applicable required collateralization levels and required purchases of activity based stock | 100 | 400 | |||
Floating Rate Debt Surplus Notes Subject To Set Off Arrangement | Prudential Arizona Reinsurance Universal Company | |||||
Debt Instrument [Line Items] | |||||
Estimated maximum borrowing capacity, after taking into account applicable required collateralization levels and required purchases of activity based stock | 775 | 700 | |||
Regulation XXX | Surplus notes | Captive Reinsurance Subsidiary | |||||
Debt Instrument [Line Items] | |||||
Debt Instrument Authorized | 1,750 | ||||
Outstanding amount of notes | 2,330 | 2,330 | |||
Capacity | 2,400 | ||||
Regulation XXX | Surplus notes subject to set-off arrangements | Captive Reinsurance Subsidiary | |||||
Debt Instrument [Line Items] | |||||
Outstanding amount of notes | 1,600 | 1,750 | |||
Regulation XXX | Floating Rate Debt Surplus Notes Subject To Set Off Arrangement | Captive Reinsurance Subsidiary | |||||
Debt Instrument [Line Items] | |||||
Debt Instrument Authorized | $ 1,600 | ||||
Estimated maximum borrowing capacity, after taking into account applicable required collateralization levels and required purchases of activity based stock | 920 | 1,070 | |||
Regulation XXX | Floating Rate Debt Surplus Notes Subject To Set Off Arrangement | Captive Reinsurance Subsidiary | Total Prudential Financial, Inc. Equity | |||||
Debt Instrument [Line Items] | |||||
Assets Under Set Off Arrangements | 500 | ||||
Guideline AXXX | Surplus notes subject to set-off arrangements | |||||
Debt Instrument [Line Items] | |||||
Future Debt Instrument Authorized | 4,500 | ||||
Guideline AXXX | Surplus notes subject to set-off arrangements | Captive Reinsurance Subsidiary | |||||
Debt Instrument [Line Items] | |||||
Outstanding amount of notes | 3,500 | 3,248 | |||
Future Debt Instrument Authorized | 3,500 | ||||
Guideline AXXX | Floating Rate Debt Surplus Notes Subject To Set Off Arrangement | Captive Reinsurance Subsidiary | |||||
Debt Instrument [Line Items] | |||||
Estimated maximum borrowing capacity, after taking into account applicable required collateralization levels and required purchases of activity based stock | $ 1,466 | $ 1,466 |
Short-Term and Long-Term Debt (Schedule of Junior Subordinated Notes) (Details) $ in Millions |
12 Months Ended |
---|---|
Dec. 31, 2021
USD ($)
| |
Junior Subordinated Institutional Notes August 2012 | |
Debt Instrument [Line Items] | |
Principal Amount | $ 1,000 |
Interest Rate | 5.88% |
Interest Rate Subsequent to Optional Redemption Date | 4.18% |
Junior Subordinated Institutional Notes November 2012 | |
Debt Instrument [Line Items] | |
Principal Amount | $ 1,500 |
Interest Rate | 5.63% |
Interest Rate Subsequent to Optional Redemption Date | 3.92% |
Junior Subordinated Retail Notes March 2013 | |
Debt Instrument [Line Items] | |
Principal Amount | $ 500 |
Interest Rate | 5.20% |
Interest Rate Subsequent to Optional Redemption Date | 3.04% |
Junior Subordinated Institutional Notes September 2017 | |
Debt Instrument [Line Items] | |
Principal Amount | $ 750 |
Interest Rate | 4.50% |
Interest Rate Subsequent to Optional Redemption Date | 2.38% |
Junior Subordinated Institutional Notes September 2018 | |
Debt Instrument [Line Items] | |
Principal Amount | $ 1,000 |
Interest Rate | 5.70% |
Interest Rate Subsequent to Optional Redemption Date | 2.67% |
Junior Subordinated Retail Notes August 2020 4.13% | |
Debt Instrument [Line Items] | |
Principal Amount | $ 500 |
Interest Rate | 4.13% |
Junior Subordinated Institutional Notes August 2020 3.70% | |
Debt Instrument [Line Items] | |
Principal Amount | $ 800 |
Interest Rate | 3.70% |
Interest Rate Subsequent to Optional Redemption Date | 3.04% |
Junior Subordinated Retail Notes May 2015 | |
Debt Instrument [Line Items] | |
Principal Amount | $ 1,000 |
Interest Rate | 5.38% |
Interest Rate Subsequent to Optional Redemption Date | 3.03% |
Junior Subordinated Institutional Notes August 2018 | |
Debt Instrument [Line Items] | |
Principal Amount | $ 565 |
Interest Rate | 5.63% |
Employee Benefit Plans (Narrative) (Details) - USD ($) $ in Millions |
12 Months Ended | |||
---|---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
Dec. 31, 2018 |
|
Defined Benefit Plan Disclosure [Line Items] | ||||
Qualified Pension Plan | 78.00% | |||
Pension Benefit Percent Allocation Traditional | 67.00% | |||
Pension Benefit Percent Allocation Cash Balance | 33.00% | |||
Percentage of annual salary Contributed by the Company for employees (401(k) plans) | 4.00% | |||
General And Administrative Expense | ||||
Defined Benefit Plan Disclosure [Line Items] | ||||
Defined Contribution Plan, Cost | $ 80 | $ 82 | $ 84 | |
Other liabilities | ||||
Defined Benefit Plan Disclosure [Line Items] | ||||
Net accumulated liability for non-retiree postemployment benefits provided to former or inactive employee | 34 | 15 | ||
Rabbi Trust | ||||
Defined Benefit Plan Disclosure [Line Items] | ||||
Defined Benefit Plan Obligation | 1,327 | 1,360 | ||
Fair value of plan assets | 1,109 | 1,044 | ||
Rabbi Trust | Discontinued Operations | ||||
Defined Benefit Plan Disclosure [Line Items] | ||||
Defined Benefit Plan Obligation | 73 | 77 | ||
Fair value of plan assets | 102 | 111 | ||
Pension Benefits | ||||
Defined Benefit Plan Disclosure [Line Items] | ||||
Defined Benefit Plan Obligation | 14,787 | 15,483 | 14,637 | |
Fair value of plan assets | $ 15,242 | $ 14,897 | $ 13,906 | |
Bond Yield rate used in determining Discount rate | 2.85% | 2.55% | 3.30% | 4.30% |
Expected long-term rate of return on plan assets | 6.00% | 5.75% | 6.00% | 6.50% |
Defined Benefit Plans Estimated Future Employer Contributions in Next Fiscal Year | $ 190 | |||
Postretirement | ||||
Defined Benefit Plan Disclosure [Line Items] | ||||
Defined Benefit Plan Obligation | 1,793 | $ 2,040 | $ 1,993 | |
Fair value of plan assets | $ 1,621 | $ 1,589 | $ 1,557 | |
Bond Yield rate used in determining Discount rate | 2.75% | 2.40% | 3.25% | 4.30% |
Expected long-term rate of return on plan assets | 7.00% | 6.75% | 6.75% | 7.00% |
Defined Benefit Plans Estimated Future Employer Contributions in Next Fiscal Year | $ 10 | |||
Maximum | ||||
Defined Benefit Plan Disclosure [Line Items] | ||||
Bond Yield rate used in determining Discount rate | 90.00% | |||
Maximum | Postretirement | ||||
Defined Benefit Plan Disclosure [Line Items] | ||||
Deferred Compensation Arrangement with Individual, Requisite Age | 55 years | |||
Deferred Compensation Arrangement with Individual, Requisite Service Period | 20 years | |||
Minimum | ||||
Defined Benefit Plan Disclosure [Line Items] | ||||
Bond Yield rate used in determining Discount rate | 10.00% | |||
Minimum | Postretirement | ||||
Defined Benefit Plan Disclosure [Line Items] | ||||
Deferred Compensation Arrangement with Individual, Requisite Age | 50 years | |||
Deferred Compensation Arrangement with Individual, Requisite Service Period | 10 years | |||
Foreign plans | ||||
Defined Benefit Plan Disclosure [Line Items] | ||||
Defined Benefit Plan Weighted Average Asset Allocations | 4.00% | |||
Foreign plans | Pension Benefits | ||||
Defined Benefit Plan Disclosure [Line Items] | ||||
Pension benefits for foreign plans percentage of the ending benefit obligation | 12.00% | 13.00% |
Employee Benefit Plans (Status of Prepaid Benefits Costs and Accrued Benefit Liabilities Included in Other Assets and Other Liabilities) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Pension Benefits | |||
Change in benefit obligation | |||
Benefit obligation at the beginning of period | $ (15,483) | $ (14,637) | |
Service cost | (328) | (321) | $ (291) |
Interest cost | (364) | (429) | (489) |
Plan participants’ contributions | 0 | 0 | |
Medicare Part D subsidy receipts | 0 | 0 | |
Amendments | 0 | 0 | |
Curtailments | 0 | 16 | |
Actuarial gains (losses), net | 310 | (978) | |
Settlements | 24 | 43 | |
Special termination benefits | (1) | (7) | |
Benefits paid | 868 | 878 | |
Acquisition/Divestiture | 13 | 46 | |
Foreign currency changes and other | 174 | (94) | |
Benefit obligation at end of period | (14,787) | (15,483) | (14,637) |
Change in plan assets | |||
Plan assets at beginning of period | 14,897 | 13,906 | |
Actual return on plan assets | 1,059 | 1,740 | |
Employer contributions | 205 | 200 | |
Plan participants’ contributions | 0 | 0 | |
Disbursement for settlements | (24) | (43) | |
Benefits paid | (868) | (878) | |
Acquisition/Divestiture | (5) | (51) | |
Foreign currency changes and other | (22) | 23 | |
Plan assets at end of period | 15,242 | 14,897 | 13,906 |
Funded status at end of period | 455 | (586) | |
Amounts recognized in the Statements of Financial Position | |||
Prepaid benefit cost | 3,272 | 2,426 | |
Accrued benefit liability | (2,817) | (3,012) | |
Net amount recognized | 455 | (586) | |
Items recorded in “Accumulated other comprehensive income (loss)” not yet recognized as a component of net periodic (benefit) cost: | |||
Prior service cost | (5) | (10) | |
Net actuarial loss | 3,131 | 3,972 | |
Net amount not recognized | 3,126 | 3,962 | |
Accumulated benefit obligation | (13,969) | (14,690) | |
Other Postretirement Benefits | |||
Change in benefit obligation | |||
Benefit obligation at the beginning of period | (2,040) | (1,993) | |
Service cost | (27) | (24) | (22) |
Interest cost | (49) | (64) | (78) |
Plan participants’ contributions | (23) | (22) | |
Medicare Part D subsidy receipts | (5) | (7) | |
Amendments | 121 | 0 | |
Curtailments | 0 | 0 | |
Actuarial gains (losses), net | 55 | (101) | |
Settlements | 0 | 0 | |
Special termination benefits | 0 | 0 | |
Benefits paid | 173 | 171 | |
Acquisition/Divestiture | 0 | 0 | |
Foreign currency changes and other | 2 | 0 | |
Benefit obligation at end of period | (1,793) | (2,040) | (1,993) |
Change in plan assets | |||
Plan assets at beginning of period | 1,589 | 1,557 | |
Actual return on plan assets | 174 | 171 | |
Employer contributions | 8 | 10 | |
Plan participants’ contributions | 23 | 22 | |
Disbursement for settlements | 0 | 0 | |
Benefits paid | (173) | (171) | |
Acquisition/Divestiture | 0 | 0 | |
Foreign currency changes and other | 0 | 0 | |
Plan assets at end of period | 1,621 | 1,589 | $ 1,557 |
Funded status at end of period | (172) | (451) | |
Amounts recognized in the Statements of Financial Position | |||
Prepaid benefit cost | 0 | 0 | |
Accrued benefit liability | (172) | (451) | |
Net amount recognized | (172) | (451) | |
Items recorded in “Accumulated other comprehensive income (loss)” not yet recognized as a component of net periodic (benefit) cost: | |||
Prior service cost | (69) | 59 | |
Net actuarial loss | 211 | 354 | |
Net amount not recognized | 142 | 413 | |
Accumulated benefit obligation | $ (1,793) | $ (2,040) |
Employee Benefit Plans (Information for Pension Plans with a Projected and Accumulated Benefit Obligation in Excess of Plan Assets) (Details) - USD ($) $ in Millions |
Dec. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Defined Benefit Plan, Pension Plan with Project Benefit Obligation in Excess of Plan Assets [Abstract] | ||
Projected benefit obligation | $ 2,817 | $ 3,012 |
Fair value of plan assets | 0 | 0 |
Information On Pension Plans With Accumulated Benefit Obligation In Excess Of Plan Assets [Abstract] | ||
Accumulated benefit obligation | 2,620 | 2,834 |
Fair value of plan assets | $ 0 | $ 0 |
Employee Benefit Plans (Components of Net Periodic Benefit Cost Included in General and Administrative Expenses) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Pension Benefits | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Service cost | $ 328 | $ 321 | $ 291 |
Interest cost | 364 | 429 | 489 |
Expected return on plan assets | (824) | (804) | (816) |
Amortization of prior service cost | (3) | (4) | (4) |
Amortization of actuarial (gain) loss, net | 245 | 262 | 217 |
Settlements | 5 | 9 | 59 |
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Curtailment | (1) | 0 | 0 |
Special termination benefits | 1 | 7 | 26 |
Net periodic (benefit) cost | 117 | 220 | 262 |
Other Postretirement Benefits | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Service cost | 27 | 24 | 22 |
Interest cost | 49 | 64 | 78 |
Expected return on plan assets | (102) | (100) | (95) |
Amortization of prior service cost | 6 | 6 | 4 |
Amortization of actuarial (gain) loss, net | 16 | 16 | 24 |
Settlements | 0 | 0 | 0 |
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Curtailment | 0 | 0 | 0 |
Special termination benefits | 0 | 0 | 1 |
Net periodic (benefit) cost | $ (4) | $ 10 | $ 34 |
Employee Benefit Plans (Amounts Recorded in Accumulated Other Comprehensive Income not yet Recognized) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Pension Benefits | |||
Pension And Other Postretirement Benefit Plans, Accumulated Other Comprehensive Income (Loss), Before Tax [Roll Forward] | |||
Balance, beginning of year | $ 3,962 | ||
Amortization for the period | 245 | $ 262 | $ 217 |
Deferrals for the period | 310 | (978) | |
Impact of foreign currency changes and other | (174) | 94 | |
Balance, end of period | 3,126 | 3,962 | |
Pension Benefits | Prior Service Cost | |||
Pension And Other Postretirement Benefit Plans, Accumulated Other Comprehensive Income (Loss), Before Tax [Roll Forward] | |||
Balance, beginning of year | (10) | (12) | (15) |
Amortization for the period | 3 | 4 | 4 |
Deferrals for the period | 0 | 0 | 0 |
Impact of foreign currency changes and other | 2 | (2) | (1) |
Balance, end of period | (5) | (10) | (12) |
Pension Benefits | Net Actuarial (Gain) Loss | |||
Pension And Other Postretirement Benefit Plans, Accumulated Other Comprehensive Income (Loss), Before Tax [Roll Forward] | |||
Balance, beginning of year | 3,972 | 4,191 | 3,829 |
Amortization for the period | (245) | (262) | (217) |
Deferrals for the period | (545) | 42 | 634 |
Impact of foreign currency changes and other | (51) | 1 | (55) |
Balance, end of period | 3,131 | 3,972 | 4,191 |
Other Postretirement Benefits | |||
Pension And Other Postretirement Benefit Plans, Accumulated Other Comprehensive Income (Loss), Before Tax [Roll Forward] | |||
Balance, beginning of year | 413 | ||
Amortization for the period | 16 | 16 | 24 |
Deferrals for the period | 55 | (101) | |
Impact of foreign currency changes and other | (2) | 0 | |
Balance, end of period | 142 | 413 | |
Other Postretirement Benefits | Prior Service Cost | |||
Pension And Other Postretirement Benefit Plans, Accumulated Other Comprehensive Income (Loss), Before Tax [Roll Forward] | |||
Balance, beginning of year | 59 | 65 | 41 |
Amortization for the period | (6) | (6) | (4) |
Deferrals for the period | (121) | 0 | 27 |
Impact of foreign currency changes and other | (1) | 0 | 1 |
Balance, end of period | (69) | 59 | 65 |
Other Postretirement Benefits | Net Actuarial (Gain) Loss | |||
Pension And Other Postretirement Benefit Plans, Accumulated Other Comprehensive Income (Loss), Before Tax [Roll Forward] | |||
Balance, beginning of year | 354 | 341 | 408 |
Amortization for the period | (16) | (16) | (24) |
Deferrals for the period | (127) | 30 | (45) |
Impact of foreign currency changes and other | 0 | (1) | 2 |
Balance, end of period | $ 211 | $ 354 | $ 341 |
Employee Benefit Plans (Assumptions Related to Calculation of Domestic Benefit Obligation (End of Period) and Determination of Net Periodic (Benefit) Cost (Beginning of Period)) (Details) |
12 Months Ended | |||
---|---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
Dec. 31, 2018 |
|
Pension Benefits | ||||
Defined Benefit Plan Disclosure [Line Items] | ||||
Discount rate | 2.85% | 2.55% | 3.30% | 4.30% |
Rate of increase in compensation levels | 4.50% | 4.50% | 4.50% | 4.50% |
Expected return on plan assets | 6.00% | 5.75% | 6.00% | 6.50% |
Interest Crediting Rate | 4.25% | 4.25% | 4.30% | 4.30% |
Other Postretirement Benefits | ||||
Defined Benefit Plan Disclosure [Line Items] | ||||
Discount rate | 2.75% | 2.40% | 3.25% | 4.30% |
Expected return on plan assets | 7.00% | 6.75% | 6.75% | 7.00% |
Health care cost trend rates | 6.00% | 6.25% | 6.25% | 6.00% |
Ultimate health care cost trend rate | 4.50% | 4.50% | 4.50% | 5.00% |
Employee Benefit Plans (Asset Allocation Targets Reflecting a Percentage of Total Assets by Asset Class) (Details) |
Dec. 31, 2021 |
---|---|
Minimum | Pension Benefits | U.S. Equities | |
Defined Benefit Plan Disclosure [Line Items] | |
Asset allocation targets | 2.00% |
Minimum | Pension Benefits | International Equities | |
Defined Benefit Plan Disclosure [Line Items] | |
Asset allocation targets | 3.00% |
Minimum | Pension Benefits | Fixed Maturities | |
Defined Benefit Plan Disclosure [Line Items] | |
Asset allocation targets | 50.00% |
Minimum | Pension Benefits | Short-term Investments | |
Defined Benefit Plan Disclosure [Line Items] | |
Asset allocation targets | 0.00% |
Minimum | Pension Benefits | Real Estate | |
Defined Benefit Plan Disclosure [Line Items] | |
Asset allocation targets | 2.00% |
Minimum | Pension Benefits | Other | |
Defined Benefit Plan Disclosure [Line Items] | |
Asset allocation targets | 5.00% |
Minimum | Postretirement | U.S. Equities | |
Defined Benefit Plan Disclosure [Line Items] | |
Asset allocation targets | 34.00% |
Minimum | Postretirement | International Equities | |
Defined Benefit Plan Disclosure [Line Items] | |
Asset allocation targets | 2.00% |
Minimum | Postretirement | Fixed Maturities | |
Defined Benefit Plan Disclosure [Line Items] | |
Asset allocation targets | 10.00% |
Minimum | Postretirement | Short-term Investments | |
Defined Benefit Plan Disclosure [Line Items] | |
Asset allocation targets | 0.00% |
Minimum | Postretirement | Real Estate | |
Defined Benefit Plan Disclosure [Line Items] | |
Asset allocation targets | 0.00% |
Minimum | Postretirement | Other | |
Defined Benefit Plan Disclosure [Line Items] | |
Asset allocation targets | 0.00% |
Maximum | Pension Benefits | U.S. Equities | |
Defined Benefit Plan Disclosure [Line Items] | |
Asset allocation targets | 6.00% |
Maximum | Pension Benefits | International Equities | |
Defined Benefit Plan Disclosure [Line Items] | |
Asset allocation targets | 8.00% |
Maximum | Pension Benefits | Fixed Maturities | |
Defined Benefit Plan Disclosure [Line Items] | |
Asset allocation targets | 65.00% |
Maximum | Pension Benefits | Short-term Investments | |
Defined Benefit Plan Disclosure [Line Items] | |
Asset allocation targets | 13.00% |
Maximum | Pension Benefits | Real Estate | |
Defined Benefit Plan Disclosure [Line Items] | |
Asset allocation targets | 16.00% |
Maximum | Pension Benefits | Other | |
Defined Benefit Plan Disclosure [Line Items] | |
Asset allocation targets | 32.00% |
Maximum | Postretirement | U.S. Equities | |
Defined Benefit Plan Disclosure [Line Items] | |
Asset allocation targets | 74.00% |
Maximum | Postretirement | International Equities | |
Defined Benefit Plan Disclosure [Line Items] | |
Asset allocation targets | 25.00% |
Maximum | Postretirement | Fixed Maturities | |
Defined Benefit Plan Disclosure [Line Items] | |
Asset allocation targets | 43.00% |
Maximum | Postretirement | Short-term Investments | |
Defined Benefit Plan Disclosure [Line Items] | |
Asset allocation targets | 26.00% |
Maximum | Postretirement | Real Estate | |
Defined Benefit Plan Disclosure [Line Items] | |
Asset allocation targets | 0.00% |
Maximum | Postretirement | Other | |
Defined Benefit Plan Disclosure [Line Items] | |
Asset allocation targets | 0.00% |
Employee Benefit Plans (Pension and Post Retirement Asset Allocations in Accordance with Investment Guidelines) (Details) - USD ($) $ in Millions |
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
---|---|---|---|
Defined Benefit Plan Disclosure [Line Items] | |||
Notional | $ 471,246 | $ 445,049 | |
Pension Benefits | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 15,242 | 14,897 | $ 13,906 |
Pension Benefits | Fixed Maturities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 6,758 | 7,213 | |
Pension Benefits | Other | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 3,104 | 2,561 | |
Pension Benefits | Net assets in the fair value hierarchy | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 10,860 | 10,612 | |
Postretirement | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 1,621 | 1,589 | 1,557 |
Postretirement | Equities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 50 | 45 | |
Postretirement | Defined Benefit Plan, Debt Security | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 45 | |
Postretirement | Net assets in the fair value hierarchy | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 164 | 255 | |
Postretirement | Variable Life Insurance Policies at contract value | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 1,163 | 1,055 | |
Level 1 | Pension Benefits | Fixed Maturities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 96 | 129 | |
Level 1 | Pension Benefits | Other | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
Level 1 | Pension Benefits | Net assets in the fair value hierarchy | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 96 | 129 | |
Level 1 | Postretirement | Equities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
Level 1 | Postretirement | Defined Benefit Plan, Debt Security | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 19 | |
Level 1 | Postretirement | Net assets in the fair value hierarchy | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 114 | 184 | |
Level 2 | Pension Benefits | Fixed Maturities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 6,620 | 7,049 | |
Level 2 | Pension Benefits | Other | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
Level 2 | Pension Benefits | Net assets in the fair value hierarchy | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 6,620 | 7,049 | |
Level 2 | Postretirement | Equities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 50 | 45 | |
Level 2 | Postretirement | Defined Benefit Plan, Debt Security | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 26 | |
Level 2 | Postretirement | Net assets in the fair value hierarchy | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 50 | 71 | |
Level 3 | Pension Benefits | Fixed Maturities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 42 | 35 | |
Level 3 | Pension Benefits | Other | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 3,104 | 2,561 | |
Level 3 | Pension Benefits | Net assets in the fair value hierarchy | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 4,144 | 3,434 | |
Level 3 | Postretirement | Equities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
Level 3 | Postretirement | Defined Benefit Plan, Debt Security | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
Level 3 | Postretirement | Net assets in the fair value hierarchy | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
Investment Measure at Net Asset Value as a practical expedient | Postretirement | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 294 | 279 | |
Mortgage-backed | Pension Benefits | Fixed Maturities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 1 | |
Mortgage-backed | Level 1 | Pension Benefits | Fixed Maturities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
Mortgage-backed | Level 2 | Pension Benefits | Fixed Maturities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 1 | |
Mortgage-backed | Level 3 | Pension Benefits | Fixed Maturities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
U.S. Equities | Postretirement | Equities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 40 | 36 | |
U.S. Equities | Level 1 | Postretirement | Equities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
U.S. Equities | Level 2 | Postretirement | Equities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 40 | 36 | |
U.S. Equities | Level 3 | Postretirement | Equities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
International Equities | Postretirement | Equities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 10 | 9 | |
International Equities | Level 1 | Postretirement | Equities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
International Equities | Level 2 | Postretirement | Equities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 10 | 9 | |
International Equities | Level 3 | Postretirement | Equities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
Other U.S. government securities | Pension Benefits | Fixed Maturities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 1,081 | 985 | |
Other U.S. government securities | Postretirement | Defined Benefit Plan, Debt Security | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 9 | |
Other U.S. government securities | Level 1 | Pension Benefits | Fixed Maturities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
Other U.S. government securities | Level 1 | Postretirement | Defined Benefit Plan, Debt Security | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
Other U.S. government securities | Level 2 | Pension Benefits | Fixed Maturities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 1,081 | 985 | |
Other U.S. government securities | Level 2 | Postretirement | Defined Benefit Plan, Debt Security | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 9 | |
Other U.S. government securities | Level 3 | Pension Benefits | Fixed Maturities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
Other U.S. government securities | Level 3 | Postretirement | Defined Benefit Plan, Debt Security | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
U.S. government securities (state & other) | Pension Benefits | Fixed Maturities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 518 | 588 | |
U.S. government securities (state & other) | Level 1 | Pension Benefits | Fixed Maturities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
U.S. government securities (state & other) | Level 2 | Pension Benefits | Fixed Maturities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 518 | 588 | |
U.S. government securities (state & other) | Level 3 | Pension Benefits | Fixed Maturities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
Non-U.S. government securities | Pension Benefits | Fixed Maturities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 114 | 103 | |
Non-U.S. government securities | Postretirement | Defined Benefit Plan, Debt Security | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 1 | |
Non-U.S. government securities | Level 1 | Pension Benefits | Fixed Maturities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
Non-U.S. government securities | Level 1 | Postretirement | Defined Benefit Plan, Debt Security | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
Non-U.S. government securities | Level 2 | Pension Benefits | Fixed Maturities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 114 | 103 | |
Non-U.S. government securities | Level 2 | Postretirement | Defined Benefit Plan, Debt Security | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 1 | |
Non-U.S. government securities | Level 3 | Pension Benefits | Fixed Maturities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
Non-U.S. government securities | Level 3 | Postretirement | Defined Benefit Plan, Debt Security | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
Corporate bonds | Pension Benefits | Fixed Maturities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 3,809 | 4,290 | |
Corporate bonds | Postretirement | Defined Benefit Plan, Debt Security | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 7 | |
Corporate bonds | Level 1 | Pension Benefits | Fixed Maturities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
Corporate bonds | Level 1 | Postretirement | Defined Benefit Plan, Debt Security | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
Corporate bonds | Level 2 | Pension Benefits | Fixed Maturities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 3,809 | 4,290 | |
Corporate bonds | Level 2 | Postretirement | Defined Benefit Plan, Debt Security | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 7 | |
Corporate bonds | Level 3 | Pension Benefits | Fixed Maturities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
Corporate bonds | Level 3 | Postretirement | Defined Benefit Plan, Debt Security | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
Asset-backed | Pension Benefits | Fixed Maturities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 23 | 25 | |
Asset-backed | Postretirement | Defined Benefit Plan, Debt Security | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 2 | |
Asset-backed | Level 1 | Pension Benefits | Fixed Maturities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
Asset-backed | Level 1 | Postretirement | Defined Benefit Plan, Debt Security | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
Asset-backed | Level 2 | Pension Benefits | Fixed Maturities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 23 | 25 | |
Asset-backed | Level 2 | Postretirement | Defined Benefit Plan, Debt Security | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 2 | |
Asset-backed | Level 3 | Pension Benefits | Fixed Maturities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
Asset-backed | Level 3 | Postretirement | Defined Benefit Plan, Debt Security | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
Collateralized mortgage obligations | Pension Benefits | Fixed Maturities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 570 | 614 | |
Collateralized mortgage obligations | Postretirement | Defined Benefit Plan, Debt Security | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 3 | |
Collateralized mortgage obligations | Level 1 | Pension Benefits | Fixed Maturities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
Collateralized mortgage obligations | Level 1 | Postretirement | Defined Benefit Plan, Debt Security | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
Collateralized mortgage obligations | Level 2 | Pension Benefits | Fixed Maturities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 570 | 614 | |
Collateralized mortgage obligations | Level 2 | Postretirement | Defined Benefit Plan, Debt Security | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 3 | |
Collateralized mortgage obligations | Level 3 | Pension Benefits | Fixed Maturities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
Collateralized mortgage obligations | Level 3 | Postretirement | Defined Benefit Plan, Debt Security | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
Collateralized loan obligations | Pension Benefits | Fixed Maturities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 502 | 441 | |
Collateralized loan obligations | Postretirement | Defined Benefit Plan, Debt Security | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 4 | |
Collateralized loan obligations | Level 1 | Pension Benefits | Fixed Maturities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
Collateralized loan obligations | Level 1 | Postretirement | Defined Benefit Plan, Debt Security | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
Collateralized loan obligations | Level 2 | Pension Benefits | Fixed Maturities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 502 | 441 | |
Collateralized loan obligations | Level 2 | Postretirement | Defined Benefit Plan, Debt Security | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 4 | |
Collateralized loan obligations | Level 3 | Pension Benefits | Fixed Maturities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
Collateralized loan obligations | Level 3 | Postretirement | Defined Benefit Plan, Debt Security | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
Interest Rate Swaps | Pension Benefits | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Notional | 433 | 13 | |
Interest Rate Swaps | Pension Benefits | Fixed Maturities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | (1) | 0 | |
Interest Rate Swaps | Level 1 | Pension Benefits | Fixed Maturities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
Interest Rate Swaps | Level 2 | Pension Benefits | Fixed Maturities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | (1) | 0 | |
Interest Rate Swaps | Level 3 | Pension Benefits | Fixed Maturities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
Registered investment companies | Pension Benefits | Fixed Maturities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 85 | 96 | |
Registered investment companies | Postretirement | Defined Benefit Plan, Debt Security | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 19 | |
Registered investment companies | Postretirement | Short-term Investments | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 114 | 165 | |
Registered investment companies | Level 1 | Pension Benefits | Fixed Maturities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 85 | 96 | |
Registered investment companies | Level 1 | Postretirement | Defined Benefit Plan, Debt Security | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 19 | |
Registered investment companies | Level 1 | Postretirement | Short-term Investments | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 114 | 165 | |
Registered investment companies | Level 2 | Pension Benefits | Fixed Maturities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
Registered investment companies | Level 2 | Postretirement | Defined Benefit Plan, Debt Security | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
Registered investment companies | Level 2 | Postretirement | Short-term Investments | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
Registered investment companies | Level 3 | Pension Benefits | Fixed Maturities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
Registered investment companies | Level 3 | Postretirement | Defined Benefit Plan, Debt Security | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
Registered investment companies | Level 3 | Postretirement | Short-term Investments | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
Other | Pension Benefits | Fixed Maturities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 57 | 70 | |
Other | Level 1 | Pension Benefits | Fixed Maturities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 11 | 33 | |
Other | Level 2 | Pension Benefits | Fixed Maturities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 4 | 2 | |
Other | Level 3 | Pension Benefits | Fixed Maturities | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 42 | 35 | |
Partnerships | Pension Benefits | Real Estate | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 998 | 838 | |
Partnerships | Pension Benefits | Other | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 1,800 | 1,234 | |
Partnerships | Level 1 | Pension Benefits | Real Estate | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
Partnerships | Level 1 | Pension Benefits | Other | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
Partnerships | Level 2 | Pension Benefits | Real Estate | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
Partnerships | Level 2 | Pension Benefits | Other | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
Partnerships | Level 3 | Real Estate | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 998 | 838 | 688 |
Partnerships | Level 3 | Other | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 1,800 | 1,234 | 973 |
Partnerships | Level 3 | Pension Benefits | Real Estate | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 998 | 838 | |
Partnerships | Level 3 | Pension Benefits | Other | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 1,800 | 1,234 | |
Hedge Fund | Pension Benefits | Other | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 1,304 | 1,327 | |
Hedge Fund | Level 1 | Pension Benefits | Other | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
Hedge Fund | Level 2 | Pension Benefits | Other | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
Hedge Fund | Level 3 | Other | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 1,304 | 1,327 | $ 1,312 |
Hedge Fund | Level 3 | Pension Benefits | Other | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 1,304 | 1,327 | |
Pooled separate accounts | Investment Measure at Net Asset Value as a practical expedient | Pension Benefits | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 2,554 | 2,659 | |
Common/collective trusts | Investment Measure at Net Asset Value as a practical expedient | Pension Benefits | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 1,643 | 1,440 | |
Other countries | Investment Measure at Net Asset Value as a practical expedient | Pension Benefits | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | 185 | 186 | |
Net assets at fair value | Postretirement | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Plan Assets, Amount | $ 458 | $ 534 |
Employee Benefit Plans (Changes in Fair Value of Level 3 Pension and Post Retirement Assets) (Details) - USD ($) $ in Millions |
12 Months Ended | |
---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
|
Postretirement | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Plan assets at beginning of period | $ 1,589 | $ 1,557 |
Actual Return on Assets: | ||
Plan assets at end of period | 1,621 | 1,589 |
Other | Level 3 | Fixed Maturities | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Plan assets at beginning of period | 35 | 44 |
Actual Return on Assets: | ||
Relating to assets still held at the reporting date | 0 | 0 |
Relating to assets sold during the period | 0 | 0 |
Purchases, sales and settlements | 7 | (9) |
Transfers in and/or out of Level 3 | 0 | 0 |
Plan assets at end of period | 42 | 35 |
Partnerships | Level 3 | Real Estate | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Plan assets at beginning of period | 838 | 688 |
Actual Return on Assets: | ||
Relating to assets still held at the reporting date | 128 | 11 |
Relating to assets sold during the period | 0 | 0 |
Purchases, sales and settlements | 32 | 139 |
Transfers in and/or out of Level 3 | 0 | 0 |
Plan assets at end of period | 998 | 838 |
Partnerships | Level 3 | Other | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Plan assets at beginning of period | 1,234 | 973 |
Actual Return on Assets: | ||
Relating to assets still held at the reporting date | 639 | 161 |
Relating to assets sold during the period | 0 | 0 |
Purchases, sales and settlements | (73) | 100 |
Transfers in and/or out of Level 3 | 0 | 0 |
Plan assets at end of period | 1,800 | 1,234 |
Hedge Fund | Level 3 | Other | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Plan assets at beginning of period | 1,327 | 1,312 |
Actual Return on Assets: | ||
Relating to assets still held at the reporting date | 98 | 116 |
Relating to assets sold during the period | 0 | 0 |
Purchases, sales and settlements | (121) | (101) |
Transfers in and/or out of Level 3 | 0 | 0 |
Plan assets at end of period | $ 1,304 | $ 1,327 |
Employee Benefit Plans (Expected Benefit Payments for Company's Pension and Postretirement Plans as well as Expected Medicare Part D Subsidy Receipts Related to Postretirement Plan) (Details) $ in Millions |
Dec. 31, 2021
USD ($)
|
---|---|
Pension Benefits | |
Defined Benefit Plan Disclosure [Line Items] | |
2022 | $ 823 |
2023 | 852 |
2024 | 859 |
2025 | 890 |
2026 | 898 |
2027-2031 | 4,683 |
Total | 9,005 |
Postretirement | |
Defined Benefit Plan Disclosure [Line Items] | |
2022 | 160 |
2023 | 161 |
2024 | 160 |
2025 | 155 |
2026 | 150 |
2027-2031 | 583 |
Total | 1,369 |
Other Postretirement Benefits– Medicare Part D Subsidy Receipts | |
Defined Benefit Plan Disclosure [Line Items] | |
2022 | 6 |
2023 | 6 |
2024 | 6 |
2025 | 6 |
2026 | 6 |
2027-2031 | 26 |
Total | $ 56 |
Equity (Narrative) (Details) - USD ($) $ / shares in Units, $ in Millions |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Class of Stock [Line Items] | |||
Preferred Stock, Shares Authorized | 10,000,000 | 10,000,000 | 10,000,000 |
Preferred Stock, Shares Outstanding | 0 | 0 | 0 |
Common Stock, par value (in dollars per share) | $ 0.01 | $ 0.01 | |
Prudential Financial | |||
Class of Stock [Line Items] | |||
Preferred Stock, Shares Authorized | 10,000,000 | 10,000,000 | |
Common Stock, par value (in dollars per share) | $ 0.01 | $ 0.01 | |
Cash and short-term investments at carrying value excluding intercompany liquidity account | $ 3,553 | ||
Gibraltar Life | |||
Class of Stock [Line Items] | |||
Japan Permitted Percentage of Statutory Earnings w/o approval | 83.00% | ||
RBC or solvency margin capital in excess of the regulatory required minimums | 3.5 | ||
Prudential Insurance | |||
Class of Stock [Line Items] | |||
Unassigned Surplus | $ 8,934 | ||
Percentage exceed the greater/lesser of statutory surplus | 10.00% | ||
Prudential Annuities Life Assurance Corporation | |||
Class of Stock [Line Items] | |||
Percentage exceed the greater/lesser of statutory surplus | 10.00% | ||
POJ | |||
Class of Stock [Line Items] | |||
Japan Permitted Percentage of Statutory Earnings w/o approval | 83.00% | ||
Japan-Retained Earnings Level- Permitted Percentage of Prior Year Statutory Earnings | 100.00% | ||
RBC or solvency margin capital in excess of the regulatory required minimums | 3.5 | ||
Prudential International Insurance Holdings | |||
Class of Stock [Line Items] | |||
Proceeds from Dividends Received | $ 1,184 | ||
Prudential International Insurance Holdings | In-kind dividend | |||
Class of Stock [Line Items] | |||
Proceeds from Dividends Received | 994 | ||
Prudential of Korea | |||
Class of Stock [Line Items] | |||
Proceeds from Dividends Received | $ 1,627 | ||
Permitted to be paid in 2022 | Prudential Insurance | |||
Class of Stock [Line Items] | |||
Statutory Accounting Practices, Statutory Amount Available for Dividend Payments without Regulatory Approval | $ 1,912 |
Equity (Common Stock Changes in Number of Shares Issued, Held in Treasury and Outstanding) (Details) |
12 Months Ended | |||||
---|---|---|---|---|---|---|
Aug. 02, 2019
USD ($)
shares
|
Dec. 31, 2021
USD ($)
shares
|
Dec. 31, 2020
shares
|
Dec. 31, 2019
shares
|
Sep. 30, 2011
USD ($)
|
Sep. 30, 2009
USD ($)
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Beginning Balance | 666,305,189 | |||||
Ending Balance | 666,305,189 | 666,305,189 | ||||
Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities | 0.0 | 0.0 | 3,600,000 | |||
Issued | ||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Beginning Balance | 666,300,000 | 666,300,000 | 660,100,000 | |||
Common stock issued | 0.0 | 0.0 | 6,200,000 | |||
Common Stock acquired | (0.0) | (0.0) | (0.0) | |||
Stock-based compensation programs | (0.0) | (0.0) | (0.0) | |||
Ending Balance | 666,300,000 | 666,300,000 | 666,300,000 | |||
Held In Treasury | ||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Beginning Balance | 269,900,000 | 267,500,000 | 249,400,000 | |||
Common stock issued | 0.0 | 0.0 | (5,500,000) | |||
Common Stock acquired | 24,500,000 | 6,700,000 | 27,200,000 | |||
Stock-based compensation programs | (4,400,000) | (4,300,000) | (3,600,000) | |||
Ending Balance | 290,000,000.0 | 269,900,000 | 267,500,000 | |||
Outstanding | ||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Beginning Balance | 396,400,000 | 398,800,000 | 410,700,000 | |||
Common stock issued | 0.0 | 0.0 | 11,700,000 | |||
Common Stock acquired | (24,500,000) | (6,700,000) | (27,200,000) | |||
Stock-based compensation programs | 4,400,000 | 4,300,000 | 3,600,000 | |||
Ending Balance | 376,300,000 | 396,400,000 | 398,800,000 | |||
Exhangeable Surplus Notes | Long-term Debt | ||||||
Class of Stock [Line Items] | ||||||
Debt Instrument, Face Amount | $ | $ 500,000,000 | $ 500,000,000 | ||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities | 6,200,000 | |||||
Debt Instrument, Convertible, Conversion Ratio | 12.3877 | |||||
Surplus Notes | $ | $ 1,000 | $ 1,000 | ||||
Common Stock Held in Treasury | Common Stock | ||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Stock Issued During Period, Shares, Acquisitions | 5,500,000 |
Equity (Share Repurchases Authorizations) (Details) - USD ($) shares in Millions, $ in Millions |
12 Months Ended | ||||
---|---|---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
Sep. 05, 2019 |
Dec. 31, 2018 |
|
Under December 2018 Board Of Directors Authorization | |||||
Equity, Class of Treasury Stock [Line Items] | |||||
Stock Repurchase Program, Authorized Amount | $ 1,500 | ||||
Increased Under September 2019 Board Of Directors Authorization | |||||
Equity, Class of Treasury Stock [Line Items] | |||||
Stock Repurchase Program, Authorized Amount | $ 2,500 | ||||
Under December 2017 Board Of Directors Authorization | |||||
Equity, Class of Treasury Stock [Line Items] | |||||
Stock Repurchase Program, Authorized Amount | $ 2,000 | ||||
Under December 2016 Board Of Directors Authorization | |||||
Equity, Class of Treasury Stock [Line Items] | |||||
Stock Repurchase Program, Authorized Amount | $ 2,500 | ||||
Other common stocks | Increased Under September 2019 Board Of Directors Authorization | |||||
Equity, Class of Treasury Stock [Line Items] | |||||
Number of Treasury Stock Shares Acquired | 24.5 | ||||
Other common stocks | Under December 2017 Board Of Directors Authorization | |||||
Equity, Class of Treasury Stock [Line Items] | |||||
Number of Treasury Stock Shares Acquired | 6.7 | ||||
Other common stocks | Under December 2016 Board Of Directors Authorization | |||||
Equity, Class of Treasury Stock [Line Items] | |||||
Number of Treasury Stock Shares Acquired | 27.2 |
Equity (Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | |||
Beginning balance | $ 30,738 | ||
Income tax benefit (expense) | 2,314 | $ (1,252) | $ (3,811) |
Ending balance | 21,324 | 30,738 | |
Foreign Currency Translation Adjustment | |||
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | |||
Beginning balance | 52 | (536) | (564) |
Change in OCI before reclassification | (1,058) | 455 | 37 |
Amounts reclassified from AOCI | (65) | 57 | 27 |
Income tax benefit (expense) | (79) | 76 | (36) |
Cumulative effect of adoption of ASU 2017-12 | 0 | ||
Ending balance | (1,150) | 52 | (536) |
Net Unrealized Investment Gains (Losses) | |||
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | |||
Beginning balance | 34,065 | 28,112 | 14,745 |
Change in OCI before reclassification | (9,226) | 8,112 | 18,540 |
Amounts reclassified from AOCI | (2,486) | (883) | (1,345) |
Income tax benefit (expense) | 2,634 | (1,276) | (3,835) |
Cumulative effect of adoption of ASU 2017-12 | 7 | ||
Ending balance | 24,987 | 34,065 | 28,112 |
Pension and Postretirement Unrecognized Net Periodic Benefit (Cost) | |||
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | |||
Beginning balance | (3,379) | (3,537) | (3,275) |
Change in OCI before reclassification | 843 | (70) | (563) |
Amounts reclassified from AOCI | 264 | 280 | 241 |
Income tax benefit (expense) | (241) | (52) | 60 |
Cumulative effect of adoption of ASU 2017-12 | 0 | ||
Ending balance | (2,513) | (3,379) | (3,537) |
Accumulated Other Comprehensive Income (Loss) | |||
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | |||
Beginning balance | 30,738 | 24,039 | 10,906 |
Change in OCI before reclassification | (9,441) | 8,497 | 18,014 |
Amounts reclassified from AOCI | (2,287) | (546) | (1,077) |
Income tax benefit (expense) | 2,314 | (1,252) | (3,811) |
Cumulative effect of adoption of ASU 2017-12 | 7 | ||
Ending balance | 21,324 | 30,738 | 24,039 |
Cash flow hedges | Net Unrealized Investment Gains (Losses) | |||
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | |||
Beginning balance | (168) | 832 | |
Ending balance | 1,019 | (168) | 832 |
Fair value hedges | Net Unrealized Investment Gains (Losses) | |||
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | |||
Beginning balance | 10 | 0 | |
Ending balance | $ (35) | $ 10 | $ 0 |
Equity (Reclassifications out of Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Reclassification Adjustment Out Of Accumulated Other Comprehensive Income [Line Items] | |||
Realized investment gains (losses), net | $ 4,024 | $ (3,887) | $ (459) |
Other income (loss) | 2,951 | 1,950 | 3,262 |
Total Foreign Currency Translation Adjustment | |||
Reclassification Adjustment Out Of Accumulated Other Comprehensive Income [Line Items] | |||
Amounts reclassified from AOCI | (65) | 57 | 27 |
Net Unrealized Investment Gains (Losses) | |||
Reclassification Adjustment Out Of Accumulated Other Comprehensive Income [Line Items] | |||
Amounts reclassified from AOCI | (2,486) | (883) | (1,345) |
Total amortization of defined benefit pension items | |||
Reclassification Adjustment Out Of Accumulated Other Comprehensive Income [Line Items] | |||
Amounts reclassified from AOCI | 264 | 280 | 241 |
Accumulated Other Comprehensive Income (Loss) | |||
Reclassification Adjustment Out Of Accumulated Other Comprehensive Income [Line Items] | |||
Amounts reclassified from AOCI | (2,287) | (546) | (1,077) |
Amounts reclassified from AOCI | |||
Reclassification Adjustment Out Of Accumulated Other Comprehensive Income [Line Items] | |||
Realized investment gains (losses), net | 2 | 1 | (27) |
Other income (loss) | 63 | (58) | 0 |
Amortization of defined benefit items: | |||
Prior service cost | (3) | (2) | 0 |
Actuarial gain (loss) | (261) | (278) | (241) |
Amounts reclassified from AOCI | Total Foreign Currency Translation Adjustment | |||
Reclassification Adjustment Out Of Accumulated Other Comprehensive Income [Line Items] | |||
Amounts reclassified from AOCI | 65 | (57) | (27) |
Amounts reclassified from AOCI | Net Unrealized Investment Gains (Losses) | |||
Reclassification Adjustment Out Of Accumulated Other Comprehensive Income [Line Items] | |||
Amounts reclassified from AOCI | 2,486 | 883 | 1,345 |
Amounts reclassified from AOCI | Total amortization of defined benefit pension items | |||
Reclassification Adjustment Out Of Accumulated Other Comprehensive Income [Line Items] | |||
Amounts reclassified from AOCI | (264) | (280) | (241) |
Amounts reclassified from AOCI | Accumulated Other Comprehensive Income (Loss) | |||
Reclassification Adjustment Out Of Accumulated Other Comprehensive Income [Line Items] | |||
Amounts reclassified from AOCI | 2,287 | 546 | 1,077 |
Amounts reclassified from AOCI | Net unrealized investment gains (losses) on available-for-sale securities | |||
Reclassification Adjustment Out Of Accumulated Other Comprehensive Income [Line Items] | |||
Net unrealized investment gains (losses) | 1,939 | 729 | 966 |
Amounts reclassified from AOCI | Interest Rate | Cash Flow Hedges | |||
Reclassification Adjustment Out Of Accumulated Other Comprehensive Income [Line Items] | |||
Net unrealized investment gains (losses) | 0 | 40 | 58 |
Amounts reclassified from AOCI | Currency | Cash Flow Hedges | |||
Reclassification Adjustment Out Of Accumulated Other Comprehensive Income [Line Items] | |||
Net unrealized investment gains (losses) | (4) | 5 | 6 |
Amounts reclassified from AOCI | Currency | Fair value hedges | |||
Reclassification Adjustment Out Of Accumulated Other Comprehensive Income [Line Items] | |||
Net unrealized investment gains (losses) | (6) | (1) | 0 |
Amounts reclassified from AOCI | Currency/Interest Rate | Cash Flow Hedges | |||
Reclassification Adjustment Out Of Accumulated Other Comprehensive Income [Line Items] | |||
Net unrealized investment gains (losses) | $ 557 | $ 110 | $ 315 |
Equity (Net Unrealized Investment Gains (Losses) in AOCI on AFS Fixed Maturity Securities with OTTI, Allowance for Credit Losses and All Other Investments) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | |||
Beginning balance | $ 30,738 | ||
Ending balance | 21,324 | $ 30,738 | |
Net Unrealized Investment Gain (Loss) on AFS Fixed Maturity Securities With OTTI Pre Tax | |||
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | |||
Beginning balance | 0 | 243 | $ 189 |
Net investment gains (losses) on investments arising during the period | 129 | ||
Reclassification adjustment for (gains) losses included in net income | 96 | ||
Reclassification adjustment for OTTI losses excluded from net income | (21) | ||
Reclassification due to implementation of ASU 2016-13 | (243) | ||
Ending balance | 0 | 0 | 243 |
Net Unrealized Investment Gain (Loss) on AFS Fixed Maturity Securities With AllowancePre Tax | |||
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | |||
Beginning balance | (25) | 0 | 0 |
Net investment gains (losses) on investments arising during the period | 41 | 47 | |
Reclassification adjustment for (gains) losses included in net income | 10 | 25 | |
Reclassification due to allowance for credit losses recorded during the period | (3) | (97) | |
Ending balance | 23 | (25) | 0 |
Net unrealized gains (losses) on all other investments | |||
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | |||
Beginning balance | 58,442 | 45,096 | 22,531 |
Net investment gains (losses) on investments arising during the period | (15,505) | 13,914 | 23,826 |
Reclassification adjustment for (gains) losses included in net income | (2,496) | (908) | (1,249) |
Reclassification adjustment for OTTI losses excluded from net income | (21) | ||
Cumulative effect of adoption of ASU 2017-12 | 9 | ||
Reclassification due to implementation of ASU 2016-13 | 243 | ||
Reclassification due to allowance for credit losses recorded during the period | 3 | 97 | |
Ending balance | 40,444 | 58,442 | 45,096 |
DAC, DSI, VOBA and Reinsurance Recoverables | |||
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | |||
Beginning balance | (1,229) | (1,585) | (739) |
Impact of net unrealized investment (gains) losses | 686 | 356 | (846) |
Ending balance | (543) | (1,229) | (1,585) |
Future Policy Benefits, Policyholders’ Account Balances and Reinsurance Payables | |||
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | |||
Beginning balance | (6,588) | (2,909) | (787) |
Impact of net unrealized investment (gains) losses | 3,317 | (3,679) | (2,122) |
Ending balance | (3,271) | (6,588) | (2,909) |
Policyholders’ Dividends | |||
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | |||
Beginning balance | (5,892) | (3,366) | (917) |
Impact of net unrealized investment (gains) losses | 2,235 | (2,526) | (2,449) |
Ending balance | (3,657) | (5,892) | (3,366) |
Income Tax Benefit (Expense) | |||
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | |||
Beginning balance | (10,643) | (9,367) | (5,532) |
Net investment gains (losses) on investments arising during the period | 3,435 | (2,665) | (5,311) |
Reclassification adjustment for (gains) losses included in net income | 552 | 168 | 298 |
Reclassification adjustment for OTTI losses excluded from net income | 0 | ||
Impact of net unrealized investment (gains) losses | (1,353) | 1,221 | 1,180 |
Cumulative effect of adoption of ASU 2017-12 | (2) | ||
Reclassification due to implementation of ASU 2016-13 | 0 | ||
Reclassification due to allowance for credit losses recorded during the period | 0 | 0 | |
Ending balance | (8,009) | (10,643) | (9,367) |
Accumulated Other Comprehensive Income (Loss) Related to Net Unrealized Investment Gains (Losses) | |||
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | |||
Beginning balance | 34,065 | 28,112 | 14,745 |
Net investment gains (losses) on investments arising during the period | (12,029) | 11,296 | 18,644 |
Reclassification adjustment for (gains) losses included in net income | (1,934) | (715) | (1,047) |
Reclassification adjustment for OTTI losses excluded from net income | 0 | ||
Impact of net unrealized investment (gains) losses | 4,885 | (4,628) | (4,237) |
Cumulative effect of adoption of ASU 2017-12 | 7 | ||
Reclassification due to implementation of ASU 2016-13 | 0 | ||
Reclassification due to allowance for credit losses recorded during the period | 0 | 0 | |
Ending balance | $ 24,987 | $ 34,065 | $ 28,112 |
Equity (Statutory Financial Information) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Prudential Insurance | |||
Statutory Accounting Practices [Line Items] | |||
Statutory net income (loss) | $ 966 | $ 1,770 | $ (169) |
Statutory capital and surplus | 19,123 | 11,597 | 11,483 |
PALAC | |||
Statutory Accounting Practices [Line Items] | |||
Statutory net income (loss) | 2,045 | (768) | (2,052) |
Statutory capital and surplus | 1,014 | $ 6,131 | $ 4,748 |
Permitted to be paid in 2022 | Prudential Insurance | |||
Statutory Accounting Practices [Line Items] | |||
Statutory Accounting Practices, Statutory Amount Available for Dividend Payments without Regulatory Approval | 1,912 | ||
Permitted to be paid prior to December 13, 2022 | Prudential Insurance | |||
Statutory Accounting Practices [Line Items] | |||
Statutory Accounting Practices, Statutory Amount Available for Dividend Payments without Regulatory Approval | 812 | ||
Permitted to be paid after to December 13, 2022 | Prudential Insurance | |||
Statutory Accounting Practices [Line Items] | |||
Statutory Accounting Practices, Statutory Amount Available for Dividend Payments without Regulatory Approval | $ 1,100 |
Earnings Per Share (Narrative) (Details) shares in Millions |
12 Months Ended | |||||
---|---|---|---|---|---|---|
Aug. 02, 2019
USD ($)
shares
|
Dec. 31, 2021
USD ($)
shares
|
Dec. 31, 2020
shares
|
Dec. 31, 2019
shares
|
Sep. 30, 2011
USD ($)
|
Sep. 30, 2009
USD ($)
|
|
Debt Instrument [Line Items] | ||||||
Undistributed earnings allocated to participating unvested share-based payment awards, weighted outstanding shares | 5.8 | 4.9 | 4.6 | |||
Exchangeable Surplus Notes (in shares) | 0.0 | 0.0 | 3.6 | |||
Long-term Debt | Exhangeable Surplus Notes | ||||||
Debt Instrument [Line Items] | ||||||
Debt Instrument, Face Amount | $ | $ 500,000,000 | $ 500,000,000 | ||||
Interest Rate | 5.36% | |||||
Debt Instrument, Convertible, Conversion Ratio | 12.3877 | |||||
Surplus notes principal amount, for each | $ | $ 1,000 | $ 1,000 | ||||
Exchangeable Surplus Notes (in shares) | 6.2 |
Earnings Per Share (Reconciliation of the Numerators and Denominators of the Basic and Diluted Per Share) (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Basic earnings per share | |||
Net income (loss) | $ 7,794 | $ (146) | $ 4,238 |
Less: Income (loss) attributable to noncontrolling interests | 70 | 228 | 52 |
Less: Dividends and undistributed earnings allocated to participating unvested share-based payment awards | 115 | 21 | 46 |
Net income (loss) attributable to Prudential Financial available to holders of Common Stock, Basic Income | $ 7,609 | $ (395) | $ 4,140 |
Net income (loss) attributable to Prudential Financial available to holders of Common Stock, Basic Weighted Average Shares | 387.2 | 395.8 | 404.8 |
Net income (loss) attributable to Prudential Financial available to holders of Common Stock, Basic Per Share Amount | $ 19.65 | $ (1.00) | $ 10.23 |
Dilutive Securities, Effect on Basic Earnings Per Share [Abstract] | |||
Add: Dividends and undistributed earnings allocated to participating unvested share-based payment awards—Basic | $ 115 | $ 21 | $ 46 |
Less: Dividends and undistributed earnings allocated to participating unvested share-based payment awards—Diluted | $ 115 | $ 21 | $ 45 |
Stock options, Weighted Average Shares | 0.7 | 0.0 | 1.1 |
Deferred and long-term compensation programs (in shares) | 2.2 | 0.0 | 1.4 |
Exchangeable Surplus Notes | $ 0 | $ 0 | $ 12 |
Exchangeable Surplus Notes (in shares) | 0.0 | 0.0 | 3.6 |
Diluted earnings per share | |||
Net income (loss) attributable to Prudential Financial available to holders of Common Stock, Diluted Income | $ 7,609 | $ (395) | $ 4,153 |
Net income (loss) attributable to Prudential Financial available to holders of Common Stock, Diluted Weighted Average Shares | 390.1 | 395.8 | 410.9 |
Net income (loss) attributable to Prudential Financial available to holders of Common Stock, Diluted Per Share Amount | $ 19.51 | $ (1.00) | $ 10.11 |
Earnings Per Share (Antidilutive Securities Excluded From the Computation of Diluted Earnings Per Share) (Details) - $ / shares shares in Millions |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] | |||
Weighted average shares of antidilutive security excluded from computation of diluted earnings per share (in shares) | 1.0 | 5.5 | 1.2 |
Antidilutive stock options based on application of the treasury stock method | |||
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] | |||
Weighted average shares of antidilutive security excluded from computation of diluted earnings per share (in shares) | 1.0 | 3.3 | 1.2 |
Weighted average exercise price of options excluded from computation of diluted earnings per share (in dollars per share) | $ 102.54 | $ 82.06 | $ 102.84 |
Antidilutive stock options due to net loss available to holders of Common Stock | |||
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] | |||
Weighted average shares of antidilutive security excluded from computation of diluted earnings per share (in shares) | 0.0 | 0.4 | 0.0 |
Antidilutive shares based on application of the treasury stock method | |||
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] | |||
Weighted average shares of antidilutive security excluded from computation of diluted earnings per share (in shares) | 0.0 | 0.2 | 0.0 |
Antidilutive shares due to net loss available to holders of Common Stock | |||
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] | |||
Weighted average shares of antidilutive security excluded from computation of diluted earnings per share (in shares) | 0.0 | 1.6 | 0.0 |
Share-Based Payments (Narrative) (Details) - USD ($) $ / shares in Units, $ in Thousands |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||
Tax benefit realized for exercises of stock options | $ 12,000 | $ 3,000 | $ 5,000 |
Tax benefit realized upon vesting of restricted stock shares, restricted stock units, and performance shares | 30,000 | 44,000 | 52,000 |
Cash used to settle performance units | 1,000 | 2,000 | 32,000 |
Assurance IQ | |||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||
Tax benefit realized for exercises of stock options | $ 4,000 | $ 3,000 | $ 2,000 |
Omnibus Incentive Plan | |||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||
Authorized shares remain available for grant including previously authorized but unissued shares under the Option Plan | 12,362,031 | ||
Employee stock options | |||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||
Maximum term of stock option granted (in years) | 10 years | ||
Vesting period | 3 years | ||
Weighed Average grant date fair value of stock options granted (in dollars per share) | $ 18.00 | $ 20.02 | |
The total intrinsic value of stock options exercised | $ 48,000 | $ 13,000 | $ 21,000 |
Unrecognized Compensation Cost | $ 1,000 | ||
Weighted Average Recognition Period (in years) | 1 year 21 days | ||
Granted (in shares) | 0 | ||
Employee stock options | Assurance IQ | |||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||
Maximum term of stock option granted (in years) | 10 years | ||
Vesting period | 3 years | ||
Weighed Average grant date fair value of stock options granted (in dollars per share) | $ 0 | $ 0 | $ 86.31 |
The total intrinsic value of stock options exercised | $ 15,000 | $ 10,000 | $ 3,000 |
Unrecognized Compensation Cost | $ 13,000 | ||
Weighted Average Recognition Period (in years) | 1 year 2 months 26 days | ||
Granted (in shares) | 0 | ||
Employee Restricted Stock Restricted Units And Performance Shares | |||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||
The fair market value of share awards released | $ 155,000 | 191,000 | 255,000 |
Unrecognized Compensation Cost | $ 170,000 | ||
Weighted Average Recognition Period (in years) | 1 year 9 months 3 days | ||
Employee Restricted Stock Restricted Units And Performance Shares | Assurance IQ | |||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||
The fair market value of share awards released | $ 3,000 | $ 2,000 | $ 0 |
Unrecognized Compensation Cost | $ 3,980 | ||
Weighted Average Recognition Period (in years) | 2 years 2 months 1 day | ||
Employee restricted stock units | |||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||
Granted (in dollars per share) | $ 81.82 | $ 93.88 | $ 93.35 |
Employee restricted stock units | Assurance IQ | |||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||
Granted (in dollars per share) | 0 | 0 | 87.67 |
Employee performance shares and performance units | |||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||
Granted (in dollars per share) | 81.43 | 95.42 | 90.68 |
Employee performance shares and performance units | Assurance IQ | |||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||
Granted (in dollars per share) | $ 0.00 | $ 63.30 | $ 89.91 |
Tax benefit realized upon vesting of restricted stock shares, restricted stock units, and performance shares | $ 1,000 | $ 1,000 |
Share-Based Payments (Weighted Average Grant Date Assumptions Used in Binomial Optional Valuation Model) (Details) |
12 Months Ended | |
---|---|---|
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Share-based Payment Arrangement [Abstract] | ||
Expected volatility | 33.99% | 34.63% |
Expected dividend yield | 4.59% | 4.26% |
Expected term | 5 years 7 months 6 days | 5 years 6 months 14 days |
Risk-free interest rate | 1.42% | 2.50% |
Share-Based Payments (Compensation Cost Recognized and Related Income Tax Benefit for Stock Options, Restricted Stock Shares, Restricted Stock Units, and Performance Share Awards) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||
Total Compensation Cost Recognized | $ 268 | $ 226 | $ 231 |
Income Tax Benefit | 61 | 53 | 55 |
Assurance IQ | |||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||
Total Compensation Cost Recognized | 16 | 16 | |
Income Tax Benefit | 3 | 5 | |
Employee stock options | |||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||
Total Compensation Cost Recognized | 2 | 11 | 11 |
Income Tax Benefit | 0 | 3 | 3 |
Employee stock options | Assurance IQ | |||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||
Total Compensation Cost Recognized | 14 | 14 | |
Income Tax Benefit | 3 | 4 | |
Employee restricted stock units | |||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||
Total Compensation Cost Recognized | 178 | 162 | 149 |
Income Tax Benefit | 41 | 38 | 35 |
Employee restricted stock units | Assurance IQ | |||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||
Total Compensation Cost Recognized | 2 | 2 | |
Income Tax Benefit | 0 | 1 | |
Employee performance shares and performance units | |||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||
Total Compensation Cost Recognized | 88 | 53 | 71 |
Income Tax Benefit | 20 | 12 | $ 17 |
Employee performance shares and performance units | Assurance IQ | |||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||
Total Compensation Cost Recognized | 0 | 0 | |
Income Tax Benefit | $ 0 | $ 0 |
Share-Based Payments (Summary of the Status of the Company's Employee Stock Option Grants) (Details) - Employee stock options |
12 Months Ended |
---|---|
Dec. 31, 2021
$ / shares
shares
| |
Shares | |
Outstanding (in shares) | shares | 4,563,852 |
Granted (in shares) | shares | 0 |
Exercised (in shares) | shares | (1,505,572) |
Forfeited (in shares) | shares | (8,057) |
Expired (in shares) | shares | (16,120) |
Outstanding (in shares) | shares | 3,034,103 |
Exercisable (in shares) | shares | 2,445,731 |
Weighted Average Exercise Price | |
Outstanding (in dollars per share) | $ / shares | $ 81.21 |
Granted (in dollars per share) | $ / shares | 0.00 |
Exercised (in dollars per share) | $ / shares | 68.33 |
Forfeited (in dollars per share) | $ / shares | 95.11 |
Expired (in dollars per share) | $ / shares | 85.31 |
Outstanding (in dollars per share) | $ / shares | 87.54 |
Exercisable (in dollars per share) | $ / shares | $ 85.72 |
Assurance IQ | |
Shares | |
Outstanding (in shares) | shares | 394,266 |
Granted (in shares) | shares | 0 |
Exercised (in shares) | shares | (155,818) |
Forfeited (in shares) | shares | (26,927) |
Expired (in shares) | shares | (59) |
Outstanding (in shares) | shares | 211,462 |
Exercisable (in shares) | shares | 54,618 |
Weighted Average Exercise Price | |
Outstanding (in dollars per share) | $ / shares | $ 1.60 |
Granted (in dollars per share) | $ / shares | 0.00 |
Exercised (in dollars per share) | $ / shares | 0.93 |
Forfeited (in dollars per share) | $ / shares | 1.38 |
Expired (in dollars per share) | $ / shares | 0.81 |
Outstanding (in dollars per share) | $ / shares | 2.12 |
Exercisable (in dollars per share) | $ / shares | $ 4.91 |
Share-Based Payments (Weighted Average Remaining Contractual Term and Aggregate Intrinsic Value of Stock Options Outstanding, Vested and Expected to Vest, and Exercisable) (Details) - Employee stock options $ in Millions |
12 Months Ended |
---|---|
Dec. 31, 2021
USD ($)
| |
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |
Outstanding, Weighted Average Remaining Contractual Term | 4 years 3 months 25 days |
Exercisable, Weighted Average Remaining Contractual Term | 3 years 8 months 8 days |
Outstanding, Aggregate Intrinsic Value | $ 64 |
Exercisable, Aggregate Intrinsic Value | $ 56 |
Assurance IQ | |
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |
Outstanding, Weighted Average Remaining Contractual Term | 6 years 7 months 9 days |
Exercisable, Weighted Average Remaining Contractual Term | 7 years 18 days |
Outstanding, Aggregate Intrinsic Value | $ 22 |
Exercisable, Aggregate Intrinsic Value | $ 6 |
Share-Based Payments (Summary of the Company's Employee Restricted Stock Shares, Restricted Stock Units and Performance Shares (Details) - USD ($) $ / shares in Units, $ in Millions |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Minimum | |||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||
Number of shares to be awarded at the end of each performance period | 0.00% | ||
Maximum | |||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||
Number of shares to be awarded at the end of each performance period | 150.00% | ||
Employee restricted stock units | |||
Restricted Awards | |||
Restricted (in shares) | 4,758,239 | ||
Granted (in shares) | 2,601,617 | ||
Forfeited (in shares) | (278,416) | ||
Performance adjustment (in shares) | 0 | ||
Released (in shares) | (1,278,051) | ||
Restricted (in shares) | 5,803,389 | 4,758,239 | |
Weighted Average Grant Date Fair Value | |||
Restricted (in dollars per share) | $ 96.87 | ||
Granted (in dollars per share) | 81.82 | $ 93.88 | $ 93.35 |
Forfeited (in dollars per share) | 88.41 | ||
Performance adjustment (in dollars per share) | 0.00 | ||
Released (in dollars per share) | 105.52 | ||
Restricted (in dollars per share) | $ 88.62 | $ 96.87 | |
Employee performance shares and performance units | |||
Restricted Awards | |||
Restricted (in shares) | 1,905,640 | ||
Granted (in shares) | 867,578 | ||
Forfeited (in shares) | (41,356) | ||
Performance adjustment (in shares) | 17,692 | ||
Released (in shares) | (590,064) | ||
Restricted (in shares) | 2,159,490 | 1,905,640 | |
Weighted Average Grant Date Fair Value | |||
Restricted (in dollars per share) | $ 92.07 | ||
Granted (in dollars per share) | 81.43 | $ 95.42 | 90.68 |
Forfeited (in dollars per share) | 97.42 | ||
Performance adjustment (in dollars per share) | 89.70 | ||
Released (in dollars per share) | 89.84 | ||
Restricted (in dollars per share) | $ 88.46 | $ 92.07 | |
Assurance IQ | Minimum | |||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||
Number of shares to be awarded at the end of each performance period | 0.00% | ||
Variable profit sharing | $ 900 | ||
Assurance IQ | Maximum | |||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||
Number of shares to be awarded at the end of each performance period | 100.00% | ||
Variable profit sharing | $ 1,300 | ||
Assurance IQ | Employee restricted stock units | |||
Restricted Awards | |||
Restricted (in shares) | 72,697 | ||
Granted (in shares) | 0 | ||
Forfeited (in shares) | (6,415) | ||
Performance adjustment (in shares) | 0 | ||
Released (in shares) | (29,470) | ||
Restricted (in shares) | 36,812 | 72,697 | |
Weighted Average Grant Date Fair Value | |||
Restricted (in dollars per share) | $ 87.67 | ||
Granted (in dollars per share) | 0 | $ 0 | 87.67 |
Forfeited (in dollars per share) | 87.67 | ||
Performance adjustment (in dollars per share) | 0.00 | ||
Released (in dollars per share) | 87.67 | ||
Restricted (in dollars per share) | $ 87.67 | $ 87.67 | |
Assurance IQ | Employee performance shares and performance units | |||
Restricted Awards | |||
Restricted (in shares) | 2,065,995 | ||
Granted (in shares) | 0 | ||
Forfeited (in shares) | (738,059) | ||
Performance adjustment (in shares) | 0 | ||
Released (in shares) | 0 | ||
Restricted (in shares) | 1,327,936 | 2,065,995 | |
Weighted Average Grant Date Fair Value | |||
Restricted (in dollars per share) | $ 88.43 | ||
Granted (in dollars per share) | 0.00 | $ 63.30 | $ 89.91 |
Forfeited (in dollars per share) | 88.22 | ||
Performance adjustment (in dollars per share) | 0.00 | ||
Released (in dollars per share) | 0.00 | ||
Restricted (in dollars per share) | $ 88.50 | $ 88.43 |
Segment Information (Narrative) (Details) $ in Millions |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021
USD ($)
segment
|
Dec. 31, 2020
USD ($)
|
Dec. 31, 2019
USD ($)
|
|
Segment Reporting Information [Line Items] | |||
Number of Reportable Segments | segment | 8 | ||
Total deferred gain (loss) | $ 1,099 | ||
Synthetic Gic Fees | 111 | $ 113 | $ 125 |
Segment Reconciling Items | |||
Segment Reporting Information [Line Items] | |||
Derivative, Gain (Loss) on Derivative, Net, Terminated Or Offset Before Maturity | $ 66 | $ 45 | $ 44 |
Segment Information (Operating Income of Reportable Segments) (Reconciling Items) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Segment Reporting Information [Line Items] | |||
(Gains) Losses On Assets Supporting Experience-Rated Contractholder Liabilities, Net | $ (299) | $ 743 | $ 971 |
Impairments | (1,060) | ||
Assurance IQ | |||
Segment Reporting Information [Line Items] | |||
Impairments | (1,060) | ||
Segment Reconciling Items | |||
Segment Reporting Information [Line Items] | |||
Terminated hedges of foreign currency earnings | 72 | 64 | |
Current period yield adjustments | 293 | 277 | |
Principal source of earnings | 57 | (37) | |
Investments carried at fair value through net income | (123) | 149 | 488 |
Foreign currency exchange movements | 22 | (14) | 30 |
Other activities | $ (33) | $ (39) | $ (30) |
Segment Information (Operating Income of Reportable Segments) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items] | |||
Income (loss) before income taxes and equity in earnings of operating joint ventures | $ 9,381 | $ (323) | $ 5,085 |
Operating Segments | |||
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items] | |||
Income (loss) before income taxes and equity in earnings of operating joint ventures | 7,301 | 4,950 | 5,655 |
Operating Segments | PGIM | PGIM | |||
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items] | |||
Income (loss) before income taxes and equity in earnings of operating joint ventures | 1,643 | 1,262 | 998 |
Operating Segments | Total International Insurance division | International Businesses | |||
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items] | |||
Income (loss) before income taxes and equity in earnings of operating joint ventures | 3,390 | 2,952 | 3,112 |
Operating Segments | U.S. Businesses Division | Retirement | |||
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items] | |||
Income (loss) before income taxes and equity in earnings of operating joint ventures | 2,178 | 1,385 | 1,238 |
Operating Segments | U.S. Businesses Division | Group Insurance | |||
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items] | |||
Income (loss) before income taxes and equity in earnings of operating joint ventures | (455) | (16) | 285 |
Operating Segments | U.S. Businesses Division | Individual Annuities | |||
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items] | |||
Income (loss) before income taxes and equity in earnings of operating joint ventures | 1,901 | 1,470 | 1,843 |
Operating Segments | U.S. Businesses Division | Individual Life | |||
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items] | |||
Income (loss) before income taxes and equity in earnings of operating joint ventures | 393 | (48) | 87 |
Operating Segments | U.S. Businesses Division | Assurance IQ | |||
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items] | |||
Income (loss) before income taxes and equity in earnings of operating joint ventures | (142) | (88) | (9) |
Operating Segments | Total Corporate and Other | Total Corporate and Other | |||
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items] | |||
Income (loss) before income taxes and equity in earnings of operating joint ventures | (1,607) | (1,967) | (1,899) |
Segment Reconciling Items | Realized investment gains (losses), net, and related adjustments | |||
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items] | |||
Income (loss) before income taxes and equity in earnings of operating joint ventures | 1,947 | (4,140) | (876) |
Segment Reconciling Items | Charges related to realized investment gains (losses), net | |||
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items] | |||
Income (loss) before income taxes and equity in earnings of operating joint ventures | (320) | (160) | (123) |
Segment Reconciling Items | Segment Reconciling Items, Market Experience Updates | |||
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items] | |||
Income (loss) before income taxes and equity in earnings of operating joint ventures | 750 | (640) | (449) |
Segment Reconciling Items | Segment Reconciling Items, Other Adjustments | |||
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items] | |||
Income (loss) before income taxes and equity in earnings of operating joint ventures | (1,112) | 51 | (47) |
Segment Reconciling Items | Equity in earnings of operating joint ventures and earnings attributable to noncontrolling interests | |||
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items] | |||
Income (loss) before income taxes and equity in earnings of operating joint ventures | (41) | 90 | (103) |
Segment Reconciling Items | Closed Block division | |||
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items] | |||
Income (loss) before income taxes and equity in earnings of operating joint ventures | 140 | (24) | 36 |
Segment Reconciling Items | Other Divested and Run-off Businesses | |||
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items] | |||
Income (loss) before income taxes and equity in earnings of operating joint ventures | 716 | (450) | 992 |
U.S. Businesses | Operating Segments | |||
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items] | |||
Income (loss) before income taxes and equity in earnings of operating joint ventures | $ 3,875 | $ 2,703 | $ 3,444 |
Segment Information (Certain Financial Information for the Reportable Segments) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Segment Reporting Information [Line Items] | |||
Assets | $ 937,582 | $ 940,722 | |
Revenues | 70,934 | 57,033 | $ 64,807 |
Net Investment Income | 18,287 | 17,410 | 17,585 |
Total benefits and expenses | 61,553 | 57,356 | 59,722 |
Policyholders’ Benefits | 38,458 | 35,059 | 36,820 |
Interest Credited to Policyholders’ Account Balances | 3,482 | 4,538 | 4,880 |
Dividends to Policyholders | 2,874 | 1,625 | 2,274 |
Interest expense | 1,478 | 1,560 | 1,551 |
Amortization of DAC | 2,097 | 2,221 | 2,332 |
Closed Block Business | Closed Block division | |||
Segment Reporting Information [Line Items] | |||
Revenues | 5,947 | 4,766 | 5,642 |
Net Investment Income | 2,500 | 2,240 | 2,323 |
Total benefits and expenses | 5,807 | 4,790 | 5,606 |
Policyholders’ Benefits | 2,557 | 2,757 | 2,907 |
Interest Credited to Policyholders’ Account Balances | 124 | 127 | 130 |
Dividends to Policyholders | 2,794 | 1,549 | 2,187 |
Interest expense | 0 | 1 | 7 |
Amortization of DAC | 21 | 26 | 29 |
Operating Segments | |||
Segment Reporting Information [Line Items] | |||
Revenues | 59,781 | 52,282 | 53,932 |
Net Investment Income | 14,160 | 13,132 | 12,973 |
Total benefits and expenses | 52,480 | 47,332 | 48,277 |
Policyholders’ Benefits | 35,287 | 29,924 | 31,491 |
Interest Credited to Policyholders’ Account Balances | 2,683 | 2,781 | 2,867 |
Dividends to Policyholders | 81 | 76 | 84 |
Interest expense | 1,474 | 1,551 | 1,531 |
Amortization of DAC | 2,080 | 2,078 | 2,201 |
Operating Segments | Other Divested and Run-off Businesses | |||
Segment Reporting Information [Line Items] | |||
Revenues | 2,903 | 4,420 | 6,324 |
Net Investment Income | 1,667 | 2,077 | 2,323 |
Total benefits and expenses | 2,187 | 4,870 | 5,332 |
Policyholders’ Benefits | 979 | 2,117 | 2,367 |
Interest Credited to Policyholders’ Account Balances | 270 | 1,599 | 1,706 |
Dividends to Policyholders | (1) | 0 | 3 |
Interest expense | 4 | 8 | 13 |
Amortization of DAC | 6 | 100 | 145 |
Operating Segments | PGIM | PGIM | |||
Segment Reporting Information [Line Items] | |||
Assets | 53,566 | 48,680 | |
Revenues | 4,493 | 4,153 | 3,589 |
Net Investment Income | 157 | 304 | 200 |
Total benefits and expenses | 2,850 | 2,891 | 2,591 |
Policyholders’ Benefits | 0 | 0 | 0 |
Interest Credited to Policyholders’ Account Balances | 0 | 0 | 0 |
Dividends to Policyholders | 0 | 0 | 0 |
Interest expense | 25 | 19 | 49 |
Amortization of DAC | 6 | 8 | 6 |
Operating Segments | Total International Insurance division | International Businesses | |||
Segment Reporting Information [Line Items] | |||
Assets | 222,736 | 231,128 | |
Revenues | 21,915 | 21,576 | 20,936 |
Net Investment Income | 5,403 | 4,982 | 4,944 |
Total benefits and expenses | 18,525 | 18,624 | 17,824 |
Policyholders’ Benefits | 13,804 | 13,714 | 12,925 |
Interest Credited to Policyholders’ Account Balances | 799 | 851 | 876 |
Dividends to Policyholders | 46 | 40 | 46 |
Interest expense | 6 | 8 | 25 |
Amortization of DAC | 1,148 | 1,204 | 1,116 |
Operating Segments | Corporate and Other | Corporate and Other | |||
Segment Reporting Information [Line Items] | |||
Revenues | (511) | (513) | (557) |
Net Investment Income | 664 | 660 | 701 |
Total benefits and expenses | 1,096 | 1,454 | 1,342 |
Policyholders’ Benefits | (24) | 30 | 36 |
Interest Credited to Policyholders’ Account Balances | 135 | 129 | 125 |
Dividends to Policyholders | 0 | 0 | 0 |
Interest expense | 645 | 668 | 518 |
Amortization of DAC | (55) | (49) | (46) |
Operating Segments | U.S. Businesses Division | Retirement | |||
Segment Reporting Information [Line Items] | |||
Assets | 114,016 | 115,237 | |
Revenues | 15,298 | 10,051 | 13,003 |
Net Investment Income | 3,921 | 3,446 | 3,401 |
Total benefits and expenses | 13,120 | 8,666 | 11,765 |
Policyholders’ Benefits | 12,525 | 8,009 | 11,060 |
Interest Credited to Policyholders’ Account Balances | 348 | 410 | 416 |
Dividends to Policyholders | 0 | 0 | 0 |
Interest expense | 14 | 20 | 40 |
Amortization of DAC | 22 | 16 | 28 |
Operating Segments | U.S. Businesses Division | Group Insurance | |||
Segment Reporting Information [Line Items] | |||
Assets | 43,286 | 45,601 | |
Revenues | 6,217 | 5,786 | 5,750 |
Net Investment Income | 538 | 526 | 624 |
Total benefits and expenses | 6,672 | 5,802 | 5,465 |
Policyholders’ Benefits | 5,482 | 4,664 | 4,257 |
Interest Credited to Policyholders’ Account Balances | 171 | 206 | 286 |
Dividends to Policyholders | 0 | 0 | 0 |
Interest expense | 3 | 3 | 2 |
Amortization of DAC | 5 | 8 | 7 |
Operating Segments | U.S. Businesses Division | Individual Annuities | |||
Segment Reporting Information [Line Items] | |||
Assets | 201,273 | 200,718 | |
Revenues | 4,914 | 4,440 | 4,995 |
Net Investment Income | 925 | 898 | 856 |
Total benefits and expenses | 3,013 | 2,970 | 3,152 |
Policyholders’ Benefits | 281 | 337 | 435 |
Interest Credited to Policyholders’ Account Balances | 359 | 337 | 334 |
Dividends to Policyholders | 0 | 0 | 0 |
Interest expense | 18 | 59 | 122 |
Amortization of DAC | 559 | 524 | 513 |
Operating Segments | U.S. Businesses Division | Individual Life | |||
Segment Reporting Information [Line Items] | |||
Assets | 118,237 | 110,953 | |
Revenues | 6,897 | 6,398 | 6,115 |
Net Investment Income | 2,550 | 2,314 | 2,247 |
Total benefits and expenses | 6,504 | 6,446 | 6,028 |
Policyholders’ Benefits | 3,219 | 3,170 | 2,778 |
Interest Credited to Policyholders’ Account Balances | 871 | 848 | 830 |
Dividends to Policyholders | 35 | 36 | 38 |
Interest expense | 752 | 769 | 774 |
Amortization of DAC | 395 | 367 | 577 |
Operating Segments | U.S. Businesses Division | Assurance IQ | |||
Segment Reporting Information [Line Items] | |||
Assets | 1,788 | 2,703 | |
Revenues | 558 | 391 | 101 |
Net Investment Income | 2 | 2 | 0 |
Total benefits and expenses | 700 | 479 | 110 |
Policyholders’ Benefits | 0 | 0 | 0 |
Interest Credited to Policyholders’ Account Balances | 0 | 0 | 0 |
Dividends to Policyholders | 0 | 0 | 0 |
Interest expense | 11 | 5 | 1 |
Amortization of DAC | 0 | 0 | 0 |
Operating Segments | Total Corporate and Other | Corporate and Other | |||
Segment Reporting Information [Line Items] | |||
Assets | 122,701 | 123,613 | |
Operating Segments | Total Closed Block division | Closed Block division | |||
Segment Reporting Information [Line Items] | |||
Assets | 59,979 | 62,089 | |
Segment Reconciling Items | Realized investment gains (losses), net, and related adjustments | |||
Segment Reporting Information [Line Items] | |||
Revenues | 2,313 | (4,072) | (609) |
Net Investment Income | (40) | (39) | (34) |
Total benefits and expenses | 366 | 68 | 267 |
Policyholders’ Benefits | 0 | 0 | 0 |
Interest Credited to Policyholders’ Account Balances | 366 | 68 | 267 |
Dividends to Policyholders | 0 | 0 | 0 |
Interest expense | 0 | 0 | 0 |
Amortization of DAC | 0 | 0 | 0 |
Segment Reconciling Items | Charges related to realized investment gains (losses), net | |||
Segment Reporting Information [Line Items] | |||
Revenues | (248) | (134) | (252) |
Net Investment Income | 0 | 0 | 0 |
Total benefits and expenses | 72 | 26 | (129) |
Policyholders’ Benefits | (165) | 0 | (136) |
Interest Credited to Policyholders’ Account Balances | 84 | (58) | (94) |
Dividends to Policyholders | 0 | 0 | 0 |
Interest expense | 0 | 0 | 0 |
Amortization of DAC | 153 | (115) | (182) |
Segment Reconciling Items | Segment Reconciling Items, Market Experience Updates | |||
Segment Reporting Information [Line Items] | |||
Revenues | 335 | (196) | (79) |
Net Investment Income | 0 | 0 | 0 |
Total benefits and expenses | (415) | 444 | 370 |
Policyholders’ Benefits | (200) | 261 | 191 |
Interest Credited to Policyholders’ Account Balances | (45) | 21 | 4 |
Dividends to Policyholders | 0 | 0 | 0 |
Interest expense | 0 | 0 | 0 |
Amortization of DAC | (163) | 132 | 139 |
Segment Reconciling Items | Segment Reconciling Items, Other Adjustments | |||
Segment Reporting Information [Line Items] | |||
Revenues | 0 | 105 | (5) |
Net Investment Income | 0 | 0 | 0 |
Total benefits and expenses | 1,112 | 54 | 42 |
Policyholders’ Benefits | 0 | 0 | 0 |
Interest Credited to Policyholders’ Account Balances | 0 | 0 | 0 |
Dividends to Policyholders | 0 | 0 | 0 |
Interest expense | 0 | 0 | 0 |
Amortization of DAC | 0 | 0 | 0 |
Segment Reconciling Items | Equity in earnings of operating joint ventures and earnings attributable to noncontrolling interests | |||
Segment Reporting Information [Line Items] | |||
Revenues | (97) | (138) | (146) |
Net Investment Income | 0 | 0 | 0 |
Total benefits and expenses | (56) | (228) | (43) |
Policyholders’ Benefits | 0 | 0 | 0 |
Interest Credited to Policyholders’ Account Balances | 0 | 0 | 0 |
Dividends to Policyholders | 0 | 0 | 0 |
Interest expense | 0 | 0 | 0 |
Amortization of DAC | 0 | 0 | 0 |
U.S. Businesses | Operating Segments | |||
Segment Reporting Information [Line Items] | |||
Assets | 478,600 | 475,212 | |
Revenues | 33,884 | 27,066 | 29,964 |
Net Investment Income | 7,936 | 7,186 | 7,128 |
Total benefits and expenses | 30,009 | 24,363 | 26,520 |
Policyholders’ Benefits | 21,507 | 16,180 | 18,530 |
Interest Credited to Policyholders’ Account Balances | 1,749 | 1,801 | 1,866 |
Dividends to Policyholders | 35 | 36 | 38 |
Interest expense | 798 | 856 | 939 |
Amortization of DAC | $ 981 | $ 915 | $ 1,125 |
Segment Information (Revenues and Asset Management Revenues) (Details) - USD ($) $ in Millions |
12 Months Ended | ||||||
---|---|---|---|---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|||||
Segment Reporting Information [Line Items] | |||||||
Asset management and service fees | $ 4,901 | $ 4,391 | $ 4,239 | ||||
Total revenues | 70,934 | 57,033 | 64,807 | ||||
PGIM | PGIM | Intersegment Eliminations | |||||||
Segment Reporting Information [Line Items] | |||||||
Total revenues | 939 | 866 | 777 | ||||
United States | |||||||
Segment Reporting Information [Line Items] | |||||||
Total revenues | 45,286 | 30,803 | [1] | 38,043 | [1] | ||
Japan | |||||||
Segment Reporting Information [Line Items] | |||||||
Total revenues | 18,852 | 20,028 | [1] | 19,771 | [1] | ||
Other Countries | |||||||
Segment Reporting Information [Line Items] | |||||||
Total revenues | 6,796 | 6,202 | [1] | 6,993 | [1] | ||
Management Service, Base | |||||||
Segment Reporting Information [Line Items] | |||||||
Asset management and service fees | 4,111 | 3,615 | 3,489 | ||||
Management Service, Incentive | |||||||
Segment Reporting Information [Line Items] | |||||||
Asset management and service fees | 147 | 193 | 169 | ||||
Financial Service, Other | |||||||
Segment Reporting Information [Line Items] | |||||||
Asset management and service fees | $ 643 | $ 583 | $ 581 | ||||
|
Commitments and Contingent Liabilities (Details) - USD ($) $ in Millions |
12 Months Ended | |
---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
|
Commitments and Contingent Liabilities [Line Items] | ||
Fair value of collateral supporting these assets | $ 802 | $ 806 |
Other assets: | ||
Premium tax offset for future undiscounted assessments | 40 | 44 |
Premium tax offset currently available for paid assessments | 2 | 3 |
Total | 42 | 47 |
Other liabilities: | ||
Insolvency assessments | 35 | 36 |
Commitments | Commercial Mortgage Loans | ||
Commitments and Contingent Liabilities [Line Items] | ||
Total outstanding mortgage loan commitments | 2,300 | 2,357 |
Portion of commitment where prearrangement to sell to investor exists | 1,102 | 882 |
Allowance for credit losses | 1 | 0 |
Change in allowance for credit loss expense (reversal) | 0 | (2) |
Commitments | Commercial Mortgage Loans | Held-for-sale | ||
Commitments and Contingent Liabilities [Line Items] | ||
Total outstanding mortgage loan commitments | 21 | |
Expected to be funded from the GA and other operations outside the SA | ||
Commitments and Contingent Liabilities [Line Items] | ||
Commitments to Purchase Investment (excluding Commercial Mortgage Loans) | 10,347 | 9,567 |
Expected to be funded from the GA and other operations outside the SA | Held-for-sale | ||
Commitments and Contingent Liabilities [Line Items] | ||
Commitments to Purchase Investment (excluding Commercial Mortgage Loans) | 118 | |
Expected to be funded from separate accounts | ||
Commitments and Contingent Liabilities [Line Items] | ||
Commitments to Purchase Investment (excluding Commercial Mortgage Loans) | 236 | 336 |
Indemnification | Securities Lending and Securities Repurchase Transactions | ||
Commitments and Contingent Liabilities [Line Items] | ||
Indemnification provided to certain clients for securities lending and securities repurchase transactions | 6,499 | 7,108 |
Fair value of related collateral associated with above indemnifications | 6,635 | 7,254 |
Accrued Liability associated with guarantee | 0 | 0 |
Indemnification | Securities Repurchase Transactions | ||
Commitments and Contingent Liabilities [Line Items] | ||
Indemnification provided to certain clients for securities lending and securities repurchase transactions | 30 | 34 |
Fair value of related collateral associated with above indemnifications | 29 | 34 |
Indemnification | Serviced Mortgage Loans | ||
Commitments and Contingent Liabilities [Line Items] | ||
Maximum exposure under indemnification agreements for mortgage loans serviced by the Company | 2,930 | 2,684 |
First-loss exposure portion of above | 854 | 784 |
Accrued Liability associated with guarantee | 41 | 41 |
Allowance for credit losses | 20 | 20 |
Change in allowance for credit loss expense (reversal) | 0 | 1 |
Guarantee of Asset Values | ||
Commitments and Contingent Liabilities [Line Items] | ||
Guaranteed value of third parties’ assets | 81,984 | 86,264 |
Fair value of collateral supporting these assets | 83,609 | 90,612 |
Asset associated with guarantee, carried at fair value | 1 | 0 |
Other Guarantees | ||
Commitments and Contingent Liabilities [Line Items] | ||
Other guarantees where amount can be determined | 47 | 52 |
Accrued Liability associated with guarantee | $ 34 | $ 0 |
Commitments and Contingent Liabilities (Narrative Assurance IQ Contingent Consideration Liability) (Details) - USD ($) $ in Millions |
Dec. 31, 2021 |
Dec. 31, 2020 |
Oct. 31, 2019 |
---|---|---|---|
Acquisition of Assurance IQ, Inc. | |||
Business Acquisition [Line Items] | |||
Contingent consideration, liability | $ 0 | $ 0 | $ 100 |
Commitments and Contingent Liabilities (Narrative Excluding Litigation) (Details) $ in Millions |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021
USD ($)
|
Dec. 31, 2020
USD ($)
|
Dec. 31, 2019
USD ($)
|
|
Commitments | Commercial Mortgage Loans | |||
Commitments and Contingent Liabilities [Line Items] | |||
Allowance for credit losses | $ 1 | $ 0 | |
Change in allowance for credit loss expense (reversal) | 0 | (2) | |
Purchase Investments | |||
Commitments and Contingent Liabilities [Line Items] | |||
Change in allowance for credit loss expense (reversal) | $ 0 | 0 | |
Indemnification | Securities Lending and Securities Repurchase Transactions | |||
Commitments and Contingent Liabilities [Line Items] | |||
Guarantor Obligations, Liquidation Proceeds, Percentage | 102.00% | ||
Indemnification | Securities Repurchase Transactions | |||
Commitments and Contingent Liabilities [Line Items] | |||
Guarantor Obligations, Liquidation Proceeds, Percentage | 95.00% | ||
Indemnification | Serviced Mortgage Loans | |||
Commitments and Contingent Liabilities [Line Items] | |||
Allowance for credit losses | $ 20 | 20 | |
Change in allowance for credit loss expense (reversal) | 0 | 1 | |
Mortgages subject to loss-sharing arrangements | $ 22,963 | $ 21,465 | |
Weighted-average debt service coverage ratio of mortgages subject to loss-sharing arrangements | 1.93 | 1.99 | |
Weighted-average loan-to-value ratio of mortgages subject to loss-sharing arrangements | 63.00% | 63.00% | |
Losses related to indemnifications that were settled | $ 2 | $ 0 | $ 0 |
Indemnification | Minimum | Serviced Mortgage Loans | |||
Commitments and Contingent Liabilities [Line Items] | |||
Percentage share of losses incurred on certain loans serviced | 4.00% | ||
Indemnification | Maximum | Serviced Mortgage Loans | |||
Commitments and Contingent Liabilities [Line Items] | |||
Percentage share of losses incurred on certain loans serviced | 20.00% | ||
Yield maintenance guarantee | |||
Commitments and Contingent Liabilities [Line Items] | |||
Guarantees related to certain investments the Company sold | $ 0 | $ 9 |
Commitments and Contingent Liabilities (Litigation Narrative) (Details) $ in Millions |
1 Months Ended | ||
---|---|---|---|
Dec. 31, 2017
defendant
|
Dec. 31, 2021
USD ($)
|
May 31, 2014
defendant
|
|
Loss Contingencies [Line Items] | |||
Estimate of possible losses in excess of accruals (less than) for litigation and regulatory matters | $ | $ 250 | ||
Total Asset Recovery Services, LLC v. MetLife, Inc., and Prudential | Pending Litigation | |||
Loss Contingencies [Line Items] | |||
Loss Contingency, Number of Defendants | 19 | ||
London Interbank Offered Rate (LIBOR) | Positive Outcome of Litigation | |||
Loss Contingencies [Line Items] | |||
Number of defendants in legal action filed by the company | 10 |
Subsequent Events (Narrative) (Details) - $ / shares |
12 Months Ended | |||
---|---|---|---|---|
Feb. 03, 2022 |
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Subsequent Event [Line Items] | ||||
Dividends declared per share of Common Stock (in dollars per share) | $ 4.60 | $ 4.40 | $ 4.00 | |
Subsequent Event | ||||
Subsequent Event [Line Items] | ||||
Dividends declared per share of Common Stock (in dollars per share) | $ 1.20 |
Schedule I - Summary of Investments Other Than investments in Related Parties (Details) - USD ($) $ in Millions |
Dec. 31, 2021 |
Dec. 31, 2020 |
||
---|---|---|---|---|
Schedule of Investments [Line Items] | ||||
Commercial mortgage and other loans | [1] | $ 58,666 | $ 65,425 | |
Fixed Maturities, Available-for-sale, Amortized Cost | 333,459 | 354,470 | ||
Fixed Maturities, Available for Sale, Fair Value | [1] | 372,410 | 412,905 | |
Amortized Cost | [1] | 1,514 | 1,930 | |
Fixed Maturities, Held-to-maturity, Fair Value | 1,803 | 2,298 | ||
Equity securities, Fair Value | [1] | 8,574 | 8,135 | |
Fixed Maturities, Trading, amortized cost | 8,741 | 3,670 | ||
Fixed maturities, trading, at fair value | [1] | 8,823 | 3,914 | |
Assets supporting experience-rated contractholder liabilities, at amortized cost | 2,861 | 22,438 | ||
Assets supporting experience-rated contractholder liabilities, at fair value | 3,358 | 24,115 | ||
Commercial mortgage and other loans | 58,666 | 65,425 | ||
Policy loans | 10,386 | 11,271 | ||
Short-term investments | 6,635 | |||
Other invested assets | [1] | 21,833 | 18,125 | |
Total Investment at Cost | 449,915 | |||
Total investment | 492,199 | 553,620 | ||
Held-for-sale | ||||
Schedule of Investments [Line Items] | ||||
Commercial mortgage and other loans | 6,565 | |||
Fixed Maturities, Available-for-sale, Amortized Cost | 13,569 | |||
Equity securities, Fair Value | 322 | |||
Fixed Maturities, Trading, amortized cost | 401 | |||
Assets supporting experience-rated contractholder liabilities, at fair value | 18,818 | |||
Policy loans | 12 | |||
Other invested assets | 104 | |||
Total investment | 40,669 | |||
Fixed Maturities | ||||
Schedule of Investments [Line Items] | ||||
Fixed Maturities, Available-for-sale, Amortized Cost | 333,459 | 354,470 | ||
Fixed Maturities, Available for Sale, Fair Value | 372,410 | 412,905 | ||
Amortized Cost | 1,519 | 1,939 | ||
Fixed Maturities, Held-to-maturity, Fair Value | 1,803 | 2,298 | ||
Fixed maturities securities, HTM, AC in BS | 1,514 | 1,930 | ||
Assets supporting experience-rated contractholder liabilities, at amortized cost | 1,044 | 20,119 | ||
Assets supporting experience-rated contractholder liabilities, at fair value | 1,057 | 21,414 | ||
Equity securities | ||||
Schedule of Investments [Line Items] | ||||
Equity securities, at cost | 5,815 | |||
Equity securities, Fair Value | 8,574 | |||
Assets supporting experience-rated contractholder liabilities, at amortized cost | 1,787 | 1,661 | ||
Assets supporting experience-rated contractholder liabilities, at fair value | 2,271 | 2,043 | ||
Available-for-sale | Fixed Maturities | ||||
Schedule of Investments [Line Items] | ||||
Fixed Maturities, Available-for-sale, Amortized Cost | 333,459 | |||
Fixed Maturities, Available for Sale, Fair Value | 372,410 | |||
Held-to-maturity | Fixed Maturities | ||||
Schedule of Investments [Line Items] | ||||
Amortized Cost | 1,519 | |||
Fixed Maturities, Held-to-maturity, Fair Value | 1,803 | |||
Fixed maturities securities, HTM, AC in BS | 1,514 | |||
Trading | Fixed Maturities | ||||
Schedule of Investments [Line Items] | ||||
Fixed Maturities, Trading, amortized cost | 8,741 | |||
Fixed maturities, trading, at fair value | 8,823 | |||
U.S. Treasury securities and obligations of U.S. government authorities and agencies | Fixed Maturities | ||||
Schedule of Investments [Line Items] | ||||
Fixed Maturities, Available-for-sale, Amortized Cost | 26,231 | 30,766 | ||
Fixed Maturities, Available for Sale, Fair Value | 32,158 | 40,448 | ||
U.S. Treasury securities and obligations of U.S. government authorities and agencies | Available-for-sale | Fixed Maturities | ||||
Schedule of Investments [Line Items] | ||||
Fixed Maturities, Available-for-sale, Amortized Cost | 26,231 | |||
Fixed Maturities, Available for Sale, Fair Value | 32,158 | |||
Obligations of U.S. states and their political subdivisions | Fixed Maturities | ||||
Schedule of Investments [Line Items] | ||||
Fixed Maturities, Available-for-sale, Amortized Cost | 10,445 | 10,668 | ||
Fixed Maturities, Available for Sale, Fair Value | 12,218 | 12,811 | ||
Obligations of U.S. states and their political subdivisions | Available-for-sale | Fixed Maturities | ||||
Schedule of Investments [Line Items] | ||||
Fixed Maturities, Available-for-sale, Amortized Cost | 10,445 | |||
Fixed Maturities, Available for Sale, Fair Value | 12,218 | |||
Foreign governments | Available-for-sale | Fixed Maturities | ||||
Schedule of Investments [Line Items] | ||||
Fixed Maturities, Available-for-sale, Amortized Cost | 83,363 | |||
Fixed Maturities, Available for Sale, Fair Value | 94,669 | |||
Asset-backed securities | Fixed Maturities | ||||
Schedule of Investments [Line Items] | ||||
Fixed Maturities, Available-for-sale, Amortized Cost | 11,402 | 14,489 | ||
Fixed Maturities, Available for Sale, Fair Value | 11,525 | 14,591 | ||
Assets supporting experience-rated contractholder liabilities, at amortized cost | 0 | 1,665 | ||
Assets supporting experience-rated contractholder liabilities, at fair value | 0 | 1,697 | ||
Asset-backed securities | Available-for-sale | Fixed Maturities | ||||
Schedule of Investments [Line Items] | ||||
Fixed Maturities, Available-for-sale, Amortized Cost | 11,402 | |||
Fixed Maturities, Available for Sale, Fair Value | 11,525 | |||
Residential mortgage-backed securities | Fixed Maturities | ||||
Schedule of Investments [Line Items] | ||||
Fixed Maturities, Available-for-sale, Amortized Cost | 2,749 | 2,683 | ||
Fixed Maturities, Available for Sale, Fair Value | 2,858 | 2,887 | ||
Amortized Cost | 191 | 266 | ||
Fixed Maturities, Held-to-maturity, Fair Value | 205 | 286 | ||
Fixed maturities securities, HTM, AC in BS | 191 | 266 | ||
Assets supporting experience-rated contractholder liabilities, at amortized cost | 0 | 964 | ||
Assets supporting experience-rated contractholder liabilities, at fair value | 0 | 1,018 | ||
Residential mortgage-backed securities | Available-for-sale | Fixed Maturities | ||||
Schedule of Investments [Line Items] | ||||
Fixed Maturities, Available-for-sale, Amortized Cost | 2,749 | |||
Fixed Maturities, Available for Sale, Fair Value | 2,858 | |||
Residential mortgage-backed securities | Held-to-maturity | Fixed Maturities | ||||
Schedule of Investments [Line Items] | ||||
Amortized Cost | 191 | |||
Fixed Maturities, Held-to-maturity, Fair Value | 205 | |||
Fixed maturities securities, HTM, AC in BS | 191 | |||
Commercial Mortgage Backed Securities | Fixed Maturities | ||||
Schedule of Investments [Line Items] | ||||
Fixed Maturities, Available-for-sale, Amortized Cost | 12,490 | 15,036 | ||
Fixed Maturities, Available for Sale, Fair Value | 13,099 | 16,303 | ||
Assets supporting experience-rated contractholder liabilities, at amortized cost | 0 | 1,743 | ||
Assets supporting experience-rated contractholder liabilities, at fair value | 0 | 1,839 | ||
Commercial Mortgage Backed Securities | Available-for-sale | Fixed Maturities | ||||
Schedule of Investments [Line Items] | ||||
Fixed Maturities, Available-for-sale, Amortized Cost | 12,490 | |||
Fixed Maturities, Available for Sale, Fair Value | 13,099 | |||
Public utilities | Available-for-sale | Fixed Maturities | ||||
Schedule of Investments [Line Items] | ||||
Fixed Maturities, Available-for-sale, Amortized Cost | 26,993 | |||
Fixed Maturities, Available for Sale, Fair Value | 30,436 | |||
All other corporate bonds | Available-for-sale | Fixed Maturities | ||||
Schedule of Investments [Line Items] | ||||
Fixed Maturities, Available-for-sale, Amortized Cost | 159,363 | |||
Fixed Maturities, Available for Sale, Fair Value | 174,973 | |||
All other corporate bonds | Held-to-maturity | Fixed Maturities | ||||
Schedule of Investments [Line Items] | ||||
Amortized Cost | 495 | |||
Fixed Maturities, Held-to-maturity, Fair Value | 544 | |||
Fixed maturities securities, HTM, AC in BS | 490 | |||
Redeemable preferred stock | Available-for-sale | Fixed Maturities | ||||
Schedule of Investments [Line Items] | ||||
Fixed Maturities, Available-for-sale, Amortized Cost | 423 | |||
Fixed Maturities, Available for Sale, Fair Value | 474 | |||
Foreign government bonds | Fixed Maturities | ||||
Schedule of Investments [Line Items] | ||||
Fixed Maturities, Available-for-sale, Amortized Cost | 83,363 | 94,110 | ||
Fixed Maturities, Available for Sale, Fair Value | 94,669 | 110,244 | ||
Amortized Cost | 833 | 935 | ||
Fixed Maturities, Held-to-maturity, Fair Value | 1,054 | 1,205 | ||
Fixed maturities securities, HTM, AC in BS | 833 | 935 | ||
Assets supporting experience-rated contractholder liabilities, at amortized cost | 761 | 934 | ||
Assets supporting experience-rated contractholder liabilities, at fair value | 761 | $ 945 | ||
Foreign government bonds | Held-to-maturity | Fixed Maturities | ||||
Schedule of Investments [Line Items] | ||||
Amortized Cost | 833 | |||
Fixed Maturities, Held-to-maturity, Fair Value | 1,054 | |||
Fixed maturities securities, HTM, AC in BS | 833 | |||
Other common stocks | Equity securities | ||||
Schedule of Investments [Line Items] | ||||
Equity securities, at cost | 3,909 | |||
Equity securities, Fair Value | 5,850 | |||
Mutual funds | Equity securities | ||||
Schedule of Investments [Line Items] | ||||
Equity securities, at cost | 1,635 | |||
Equity securities, Fair Value | 2,366 | |||
Nonredeemable preferred stock | Equity securities | ||||
Schedule of Investments [Line Items] | ||||
Equity securities, at cost | 105 | |||
Equity securities, Fair Value | 146 | |||
Perpetual preferred stock | Equity securities | ||||
Schedule of Investments [Line Items] | ||||
Equity securities, at cost | 166 | |||
Equity securities, Fair Value | 212 | |||
Commercial mortgage and agricultural properties loans and other collateralized loans | ||||
Schedule of Investments [Line Items] | ||||
Commercial mortgage and other loans | 58,109 | |||
Uncollateralized loans | ||||
Schedule of Investments [Line Items] | ||||
Commercial mortgage and other loans | $ 557 | |||
|
Schedule II - Condensed Financial Information of Registrant (Condensed Statements of Financial Position) (Details) - USD ($) $ / shares in Units, $ in Millions |
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
Dec. 31, 2018 |
||||
---|---|---|---|---|---|---|---|---|
ASSETS | ||||||||
Fixed maturities, available for sale, at fair value (amortized cost: 2021- $1,052; 2020- $1,529) | [1] | $ 372,410 | $ 412,905 | |||||
Equity securities, at fair value (cost: 2021- $25; 2020- $25) | [1] | 8,574 | 8,135 | |||||
Other invested assets | [1] | 21,833 | 18,125 | |||||
Total investment | 492,199 | 553,620 | ||||||
Cash and cash equivalents | 12,888 | [1] | 13,701 | [1] | $ 16,327 | |||
Investment in subsidiaries | 1,317 | 1,394 | $ 1,309 | |||||
Other assets | [1] | 10,739 | 22,801 | |||||
TOTAL ASSETS | 937,582 | 940,722 | ||||||
LIABILITIES | ||||||||
Short-term debt | 722 | 925 | ||||||
Long-term debt | 18,622 | 19,718 | ||||||
Other liabilities | [1] | 11,755 | 20,323 | |||||
Total liabilities | 874,974 | 872,512 | ||||||
EQUITY | ||||||||
Preferred Stock ($0.01 par value; 10,000,000 shares authorized; none issued) | 0 | 0 | ||||||
Common Stock ($0.01 par value; 1,500,000,000 shares authorized; 666,305,189 shares issued as of December 31, 2021 and December 31, 2020) | 6 | 6 | ||||||
Additional paid-in capital | 25,732 | 25,584 | ||||||
Common Stock held in treasury, at cost (290,018,851 and 269,867,738 shares as of December 31, 2021 and 2020, respectively) | (21,838) | (19,652) | ||||||
Accumulated other comprehensive income (loss) | 21,324 | 30,738 | ||||||
Retained earnings | 36,652 | 30,749 | ||||||
Total equity | 61,876 | 67,425 | ||||||
Total liabilities and equity | 937,582 | 940,722 | ||||||
Fixed Maturities, Available-for-sale, Amortized Cost | $ 333,459 | $ 354,470 | ||||||
Preferred Stock, par value (in dollars per share) | $ 0.01 | $ 0.01 | ||||||
Preferred Stock, Shares Authorized | 10,000,000 | 10,000,000 | 10,000,000 | |||||
Preferred Stock, Shares Issued | 0 | 0 | ||||||
Common Stock, par value (in dollars per share) | $ 0.01 | $ 0.01 | ||||||
Common Stock, Shares Authorized | 1,500,000,000 | 1,500,000,000 | ||||||
Common Stock, Shares, Issued | 666,305,189 | 666,305,189 | ||||||
Treasury Stock, Shares | 290,018,851 | 269,867,738 | ||||||
Prudential Financial | ||||||||
ASSETS | ||||||||
Investment contracts from subsidiaries | $ 1 | $ 1 | ||||||
Fixed maturities, available for sale, at fair value (amortized cost: 2021- $1,052; 2020- $1,529) | 1,072 | 1,648 | ||||||
Equity securities, at fair value (cost: 2021- $25; 2020- $25) | 25 | 25 | ||||||
Other invested assets | 1,958 | 3,876 | ||||||
Total investment | 3,056 | 5,550 | ||||||
Cash and cash equivalents | 1,251 | 1,062 | $ 1,162 | $ 1,327 | ||||
Due from subsidiaries | 3,458 | 2,023 | ||||||
Loans receivable from subsidiaries | 7,876 | 8,027 | ||||||
Investment in subsidiaries | 73,097 | 78,345 | ||||||
Property, plant and equipment | 428 | 446 | ||||||
Income taxes receivable | 178 | 467 | ||||||
Other assets | 112 | 116 | ||||||
TOTAL ASSETS | 89,456 | 96,036 | ||||||
LIABILITIES | ||||||||
Due to subsidiaries | 3,899 | 3,290 | ||||||
Loans payable to subsidiaries | 5,396 | 5,526 | ||||||
Short-term debt | 25 | 424 | ||||||
Long-term debt | 17,673 | 18,561 | ||||||
Other liabilities | 587 | 810 | ||||||
Total liabilities | 27,580 | 28,611 | ||||||
EQUITY | ||||||||
Preferred Stock ($0.01 par value; 10,000,000 shares authorized; none issued) | 0 | 0 | ||||||
Common Stock ($0.01 par value; 1,500,000,000 shares authorized; 666,305,189 shares issued as of December 31, 2021 and December 31, 2020) | 6 | 6 | ||||||
Additional paid-in capital | 25,732 | 25,584 | ||||||
Common Stock held in treasury, at cost (290,018,851 and 269,867,738 shares as of December 31, 2021 and 2020, respectively) | (21,838) | (19,652) | ||||||
Accumulated other comprehensive income (loss) | 21,324 | 30,738 | ||||||
Retained earnings | 36,652 | 30,749 | ||||||
Total equity | 61,876 | 67,425 | ||||||
Total liabilities and equity | 89,456 | 96,036 | ||||||
Fixed Maturities, Available-for-sale, Amortized Cost | 1,052 | 1,529 | ||||||
Equity securities, at cost | $ 25 | $ 25 | ||||||
Preferred Stock, par value (in dollars per share) | $ 0.01 | $ 0.01 | ||||||
Preferred Stock, Shares Authorized | 10,000,000 | 10,000,000 | ||||||
Preferred Stock, Shares Issued | 0 | 0 | ||||||
Common Stock, par value (in dollars per share) | $ 0.01 | $ 0.01 | ||||||
Common Stock, Shares Authorized | 1,500,000,000 | 1,500,000,000 | ||||||
Common Stock, Shares, Issued | 666,305,189 | 666,305,189 | ||||||
Treasury Stock, Shares | 290,018,851 | 269,867,738 | ||||||
|
Schedule II - Condensed Financial Information of Registrant (Condensed Statements of Operations) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
REVENUES | |||
Net investment income | $ 18,287 | $ 17,410 | $ 17,585 |
Realized investment gains (losses), net | 4,024 | (3,887) | (459) |
Other income (loss) | 2,951 | 1,950 | 3,262 |
Total revenues | 70,934 | 57,033 | 64,807 |
EXPENSES | |||
Interest expense | 1,478 | 1,560 | 1,551 |
Income (loss) before income taxes and equity in earnings of operating joint ventures | 9,381 | (323) | 5,085 |
Total income tax expense (benefit) | 1,674 | (81) | 947 |
INCOME (LOSS) BEFORE EQUITY IN EARNINGS OF OPERATING JOINT VENTURES | 7,707 | (242) | 4,138 |
Equity in earnings of subsidiaries | 87 | 96 | 100 |
NET INCOME (LOSS) ATTRIBUTABLE TO PRUDENTIAL FINANCIAL, INC. | 7,724 | (374) | 4,186 |
Comprehensive income (loss) attributable to Prudential Financial, Inc. | (1,690) | 6,325 | 17,312 |
Prudential Financial | |||
REVENUES | |||
Net investment income | 62 | 97 | 203 |
Realized investment gains (losses), net | 90 | (262) | (250) |
Affiliated interest revenue | 358 | 345 | 362 |
Other income (loss) | 18 | 110 | 21 |
Total revenues | 528 | 290 | 336 |
EXPENSES | |||
General and administrative expenses | 166 | 273 | 92 |
Interest expense | 1,088 | 1,157 | 1,161 |
Total expenses | 1,254 | 1,430 | 1,253 |
Income (loss) before income taxes and equity in earnings of operating joint ventures | (726) | (1,140) | (917) |
Total income tax expense (benefit) | (130) | (357) | (223) |
INCOME (LOSS) BEFORE EQUITY IN EARNINGS OF OPERATING JOINT VENTURES | (596) | (783) | (694) |
Equity in earnings of subsidiaries | 8,320 | 409 | 4,880 |
NET INCOME (LOSS) ATTRIBUTABLE TO PRUDENTIAL FINANCIAL, INC. | 7,724 | (374) | 4,186 |
Other Comprehensive Income (loss) | (9,414) | 6,699 | 13,126 |
Comprehensive income (loss) attributable to Prudential Financial, Inc. | $ (1,690) | $ 6,325 | $ 17,312 |
Schedule II - Condensed Financial Information of Registrant (Condensed Statements of Cash Flow) (Details) - USD ($) $ in Millions |
12 Months Ended | ||||||
---|---|---|---|---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|||||
CASH FLOWS FROM OPERATING ACTIVITIES | |||||||
Net income (loss) | $ 7,794 | $ (146) | $ 4,238 | ||||
Adjustments to reconcile net income to cash provided by operating activities: | |||||||
Realized investment (gains) losses, net | (4,024) | 3,887 | 459 | ||||
Dividends received from subsidiaries | 116 | 60 | 70 | ||||
Change in: | |||||||
Other, operating | (1,524) | (3,884) | 1,671 | ||||
Cash flows from (used in) operating activities | 9,812 | 8,368 | 19,625 | ||||
Proceeds from the sale/maturity of: | |||||||
Fixed maturities, available-for-sale | 64,759 | 44,106 | 52,306 | ||||
Short-term investments | 32,696 | 47,339 | 38,095 | ||||
Payments for the purchase of: | |||||||
Fixed maturities, available-for-sale | (65,174) | (56,523) | (64,570) | ||||
Short-term investments | (32,329) | (49,802) | (37,286) | ||||
Other, investing | (596) | (278) | (437) | ||||
Cash flows from (used in) investing activities | (5,342) | (16,210) | (17,028) | ||||
CASH FLOWS FROM FINANCING ACTIVITIES | |||||||
Cash dividends paid on Common Stock | (1,814) | (1,766) | (1,641) | ||||
Common Stock acquired | (2,500) | (500) | (2,500) | ||||
Common Stock reissued for exercise of stock options | 200 | 153 | 133 | ||||
Proceeds from the issuance of debt (maturities longer than 90 days) | 268 | 3,013 | 2,993 | ||||
Repayments of debt (maturities longer than 90 days) | (1,708) | (2,743) | (1,429) | ||||
Net change in financing arrangements (maturities 90 days or less) | 297 | (21) | (181) | ||||
Other, financing | (364) | (456) | (181) | ||||
Cash flows from (used in) financing activities | (3,011) | 4,883 | (1,634) | ||||
CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR | 13,701 | [1] | 16,327 | ||||
CASH AND CASH EQUIVALENTS, END OF YEAR | 12,888 | [1] | 13,701 | [1] | 16,327 | ||
SUPPLEMENTAL CASH FLOW INFORMATION | |||||||
Cash paid (refunds received) during the period for taxes | 1,668 | 287 | 1,348 | ||||
Acquisitions | |||||||
Treasury Stock shares issued | 454 | ||||||
Prudential Financial | |||||||
CASH FLOWS FROM OPERATING ACTIVITIES | |||||||
Net income (loss) | 7,724 | (374) | 4,186 | ||||
Adjustments to reconcile net income to cash provided by operating activities: | |||||||
Equity in earnings of subsidiaries | (8,320) | (409) | (4,880) | ||||
Realized investment (gains) losses, net | (90) | 262 | 250 | ||||
Dividends received from subsidiaries | 3,239 | 4,042 | 2,269 | ||||
Property, plant and equipment | (4) | (1) | 0 | ||||
Change in: | |||||||
Due to/from subsidiaries, net | (513) | 649 | 669 | ||||
Other, operating | 63 | 359 | (229) | ||||
Cash flows from (used in) operating activities | 2,099 | 4,528 | 2,265 | ||||
Proceeds from the sale/maturity of: | |||||||
Fixed maturities, available-for-sale | 969 | 412 | 371 | ||||
Short-term investments | 15,718 | 18,489 | 21,700 | ||||
Payments for the purchase of: | |||||||
Fixed maturities, available-for-sale | (500) | (298) | (660) | ||||
Short-term investments | (13,795) | (20,039) | (20,486) | ||||
Capital contributions to subsidiaries | (874) | (386) | (593) | ||||
Returns of capital contributions from subsidiaries | 430 | 813 | 1,013 | ||||
Net cash paid on acquisition | 0 | 0 | (1,758) | ||||
Loans to subsidiaries, net of maturities | 151 | (876) | (108) | ||||
Other, investing | 7 | 0 | 0 | ||||
Cash flows from (used in) investing activities | 2,106 | (1,885) | (521) | ||||
CASH FLOWS FROM FINANCING ACTIVITIES | |||||||
Cash dividends paid on Common Stock | (1,814) | (1,766) | (1,641) | ||||
Common Stock acquired | (2,500) | (500) | (2,500) | ||||
Common Stock reissued for exercise of stock options | 200 | 153 | 133 | ||||
Proceeds from the issuance of debt (maturities longer than 90 days) | 0 | 2,768 | 2,465 | ||||
Repayments of debt (maturities longer than 90 days) | (1,308) | (2,467) | (1,114) | ||||
Repayments of loans from subsidiaries | 151 | (1,023) | (7) | ||||
Proceeds from loans payable to subsidiaries | 1,411 | 166 | 818 | ||||
Net change in financing arrangements (maturities 90 days or less) | 0 | 0 | 9 | ||||
Other, financing | (156) | (74) | (72) | ||||
Cash flows from (used in) financing activities | (4,016) | (2,743) | (1,909) | ||||
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 189 | (100) | (165) | ||||
CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR | 1,062 | 1,162 | 1,327 | ||||
CASH AND CASH EQUIVALENTS, END OF YEAR | 1,251 | 1,062 | 1,162 | ||||
SUPPLEMENTAL CASH FLOW INFORMATION | |||||||
Cash paid during the period for interest | 1,050 | 1,088 | 1,084 | ||||
Cash paid (refunds received) during the period for taxes | (330) | (482) | (103) | ||||
NON-CASH TRANSACTIONS DURING THE YEAR | |||||||
Non-cash capital contributions to subsidiaries | (3,607) | (1) | (596) | ||||
Non-cash dividends/returns of capital from subsidiaries | 4,582 | 470 | 1 | ||||
Treasury Stock shares issued for stock-based compensation programs | 0 | 0 | 197 | ||||
Acquisitions | |||||||
Net cash paid on acquisition | 0 | 0 | (1,758) | ||||
Acquisition | |||||||
Payments for the purchase of: | |||||||
Net cash paid on acquisition | 0 | 0 | 1,755 | ||||
Acquisitions | |||||||
Assets acquired | 0 | 0 | 2,425 | ||||
Liabilities assumed | 0 | 0 | 216 | ||||
Treasury Stock shares issued | 0 | 0 | 454 | ||||
Net cash paid on acquisition | 0 | 0 | 1,755 | ||||
Acquisition | Prudential Financial | |||||||
Payments for the purchase of: | |||||||
Net cash paid on acquisition | 0 | 0 | 1,758 | ||||
Acquisitions | |||||||
Assets acquired | 0 | 0 | 2,428 | ||||
Liabilities assumed | 0 | 0 | 216 | ||||
Treasury Stock shares issued | 0 | 0 | 454 | ||||
Net cash paid on acquisition | $ 0 | $ 0 | $ 1,758 | ||||
|
Schedule II - Condensed Financial Information of Registrant (Short and Long-Term Debt) (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Debt Instrument [Line Items] | |||
Short-term debt | $ 722,000 | $ 925,000 | |
Long-term debt | $ 18,622,000 | $ 19,718,000 | |
Commercial Paper, Weighted Average Interest Rate | 0.08% | 0.11% | |
Interest expense | $ 1,478,000 | $ 1,560,000 | $ 1,551,000 |
Senior notes | |||
Debt Instrument [Line Items] | |||
Short-term debt | 0 | 399,000 | |
Commercial Paper | |||
Debt Instrument [Line Items] | |||
Short-term debt | 420,000 | 380,000 | |
Current portion of long-term debt | |||
Debt Instrument [Line Items] | |||
Short-term debt | 697,000 | 1,027,000 | |
Prudential Financial | |||
Debt Instrument [Line Items] | |||
Short-term debt | 25,000 | 424,000 | |
Long-term debt | 17,673,000 | 18,561,000 | |
Interest expense | 1,088,000 | 1,157,000 | 1,161,000 |
Prudential Financial | Derivatives | |||
Debt Instrument [Line Items] | |||
Interest expense | 0 | 400 | $ 300 |
Prudential Financial | Commercial Paper | |||
Debt Instrument [Line Items] | |||
Short-term debt | $ 25,000 | $ 25,000 | |
Commercial Paper, Weighted Average Interest Rate | 0.12% | 0.12% | |
Prudential Financial | Current portion of long-term debt | |||
Debt Instrument [Line Items] | |||
Short-term debt | $ 0 | $ 399,000 | |
Prudential Financial | Junior subordinated debt | |||
Debt Instrument [Line Items] | |||
Long-term debt | $ 7,564,000 | 7,554,000 | |
Prudential Financial | Minimum | Junior subordinated debt | |||
Debt Instrument [Line Items] | |||
Interest Rate | 3.70% | ||
Prudential Financial | Maximum | Junior subordinated debt | |||
Debt Instrument [Line Items] | |||
Interest Rate | 5.88% | ||
Fixed rate | Prudential Financial | Senior notes | |||
Debt Instrument [Line Items] | |||
Long-term debt | $ 10,109,000 | $ 11,007,000 | |
Fixed rate | Prudential Financial | Minimum | Senior notes | |||
Debt Instrument [Line Items] | |||
Interest Rate | 1.50% | ||
Fixed rate | Prudential Financial | Maximum | Senior notes | |||
Debt Instrument [Line Items] | |||
Interest Rate | 6.63% |
Schedule II - Condensed Financial Information of Registrant (Contractual Maturities for Long-Term Debt) (Details) - USD ($) $ in Millions |
Dec. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Debt Instrument [Line Items] | ||
2023 | $ 203 | |
2024 | 324 | |
2025 | 345 | |
2026 | 500 | |
2027 and thereafter | 17,250 | |
Long-term debt | 18,622 | $ 19,718 |
Prudential Financial | ||
Debt Instrument [Line Items] | ||
2023 | 0 | |
2024 | 0 | |
2025 | 0 | |
2026 | 500 | |
2027 and thereafter | 17,173 | |
Long-term debt | $ 17,673 | $ 18,561 |
Schedule II - Condensed Financial Information of Registrant (Dividends and Returns of Capital) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Prudential of Korea | |||
Condensed Financial Statements, Captions [Line Items] | |||
Proceeds from Dividends Received | $ 1,627 | ||
Pramerica SGR | |||
Condensed Financial Statements, Captions [Line Items] | |||
Proceeds from Dividends Received | $ 450 | ||
The Prudential Life Insurance Company of Taiwan Inc. | |||
Condensed Financial Statements, Captions [Line Items] | |||
Proceeds from Dividends Received | 198 | ||
Prudential Financial | |||
Condensed Financial Statements, Captions [Line Items] | |||
Dividends or Returns of Capital received by Parent Company from Subsidiaries | 3,670 | 4,854 | $ 3,282 |
Prudential Annuities Holding Company | Prudential Financial | |||
Condensed Financial Statements, Captions [Line Items] | |||
Dividends or Returns of Capital received by Parent Company from Subsidiaries | 73 | 120 | 163 |
International Insurance and Investments Holding Companies | Prudential Financial | |||
Condensed Financial Statements, Captions [Line Items] | |||
Dividends or Returns of Capital received by Parent Company from Subsidiaries | 838 | 3,061 | 1,065 |
Prudential Insurance Company of America | Prudential Financial | |||
Condensed Financial Statements, Captions [Line Items] | |||
Dividends or Returns of Capital received by Parent Company from Subsidiaries | 1,100 | 500 | 600 |
PGIM Holding Company | Prudential Financial | |||
Condensed Financial Statements, Captions [Line Items] | |||
Dividends or Returns of Capital received by Parent Company from Subsidiaries | 540 | 399 | 462 |
Prudential Annuities Life Assurance Corporation | Prudential Financial | |||
Condensed Financial Statements, Captions [Line Items] | |||
Dividends or Returns of Capital received by Parent Company from Subsidiaries | 1,057 | 760 | 978 |
Other Holding Companies | Prudential Financial | |||
Condensed Financial Statements, Captions [Line Items] | |||
Dividends or Returns of Capital received by Parent Company from Subsidiaries | $ 62 | $ 14 | $ 14 |
Schedule II - Condensed Financial Information of Registrant (Narratives) (Details) € in Millions, $ in Millions, ₩ in Trillions |
1 Months Ended | 12 Months Ended | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Oct. 31, 2019
USD ($)
|
Dec. 31, 2021
USD ($)
|
Dec. 31, 2020
USD ($)
|
Dec. 31, 2019
USD ($)
|
Jun. 30, 2021
USD ($)
|
Jun. 30, 2021
TWD ($)
|
Mar. 31, 2021
USD ($)
|
Mar. 31, 2021
EUR (€)
|
Aug. 31, 2020
USD ($)
|
Aug. 31, 2020
KRW (₩)
|
Dec. 31, 2013
USD ($)
|
|
Schedule II Narrative [Line Items] | |||||||||||
Increase (Decrease) In Interest Expense, Derivative Instruments | $ 1,478,000,000 | $ 1,560,000,000 | $ 1,551,000,000 | ||||||||
Other Income | (2,951,000,000) | (1,950,000,000) | (3,262,000,000) | ||||||||
The Prudential Life Insurance Company of Korea, Ltd. | |||||||||||
Schedule II Narrative [Line Items] | |||||||||||
Cash considerations for sale of a business | $ 1,900,000,000 | ₩ 2.3 | |||||||||
Other Income | 800,000,000 | ||||||||||
Pramerica SGR | |||||||||||
Schedule II Narrative [Line Items] | |||||||||||
Cash considerations for sale of a business | $ 503,000,000 | € 427 | |||||||||
The Prudential Life Insurance Company of Taiwan Inc. | |||||||||||
Schedule II Narrative [Line Items] | |||||||||||
Cash considerations for sale of a business | $ 200,000,000 | $ 5,500 | |||||||||
The Prudential Life Insurance Company of Taiwan Inc. | Fair Value | |||||||||||
Schedule II Narrative [Line Items] | |||||||||||
Cash considerations for sale of a business | $ 80,000,000 | ||||||||||
Acquisition of Assurance IQ, Inc. | |||||||||||
Schedule II Narrative [Line Items] | |||||||||||
Transaction costs | $ 1,758,000,000 | ||||||||||
Equity interest issued | $ 454,000,000 | ||||||||||
Prudential Financial | |||||||||||
Schedule II Narrative [Line Items] | |||||||||||
Increase (Decrease) In Interest Expense, Derivative Instruments | 1,088,000,000 | 1,157,000,000 | 1,161,000,000 | ||||||||
Other Income | (18,000,000) | (110,000,000) | (21,000,000) | ||||||||
Derivatives | Prudential Financial | |||||||||||
Schedule II Narrative [Line Items] | |||||||||||
Increase (Decrease) In Interest Expense, Derivative Instruments | 0 | $ 400,000 | $ 300,000 | ||||||||
Commercial Paper | Prudential Financial | |||||||||||
Schedule II Narrative [Line Items] | |||||||||||
Guarantee obligation | 395,000,000 | ||||||||||
Investee Debt | Prudential Financial | |||||||||||
Schedule II Narrative [Line Items] | |||||||||||
Guarantee obligation | $ 4,000,000,000 | ||||||||||
Commitments to Extend Credit | Prudential Financial | |||||||||||
Schedule II Narrative [Line Items] | |||||||||||
Guarantee obligation | $ 500,000,000 |
Schedule III - Supplementary Insurance Information (Details) - USD ($) $ in Millions |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items] | |||
Deferred Policy Acquisition Costs | $ 18,192 | $ 19,027 | $ 19,912 |
Future Policy Benefits, Losses, Claims Expenses | 290,442 | 306,002 | 293,199 |
Unearned Premiums | 342 | 341 | 328 |
Other Policy Claims and Benefits Payable | 131,364 | 171,206 | 159,098 |
Premiums, Policy Charges and Fee Income | 40,771 | 37,169 | 40,180 |
Net Investment Income | 18,287 | 17,410 | 17,585 |
Benefits, Claims, Losses and Settlement Expenses | 44,814 | 41,222 | 43,974 |
Amortization of DAC | 2,097 | 2,221 | 2,332 |
Other Operating Expenses | 14,642 | 13,913 | 13,416 |
U.S. Businesses Division | |||
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items] | |||
Deferred Policy Acquisition Costs | 10,714 | 11,073 | 11,000 |
Future Policy Benefits, Losses, Claims Expenses | 108,185 | 116,327 | 105,126 |
Unearned Premiums | 254 | 246 | 242 |
Other Policy Claims and Benefits Payable | 59,991 | 67,758 | 62,104 |
Premiums, Policy Charges and Fee Income | 22,154 | 17,214 | 20,111 |
Net Investment Income | 7,923 | 7,165 | 7,130 |
Benefits, Claims, Losses and Settlement Expenses | 22,977 | 18,224 | 20,383 |
Amortization of DAC | 971 | 903 | 1,046 |
Other Operating Expenses | 6,821 | 5,715 | 5,274 |
Total PFI excluding Closed Block division | |||
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items] | |||
Deferred Policy Acquisition Costs | 18,004 | 18,818 | 19,677 |
Future Policy Benefits, Losses, Claims Expenses | 244,846 | 259,240 | 245,585 |
Unearned Premiums | 342 | 341 | 328 |
Other Policy Claims and Benefits Payable | 117,984 | 156,911 | 147,259 |
Premiums, Policy Charges and Fee Income | 38,982 | 35,187 | 37,973 |
Net Investment Income | 15,787 | 15,170 | 15,262 |
Benefits, Claims, Losses and Settlement Expenses | 39,339 | 36,789 | 38,751 |
Amortization of DAC | 2,076 | 2,195 | 2,303 |
Other Operating Expenses | 14,331 | 13,582 | 13,063 |
PGIM | PGIM | |||
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items] | |||
Deferred Policy Acquisition Costs | 0 | 0 | 0 |
Future Policy Benefits, Losses, Claims Expenses | 0 | 0 | 0 |
Unearned Premiums | 0 | 0 | 0 |
Other Policy Claims and Benefits Payable | 0 | 0 | 0 |
Premiums, Policy Charges and Fee Income | 0 | 0 | 0 |
Net Investment Income | 157 | 304 | 200 |
Benefits, Claims, Losses and Settlement Expenses | 0 | 0 | 0 |
Amortization of DAC | 6 | 8 | 6 |
Other Operating Expenses | 2,772 | 2,637 | 2,520 |
Retirement | U.S. Businesses Division | |||
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items] | |||
Deferred Policy Acquisition Costs | 43 | 39 | 35 |
Future Policy Benefits, Losses, Claims Expenses | 70,105 | 68,764 | 67,693 |
Unearned Premiums | 0 | 0 | 0 |
Other Policy Claims and Benefits Payable | 16,601 | 18,806 | 15,842 |
Premiums, Policy Charges and Fee Income | 10,830 | 6,297 | 9,256 |
Net Investment Income | 3,946 | 3,470 | 3,385 |
Benefits, Claims, Losses and Settlement Expenses | 12,899 | 8,429 | 11,481 |
Amortization of DAC | 14 | 8 | 19 |
Other Operating Expenses | 219 | 228 | 259 |
Group Insurance | U.S. Businesses Division | |||
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items] | |||
Deferred Policy Acquisition Costs | 146 | 149 | 156 |
Future Policy Benefits, Losses, Claims Expenses | 5,532 | 5,176 | 4,865 |
Unearned Premiums | 254 | 246 | 242 |
Other Policy Claims and Benefits Payable | 6,306 | 7,470 | 8,587 |
Premiums, Policy Charges and Fee Income | 5,580 | 5,171 | 5,024 |
Net Investment Income | 513 | 516 | 623 |
Benefits, Claims, Losses and Settlement Expenses | 5,654 | 4,870 | 4,544 |
Amortization of DAC | 5 | 8 | 7 |
Other Operating Expenses | 1,013 | 924 | 915 |
Individual Annuities | Held-for-sale | |||
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items] | |||
Deferred Policy Acquisition Costs | (1,097) | ||
Future Policy Benefits, Losses, Claims Expenses | (4,505) | ||
Other Policy Claims and Benefits Payable | (11,750) | ||
Individual Annuities | U.S. Businesses Division | |||
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items] | |||
Deferred Policy Acquisition Costs | 3,627 | 4,689 | 4,973 |
Future Policy Benefits, Losses, Claims Expenses | 11,040 | 21,325 | 15,151 |
Unearned Premiums | 0 | 0 | 0 |
Other Policy Claims and Benefits Payable | 7,028 | 12,383 | 9,529 |
Premiums, Policy Charges and Fee Income | 2,489 | 2,399 | 2,748 |
Net Investment Income | 929 | 898 | 854 |
Benefits, Claims, Losses and Settlement Expenses | 561 | 664 | 680 |
Amortization of DAC | 600 | 481 | 321 |
Other Operating Expenses | 1,811 | 1,771 | 1,869 |
Individual Life | U.S. Businesses Division | |||
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items] | |||
Deferred Policy Acquisition Costs | 6,898 | 6,196 | 5,836 |
Future Policy Benefits, Losses, Claims Expenses | 21,508 | 21,062 | 17,417 |
Unearned Premiums | 0 | 0 | 0 |
Other Policy Claims and Benefits Payable | 30,056 | 29,099 | 28,146 |
Premiums, Policy Charges and Fee Income | 3,255 | 3,347 | 3,083 |
Net Investment Income | 2,533 | 2,279 | 2,268 |
Benefits, Claims, Losses and Settlement Expenses | 3,863 | 4,261 | 3,678 |
Amortization of DAC | 352 | 406 | 699 |
Other Operating Expenses | 1,979 | 2,259 | 2,080 |
Assurance IQ | U.S. Businesses Division | |||
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items] | |||
Deferred Policy Acquisition Costs | 0 | 0 | 0 |
Future Policy Benefits, Losses, Claims Expenses | 0 | 0 | 0 |
Unearned Premiums | 0 | 0 | 0 |
Other Policy Claims and Benefits Payable | 0 | 0 | 0 |
Premiums, Policy Charges and Fee Income | 0 | 0 | 0 |
Net Investment Income | 2 | 2 | 0 |
Benefits, Claims, Losses and Settlement Expenses | 0 | 0 | 0 |
Amortization of DAC | 0 | 0 | 0 |
Other Operating Expenses | 1,799 | 533 | 151 |
International Businesses | International Businesses | |||
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items] | |||
Deferred Policy Acquisition Costs | 7,658 | 7,668 | 7,442 |
Future Policy Benefits, Losses, Claims Expenses | 127,574 | 128,682 | 117,298 |
Unearned Premiums | 87 | 94 | 86 |
Other Policy Claims and Benefits Payable | 49,545 | 51,476 | 49,599 |
Premiums, Policy Charges and Fee Income | 15,980 | 16,155 | 15,604 |
Net Investment Income | 5,400 | 4,973 | 4,916 |
Benefits, Claims, Losses and Settlement Expenses | 15,014 | 14,676 | 14,122 |
Amortization of DAC | 1,149 | 1,239 | 1,144 |
Other Operating Expenses | 2,725 | 2,809 | 2,861 |
Corporate and Other | |||
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items] | |||
Deferred Policy Acquisition Costs | (368) | 77 | 1,235 |
Future Policy Benefits, Losses, Claims Expenses | 9,087 | 14,231 | 23,161 |
Unearned Premiums | 1 | 1 | 0 |
Other Policy Claims and Benefits Payable | 8,448 | 37,677 | 35,556 |
Premiums, Policy Charges and Fee Income | 848 | 1,818 | 2,258 |
Net Investment Income | 2,307 | 2,728 | 3,016 |
Benefits, Claims, Losses and Settlement Expenses | 1,348 | 3,889 | 4,246 |
Amortization of DAC | (50) | 45 | 107 |
Other Operating Expenses | 2,013 | 2,421 | 2,408 |
Corporate and Other | Held-for-sale | |||
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items] | |||
Deferred Policy Acquisition Costs | (100) | ||
Future Policy Benefits, Losses, Claims Expenses | (157) | ||
Other Policy Claims and Benefits Payable | (28,164) | ||
Closed Block division | |||
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items] | |||
Deferred Policy Acquisition Costs | 188 | 209 | 235 |
Future Policy Benefits, Losses, Claims Expenses | 45,596 | 46,762 | 47,614 |
Unearned Premiums | 0 | 0 | 0 |
Other Policy Claims and Benefits Payable | 13,380 | 14,295 | 11,839 |
Premiums, Policy Charges and Fee Income | 1,789 | 1,982 | 2,207 |
Net Investment Income | 2,500 | 2,240 | 2,323 |
Benefits, Claims, Losses and Settlement Expenses | 5,475 | 4,433 | 5,223 |
Amortization of DAC | 21 | 26 | 29 |
Other Operating Expenses | $ 311 | $ 331 | $ 353 |
Schedule IV - Reinsurance (Details) - USD ($) $ in Millions |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Reinsurance Face Amount/Premiums for Insurance Companies, by Product Segment [Line Items] | |||
Gross Amount | $ 4,067,801 | $ 4,015,943 | $ 4,123,019 |
Ceded to Other Companies | 835,774 | 887,028 | 862,460 |
Assumed from Other Companies | 177,089 | 180,343 | 188,576 |
Net Amount | $ 3,409,116 | $ 3,309,258 | $ 3,449,135 |
Percentage of Amount Assumed to Net | 5.20% | 5.40% | 5.50% |
Gross Amount | $ 31,623 | $ 29,091 | $ 33,260 |
Ceded to Other Companies | 2,377 | 2,287 | 2,080 |
Assumed from Other Companies | 5,581 | 4,336 | 3,022 |
Premiums | $ 34,827 | $ 31,140 | $ 34,202 |
Percentage of Amount Assumed to Net | 16.00% | 13.90% | 8.80% |
Life Insurance | |||
Reinsurance Face Amount/Premiums for Insurance Companies, by Product Segment [Line Items] | |||
Gross Amount | $ 28,637 | $ 26,197 | $ 30,333 |
Ceded to Other Companies | 2,289 | 2,199 | 1,990 |
Assumed from Other Companies | 5,581 | 4,336 | 3,022 |
Premiums | $ 31,929 | $ 28,334 | $ 31,365 |
Percentage of Amount Assumed to Net | 17.50% | 15.30% | 9.60% |
Accident and Health Insurance | |||
Reinsurance Face Amount/Premiums for Insurance Companies, by Product Segment [Line Items] | |||
Gross Amount | $ 2,986 | $ 2,894 | $ 2,927 |
Ceded to Other Companies | 88 | 88 | 90 |
Assumed from Other Companies | 0 | 0 | 0 |
Premiums | $ 2,898 | $ 2,806 | $ 2,837 |
Percentage of Amount Assumed to Net | 0.00% | 0.00% | 0.00% |